docid,entityid,type
0,Early Phase Clinical Trial,Topic
0,Phase I Trials,Topic
0,Cytotoxic Agents,Topic
0,Bayesian Early Phase Trial Designs,Topic
0,Peter F. Thall,Author
1,Deep Historical Borrowing Framework To Prospectively And Simultaneously Synthesize Control Information In Confirmatory Clinical Trials With Multiple Endpoints,Paper
1,Tianyu Zhan,Author
1,Yiwang Zhou,Author
1,Ziqian Geng,Author
1,Yihua Gu,Author
1,Jian Kang,Author
1,Li Wang,Author
1,Xiaohong Huang,Author
1,Elizabeth H. Slate,Author
2,Pilot Studies Of Structured Treatment Interruptions (Sti) In Hiv Therapy,Topic
2,Hiv Therapy,Topic
2,Virologic Failure,Topic
2,Novel Hypothesis,Topic
2,Mathematical Model Of Hiv Within-Host Viral Dynamics,Topic
2,Nonlinear Parametric Resonance,Topic
2,Clinical Trial Data,Topic
2,Patient-Specific Resonant Spectra,Topic
2,Heterogeneity Of Patient Response,Topic
2,Immunologic And Virologic Parameters,Topic
2,Romulus Breban,Author
2,Sally Blower,Author
3,Preventive Vaccines,Topic
3,Hiv,Topic
3,Immune Response Markers,Topic
3,Two-Phase Sampling,Topic
3,Nonparametric Methodology,Topic
3,Txshift R Package,Topic
3,Nima S. Hejazi,Author
3,Mark J. Van Der Laan,Author
3,Holly E. Janes,Author
3,Peter B. Gilbert,Author
3,David C. Benkeser,Author
4,Phase 1-2 Designs,Topic
4,Generalized Phase 1-2 Design,Topic
4,Biological Outcome,Topic
4,Therapeutically Optimal Dose,Topic
4,Demo,Paper
5,Align,Topic
5,Nabeel Seedat,Author
5,Caterina Tozzi,Author
5,Andrea Hita Ardiaca,Author
5,Mihaela Van Der Schaar,Author
5,James Weatherall,Author
5,Adam Taylor,Author
5,Large Language Models,Topic
5,Anatomical Therapeutic Chemical,Topic
5,Medical Dictionary For Regulatory Activities,Topic
5,Clinical Trial Data,Topic
5,Drug Development,Topic
6,Ross M. Kedl,Author
6,Sars-Cov2 And Variants Of Concern,Topic
6,Moderna Phase Iii Clinical Trial,Topic
6,Longitudinal Evaluation Of T And B Cell Immunity,Topic
6,Covid-19 Vaccine Trial,Topic
6,An Immunological Autobiography,Paper
7,Sleep Monitoring Algorithm,Topic
7,Hao He,Author
7,Chao Li,Author
7,Wolfgang Ganglberger,Author
7,Kaileigh Gallagher,Author
7,Rumen Hristov,Author
7,Michail Ouroutzoglou,Author
7,Haoqi Sun,Author
7,Jimeng Sun,Author
7,Brandon Westover,Author
7,Dina Katabi,Author
8,Vaccine Efficacy Estimands,Topic
8,Mats Stensrud,Author
8,Daniel Nevo,Author
8,Uri Obolski,Author
8,Influenza Vaccine Trial,Topic
9,Panacea,Topic
9,Trialalign,Topic
9,Trialinstruct,Topic
9,Trialpanorama,Topic
9,Jiacheng Lin,Author
9,Hanwen Xu,Author
9,Zifeng Wang,Author
9,Sheng Wang,Author
9,Jimeng Sun,Author
10,Immune Correlates Of Protection,Topic
10,Correlates Of Risk,Topic
10,Controlled Vaccine Efficacy Curve,Topic
10,Controlled-Risk Curve,Topic
10,50% Neutralizing Antibody Titer,Topic
10,Virologically Confirmed Dengue,Topic
10,Peter B. Gilbert,Author
10,Youyi Fong,Author
10,Marco Carone,Author
10,Cyd14,Paper
10,Cyd15,Paper
11,Trial2Vec,Topic
11,Zifeng Wang,Author
11,Jimeng Sun,Author
11,Clinical Trials,Topic
11,Umls Knowledge Base,Topic
12,Clinical Trials,Topic
12,Drug Development,Topic
12,Trial Outcome Prediction,Topic
12,Spot,Paper
13,Drug Discovery And Development,Topic
13,Clinical Trials,Topic
13,Clinical Trial Outcome (Cto) Dataset,Paper
13,Chufan Gao,Author
13,Jathurshan Pradeepkumar,Author
13,Trisha Das,Author
13,Shivashankar Thati,Author
13,Jimeng Sun,Author
14,Matrix-Valued Time-Series Data Clustering,Topic
14,Low-Dimensional Embedding,Topic
14,Static Clinical Covariates,Topic
14,High-Dimensional Longitudinal Features,Topic
14,Sparse And Irregular Nature Of Sample Collection,Topic
14,Smoothed Probabilistic Parafac Model With Covariates (Spaco),Paper
15,World Health Organization,Topic
15,Hiv Treatment Monitoring,Topic
15,Viral Load Testing,Topic
15,Diagnostic Algorithm,Topic
15,Miriam Hospital Immunology Clinic,Topic
15,Tao Liu,Author
15,Joseph W. Hogan,Author
15,Lisa Wang,Author
15,Shangxuan Zhang,Author
15,Rami Kantor,Author
16,Clinical Trials,Topic
16,Nlp,Topic
16,Eligibility Classification,Topic
16,Phase 3 Cancer Trials,Topic
16,Phase 1 And 2 Cancer Trials,Topic
16,Heart Disease Trials,Topic
16,Type 2 Diabetes Trials,Topic
16,Observational Trials,Topic
16,Yumeng Yang,Author
16,Ashley Gilliam,Author
16,Ethan B Ludmir,Author
16,Kirk Roberts,Author
16,Annotated Eligibility Criteria Dataset,Topic
17,Trialsynth,Topic
17,Chufan Gao,Author
17,Mandis Beigi,Author
17,Afrah Shafquat,Author
17,Jacob Aptekar,Author
17,Jimeng Sun,Author
18,Natural Language Processing (Nlp) Of Clinical Trial Documents,Topic
18,Ct-Bert,Topic
18,Xiong Liu,Author
18,Greg L. Hersch,Author
18,Iya Khalil,Author
18,Murthy Devarakonda,Author
18,Clinical Trial Nlp,Topic
18,Named Entity Recognition (Ner) Models,Topic
18,Attention-Based Bilstm,Topic
18,Criteria2Query,Topic
19,Ctp-Llm,Topic
19,Phasetransition Dataset,Topic
19,Michael Reinisch,Author
19,Jianfeng He,Author
19,Chenxi Liao,Author
19,Sauleh Ahmad Siddiqui,Author
19,Bei Xiao,Author
19,Clinical Trial Outcome Prediction (Ctop),Topic
20,Machine Learning,Topic
20,Clinical Domain,Topic
20,Data Scarcity,Topic
20,Ethical Considerations,Topic
20,Clinical Trials,Topic
20,Privacy Regulations,Topic
20,High Costs,Topic
20,Extended Duration,Topic
20,Large Language Models,Topic
20,Retrieval-Reasoning Few-Shot Framework,Topic
20,Synthetic Clinical Trials,Topic
20,Binary Success/Failure Labels,Topic
20,Clinicaltrials.Gov,Topic
20,Synthetic Data,Topic
20,Pre-Trained Model,Topic
20,Binary Classifier,Topic
20,Trial Outcome Prediction,Topic
20,Zerui Xu,Author
20,Fang Wu,Author
20,Yuanyuan Zhang,Author
20,Yue Zhao,Author
20,Https://Anonymous.4Open.Science/R/Retrieval_Reasoning_Clinical_Trial_Generation-3Ec4,Paper
21,Clinical Trials,Topic
21,Drug Development,Topic
21,Phase I,Topic
21,Phase Ii,Topic
21,Phase Iii,Topic
21,Phase Iv,Topic
21,Challenges In Clinical Trials,Topic
21,Innovative Technologies,Topic
21,Emerging Therapies,Topic
21,Regulatory Reforms,Topic
21,Global Collaboration,Topic
21,From Bench To Bedside: A Review Of Clinical Trials In Drug Discovery And Development,Paper
21,Tianyang Wang,Author
21,Ming Liu,Author
21,Benji Peng,Author
21,Xinyuan Song,Author
21,Charles Zhang,Author
21,Xintian Sun,Author
21,Qian Niu,Author
21,Junyu Liu,Author
21,Silin Chen,Author
21,Keyu Chen,Author
21,Ming Li,Author
21,Pohsun Feng,Author
21,Ziqian Bi,Author
21,Yunze Wang,Author
21,Yichao Zhang,Author
21,Cheng Fei,Author
21,Lawrence Kq Yan,Author
22,Bayesian Adaptive Designs,Topic
22,Clinical Trials,Topic
22,Covid-19 Pandemic,Topic
22,Shirin Golchi,Author
22,Designing Bayesian Adaptive Trials,Topic
22,Efficient Estimation And Uncertainty Quantification,Topic
22,Sampling Distribution Of Bayesian Probability Statements,Topic
22,Ordinal Disease-Progression Scale Endpoint,Topic
22,Design Operating Characteristics,Topic
23,Artificial Intelligence For In Silico Clinical Trials: A Review,Paper
23,Zifeng Wang,Author
23,Chufan Gao,Author
23,Lucas M. Glass,Author
23,Jimeng Sun,Author
23,Clinical Simulation,Topic
23,Individualized Predictive Modeling,Topic
23,Computer-Aided Trial Design,Topic
24,Clinical Trial Outcome Prediction,Topic
24,Language Interaction Network (Lint),Topic
24,Chufan Gao,Author
24,Tianfan Fu,Author
24,Jimeng Sun,Author
24,Biologics,Topic
24,Small-Molecule Drugs,Topic
24,Roc-Auc Scores,Topic
24,Clinical Trials,Topic
24,Drug Portfolio,Topic
25,Rats,Topic
25,Random Dot Motion Task,Topic
25,Stimulus Integration,Topic
25,Trial Difficulty,Topic
25,Reward-Related Parameters,Topic
25,Pamela Reinagel,Author
25,Emily Mankin,Author
25,Adam Calhoun,Author
26,A Latent Gaussian Process Model With Application To Monitoring Clinical Trials,Paper
26,Yanxun Xu,Author
26,Yuan Ji,Author
26,Bayesian Trial Monitoring Scheme,Topic
26,Latent Gaussian Process,Topic
26,Clinical Trials,Topic
26,Repeated Outcomes,Topic
26,Binary Outcomes,Topic
26,Posterior Inference,Topic
26,Monte Carlo Algorithm,Topic
26,Simulation Studies,Topic
26,Case Study,Topic
27,Clinical Trial Site Matching With Improved Diversity Using Fair Policy Learning,Paper
27,Clinical Trials,Topic
27,Diversity And Inclusion,Topic
28,Ongoing Vaccine And Monoclonal Antibody Hiv Prevention Efficacy Trials And Considerations For Sequel Efficacy Trial Designs,Paper
28,Hvtn 702,Topic
28,Hvtn 705,Topic
28,Hvtn 703/Hptn 081,Topic
28,Hvtn 704/Hptn 085,Topic
28,Hiv-1 Infection,Topic
28,Sequel Efficacy Trials,Topic
28,Correlates Of Protection,Topic
28,Monoclonal Antibody Trials,Topic
29,Adaptive Immune System,Topic
29,B- And T-Cell Receptors,Topic
29,Human Immune System,Topic
29,Immunoengineers,Topic
29,Quantitative Resolution,Topic
29,Immunotherapy,Topic
29,Autoimmunity,Topic
29,Vaccine Design,Topic
29,Biopharmaceutical Drugs,Topic
29,Immunological Phenomena,Topic
29,Computational Immunology,Topic
29,Alex J. Brown,Author
29,Igor Snapkov,Author
29,Rahmad Akbar,Author
29,Enkelejda Miho,Author
29,Geir K. Sandve,Author
29,Victor Greiff,Author
30,Competing Risks Model,Topic
30,Non-Inferiority Clinical Trials,Topic
30,Parpia Et Al.,Author
30,Proportional Sub-Distribution Hazard Model,Topic
30,Sample Size Formula,Topic
30,Sub-Distribution Hazard Ratio,Topic
30,Weibull Distribution,Topic
30,Dong Han,Author
30,Zheng Chen,Author
30,Yawen Hou,Author
31,Clinical Trial Recommendations Using Semantics-Based Inductive Inference And Knowledge Graph Embeddings,Paper
31,Clinical Trial,Topic
31,Knowledge Graph,Topic
31,Neural Embeddings,Topic
31,Kge Methods,Topic
31,Clinical Trials Data,Topic
31,Clinicaltrials.Gov,Topic
31,Recommendations,Topic
32,Matchminer-Ai,Topic
32,Ethan Cerami,Author
32,Pavel Trukhanov,Author
32,Morgan A. Paul,Author
32,Michael J. Hassett,Author
32,Irbaz B. Riaz,Author
32,James Lindsay,Author
32,Emily Mallaber,Author
32,Harry Klein,Author
32,Gufran Gungor,Author
32,Matthew Galvin,Author
32,Stephen C. Van Nostrand,Author
32,Joyce Yu,Author
32,Tali Mazor,Author
32,Kenneth L. Kehl,Author
33,Clinical Trial Process,Topic
33,Interventional Clinical Trials,Topic
33,Trialdura,Paper
33,Ling Yue,Author
33,Jonathan Li,Author
33,Sixue Xing,Author
33,Md Zabirul Islam,Author
33,Bolun Xia,Author
33,Tianfan Fu,Author
33,Jintai Chen,Author
34,Clinical Trials,Topic
34,Adaptive Clinical Trials,Topic
34,Bayesian Framework,Topic
34,Gastroenteritis Vaccine Trial,Paper
34,James M. Mcgree,Author
34,Antony M. Overstall,Author
34,Mark Jones,Author
34,Robert K. Mahar,Author
35,Trial Level General Surrogate,Topic
35,Bayesian Non-Parametric Modeling,Topic
35,Pentavalent Rotavirus Vaccine,Topic
35,Erin E. Gabriel,Author
35,Michael J. Daniels,Author
35,M. Elizabeth Halloran,Author
36,Spx,Topic
36,Rheumatoid Arthritis Clinical Trial,Topic
36,Daniel E. Schwartz,Author
36,Yuan Ji,Author
36,Li Wang,Author
37,Adversity Index For Clinical Trials: An Inclusive Approach For Analysis Of Safety Data,Paper
37,Sharayu Paranjpe,Author
37,Anil Gore,Author
38,Adaptive Immune System,Topic
38,Classical Nonself-Centered Model,Topic
38,Self-Centered Model,Topic
38,Humoral Immunity,Topic
38,T Cells,Topic
38,B Cells,Topic
38,Antibodies,Topic
38,Interleukins,Topic
38,Non-Immune Self Cells,Topic
38,Foreign Antigens,Topic
38,Mistimm,Paper
38,Tam·s Szabados,Author
38,Csaba Kerepesi,Author
38,Tibor Bak·cs,Author
39,Relational Dynamics In Perception: Impacts On Trial-To-Trial Variation,Paper
40,Pytrial,Topic
40,Clinical Trials,Topic
40,Machine Learning,Topic
40,Zifeng Wang,Author
40,Brandon Theodorou,Author
40,Tianfan Fu,Author
40,Cao Xiao,Author
40,Jimeng Sun,Author
41,Artificial Intelligence,Topic
41,Deep Learning,Topic
41,Predictive Modelling,Topic
41,Natural Language Processing,Topic
41,Sydney Anuyah,Author
41,Mallika K Singh,Author
41,Hope Nyavor,Author
42,Clinical Trials,Topic
42,Artificial Intelligence,Topic
42,Ai-Ready Datasets,Topic
42,Trial Duration Prediction,Topic
42,Patient Dropout Rate Prediction,Topic
42,Serious Adverse Event Prediction,Topic
42,Mortality Rate Prediction,Topic
42,Trial Approval Outcome Prediction,Topic
42,Trial Failure Reason Prediction,Topic
42,Drug Dose Finding Prediction,Topic
42,Eligibility Criteria Design Prediction,Topic
42,Jintai Chen,Author
42,Yaojun Hu,Author
42,Yue Wang,Author
42,Yingzhou Lu,Author
42,Xu Cao,Author
42,Miao Lin,Author
42,Hongxia Xu,Author
42,Jian Wu,Author
42,Cao Xiao,Author
42,Jimeng Sun,Author
42,Lucas Glass,Author
42,Kexin Huang,Author
42,Marinka Zitnik,Author
42,Tianfan Fu,Author
42,Trialbench,Paper
43,Clinical Trials,Topic
43,Drug Development,Topic
43,Eligibility Criteria,Topic
43,Autotrial,Paper
44,Clinical Trials,Topic
44,Oncology,Topic
44,Drug Development,Topic
44,Large Language Models,Topic
44,Gpt-3.5,Author
44,Gpt-4,Author
44,Hint,Author
44,Shuyi Jin,Author
44,Lu Chen,Author
44,Hongru Ding,Author
44,Meijie Wang,Author
44,Lun Yu,Author
44,Clinicaltrials.Gov,Topic
44,Matthews Correlation Coefficient,Topic
44,Neoplasms,Topic
44,Predictive Tools,Topic
44,Trial Duration,Topic
44,Disease Categories,Topic
45,Motor-Evoked Potentials (Meps),Topic
45,Triple-Variability-Source Model,Topic
45,Logarithmic Logistic Function,Topic
45,Ke Ma,Author
45,Siwei Liu,Author
45,Mengjie Qin,Author
45,Stefan Goetz,Author
45,Bayesian Information Criterion,Topic
45,Cortical Excitability,Topic
45,Neuromodulation Effects,Topic
45,Input-Output (Io) Curves,Topic
45,Background Noise,Topic
45,Physiological Variability,Topic
45,Neural Recruitment Curve,Topic
45,Clinical And Experimental Neuroscience,Topic
46,Clinical Trial Result Prediction,Topic
46,Evidence-Based Medicine,Topic
46,Pico,Topic
46,Evidence Integration Dataset,Topic
46,Biobert,Topic
46,Covid-19 Clinical Trials,Topic
46,Qiao Jin,Author
46,Chuanqi Tan,Author
46,Mosha Chen,Author
46,Xiaozhong Liu,Author
46,Songfang Huang,Author
47,Leaf Clinical Trials Corpus,Topic
47,Nicholas J Dobbins,Author
47,Tony Mullen,Author
47,Ozlem Uzuner,Author
47,Meliha Yetisgen,Author
48,Clinical Trials,Topic
48,Drug Discovery Process,Topic
48,Clinical Model Development,Topic
48,Protocol Design,Topic
48,Quantum Computing,Topic
48,Clinical Trial Simulations,Topic
48,Site Selection,Topic
48,Cohort Identification,Topic
48,Hakan Doga,Author
48,M. Emre Sahin,Author
48,Joao Bettencourt-Silva,Author
48,Anh Pham,Author
48,Eunyoung Kim,Author
48,Alan Andress,Author
48,Sudhir Saxena,Author
48,Aritra Bose,Author
48,Laxmi Parida,Author
48,Jan Lukas Robertus,Author
48,Hideaki Kawaguchi,Author
48,Radwa Soliman,Author
48,Daniel Blankenberg,Author
48,Towards Quantum Computing For Clinical Trial Design And Optimization: A Perspective On New Opportunities And Challenges,Paper
49,Adaptive Cohort Size Determination Method For Bayesian Optimal Interval Phase I/Ii Design To Shorten Clinical Trial Duration,Paper
49,Masahiro Kojima,Author
49,Dose Optimization In Oncology,Topic
50,Large Language Models,Topic
50,Multi-Agent Systems,Topic
50,Clinical Agent System,Topic
50,Gpt-4,Topic
50,Least-To-Most,Topic
50,React Reasoning Technology,Topic
50,Clinical Trial Outcome Prediction,Topic
50,Ling Yue,Author
50,Sixue Xing,Author
50,Jintai Chen,Author
50,Tianfan Fu,Author
50,Clinicalagent,Paper
51,Predictive Directions For Individualized Treatment Selection In Clinical Trials,Paper
51,Debashis Ghosh,Author
51,Youngjoo Cho,Author
51,Clinical Trials,Topic
51,Colorectal Cancer,Topic
52,Clinical Trials Ontology Engineering With Large Language Models,Paper
52,Clinical Trial Information Management,Topic
52,Large Language Models,Topic
53,Conditional Approval,Topic
53,Harmonic Mean Chi-Squared Test,Topic
53,Post-Market Clinical Trial,Topic
53,Two-Trials Rule,Topic
53,Fisher'S Criterion,Topic
53,Stouffer'S Method,Topic
53,Manja Deforth,Author
53,Charlotte Micheloud,Author
53,Kit C Roes,Author
53,Leonhard Held,Author
53,Simulation Study,Topic
54,Medical Digital Twins,Topic
54,Immune System,Topic
54,February 2023 Meeting,Topic
54,Reinhard Laubenbacher,Author
54,Fred Adler,Author
54,Gary An,Author
54,Filippo Castiglione,Author
54,Stephen Eubank,Author
54,Luis L. Fonseca,Author
54,James Glazier,Author
54,Tomas Helikar,Author
54,Marti Jett-Tilton,Author
54,Denise Kirschner,Author
54,Paul Macklin,Author
54,Borna Mehrad,Author
54,Beth Moore,Author
54,Virginia Pasour,Author
54,Ilya Shmulevich,Author
54,Amber Smith,Author
54,Isabel Voigt,Author
54,Thomas E. Yankeelov,Author
54,Tjalf Ziemssen,Author
55,Machine Learning,Topic
55,Healthcare,Topic
55,Fairness In Machine Learning,Topic
55,Clinical Trials,Topic
55,Isabel Chien,Author
55,Nina Deliu,Author
55,Richard E. Turner,Author
55,Adrian Weller,Author
55,Sofia S. Villar,Author
55,Niki Kilbertus,Author
56,Clinical Trials,Topic
56,Medical Device Validation,Topic
56,Model-Based Pre-Clinical Trial Framework,Paper
56,Statistical Model Checking,Topic
56,Physiological Models,Topic
56,Implantable Cardioverter Defibrillators,Topic
57,Drug Development,Topic
57,Phase Ii / Iii Cancer Clinical Trials,Topic
57,Seamless Clinical Trials,Topic
57,Master Protocols,Topic
57,Abigail Burdon,Author
57,Thomas Jaki,Author
57,Xijin Chen,Author
57,Pavel Mozgunov,Author
57,Haiyan Zheng,Author
57,Richard Baird,Author
58,Hint,Topic
58,Clinical Trials,Topic
58,Tianfan Fu,Author
58,Kexin Huang,Author
58,Cao Xiao,Author
58,Lucas M. Glass,Author
58,Jimeng Sun,Author
59,Text Classification Of Cancer Clinical Trial Eligibility Criteria,Paper
59,Cancer Trials,Topic
60,Clinical Trial Active Learning,Paper
60,Zoe Fowler,Author
60,Kiran Kokilepersaud,Author
60,Mohit Prabhushankar,Author
60,Ghassan Alregib,Author
60,Active Learning,Topic
60,Clinical Trials,Topic
60,Optical Coherence Tomography,Topic
60,Prospective Active Learning,Topic
60,Retrospective Active Learning,Topic
61,Accept,Topic
61,Clinical Trials,Topic
61,Michelle N. Clements,Author
61,Ian R. White,Author
61,Andrew J. Copas,Author
61,Victoria Cornelius,Author
61,Suzie Cro,Author
61,David T Dunn,Author
61,Matteo Quartagno,Author
61,Rebecca M. Turner,Author
61,Conor D. Tweed,Author
61,A. Sarah Walker,Author
62,Statistical Methods For Clinical Trial Design,Topic
62,Adequately Powered Study,Topic
62,Statistical Significance,Topic
62,Clinical Interpretability,Topic
62,Calibrate Randomised Trial Designs,Topic
62,Strong Clinical Equipoise Imbalance,Topic
62,Least Informed Population Distribution,Topic
62,Pre-Trial Odds Of The Design Hypotheses,Topic
62,Primary Analysis Outcomes,Topic
62,Phase 3 Superiority Designs,Topic
62,95% Power At 5% False Positive Rate,Topic
62,Robustly Powered Study,Topic
62,Clinical Development Plans,Topic
62,Randomised Phase 2 And Phase 3 Studies,Topic
62,Oncology Clinical Endpoints,Topic
62,Positive Outcomes,Topic
62,Negative Primary Outcome,Topic
62,Large Sample Sizes,Topic
62,Clinically Meaningful Effect Sizes,Topic
62,Equipoise Calibration,Topic
62,Fabio Rigat,Author
63,Clinical Trials With A Hybrid Control Arm,Topic
63,Joanna Harton,Author
63,Brian Segal,Author
63,Ronac Mamtani,Author
63,Nandita Mitra,Author
63,Rebecca Hubbard,Author
63,Combining Real-World And Randomized Control Trial Data Using Data-Adaptive Weighting Via The On-Trial Score,Paper
64,Clinical Trial,Topic
64,Clinidigest,Topic
64,Renee D. White,Author
64,Tristan Peng,Author
64,Pann Sripitak,Author
64,Alexander Rosenberg Johansen,Author
64,Michael Snyder,Author
65,Clinical Trial Matching,Topic
65,Large Language Models,Topic
65,Oncollm,Topic
65,Shashi Kant Gupta,Author
65,Aditya Basu,Author
65,Mauro Nievas,Author
65,Jerrin Thomas,Author
65,Nathan Wolfrath,Author
65,Adhitya Ramamurthi,Author
65,Bradley Taylor,Author
65,Anai N. Kothari,Author
65,Regina Schwind,Author
65,Therica M. Miller,Author
65,Sorena Nadaf-Rahrov,Author
65,Yanshan Wang,Author
65,Hrituraj Singh,Author
65,Real-World Ehrs,Topic
65,Clinical Notes,Topic
65,Clinical Trials,Topic
65,Cancer Center In The United States,Topic
66,Clinical Trials,Topic
66,Medical Research,Topic
66,New Treatments,Topic
66,Virtual Clinical Trials,Topic
66,Patient Safety,Topic
66,Cost Reduction,Topic
66,Scientific Knowledge,Topic
66,Electronic Health Records,Topic
66,Clinical Trial Outcome Prediction,Topic
66,Large Language Models,Topic
66,Twin-Gpt,Paper
67,Covid-19 Epidemiological Models,Topic
67,Immune Response Model,Paper
67,Immunological Assay,Topic
67,Sars-Cov-2 Vaccines,Topic
68,Phase Iii Randomized Clinical Trials,Topic
68,New Medical Products,Topic
68,Statistical Principles,Topic
68,Statistical Hypothesis Testing,Topic
68,Frequentist Paradigm,Topic
68,Bayesian Perspectives,Topic
68,Effect Sizes,Topic
68,Clinicaltrials.Gov,Topic
68,Changyu Shen,Author
68,Xiaochun Li,Author
68,Towards More Flexible False Positive Control In Phase Iii Randomized Clinical Trials,Paper
69,A Machine Learning Approach For Recruitment Prediction In Clinical Trial Design,Paper
70,Multi-Arm Clinical Trials,Topic
70,Michael J Grayling,Author
70,James Ms Wason,Author
70,Web Application For Sample Size Calculation,Paper
71,Bevacizumab Colorectal Cancer Treatment Trials,Topic
71,Qian Li,Author
71,Zhe He,Author
71,Yi Guo,Author
71,Hansi Zhang,Author
71,Thomas J George Jr,Author
71,William Hogan,Author
71,Neil Charness,Author
71,Jiang Bian,Author
71,Cptg Scores,Topic
71,Serious Adverse Events,Topic
71,Oneflorida Consortium,Topic
71,Zero-Inflated Negative Binomial Model,Topic
71,Patient-Level Data,Topic
71,Electronic Health Records,Topic
71,Real-World Clinical Practice,Topic
71,Clinical Outcomes,Topic
71,Patient-Trial Generalizability,Topic
72,Bayesian Sequential Clinical Trial Designs,Paper
72,Tianjian Zhou,Author
72,Yuan Ji,Author
73,"Multi-Arm, Multi-Stage (Mams) Clinical Trial Designs",Topic
73,Adaptive Designs (Ad),Topic
73,Multi-Arm (Ma) Designs,Topic
73,Factorial Clinical Trials Designs,Topic
73,Factorial Adaptive Multi-Arm Multi-Stage (Fast) Designs,Topic
73,Jonathan Beall,Author
73,Jordan Elm,Author
73,Mathew W Semler,Author
73,Li Wang,Author
73,Todd Rice,Author
73,Hooman Kamel,Author
73,William Mack,Author
73,Akshitkumar M. Mistry,Author
74,Monitoring Fidelity Of Online Reinforcement Learning Algorithms In Clinical Trials,Paper
74,Anna L. Trella,Author
74,Kelly W. Zhang,Author
74,Inbal Nahum-Shani,Author
74,Vivek Shetty,Author
74,Iris Yan,Author
74,Finale Doshi-Velez,Author
74,Susan A. Murphy,Author
74,Oralytics Clinical Trial,Topic
75,Augmented Binary Method For Basket Trials (Abba),Topic
75,Svetlana Cherlin,Author
75,James M S Wason,Author
75,Clinical Trials,Topic
75,Bayesian Hierarchical Modelling,Topic
75,Rheumatology,Topic
75,Basket Trials,Topic
75,Treatment Effect,Topic
75,Subtrials,Topic
75,Log Odds Ratio,Topic
75,High Density Interval,Topic
76,On An Approach To Bayesian Sample Sizing In Clinical Trials,Paper
76,Robb J. Muirhead,Author
76,Adina I. Soaita,Author
76,Bayesian Sample Size Determination,Topic
76,Clinical Trials,Topic
76,Posterior Probability,Topic
76,Marginal Distribution Of The Data,Topic
76,Superiority Of A New Drug Over A Control,Topic
77,Assurance For Clinical Trial Design With Normally Distributed Outcomes: Eliciting Uncertainty About Variances,Paper
77,Ziyad A. Alhussain,Author
77,Jeremy E. Oakley,Author
77,Clinical Trial Planning,Topic
77,Elicitation Method,Topic
78,Clinical Trials,Topic
78,Deep Learning Frameworks,Topic
78,Fair Patient-Trial Matching Framework,Topic
78,Chia-Yuan Chang,Author
78,Jiayi Yuan,Author
78,Sirui Ding,Author
78,Qiaoyu Tan,Author
78,Kai Zhang,Author
78,Xiaoqian Jiang,Author
78,Xia Hu,Author
78,Na Zou,Author
79,Clinical Trials,Topic
79,Part 11 Of Title 21 Of The Code Of Federal Regulations,Topic
79,Iso 27789,Topic
79,Context-Aware Smart Devices,Topic
79,Wearable Iot Devices,Topic
79,Electronic Data Capture (Edc),Topic
79,Clinical Data Management Systems (Cdms),Topic
79,Healthcare Digital Threat Landscape,Topic
79,Sensor Fusion,Topic
79,Scrybe,Paper
80,Local Explanations For Clinical Search Engine Results,Paper
81,Clinical Trials,Topic
81,Evidence-Based Medicine,Topic
81,Meta-Analyses,Topic
81,Clinical Practice Guidelines,Topic
81,Data Science,Topic
81,Big Data,Topic
81,Visual Analytics,Topic
81,Trial Registries,Topic
81,Platform For Analyzing Safety Events,Paper
81,Ontological Model,Topic
81,Adverse Drug Events (Ade),Topic
81,Pain Treatments,Topic
81,Flower Glyph,Topic
81,Drug Safety Experts,Author
82,Phase-3 Clinical Trials,Topic
82,Trend-Adaptive Design With A Synthetic-Intervention-Based Estimator,Topic
82,Secrets,Topic
82,Sayeri Lala,Author
82,Niraj K. Jha,Author
82,Tad,Topic
83,Biomarker Clustering Of Colorectal Cancer Data To Complement Clinical Classification,Paper
83,Chris Roadknight,Author
83,Uwe Aickelin,Author
83,Alex Ladas,Author
83,Daniele Soria,Author
83,John Scholefield,Author
83,Lindy Durrant,Author
84,Basket Trials,Topic
84,Baskexact,Paper
84,R Package,Topic
84,Empirical Bayes Techniques,Topic
84,Single-Stage Designs,Topic
84,Two-Stage Designs,Topic
85,Improving Patient Pre-Screening For Clinical Trials: Assisting Physicians With Large Language Models,Paper
85,Instructgpt,Topic
85,Large Language Models,Topic
85,Clinical Trials,Topic
85,Physicians,Topic
86,Virtual Clinical Trial,Topic
86,Tobias K. S. Ritschel,Author
86,Asbj¯rn Thode Reenberg,Author
86,John Bagterp J¯rgensen,Author
87,Confirmatory Clinical Trials,Topic
87,Experimental Treatments,Topic
87,Control,Topic
87,Standard Of Care,Topic
87,Placebo,Topic
87,Randomised Controlled Trials,Topic
87,Hypothesis Testing Methods,Topic
87,Error Rate,Topic
87,Power,Topic
87,Bonferroni Adjustment,Topic
87,Multi-Stage Adaptive Trials,Topic
87,Clinical Trials Setting,Topic
87,Thomas Burnett,Author
87,Thomas Jaki,Author
88,Inspire Project,Topic
88,T. Friede,Author
88,M. Posch,Author
88,S. Zohar,Author
88,C. Alberti,Author
88,N. Benda,Author
88,E. Comets,Author
88,S. Day,Author
88,A. Dmitrenko,Author
88,A. Graf,Author
88,B. K. G¸nhan,Author
88,S. W. Hee,Author
88,F. Lentz,Author
88,J. Madan,Author
88,F. Miller,Author
88,T. Ondra,Author
88,M. Pearce,Author
88,C. Rˆver,Author
88,A. Tournazi,Author
88,S. Unkel,Author
88,M. Ursino,Author
88,G. Wassmer,Author
88,N. Stallard,Author
89,Selection Induced Contrast Estimate (Sice) Effect,Topic
89,Junshui Ma,Author
89,Daniel J. Holder,Author
89,Defining The Inclusion/Exclusion (I/E) Criteria Of A Trial,Paper
90,Covid-19,Topic
90,Sars-Cov-2,Topic
90,World Health Organization,Author
90,Tobias M¸tze,Author
90,Tim Friede,Author
90,Data Monitoring Committee,Topic
90,Clinical Trials,Topic
90,Vaccination,Topic
90,Diagnostics,Topic
90,Mortality,Topic
90,Platform Trials,Topic
90,Adaptive Designs,Topic
90,Simulation Study,Topic
91,Coping With Information Loss And The Use Of Auxiliary Sources Of Data: A Report From The Niss Ingram Olkin Forum Series On Unplanned Clinical Trial Disruptions,Paper
91,Silvia Calderazzo,Author
91,Sergey Tarima,Author
91,Carissa Reid,Author
91,Nancy Flournoy,Author
91,Tim Friede,Author
91,Nancy Geller,Author
91,James L Rosenberger,Author
91,Nigel Stallard,Author
91,Moreno Ursino,Author
91,Marc Vandemeulebroecke,Author
91,Kelly Van Lancker,Author
91,Sarah Zohar,Author
91,Sars-Cov-2,Topic
91,Covid-19,Topic
91,Primary Care Pediatrics Learning Activity Nutrition (Plan) Study,Topic
92,Oncology Clinical Trial Design Planning Based On A Multistate Model That Jointly Models Progression-Free And Overall Survival Endpoints,Paper
92,Alexandra Erdmann,Author
92,Jan Beyersmann,Author
92,Kaspar Rufibach,Author
92,Overall Survival (Os),Topic
92,Progression-Free Survival (Pfs),Topic
92,Multistate Model,Topic
92,Non-Small-Cell Lung Cancer,Topic
92,Clinical Trial Design,Topic
92,R Package,Topic
93,Hierarchical Bayesian Inference,Topic
93,Cortical Hierarchies,Topic
93,Anatomical Accounts Of Cortical Organisation,Topic
93,Andreea O. Diaconescu,Author
93,Vladimir Litvak,Author
93,Christoph Mathys,Author
93,Lars Kasper,Author
93,Karl J. Friston,Author
93,Klaas E. Stephan,Author
93,Neuroimaging And Electrophysiological Data,Topic
93,Social Learning Task,Topic
93,Disorders Of Perception,Topic
93,Schizophrenia,Topic
93,Autism,Topic
94,Alzheimer'S Disease,Topic
94,Bayesian Neural Networks,Topic
94,Quantitative Eeg Markers,Topic
94,Wolfgang Fruehwirt,Author
94,Adam D. Cobb,Author
94,Martin Mairhofer,Author
94,Leonard Weydemann,Author
94,Heinrich Garn,Author
94,Reinhold Schmidt,Author
94,Thomas Benke,Author
94,Peter Dal-Bianco,Author
94,Gerhard Ransmayr,Author
94,Markus Waser,Author
94,Dieter Grossegger,Author
94,Pengfei Zhang,Author
94,Georg Dorffner,Author
94,Stephen Roberts,Author
95,Clinical Trials,Topic
95,Randomization,Topic
95,Treatment Efficacies,Topic
95,Post Hoc Studies,Topic
95,Supervised-Learning Methods,Topic
95,Reinforcement-Learning Methods,Topic
95,Multi-Arm Bandits,Topic
95,Contextual-Bandit-Based Online Treatment Optimization Algorithm,Topic
95,International Stroke Trial,Topic
95,Yogatheesan Varatharajah,Author
95,Brent Berry,Author
95,Sanmi Koyejo,Author
95,Ravishankar Iyer,Author
96,C3T-Budget,Topic
96,Clinical Trials,Topic
96,Hyun-Suk Lee,Author
96,Cong Shen,Author
96,James Jordon,Author
96,Mihaela Van Der Schaar,Author
97,Clinical Trial,Topic
97,Treatment Effect,Topic
97,Helicobacter Pylori Infection,Topic
97,Xinyu Li,Author
97,Wang Miao,Author
97,Fang Lu,Author
97,Xiao-Hua Zhou,Author
97,External Control Data,Topic
97,Doubly Robust Estimator,Topic
97,Locally Efficient Estimator,Topic
97,Average Treatment Effect,Topic
97,Simulation,Topic
97,Combination Treatment,Topic
97,Triple Therapy,Topic
98,Causal Inference,Topic
98,Estimand Framework,Topic
98,Target Trial Framework,Topic
98,Patient-Level Clinical Trials,Topic
98,Observational Data,Topic
98,Long-Term Outcomes,Topic
98,Metastatic Non-Small Cell Lung Cancer,Topic
98,Letizia Polito,Author
98,Qixing Liang,Author
98,Navdeep Pal,Author
98,Philani Mpofu,Author
98,Ahmed Sawas,Author
98,Olivier Humblet,Author
98,Kaspar Rufibach,Author
98,Dominik Heinzmann,Author
99,Scaling Clinical Trial Matching Using Large Language Models: A Case Study In Oncology,Paper
99,Cliff Wong,Author
99,Sheng Zhang,Author
99,Yu Gu,Author
99,Christine Moung,Author
99,Jacob Abel,Author
99,Naoto Usuyama,Author
99,Roshanthi Weerasinghe,Author
99,Brian Piening,Author
99,Tristan Naumann,Author
99,Carlo Bifulco,Author
99,Hoifung Poon,Author
100,Pragmatic Clinical Trials,Topic
100,Health Interventions,Topic
100,Negative Spillover,Topic
100,Control Group,Topic
100,Treatment Effect,Topic
100,Social Welfare Interventions,Topic
100,Public Health Interventions,Topic
100,Patient Navigation,Topic
100,Ai-Based Physiological Alarms,Topic
100,Elective Induction Of Labor,Topic
100,Sean Mann,Author
100,Negative Spillover: A Potential Source Of Bias In Pragmatic Clinical Trials,Paper
101,Incorporating External Data For Analyzing Randomized Clinical Trials: A Transfer Learning Approach,Paper
101,Randomized Clinical Trials,Topic
101,Transfer Learning,Topic
102,A Conservative Approach To Leveraging External Evidence For Effective Clinical Trial Design,Paper
102,Fabio Rigat,Author
102,Clinical Trial Design,Topic
102,Bayesian Trial Design,Topic
102,Clinical Equipoise,Topic
102,Phase Ii Study Sample Size,Topic
102,Group Sequential Confirmatory Designs,Topic
103,"Leveraging Historical Data For High-Dimensional Regression Adjustment, A Composite Covariate Approach",Paper
103,Samuel Branders,Author
103,Alvaro Pereira,Author
103,Guillaume Bernard,Author
103,Marie Ernst,Author
103,Adelin Albert,Author
104,Clinical Trials,Topic
104,Electronic Health Records,Topic
104,Chatgpt,Topic
104,Georgios Peikos,Author
104,Symeon Symeonidis,Author
104,Pranav Kasela,Author
104,Gabriella Pasi,Author
105,Multivariate Rank-Based Analysis Of Multiple Endpoints In Clinical Trials: A Global Test Approach,Paper
105,Kexuan Li,Author
105,Lingli Yang,Author
105,Shaofei Zhao,Author
105,Susie Sinks,Author
105,Luan Lin,Author
105,Peng Sun,Author
106,Team Ielab,Topic
106,Csiro,Topic
106,The University Of Queensland,Topic
106,2023 Trec Clinical Trials Track,Topic
106,Chatgpt,Topic
106,Pubmedbert,Topic
106,Gpt-4,Topic
106,Shengyao Zhuang,Author
106,Bevan Koopman,Author
106,Guido Zuccon,Author
107,"Tables, Figures, And Listings (Tfls)",Topic
107,Clinical Trial Data,Topic
107,Large Language Models (Llms),Topic
107,Prompt Engineering,Topic
107,Few-Shot Transfer Learning,Topic
107,Public Clinical Trial Data In Adam Format,Topic
107,Clinical Trial Tfl Generation Agent,Topic
107,Yumeng Yang,Author
107,Peter Krusche,Author
107,Kristyn Pantoja,Author
107,Cheng Shi,Author
107,Ethan Ludmir,Author
107,Kirk Roberts,Author
107,Gen Zhu,Author
108,Comprehensive Cancer Center,Topic
108,Clinical Trials,Topic
108,Oncologists,Topic
108,Most Responsible Physicians,Topic
108,Patient Movements,Topic
108,Social Network Analysis,Topic
108,Community Detection Algorithms,Topic
108,Girvan-Newman,Topic
108,Louvain,Topic
108,Author'S Algorithm,Topic
108,Epidemiological Research,Topic
108,Centrality In Collaboration: A Novel Algorithm For Social Partitioning Gradients In Community Detection For Multiple Oncology Clinical Trial Enrollments,Paper
108,Benjamin Smith,Author
108,Tyler Pittman,Author
108,Wei Xu,Author
109,Clinical Trials,Topic
109,Binary Outcomes,Topic
109,Minge Xie,Author
109,Regina Y. Liu,Author
109,C. V. Damaraju,Author
109,William H. Olson,Author
109,Discrepant Posterior Phenomenon,Topic
109,Bayesian Approach,Topic
109,Confidence Distribution,Topic
110,Sample Size Calculation For Clinical Trials,Topic
110,Rmtld,Topic
110,Weibull Distribution,Topic
110,Xiang Geng,Author
110,Zhaojin Li,Author
110,Chengfeng Zhang,Author
110,Yanjie Wang,Author
110,Haoning Shen,Author
110,Zhiheng Huang,Author
110,Yawen Hou,Author
110,Zheng Chen,Author
111,Bayesian Predictive Probabilities Of Success (Ppos),Topic
111,Interim Trial Data,Topic
111,Simulation-Based Approach,Topic
111,Clinical Trials,Topic
111,Competing Event Data,Topic
111,Joint Distribution Of Time To Event And Event Type,Topic
111,I-Spy Covid Phase Ii Trial,Paper
111,Sthlm3 Prostate Cancer Diagnostic Trial,Paper
111,Nct04488081,Topic
111,Isrctn84445406,Topic
112,Electronic Health Records,Topic
112,Patient Information,Topic
112,Structured Data,Topic
112,Unstructured Data,Topic
112,Clinical Applications,Topic
112,Eligibility Criteria,Topic
112,Chronic Lymphocytic Leukemia,Topic
112,Prostate Cancer,Topic
112,Temporal Reasoning,Topic
112,Information Integration,Topic
112,Preethi Raghavan,Author
112,James L. Chen,Author
112,Eric Fosler-Lussier,Author
112,Albert M. Lai,Author
113,Failures In Phase 3 Clinical Trials,Topic
113,Drug Development In Oncology,Topic
113,Responders To An Oncology Treatment,Topic
113,Deep-Learning Derived Digital Pathology Scores,Topic
113,Immunohistochemistry Images,Topic
113,Tumor Biopsy Samples,Topic
113,Phase 1 Non-Small Cell Lung Cancer Clinical Trial,Paper
113,Auc Of Roc Curve,Topic
113,Auc Of Precision-Recall Curve,Topic
113,Tumor Proportion Score (Tps),Topic
113,Independent Testing Set Of Patients,Topic
113,Deep-Learning Derived Score,Topic
113,Qi Tang,Author
113,Vardaan Kishore Kumar,Author
114,Clinical Trials,Topic
114,Large Language Models,Topic
114,Clinical Trial Protocols,Topic
114,Nigel Markey,Author
114,Ilyass El-Mansouri,Author
114,Gaetan Rensonnet,Author
114,Casper Van Langen,Author
114,Christoph Meier,Author
114,Retrieval-Augmented Generation,Topic
114,Document Quality Improvement,Topic
115,Information Theory,Topic
115,Shannon Entropy,Topic
115,Kullback-Leibler Divergence,Topic
115,Mutual Information,Topic
115,Robin A. A. Ince,Author
115,Stefano Panzeri,Author
115,Simon R. Schultz,Author
115,Estimation Of Information-Theoretic Quantities,Paper
115,Applications Of Information-Theoretic Quantities In Neuroscience,Paper
116,Inverse Probability Weighting (Ipsw),Topic
116,Population Average Treatment Effect,Topic
116,Missing Data,Topic
116,Multiple Imputation (Mi),Topic
116,Frequent Hemodialysis Network (Fhn) Daily Trial,Topic
116,United States Renal Stage System (Usrds),Topic
116,Albee Y. Ling,Author
116,Maria E. Montez-Rath,Author
116,Kris Kapphahn,Author
116,Manisha Desai,Author
117,Response-Adaptive Randomization,Topic
117,Sequential Multiple Assignment Randomized Trials,Topic
117,Thompson Sampling,Topic
117,Peter Norwood,Author
117,Marie Davidian,Author
117,Eric Laber,Author
117,Adaptive Randomization Methods For Sequential Multiple Assignment Randomized Trials (Smarts) Via Thompson Sampling,Paper
118,Single-Cell Technologies,Topic
118,Immune Cell-Types,Topic
118,Machine Learning Approaches,Topic
118,Immunological Summaries,Topic
118,Cytocoset,Topic
118,Chi-Jane Chen,Author
118,Haidong Yi,Author
118,Natalie Stanley,Author
118,Clinical Covariates,Topic
118,Clinical Outcome,Topic
118,Per-Sample Featurizations,Topic
118,Loss Function,Topic
118,Triplet Term,Topic
118,Embedding Results,Topic
119,Utilising High-Dimensional Data In Randomised Clinical Trials: A Review Of Methods And Practice,Paper
119,Svetlana Cherlin,Author
119,Theophile Bigirumurame,Author
119,Michael J Grayling,Author
119,JÈrÈmie Nsengimana,Author
119,Luke Ouma,Author
119,Aida Santaolalla,Author
119,Fang Wan,Author
119,S Faye Williamson,Author
119,James M S Wason,Author
120,How Biomedical Papers Accumulated Their Clinical Citations: A Large-Scale Retrospective Analysis Based On Pubmed,Paper
120,Xin Li,Author
120,Xuli Tang,Author
120,Wei Lu,Author
121,Ibex,Topic
121,Ibex Knowledge-Base,Topic
121,Open Science,Topic
121,Andrea J. Radtke,Author
121,Ifeanyichukwu Anidi,Author
121,Leanne Arakkal,Author
121,Armando Arroyo-Mejias,Author
121,Rebecca T. Beuschel,Author
121,Katy Borner,Author
121,Colin J. Chu,Author
121,Beatrice Clark,Author
121,Menna R. Clatworthy,Author
121,Jake Colautti,Author
121,Joshua Croteau,Author
121,Saven Denha,Author
121,Rose Dever,Author
121,Walderez O. Dutra,Author
121,Sonja Fritzsche,Author
121,Spencer Fullam,Author
121,Michael Y. Gerner,Author
121,Anita Gola,Author
121,Kenneth J. Gollob,Author
121,Jonathan M. Hernandez,Author
121,Jyh Liang Hor,Author
121,Hiroshi Ichise,Author
121,Zhixin Jing,Author
121,Danny Jonigk,Author
121,Evelyn Kandov,Author
121,Wolfgang Kastenmueller,Author
121,Joshua F. E. Koenig,Author
121,Aanandita Kothurkar,Author
121,Alexandra Y. Kreins,Author
121,Ian Lamborn,Author
121,Yuri Lin,Author
121,Katia Luciano Pereira Morais,Author
121,Aleksandra Lunich,Author
121,Jean C. S. Luz,Author
121,Ryan B. Macdonald,Author
121,Chen Makranz,Author
121,Vivien I. Maltez,Author
121,Ryan V. Moriaty,Author
121,Juan M. Ocampo-Godinez,Author
121,Vitoria M. Olyntho,Author
121,Kartika Padhan,Author
121,Kirsten Remmert,Author
121,Nathan Richoz,Author
121,Edward C. Schrom,Author
121,Wanjing Shang,Author
121,Lihong Shi,Author
121,Rochelle M. Shih,Author
121,Emily Speranza,Author
121,Salome Stierli,Author
121,Sarah A. Teichmann,Author
121,Tibor Z. Veres,Author
121,Megan Vierhout,Author
121,Brianna T. Wachter,Author
121,Adam K. Wade-Vallance,Author
121,Margaret Williams,Author
121,Nathan Zangger,Author
121,Ronald N. Germain,Author
121,Ziv Yaniv,Author
122,Neural Latent Aligner,Topic
122,Cheol Jun Cho,Author
122,Edward F. Chang,Author
122,Gopala K. Anumanchipalli,Author
122,Intracranial Electrocorticography,Topic
122,Complex Human Behaviors,Topic
122,Neural Representations,Topic
122,Time Warping Model,Topic
122,Behavioral Coherence,Topic
122,Cross-Trial Consistent Representations,Topic
123,Neurocave,Topic
123,Connectomes,Topic
123,Clinical Neuroscience,Topic
123,Neuropsychiatric Disorders,Topic
123,Johnson J. G. Keiriz,Author
123,Liang Zhan,Author
123,Morris Chukhman,Author
123,Olu Ajilore,Author
123,Alex D. Leow,Author
123,Angus G. Forbes,Author
124,Pranab K. Sen,Author
124,Sequential Nonparametrics,Topic
124,Semiparametrics,Topic
124,Clinical Trials,Topic
124,Tze Leung Lai,Author
124,Zheng Su,Author
124,Nonparametric Inference,Topic
124,Semiparametric Inference,Topic
124,Computational Methods,Topic
124,Time-Sequential Clinical Trials,Topic
124,Survival Endpoints,Topic
125,Generalized Likelihood Ratio Statistics And Uncertainty Adjustments In Efficient Adaptive Design Of Clinical Trials,Paper
126,Toronto Metropolitan University,Topic
126,Trec Clinical Trials Track 2023,Topic
126,Aritra Kumar Lahiri,Author
126,Emrul Hasan,Author
126,Qinmin Vivian Hu,Author
126,Cherie Ding,Author
126,Team - V-Torontomu,Topic
127,Interim Analyses In Clinical Trials,Topic
127,Elina Asikanius,Author
127,Benjamin Hofner,Author
127,Lisa V. Hampson,Author
127,Gernot Wassmer,Author
127,Christopher Jennison,Author
127,Tobias Mielke,Author
127,Cornelia Ursula Kunz,Author
127,Kaspar Rufibach,Author
128,Drug Combinations In Clinical Trials,Topic
128,Phase I Clinical Trials,Topic
128,Phase Ii Clinical Trials,Topic
128,Two-Stage Designs,Topic
128,New Two-Stage Design,Topic
128,JosÈ L. JimÈnez,Author
128,Sungjin Kim,Author
128,Mourad Tighiouart,Author
129,On The Relevance Of Prognostic Information For Clinical Trials: A Theoretical Quantification,Paper
129,Bayesian Information Borrowing,Topic
129,Propensity Score Methods,Topic
129,Stratification,Topic
129,Covariate Adjustment,Topic
129,Prognostic Score,Topic
129,Machine Learning,Topic
129,Sample Size Reduction Formula,Topic
129,Historical Data,Topic
129,Randomised Clinical Trials,Topic
130,Cancer Clinical Trials,Topic
130,Large Language Models,Topic
130,Gpt4,Topic
130,Clinicaltrials.Gov,Topic
130,Mingye Gao,Author
130,Aman Varshney,Author
130,Shan Chen,Author
130,Vikram Goddla,Author
130,Jack Gallifant,Author
130,Patrick Doyle,Author
130,Claire Novack,Author
130,Maeve Dillon-Martin,Author
130,Teresia Perkins,Author
130,Xinrong Correia,Author
130,Erik Duhaime,Author
130,Howard Isenstein,Author
130,Elad Sharon,Author
130,Lisa Soleymani Lehmann,Author
130,David Kozono,Author
130,Brian Anthony,Author
130,Dmitriy Dligach,Author
130,Danielle S. Bitterman,Author
131,Treement,Topic
131,Brandon Theodorou,Author
131,Cao Xiao,Author
131,Jimeng Sun,Author
131,Clinical Trials,Topic
131,Machine Learning Models,Topic
131,Patient Electronic Health Records,Topic
132,Deep Learning,Topic
132,Neuroscience,Topic
132,Louis Fabrice Tshimanga,Author
132,Manfredo Atzori,Author
132,Federico Del Pup,Author
132,Maurizio Corbetta,Author
132,Biomedical Data Analysis,Topic
132,Neuroinformatic Toolboxes,Topic
133,Clinical Trial Outcome Prediction,Topic
133,Lifted,Topic
133,Wenhao Zheng,Author
133,Liaoyaqi Wang,Author
133,Dongshen Peng,Author
133,Hongxia Xu,Author
133,Yun Li,Author
133,Hongtu Zhu,Author
133,Tianfan Fu,Author
133,Huaxiu Yao,Author
134,Zero-Shot Multi-Lingual Speaker Verification In Clinical Trials,Paper
134,Ali Akram,Author
134,Marija Stanojevic,Author
134,Malikeh Ehghaghi,Author
134,Jekaterina Novikova,Author
134,Clinical Trials,Topic
134,Speaker Verification,Topic
134,Cognitive And Mental Health Disorders,Topic
134,Titanet,Topic
134,Ecapa-Tdnn,Topic
134,Speakernet,Topic
134,Speech Data,Topic
134,European Languages,Topic
134,Arabic,Topic
135,Linkedct,Topic
135,Oktie Hassanzadeh,Author
135,Anastasios Kementsietsidis,Author
135,Lipyeow Lim,Author
135,Renee J. Miller,Author
135,Min Wang,Author
136,Individualized Treatment Rules (Itrs),Topic
136,Patient Care,Topic
136,Randomized Clinical Trials,Topic
136,Cost-Effective Estimation Method,Topic
136,Active Learning Perspective,Topic
136,Most Informative Patients,Topic
136,Simulation Studies,Topic
136,Real-Data Examples,Topic
136,Risk Bounds,Topic
136,Stanislav Minsker,Author
136,Ying-Qi Zhao,Author
136,Guang Cheng,Author
136,Active Clinical Trials For Personalized Medicine,Paper
137,A Blockchain Framework For Managing And Monitoring Data In Multi-Site Clinical Trials,Paper
138,Phase I Dose-Finding Trials,Topic
138,Maximum Tolerated Dose (Mtd),Topic
138,Safe Efficacy Exploration Dose Allocation (Seeda),Topic
138,Cumulative Efficacy,Topic
138,Toxicity Violation Probability,Topic
138,Sample Efficiency,Topic
138,Seeda-Plateau Algorithm,Topic
138,Cong Shen,Author
138,Zhiyang Wang,Author
138,Sofia S. Villar,Author
138,Mihaela Van Der Schaar,Author
139,Clinical Trials,Topic
139,New Treatments,Topic
139,Medical Knowledge,Topic
139,Intervention Effectiveness Prediction Method,Topic
139,Pubmed Articles,Topic
139,Evidence Sentences,Topic
139,Bert-Based Classifier,Topic
139,Georgios Katsimpras,Author
139,Georgios Paliouras,Author
139,Dataset Of Clinical Trials,Topic
139,Short Informative Summaries,Topic
140,Pragmatic Clinical Trials In The Rubric Of Structural Causal Models,Paper
140,Explanatory Studies,Topic
140,Observational Studies,Topic
140,Structural Causal Model (Scm),Topic
140,Do-Calculus,Topic
140,Pragmatic Clinical Trials (Pct),Topic
140,Generalized Representation Of Pct,Topic
140,Analysis Techniques In Pct,Topic
140,Experimental Dataset From A Pragmatic Clinical Trial,Topic
141,Robust Detection Of Covariate-Treatment Interactions In Clinical Trials,Paper
142,Alzheimer'S Disease,Topic
142,Cognitive Decline,Topic
142,Mild Cognitive Impairment,Topic
142,Neda Shafiee,Author
142,Mahsa Dadar,Author
142,Simon Ducharme,Author
142,D. Louis Collins,Author
142,Prognostic Model,Topic
142,Clinical Trials,Topic
142,Mri-Based Features,Topic
142,Baseline Cognitive Scores,Topic
142,Cdr-Sb,Topic
142,2-Year Follow-Up,Topic
142,3-Year Follow-Up,Topic
142,Treatment Effect,Topic
142,Cohort Enrichment Tool,Topic
143,Incorporating External Data Into The Analysis Of Clinical Trials Via Bayesian Additive Regression Trees,Paper
143,Bayesian Additive Regression Trees,Topic
143,Clinical Trials,Topic
144,High-Performance Uncertainty Quantification In Large-Scale Virtual Clinical Trials Of Closed-Loop Diabetes Treatment,Paper
144,Asbj¯rn Thode Reenberg,Author
144,Tobias K. S. Ritschel,Author
144,Bernd Dammann,Author
144,John Bagterp J¯rgensen,Author
145,Clinical Trial Aggregation Program,Topic
145,Frantiöek Bartoö,Author
145,Eric-Jan Wagenmakers,Author
145,Christiaan H. Vinkers,Author
145,Kees P. J. Braun,Author
145,Willem M. Otte,Author
145,Randomized Controlled Trial,Topic
146,Modern Randomization Methods In Clinical Trials,Topic
146,Adaptive Randomization Methods,Topic
146,Mathematical Programming,Topic
146,Energy Distance Measure,Topic
146,Alan R. Vazquez,Author
146,Weng Kee Wong,Author
146,Small Clinical Trials,Topic
146,R Codes,Topic
146,Two-Arm Clinical Trials,Topic
146,Real Data,Topic
147,Clinical Trials Protocol Authoring Using Llms,Paper
147,Gpt-4,Topic
147,Clinical Trial Protocols,Topic
148,Design Of Bayesian Clinical Trials With Clustered Data And Multiple Endpoints,Paper
148,Luke Hagar,Author
148,Shirin Golchi,Author
148,Bayesian Clinical Trials,Topic
148,Operating Characteristics,Topic
148,Monte Carlo Simulation,Topic
148,Clustered Data,Topic
148,Sample Sizes,Topic
148,Posterior Probabilities,Topic
148,Simulation Variability,Topic
148,Current Clinical Trial,Topic
149,Choriocapillaris Flow Signal Impairment In Sorsby Fundus Dystrophy,Paper
149,Sorsby Fundus Dystrophy,Topic
149,Oct-A,Topic
149,Choriocapillaris,Topic
150,Estimands In Hematologic Oncology Trials,Paper
150,Ich E9 Guideline,Topic
150,Hematological Malignancies,Topic
151,Clinical Trial,Topic
151,Survival Outcome,Topic
151,Interim Analysis,Topic
151,New Treatment,Topic
151,Placebo,Topic
151,Kaplan-Meier Curves,Topic
151,Marianne A Jonker,Author
151,Steven Teerenstra,Author
152,Active Learning For Developing Personalized Treatment,Paper
152,Kun Deng,Author
152,Joelle Pineau,Author
152,Susan A. Murphy,Author
152,Personalized Treatment,Topic
152,Active Learning Techniques,Topic
152,Clinical Trials,Topic
152,Minimax Bandit Model,Topic
152,Computational Challenges,Topic
152,Simulated Data,Topic
152,Depressed Individuals,Topic
153,Medical Research,Topic
153,Randomized Clinical Trials,Topic
153,Hypothesis Testing,Topic
153,Bayesians,Topic
153,Subjective Expected Utility,Topic
153,Treatment Response,Topic
153,Frequentist Statistical Decision Theory,Topic
153,Wald (1950),Author
153,Hoeffding (1963),Author
153,Charles F. Manski,Author
153,Aleksey Tetenov,Author
154,Covid-19 Clinical Trial Design,Topic
154,Deep Learning Approach,Topic
154,Att-Bilstm,Topic
154,Ontology-Based Method,Topic
154,Benchmark Dataset,Topic
154,Xiong Liu,Author
154,Luca A. Finelli,Author
154,Greg L. Hersch,Author
154,Iya Khalil,Author
155,Clinical Trial Enrollment Success Prediction,Topic
155,Ling Yue,Author
155,Sixue Xing,Author
155,Jintai Chen,Author
155,Tianfan Fu,Author
156,Trail Making Test,Topic
156,Ignacio Linari,Author
156,Gustavo Juantorena,Author
156,Agustin IbaÒez,Author
156,Agustin Petroni,Author
156,Juan E. Kamienkowski,Author
156,Executive Functions,Topic
156,Ctmt,Topic
156,Traditional Tmt,Topic
157,Multinomial Sequential Unbiased Estimators,Topic
157,Binomial Samples,Topic
157,Multidimensional Random Walks,Topic
157,Multinomial Random Walks,Topic
157,Clinical Trials,Topic
157,Boundary Crossing Random Walks,Topic
157,Enrico Bibbona,Author
157,Alessandro Rubba,Author
158,Multivariate Bayesian Logistic Regression For Analysis Of Clinical Trial Safety Issues,Paper
158,Bradley W. Mcevoy,Author
158,Ram C. Tiwari,Author
159,Multivariate Bayesian Logistic Regression For Analysis Of Clinical Trial Safety Issues,Paper
159,Don Berry,Author
160,"Rejoinder To ""Multivariate Bayesian Logistic Regression For Analysis Of Clinical Trial Safety Issues""",Paper
161,N2C2 2018 Challenge Task 1,Topic
161,Generic Rule-Based Natural Language Pipeline,Topic
161,Jianlin Shi,Author
161,Kevin Graves,Author
161,John F. Hurdle,Author
162,Disruptions In Clinical Trials,Topic
162,Uschner Et Al. (2023),Paper
163,Alzheimer'S Disease,Topic
163,Fda,Topic
163,Aducanumab,Topic
163,Lecanemab,Topic
163,Donanemab,Topic
163,Leonardino A. Digma Md,Author
163,Joseph R. Winer Phd,Author
163,Michael D. Greicius Md,Author
163,Anti-Amyloid Therapies,Topic
164,App-Based N-Of-1 Trials,Topic
164,Ivana Malenica,Author
164,Yongyi Guo,Author
164,Kyra Gan,Author
164,Stefan Konigorski,Author
164,Potential Outcomes Framework,Topic
164,Valid Confidence Sequences,Topic
164,Anytime-Valid Inference,Topic
164,Treatment Effects,Topic
164,N-Of-1 Trials,Topic
165,21St Century Cures Act,Topic
165,Bayesian Statistics,Topic
165,Historical Data,Topic
165,Bayesian Meta-Analytic Approach,Topic
165,Time-To-Event Endpoints,Topic
165,Piecewise Exponential Data,Topic
165,Satrajit Roychoudhury,Author
165,Beat Neuenschwander,Author
165,Ovarian Carcinoma Trial,Topic
165,Non-Small-Cell Cancer Trial,Topic
166,Trialstreamer,Topic
166,Benjamin E. Nye,Author
166,Ani Nenkova,Author
166,Iain J. Marshall,Author
166,Byron C. Wallace,Author
166,Medline,Topic
166,Randomized Controlled Trials,Topic
166,Evidence Maps,Topic
167,Clinical Evidence Engine,Topic
167,Bojian Hou,Author
167,Hao Zhang,Author
167,Gur Ladizhinsky,Author
167,Stephen Yang,Author
167,Volodymyr Kuleshov,Author
167,Fei Wang,Author
167,Qian Yang,Author
167,Clinical Decision Support Systems,Topic
167,Clinical Biobert,Topic
167,Cardiovascular Diseases,Topic
167,Autism,Topic
167,Cancer,Topic
167,Clinical Trial Reports,Topic
167,Povidone Iodine-Alcohol,Topic
167,Risks Of Catheter Infection,Topic
167,Adult Patients In Intensive Care Unit Who Require Arterial Catheters,Topic
168,Compose,Topic
168,Junyi Gao,Author
168,Cao Xiao,Author
168,Lucas M. Glass,Author
168,Jimeng Sun,Author
168,Clinical Trials,Topic
169,Doctor2Vec,Topic
169,Siddharth Biswal,Author
169,Cao Xiao,Author
169,Lucas M. Glass,Author
169,Elizabeth Milkovits,Author
169,Jimeng Sun,Author
169,Ehrs,Topic
170,Covid-19 Vaccine Efficacy Trials,Topic
170,David Benkeser,Author
170,Iv·n DÌaz,Author
170,Jialu Ran,Author
170,Sars-Cov2 Pandemic,Topic
170,Preventive Vaccines,Topic
170,Immunological Marker,Topic
170,Case-Cohort Sampling Design,Topic
170,Mediation Parameters,Topic
170,Natural Mediation Effects,Topic
170,Correlates Of Protection,Topic
171,Flow Cytometry Analysis,Topic
172,Transient Recurring Phenomena,Topic
172,Neuroscience,Topic
172,Meteorology,Topic
172,Time Inhomogenous Vector Autoregressive Models (Var),Topic
172,Multi-Trial Data,Topic
172,Akaike Information Criteria (Aic),Topic
172,Bayesian Information Criteria (Bic),Topic
172,Multi-Trial Bic,Topic
172,Kaidi Shao,Author
172,Nikos K. Logothetis,Author
172,Michel Besserve,Author
173,Statistical Neuroscience In The Single Trial Limit,Paper
173,Neural Activity,Topic
173,Neural Variability,Topic
173,Cognitive And Behavioral State,Topic
173,Statistical Modeling,Topic
173,Neural Circuits,Topic
174,Adaptive Designs For Clinical Trials,Topic
174,Thomas Burnett,Author
174,Pavel Mozgunov,Author
174,Philip Pallmann,Author
174,Sofia S. Villar,Author
174,Graham M. Wheeler,Author
174,Thomas Jaki,Author
174,Adding Flexibility To Clinical Trial Designs: An Example-Based Guide To The Practical Use Of Adaptive Designs,Paper
175,Covid-19 Pandemic,Topic
175,Clinical Trials,Topic
175,Ich E9(R1) Addendum,Topic
175,Estimands,Topic
175,Sensitivity Analyses,Topic
175,Niss Ingram Olkin Forum Series,Topic
175,Kelly Van Lancker,Author
175,Sergey Tarima,Author
175,Jonathan Bartlett,Author
175,Madeline Bauer,Author
175,Bharani Bharani-Dharan,Author
175,Frank Bretz,Author
175,Nancy Flournoy,Author
175,Hege Michiels,Author
175,Camila Olarte Parra,Author
175,James L Rosenberger,Author
175,Suzie Cro,Author
175,Stylized Trial,Topic
175,Unforeseen Disruptions,Topic
176,Decentralized Clinical Trials In The Era Of Real-World Evidence: A Statistical Perspective,Paper
176,Jie Chen,Author
176,Junrui Di,Author
176,Nadia Daizadeh,Author
176,Ying Lu,Author
176,Hongwei Wang,Author
176,Yuan-Li Shen,Author
176,Jennifer Kirk,Author
176,Frank W. Rockhold,Author
176,Herbert Pang,Author
176,Jing Zhao,Author
176,Weili He,Author
176,Andrew Potter,Author
176,Hana Lee,Author
177,Information Extraction Approach To Prescreen Heart Failure Patients For Clinical Trials,Paper
177,Abhishek Kalyan Adupa,Author
177,Ravi Prakash Garg,Author
177,Jessica Corona-Cox,Author
177,Sanjiv. J. Shah,Author
177,Siddhartha R. Jonnalagadda,Author
178,Automating The Compilation Of Potential Core-Outcomes For Clinical Trials,Paper
178,Natural Language Processing,Topic
178,Biobert,Topic
178,Cosine Similarity,Topic
178,Jaccard Similarity,Topic
179,Hecix-Kg,Topic
179,Clinicaltrials.Gov,Topic
179,Hetionet,Topic
179,Hecix,Topic
179,Prerana Sanjay Kulkarni,Author
179,Muskaan Jain,Author
179,Disha Sheshanarayana,Author
179,Srinivasan Parthiban,Author
180,Diabetes,Topic
180,Uva/Padova Type 1 Diabetes Simulator,Topic
180,Uva Virtual Lab (Uvlab),Topic
180,Distribution-Based Population Selection (Dsps),Topic
180,Insulin Degludec (Ideg),Topic
180,Mohammadreza Ganji,Author
180,Anas El Fathi,Author
180,Chiara Fabris,Author
180,Dayu Lv,Author
180,Boris Kovatchev,Author
180,Marc Breton,Author
181,Synrl: Aligning Synthetic Clinical Trial Data With Human-Preferred Clinical Endpoints Using Reinforcement Learning,Paper
181,Trisha Das,Author
181,Zifeng Wang,Author
181,Afrah Shafquat,Author
181,Mandis Beigi,Author
181,Jason Mezey,Author
181,Jimeng Sun,Author
181,Synthetic Patient Data,Topic
181,Reinforcement Learning,Topic
181,Clinical Trials,Topic
181,Data Generation,Topic
181,Privacy Concerns,Topic
182,Gan-Biobert,Topic
182,Joshua J Myszewski,Author
182,Emily Klossowski,Author
182,Patrick Meyer,Author
182,Kristin Bevil,Author
182,Lisa Klesius,Author
182,Kristopher M Schroeder,Author
182,Clinical Trial Abstracts,Topic
183,Clinical Trial Registries,Topic
183,Systematic Reviews,Topic
183,Type 2 Diabetes,Topic
183,Didi Surian,Author
183,Adam G. Dunn,Author
183,Liat Orenstein,Author
183,Rabia Bashir,Author
183,Enrico Coiera,Author
183,Florence T. Bourgeois,Author
183,Matrix Factorisation Approach,Topic
183,Document Similarity Approach,Topic
183,Clinicaltrials.Gov,Topic
183,Cochrane Database Of Systematic Reviews,Topic
183,Trial Registrations,Topic
183,Semi-Automated Pipeline,Topic
184,Ebola Research,Topic
184,David Fajardo-Ortiz,Author
184,Josw Ortega-Sanchez-De-Tagle,Author
184,Victor-M Castano,Author
184,Ebola Virus Proteins,Topic
184,Vaccines,Topic
184,Clinical-Epidemiology Research,Topic
184,Basic Research,Topic
184,Patent Families Network,Topic
184,Us Army,Topic
184,Research Fronts,Topic
185,Phase Ii Trials,Topic
185,Statistical Significance,Topic
185,Clinical Relevance,Topic
185,Dual-Criterion Designs,Topic
185,Satrajit Roychoudhury,Author
185,Nicolas Scheuer,Author
185,Beat Neuenschwander,Author
186,National Research Council,Topic
186,Impi Trial,Topic
186,Cd4 Count Data,Topic
186,Abdul-Karim Iddrisu,Author
186,Abukari Alhassan,Author
186,Primary Analysis Method,Topic
186,Sensitivity Analysis,Topic
186,Maximum Likelihood Method,Topic
186,Multiple Imputation Method,Topic
186,Complete Case Analysis,Topic
186,Simple Imputation Methods,Topic
186,Treatment Effect,Topic
186,Effectiveness Estimand Hypothesis,Topic
187,Clinical Trials,Topic
187,Blinding,Topic
187,Placebo Effects,Topic
187,Instrumental Variables,Topic
187,Treatment Effects,Topic
187,Elias Chaibub Neto,Author
187,Randomized Clinical Trials,Topic
187,Confounders,Topic
187,Psychological Encouragement Messages,Topic
187,Unblinded Trials,Topic
187,Blinded Studies,Topic
188,Sars-Cov-2,Topic
188,Covid-19,Topic
188,World Health Organization,Author
188,Clinical Trials,Topic
188,Cornelia Ursula Kunz,Author
188,Silke Jˆrgens,Author
188,Frank Bretz,Author
188,Nigel Stallard,Author
188,Kelly Van Lancker,Author
188,Dong Xi,Author
188,Sarah Zohar,Author
188,Christoph Gerlinger,Author
188,Tim Friede,Author
188,Adaptive Designs,Topic
188,Bayesian Techniques,Topic
188,R Shiny App,Topic
188,Data Monitoring Committees,Topic
189,Clinical Trials,Topic
189,Adaptive Designs,Topic
189,Multi-Arm Phase Ii Clinical Trials,Topic
189,Treatment Allocation,Topic
189,Fixed Block Randomization,Topic
189,Posterior Distribution,Topic
189,Model Parameter,Topic
189,Treatment Arms,Topic
189,Pre-Defined Criteria,Topic
189,Joint Posterior,Topic
189,Treatment,Topic
189,Participant Accrual,Topic
189,Adaptive Treatment Selection,Topic
189,Early Stopping,Topic
189,Binary Outcomes,Topic
189,Time-To-Event Data,Topic
189,Elja Arjas,Author
189,Dario Gasbarra,Author
189,Adaptive Treatment Allocation And Selection In Multi-Arm Clinical Trials: A Bayesian Perspective,Paper
190,Trialr,Topic
190,Kristian Brock,Author
190,Continual Reassessment Method,Topic
190,Efftox,Topic
190,Augmented Binary Method,Topic
191,Finding Translational Biomarkers,Topic
191,Personalized Medicine,Topic
191,Yichen Lu,Author
191,Jane Fridlyand,Author
191,Tiffany Tang,Author
191,Ting Qi,Author
191,Noah Simon,Author
191,Ning Leng,Author
191,Leave-One-Study-Out (Loso),Topic
191,K-Fold,Topic
191,Clinical Trials,Topic
191,Biomarkers,Topic
191,Cross-Validation (Cv) Methods,Topic
191,Effect Size,Topic
191,Evaluation Metrics,Topic
191,Statistical Methods,Topic
191,The Future Will Be Different Than Today: Model Evaluation Considerations When Developing Translational Clinical Biomarker,Paper
192,Natural Language Processing Team,Topic
192,Australian Research Council Industrial Transformation Training Centre,Topic
192,Cognitive Computing In Medical Technologies,Topic
192,Trec 2021 Clinical Trials Track,Topic
192,Thinh Hung Truong,Author
192,Yulia Otmakhova,Author
192,Rahmad Mahendra,Author
192,Timothy Baldwin,Author
192,Jey Han Lau,Author
192,Trevor Cohn,Author
192,Lawrence Cavedon,Author
192,Damiano Spina,Author
192,Karin Verspoor,Author
193,A Matching Design For Augmenting A Randomized Clinical Trial With External Control,Paper
193,U.S. Food And Drug Administration,Author
194,Large Language Models For Healthcare Data Augmentation: An Example On Patient-Trial Matching,Paper
195,Bayesian Statistics,Topic
195,Medical Science,Topic
195,Healthcare Companies,Topic
195,Regulators,Topic
195,Stakeholders,Topic
195,New Treatments,Topic
195,Interventions,Topic
195,Medical Procedures,Topic
195,Classical Framework,Topic
195,Prior Information,Topic
195,Quality External Data,Topic
195,Historical Data,Topic
195,Co-Data,Topic
195,Regulatory Submissions,Topic
195,Decision-Making,Topic
195,Clinical Trials,Topic
195,Frequentist Trials,Topic
195,Frequentist Operating Characteristics,Topic
195,Frequentist Type I Error Rate,Topic
195,Power,Topic
195,Bayesian Sample Size Determination,Topic
195,Se Yoon Lee,Author
195,Using Bayesian Statistics In Confirmatory Clinical Trials In The Regulatory Setting,Paper
196,Randomized Clinical Trials,Topic
196,Longitudinal Rank-Sum Test,Topic
196,Multi-Arm Lrst,Topic
196,Bapineuzumab 301 Trial,Topic
196,Dhrubajyoti Ghosh,Author
196,Sheng Luo,Author
197,Information Theory,Topic
197,Neuroscience,Topic
197,Simon R. Schultz,Author
197,Robin A. A. Ince,Author
197,Stefano Panzeri,Author
198,Spatial Auditory Attention Decoding,Topic
198,Prototype Training,Topic
198,Eegwavenet,Topic
198,Zelin Qiu,Author
198,Jianjun Gu,Author
198,Dingding Yao,Author
198,Junfeng Li,Author
199,Academic Research,Topic
199,Sources Of Knowledge,Topic
199,Sinks Of Knowledge,Topic
199,Human Knowledge,Topic
199,Diaspora Of Knowledge,Topic
199,Medicine,Topic
199,Physics,Topic
199,Chemistry,Topic
199,Material Science,Topic
199,Chemical Engineering,Topic
199,Neuroscience,Topic
199,Immunology,Topic
199,Microbiology,Topic
199,Environmental Science,Topic
199,Manlio De Domenico,Author
199,Elisa Omodei,Author
199,Alex Arenas,Author
200,Comparing Trial Evidence To Target Populations,Topic
200,Hiv Interventions,Topic
200,Aids Clinical Trials Group (Actg),Topic
200,Fan Li,Author
200,Ashley L. Buchanan,Author
200,Stephen R. Cole,Author
200,Generalizability Of Trial Evidence,Topic
200,Causal Effects Estimation,Topic
200,Simulation Study,Topic
201,Trialgpt,Topic
201,Trialgpt-Retrieval,Topic
201,Trialgpt-Matching,Topic
201,Trialgpt-Ranking,Topic
201,Qiao Jin,Author
201,Zifeng Wang,Author
201,Charalampos S. Floudas,Author
201,Fangyuan Chen,Author
201,Changlin Gong,Author
201,Dara Bracken-Clarke,Author
201,Elisabetta Xue,Author
201,Yifan Yang,Author
201,Jimeng Sun,Author
201,Zhiyong Lu,Author
202,Quant-Ph/0208006,Topic
202,Alexander Yu. Vlasov,Author
203,Stochastic Multi-Armed Bandit Problem,Topic
203,Adaptive Clinical Trials,Topic
203,Regret,Topic
203,Besa Algorithm,Topic
203,Hossein Aboutalebi,Author
203,Doina Precup,Author
203,Tibor Schuster,Author
204,High-Dimensional Biomarkers,Topic
204,Genomics,Topic
204,Randomized Clinical Trials,Topic
204,Biomarker-Treatment Interactions,Topic
204,Two-Stage Interaction Detecting Procedures,Topic
204,Multivariate Screening Strategy,Topic
204,Ridge Regression,Topic
204,Family-Wise Error Rate Control,Topic
204,Asymptotic Between-Stage Independence,Topic
204,Simulation Results,Topic
204,Traditional One-Biomarker-At-A-Time Screening Procedure,Topic
204,Real Clinical Trial Data Applications,Topic
204,Two-Stage Penalized Regression Screening To Detect Biomarker-Treatment Interactions In Randomized Clinical Trials,Paper
204,Jixiong Wang,Author
204,Ashish Patel,Author
204,James M. S. Wason,Author
204,Paul J. Newcombe,Author
205,Bayesian Optimal Phase Ii Trial Design With Dual-Criterion Decision Making (Bop2-Dc),Topic
205,Yujie Zhao,Author
205,Daniel Li,Author
205,Rong Liu,Author
205,Ying Yuan,Author
206,Safe Biomedical Natural Language Inference For Clinical Trials,Topic
206,Multi-Evidence Natural Language Inference For Clinical Trial Data (Nli4Ct),Topic
206,Textual Entailment (Te) Task,Topic
206,Clinical Trial Reports (Ctr),Topic
206,Masked Language Models,Topic
206,Large Language Models,Topic
206,Chain-Of-Thought,Topic
206,Contrastive Chain-Of-Thought,Topic
206,Flan-T5-Large,Topic
206,Mathilde Aguiar,Author
206,Pierre Zweigenbaum,Author
206,Nona Naderi,Author
206,Seme At Semeval-2024 Task 2,Paper
207,Method For Assigning High-Quality Labels To Unstructured Text,Topic
207,Open-Source Language Model,Topic
207,Proprietary Language Model,Topic
207,Census Of Published Clinical Trials,Topic
207,Pharmaceutical Sector Productivity,Topic
207,Maya M. Durvasula,Author
207,Sabri Eyuboglu,Author
207,David M. Ritzwoller,Author
207,Clinical Trials Data Since 2010,Topic
207,Previous Measurements Of Clinical Trials,Topic
208,Clinical Trial Cohort Selection Using Large Language Models On N2C2 Challenges,Paper
208,Clinical Trials,Topic
208,Cohort Selection,Topic
208,Natural Language Processing (Nlp),Topic
208,Large Language Models (Llms),Topic
209,Kidney Paired Donation,Topic
209,Sommer Gentry,Author
209,Michal Mankowski,Author
209,T. S. Michael,Author
209,Dorry Segev,Author
209,Maximum Matchings In Graphs For Allocating Kidney Paired Donation,Paper
210,On Preparing A List Of Random Treatment Assigns,Paper
210,N. S. Santos-Magalhaes,Author
210,H. M. De Oliveira,Author
210,A. J. Alves,Author
211,Insertus.Jl,Topic
211,Yevgen Ryeznik,Author
211,Oleksandr Sverdlov,Author
212,A Clinical Trial Design Approach To Auditing Language Models In Healthcare Setting,Paper
212,Language Models,Topic
212,Healthcare Setting,Topic
212,Audit Mechanism,Topic
212,Clinical Trial Design,Topic
212,Subject Matter Experts,Topic
212,Sample Size And Power Calculations,Topic
212,Audit Integrity,Topic
212,Statistical Soundness,Topic
212,Public Health Network,Topic
213,Clinical Trial Adaptation,Topic
213,Ognjen Arandjelovic,Author
213,Sample-Targeted Clinical Trial Adaptation,Paper
214,Principal Stratification,Topic
214,Randomized Experiments,Topic
214,Post-Treatment Variable,Topic
214,Treatment Variable,Topic
214,Endpoint Variable,Topic
214,Phase Iii Adjuvant Colon Clinical Trials,Topic
214,Principal Causal Effects,Topic
214,Exclusion Restriction Assumption,Topic
214,Monotonicity Assumption,Topic
214,Disease-Free Survival,Topic
214,Overall Survival,Topic
214,Zhichao Jiang,Author
214,Peng Ding,Author
214,Zhi Geng,Author
215,Optimizing Trial Designs For Targeted Therapies,Paper
215,Thomas Ondra,Author
215,Sebastian Jobjˆrnsson,Author
215,Robert A. Beckman,Author
215,Carl-Fredrik Burman,Author
215,Franz Kˆnig,Author
215,Nigel Stallard,Author
215,Martin Posch,Author
216,Randomization,Topic
216,Clinical Trials,Topic
216,Superiority Trials,Topic
216,Non-Inferiority Trials,Topic
216,Imbalanced Randomization In Clinical Trials,Paper
217,Novel Adaptive Design Algorithm,Topic
217,Laplace Approximations,Topic
217,N-Of-1 Clinical Trials,Topic
217,Multi-Armed Bandit Approach,Topic
217,Randomised N-Of-1 Trial Design,Topic
217,S. G. Jagath Senarathne,Author
217,Antony M. Overstall,Author
217,James M. Mcgree,Author
218,A Scalable Ai Approach For Clinical Trial Cohort Optimization,Paper
218,Xiong Liu,Author
218,Cheng Shi,Author
218,Uday Deore,Author
218,Yingbo Wang,Author
218,Myah Tran,Author
218,Iya Khalil,Author
218,Murthy Devarakonda,Author
218,Cohort Optimization,Topic
218,Clinical Trials,Topic
218,Breast Cancer Trial Design,Topic
219,Randomized Controlled Trials,Topic
219,Trialview,Paper
219,Graph Artificial Intelligence,Topic
219,Visual Analytics,Topic
219,Clinical Trials,Topic
219,Temporal Event Data,Topic
219,Knowledge-Guided Clustering,Topic
219,Explanatory Modeling,Topic
219,Graph-Based Agglomeration Algorithms,Topic
220,Biomarker-Guided Adaptive Enrichment Design With Threshold Detection For Clinical Trials With Time-To-Event Outcome,Paper
220,Kaiyuan Hua,Author
220,Hwanhee Hong,Author
220,Xiaofei Wang,Author
221,Bayesian Predictive Probabilities,Topic
221,Clinical Trials,Topic
221,Efficacy And Futility Stopping Rules,Topic
221,Predictive Probabilities,Topic
221,Approximation For Computing Predictive Probabilities,Topic
221,Monte Carlo Imputation Methods,Topic
221,Dichotomous Endpoints,Topic
221,Time-To-Event Endpoints,Topic
221,Ordinal Endpoints,Topic
221,Historical Borrowing,Topic
221,Longitudinal Modeling,Topic
221,Joe Marion,Author
221,Liz Lorenzi,Author
221,Cora Allen-Savietta,Author
221,Scott Berry,Author
221,Kert Viele,Author
221,Predictive Probabilities Made Simple: A Fast And Accurate Method For Clinical Trial Decision Making,Paper
222,Confidence Intervals For Adaptive Trial Designs I: A Methodological Review,Paper
223,Confidence Intervals For Adaptive Trial Designs Ii: Case Study And Practical Guidance,Paper
224,End-To-End Clinical Trial Matching With Large Language Models,Paper
224,Large Language Models,Topic
224,Clinicaltrials.Gov,Topic
224,Electronic Health Records,Topic
224,Oncology,Topic
224,Gpt-4O,Topic
225,Ich E9,Topic
225,Estimands,Topic
225,Sensitivity Analyses,Topic
225,Kaspar Rufibach,Author
226,Covid-19 Pandemic,Topic
226,Clinical Research Activity,Topic
226,Randomized Controlled Clinical Trials,Topic
226,Adaptive Designs For Clinical Trials,Topic
226,Nigel Stallard,Author
226,Lisa Hampson,Author
226,Norbert Benda,Author
226,Werner Brannath,Author
226,Tom Burnett,Author
226,Tim Friede,Author
226,Peter K. Kimani,Author
226,Franz Koenig,Author
226,Johannes Krisam,Author
226,Pavel Mozgunov,Author
226,Martin Posch,Author
226,James Wason,Author
226,Gernot Wassmer,Author
226,John Whitehead,Author
226,S. Faye Williamson,Author
226,Sarah Zohar,Author
226,Thomas Jaki,Author
227,Leveraging External Data In The Analysis Of Randomized Controlled Trials: A Comparative Analysis,Paper
228,Advanced Adaptive Randomised Clinical Trials,Topic
228,Bayesian Statistical Framework,Topic
228,Adaptr R Package,Topic
228,Anders Granholm,Author
228,Aksel Karl Georg Jensen,Author
228,Theis Lange,Author
228,Anders Perner,Author
228,Morten Hylander M¯ller,Author
228,Benjamin Skov Kaas-Hansen,Author
228,Designing And Evaluating Advanced Adaptive Randomised Clinical Trials: A Practical Guide,Paper
229,Multi-Center Clinical Trials: Randomization And Ancillary Statistics,Paper
229,Lu Zheng,Author
229,Marvin Zelen,Author
230,Framm,Topic
230,Brandon Theodorou,Author
230,Lucas Glass,Author
230,Cao Xiao,Author
230,Jimeng Sun,Author
230,Clinical Trials,Topic
230,Diversity In Clinical Trials,Topic
230,Enrollment In Clinical Trials,Topic
231,Indolent Cancers,Topic
231,Overall Survival (Os),Topic
231,Progression-Free Survival (Pfs),Topic
231,Us Food And Drug Administration,Author
231,American Association For Cancer Research,Author
231,American Statistical Association,Author
231,Thomas R Fleming,Author
231,Lisa V Hampson,Author
231,Bharani Bharani-Dharan,Author
231,Frank Bretz,Author
231,Arunava Chakravartty,Author
231,Thibaud Coroller,Author
231,Evanthia Koukouli,Author
231,Janet Wittes,Author
231,Nigel Yateman,Author
231,Emmanuel Zuber,Author
232,Time-To-Event Estimands,Topic
232,Estimand Framework,Topic
232,Oncology Clinical Trials,Topic
232,Jonathan Siegel,Author
232,Hans-Jochen Weber,Author
232,Stefan Englert,Author
232,Feng Liu,Author
233,Single-World Intervention Graph (Swig),Topic
233,Clinical Trial,Topic
233,Estimand,Topic
233,Alex Ocampo,Author
233,Jemar R. Bather,Author
234,Clinical Trials,Topic
234,Response-Adaptive Randomization (Rar),Topic
234,Sequential Monitoring,Topic
234,Sequentially Monitor Response-Adaptive Randomized Clinical Trial,Paper
234,Brownian Motion,Topic
234,Canonical Joint Distribution,Topic
234,Maternal-Infant Hiv Transmission,Topic
235,Multi-Armed Bandit Problems,Topic
235,Optimal Control Problem,Topic
235,Resource Allocation Under Uncertainty,Topic
235,Clinical Trials,Topic
235,Infinite-Horizon Bayesian Bernoulli Mabp,Topic
235,Finite-Horizon Variant,Topic
235,Fixed Randomization,Topic
235,Bandit-Based Patient Allocation Rule,Topic
235,SofÌa S. Villar,Author
235,Jack Bowden,Author
235,James Wason,Author
235,Multi-Armed Bandit Models For The Optimal Design Of Clinical Trials: Benefits And Challenges,Paper
236,Osteoarthritis Clinical Trials,Topic
236,Patient Selection Problem,Topic
236,Multi-Class Classification Task,Topic
236,Oai,Topic
236,Check,Topic
236,Paco M. J. Welsing,Author
236,Christoph Ladel,Author
236,John Loughlin,Author
236,Floris P. J. G. Lafeber,Author
236,Florence Petit Dop,Author
236,Jonathan Larkin,Author
236,Harrie Weinans,Author
236,Ali Mobasheri,Author
236,Jaume Bacardit,Author
237,Personalized Medicine,Topic
237,Biomarker,Topic
237,Clinical Trial Design,Topic
237,Optimization Problem,Topic
237,Monte-Carlo And Smoothing Methods,Topic
237,General-Purpose Computing On Graphics Processing Units,Topic
237,Yitao Lu,Author
237,Julie Zhou,Author
237,Li Xing,Author
237,Xuekui Zhang,Author
238,Zero-Shot Clinical Trial Patient Matching With Llms,Paper
238,Michael Wornow,Author
238,Alejandro Lozano,Author
238,Dev Dash,Author
238,Jenelle Jindal,Author
238,Kenneth W. Mahaffey,Author
238,Nigam H. Shah,Author
239,Ctbench,Topic
239,Clinical Trial,Topic
239,Ct-Repo,Topic
239,Ct-Pub,Topic
239,Listmatch-Lm,Topic
239,Listmatch-Bert,Topic
239,Nafis Neehal,Author
239,Bowen Wang,Author
239,Shayom Debopadhaya,Author
239,Soham Dan,Author
239,Keerthiram Murugesan,Author
239,Vibha Anand,Author
239,Kristin P. Bennett,Author
240,Mantel-Haenszel Risk Difference Estimator,Topic
240,Xiaoyu Qiu,Author
240,Yuhan Qian,Author
240,Jaehwan Yi,Author
240,Jinqiu Wang,Author
240,Yu Du,Author
240,Yanyao Yi,Author
240,Ting Ye,Author
241,Decentralized Clinical Trials,Topic
241,Covid-19 Pandemic,Topic
241,Blockchain Technology,Topic
241,Internet Of Things,Topic
241,Zero-Trust Architecture Blockchain,Paper
242,Doubly Robust Estimation And Sensitivity Analysis With Outcomes Truncated By Death In Multi-Arm Clinical Trials,Paper
242,Jiaqi Tong,Author
242,Chao Cheng,Author
242,Guangyu Tong,Author
242,Michael O. Harhay,Author
242,Fan Li,Author
242,Clinical Trials,Topic
242,Survivor Average Causal Effect,Topic
242,Principal Stratification,Topic
242,Multi-Arm Clinical Trials,Topic
242,Doubly Robust Estimators,Topic
242,Sensitivity Analysis,Topic
243,Accurate Immunological Models,Topic
243,Immunological Memory,Topic
243,Experimental Immunological Simulator,Topic
243,Theory Of Immunological Memory,Topic
243,Simon Garret,Author
243,Martin Robbins,Author
243,Joanne Walker,Author
243,William Wilson,Author
243,Uwe Aickelin,Author
244,Naplib-Python,Topic
244,Gavin Mischler,Author
244,Vinay Raghavan,Author
244,Menoua Keshishian,Author
244,Nima Mesgarani,Author
245,Group Sequential Clinical Trial Design,Topic
245,Pivotal Trial,Topic
245,Regulatory Review,Topic
245,Single Stage Design,Topic
245,Group Sequential Methodology,Topic
245,Key Operating Characteristics,Topic
245,Decision Makers,Topic
245,Fraser I Lewis,Author
245,Introduction To Group Sequential Methods: Planning And Multi-Aspect Optimization,Paper
246,T Cell Receptors,Topic
246,Eli N. Weinstein,Author
246,Elizabeth B. Wood,Author
246,David M. Blei,Author
246,Covid-19 Severity,Topic
246,Tcr Repertoire Sequencing,Topic
246,Causal Effects Of Tcrs,Topic
247,Interventional Cancer Clinical Trials,Topic
247,Aurelia Bustos,Author
247,Antonio Pertusa,Author
247,Learning Eligibility In Cancer Clinical Trials Using Deep Neural Networks,Paper
248,Blinded Sample Size Re-Estimation,Topic
248,Gold Standard Design,Topic
248,Tobias M¸tze,Author
248,Tim Friede,Author
248,Three-Arm Clinical Trial,Topic
248,Xing-Ganju Variance Estimator,Topic
248,Sample Size Re-Estimation Procedures,Topic
248,Operating Characteristics,Topic
248,Outcome Variance,Topic
248,Internal Pilot Study,Topic
248,Nuisance Parameters,Topic
248,Power,Topic
248,Type I Error,Topic
248,Inflation Factor,Topic
248,Overpowered Trials,Topic
248,Underpowered Trials,Topic
249,Deepenroll,Topic
249,Xingyao Zhang,Author
249,Cao Xiao,Author
249,Lucas M. Glass,Author
249,Jimeng Sun,Author
249,Clinical Trials,Topic
250,Platform Trial,Topic
250,Estimand,Topic
250,Entire Concurrently Eligible (Ece) Population,Topic
250,Treatment Effects,Topic
250,Simplify Trial,Topic
250,Yuhan Qian,Author
250,Yifan Yi,Author
250,Jun Shao,Author
250,Yanyao Yi,Author
250,Gregory Levin,Author
250,Nicole Mayer-Hamblett,Author
250,Patrick J. Heagerty,Author
250,Ting Ye,Author
251,Bayesian Adaptive Cluster-Randomized Trials,Topic
251,Junwei Shen,Author
251,Shirin Golchi,Author
251,Erica E. M. Moodie,Author
251,David Benrimoh,Author
251,Machine-Learning Based Clinical Decision Support System,Topic
251,Depression,Topic
251,Adaptive Designs For Cluster-Randomized Trials,Topic
251,Two Bayesian Adaptive Designs,Topic
251,Early Stopping For Efficacy,Topic
251,Simulation Results,Topic
252,Prognostic Adjustment With Efficient Estimators To Unbiasedly Leverage Historical Data In Randomized Trials,Paper
252,Randomized Controlled Trials,Topic
252,Observational Studies,Topic
252,Historical Data,Topic
252,Prognostic Covariate Adjustment,Topic
252,Novo Nordisk A/S,Author
253,Dengue,Topic
253,Denv,Topic
253,Asymptomatic Viremic Individuals,Topic
253,Clinical Dengue Patients,Topic
253,Etienne Simon-Loriere,Author
253,Veasna Duong,Author
253,Ahmed Tawfik,Author
253,Sivlin Ung,Author
253,Sowath Ly,Author
253,Isabelle Casademont,Author
253,Matthieu Prot,Author
253,NoÈmie Courtejoie,Author
253,Kevin Bleakley,Author
253,Philippe Buchy,Author
253,Arnaud Tarantola,Author
253,Philippe Dussart,Author
253,Tineke Cantaert,Author
253,Anavaj Sakuntabhai,Author
254,Sars-Cov-2,Topic
254,Covid-19,Topic
254,Cytokine Storm,Topic
254,Nf-Kappab,Topic
254,Proteasome Inhibitors,Topic
254,Ralf Kircheis,Author
254,Emanuel Haasbach,Author
254,Daniel Lueftenegger,Author
254,Willm T. Heyken,Author
254,Matthias Ocker,Author
254,Oliver Planz,Author
255,Trialgraph,Topic
255,Clinical Trial,Topic
255,Machine Learning,Topic
255,Christopher Yacoumatos,Author
255,Stefano Bragaglia,Author
255,Anshul Kanakia,Author
255,Nils SvangÂrd,Author
255,Jonathan Mangion,Author
255,Claire Donoghue,Author
255,Jim Weatherall,Author
255,Faisal M. Khan,Author
255,Khader Shameer,Author
255,Metapath2Vec,Topic
255,Roc-Auc,Topic
255,Ct.Gov,Topic
255,Aact,Topic
255,Trialtrove,Topic
256,Dose Finding With Escalation With Overdose Control (Ewoc) In Cancer Clinical Trials,Paper
256,Mourad Tighiouart,Author
256,AndrÈ Rogatko,Author
256,Maximum Tolerated Dose (Mtd),Topic
256,Bayesian Adaptive Design,Topic
256,Escalation With Overdose Control (Ewoc),Topic
256,Abr-217620 (Naptumomab Estafenatox) Trial,Topic
257,Bias In Clinical Trials,Topic
257,Active Controlled Noninferiority Trials,Topic
257,Likelihood Reweighting Method,Topic
257,Historically Controlled Trials,Topic
257,Meta-Analyses,Topic
257,Comparative Effectiveness Analyses,Topic
257,Lei Nie,Author
257,Zhiwei Zhang,Author
257,Daniel Rubin,Author
257,Jianxiong Chu,Author
258,Non-Alcoholic Steatohepatitis (Nash),Topic
258,Nonalcoholic Fatty Liver Disease (Nafld),Topic
258,Eu-Pearl Consortium,Topic
258,Elias Laurin Meyer,Author
258,Peter Mesenbrink,Author
258,Nicholas A. Di Prospero,Author
258,Juan M. Peric‡s,Author
258,Ekkehard Glimm,Author
258,Vlad Ratziu,Author
258,Elena Sena,Author
258,Franz Kˆnig,Author
259,An Empirical Likelihood Approach To Nonparametric Covariate Adjustment In Randomized Clinical Trials,Paper
259,Covariate Adjustment,Topic
259,Empirical Likelihood Method,Topic
259,Gusto-I Trial,Topic
260,C-Pass-Pc,Topic
260,Haibin Wang,Author
260,Cloud Computing,Topic
260,Clinical Trials,Topic
260,Google App Engine,Topic
260,Google Cloud Sql-Mysql,Topic
260,Php,Topic
260,Jquery,Topic
260,Css,Topic
260,Oracle,Topic
260,Data Coordinating Center,Topic
261,Use Of Historical Individual Patient Data In Analysis Of Clinical Trials,Paper
261,Bayesian Framework,Topic
261,Informative Prior,Topic
261,Historical Data,Topic
261,Individual Patient Data,Topic
261,Non-Small Cell Lung Cancer,Topic
262,Vaccsc,Topic
262,Sars-Cov-2,Topic
262,Ivan Da Silva Sendin,Author
262,Rodrigo Sanches Miani,Author
263,Clinical Trials,Topic
263,Medical Experts,Topic
263,Treatments,Topic
263,Outcomes,Topic
263,Benjamin E. Nye,Author
263,Jay Deyoung,Author
263,Eric Lehman,Author
263,Ani Nenkova,Author
263,Iain J. Marshall,Author
263,Byron C. Wallace,Author
263,End-To-End Evidence Extraction Systems,Topic
263,Cancer,Topic
263,Natural Language Processing,Topic
263,Data-Driven Baselines,Topic
263,Fielded Evaluation,Topic
264,Custom2Vec,Topic
264,Clinical_Trials,Topic
264,Non-Small_Cell_Lung_Cancer,Topic
264,Xiong Liu,Author
264,Iya Khalil,Author
264,Murthy Devarakonda,Author
265,A Connection Between Covariate Adjustment And Stratified Randomization In Randomized Clinical Trials,Paper
265,Randomized Clinical Trials,Topic
265,Covariate Adjustment,Topic
265,Stratified Randomization,Topic
265,Baseline Covariates,Topic
265,Asymptotically Linear Estimators,Topic
265,Optimal Augmentation Function,Topic
265,Prognostic Information,Topic
265,Simulation Study,Topic
265,Real Clinical Trial Data,Topic
266,Dental Disease,Topic
266,Oralytics,Paper
266,Mhealth Intervention System,Topic
266,Online Reinforcement Learning Algorithm,Topic
266,Clinical Trial,Topic
266,Randomized Control Trial,Topic
266,Spring 2025,Topic
267,Controlled Llm-Based Reasoning For Clinical Trial Retrieval,Paper
267,Trec 2022 Clinical Trials,Topic
268,Digital Twinning Of The Human Ventricular Activation Sequence To Clinical 12-Lead Ecgs And Magnetic Resonance Imaging Using Realistic Purkinje Networks For In Silico Clinical Trials,Paper
268,Julia Camps,Author
268,Lucas Arantes Berg,Author
268,Zhinuo Jenny Wang,Author
268,Rafael Sebastian,Author
268,Leto Luana Riebel,Author
268,Ruben Doste,Author
268,Xin Zhou,Author
268,Rafael Sachetto,Author
268,James Coleman,Author
268,Brodie Lawson,Author
268,Vicente Grau,Author
268,Kevin Burrage,Author
268,Alfonso Bueno-Orovio,Author
268,Rodrigo Weber,Author
268,Blanca Rodriguez,Author
269,Minimum Clinically Important Difference,Topic
269,A. S. Hedayat,Author
269,Junhui Wang,Author
269,Tu Xu,Author
269,Estimation Framework Of Mcid,Paper
270,A Statistical Inference Framework For The Minimal Clinically Important Difference,Paper
270,Minimal Clinically Important Difference,Topic
270,Champ Trial,Topic
271,The Use Of External Controls: To What Extent Can It Currently Be Recommended?,Paper
271,Hans Ulrich Burger,Author
271,Christoph Gerlinger,Author
271,Chris Harbron,Author
271,Armin Koch,Author
271,Martin Posch,Author
271,Justine Rochon,Author
271,Anja Schiel,Author
272,Learning Health System,Topic
272,Esource,Topic
272,Clinical Research Information Model,Topic
272,Clinical Data Integration Model,Topic
272,Cdisc Operational Data Model,Topic
272,Transform Project,Topic
272,Jean-Francois Ethier,Author
272,Vasa Curcin,Author
272,Mark M. Mcgilchrist,Author
272,Sarah N. Lim Choi Keung,Author
272,Lei Zhao,Author
272,Anna Andreasson,Author
272,Piotr BrÛdka,Author
272,Radoslaw Michalski,Author
272,Theodoros N. Arvanitis,Author
272,Nikolaos Mastellos,Author
272,Anita Burgun,Author
272,Brendan C. Delaney,Author
273,N-Of-1 Trials,Topic
273,T-Tests,Topic
273,Serial Correlation,Topic
273,Jillian Tang,Author
273,Reid D. Landes,Author
273,Fibromyalgia Patients,Topic
273,Behavioral Health Setting,Topic
274,A Model Of A Randomized Experiment With An Application To The Prowess Clinical Trial,Paper
274,Amanda Kowalski,Author
274,Prowess Trial,Topic
275,Individualizing Treatment Assignment,Topic
275,Diseases With Patient-To-Patient Variability,Topic
275,Treatment Effect Heterogeneity,Topic
275,Covariate Data,Topic
275,Major Depressive Disorder,Topic
275,Summary Statistics,Topic
275,Depression Treatment Trial,Topic
275,Rct2Otrbounds R Package,Topic
275,Nina Galanter,Author
275,Marco Carone,Author
275,Ronald C. Kessler,Author
275,Alex Luedtke,Author
276,Anscombe'S Classical Model,Topic
276,N,Topic
276,Sebastian Jobjˆrnsson,Author
276,Sˆren Christensen,Author
276,Conjugate Normal Priors,Topic
276,General Form Priors,Topic
276,Numerical Solutions,Topic
276,Asymmetric Treatments,Topic
276,Random Variable N,Topic
277,Pragmatic Randomized Trials,Topic
277,Eleanor J. Murray,Author
277,Sonja A. Swanson,Author
277,Miguel A. Hern·n,Author
277,Guidelines For Estimating Causal Effects In Pragmatic Randomized Trials,Paper
278,Alzheimer'S Disease,Topic
278,Participant Selection,Topic
278,Cognitive Trajectories,Topic
278,Machine Learning Models,Topic
278,Early Alzheimer'S Disease,Topic
278,Presymptomatic Individuals,Topic
278,Magnetic Resonance Imaging,Topic
278,Cognitive Tests,Topic
278,Demographics,Topic
278,Apoe Genotype,Topic
278,Cdr-Sum Of Boxes,Topic
278,Angela Tam,Author
278,CÈsar Laurent,Author
278,Serge Gauthier,Author
278,Christian Dansereau,Author
279,Randomized Clinical Trials,Topic
279,Observational Datasets,Topic
279,Optimum In Convex Hulls (Och),Topic
279,Eric V. Strobl,Author
279,Thomas A. Lasko,Author
279,Treatment Response,Topic
279,Confounding,Topic
279,Exclusion Criteria,Topic
279,Treatment Effect,Topic
279,Algorithm,Topic
280,Multi-Agents For Knowledge Augmentation (Maka),Topic
280,Hanwen Shi,Author
280,Jin Zhang,Author
280,Kunpeng Zhang,Author
280,Patient-Trial Matching,Topic
280,Knowledge Augmentation,Topic
280,Clinical Trials,Topic
280,Knowledge Probing Agent,Topic
280,Navigation Agent,Topic
280,Supervision Agent,Topic
280,Matching Agent,Topic
280,Knowledge Augmentation Agent,Topic
281,Two-Arm Clinical Trials,Topic
281,Scalar Treatment Effect Parameter,Topic
281,Treatment-Specific Means,Topic
281,Risk Difference,Topic
281,Risk Ratio,Topic
281,Odds Ratio,Topic
281,Interim Analysis,Topic
281,Censoring,Topic
281,Baseline Covariates,Topic
281,Time-Dependent Covariates,Topic
281,Group Sequential Framework,Topic
281,Semiparametric Theory,Topic
281,Anastasios A. Tsiatis,Author
281,Marie Davidian,Author
282,Participation Incentives,Topic
282,Randomized Controlled Trials,Topic
282,Medicine,Topic
282,User Dissatisfaction,Topic
282,Exploration-Exploitation Tradeoff,Topic
282,Agents,Topic
282,Incentive-Compatible Mechanism,Topic
282,Yingkai Li,Author
282,Aleksandrs Slivkins,Author
282,Statistical Performance,Topic
282,Worst-Case Estimation Error,Topic
282,Adversarially Generated Outcomes,Topic
282,Homogeneous Agents,Topic
282,Heterogeneous Agents,Topic
282,Estimated Type Frequencies,Topic
283,Fda Guidance On Covariate Adjustment,Topic
283,Covariate Adjustment,Topic
283,Machine Learning Algorithms,Topic
283,Kelly Van Lancker,Author
283,Iv·n DÌaz,Author
283,Stijn Vansteelandt,Author
284,Adaptive Designs For Multi-Armed Clinical Trials,Topic
284,Multi-Armed Bandit Problems,Topic
284,Normally Distributed Endpoint,Topic
284,Adam Smith,Author
284,Sofia S. Villar,Author
284,Simulation-Based Testing Procedure,Topic
284,Type I Error,Topic
284,Power,Topic
284,Bias,Topic
284,Patient Benefit,Topic
284,Rare Disease Context,Topic
284,Common Diseases,Topic
285,Copd,Topic
285,Stefan Andreas,Author
285,Christian Rˆver,Author
285,Judith Heinz,Author
285,Sebastian Straube,Author
285,Henrik Watz,Author
285,Tim Friede,Author
285,Exacerbation Rates,Topic
285,Meta-Regression,Topic
285,Randomized Controlled Trials,Topic
285,Bayesian Negative Binomial Model,Topic
285,Systematic Review,Topic
285,Clinical Trials,Topic
285,Placebo Groups,Topic
285,Adjunct Therapy,Topic
285,Exacerbation Frequency,Topic
285,Forced Expiratory Volume In 1 S (Fev1),Topic
285,Decline Of Copd Exacerbations,Topic
286,Clinical Trial Eligibility Criteria,Topic
286,Yitong Tseo,Author
286,M. I. Salkola,Author
286,Ahmed Mohamed,Author
286,Anuj Kumar,Author
286,Freddy Abnousi,Author
287,Use Of Historical Data And Real-World Evidence,Topic
287,Clinical Trials,Topic
287,Elastic Prior Approach,Topic
287,Clinically Meaningful Difference,Topic
287,Liyun Jiang,Author
287,Lei Nie,Author
287,Ying Yuan,Author
287,Simulation Study,Topic
287,Type I Error,Topic
287,Type Ii Error,Topic
287,Information Borrowing,Topic
287,Data Dredging,Topic
287,Bias,Topic
287,Power,Topic
287,Information-Borrowing Constraints,Topic
287,Congruence Measure,Topic
287,Historical Data,Topic
287,Trial Data,Topic
288,Trialmdp,Topic
288,David Merrell,Author
288,Thevaa Chandereng,Author
288,Yeonhee Park,Author
288,Response-Adaptive Randomization,Topic
288,Blocked Rar,Topic
289,Estimating Treatment Effects From Observational Data,Topic
289,Causal Inference,Topic
289,Basket Trial,Topic
289,Multi-Task Adversarial Learning (Mtal),Topic
289,Zhixuan Chu,Author
289,Stephen L. Rathbun,Author
289,Sheng Li,Author
289,Ihdp,Topic
289,News,Topic
290,Modeling Restricted Enrollment And Optimal Cost-Efficient Design In Multicenter Clinical Trials,Paper
290,Vladimir Anisimov,Author
290,Matthew Austin,Author
290,Clinical Research,Topic
290,Statistical Methodology,Topic
290,Artificial Intelligence,Topic
291,Bayesian Inference,Topic
291,Posterior Probabilities,Topic
291,Posterior Predictive Probabilities,Topic
291,Decision Making,Topic
291,Clinical Trials,Topic
291,Bayesian Clinical Trials,Topic
291,Hybrid Bayesian-Frequentist Approach,Topic
291,Frequentist Operating Characteristics,Topic
291,Power,Topic
291,Type I Error Rate,Topic
291,Simulation Studies,Topic
291,Bayesian Measures,Topic
291,Assurance,Topic
291,Computational Burden,Topic
291,Methodology,Topic
291,Large Sample Theory,Topic
291,Posterior Distribution,Topic
291,Parametric Models,Topic
291,Sampling Distribution,Topic
291,Posterior Summaries,Topic
291,Small Number Of Simulation Scenarios,Topic
291,Conditional Operating Characteristics,Topic
291,Marginal Operating Characteristics,Topic
291,Sample Size Determination,Topic
291,Design Prior,Topic
291,Shirin Golchi,Author
291,James Willard,Author
291,Estimating The Sampling Distribution Of Posterior Decision Summaries In Bayesian Clinical Trials,Paper
292,Assurance Methods For Designing A Clinical Trial With A Delayed Treatment Effect,Paper
292,Immuno-Oncology,Topic
293,Large Language Models,Topic
293,Healthcare,Topic
293,Patient-Trial Matching,Topic
293,Gpt-3.5,Author
293,Gpt-4,Author
293,Llama 7B,Author
293,Llama 13B,Author
293,Llama 70B,Author
293,Mauro Nievas,Author
293,Aditya Basu,Author
293,Yanshan Wang,Author
293,Hrituraj Singh,Author
293,Trial-Llama,Topic
293,Synthetic Dataset,Topic
293,Evaluation Dataset,Topic
294,Biosimilars Development,Topic
294,Ryuji Uozumi,Author
294,Chikuma Hamada,Author
295,Rheumatoid Arthritis Clinical Trials,Topic
295,Das28 Scores,Topic
295,Etanercept,Topic
295,Methotrexate,Topic
295,Tempo,Topic
295,Violeta G. Hennessey,Author
295,Luis G. Leon-Novelo,Author
295,Juan Li,Author
295,Li Zhu,Author
295,Eric Chi,Author
295,Joseph G. Ibrahim,Author
295,Bayesian Joint Model,Topic
295,Informative Dropout,Topic
295,Longitudinal Data Collection,Topic
296,Prognostic Model,Topic
296,Patients,Topic
296,Clinicians,Topic
296,Decision Rule,Topic
296,Randomized Trial,Topic
296,Observational Data,Topic
296,Michael C Sachs,Author
296,Arvid Sjˆlander,Author
296,Erin E Gabriel,Author
297,Antioxidants,Topic
297,Cancer Therapy,Topic
297,Free Radicals,Topic
297,Oxidative Stress,Topic
297,Qurat-Ul-Ain,Author
297,M. Iqbal Choudhary,Author
297,Emerging Classes Of Antioxidant To Cancer Therapy: A Review Of Clinical And Experimental Studies,Paper
298,Machine Learning For Health: Personalized Models For Forecasting Of Alzheimer Disease Progression,Paper
298,Alzheimer Disease,Topic
298,Tadpole Challenge,Topic
298,Adas-Cog13 Scores,Topic
298,Cox Model,Topic
298,Mit Medialab,Author
299,Ct-Ade,Topic
299,Adverse Drug Events,Topic
299,Anthony Yazdani,Author
299,Alban Bornet,Author
299,Philipp Khlebnikov,Author
299,Boya Zhang,Author
299,Hossein Rouhizadeh,Author
299,Poorya Amini,Author
299,Douglas Teodoro,Author
300,Watch,Topic
300,Treatment Effect Heterogeneity,Topic
300,Konstantinos Sechidis,Author
300,Sophie Sun,Author
300,Yao Chen,Author
300,Jiarui Lu,Author
300,Cong Zhang,Author
300,Mark Baillie,Author
300,David Ohlssen,Author
300,Marc Vandemeulebroecke,Author
300,Rob Hemmings,Author
300,Stephen Ruberg,Author
300,Bjˆrn Bornkamp,Author
301,Cox Proportional Hazards Models,Topic
301,St-Segment Elevation Myocardial Infarction (Stemi),Topic
301,Non-Stemi,Topic
301,Thomas Mcandrew,Author
301,Bjorn Redfors,Author
301,Aaron Crowley,Author
301,Yiran Zhang,Author
301,Shmuel Chen,Author
301,Mordechai Golomb,Author
301,Maria Alu,Author
301,Dominic Francese,Author
301,Ori Ben-Yehuda,Author
301,Akiko Maehara,Author
301,Gary Mintz,Author
301,Gregg Stone,Author
301,Paul Jenkins,Author
302,Pediatric Rare Diseases,Topic
302,Clinical Research,Topic
302,Pediatric Regulation,Topic
302,Orphan Regulation,Topic
302,Victoria Hedley,Author
302,Rebecca Leary,Author
302,Anando Sen,Author
302,Anna Irvin,Author
302,Emma Heslop,Author
302,Volker Straub,Author
303,Phase I Clinical Trial Design,Topic
303,Xiaojun Zhu,Author
304,Platform Trials,Topic
304,Marta Bofill Roig,Author
304,Ekkehard Glimm,Author
304,Tobias Mielke,Author
304,Martin Posch,Author
304,Optimal Allocation Strategies In Platform Trials,Paper
305,Surrogate Endpoint For Overall Survival In Cancer Patients,Topic
305,Oncology Drug Development,Topic
305,Patient Level Association With Survival,Topic
305,Clinical Or Biological Features,Topic
305,Discovery Cohort,Topic
305,Trial Level Association,Topic
305,Meta-Analysis,Topic
305,Causal Biological Trajectories,Topic
305,Bi-Exponential Functions,Topic
305,Simulated Discovery Cohorts,Topic
305,C Index,Topic
305,Integrated Brier Score,Topic
305,Log Hazard Ratio,Topic
305,Simulated Studies,Topic
305,Trial Level Metric,Topic
305,Wei Zou,Author
305,Metrics To Find A Surrogate Endpoint Of Os In Metastatic Oncology Trials: A Simulation Study,Paper
306,Analysis Of An Incomplete Binary Outcome Dichotomized From An Underlying Continuous Variable In Clinical Trials,Paper
306,Chenchen Ma,Author
306,Xin Shen,Author
306,Yongming Qu,Author
306,Yu Du,Author
306,Glmm,Topic
306,Mi,Topic
306,Clinical Trials,Topic
307,Alzheimer'S Disease,Topic
307,Mild Cognitive Impairment,Topic
307,Conditional Restricted Boltzmann Machines,Topic
307,Digital Twins,Topic
307,Daniele Bertolini,Author
307,Anton D. Loukianov,Author
307,Aaron M. Smith,Author
307,David Li-Bland,Author
307,Yannick Pouliot,Author
307,Jonathan R. Walsh,Author
307,Charles K. Fisher,Author
308,Factors Affecting The Performance Of Automated Speaker Verification In Alzheimer'S Disease Clinical Trials,Paper
308,Automated Speaker Verification,Topic
308,Alzheimer'S Disease,Topic
308,659 Participants,Topic
308,Male Speakers,Topic
308,Female Speakers,Topic
308,Non-Native English Speakers,Topic
308,Native English Speakers,Topic
308,Clinician Interference,Topic
308,Noisy Background,Topic
308,Unclear Participant Speech,Topic
308,Severity Level Of Alzheimer'S Disease,Topic
308,Voice Biometrics,Topic
308,Data Collection Settings,Topic
309,Trialscope,Topic
309,Javier Gonz·lez,Author
309,Cliff Wong,Author
309,Zelalem Gero,Author
309,Jass Bagga,Author
309,Risa Ueno,Author
309,Isabel Chien,Author
309,Eduard Oravkin,Author
309,Emre Kiciman,Author
309,Aditya Nori,Author
309,Roshanthi Weerasinghe,Author
309,Rom S. Leidner,Author
309,Brian Piening,Author
309,Tristan Naumann,Author
309,Carlo Bifulco,Author
309,Hoifung Poon,Author
310,Gather,Topic
310,David Narganes-Carlon,Author
310,Anniek Myatt,Author
310,Mani Mudaliar,Author
310,Daniel J. Crowther,Author
310,Pharmaceutical Drug Discovery,Topic
310,Clinical Trial,Topic
310,Gatv3,Topic
310,Gatv3Heteroconv,Topic
310,Captum,Topic
311,Causal Inferences,Topic
311,Generalizability,Topic
311,Transportability,Topic
311,Sensitivity Analysis,Topic
311,Randomized Trial,Topic
311,Non-Randomized Individuals,Topic
311,Chronic Hepatitis C Infection,Topic
311,Issa J. Dahabreh,Author
311,James M. Robins,Author
311,Sebastien J-P. A. Haneuse,Author
311,Iman Saeed,Author
311,Sarah E. Robertson,Author
311,Elisabeth A. Stuart,Author
311,Miguel A. Hern·n,Author
312,Basket Trials,Topic
312,R-Package Basket,Topic
312,Michael J. Kane,Author
312,Nan Chen,Author
312,Alexander M. Kaizer,Author
312,Xun Jiang,Author
312,H. Amy Xia,Author
312,Brian P. Hobbs,Author
313,Results From Clinical Trials,Topic
313,P-Hacking,Topic
313,Pre-Spec Framework,Topic
313,Spirit Statement,Topic
313,Brennan C Kahan,Author
313,Gordon Forbes,Author
313,Suzie Cro,Author
314,Dose-Finding Clinical Trials In Oncology,Topic
314,Maximum Tolerated Dose (Mtd),Topic
314,Patient-Reported Outcomes (Pros),Topic
314,Pro Continual Reassessment Method (Pro-Crm),Topic
314,Tite-Pro-Crm,Topic
314,Tite-Crm+Pro,Topic
314,AnaÔs Andrillon,Author
314,Lucie Biard,Author
314,Shing M. Lee,Author
315,Phase I Dose Escalation Trials,Topic
315,Maximum Tolerated Dose (Mtd),Topic
315,Optimal Biological Dose (Obd),Topic
315,Estimand Framework,Topic
315,Ich E9(R1) Guidelines,Topic
315,Pharmacokinetics (Pk) Data,Topic
315,Toxicity Data,Topic
315,Efficacy Data,Topic
315,Utility Functions,Topic
315,Intercurrent Events,Topic
315,Ayon Mukherjee,Author
315,Jonathan L. Moscovici,Author
315,Zheng Liu,Author
316,Stem Cell Transplantation As A Dynamical System: Are Clinical Outcomes Deterministic?,Paper
316,Amir A Toor,Author
316,Jared D Kobulnicky,Author
316,Salman Salman,Author
316,Catherine H Roberts,Author
316,Max Jameson-Lee,Author
316,Jeremy Meier,Author
316,Allison Scalora,Author
316,Nihar Sheth,Author
316,Vishal Koparde,Author
316,Myrna Serrano,Author
316,Gregory A Buck,Author
316,William Clark,Author
316,John Mccarty,Author
316,Harold Chung,Author
316,Masoud H Manjili,Author
316,Roy T Sabo,Author
316,Michael C Neale,Author
317,Artificial Intelligence,Topic
317,Clinical Practice,Topic
317,Evaluation Methodologies,Topic
317,Dc-Ai Rcts,Topic
317,Vc-Medai,Topic
317,Wanling Gao,Author
317,Yunyou Huang,Author
317,Dandan Cui,Author
317,Zhuoming Yu,Author
317,Wenjing Liu,Author
317,Xiaoshuang Liang,Author
317,Jiahui Zhao,Author
317,Jiyue Xie,Author
317,Hao Li,Author
317,Li Ma,Author
317,Ning Ye,Author
317,Yumiao Kang,Author
317,Dingfeng Luo,Author
317,Peng Pan,Author
317,Wei Huang,Author
317,Zhongmou Liu,Author
317,Jizhong Hu,Author
317,Gangyuan Zhao,Author
317,Chongrong Jiang,Author
317,Fan Huang,Author
317,Tianyi Wei,Author
317,Suqin Tang,Author
317,Bingjie Xia,Author
317,Zhifei Zhang,Author
317,Jianfeng Zhan,Author
317,Chinese Clinical Trial Registration,Topic
317,Chictr2400086816,Topic
318,A Hassle-Free Machine Learning Method For Cohort Selection Of Clinical Trials,Paper
318,Liu Man,Author
319,Heterogeneous Clinical Trial Outcomes Via Multi-Output Gaussian Processes,Paper
319,Owen Thomas,Author
319,Leiv R¯nneberg,Author
319,Gaussian Process Models,Topic
319,Clinical Data Sets,Topic
319,Bayesian Nonparametric Models,Topic
319,Stan,Topic
319,Brms,Topic
319,Radiological Image Quality,Topic
319,Parametric Models,Topic
319,Random Effects,Topic
320,Space Biology Research,Topic
320,National Aeronautics And Space Administration,Author
320,Artificial Intelligence,Topic
320,Machine Learning,Topic
320,Modeling Applications,Topic
320,Lauren M. Sanders,Author
320,Jason H. Yang,Author
320,Ryan T. Scott,Author
320,Amina Ann Qutub,Author
320,Hector Garcia Martin,Author
320,Daniel C. Berrios,Author
320,Jaden J. A. Hastings,Author
320,Jon Rask,Author
320,Graham Mackintosh,Author
320,Adrienne L. Hoarfrost,Author
320,Stuart Chalk,Author
320,John Kalantari,Author
320,Kia Khezeli,Author
320,Erik L. Antonsen,Author
320,Joel Babdor,Author
320,Richard Barker,Author
320,Sergio E. Baranzini,Author
320,Afshin Beheshti,Author
320,Guillermo M. Delgado-Aparicio,Author
320,Benjamin S. Glicksberg,Author
320,Casey S. Greene,Author
320,Melissa Haendel,Author
320,Arif A. Hamid,Author
320,Philip Heller,Author
320,Daniel Jamieson,Author
320,Katelyn J. Jarvis,Author
320,Svetlana V. Komarova,Author
320,Matthieu Komorowski,Author
320,Prachi Kothiyal,Author
320,Ashish Mahabal,Author
320,Uri Manor,Author
320,Christopher E. Mason,Author
320,Mona Matar,Author
320,George I. Mias,Author
320,Jack Miller,Author
320,Jerry G. Myers Jr.,Author
320,Charlotte Nelson,Author
320,Jonathan Oribello,Author
320,Seung-Min Park,Author
320,Patricia Parsons-Wingerter,Author
320,R. K. Prabhu,Author
320,Robert J. Reynolds,Author
320,Amanda Saravia-Butler,Author
320,Suchi Saria,Author
320,Aenor Sawyer,Author
320,Nitin Kumar Singh,Author
320,Frank Soboczenski,Author
320,Michael Snyder,Author
320,Karthik Soman,Author
320,Corey A. Theriot,Author
320,David Van Valen,Author
320,Kasthuri Venkateswaran,Author
320,Liz Warren,Author
320,Liz Worthey,Author
320,Marinka Zitnik,Author
320,Sylvain V. Costes,Author
321,"Beyond Low Earth Orbit: Biomonitoring, Artificial Intelligence, And Precision Space Health",Paper
321,National Aeronautics And Space Administration,Topic
322,Interadapt R Package,Topic
322,Aaron Fisher,Author
322,Harris Jaffee,Author
322,Michael Rosenblum,Author
323,Nonlinear Regression Models,Topic
323,Dose-Finding Trials,Topic
323,Pharmaceutical Drug Development,Topic
323,Optimal Designs,Topic
323,Efficacy And Toxicity,Topic
323,Bivariate Continuous Outcomes,Topic
323,Polynomials,Topic
323,Michaelis-Menten Model,Topic
323,Emax Model,Topic
323,D-Optimal Designs,Topic
323,Holger Dette,Author
323,Katrin Kettelhake,Author
323,Kirsten Schorning,Author
323,Weng Kee Wong,Author
323,Frank Bretz,Author
324,Composite Endpoints,Topic
324,Time-To-Event Endpoints,Topic
324,Comparedesign,Topic
324,Jordi CortÈs Martinez,Author
324,Marta Bofill Roig,Author
324,Guadalupe GÛmez Melis,Author
325,Information Theory,Topic
325,Communication Over Noisy Channels,Topic
325,Nervous System,Topic
325,Robin A. A. Ince,Author
325,Simon R. Schultz,Author
325,Stefano Panzeri,Author
326,Ibex Knowledge-Base,Topic
326,Ziv Yaniv,Author
326,Ifeanyichukwu U. Anidi,Author
326,Leanne Arakkal,Author
326,Armando J. Arroyo-MejÌas,Author
326,Rebecca T. Beuschel,Author
326,Katy Bˆrner,Author
326,Colin J. Chu,Author
326,Beatrice Clark,Author
326,Menna R. Clatworthy,Author
326,Jake Colautti,Author
326,Fabian Coscia,Author
326,Joshua Croteau,Author
326,Saven Denha,Author
326,Rose Dever,Author
326,Walderez O. Dutra,Author
326,Sonja Fritzsche,Author
326,Spencer Fullam,Author
326,Michael Y. Gerner,Author
326,Anita Gola,Author
326,Kenneth J. Gollob,Author
326,Jonathan M. Hernandez,Author
326,Jyh Liang Hor,Author
326,Hiroshi Ichise,Author
326,Zhixin Jing,Author
326,Danny Jonigk,Author
326,Evelyn Kandov,Author
326,Wolfgang Kastenm¸ller,Author
326,Joshua F. E. Koenig,Author
326,Aanandita Kothurkar,Author
326,Rosa K. Kortekaas,Author
326,Alexandra Y. Kreins,Author
326,Ian T. Lamborn,Author
326,Yuri Lin,Author
326,Katia Luciano Pereira Morais,Author
326,Aleksandra Lunich,Author
326,Jean C. S. Luz,Author
326,Ryan B. Macdonald,Author
326,Chen Makranz,Author
326,Vivien I. Maltez,Author
326,John E. Mcdonough,Author
326,Ryan V. Moriarty,Author
326,Juan M. Ocampo-Godinez,Author
326,Vitoria M. Olyntho,Author
326,Annette Oxenius,Author
326,Kartika Padhan,Author
326,Kirsten Remmert,Author
326,Nathan Richoz,Author
326,Edward C. Schrom,Author
326,Wanjing Shang,Author
326,Lihong Shi,Author
326,Rochelle M. Shih,Author
326,Emily Speranza,Author
326,Salome Stierli,Author
326,Sarah A. Teichmann,Author
326,Tibor Z. Veres,Author
326,Megan Vierhout,Author
326,Brianna T. Wachter,Author
326,Margaret Williams,Author
326,Nathan Zangger,Author
326,Ronald N. Germain,Author
326,Andrea J. Radtke,Author
327,Rheumatoid Arthritis Clinical Trial,Topic
327,Andrew J Mcmurry,Author
327,Richen Zhang,Author
327,Alex Foxman,Author
327,Lawrence Reiter,Author
327,Ronny Schnel,Author
327,Deleys Brandman,Author
327,Electronic Health Record Systems,Topic
327,Hipaa Privacy Rules,Topic
327,Patient Cohort Development,Topic
327,Clinical Trials,Topic
327,Accountable Care Organization,Topic
327,Prevalence Of Ra,Topic
327,De-Identification Of Phi,Topic
327,Clinical Documentation Extraction,Topic
327,Study Population,Topic
327,Patient Privacy,Topic
327,Clinical Study Planning,Topic
328,Immersive Virtual Reality,Topic
328,Vr Induced Adverse Symptoms And Effects,Topic
328,Cognitive Neuroscience,Topic
328,Panagiotis Kourtesis,Author
328,Simona Collina,Author
328,Leonidas A. A. Doumas,Author
328,Sarah E. Macpherson,Author
328,New Generation Hmds,Topic
328,Commercial Versions Of Hmds,Topic
328,Technological Competency,Topic
328,Health And Safety Standards,Topic
328,Scientific Results,Topic
328,Meta-Analysis Of Vr Studies,Topic
328,Technological Systematic Literature,Topic
328,Adverse Symptomatology,Topic
328,Ergonomic Interactions,Topic
328,Neuroscientific Results,Topic
329,Adaptive Allocation Theory In Clinical Trials,Paper
329,Adaptive Designs,Topic
329,Play-The-Winner Rule,Topic
329,Markov Chain Model,Topic
329,Randomized Play-The-Winner Rule,Topic
329,Urn Models,Topic
329,Drop-The-Loser Rule,Topic
329,Doubly Biased Coin Adaptive Design,Topic
329,Asymptotic Theories,Topic
329,Delayed Responses,Topic
329,Power And Variability Comparison,Topic
330,Application Of The Signature Method To Pattern Recognition In The Cequel Clinical Trial,Paper
330,A. B. Kormilitzin,Author
330,K. E. A. Saunders,Author
330,P. J. Harrison,Author
330,J. R. Geddes,Author
330,T. J. Lyons,Author
331,Group Sequential Clinical Trial Designs For Normally Distributed Outcome Variables,Paper
331,Michael Grayling,Author
331,James Wason,Author
331,Adrian Mander,Author
332,Itzhaky Et Al,Paper
332,Statistical Methods,Topic
333,Aducanumab,Topic
333,Tommaso Costa,Author
333,Franco Cauda,Author
334,Adaptive Experiments And A Rigorous Framework For Type I Error Verification And Computational Experiment Design,Paper
334,Michael Sklar,Author
334,Adaptive Experiment Design,Topic
334,Clinical Trial Designs,Topic
334,Multi-Armed Bandit Theory,Topic
334,Bandit And Covariate Processes,Topic
334,Simulation-Based Verification,Topic
335,Robust Variance Estimation For Covariate-Adjusted Unconditional Treatment Effect In Randomized Clinical Trials With Binary Outcomes,Paper
336,Drug Supply Chain Optimization For Adaptive Clinical Trials,Paper
337,Nph2Ph-Transform,Topic
337,Sean M. Devlin,Author
337,John O'Quigley,Author
338,Uncertainty Quantification On Clinical Trial Outcome Prediction,Paper
339,The Power Of A Large Clinical Trial,Topic
339,"Low Recruitment, Follow-Up And Adherence Rates",Topic
339,External Pilot Trials,Topic
339,Definitive Trial,Topic
339,Hypothesis Test Of The Feasibility Of A Definitive Trial,Topic
339,Tiga-Cub,Paper
340,Hptn 084,Topic
340,Long-Acting Cabotegravir,Topic
340,Tenofovir Disoproxil Fumarate Plus Emtricitabine,Topic
340,Qijia He,Author
340,Fei Gao,Author
340,Oliver Dukes,Author
340,Sinead Delany-Moretlwe,Author
340,Bo Zhang,Author
341,Phase Ii/Iii Trial Design,Topic
341,Gated Group Sequential Design,Topic
341,Guanhong Miao,Author
341,Jason J. Z. Liao,Author
341,Jing Yang,Author
341,Keaven Anderson,Author
342,Three-Arm Non-Inferiority Trials,Topic
342,Placebo Group,Topic
342,Koch-Rˆhmel Design,Topic
342,Martin Scharpenberg,Author
342,Werner Brannath,Author
342,Non-Inferiority,Topic
342,Assay Sensitivity,Topic
342,Superiority To Placebo,Topic
342,"$	Heta$-Superiority",Topic
342,Simultaneous Confidence Intervals,Topic
342,Clinical Trial Example,Topic
343,Master Protocols,Topic
343,Oncology Clinical Trials,Topic
343,External Controls,Topic
343,Jie Chen,Author
343,Xiaoyun,Author
343,Li,Author
343,Chengxing,Author
343,Lu,Author
343,Sammy Yuan,Author
343,Godwin Yung,Author
343,Jingjing Ye,Author
343,Hong Tian,Author
343,Jianchang Lin,Author
344,Non-Inferiority Trials,Topic
344,Estimands Framework,Topic
344,Katy E Morgan,Author
344,Ian R White,Author
344,ClÈmence Leyrat,Author
344,Simon Stanworth,Author
344,Brennan C Kahan,Author
344,Inverse Probability Weighting,Topic
344,Instrumental Variable Approaches,Topic
344,Hypothetical Estimand,Topic
344,Per Protocol Analyses,Topic
345,Bayesian Trial Designs,Topic
345,Frequentist Type I Error Rate,Topic
345,2-Arm Superiority Trial,Topic
345,Dichotomous Outcomes,Topic
345,False Discovery Probability (Fdp),Topic
345,False Futility Probability (Ffp),Topic
345,Elja Arjas,Author
345,Dario Gasbarra,Author
346,Algorithms For Multi-Armed Bandit Problems,Paper
346,Volodymyr Kuleshov,Author
346,Doina Precup,Author
346,Multi-Armed Bandit Algorithms,Topic
346,Clinical Trials,Topic
347,Prior Information Incorporation,Topic
347,Nuisance Parameter,Topic
347,Bayesian Meta-Analytic-Predictive Approach,Topic
347,Simulation Study,Topic
347,Tobias M¸tze,Author
347,Heinz Schmidli,Author
347,Tim Friede,Author
348,Graphical Approaches For The Control Of Generalised Error Rates,Paper
348,David S. Robertson,Author
348,James M. S. Wason,Author
348,Frank Bretz,Author
349,Clinical Research,Topic
349,Ethical And Scientific Integrity,Topic
349,Human Lives,Topic
349,Economic Incentives,Topic
349,Conflicts Of Interest,Topic
349,Investigators,Topic
349,Unfavorable Results,Topic
349,Data Tampering,Topic
349,Clinical Trial Results,Topic
349,P-Values,Topic
349,Phase Ii Drug Trials,Topic
349,Phase Iii Drug Trials,Topic
349,Clinicaltrials.Gov Registry,Topic
349,5% Threshold,Topic
349,Density Discontinuity Test,Topic
349,Significant Results,Topic
349,Early Favorable Results,Topic
349,Selective Continuation,Topic
349,JÈrÙme Adda,Author
349,Christian Decker,Author
349,Marco Ottaviani,Author
350,Estimating Causal Effects From Randomized Experiments,Topic
350,Clinical Research,Topic
350,Statistical Uncertainty,Topic
350,Historical Data,Topic
350,Prognostic Model,Topic
350,Treatment Effect,Topic
350,Linear Regression,Topic
350,Alzheimer'S Disease Clinical Trial,Topic
350,Alejandro Schuler,Author
350,David Walsh,Author
350,Diana Hall,Author
350,Jon Walsh,Author
350,Charles Fisher,Author
351,Pico Span Detection,Topic
351,Shifeng Liu,Author
351,Yifang Sun,Author
351,Bing Li,Author
351,Wei Wang,Author
351,Florence T. Bourgeois,Author
351,Adam G. Dunn,Author
351,Sent2Span: Span Detection For Pico Extraction In The Biomedical Text Without Span Annotations,Paper
352,A Bayesian Precision Response-Adaptive Phase Ii Clinical Trial Design For Radiotherapies With Competing Risk Survival Outcomes,Paper
352,Radiotherapy,Topic
352,Competing Risk Survival Outcomes,Topic
353,Factive,Topic
353,Cornelia Dunger-Baldauf,Author
353,Rob Hemmings,Author
353,Frank Bretz,Author
353,Byron Jones,Author
353,Anja Schiel,Author
353,Chris Holmes,Author
353,Hta,Topic
354,Broadening Eligibility Criteria In Cancer Trials,Topic
354,Precision Dose-Finding Design,Topic
354,Phase I Cancer Clinical Trials,Topic
354,Rebecca B. Silva,Author
354,Bin Cheng,Author
354,Richard D. Carvajal,Author
354,Shing M. Lee,Author
355,Precision Medicine,Topic
355,Individual Heterogeneity,Topic
355,Clinical Practice,Topic
355,Treatment Effect Heterogeneity,Topic
355,Statistical Methods,Topic
355,Patient Stratification,Topic
355,Multi-Arm Trial,Topic
355,Bayesian Nonparametric Framework,Topic
355,Bayesian Additive Regression Trees (Bart),Topic
355,Bayesian Profile Regression,Topic
355,Variable Selection Procedure,Topic
355,Simulation Studies,Topic
355,Uk-Based Multi-Arm Blood Donation Trial,Topic
355,Yuejia Xu,Author
355,Angela M. Wood,Author
355,Brian D. M. Tom,Author
356,Rct,Topic
356,Cross-Over Trial,Topic
356,Secrets,Topic
356,Synthetic Intervention,Topic
356,Sayeri Lala,Author
356,Niraj K. Jha,Author
357,Biomarker-Guided Clinical Trials,Topic
357,Precision Medicine,Topic
357,Mixture Distributions,Topic
357,Detest,Topic
357,Hong Zhang,Author
357,Jie Pu,Author
357,Shibing Deng,Author
357,Satrajit Roychoudhury,Author
357,Haitao Chu,Author
357,Douglas Robinson,Author
358,Kaplan-Meier Analysis,Topic
358,Chauhan Weighted Trajectory Analysis,Topic
358,Progression Free Survival,Topic
358,Overall Survival,Topic
358,Utkarsh Chauhan,Author
358,Daylen Mackey,Author
358,John R. Mackey,Author
359,Oncology,Topic
359,Phase Ii Trials,Topic
359,Clinical Development Plans,Topic
359,Potent Agents,Topic
359,Short-Term Treatment Efficacy,Topic
359,Response Evaluation Criteria In Solid Tumors,Topic
359,Generalized Bayes' Theorem,Topic
359,Takuya Yoshimoto,Author
359,Satoru Shinoda,Author
359,Kouji Yamamoto,Author
359,Kouji Tahata,Author
360,Mexa-Ctp,Topic
360,Yiqing Zhang,Author
360,Xiaozhong Liu,Author
360,Fabricio Murai,Author
360,Clinical Trials,Topic
360,Deep Learning,Topic
360,Trial Outcome Prediction (Top),Topic
361,Ultrasonic Actuation Of A Fine-Needle Improves Biopsy Yield,Paper
361,Emanuele Perra,Author
361,Eetu Lampsij‰rvi,Author
361,GonÁalo Barreto,Author
361,Muhammad Arif,Author
361,Tuomas Puranen,Author
361,Edward HÊggstrˆm,Author
361,Kenneth P. H. Pritzker,Author
361,Heikki J. Nieminen,Author
361,Sonolancet,Topic
362,Baysize,Topic
362,Xiaolei Lin,Author
362,Jiaying Lyu,Author
362,Shijie Yuan,Author
362,Sue-Jane Wang,Author
362,Yuan Ji,Author
363,Treatments For Pregestational Chronic Conditions During Pregnancy: Emulating A Target Trial With A Treatment Decision Design,Paper
363,Mollie E. Wood,Author
363,Chase D. Latour,Author
363,Lucia C. Petito,Author
363,Causal Effects Of Early-Pregnancy Pharmacotherapies On Pregnancy Outcomes,Topic
363,Target Trial,Topic
363,Treatment Decision Design,Topic
363,Antidepressant Use For Pre-Existing Depressive Disorder,Topic
363,Antihypertensive Medication Use For Mild-To-Moderate Chronic Hypertension,Topic
364,Clinical Tools Involving Immersive Virtual Reality,Topic
364,Cognitive Neuroscience,Topic
364,Neuropsychology,Topic
364,American Academy Of Clinical Neuropsychology,Author
364,National Academy Of Neuropsychology,Author
364,Computerized Neuropsychological Assessment Devices,Topic
364,Vr Everyday Assessment Lab,Topic
364,Panagiotis Kourtesis,Author
364,Sarah E. Macpherson,Author
364,Vr-Eal,Topic
365,Statistical Research Regarding Health-Related Quality Of Life (Hrqol),Topic
365,Mixed Models From The Item Response Theory,Topic
365,Generalized Linear Models For Categorical Data,Topic
365,Cancer Clinical Trials,Topic
365,Antoine Barbieri,Author
365,Jean Peyhardi,Author
365,Thierry Conroy,Author
365,Sophie Gourgou,Author
365,Christian Lavergne,Author
365,Caroline Mollevi,Author
366,Count Data And Recurrent Events In Clinical Trials,Topic
366,Negative Binomial Distributions,Topic
366,Group Sequential Designs,Topic
366,Wald Statistics,Topic
366,Maximum Likelihood Estimators,Topic
366,Asymptotic Normal Theory,Topic
366,Student'S T-Distribution,Topic
366,Resampling,Topic
366,Gscounts,Paper
367,Prospective Registration Of Study Protocols In Clinical Trial Registries,Topic
367,Publication Bias,Topic
367,Meta-Analysis,Topic
367,Sensitivity Analysis,Topic
367,Copas Selection Model,Topic
367,Funnel-Plot,Topic
367,Trim-And-Fill Method,Topic
367,Alternative Inference Procedure,Topic
367,Simulation Study,Topic
367,Clinical Trial Registries,Topic
367,Ao Huang,Author
367,Sho Komukai,Author
367,Tim Friede,Author
367,Satoshi Hattori,Author
368,Covid-19,Topic
368,Oncology Clinical Trials,Topic
368,Estimand Framework,Topic
368,Evgeny Degtyarev,Author
368,Kaspar Rufibach,Author
368,Yue Shentu,Author
368,Godwin Yung,Author
368,Michelle Casey,Author
368,Stefan Englert,Author
368,Feng Liu,Author
368,Yi Liu,Author
368,Oliver Sailer,Author
368,Jonathan Siegel,Author
368,Steven Sun,Author
368,Rui Tang,Author
368,Jiangxiu Zhou,Author
369,Combining Experimental And Observational Follow-Up Datasets,Topic
369,Long-Term Effect Estimation When Combining Clinical Trial And Observational Follow-Up Datasets,Paper
370,Concept Normalization,Topic
370,Text-Mining Pipeline,Topic
370,Bidirectional Encoder Representations From Transformers (Bert),Topic
370,Biomedical Domain,Topic
370,Drug Discovery And Development,Topic
370,Clinical Trials,Topic
370,Zulfat Miftahutdinov,Author
370,Artur Kadurin,Author
370,Roman Kudrin,Author
370,Elena Tutubalina,Author
370,Two-Stage Neural Approach,Topic
370,Metric Learning Model,Topic
370,Triplet Loss,Topic
370,Vector Embeddings,Topic
370,Embedding Space,Topic
370,Dataset Of Abstracts,Topic
370,Real-World Dataset Of Trial Records,Topic
370,Drug And Disease Terminologies,Topic
370,Knowledge Transfer,Topic
371,Using Targeted Maximum Likelihood Estimation To Estimate Treatment Effect With Longitudinal Continuous Or Binary Data: A Systematic Evaluation Of 28 Diabetes Clinical Trials,Paper
371,Lingjing Jiang,Author
371,Michael Rosenblum,Author
371,Yu Du,Author
371,Diabetes Clinical Trials,Topic
371,Mmrm,Topic
371,Glmm,Topic
371,Tmle,Topic
371,Longitudinal Continuous Outcome,Topic
371,Longitudinal Binary Outcome,Topic
371,Average Treatment Effect,Topic
371,Missing Data Scenarios,Topic
371,Real Data Sets,Topic
371,Cumbersome Covariance Fitting Procedure,Topic
372,Confirmatory Clinical Trials,Topic
372,Survival Outcomes,Topic
372,Interim Analyses,Topic
372,Log Rank Test,Topic
372,Cox Regression Model,Topic
372,Proportional Hazards Assumption,Topic
372,Type I Error Rate,Topic
372,Loss Of Power,Topic
372,Immunotherapy,Topic
372,Chemotherapy,Topic
372,Group Sequential Tests,Topic
372,Survival Curves,Topic
372,Covariate Adjustment,Topic
372,Test Statistics,Topic
372,Marginal Comparisons,Topic
372,Clinical Trial Dataset,Topic
372,Blood And Marrow Transplant Clinical Trials Network 1101 Trial,Topic
372,Peter Zhang,Author
372,Brent Logan,Author
372,Michael Martens,Author
373,Alpapico: Extraction Of Pico Frames From Clinical Trial Documents Using Llms,Paper
373,Madhusudan Ghosh,Author
373,Shrimon Mukherjee,Author
373,Asmit Ganguly,Author
373,Partha Basuchowdhuri,Author
373,Sudip Kumar Naskar,Author
373,Debasis Ganguly,Author
373,Pico,Topic
373,Clinical Trial Documents,Topic
373,Large Language Models,Topic
373,In-Context Learning,Topic
373,Instruction Tuning,Topic
373,Low Rank Adaptation,Topic
373,Ebm-Nlp Datasets,Topic
374,Fragility Index For Time-To-Event Endpoints In Single-Arm Clinical Trials,Paper
374,Arnab Kumar Maity,Author
374,Jhanvi Garg,Author
374,Cynthia Basu,Author
375,A Simple Cellular Automaton Model For Influenza A Viral Infections,Paper
375,Catherine Beauchemin,Author
375,John Samuel,Author
375,Jack Tuszynski,Author
375,Viral Kinetics,Topic
375,Influenza A,Topic
376,Natural Igm Autoantibodies,Topic
376,Systemic Lupus Erythematosus (Sle),Topic
376,Igm Responses,Topic
376,Hla-Drb1*03,Topic
376,Cardiovascular Disease,Topic
376,Caroline Gronwall,Author
376,Uta Hardt,Author
376,Johanna T. Gustafsson,Author
376,Kerstin Elvin,Author
376,Kerstin Jensen-Urstad,Author
376,Marika Kvarnstrom,Author
376,Giorgia Grosso,Author
376,Johan Ronnelid,Author
376,Leonid Padyukov,Author
376,Iva Gunnarsson,Author
376,Gregg J. Silverman,Author
376,Elisabet Svenungsson,Author
377,Head And Neck Squamous Cell Carcinoma,Topic
377,Alcohol,Topic
377,Tobacco,Topic
377,Human Papillomavirus,Topic
377,Hpv Status,Topic
377,Triplet-Ranking Loss Function,Topic
377,Multiple Instance Learning Pipeline,Topic
377,Hpv Detection,Topic
377,Tumour Microenvironment Profiling,Topic
377,T Cells,Topic
377,Macrophages,Topic
377,Fibroblast,Topic
377,Gene Expression Profiles,Topic
377,Ruoyu Wang,Author
377,Syed Ali Khurram,Author
377,Amina Asif,Author
377,Lawrence Young,Author
377,Nasir Rajpoot,Author
378,Model-Based Recursive Partitioning (Mob),Topic
378,Subgroup Identification,Topic
378,Metamob,Topic
378,Generalized Mixed-Effects Model Tree (Glmm Tree),Topic
378,Randomized Controlled Clinical Trials,Topic
378,Cynthia Huber,Author
378,Norbert Benda,Author
378,Tim Friede,Author
379,Vaccine Efficacy For Binary Post-Infection Outcomes Under Misclassification Without Monotonicity,Paper
379,Regulatory Approval,Topic
379,Pharmaceutical Companies,Topic
379,Vaccines,Topic
379,Principal Stratification,Topic
379,Causal Effect,Topic
379,Vaccine Efficacy,Topic
379,Clinical Trial Settings,Topic
379,Measurement Error,Topic
379,Multi-Arm Clinical Trials,Topic
380,Oncology Dose Finding Using Approximate Bayesian Computation Design,Paper
381,Information-Adaptive Clinical Trials: A Selective Recruitment Design,Paper
381,Clinical Trials,Topic
381,Time-To-Event Outcomes,Topic
381,Covariates,Topic
381,Biomarkers,Topic
381,Proportional Hazards Model,Topic
381,Expected Entropy,Topic
381,German Breast Cancer Study Group,Topic
381,Biomarker Validation Trial,Topic
382,Combining Survival Trials Using Aggregate Data Based On Misspecified Models,Paper
383,Stopped Negative Binomial Distribution,Topic
383,Michelle Deveaux,Author
383,Michael J. Kane,Author
383,Daniel Zelterman,Author
384,Selective Recruitment Designs,Topic
384,Information-Adaptive Design,Topic
384,Statistical Information Methods,Topic
384,James E. Barrett,Author
385,Aaa,Topic
385,Jiaying Lyu,Author
385,Yuan Ji,Author
385,Naiqing Zhao,Author
385,Daniel V. T. Catenacci,Author
386,Power Priors Based On Multiple Historical Studies For Binary Outcomes,Paper
386,Clinical Trial,Topic
386,Antibiotics,Topic
386,Empirical Bayes,Topic
386,Bayesian Approaches,Topic
386,Historical Trials,Topic
386,Drug Resistant Infections,Topic
387,Optimizing Interim Analysis Timing For Bayesian Adaptive Commensurate Designs,Paper
387,Xiao Wu,Author
387,Yi Xu,Author
387,Bradley P. Carlin,Author
388,Recruitment Prediction Framework,Topic
388,Szymon Urbas,Author
388,Chris Sherlock,Author
388,Paul Metcalfe,Author
388,Inhomogeneous Poisson Process,Topic
389,Covid-19 Pandemic,Topic
389,Statistical Issues And Recommendations For Clinical Trials Conducted During The Covid-19 Pandemic,Paper
390,Survival Analysis Under Non-Proportional Hazards: Investigating Non-Inferiority Or Equivalence In Time-To-Event Data,Paper
390,Kaplan-Meier Curves,Topic
390,Hazard Ratio,Topic
390,Log-Rank Test,Topic
390,Cox Proportional Hazard Model,Topic
390,Non-Proportional Hazards,Topic
390,Equivalence Trials,Topic
390,Non-Inferiority Trials,Topic
390,Parametric Framework,Topic
390,Pointwise Confidence Bands,Topic
390,Test Procedure,Topic
390,Clinical Trial Example,Topic
390,Simulation Results,Topic
391,Identifying Heterogeneous Treatment Effects In Randomized Controlled Trials,Topic
391,Erin Craig,Author
391,Donald A Redelmeier,Author
391,Robert J Tibshirani,Author
392,Bayesian Prognostic Covariate Adjustment,Topic
392,David Walsh,Author
392,Alejandro Schuler,Author
392,Diana Hall,Author
392,Jon Walsh,Author
392,Charles Fisher,Author
393,Bnt162B2 Mrna Covid-19 Vaccine Trial,Topic
393,Bayesian Design And Analysis,Topic
393,Bayesian Statistics,Topic
393,Bayesian Credible Intervals,Topic
393,Confidence Intervals,Topic
393,Posterior Probabilities,Topic
393,Yuan Ji,Author
393,Shijie Yuan,Author
393,Regulatory Decision Making,Topic
393,Bi,Topic
393,Ci,Topic
393,Lessons Learned From The Bayesian Design And Analysis For The Bnt162B2 Covid-19 Vaccine Phase 3 Trial,Paper
394,Multi-Armed Bandits,Topic
394,Model-Assisted Designs,Topic
394,Dose-Finding Clinical Trials,Topic
394,Thompson Sampling,Topic
394,Regularized Thompson Sampling,Topic
394,Greedy Algorithm,Topic
394,Posterior Mean,Topic
394,Posterior Median,Topic
394,Masahiro Kojima,Author
394,Simulation Studies,Topic
395,Priors From Envisioned Posterior Judgments: A Novel Elicitation Approach With Application To Bayesian Clinical Trials,Paper
395,Yongdong Ouyang,Author
395,Janice J Eng,Author
395,Denghuang Zhan,Author
395,Hubert Wong,Author
396,Multiple Sclerosis,Topic
396,Andy A. Shen,Author
396,Aidan Mcloughlin,Author
396,Zoe Vernon,Author
396,Jonathan Lin,Author
396,Richard A. D. Carano,Author
396,Peter J. Bickel,Author
396,Zhuang Song,Author
396,Haiyan Huang,Author
397,Handling Covariates In The Design Of Clinical Trials,Paper
397,Covariate-Adjusted Response-Adaptive Randomization,Topic
397,Clinical Trial Design,Topic
397,Stratification And Covariate-Adaptive Randomization,Topic
398,Hypothesis Tests Based On Linear Models,Topic
398,Organizations That Regulate Clinical Trials,Topic
398,Parametric Distributions,Topic
398,Permutation Tests,Topic
398,Analysis Of Covariance (Ancova),Topic
398,Linear Regression,Topic
398,Pretreatment Covariates,Topic
398,Kellie Ottoboni,Author
398,Fraser Lewis,Author
398,Luigi Salmaso,Author
398,Gastroesophageal Reflux Disease,Topic
398,An Empirical Comparison Of Parametric And Permutation Tests For Regression Analysis Of Randomized Experiments,Paper
399,Quantifying And Detecting Individual Level 'Always Survivor' Causal Effects Under 'Truncation By Death' And Censoring Through Time,Paper
399,Jaffer M. Zaidi,Author
399,Eric J. Tchetgen Tchetgen,Author
399,Tyler J. Vanderweele,Author
400,Clinical Trial Records,Topic
400,Patients,Topic
400,Diseases,Topic
400,Eligibility Criteria,Topic
400,Summary Of Results,Topic
400,Conclusions,Topic
400,Computer-Based Eligibility Query Formulation,Topic
400,Electronic Patient Screening,Topic
400,Previous Research,Topic
400,Knowledge-Guided Text Structuring Framework,Topic
400,Knowledge Base,Topic
400,Word Dependency Relations,Topic
400,Formal Representations,Topic
400,High Precision And Recall,Topic
400,Yingcheng Sun,Author
400,Kenneth Loparo,Author
401,Response Adaptive Randomization,Topic
401,Response Adaptive Block Randomization,Topic
401,Doubly Adaptive Biased Coin Design,Topic
401,Tianyu Zhan,Author
401,Lu Cui,Author
401,Ziqian Geng,Author
401,Lanju Zhang,Author
401,Yihua Gu,Author
401,Ivan S. F. Chan,Author
402,Response-Adaptive Randomization,Topic
402,David S. Robertson,Author
402,Kim May Lee,Author
402,Boryana C. Lopez-Kolkovska,Author
402,Sofia S. Villar,Author
402,Clinical Trials,Topic
402,Data-Dependent Sampling Algorithms,Topic
402,Biostatistical Literature,Topic
402,Machine Learning,Topic
403,Randomised Clinical Trial Results,Topic
403,Intercurrent Events,Topic
403,Rescue Medication,Topic
403,Intention-To-Treat Analysis,Topic
403,Estimand,Topic
403,Treatment Effect,Topic
403,Inverse Probability Weighting Method,Topic
403,Sensitivity Analysis,Topic
403,Clinical Trial,Topic
403,Janssen Pharmaceuticals,Author
403,Hege Michiels,Author
403,Cristina Sotto,Author
403,An Vandebosch,Author
403,Stijn Vansteelandt,Author
404,Semeval-2023 Task 7,Topic
404,Juraj Vladika,Author
404,Florian Matthes,Author
404,Nlp Solutions,Topic
404,Clinical Trial Reports,Topic
404,Evidence Retrieval,Topic
404,Natural Language Inference,Topic
404,Pipeline System,Topic
404,Joint System,Topic
404,Ensemble System,Topic
405,Stratification In Randomized Clinical Trials,Topic
405,Neal Thomas,Author
405,Misclassification Errors,Topic
405,Corrected Values,Topic
405,Likelihood Function,Topic
405,Standard Errors,Topic
405,Unbiased Linear Estimation,Topic
405,Confidence Interval Coverage,Topic
406,Heterogeneous Treatment Effects,Topic
406,Randomized Clinical Trials,Topic
406,Richard Berk,Author
406,Matthew Olson,Author
406,Andreas Buja,Author
406,Aurelie Ouss,Author
406,Using Recursive Partitioning To Find And Estimate Heterogenous Treatment Effects In Randomized Clinical Trials,Paper
407,A Simulation Study Evaluating Phase I Clinical Trial Designs For Combinational Agents,Paper
407,Shu Wang,Author
407,Ji-Hyun Lee,Author
407,Phase I Clinical Trial Designs,Topic
408,Bayesian Optimization,Topic
408,Clinical Trials,Topic
408,Design Selection Process,Topic
408,Adaptive Seamless Designs,Topic
408,Jakob Richter,Author
408,Tim Friede,Author
408,Jˆrg Rahnenf¸hrer,Author
409,The Predictive Individual Effect For Survival Data,Paper
409,Beat Neuenschwander,Author
409,Satrajit Roychoudhury,Author
409,Simon Wandel,Author
409,Kannan Natarajan,Author
409,Emmanuel Zuber,Author
409,Patient-Focused Drug Development,Topic
409,Oncology Trials,Topic
410,Statistical Modelling And Prediction Of Patient Recruitment In Clinical Trials,Paper
410,Vladimir Anisimov,Author
410,Guillaume Mijoule,Author
410,Armando Turchetta,Author
410,Nicolas Savy,Author
410,Poisson-Gamma Model,Topic
410,Dropout Process,Topic
410,Recruitment Forecasting,Topic
411,Missing Data Imputation For A Multivariate Outcome Of Mixed Variable Types,Paper
411,Tuo Wang,Author
411,Rachel Zilinskas,Author
411,Ying Li,Author
411,Yongming Qu,Author
412,Unimib Team,Topic
412,Trec 2021 Clinical Trials Track,Topic
412,Georgios Peikos,Author
412,Oscar Espitia,Author
412,Gabriella Pasi,Author
412,Neural Re-Ranking Approach,Topic
412,Dense Text Representations,Topic
412,Decision-Theoretic Model,Topic
412,Relevance Estimation,Topic
412,Keyword Extraction Method,Topic
412,Bm25 Model,Topic
412,Ndcg@10,Topic
412,Rpec@10,Topic
413,Mixed Model Repeated Measures (Mmrm),Topic
413,Constrained Longitudinal Data Analysis,Topic
413,Natural Cubic Splines,Topic
413,Alzheimer'S Disease,Topic
413,M. C. Donohue,Author
413,O. Langford,Author
413,P. Insel,Author
413,C. H. Van Dyck,Author
413,R. C. Petersen,Author
413,S. Craft,Author
413,G. Sethuraman,Author
413,R. Raman,Author
413,P. S. Aisen,Author
414,Modern Approaches For Evaluating Treatment Effect Heterogeneity From Clinical Trials And Observational Data,Paper
414,Ilya Lipkovich,Author
414,David Svensson,Author
414,Bohdana Ratitch,Author
414,Alex Dmitrienko,Author
415,Non-Proportional Hazards,Topic
415,Clinical Trials,Topic
415,Time-To-Event Endpoints,Topic
415,Immunotherapy For Cancer,Topic
415,Group Sequential Design,Topic
415,Average Hazard Ratio,Topic
415,Weighted Logrank Test,Topic
415,Maxcombo Combination Test,Topic
415,Gsdesign2 R Package,Topic
415,Yujie Zhao,Author
415,Yilong Zhang,Author
415,Larry Leon,Author
415,Keaven M. Anderson,Author
416,Large Language Models,Topic
416,Conversational Ai,Topic
416,Content Generation,Topic
416,Information Retrieval,Topic
416,Business Intelligence,Topic
416,Medical,Topic
416,Clinical Trials,Topic
416,Shortcut Learning,Topic
416,Factual Inconsistency,Topic
416,Performance Degradation,Topic
416,Adversarial Testing,Topic
416,Robust Testing,Topic
416,Ambiguity,Topic
416,Reasoning Integrity,Topic
416,Syntactic Understanding,Topic
416,Semantic Understanding,Topic
416,Mnestic Probing,Topic
416,Sci-Five Model,Topic
416,Natural Logic,Topic
416,Task Specific Probes,Topic
416,Iterative Null Projection,Topic
416,Model Accuracy,Topic
416,Probe Size,Topic
416,Ata Mustafa,Author
416,Enhancing Robustness In Biomedical Nli Models: A Probing Approach For Clinical Trials,Paper
417,Large Language Models,Topic
417,Natural Language Processing,Topic
417,Natural Language Inference,Topic
417,Breast Cancer Clinical Trial Reports,Topic
417,Semeval 2024 Task 2,Topic
417,Retrieval-Augmented Generation,Topic
417,Iitk,Author
417,Shreyasi Mandal,Author
417,Ashutosh Modi,Author
417,Gpt-3.5,Paper
417,Gemini Pro,Paper
417,Evaluation Results,Topic
418,Considerations For Single-Arm Trials To Support Accelerated Approval Of Oncology Drugs,Paper
418,Feinan Lu,Author
418,Tao Wang,Author
418,Ying Lu,Author
418,Jie Chen,Author
419,Large Language Models In Drug Discovery And Development: From Disease Mechanisms To Clinical Trials,Paper
419,Yizhen Zheng,Author
419,Huan Yee Koh,Author
419,Maddie Yang,Author
419,Li Li,Author
419,Lauren T. May,Author
419,Geoffrey I. Webb,Author
419,Shirui Pan,Author
419,George Church,Author
419,Computational Biology,Topic
419,Pharmacology,Topic
419,Ai4Science,Topic
419,Drug Discovery,Topic
419,Drug Development,Topic
419,Disease Mechanisms,Topic
419,Clinical Trials,Topic
420,Randomized Clinical Trials,Topic
420,Observational Studies,Topic
420,Sensitivity Analysis,Topic
420,Synthesis Estimator,Topic
420,Average Treatment Effect,Topic
420,Kuan Jiang,Author
420,Wenjie Hu,Author
420,Shu Yang,Author
420,Xinxing Lai,Author
420,Xiaohua Zhou,Author
420,Improve Sensitivity Analysis Synthesizing Randomized Clinical Trials With Limited Overlap,Paper
421,G-Estimation,Topic
421,Intercurrent Events,Topic
421,Ich E9(R1) Addendum,Topic
421,Alzheimer Disease,Topic
421,Florian Lasch,Author
421,Lorenzo Guizzaro,Author
421,Wen Wei Loh,Author
422,Pattern-Mixture Models,Topic
422,Treatment Effects,Topic
422,Clinical Trials,Topic
422,Nonignorable Missing Data,Topic
422,Multiple Imputation,Topic
422,Rubin'S Approach,Topic
422,Bootstrap Methods,Topic
422,Direct Likelihood-Based Approaches,Topic
422,Analytical Framework,Topic
422,Return-To-Baseline,Topic
422,Jump-To-Reference,Topic
422,Placebo Washout,Topic
422,Retrieved Dropout Imputations,Topic
422,Tipping Point Analysis,Topic
422,Simulation Studies,Topic
422,Clinical Trial Evaluating A Treatment For Type 2 Diabetes,Topic
422,Jitong Lou,Author
422,Mallikarjuna Rettiganti,Author
422,Yongming Qu,Author
422,Direct Estimation For Commonly Used Pattern-Mixture Models In Clinical Trials,Paper
423,Pkg2.0,Topic
423,Biomedical Literature,Topic
423,Jian Xu,Author
423,Chao Yu,Author
423,Jiawei Xu,Author
423,Ying Ding,Author
423,Vetle I. Torvik,Author
423,Jaewoo Kang,Author
423,Mujeen Sung,Author
423,Min Song,Author
424,Neurodegenerative Disorders,Topic
424,Alzheimer'S Disease,Topic
424,Longitudinal Rank Sum Test,Topic
424,Xiaoming Xu,Author
424,Dhrubajyoti Ghosh,Author
424,Sheng Luo,Author
424,A Novel Longitudinal Rank-Sum Test For Multiple Primary Endpoints In Clinical Trials: Applications To Neurodegenerative Disorders,Paper
425,G-Computation For Increasing Performances Of Clinical Trials With Individual Randomization And Binary Response,Paper
425,Clinical Trials,Topic
425,Machine Learning,Topic
425,Penalized Regressions,Topic
425,Algorithm-Based Methods,Topic
426,Sparsevm,Topic
426,3D Mr Scans,Topic
426,Voxelmorph Package,Topic
426,Kathleen M. Lewis,Author
426,Natalia S. Rost,Author
426,John Guttag,Author
426,Adrian V. Dalca,Author
427,Multi-Arm Multi-Stage Trial,Topic
427,Allocation Ratio,Topic
427,Optimal Allocation Ratio,Topic
427,Martin Law,Author
428,Leafai,Topic
428,Nicholas J Dobbins,Author
428,Bin Han,Author
428,Weipeng Zhou,Author
428,Kristine Lan,Author
428,H. Nina Kim,Author
428,Robert Harrington,Author
428,Ozlem Uzuner,Author
428,Meliha Yetisgen,Author
428,Clinical Trials,Topic
429,Sex Differences In Severity And Mortality Among Patients With Covid-19: Evidence From Pooled Literature Analysis And Insights From Integrated Bioinformatic Analysis,Paper
429,Covid-19,Topic
430,Bapofi,Topic
430,Bapofi-Tte,Topic
430,Satoshi Morita,Author
430,Peter M¸ller,Author
430,Hiroyasu Abe,Author
430,Biometrics,Topic
431,Monte Carlo Simulations Of Stroke,Topic
431,3D Stroke Simulations,Topic
431,James P. Hague,Author
431,Jonathan Keelan,Author
431,Lucy Beishon,Author
431,David Swienton,Author
431,Thompson G. Robinson,Author
431,Emma M. L. Chung,Author
431,In-Silico Trials,Topic
431,Probabilistic Lesion Overlap Maps,Topic
431,Equation For Sizing Emboli,Topic
432,Misclassification Of Vaccination Status In Electronic Health Records: A Bayesian Approach In Cluster Randomized Trials,Paper
432,Misclassification,Topic
432,Public Health,Topic
432,Vaccinations,Topic
432,Cluster Controlled Randomized Trial (Ccrt),Topic
432,Bayesian Logistic Regression,Topic
432,Behavioral Intervention,Topic
432,Vaccination Uptake,Topic
432,U.S. Veterans,Topic
433,Clinical Trials,Topic
433,Volodymyr Anisimov,Author
433,Lucas Oliver,Author
433,Poisson-Gamma Model,Topic
433,Patient Recruitment,Topic
433,Time-Dependent Rates,Topic
433,Homogeneity Testing,Topic
433,Analytic Methodology,Topic
434,Cure Proportion Model,Topic
434,Overall Survival,Topic
434,Phase 1 Trial,Topic
434,Phase 3 Trial,Topic
434,Futility Interim Analysis,Topic
434,Intermediate Endpoint,Topic
434,Acute Myeloid Leukemia,Topic
434,Kaspar Rufibach,Author
434,Dominik Heinzmann,Author
434,Annabelle Monnet,Author
435,Power Contours: Optimising Sample Size And Precision In Experimental Psychology And Human Neuroscience,Paper
435,Daniel H. Baker,Author
435,Greta Vilidaite,Author
435,Freya A. Lygo,Author
435,Anika K. Smith,Author
435,Tessa R. Flack,Author
435,Andre D. Gouws,Author
435,Timothy J. Andrews,Author
435,Statistical Power,Topic
435,Experimental Studies,Topic
435,Human Participants,Topic
435,Variance,Topic
435,Power Contour Plots,Topic
435,Online Tool,Topic
436,Time-Frequency Analysis,Topic
436,Brain Rhythms,Topic
436,Event-Related Protocols,Topic
436,Avgamp,Topic
436,Itc,Topic
436,Powavg,Topic
436,Jonas Benhamou,Author
436,Michel Le Van Quyen,Author
436,Guillaume Marrelec,Author
436,Relationship Between Powavg And Itc,Topic
436,S-Transform,Topic
436,Oscillatory Signal,Topic
436,Neuroscientific Toolbox,Topic
437,Covid-19 Pandemic,Topic
437,Long Covid,Topic
437,Immune Dysregulation,Topic
437,Post-Covid-19 Patients,Topic
437,2022,Topic
437,2023,Topic
437,Machine Learning Techniques,Topic
437,Immunophenotyping,Topic
437,Clinical Information,Topic
437,Immunological Information,Topic
437,Demographic Information,Topic
437,Persistent Inflammation,Topic
437,Altered Cytokine Profiles,Topic
437,Abnormal Immune Cell Subsets,Topic
437,Personalized Interventions,Topic
437,Targeted Therapies,Topic
437,Clinical Management,Topic
437,Maitham G. Yousif,Author
437,Ghizal Fatima,Author
437,Hector J. Castro,Author
437,Fadhil G. Al-Amran,Author
437,Salman Rawaf,Author
437,Unraveling Post-Covid-19 Immune Dysregulation Using Machine Learning-Based Immunophenotyping,Paper
438,Laboratory Values Estimation And Monitoring From Electrocardiogram Signals -- A Multimodal Deep Learning Approach,Paper
438,Mimic-Iv Dataset,Topic
438,Ecg Waveforms,Topic
438,Laboratory Value Abnormalities,Topic
438,Auroc Scores,Topic
438,Cardiac Abnormalities,Topic
438,Renal Abnormalities,Topic
438,Hematological Abnormalities,Topic
438,Metabolic Abnormalities,Topic
438,Immunological Abnormalities,Topic
438,Coagulation Abnormalities,Topic
439,Endpoint Choice For Randomized Controlled Trials Of Treatments For Covid-19,Topic
439,Lori E Dodd,Author
439,Dean Follmann,Author
439,Jing Wang,Author
439,Franz Koenig,Author
439,Lisa L Korn,Author
439,Christian Schoergenhofer,Author
439,Michael Proschan,Author
439,Sally Hunsberger,Author
439,Tyler Bonnett,Author
439,Mat Makowski,Author
439,Drifa Belhadi,Author
439,Yeming Wang,Author
439,Bin Cao,Author
439,France Mentre,Author
439,Thomas Jaki,Author
440,Medical Trials,Topic
440,Patients' Health Conditions,Topic
440,Demographic Factors,Topic
440,Death Rate,Topic
440,Bertillon Effect,Topic
440,Age Of The Oldest Patients,Topic
440,Gompertz'S Law,Topic
440,Marital Status,Topic
440,Age Distribution Of Those Over 65,Topic
440,Bertrand M. Roehner,Author
440,Clinical Trials,Topic
440,Reliability And Accuracy Of Trial'S Conclusions,Topic
441,Phase 1 Clinical Trials,Topic
441,Dose-Escalation Practices,Topic
441,Precautionary Coherence Principle,Topic
441,Afm11,Topic
441,Bayesian Dose-Response Model,Topic
441,David C. Norris,Author
442,What Were They Thinking? Pharmacologic Priors Implicit In A Choice Of 3+3 Dose-Escalation Design,Paper
443,Bayesian Response Adaptive Clinical Trials,Topic
443,Experimental Therapies,Topic
443,Diseases,Topic
443,Adaptive Decisions,Topic
443,Randomization Probabilities,Topic
443,New Treatments,Topic
443,Response Adaptive Trials,Topic
443,Simulation Studies,Topic
443,Operating Characteristics,Topic
443,Type I/Ii Error Rates,Topic
443,Bayesian Uncertainty Directed Trial Designs (Buds),Topic
443,Metric U,Topic
443,Information Accrued,Topic
443,Treatment Effects,Topic
443,Asymptotic Analysis,Topic
443,Allocation Of Patients,Topic
443,Treatment Arms,Topic
443,Asymptotic Normality,Topic
443,Power Of The Bud,Topic
443,Marta Bonsaglio,Author
443,Sandra Fortini,Author
443,Steffen Ventz,Author
443,Lorenzo Trippa,Author
444,Modeling Synergism In Early Phase Cancer Trials With Drug Combination With Continuous Dose Levels: Is There An Added Value?,Paper
444,Mourad Tighiouart,Author
444,JosÈ L. JimÈnez,Author
444,Marcio A. Diniz,Author
444,AndrÈ Rogatko,Author
445,Randomized Clinical Trials,Topic
445,In Silico Imaging Trials,Topic
445,Medical Device,Topic
445,Digital Representations Of Humans,Topic
445,Digital Human Models,Topic
445,Digital Cohorts,Topic
445,A Badano,Author
445,M Lago,Author
445,E Sizikova,Author
445,Jg Delfino,Author
445,S Guan,Author
445,Ma Anastasio,Author
445,B Sahiner,Author
446,Molecular Targeted Oncology Drug Development,Topic
446,Basket Trial,Topic
446,Bayesian Approach,Topic
446,Frequentist Approach,Topic
446,Satoshi Hattori,Author
446,Satoshi Morita,Author
446,Mantel-Haenszel Procedure,Topic
446,Clinical Trial Methodologies,Topic
446,Efficacy Evaluation,Topic
446,Type 1 Error Control,Topic
446,Information Criterion Approach,Topic
446,Dually Consistent Variance Estimators,Topic
447,Implementing Response-Adaptive Randomisation In Stratified Rare-Disease Trials: Design Challenges And Practical Solutions,Paper
447,Rajenki Das,Author
447,Nina Deliu,Author
447,Mark Toshner,Author
447,SofÌa S Villar,Author
448,A Comparative Evaluation Of Bayesian Model-Assisted Two-Stage Designs For Phase I/Ii Clinical Trials,Paper
448,Phase I/Ii Trial,Topic
448,Optimal Biological Dose,Topic
448,Recommended Phase Ii Doses,Topic
448,Go/No-Go Decision,Topic
448,Recommended Phase Iii Dose,Topic
448,Bayesian Model-Assisted Designs,Topic
448,Tite-Boin12 + Top,Topic
449,Robbins And Monro,Author
449,Stochastic Approximation,Topic
449,Dose-Finding Studies,Topic
449,Ying Kuen Cheung,Author
449,Stochastic Approximation Literature,Topic
449,Dose-Finding Literature,Topic
449,Clinical Studies,Topic
449,Arxiv.Result,Paper
450,Extracting Factual Min/Max Age Information From Clinical Trial Studies,Paper
450,Yufang Hou,Author
450,Debasis Ganguly,Author
450,Lea A. Deleris,Author
450,Francesca Bonin,Author
451,Intercurrent Events (Ices),Topic
451,Missing Values,Topic
451,Clinical Trials,Topic
451,Treatment Effect,Topic
451,Estimand,Topic
451,Tripartite Estimands,Topic
451,Adverse Events,Topic
451,Lack Of Efficacy,Topic
451,Primary Efficacy Outcome,Topic
451,Causal Inference Framework,Topic
451,Yongming Qu,Author
451,Junxiang Luo,Author
451,Stephen J. Ruberg,Author
451,Phase 3 Clinical Study,Topic
451,Basal Insulin Treatment,Topic
451,Type 1 Diabetes,Topic
452,A Nonparametric Method For Value Function Guided Subgroup Identification Via Gradient Tree Boosting For Censored Survival Data,Paper
452,Subgroup Identification,Topic
452,Individualized Treatment Regime,Topic
452,Gradient Tree Boosting,Topic
452,Censored Survival Data,Topic
452,Aids Clinical Trial,Topic
453,Conventional Methods For Analyzing Composite Endpoints In Clinical Trials,Topic
453,Win Ratio (Wr),Topic
453,Jialu Wang,Author
453,Yeh-Fong Chen,Author
453,Thomas Gwise,Author
453,Utilizing Win Ratio Approaches And Two-Stage Enrichment Designs For Small-Sized Clinical Trials,Paper
454,Knockoffs,Topic
454,Sequential Knockoffs For Continuous And Categorical Predictors: With Application To A Large Psoriatic Arthritis Clinical Trial Pool,Paper
455,In Silico Clinical Trials,Topic
455,Pharmacological Treatment,Topic
455,Precision Medicine,Topic
455,Stefano Sinisi,Author
455,Vadim Alimguzhin,Author
455,Toni Mancini,Author
455,Enrico Tronci,Author
455,Federico Mari,Author
455,Brigitte Leeners,Author
456,Automated Approach To Extracting Positive And Negative Clinical Research Results,Paper
456,Picoe Framework,Topic
456,Covid-19 Related Intervention-Outcomes Pairs,Topic
456,Xuanyu Shi,Author
456,Shiyao Xie,Author
456,Wenjia Wang,Author
456,Ting Chen,Author
456,Jian Du,Author
457,Estimands In Real-World Evidence Studies,Paper
457,Jie Chen,Author
457,Daniel Scharfstein,Author
457,Hongwei Wang,Author
457,Binbing Yu,Author
457,Yang Song,Author
457,Weili He,Author
457,John Scott,Author
457,Xiwu Lin,Author
457,Hana Lee,Author
458,N4U Analysis Base,Topic
458,Neurodegenerative Diseases,Topic
458,Neugrid For Users (N4U),Topic
458,Kamran Munir,Author
458,Saad Liaquat Kiani,Author
458,Khawar Hasham,Author
458,Richard Mcclatchey,Author
458,Andrew Branson,Author
458,Jetendr Shamdasani,Author
458,N4U Consortium,Author
459,Covid-19 Vaccine Trials,Topic
459,Rob Johnson,Author
459,Chris Jackson,Author
459,Anne Presanis,Author
459,Sofia S. Villar,Author
459,Daniela De Angelis,Author
460,Trials,Topic
460,Sample Size Calculations,Topic
460,Semiparametric Efficient Estimator,Topic
460,Power,Topic
460,Alejandro Schuler,Author
460,Clinical Trial,Topic
460,Design Power,Topic
460,Type I Error,Topic
460,"Two-Arm, Single-Timepoint Trial",Topic
460,Nominal Values,Topic
461,Covariate Adjustment,Topic
461,Clinical Trials,Topic
461,Group Sequential Designs,Topic
461,Information Adaptive Design,Topic
461,Kelly Van Lancker,Author
461,Joshua Betz,Author
461,Michael Rosenblum,Author
461,Estimator Performance,Topic
461,Stroke Trial,Topic
462,Basket Trials,Topic
462,Bayesian Approach,Topic
462,Sample Size Determination,Topic
462,Haiyan Zheng,Author
462,Michael J. Grayling,Author
462,Pavel Mozgunov,Author
462,Thomas Jaki,Author
462,James M. S. Wason,Author
463,Actg 175 Hiv Trial,Topic
463,Us Early-Stage Hiv Patients,Topic
463,Thailand Hiv Patients,Topic
463,Southern Ethiopia Hiv Patients,Topic
463,Treatment Effect,Topic
463,Cox Proportional Hazard Model,Topic
463,Inverse Probability Weighting Method,Topic
463,Augmented Calibration Weighting Method,Topic
463,Linear Spline-Based Hazard Regression Model,Topic
463,Dasom Lee,Author
463,Sujit Ghosh,Author
463,Shu Yang,Author
464,Using Limited Trial Evidence To Credibly Choose Treatment Dosage When Efficacy And Adverse Effects Weakly Increase With Dose,Paper
464,Charles F. Manski,Author
464,Dosage,Topic
464,Efficacy,Topic
464,Adverse Effects,Topic
464,Trial Evidence,Topic
464,Patient Care,Topic
464,Treatment Cost,Topic
464,Minimax-Regret Criterion,Topic
464,Convex Polygon,Topic
465,Major Depressive Disorder (Mdd),Topic
465,Michaela Maria Freitag,Author
465,Dario Zocholl,Author
465,Elias Laurin Meyer,Author
465,Stefan M. Gold,Author
465,Marta Bofill Roig,Author
465,Heidi De Smedt,Author
465,Martin Posch,Author
465,Franz Kˆnig,Author
465,Design Considerations For A Phase Ii Platform Trial In Major Depressive Disorder,Paper
466,Ai-Probe,Topic
466,Intra-Cranial Hemorrhage,Topic
466,Turn-Around Time,Topic
466,Aidoc,Author
466,Axel Wism¸ller,Author
466,Larry Stockmaster,Author
467,Neurosciences,Topic
467,Brain Signals,Topic
467,Replicate Locally Stationary Wavelet (Rlsw) Process,Topic
467,Jonathan Embleton,Author
467,Marina I. Knight,Author
467,Hernando Ombao,Author
467,Hippocampus,Topic
467,Nucleus Accumbens,Topic
467,Associative Learning Experiment,Topic
467,Wavelets,Topic
467,Nonstationary Behaviour,Topic
467,Spectral Estimation Framework,Topic
467,Simulation Studies,Topic
467,Theoretical Estimator Properties,Topic
468,Brain,Topic
468,Neuroscience,Topic
468,Monkey_Local_Field_Potentials,Topic
468,Go_No-Go_Task,Topic
468,Bandt-Pompe_Symbolization,Topic
468,Asymmetry_Index,Topic
468,Multi-Scale_Approach,Topic
468,Helena_B_Lucas,Author
468,Steven_L_Bressler,Author
468,Fernanda_S_Matias,Author
468,Osvaldo_A_Rosso,Author
469,Drug Repurposing,Topic
469,Clinical Connectivity Map Framework,Topic
469,Laboratory Tests,Topic
469,Clinical Drug Effect Vectors,Topic
469,Clinical Disease Sign Vectors,Topic
469,Dot Product-Based Scoring Function,Topic
469,Asthma,Topic
469,Coronary Heart Disease,Topic
469,Type 2 Diabetes,Topic
469,Qianlong Wen,Author
469,Ruoqi Liu,Author
469,Ping Zhang,Author
470,Clinical Citation Count,Topic
470,Biomedical Papers,Topic
470,Mpnn Model,Topic
470,Xin Li,Author
470,Xuli Tang,Author
470,Qikai Cheng,Author
471,Crocs,Topic
471,Dani Kiyasseh,Author
471,Tingting Zhu,Author
471,David A. Clifton,Author
471,Clinical Tasks,Topic
471,Clinical Databases,Topic
471,Dtc,Topic
472,Cluster Randomized Trials,Topic
472,Guy Harling,Author
472,Rui Wang,Author
472,Jukka-Pekka Onnela,Author
472,Victor De Gruttola,Author
472,Connectivity-Informed Trial Designs,Topic
472,Public Health Impact,Topic
472,Epidemic Control,Topic
472,Vaccine Effect Performance,Topic
472,Seir-Type Epidemic,Topic
472,Network-Structured Agent-Based Model,Topic
472,Cumulative Incidence,Topic
472,Power To Detect Differences,Topic
472,Holdback Period,Topic
473,Fusing Trial Data For Treatment Comparisons: Single Versus Multi-Span Bridging,Paper
473,Bonnie E. Shook-Sa,Author
473,Paul N. Zivich,Author
473,Samuel P. Rosin,Author
473,Jessie K. Edwards,Author
473,Adaora A. Adimora,Author
473,Michael G. Hudgens,Author
473,Stephen R. Cole,Author
474,Observational Studies,Topic
474,Randomized Controlled Trials (Rcts),Topic
474,Target Trial Emulation,Topic
474,Causal Inference,Topic
474,Novel Framework For Target Trial Emulation,Topic
474,Dimitris Bertsimas,Author
474,Angelos G. Koulouras,Author
474,Hiroshi Nagata,Author
474,Carol Gao,Author
474,Junki Mizusawa,Author
474,Yukihide Kanemitsu,Author
474,Georgios Antonios Margonis,Author
475,Hidden Markov Models For Alcoholism Treatment Trial Data,Paper
475,Markov Models,Topic
475,Hidden Markov Models,Topic
475,Naltrexone,Topic
476,Bayesian Phase I,Topic
476,Lmp1S,Topic
476,U&D,Topic
476,Assaf P. Oron,Author
476,Peter D. Hoff,Author
476,Small-Sample Behavior Of Novel Phase I Cancer Trial Designs,Paper
477,Mathematical Model Of Colorectal Cancer With Monoclonal Antibody Treatments,Paper
477,Colorectal Cancer,Topic
477,Monoclonal Antibody Therapy,Topic
477,Irinotecan,Topic
477,Cetuximab,Topic
477,Panitumumab,Topic
477,Nonlinear Ordinary Differential Equations,Topic
477,Tumor Growth Rate,Topic
477,Carrying Capacity,Topic
477,Pk/Pd Parameters,Topic
478,Response-Adaptive Randomisation (Rar),Topic
478,Sofia S. Villar,Author
478,Jack Bowden,Author
478,James Wason,Author
478,Response Adaptive Designs For Binary Responses: How To Offer Patient Benefit While Being Robust To Time Trends?,Paper
479,Phase I,Topic
479,Phase Ii,Topic
479,Phase I/Ii Clinical Trials,Topic
479,Cytotoxic Agents,Topic
479,Molecularly Targeted Agents,Topic
479,Dose-Efficacy Relationship,Topic
479,Regimen-Finding Design,Topic
479,Pavel Mozgunov,Author
479,Thomas Jaki,Author
480,Strituvad Project,Topic
480,Universal Immune System Simulator,Topic
480,Bayesian Adaptive Design,Topic
480,Digital Patients,Topic
480,Marzio Pennisi,Author
480,Miguel A. Juarez,Author
480,Giulia Russo,Author
480,Marco Viceconti,Author
480,Francesco Pappalardo,Author
481,Event-Driven Clinical Trials,Topic
481,Clinical Events,Topic
481,Oncology,Topic
481,Cardiovascular Trials,Topic
481,Patient Recruitment,Topic
481,Event Counts,Topic
481,Analytic Approach,Topic
481,Poisson-Gamma Model,Topic
481,Exponential Distribution,Topic
481,Weibull Distribution,Topic
481,Log-Normal Distribution,Topic
481,Simulation,Topic
481,Real Dataset,Topic
481,Vladimir Anisimov,Author
481,Stephen Gormley,Author
481,Rosalind Baverstock,Author
481,Cynthia Kineza,Author
482,A Bayesian Hierarchical Model For Bridging Across Patient Subgroups In Phase I Clinical Trials With Animal Data,Paper
482,Haiyan Zheng,Author
482,Lisa V. Hampson,Author
482,Thomas Jaki,Author
483,Covariate Adjustment In Randomized Clinical Trials With Missing Covariate And Outcome Data,Paper
483,Chia-Rui Chang,Author
483,Yue Song,Author
483,Fan Li,Author
483,Rui Wang,Author
483,Childhood Adenotonsillectomy Trial,Topic
484,Sensitivity Analyses Of Clinical Trial Designs: Selecting Scenarios And Summarizing Operating Characteristics,Paper
484,Simulation-Based Sensitivity Analyses,Topic
484,Candidate Designs For Future Clinical Trials,Topic
484,Design Operating Characteristics,Topic
484,Unknown Parameters,Topic
484,Plausible Simulation Scenarios,Topic
484,Optimization Techniques,Topic
485,Adaptive Identification Of Populations With Treatment Benefit In Clinical Trials: Machine Learning Challenges And Solutions,Paper
485,Patient Subpopulations,Topic
485,Adaptive Clinical Trial,Topic
485,Biostatistics,Topic
485,Machine Learning,Topic
485,Adaggi,Topic
485,Adagcpi,Topic
486,Enrollment Forecast For Clinical Trials At The Portfolio Planning Phase Based On Site-Level Historical Data,Paper
486,Sheng Zhong,Author
486,Yunzhao Xing,Author
486,Mengjia Yu,Author
486,Li Wang,Author
486,Clinical Trial Enrollment,Topic
486,Statistical Approaches,Topic
486,Generalized Linear Mixed-Effects Models,Topic
487,The Clinical Trials Puzzle: How Network Effects Limit Drug Discovery,Paper
487,Kishore Vasan,Author
487,Deisy Gysi,Author
487,Albert-Laszlo Barabasi,Author
487,Post-Genomic Medicine,Topic
487,Clinical Trials,Topic
487,Drug Discovery,Topic
487,Human Interactome,Topic
487,Network-Based Model,Topic
487,Druggable Proteins,Topic
488,Pulsar,Topic
488,Immunotherapy,Topic
488,Mathematical Model,Topic
488,Samiha Rouf,Author
488,Casey Moore,Author
488,Debabrata Saha,Author
488,Dan Nguyen,Author
488,Marylena Bleile,Author
488,Robert Timmerman,Author
488,Hao Peng,Author
488,Steve Jiang,Author
489,Gentwoarmstrialsize,Topic
489,Clinical Trials,Topic
489,R Statistical Software,Topic
489,Pharmaceutical Statisticians,Topic
490,Top-Down Multilevel Simulation Of Tumor Response To Treatment In The Context Of In Silico Oncology,Paper
490,Georgios Stamatakos,Author
490,Tumor Dynamics Modeling Method,Topic
490,Oncosimulator,Topic
491,Patients,Topic
491,Clinical Trial,Topic
491,Medication'S Efficacy,Topic
491,Trimmed Means Approach,Topic
491,Average Population Treatment Effect,Topic
491,Missing Data Problem,Topic
491,Missing Not At Random (Mnar),Topic
491,Missing At Random (Mar),Topic
491,Multiple Imputation (Mi),Topic
491,Alex Ocampo,Author
491,Heinz Schmidli,Author
491,Peter Quarg,Author
491,Francesca Callegari,Author
491,Marcello Pagano,Author
491,Permutt 2017,Paper
492,Model-Robust Inference For Clinical Trials That Improve Precision By Stratified Randomization And Covariate Adjustment,Paper
492,Bingkai Wang,Author
492,Ryoko Susukida,Author
492,Ramin Mojtabai,Author
492,Masoumeh Amin-Esmaeili,Author
492,Michael Rosenblum,Author
492,Stratified Randomization,Topic
492,Covariate Adjustment,Topic
492,Clinical Trials,Topic
493,Adaptive Enrichment,Topic
493,Clinical Trial,Topic
493,Longitudinal And Time-To-Event Data,Topic
493,Biomarkers,Topic
493,Metastatic Breast Cancer,Topic
493,Abigail J. Burdon,Author
493,Richard D. Baird,Author
493,Thomas Jaki,Author
494,Response-Adaptive Clinical Trials,Topic
494,Stef Baas,Author
494,Peter Jacko,Author
494,SofÌa S. Villar,Author
494,Exact Statistical Analysis For Response-Adaptive Clinical Trials: A General And Computationally Tractable Approach,Paper
495,Decoding The Circuitry Of Consciousness: From Local Microcircuits To Brain-Scale Networks,Paper
495,Julien Modolo,Author
495,Mahmoud Hassan,Author
495,Fabrice Wendling,Author
495,Pascal Benquet,Author
495,Consciousness,Topic
495,Disorders Of Consciousness,Topic
495,Neuroscience,Topic
496,Electroencephalography (Eeg),Topic
496,Fome (Foundation Model For Eeg),Paper
496,Enze Shi,Author
496,Kui Zhao,Author
496,Qilong Yuan,Author
496,Jiaqi Wang,Author
496,Huawen Hu,Author
496,Sigang Yu,Author
496,Shu Zhang,Author
497,Electroencephalography (Eeg),Topic
497,Pix2Pixgan,Topic
497,Eegdenoisenet Dataset,Topic
497,Haoyi Wang,Author
497,Xufang Chen,Author
497,Yue Yang,Author
497,Kewei Zhou,Author
497,Meining Lv,Author
497,Dongrui Wang,Author
497,Wenjie Zhang,Author
497,Eeg Signal Denoising Using Pix2Pix Gan: Enhancing Neurological Data Analysis,Paper
498,Real-Time Machine Learning Strategies For A New Kind Of Neuroscience Experiments,Paper
498,Ayesha Vermani,Author
498,Matthew Dowling,Author
498,Hyungju Jeon,Author
498,Ian Jordan,Author
498,Josue Nassar,Author
498,Yves Bernaerts,Author
498,Yuan Zhao,Author
498,Steven Van Vaerenbergh,Author
498,Il Memming Park,Author
499,Human Decision Making Behavior,Topic
499,Drift-Diffusion Models,Topic
499,Wiener First-Passage Time (Wfpt) Distribution,Topic
499,Cognitive Parameters,Topic
499,Drift Rate,Topic
499,Boundary Separation,Topic
499,Starting Point,Topic
499,Neuroscientists,Topic
499,Cognitive Processes Of Decision Making,Topic
499,Brain Activity,Topic
499,Choice-Response Time Data,Topic
499,Sincnet-Based Shallow Neural Network Architecture,Topic
499,Eeg Signals,Topic
499,Sincnet Layer,Topic
499,Depthwise Spatial Convolution Layer,Topic
499,Fc Layers,Topic
499,Negative Log Likelihood Function,Topic
499,Two-Alternative Forced-Choice Task,Topic
499,Qinhua Jenny Sun,Author
499,Khuong Vo,Author
499,Kitty Lui,Author
499,Michael Nunez,Author
499,Joachim Vandekerckhove,Author
499,Ramesh Srinivasan,Author
500,Transcranial Ultrasonic Stimulation,Topic
500,Tulika Nandi,Author
500,Benjamin R. Kop,Author
500,Kasra Naftchi-Ardebili,Author
500,Charlotte J. Stagg,Author
500,Kim Butts Pauly,Author
500,Lennart Verhagen,Author
500,Biophysical Effects And Neuromodulatory Dose Of Transcranial Ultrasonic Stimulation,Paper
501,Umbilical Cord Blood,Topic
501,Cord Blood Banking,Topic
501,Nivethika Sivakumaran,Author
501,Imesha Rashmini Rathnayaka,Author
501,Rashida Shabbir,Author
501,Sasini Sandareka Wimalsinghe,Author
501,J. A. Sumalimina Jayakody,Author
501,Mahisha Chandrasekaran,Author
501,Mawatha,Author
501,Sri Lanka,Author
502,A Bayesian Hierarchical Model For The Analysis Of A Longitudinal Dynamic Contrast-Enhanced Mri Cancer Study,Paper
502,Dce-Mri,Topic
503,Evaluation Of Treatment Effect Modification By Biomarkers Measured Pre- And Post-Randomization In The Presence Of Non-Monotone Missingness,Paper
503,Yingying Zhuang,Author
503,Ying Huang,Author
503,Peter B. Gilbert,Author
504,Sars-Cov-2,Topic
504,Covid-19,Topic
504,Drug Repurposing,Topic
504,Mpro,Topic
504,Oxytetracycline,Topic
504,Ribavirin,Topic
504,Codeine,Topic
504,Emilio Angelina,Author
504,Sebastian Andujar,Author
504,Oscar Parravicini,Author
504,Daniel Enriz,Author
504,Nelida Peruchena,Author
505,Zero-Inflation Bias Correction (Zibc) Method,Topic
505,Zhengyang Zhou,Author
505,Minge Xie,Author
505,David Huh,Author
505,Eun-Young Mun,Author
505,A Bias Correction Method In Meta-Analysis Of Randomized Clinical Trials With No Adjustments For Zero-Inflated Outcomes,Paper
506,Covid-19 Pandemic,Topic
506,Clinical Trials,Topic
506,Estimands,Topic
506,Ich E9 (R1),Topic
506,Yongming Qu,Author
506,Ilya Lipkovich,Author
507,Automated Causal Inference In Application To Randomized Controlled Clinical Trials,Paper
507,Autoci,Topic
507,Rcts,Topic
508,Semeval 2023 Task 7,Topic
508,Natural Language Inference Task,Topic
508,Evidence Selection Task,Topic
508,MaÎl Jullien,Author
508,Marco Valentino,Author
508,Hannah Frost,Author
508,Paul O'Regan,Author
508,Donal Landers,Author
508,AndrÈ Freitas,Author
509,Nli4Ct,Topic
509,Clinical Trial Reports,Topic
509,Natural Language Inference,Topic
509,MaÎl Jullien,Author
509,Marco Valentino,Author
509,Hannah Frost,Author
509,Paul O'Regan,Author
509,Donal Landers,Author
509,AndrÈ Freitas,Author
510,Aumcf,Topic
510,Mcc,Topic
510,Beta-Blocker Evaluation Of Survival Trial,Topic
510,Jessica Gronsbell,Author
510,Zachary R. Mccaw,Author
510,Isabelle-Emmanuella Nogues,Author
510,Xiangshan Kong,Author
510,Tianxi Cai,Author
510,Lu Tian,Author
510,Lj Wei,Author
511,Artificial Intelligence Transfer Learning Algorithms,Topic
511,Covid-19,Topic
511,Clinical Trial,Topic
511,Mexico,Topic
511,Spain,Topic
511,Usa,Topic
511,Longitudinal Audio Test,Topic
511,Icu Allocation,Topic
511,Open Collective Approach,Topic
511,Https://Opensigma.Mit.Edu,Topic
511,Brian Subirana,Author
511,Ferran Hueto,Author
511,Prithvi Rajasekaran,Author
511,Jordi Laguarta,Author
511,Susana Puig,Author
511,Josep Malvehy,Author
511,Oriol Mitja,Author
511,Antoni Trilla,Author
511,Carlos Iv·n Moreno,Author
511,JosÈ Francisco MuÒoz Valle,Author
511,Ana Esther Mercado Gonz·lez,Author
511,Barbara Vizmanos,Author
511,Sanjay Sarma,Author
512,Bacterial Infections,Topic
512,Antimicrobial Resistance,Topic
512,Acute Bacterial Skin And Skin Structure Infection (Absssi),Topic
512,Methicillin-Resistant Staphylococcus Aureus (Mrsa),Topic
512,Vancomycin,Topic
512,Inyoung Jun,Author
512,Simone Marini,Author
512,Christina A. Boucher,Author
512,J. Glenn Morris,Author
512,Jiang Bian,Author
512,Mattia Prosperi,Author
512,Machine Learning Model Of Mortality Prediction And Ite Estimation,Topic
512,Propensity Score Matching,Topic
512,Boosted/Lasso Logistic Regression,Topic
512,Support Vector Machines,Topic
512,Random Forest,Topic
512,Area Under The Receiver Characteristic (Auc),Topic
512,Counterfactuals,Topic
512,Treatment Heterogeneity,Topic
513,Blinatumomab,Topic
513,B-Cell All,Topic
513,Single-Arm Trial,Topic
513,External Control Data,Topic
513,JÈrÙme Lambert,Author
513,Etienne Lengline,Author
513,RaphaÎl Porcher,Author
513,Rodolphe ThiÈbaut,Author
513,Sarah Zohar,Author
513,Sylvie Chevret,Author
514,Functional Motor Disorder,Topic
514,Health-Related Quality Of Life,Topic
514,Sf-36 Questionnaire,Topic
514,Martin Jir·sek,Author
514,Tom·ö Sieger,Author
514,Gabriela Chaloupkov·,Author
514,Lucia Nov·kov·,Author
514,Petr Sojka,Author
514,Mark J Edwards,Author
514,Tereza Serranov·,Author
514,Seventy-Seven Patients,Paper
515,Named Clinical Entity Recognition Benchmark,Paper
515,Wadood M Abdul,Author
515,Marco Af Pimentel,Author
515,Muhammad Umar Salman,Author
515,Tathagata Raha,Author
515,ClÈment Christophe,Author
515,Praveen K Kanithi,Author
515,Nasir Hayat,Author
515,Ronnie Rajan,Author
515,Shadab Khan,Author
515,Natural Language Processing,Topic
515,Clinical Entity Recognition,Topic
515,Healthcare,Topic
515,F1-Score,Topic
515,Observational Medical Outcomes Partnership,Topic
516,Adaptive Designs For Clinical Trials,Topic
516,Jay Bartroff,Author
516,Tze Leung Lai,Author
516,Efficient Adaptive Designs With Mid-Course Sample Size Adjustment In Clinical Trials,Paper
517,Interval Designs,Topic
517,Bayesian Decision-Optimal Interval Designs For Phase I Clinical Trials,Paper
518,Mid-Study Design Modifications,Topic
518,Confirmatory Clinical Trials,Topic
518,Time-To-Event Endpoints,Topic
518,Interim Data,Topic
518,Final Test Statistic,Topic
518,Long-Term Survival,Topic
518,Adaptive Survival Trials,Topic
518,Dominic Magirr,Author
518,Thomas Jaki,Author
518,Franz Koenig,Author
518,Martin Posch,Author
519,Doctors,Topic
519,Statistical Inference,Topic
519,Personalized Medicine,Topic
519,Individualized Treatment,Topic
519,Keli Liu,Author
519,Xiao-Li Meng,Author
520,Blinded Continuous Information Monitoring Of Recurrent Event Endpoints With Time Trends In Clinical Trials,Paper
521,On Multi-Armed Bandit Designs For Dose-Finding Clinical Trials,Paper
522,Inferring Which Medical Treatments Work From Reports Of Clinical Trials,Paper
522,Clinical Trials,Topic
522,Randomized Controlled Trials,Topic
523,Bayesian Models For Survival Data Of Clinical Trials: Comparison Of Implementations Using R Software,Paper
523,Allozithro Trial,Topic
523,Lucie Biard,Author
523,Anne Bergeron,Author
523,Sylvie Chevret,Author
524,Causal Intervention Effects,Topic
524,Transmissible Infectious Disease Outcomes,Topic
524,Vaccine,Topic
524,Epidemiologists,Topic
524,Causal Estimands,Topic
524,Two-Person Partnership Model,Topic
524,Infectious Disease Transmission Dynamics,Topic
524,Empirical Intervention Trials,Topic
524,Time-To-Infection Data,Topic
524,Binary Outcome Data,Topic
524,Hiv Vaccine Trial,Topic
524,Xiaoxuan Cai,Author
524,Wen Wei Loh,Author
524,Forrest W. Crawford,Author
525,Observational Studies,Topic
525,Trialverify,Topic
525,Ethan Steinberg,Author
525,Nikolaos Ignatiadis,Author
525,Steve Yadlowsky,Author
525,Yizhe Xu,Author
525,Nigam H. Shah,Author
525,Inverse Propensity Score Weighting,Topic
525,Clinical Trial Reports,Topic
525,National Insurance Claims Dataset,Topic
526,Causal Inference Methods For Small Non-Randomized Studies: Methods And An Application In Covid-19,Paper
526,Sarah Friedrich,Author
526,Tim Friede,Author
526,Sars-Cov-2 Pandemic,Topic
526,Propensity Score Methods,Topic
526,G-Computation Approach,Topic
526,Doubly Robust Estimators,Topic
527,Sample Size Calculation For Cluster Randomized Trials With Zero-Inflated Count Outcomes,Paper
527,Zhengyang Zhou,Author
527,Dateng Li,Author
527,Song Zhang,Author
527,Cluster Randomized Trials,Topic
527,Zero-Inflated Count Outcomes,Topic
527,Generalized Estimating Equations,Topic
527,Power Analysis Methods,Topic
527,Simulation Studies,Topic
528,A Novel Statistical Test For Treatment Differences In Clinical Trials Using A Response Adaptive Forward Looking Gittins Index Rule,Paper
528,Helen Yvette Barnett,Author
528,Sofia S Villar,Author
528,Helena Geys,Author
528,Thomas Jaki,Author
529,Multiple Type I Error Criterion,Topic
529,Clinical Trials,Topic
529,Precision Medicine,Topic
529,Population-Wise Error Rate,Topic
529,Werner Brannath,Author
529,Charlie Hillner,Author
529,Kornelius Rohmeyer,Author
530,Unit Information Prior For Adaptive Information Borrowing From Multiple Historical Datasets,Paper
530,Huaqing Jin,Author
530,Guosheng Yin,Author
530,Clinical Trials,Topic
530,Historical Studies,Topic
530,Informative Prior,Topic
530,Uip,Topic
530,Alzheimer'S Disease,Topic
530,Memantine,Topic
531,Multi-Armed Parallel Group Clinical Trials,Topic
531,Personalized Treatment Rules,Topic
531,David Azriel,Author
531,Yosef Rinott,Author
531,Martin Posch,Author
531,Dietary Clinical Trial,Topic
532,Surrogacy Validation For Time-To-Event Outcomes With Illness-Death Frailty Models,Paper
532,Emily K. Roberts,Author
532,Michael R. Elliott,Author
532,Jeremy M. G. Taylor,Author
532,Intermediate Endpoint,Topic
532,Causal Association Paradigm,Topic
532,Time-To-Event Outcomes,Topic
532,Bayesian Method,Topic
532,Localized Prostate Cancer Clinical Trial,Topic
532,Surrogate S,Topic
532,True Endpoint T,Topic
532,Censored And Semi-Competing Risk Structure,Topic
532,Markov Chain Monte Carlo,Topic
532,Time To Distant Metastasis,Topic
532,Time To Death,Topic
533,Semiparametric Inference Of The Complier Average Causal Effect With Nonignorable Missing Outcomes,Paper
533,Hua Chen,Author
533,Peng Ding,Author
533,Zhi Geng,Author
533,Xiao-Hua Zhou,Author
534,Deep Neural Networks Guided Ensemble Learning For Point Estimation,Paper
534,Tianyu Zhan,Author
534,Haoda Fu,Author
534,Jian Kang,Author
534,Mean Squared Error,Topic
534,Shrinkage Based Estimation,Topic
534,Adaptive Covid-19 Treatment Trial,Topic
534,Prediction Accuracy,Topic
534,Statistical Research,Topic
535,Suppression Of Disability Progression,Topic
535,Multiple Sclerosis,Topic
535,Time To The First Confirmed Disability Progression,Topic
535,Expanded Disability Status Scale,Topic
535,Recurrent Disability Progression Events,Topic
535,Recurrent Event Analyses,Topic
535,Negative Binomial Model,Topic
535,Andersen-Gill Model,Topic
535,Lin-Wei-Ying-Yang Model,Topic
535,Jan Beyersmann,Author
535,Marcel Wolbers,Author
535,Fabian Model,Author
535,Qing Wang,Author
535,University Of Ulm,Topic
535,Comparison Of Time-To-First-Event And Recurrent Event Methods In Multiple Sclerosis Trials,Paper
536,A Critical Review Of Methods For Real-World Applications To Generalize Or Transport Clinical Trial Findings To Target Populations Of Interest,Paper
537,Intensity-Based Multistate Models,Topic
537,Disease Processes,Topic
537,Interventions,Topic
537,Loss To Follow-Up,Topic
537,Randomized Trials,Topic
537,Complex Life History Processes,Topic
537,Estimands,Topic
537,Cumulative Incidence Function Regression Models,Topic
537,Intercurrent Events,Topic
537,Clinical Trials,Topic
537,Protocols,Topic
537,Alexandra B¸hler,Author
537,Richard J. Cook,Author
537,Jerald F. Lawless,Author
537,Multistate Models As A Framework For Estimand Specification In Clinical Trials Of Complex Processes,Paper
538,Estimands And Estimators In Randomized Clinical Trials,Topic
538,Intercurrent Events,Topic
538,Oncology Case Study,Topic
538,Survival Risk Ratio Estimator,Topic
538,Hege Michiels,Author
538,An Vandebosch,Author
538,Stijn Vansteelandt,Author
539,Enrollment Forecast For Clinical Trials At The Planning Phase With Study-Level Historical Data,Paper
539,Mengjia Yu,Author
539,Sheng Zhong,Author
539,Yunzhao Xing,Author
539,Li Wang,Author
539,Clinical Trials,Topic
539,Statistical Approaches,Topic
539,Enrollment Timeline Forecasting,Topic
540,Phase Ii Studies,Topic
540,Phase Iii Trials,Topic
540,Bayesian Monitoring Strategies,Topic
540,New Index Vector,Topic
540,Takuya Yoshimoto,Author
540,Satoru Shinoda,Author
540,Kouji Yamamoto,Author
540,Kouji Tahata,Author
541,Ich E9 Addendum,Topic
541,Type 2 Diabetes Clinical Trial,Paper
541,Camila Olarte Parra,Author
541,Rhian M. Daniel,Author
541,David Wright,Author
541,Jonathan W. Bartlett,Author
542,Pam-Hc: A Bayesian Nonparametric Construction Of Hybrid Control For Randomized Clinical Trials Using External Data,Paper
542,Dehua Bi,Author
542,Tianjian Zhou,Author
542,Wei Zhong,Author
542,Yuan Ji,Author
542,Bayesian Nonparametric Model,Topic
542,Atopic Dermatitis Dataset,Topic
542,Hybrid Control,Topic
542,Randomized Clinical Trial,Topic
543,Understanding Treatment Effect Heterogeneity,Topic
543,Waverly Wei,Author
543,Xinwei Ma,Author
543,Jingshen Wang,Author
543,Adaptive Experiments Toward Learning Treatment Effect Heterogeneity,Paper
544,3 + 3 Dose-Escalation Protocol,Topic
544,David C. Norris,Author
544,Markus Triska,Author
544,Executable Specification Of Oncology Dose-Escalation Protocols With Prolog,Paper
545,Bayesian Hybrid Design With Borrowing From Historical Study,Paper
545,Bayesian Dynamic Power Prior (Dpp) Framework,Topic
545,Combination Therapy,Topic
545,Uncontrolled Single-Arm Trials,Topic
545,Hybrid Design,Topic
546,Personalized Predictions From Population Level Experiments: A Study On Alzheimer'S Disease,Paper
546,Dennis Shen,Author
546,Anish Agarwal,Author
546,Vishal Misra,Author
546,Bjoern Schelter,Author
546,Devavrat Shah,Author
546,Helen Shiells,Author
546,Claude Wischik,Author
546,Synthetic Nearest Neighbors (Snn) Estimator,Topic
546,Alzheimer'S Disease,Topic
546,Randomized Control Trials (Rcts),Topic
546,Precision Medicine,Topic
547,Use Of Real-World Data And Real-World Evidence In Rare Disease Drug Development: A Statistical Perspective,Paper
547,Jie Chen,Author
547,Susan Gruber,Author
547,Hana Lee,Author
547,Haitao Chu,Author
547,Shiowjen Lee,Author
547,Haijun Tian,Author
547,Yan Wang,Author
547,Weili He,Author
547,Thomas Jemielita,Author
547,Yang Song,Author
547,Roy Tamura,Author
547,Lu Tian,Author
547,Yihua Zhao,Author
547,Yong Chen,Author
547,Mark Van Der Laan,Author
547,Lei Nie,Author
548,Censored Survival Data,Topic
548,Clinical Trials,Topic
548,Small Control Groups,Topic
548,Rare Diseases,Topic
548,Balanced Randomization,Topic
548,External Controls,Topic
548,Historical Studies,Topic
548,Real-World Data,Topic
548,Treatment Evaluation,Topic
548,Survival Outcomes,Topic
548,Doubly Protected Estimator,Topic
548,Treatment-Specific Restricted Mean Survival Time Difference,Topic
548,Trial-Only Estimators,Topic
548,Covariate Shifts,Topic
548,Doubly Robust Estimation,Topic
548,Outcome Drift,Topic
548,Dr-Learner,Topic
548,Machine Learning,Topic
548,Survival Curves,Topic
548,Outcome Drifts,Topic
548,Comparable External Controls,Topic
548,Simulation Studies,Topic
548,Real-Data Application,Topic
548,Galcanezumab,Topic
548,Migraine Headaches,Topic
548,Chenyin Gao,Author
548,Shu Yang,Author
548,Mingyang Shan,Author
548,Wenyu Wendy Ye,Author
548,Ilya Lipkovich,Author
548,Douglas Faries,Author
549,Leveraging Large Language Models For Medical Information Extraction And Query Generation,Paper
549,Large Language Models,Topic
549,Clinical Trial Retrieval,Topic
550,Interpretable Deep Neural Networks For Single-Trial Eeg Classification,Paper
550,Irene Sturm,Author
550,Sebastian Bach,Author
550,Wojciech Samek,Author
550,Klaus-Robert M¸ller,Author
550,Deep Neural Networks,Topic
550,Layer-Wise Relevance Propagation,Topic
550,Eeg Data Analysis,Topic
550,Csp-Lda,Topic
551,Autoreject,Topic
551,Mainak Jas,Author
551,Denis A. Engemann,Author
551,Yousra Bekhti,Author
551,Federico Raimondo,Author
551,Alexandre Gramfort,Author
551,Meg,Topic
551,Eeg,Topic
551,Human Connectome Project,Topic
551,Public Datasets,Topic
551,Bad Trials,Topic
551,Cross-Validation,Topic
551,Peak-To-Peak Threshold,Topic
551,Trial-Wise Bad Sensors,Topic
551,Interpolation,Topic
551,Human Inspection,Topic
551,Data Analysis,Topic
552,Neuroscience,Topic
552,Neural Spiking Dynamics,Topic
552,Separable 2D Random Field Model,Topic
552,Yingzhuo Zhang,Author
552,Noa Malem-Shinitski,Author
552,Stephen A Allsop,Author
552,Kay Tye,Author
552,Demba Ba,Author
552,Pre-Frontal Cortex,Topic
552,Associative Learning Of Fear In Mice,Topic
553,N-Of-1 Trials,Topic
553,Multimodal Outcomes,Topic
553,Juliana Schneider,Author
553,Thomas G‰rtner,Author
553,Stefan Konigorski,Author
553,Automated Approach,Topic
553,Autoencoder,Topic
553,Principal Component Analysis,Topic
553,Treatment Effect,Topic
553,Acne Severity,Topic
553,Multimodal N-Of-1 Trials,Topic
554,Novel Development Of Llm Driven Mcode Data Model For Improved Clinical Trial Matching To Enable Standardization And Interoperability In Oncology Research,Paper
554,Aarsh Shekhar,Author
554,Mincheol Kim,Author
554,Cancer Care,Topic
554,Clinical Trial Enrollment,Topic
554,Data Standardization,Topic
554,Llm,Topic
554,Mcode Profiles,Topic
554,Ai And Ml-Based Clinical Trial Matching Engine,Topic
555,Assessing Immune Responses To Study Vaccines As Surrogates Of Protection,Topic
555,Hiv Vaccine Efficacy Trials,Topic
555,Cox Proportional Hazards Model,Topic
555,Frangakis And Rubin,Author
555,Gilbert And Hudgens,Author
555,Li Qin,Author
555,Peter B. Gilbert,Author
555,Dean Follmann,Author
555,Dongfeng Li,Author
556,Propatria,Topic
556,Richard D. Gill,Author
556,Experimental Probiotica Treatment,Topic
556,Acute Pancreatitis,Topic
556,Standard Therapy,Topic
556,New Treatment,Topic
556,Data Monitoring Committee,Topic
556,Spss,Topic
556,Life-Threatening Medical Condition,Topic
556,Clinical Trial,Topic
557,Point Estimation For Adaptive Trial Designs Ii: Practical Considerations And Guidance,Paper
557,David S. Robertson,Author
557,Babak Choodari-Oskooei,Author
557,Munya Dimairo,Author
557,Laura Flight,Author
557,Philip Pallmann,Author
557,Thomas Jaki,Author
558,Composite Binary Endpoints,Topic
558,Clinical Trials,Topic
558,Sample Size,Topic
558,Marta Bofill Roig,Author
558,Guadalupe GÛmez Melis,Author
558,Compare,Topic
558,Simulation Study,Topic
558,Real Case Study,Topic
559,Phase I Oncology Trials,Topic
559,Dose-Toxicity Model,Topic
559,Animal Data,Topic
559,Decision-Theoretic Approach,Topic
559,Haiyan Zheng,Author
559,Lisa V. Hampson,Author
559,Bayesian Decision-Theoretic Approach,Topic
559,Preclinical Information,Topic
559,Model-Based Dose-Escalation Procedure,Topic
559,Utility Of Optimal Prior Predictions,Topic
559,Commensurability,Topic
559,Dose-Escalation Procedure,Topic
559,Simulation Study,Topic
560,Hi3+3,Topic
560,Yunshan Duan,Author
560,Sue-Jane Wang,Author
560,Yuan Ji,Author
561,N-Of-1 Trials,Topic
561,Studyu Platform,Topic
561,Studyu Designer,Topic
561,Studyu App,Topic
561,Stefan Konigorski,Author
561,Sarah Wernicke,Author
561,Tamara Slosarek,Author
561,Alexander M. Zenner,Author
561,Nils Strelow,Author
561,Ferenc D. Ruether,Author
561,Florian Henschel,Author
561,Manisha Manaswini,Author
561,Fabian Pottb‰cker,Author
561,Jonathan A. Edelman,Author
561,Babajide Owoyele,Author
561,Matteo Danieletto,Author
561,Eddye Golden,Author
561,Micol Zweig,Author
561,Girish Nadkarni,Author
561,Erwin Bˆttinger,Author
562,Recent Fda Guidance On Adaptive Clinical Trial Designs,Topic
562,Point Estimation For Adaptive Trial Designs I: A Methodological Review,Paper
562,Bias,Topic
562,Adaptive Clinical Trial Designs,Topic
562,Methods To Remove Or Reduce Potential Bias,Topic
563,Contemporary Scientific Research,Topic
563,Statistical Methods,Topic
563,Hypothesis Testing,Topic
563,Agent,Topic
563,Principal,Topic
563,Stephen Bates,Author
563,Michael I. Jordan,Author
563,Michael Sklar,Author
563,Jake A. Soloff,Author
563,Significance Threshold,Topic
563,Type-I Error Level,Topic
563,Cost Of The Trial,Topic
563,Firm'S Profit,Topic
564,Meta-Analysis,Topic
564,Randomized Controlled Trials,Topic
564,Large Language Models,Topic
564,Hye Sun Yun,Author
564,David Pogrebitskiy,Author
564,Iain J. Marshall,Author
564,Byron C. Wallace,Author
564,Evaluation Dataset,Topic
565,Virtual Lung Screening Trial (Vlst),Topic
565,National Lung Screening Trial (Nlst),Topic
565,Fakrul Islam Tushar,Author
565,Liesbeth Vancoillie,Author
565,Cindy Mccabe,Author
565,Amareswararao Kavuri,Author
565,Lavsen Dahal,Author
565,Brian Harrawood,Author
565,Milo Fryling,Author
565,Mojtaba Zarei,Author
565,Saman Sotoudeh-Paima,Author
565,Fong Chi Ho,Author
565,Dhrubajyoti Ghosh,Author
565,Michael R. Harowicz,Author
565,Tina D. Tailor,Author
565,Sheng Luo,Author
565,W. Paul Segars,Author
565,Ehsan Abadi,Author
565,Kyle J. Lafata,Author
565,Joseph Y. Lo,Author
565,Ehsan Samei,Author
566,Multiscale Bayesian State Space Model For Granger Causality Analysis Of Brain Signal,Paper
567,Kaplan-Meier Estimator,Topic
567,Weighted Trajectory Analysis,Topic
567,Logrank Test,Topic
567,Generalized Estimating Equations,Topic
567,Melanoma Patients,Topic
567,Metastatic Breast Cancer Patients,Topic
567,Utkarsh Chauhan,Author
567,Kaiqiong Zhao,Author
567,John Walker,Author
567,John R. Mackey,Author
568,Personalized Medicine Based On Medical Images,Topic
568,Multiple Sclerosis (Ms),Topic
568,Neural Stochastic Differential Equations (Nsde),Topic
568,Joshua Durso-Finley,Author
568,Berardino Barile,Author
568,Jean-Pierre Falet,Author
568,Douglas L. Arnold,Author
568,Nick Pawlowski,Author
568,Tal Arbel,Author
568,Probabilistic Temporal Prediction Of Continuous Disease Trajectories And Treatment Effects Using Neural Sdes,Paper
569,Trial Design,Topic
569,Easy-Icd,Topic
569,Norway,Topic
569,Sweden,Topic
569,Mann-Whitney U Test,Topic
569,123 Seconds,Topic
569,46% Reduction,Topic
569,Clinical Workflows,Topic
569,Taridzo Chomutare,Author
569,Therese Olsen Svenning,Author
569,Miguel ¡ngel Tejedor Hern·ndez,Author
569,Phuong Dinh Ngo,Author
569,Andrius Budrionis,Author
569,Kaisa Markljung,Author
569,Lill Irene Hind,Author
569,Torbj¯rn Torsvik,Author
569,Karl ÿyvind Mikalsen,Author
569,Aleksandar Babic,Author
569,Hercules Dalianis,Author
570,Neuroscience Datasets,Topic
570,Hierarchical Bootstrap,Topic
570,Traditional Statistical Tests,Topic
570,Bengalese Finches,Topic
570,Drosophila Melanogaster,Topic
570,Varun Saravanan,Author
570,Gordon J Berman,Author
570,Samuel J Sober,Author
571,Penalized Q-Learning For Dynamic Treatment Regimes,Paper
571,Rui Song,Author
571,Weiwei Wang,Author
571,Donglin Zeng,Author
571,Michael R. Kosorok,Author
571,Dynamic Treatment Regimes,Topic
571,Reinforcement Learning,Topic
571,Statistical Inference,Topic
571,Clinical Trials,Topic
571,Longitudinal Data,Topic
571,Numerical Studies,Topic
571,Depression Clinical Trial Study,Topic
572,Medis,Topic
572,Daniela Luzi,Author
572,Fabrizio Pecoraro,Author
572,Clinical Trial Process,Topic
573,A Two-Stage Patient-Focused Study Design For Rare Disease Controlled Trials,Paper
573,Rare Disease Clinical Trials,Topic
573,Jian Yong,Author
573,Sohaib H. Mohammad,Author
573,Yan Yuan,Author
574,Transform Mobile Ehealth Solution For Remote Patient Monitoring During Clinical Trials,Paper
574,Mobile Devices,Topic
574,Clinical Trials,Topic
574,Usability Evaluation,Topic
575,Escalation With Overdose Control,Topic
575,Continuous Dose Scheme,Topic
575,Discrete Dose Scheme,Topic
575,M·rcio Augusto Diniz,Author
575,Mourad Tighiouart,Author
575,AndrÈ Rogatko,Author
575,Monte Carlo Simulation Study,Topic
575,Cancer Phase I Clinical Trial Design,Topic
575,Operating Characteristics,Topic
575,True Mtd Value,Topic
576,Personalized Medicine,Topic
576,Dirac Delta Regression,Topic
576,Eric V. Strobl,Author
576,Shyam Visweswaran,Author
576,Rct,Topic
576,Https://Github.Com/Ericstrobl/Ddr,Paper
577,Clinical Trials,Topic
577,Outcome Variables,Topic
577,Treatment,Topic
577,Bayesian Model,Topic
577,Multivariate Bernoulli Distribution,Topic
577,Decision Criterion,Topic
577,X. M. Kavelaars,Author
577,J. Mulder,Author
577,M. C. Kaptein,Author
577,Simulation Study,Topic
577,Type I Error Rates,Topic
577,Fixed Designs,Topic
577,Group Sequential Designs,Topic
577,Adaptive Designs,Topic
577,Non-Informative Prior Distributions,Topic
577,Informative Prior Distributions,Topic
578,Multiple Sclerosis,Topic
578,Conditional Restricted Boltzmann Machine,Topic
578,Jonathan R. Walsh,Author
578,Aaron M. Smith,Author
578,Yannick Pouliot,Author
578,David Li-Bland,Author
578,Anton Loukianov,Author
578,Charles K. Fisher,Author
579,Prediction Interval,Topic
579,Tolerance Interval,Topic
579,Non-Normal Models,Topic
579,Geoffrey S Johnson,Author
580,Similarity Networks,Topic
580,Recommender Systems,Topic
580,Corpora Analysis,Topic
580,Medical Informatics,Topic
580,Hammock Paths,Topic
580,M. Shahriar Hossain,Author
580,Michael Narayan,Author
580,Naren Ramakrishnan,Author
580,Netflix Dataset,Topic
580,Pubmed Corpus,Topic
580,Clinical Trials Database,Topic
581,Neoadjuvant Trials On Early-Stage Breast Cancer,Topic
581,Binary Pathological Complete Response (Pcr),Topic
581,Survival,Topic
581,Xiaoqing Tan,Author
581,Judah Abberbock,Author
581,Priya Rastogi,Author
581,Gong Tang,Author
581,Recent Clinical Trial,Topic
581,Sensitivity Analyses,Topic
581,Causal Estimand,Topic
581,Censored Outcome Data,Topic
581,Simulation Studies,Topic
582,Covid-19 Pandemic,Topic
582,Biomedical Literature,Topic
582,Clinical Trials,Topic
582,Pico Criteria,Topic
582,Standard Search Engine,Topic
582,Trec-Covid Shared Task,Topic
582,Relational Concept Selection,Topic
582,Simon äuster,Author
582,Karin Verspoor,Author
582,Timothy Baldwin,Author
582,Jey Han Lau,Author
582,Antonio Jimeno Yepes,Author
582,David Martinez,Author
582,Yulia Otmakhova,Author
583,Ich E9(R1) Addendum,Topic
583,Principal Stratification,Topic
583,Ilya Lipkovich,Author
583,Bohdana Ratitch,Author
583,Yongming Qu,Author
583,Xiang Zhang,Author
583,Mingyang Shan,Author
583,Craig Mallinckrodt,Author
584,Pplasso,Topic
584,Prognostic Biomarkers,Topic
584,Predictive Biomarkers,Topic
584,Traditional Lasso,Topic
584,Pplasso R Package,Topic
585,Clustered Multistate Process Data,Topic
585,Marginal Probability Of Being In A Particular Transient State,Topic
585,Weighted Functional Generalized Estimating Equations Approach,Topic
585,Informative Cluster Size (Ics),Topic
585,Functional Regression Coefficients,Topic
585,Nonparametric Hypothesis Testing Procedure,Topic
585,Multicenter Clinical Trial On Recurrent Or Metastatic Squamous-Cell Carcinoma Of The Head And Neck,Topic
585,Wenxian Zhou,Author
585,Giorgos Bakoyannis,Author
585,Ying Zhang,Author
585,Constantin T Yiannoutsos,Author
586,Large Language Models,Topic
586,Nlp Achievements,Topic
586,Shortcut Learning,Topic
586,Factual Inconsistency,Topic
586,Adversarial Inputs,Topic
586,Semeval-2024 Task 2,Paper
586,Nli4Ct-P Dataset,Topic
586,Interventional Reasoning Tasks,Topic
586,Causal Reasoning Tasks,Topic
586,106 Participants,Topic
586,1200 Individual Submissions,Topic
586,25 System Overview Papers,Topic
586,Healthcare,Topic
586,Biomedical Nli,Topic
586,Competition Leaderboard,Topic
586,Website,Topic
587,Comparing Restricted Mean Survival Times In Small Sample Clinical Trials Using Pseudo-Observations,Paper
588,Advances In Anticancer Therapies,Topic
588,Declining Death Rates,Topic
588,Clinical Trial,Topic
588,Overall Survival (Os),Topic
588,Statistical Approaches,Topic
588,"Shan, 2023",Author
588,"Fleming Et Al., 2024",Author
588,"Rodriguez Et Al., 2024",Author
588,Framework,Topic
588,Stakeholders,Topic
588,Fit-For-Purpose Os Data Collection And Assessment Of Harm,Topic
588,"American Association For Cancer Research, 2024",Author
588,Large B-Cell Lymphoma,Topic
588,Recommendations And Open Questions,Topic
588,Godwin Yung,Author
588,Kaspar Rufibach,Author
588,Marcel Wolbers,Author
588,Mark Yan,Author
588,Jue Wang,Author
589,Clinical Trials,Topic
589,Overall Survival (Os),Topic
589,Progression-Free Survival (Pfs),Topic
589,Response To Treatment (Rt),Topic
589,Bayesian Decision-Theoretic Framework,Topic
589,Massimiliano Russo,Author
589,Steffen Ventz,Author
589,Lorenzo Trippa,Author
590,Bayesian Phase I/Ii Adaptively Randomized Oncology Trials With Combined Drugs,Paper
590,Ying Yuan,Author
590,Guosheng Yin,Author
590,Phase I/Ii Trial Design,Topic
590,Bayesian Copula-Type Model,Topic
590,Adaptive Randomization Scheme,Topic
590,Melanoma Clinical Trial,Topic
591,Crossover Clinical Trials,Topic
591,Clot Prevention In Children Undergoing Haemodialysis,Topic
591,Optimal Crossover Trial With 30 Periods,Paper
592,Drug Combination Trials,Topic
592,Toxicity Attributions,Topic
592,Bayesian Adaptive Design,Topic
592,Copula Regression,Topic
592,Maximum Tolerated Dose (Mtd) Curve,Topic
592,Dose Escalation Algorithm,Topic
592,Continual Reassessment Method (Crm) Scheme,Topic
592,Operating Characteristics,Topic
592,Discrete Dose Combinations,Topic
592,Cancer Phase I Trial Design,Topic
592,Jose L. Jimenez,Author
592,Mourad Tighiouart,Author
592,Mauro Gasparini,Author
593,Optimality Of Testing Procedures For Survival Data,Paper
593,Andrea ArfÈ,Author
593,Brian Alexander,Author
593,Lorenzo Trippa,Author
594,A Nonparametric Bayesian Design For Drug Combination Cancer Trials,Paper
594,Zahra S. Razaee,Author
594,Galen Wien-Cook,Author
594,Mourad Tighiouart,Author
594,Maximum Tolerated Dose (Mtd),Topic
594,Dose Limiting Toxicity (Dlt),Topic
594,Phase I Clinical Trial Of Cb-839 And Gemcitabine,Topic
595,Design And Analysis Of Group-Sequential Clinical Trials Based On A Modestly-Weighted Log-Rank Test In Anticipation Of A Delayed Separation Of Survival Curves: A Practical Guidance,Paper
595,Immunotherapy,Topic
595,Survival,Topic
595,Non-Small-Cell Lung Cancer,Topic
595,Poplar Trial,Topic
595,Weighted Log-Rank Tests,Topic
595,Group-Sequential Methods,Topic
595,R Package,Topic
596,Estimating The Efficiency Gain Of Covariate-Adjusted Analyses In Future Clinical Trials Using External Data,Paper
596,Covariate-Adjusted Estimator,Topic
596,Marginal Treatment Effect,Topic
596,Randomized Trial,Topic
596,Relative Efficiency,Topic
596,Semiparametrically Efficient Estimator,Topic
596,Wald-Type Confidence Interval,Topic
596,Double Bootstrap Scheme,Topic
596,Covid-19 Therapeutic Trials,Topic
597,Causal Analysis Of The Topcat Trial: Spironolactone For Preserved Cardiac Function Heart Failure,Paper
598,Time-To-Event Model-Assisted Designs To Accelerate Phase I Clinical Trials,Paper
598,Ruitao Lin,Author
598,Ying Yuan,Author
598,Drug Development Strategies,Topic
598,Toxicity Data Handling,Topic
598,Phase I Dose-Finding Trials,Topic
599,Group Sequential Designs,Topic
599,Interim Efficacy Monitoring,Topic
599,Futility Monitoring,Topic
599,Baseline Covariates,Topic
599,Type I Error,Topic
599,Point Estimates,Topic
599,Confidence Intervals,Topic
599,Marlena S. Bannick,Author
599,Sonya L. Heltshe,Author
599,Noah Simon,Author
599,Correct Interim Monitoring,Topic
599,Estimation,Topic
599,Inference,Topic
599,Two-Arm Trials,Topic
599,Balanced Randomization,Topic
599,Continuous Outcomes,Topic
599,Simulation Studies,Topic
599,Recommendations,Topic
600,Trialssummarizer,Topic
600,Automatically Summarizing Evidence From Clinical Trials: A Prototype Highlighting Current Challenges,Paper
600,Sanjana Ramprasad,Author
600,Denis Jered Mcinerney,Author
600,Iain J. Marshal,Author
600,Byron C. Wallace,Author
601,The Use Of Covariate Adjustment In Randomized Controlled Trials: An Overview,Paper
601,Kelly Van Lancker,Author
601,Frank Bretz,Author
601,Oliver Dukes,Author
601,Covariate Adjustment,Topic
601,Randomized Controlled Trials,Topic
601,Conditional And Marginal Treatment Effects,Topic
602,Adjusted Confidence Intervals Under Covariate-Adaptive Randomization In Non-Inferiority And Equivalence Trials,Paper
602,Masahiro Kojima,Author
602,Hirotaka Mano,Author
602,Kana Yamada,Author
602,Keisuke Hanada,Author
602,Yuji Tanaka,Author
602,Junji Moriya,Author
602,Permutation Tests,Topic
602,Randomization Tests,Topic
602,Type-I Error Rate,Topic
602,Covariate-Adaptive Randomization,Topic
602,Randomized Clinical Trials,Topic
602,Non-Inferiority Trials,Topic
602,Equivalence Trials,Topic
602,Normal Variables,Topic
602,Binary Variables,Topic
602,Time-To-Event Variables,Topic
602,Simulation Results,Topic
602,Performance Evaluation,Topic
603,Clinical Trials,Topic
603,Heterogeneity In Patient Responses,Topic
603,Syntax,Topic
603,Alihan H¸y¸k,Author
603,Zhaozhi Qian,Author
603,Mihaela Van Der Schaar,Author
604,Machine Learning Assisted Adjustment Boosts Efficiency Of Exact Inference In Randomized Controlled Trials,Paper
604,Han Yu,Author
604,Alan D. Hutson,Author
604,Xiaoyi Ma,Author
604,Randomized Controlled Trials,Topic
605,Randomized Controlled Trial,Topic
605,Drug Effectiveness,Topic
605,Internal Validity,Topic
605,External Validity,Topic
605,Treatment Effects,Topic
605,Real-World Population,Topic
605,Statistical Methods,Topic
605,Augmented Inversed Probability Of Sampling Weighting,Topic
605,Omitted Variable Bias,Topic
605,Songling Xuemaikang Capsule,Topic
605,Losartan,Topic
605,Kuan Jiang,Author
605,Xin-Xing Lai,Author
605,Shu Yang,Author
605,Ying Gao,Author
605,Xiao-Hua Zhou,Author
605,A Practical Analysis Procedure On Generalizing Comparative Effectiveness In The Randomized Clinical Trial To The Real-World Trialeligible Population,Paper
606,Bayesian Adaptive Trials Simulator Software,Topic
606,R,Topic
606,Dominique-Laurent Couturier,Author
606,Elizabeth G Ryan,Author
606,Rainer Puhr,Author
606,Thomas Jaki,Author
606,Stephane Heritier,Author
607,Zikq: An Innovative Centile Chart Method For Utilizing Natural History Data In Rare Disease Clinical Development,Paper
607,Tianying Wang,Author
607,Wenfei Zhang,Author
607,Ying Wei,Author
607,Duchenne Muscular Dystrophy,Topic
608,Cognitive Science,Topic
608,Behavioural Neuroscience,Topic
608,Machine Learning,Topic
608,Artificial Intelligence,Topic
608,Convolutional Neural Networks,Topic
608,Visual Object Recognition,Topic
608,Trial-By-Trial Error Consistency,Topic
608,Robert Geirhos,Author
608,Kristof Meding,Author
608,Felix A. Wichmann,Author
608,Cornet-S,Topic
608,Resnet-50,Topic
609,Batched Bandit Problems,Topic
609,Vianney Perchet,Author
609,Philippe Rigollet,Author
609,Sylvain Chassang,Author
609,Erik Snowberg,Author
610,Compliance-Aware Bandits,Paper
610,Nicol·s Della Penna,Author
610,Mark D. Reid,Author
610,David Balduzzi,Author
610,Bandits,Topic
610,Non-Compliance,Topic
610,Regret,Topic
610,International Stoke Trial,Topic
611,Global Sensitivity Analysis,Topic
611,Variance-Covariance Structure,Topic
611,Information-Theoretic Rules,Topic
611,Variance Decomposition,Topic
611,Randomized Controlled Trials,Topic
611,Caleb Deen Bastian,Author
611,Herschel Rabitz,Author
611,Grzegorz A Rempala,Author
611,"Random Measures, Anova Models And Quantifying Uncertainty In Randomized Controlled Trials",Paper
612,Testing For Similarity Of Dose Response In Multi-Regional Clinical Trials,Paper
613,Broad Versus Narrow Research Questions In Evidence Synthesis: A Parallel To (And Plea For) Estimands,Paper
613,Antonio Remiro-AzÛcar,Author
613,Anders Gorst-Rasmussen,Author
613,Network Meta-Analysis,Topic
613,Estimand Framework,Topic
614,Mining Brain Networks Using Multiple Side Views For Neurological Disorder Identification,Paper
614,Subgraph Mining,Topic
614,Graph Classification,Topic
614,Neurological Disorder Identification,Topic
615,Cd8+ T Cell,Topic
615,Influenza A Virus,Topic
615,Mathematical Model Of Influenza Viral Dynamics,Topic
615,Pengxing Cao,Author
615,Zhongfang Wang,Author
615,Ada W. C. Yan,Author
615,Jodie Mcvernon,Author
615,Jianqing Xu,Author
615,Jane M. Heffernan,Author
615,Katherine Kedzierska,Author
615,James M. Mccaw,Author
616,Maternal Sars-Cov-2 Status,Topic
616,Placental Pathology,Topic
616,Retrospective Case-Control Study,Topic
616,Covid-19,Topic
616,Mai He,Author
616,Priya Skaria,Author
616,Kasey Kreutz,Author
616,Ling Chen,Author
616,Ian Hagemann,Author
616,Ebony B. Carter,Author
616,Indira U. Mysorekar,Author
616,D Michael Nelson,Author
616,John Pfeifer,Author
616,Louis P. Dehner,Author
616,Study Results,Topic
616,Placentas From Sars-Cov-2-Positive Women,Topic
616,Placentas From Sars-Cov-2-Negative Women,Topic
617,Estimating Waning Of Vaccine Effectiveness: A Simulation Study,Paper
617,Ariel Nikas,Author
617,Hasan Ahmed,Author
617,Veronika I. Zarnitsyna,Author
617,Vaccine Effectiveness,Topic
618,Rna Guanine-7 Methyltransferase (Rnmt),Topic
618,Shuqiang Huang,Author
618,Cuiyu Tan,Author
618,Jinzhen Zheng,Author
618,Zhugu Huang,Author
618,Zhihong Li,Author
618,Ziyin Lv,Author
618,Wanru Chen,Author
618,Cancer Cell Line Encyclopedia (Ccle),Topic
618,Genotype-Tissue Expression Project (Gtex),Topic
618,The Cancer Genome Atlas (Tcga),Topic
618,Cbioportal,Topic
618,Tisdb,Topic
618,Tumor Immune Estimation Resource (Timer),Topic
618,Gene Set Enrichment Analysis (Gsea),Topic
618,Tumor Mutation Burden (Tmb),Topic
618,Microsatellite Instability (Msi),Topic
618,Mismatch Repair (Mmr),Topic
618,Dna Methyltransferase (Dnmt),Topic
618,Colon Adenocarcinoma,Topic
618,Kidney Renal Clear Cell Carcinoma,Topic
618,Liver Hepatocellular Carcinoma,Topic
619,Colorectal Cancer Liver Metastases,Topic
619,Cd3Lowmhchigh Immunological Profile,Topic
619,Ensemble Network,Topic
619,Attentive Interpretable Tabular Learning,Topic
619,Ct-Derived Radiomic Features,Topic
619,Ralph Saber,Author
619,David Henault,Author
619,Rolando Rebolledo,Author
619,Simon Turcotte,Author
619,Samuel Kadoury,Author
619,70.0% Accuracy,Topic
619,69.4% Area Under The Curve,Topic
619,Shorter Disease-Specific Survival,Topic
619,Time-To-Recurrence,Topic
620,A Two-Stage Approach For Segmenting Spatial Point Patterns Applied To Multiplex Imaging,Paper
620,Alvin Sheng,Author
620,Brian J. Reich,Author
620,Ana-Maria Staicu,Author
620,Santhoshi N. Krishnan,Author
620,Arvind Rao,Author
620,Timothy L. Frankel,Author
621,Evidence Table,Topic
621,Randomized Clinical Trials,Topic
621,Maximum Entropy Classifier,Topic
621,Integer Linear Programming,Topic
621,Antonio Trenta,Author
621,Anthony Hunter,Author
621,Sebastian Riedel,Author
622,Palliative Medicine,Topic
622,Palliative Care Programs,Topic
622,Palliative Care Clinical Trials,Topic
622,Longitudinal Qol And Survival Data,Topic
622,Semiparametric Statistical Approach,Topic
622,Semiparametric Mixed Effects Model,Topic
622,Cox Model,Topic
622,Regression Splines Method,Topic
622,Aic,Topic
622,Novel Modeling Approach,Topic
622,A Semiparametric Joint Model For Terminal Trend Of Quality Of Life And Survival In Palliative Care Research,Paper
622,Zhigang Li,Author
622,H. R. Frost,Author
622,Tor D. Tosteson,Author
622,Lihui Zhao,Author
622,Lei Liu,Author
622,Kathleen Lyons,Author
622,Huaihou Chen,Author
622,Bernard Cole,Author
622,David Currow,Author
622,Marie Bakitas,Author
623,3+3 Design,Topic
623,I3+3 Design,Topic
623,Meizi Liu,Author
623,Sue-Jane Wang,Author
623,Yuan Ji,Author
623,Phase I Clinical Trials,Topic
624,Adaptive Seamless Designs,Topic
624,Confirmatory Testing,Topic
624,Phase Iii Trials,Topic
624,Treatment Selection,Topic
624,Subgroup Selection,Topic
624,Development Programmes Of New Drugs,Topic
624,Sample Size,Topic
624,Development Time,Topic
624,Logistical Perspective,Topic
624,Upfront Planning,Topic
624,Simulation Studies,Topic
624,Framework For Adaptive Treatment And Subgroup Selection,Topic
624,R Package Asd,Author
624,Chronic Obstructive Pulmonary Disease,Topic
624,Oncology,Topic
624,Tim Friede,Author
624,Nigel Stallard,Author
624,Nicholas Parsons,Author
624,Adaptive Enrichment Designs,Topic
624,Interim Analyses,Topic
624,Primary Outcome,Topic
624,Early Outcome,Topic
624,Operating Characteristics Of Adaptive Seamless Studies,Topic
624,Seamless Phase Ii/Iii Clinical Trials,Topic
624,Methods And Aspects Of Their Implementation,Topic
625,Stride Trial,Topic
625,Ascertainment Bias,Topic
625,E. J. Greene,Author
625,P. Peduzzi,Author
625,J. Dziura,Author
625,C. Meng,Author
625,M. E. Miller,Author
625,T. G. Travison,Author
625,D. Esserman,Author
626,"Efficient, Doubly Robust Estimation Of The Effect Of Dose Switching For Switchers In A Randomised Clinical Trial",Paper
626,Janssen Pharmaceuticals,Topic
626,Flexible Dosing Regimen,Topic
626,Placebo,Topic
626,Low Dose,Topic
626,Higher Dose,Topic
626,Fixed Dosing Trial,Topic
626,Outcome Model,Topic
626,Propensity Score Model,Topic
626,Monte Carlo Simulations,Topic
627,Doubly-Robust Imputation Framework,Topic
627,Yuqi Qiu,Author
627,Karen Messer,Author
627,Alzheimer'S Disease Cooperative Study,Topic
628,Prognostic Stratum Matching Framework,Topic
628,Optimal Policy Trees (Opts),Topic
628,Gastrointestinal Stromal Tumors (Gist),Topic
628,Extremity Sarcomas,Topic
628,Dimitris Bertsimas,Author
628,Angelos G. Koulouras,Author
628,Georgios Antonios Margonis,Author
629,Randomized Controlled Trial Transportability,Topic
629,Guanbo Wang,Author
629,Ting-Wei Ernie Liao,Author
629,David Furfaro,Author
629,Leo Anthony Celi,Author
629,Kevin Sheng-Kai Ma,Author
629,Scoping Review,Topic
629,Rcts,Topic
629,Observational Cohorts,Topic
629,Cardiovascular Diseases,Topic
629,Infectious Diseases,Topic
629,Psychiatry,Topic
629,Oncology,Topic
629,Orthopedics,Topic
629,Anesthesiology,Topic
629,Hematology,Topic
630,Traditional Phase I Dose Finding Cancer Clinical Trial Designs,Topic
630,Maximum Tolerated Dose (Mtd),Topic
630,Immuno-Oncology Therapies,Topic
630,Molecularly Targeted Therapies,Topic
630,Optimal Biological Dose (Obd),Topic
630,Model-Assisted Dose Finding Designs,Topic
630,Boin-Et,Topic
630,Boin12,Topic
630,Ubi,Topic
630,Tepi-2,Topic
630,Printe,Topic
630,Stein,Topic
630,Utpi,Topic
630,Car T-Cell Therapy Phase I Trial,Topic
630,Hao Sun,Author
630,Hsin-Yu Lin,Author
630,Jieqi Tu,Author
630,Revathi Ananthakrishnan,Author
630,Eunhee Kim,Author
631,Multiple Sclerosis,Topic
631,Markov Chain Model,Topic
631,Expanded Disability Status Scale,Topic
631,Uma Sthanu,Author
631,Gary Cutter Phd,Author
631,Clinical Trial Endpoints,Topic
632,A Framework For Generating Realistic Synthetic Tabular Data In A Randomized Controlled Trial Setting,Paper
632,Niki Z. Petrakos,Author
632,Erica E. M. Moodie,Author
632,Nicolas Savy,Author
632,Synthetic Data Generation,Topic
632,Randomized Controlled Trials,Topic
633,Test Sensitivity In The Computer-Aided Detection Of Breast Cancer From Clinical Mammographic Screening: A Meta-Analysis,Paper
633,Computer-Aided Detection Technologies,Topic
633,Breast Cancer Screening,Topic
633,Meta-Analysis,Topic
633,Clinical Studies,Topic
634,Alzheimer'S Disease,Topic
634,Machine Learning,Topic
634,Alzheimer'S Disease Neuroimaging Initiative (Adni),Topic
634,Vipul Satone,Author
634,Rachneet Kaur,Author
634,Faraz Faghri,Author
634,Mike A Nalls,Author
634,Andrew B Singleton,Author
634,Roy H Campbell,Author
635,Age-Related Macular Degeneration,Topic
635,Yifan Peng,Author
635,Tiarnan D. Keenan,Author
635,Qingyu Chen,Author
635,Elvira AgrÛn,Author
635,Alexis Allot,Author
635,Wai T. Wong,Author
635,Emily Y. Chew,Author
635,Zhiyong Lu,Author
635,Areds,Topic
635,Areds2,Topic
635,Deep Learning,Topic
635,Retinal Specialists,Topic
635,Clinical Standards,Topic
635,Independent Test Dataset,Topic
635,Prognostic Accuracy,Topic
636,Artificial Intelligence Language Models,Topic
636,Clinical Decision-Making,Topic
636,Large Language Models,Topic
636,Medical Licensure Exams,Topic
636,Complex Clinical Cases,Topic
636,Gpt4,Author
636,Gpt3.5,Author
636,Case Records Of The Massachusetts General Hospital,Topic
636,Timothy Poterucha,Author
636,Pierre Elias,Author
636,Christopher M. Haggerty,Author
636,1-Jan-22,Topic
636,16-Apr-22,Topic
636,Differential Diagnoses,Topic
636,Clinical Diagnosis,Topic
636,Diagnostic Test,Topic
636,Open-Ended Clinical Challenges,Topic
636,Human-Ai Collaboration Strategies,Topic
637,Trialmind,Topic
637,Trialreviewbench,Topic
637,Zifeng Wang,Author
637,Lang Cao,Author
637,Benjamin Danek,Author
637,Qiao Jin,Author
637,Zhiyong Lu,Author
637,Jimeng Sun,Author
638,Comparing Approaches To Treatment Effect Estimation For Subgroups In Clinical Trials,Paper
638,Marius Thomas,Author
638,Bjˆrn Bornkamp,Author
639,Randomly Censored Survival Data,Topic
639,Applied Sciences,Topic
639,Biomedical Applications,Topic
639,Reliability Applications,Topic
639,Clinical Trial Analyses,Topic
639,Statistical Hypotheses,Topic
639,Likelihood Based Tests,Topic
639,M-Estimators,Topic
639,Minimum Density Power Divergence Estimators,Topic
639,Asymptotic Variance,Topic
639,Wald-Type Tests,Topic
639,Abhik Ghosh,Author
639,Ayanendranath Basu,Author
639,Leandro Pardo,Author
639,Robust Wald-Type Tests Under Random Censoring With Applications To Clinical Trial Analyses,Paper
640,Mild Cognitive Impairment,Topic
640,Alzheimers Disease,Topic
640,Fengyi Tang,Author
640,Kaixiang Lin,Author
640,Ikechukwu Uchendu,Author
640,Hiroko H. Dodge,Author
640,Jiayu Zhou,Author
640,Reinforcement Learning Framework,Topic
640,Clinical Trial,Topic
640,Dialogue Agent,Topic
640,Mci Diagnosis,Topic
640,Supervised Learning Approaches,Topic
641,Loss Of Power And Clear Description Of Treatment Differences,Topic
641,Clinical Trial,Topic
641,Non-Proportional Hazard,Topic
641,Log-Rank Test,Topic
641,Hazard Ratio,Topic
641,Cox Regression,Topic
641,Ich E9 (R1) Addendum,Topic
641,Clinically Relevant Estimand,Topic
641,Expected Life Gain,Topic
641,Cross-Pharma Working Group,Topic
641,Combination Test,Topic
641,Robust Design And Analysis Of Clinical Trials With Non-Proportional Hazards: A Straw Man Guidance From A Cross-Pharma Working Group,Paper
642,Recruitment Prediction For Multi-Centre Clinical Trials Based On A Hierarchical Poisson-Gamma Model: Asymptotic Analysis And Improved Intervals,Paper
642,Hierarchical Poisson-Gamma Model,Topic
642,Quantile Predictions,Topic
642,Simulation Studies,Topic
642,Gamma Random Variables,Topic
642,Gaussian Approximation,Topic
643,"Evidence Inference 2.0: More Data, Better Models",Paper
643,Jay Deyoung,Author
643,Eric Lehman,Author
643,Ben Nye,Author
643,Iain J. Marshall,Author
643,Byron C. Wallace,Author
643,Nlp,Topic
643,Clinical Trials,Topic
643,Systematic Reviews,Topic
643,Evidence Inference Dataset,Topic
643,Comparative Performance,Topic
643,Treatments,Topic
643,Outcome,Topic
643,Five-Year Survival Rates,Topic
643,Operable Cancers,Topic
644,Clinical Trial Drug Safety Assessment For Studies And Submissions Impacted By Covid-19,Paper
644,Mary Nilsson,Author
644,Brenda Crowe,Author
644,Greg Anglin,Author
644,Greg Ball,Author
644,Melvin Munsaka,Author
644,Seta Shahin,Author
644,Wei Wang,Author
645,Linear Regression,Topic
645,Randomized Clinical Trials,Topic
645,Regression Models,Topic
645,Treatment Effect,Topic
645,Wei Ma,Author
645,Fuyi Tu,Author
645,Hanzhong Liu,Author
646,Quasi-(In)Dependence,Topic
646,Tamara Fern·ndez,Author
646,Wenkai Xu,Author
646,Marc Ditzhaus,Author
646,Arthur Gretton,Author
646,Nonparametric Statistical Test Of Quasi-Independence,Paper
647,Assessing Contribution Of Treatment Phases Through Tipping Point Analyses Using Rank Preserving Structural Failure Time Models,Paper
647,Sudipta Bhattacharya,Author
647,Jyotirmoy Dey,Author
647,Clinical Trials,Topic
647,Tipping Point Analysis,Topic
647,Rank-Preserving-Structural-Failure-Time Modeling,Topic
648,Optimal Multiple Testing And Design In Clinical Trials,Paper
648,Ruth Heller,Author
648,Abba Krieger,Author
648,Saharon Rosset,Author
648,Power,Topic
648,Type I Error,Topic
648,Optimization Problem,Topic
648,Hommel'S Procedure,Topic
648,Bittman Et Al. (2009),Topic
648,Apex Study,Topic
648,Simulation,Topic
649,A Permutation Test For Assessing The Presence Of Individual Differences In Treatment Effects,Paper
649,Chi Chang,Author
649,Thomas Jaki,Author
649,Muhammad Saad Sadiq,Author
649,Alena A. Kuhlemeier,Author
649,Daniel Feaster,Author
649,Nathan Cole,Author
649,Andrea Lamont,Author
649,Daniel Oberski,Author
649,Yasin Desai,Author
649,M. Lee Van Horn,Author
650,Advanced Lung Cancer,Topic
650,Immunotherapy,Topic
650,Cimavaxegf,Topic
650,Lizet Sanchez,Author
650,Patricia Lorenzo-Luaces,Author
650,Claudia Fonte,Author
650,Agustin Lage,Author
650,Mixture Survival Model,Topic
650,Randomized Clinical Trials,Topic
650,Survival Analysis,Topic
650,Therapeutic Vaccine,Topic
650,Best Supportive Care,Topic
651,Transformer Query-Target Knowledge Discovery (Tend): Drug Discovery From Cord-19,Paper
651,Roberta,Topic
651,Word2Vec,Topic
651,Covid-19 Open Research Dataset Challenge (Cord-19),Topic
651,Influenza Drug Clinical Trials Dataset,Topic
651,Influenza Clinical Trials And Antiviral Analogies Dataset,Topic
652,Motor Disturbances,Topic
652,Catching A Ball,Topic
652,Clinical Catching Trials,Topic
652,Arm And Ball Movements,Topic
652,Decision Confidence,Topic
652,Accuracy,Topic
652,Earliness,Topic
652,Decision-Making Confidence,Topic
652,Predictive Sequential Classification (Psc),Topic
652,"Predictive, Generative Recurrent Neural Network (Rnn)",Topic
652,Discriminative Rnn,Topic
652,Temporal Convolutional Network (Tcn),Topic
652,Jana Lang,Author
652,Martin A. Giese,Author
652,Matthis Synofzik,Author
652,Winfried Ilg,Author
652,Sebastian Otte,Author
653,Broadly Neutralizing Antibodies (Bnabs),Topic
653,Hiv,Topic
653,Colin Lamont,Author
653,Jakub Otwinowski,Author
653,Kanika Vanshylla,Author
653,Henning Gruell,Author
653,Florian Klein,Author
653,Armita Nourmohammad,Author
653,Bnab Therapy,Topic
653,Viral Escape,Topic
653,Hiv Sequence Data,Topic
653,Clinical Trials,Topic
653,Optimal Bnab Cocktail,Topic
653,Mutational Target Size,Topic
653,Fitness Cost Of Hiv-1 Escape,Topic
653,Rebound Times,Topic
653,Pre-Treatment Standing Variation,Topic
653,Combination Therapy,Topic
654,Missing Data In Longitudinal Clinical Trials,Topic
654,Sensitivity Analysis,Topic
654,Imputation Models,Topic
654,Distributional Imputation (Di),Topic
654,Weighted Bootstrap,Topic
654,Antidepressant Longitudinal Clinical Trial,Topic
654,Siyi Liu,Author
654,Shu Yang,Author
654,Yilong Zhang,Author
654,Guanghan,Author
654,Liu,Author
655,Robust Analyses For Longitudinal Clinical Trials With Missing And Non-Normal Continuous Outcomes,Paper
655,Siyi Liu,Author
655,Yilong Zhang,Author
655,Gregory T Golm,Author
655,Guanghan Liu,Author
655,Shu Yang,Author
656,Algorithms And Technologies,Topic
656,Health Care Research,Topic
656,Data Bias,Topic
656,Cardiovascular Diseases,Topic
656,Chiara Criscuolo,Author
656,Tommaso Dolci,Author
656,Mattia Salnitri,Author
656,Towards Assessing Data Bias In Clinical Trials,Paper
657,Dual Cox Model Theory,Topic
657,Powei Chen,Author
657,Siying Hu,Author
657,Haojin Zhou,Author
658,A Comprehensive Analysis Of Hiv Treatment Efficacy In The Actg 175 Trial Through Multiple-Endpoint Approaches,Paper
658,MarÌa Paula Cantarini,Author
658,Florencia AyelÈn Hern·ndez,Author
658,Hiv-1,Topic
658,Cd4 Cell Counts,Topic
658,Zidovudine,Topic
658,Didanosine,Topic
658,Zalcitabine,Topic
659,Novomol,Topic
659,Ishir Rao,Author
659,Imatinib,Topic
660,Dementia Research,Topic
660,Matilda Beinat,Author
660,Julian Beinat,Author
660,Mohammed Shoaib,Author
660,Jorge Gomez Magenti,Author
660,Dimensions Database,Topic
660,Catboost Classifier,Topic
660,Machine Learning,Topic
660,Uk Dementia Research Publications,Topic
660,2023,Topic
660,2040,Topic
660,1.6 Million People,Topic
660,£25 Billion,Topic
661,Savvy,Topic
661,Kaspar Rufibach,Author
661,Jan Beyersmann,Author
661,Tim Friede,Author
661,Claudia Schmoor,Author
661,Regina Stegherr,Author
662,Bayesian Framework,Topic
662,Power Prior Distributions,Topic
662,Clinical Trials,Topic
662,Treatment Effect,Topic
662,Weight Parameter,Topic
662,Historical Information,Topic
662,Prior Distribution,Topic
662,Calibrated Bayes Factor Procedure,Topic
662,Roberto MacrÏ Demartino,Author
662,Leonardo Egidi,Author
662,Nicola Torelli,Author
662,Ioannis Ntzoufras,Author
663,Drug Repurposing,Topic
663,Stedr,Topic
663,Alzheimer'S Disease,Topic
663,Seungyeon Lee,Author
663,Ruoqi Liu,Author
663,Feixiong Cheng,Author
663,Ping Zhang,Author
664,Experimental Treatments,Topic
664,Familywise Type I Error Rate (Fwer),Topic
664,Dunnett Probability,Topic
664,Babak Choodari-Oskooei,Author
664,Daniel J Bratton,Author
664,Melissa R Gannon,Author
664,Angela M Meade,Author
664,Matthew R Sydes,Author
664,Mahesh Kb Parmar,Author
665,Handling An Uncertain Control Group Event Risk In Non-Inferiority Trials: Non-Inferiority Frontiers And The Power-Stabilising Transformation,Paper
666,European Medicines Agency,Topic
666,Expected Value Of Sample Information,Topic
666,Mathyn Vervaart,Author
666,Mark Strong,Author
666,Karl P. Claxton,Author
666,Nicky J. Welton,Author
666,Torbj¯rn Wisl¯ff,Author
666,Eline Aas,Author
666,An Efficient Method For Computing Expected Value Of Sample Information For Survival Data From An Ongoing Trial,Paper
667,Biomarker-Targeted Anti-Cancer Therapies,Topic
667,Programmed Death Ligand 1,Topic
667,Programmed Death 1,Topic
667,Cancer Indications,Topic
667,Accelerated Approval,Topic
667,Single-Arm Phase Ii Trials,Topic
667,Randomized Trials,Topic
667,Atezolizumab,Author
667,Emily C. Zabor,Author
667,Alexander M. Kaizer,Author
667,Nathan A. Pennell,Author
667,Brian P. Hobbs,Author
667,Phase Iii Trial,Topic
667,Metastatic Urothelial Carcinoma,Topic
667,Optimal Efficiency Predictive Probability Method,Topic
667,Futility Stopping,Topic
667,Simulation Study,Topic
667,Comparative Efficacy,Topic
667,Phase Iii Confirmatory Trial,Topic
668,Bayesian Adaptive Trial,Topic
668,Integrated Nested Laplace Approximations,Topic
668,Markov Chain Monte Carlo Methods,Topic
668,Reyhaneh Hosseini,Author
668,Ziming Chen,Author
668,Ewan Goligher,Author
668,Eddy Fan,Author
668,Niall D. Ferguson,Author
668,Michael O. Harhay,Author
668,Sarina Sahetya,Author
668,Martin Urner,Author
668,Christopher J. Yarnell,Author
668,Anna Heath,Author
669,Composite Endpoints,Topic
669,Randomized Clinical Trials,Topic
669,Sample Size Calculations,Topic
669,Adaptive Clinical Trial Designs,Topic
669,Marta Bofill Roig,Author
669,Guadalupe GÛmez Melis,Author
669,Martin Posch,Author
669,Franz Koenig,Author
670,Three-Photon Fluorescence Microscopy,Topic
670,Deep-Tissue Imaging,Topic
670,Neuroscience,Topic
670,Immunology,Topic
670,Cancer Biology,Topic
670,Femtosecond Pulses,Topic
670,Hollow-Core Fiber,Topic
670,Mouse Brain,Topic
670,Yishai Eisenberg,Author
670,Wenchao Wang,Author
670,Shitong Zhao,Author
670,Eric S. Hebert,Author
670,Yi-Hao Chen,Author
670,Dimitre G. Ouzounov,Author
670,Hazuki Takahashi,Author
670,Anna Gruzdeva,Author
670,Aaron K. Laviolette,Author
670,Moshe Labaz,Author
670,Pavel Sidorenko,Author
670,Enrique Antonio-Lopez,Author
670,Rodrigo Amezcua-Correa,Author
670,Nilay Yapici,Author
670,Chris Xu,Author
670,Frank Wise,Author
671,Clinica,Topic
671,Alexandre Routier,Author
671,Ninon Burgos,Author
671,Mauricio DÌaz,Author
671,Michael Bacci,Author
671,Simona Bottani,Author
671,Omar El-Rifai,Author
671,Sabrina Fontanella,Author
671,Pietro Gori,Author
671,JÈrÈmy Guillon,Author
671,Alexis Guyot,Author
671,Ravi Hassanaly,Author
671,Thomas Jacquemont,Author
671,Pascal Lu,Author
671,Arnaud Marcoux,Author
671,Tristan Moreau,Author
671,Jorge Samper-Gonz·lez,Author
671,Marc Teichmann,Author
671,Elina Thibeau--Sutre,Author
671,Ghislain Vaillant,Author
671,Junhao Wen,Author
671,Adam Wild,Author
671,Marie-Odile Habert,Author
671,Stanley Durrleman,Author
671,Olivier Colliot,Author
672,Women'S Health Initiative,Topic
672,Hormone Therapy,Topic
672,Myocardial Infarction,Topic
672,Ischemic Stroke,Topic
672,Diana B. Petitti,Author
672,Wansu Chen,Author
673,Multivariate Bayesian Logistic Regression For Analysis Of Clinical Trial Safety Issues,Paper
673,Stephen Evans,Author
674,Asymptotic Normality Of Linear Rank Statistics,Topic
674,Randomization Rules,Topic
674,Clinical Trials,Topic
674,Patients' Allocation Into Treatment And Placebo Arms,Topic
674,Mcleish (1974),Author
674,Viktor Skorniakov,Author
674,General Limit Theorem,Topic
674,Well Known Results,Topic
674,Several New Results,Topic
675,Regulation Of Interferon Production As A Potential Strategy For Covid-19 Treatment,Paper
675,Xiaobing Deng,Author
675,Xiaoyu Yu,Author
675,Jianfeng Pei,Author
676,Youth Experiencing Homelessness,Topic
676,Hiv Infection,Topic
676,Health Equity,Topic
676,Peer Leaders,Topic
676,Artificial Intelligence System,Topic
676,Clinical Trial,Topic
676,Ai-Augmented Intervention For Hiv Prevention,Paper
677,Randomized Clinical Trials,Topic
677,Multiple Primary Endpoints,Topic
677,Closed Testing Principle,Topic
677,Max(Maxt) Tests,Topic
677,Simulation Study,Topic
677,Treatment-Versus-Control Comparisons,Topic
677,Multiple Correlated Endpoint,Topic
677,Ludwig A. Hothorn,Author
677,Siegfried Kropf,Author
678,Artificial Pancreas System,Topic
678,Xugui Zhou,Author
678,Maxfield Kouzel,Author
678,Haotian Ren,Author
678,Homa Alemzadeh,Author
678,Openaps,Topic
678,Basal Bolus,Topic
678,Fda,Topic
678,Type 1 Diabetes,Topic
678,Glucose Levels,Topic
678,Control Algorithms,Topic
678,Synthetic Data,Topic
678,Testbed,Topic
679,Prognostic Covariate-Adjusted Mixed Models For Repeated Measures (Procova-Mmrm),Topic
679,Alzheimer'S Disease,Topic
679,Amyotrophic Lateral Sclerosis,Topic
679,Jessica L. Ross,Author
679,Arman Sabbaghi,Author
679,Run Zhuang,Author
679,Daniele Bertolini,Author
679,The Alzheimer'S Disease Cooperative Study,Author
679,Alzheimer'S Disease Neuroimaging Initiative,Author
679,The Critical Path For Alzheimer'S Disease Database,Author
679,The European Prevention Of Alzheimer'S Disease Consortium,Author
679,The Pooled Resource Open-Access Als Clinical Trials Consortium,Author
680,Semeval 2024 Task 2,Topic
680,ClÈment Brutti-Mairesse,Author
680,LoÔc Verlingue,Author
680,Language Model-As-A-Service,Topic
680,Prompt Optimization Techniques,Topic
680,Synthetic Cot Prompts,Topic
681,Arges,Topic
681,Ulcerative Colitis,Topic
681,Mayo Endoscopic Subscore,Topic
681,Ulcerative Colitis Endoscopic Index Of Severity,Topic
681,Krishna Chaitanya,Author
681,Pablo F. Damasceno,Author
681,Shreyas Fadnavis,Author
681,Pooya Mobadersany,Author
681,Chaitanya Parmar,Author
681,Emily Scherer,Author
681,Natalia Zemlianskaia,Author
681,Lindsey Surace,Author
681,Louis R. Ghanem,Author
681,Oana Gabriela Cula,Author
681,Tommaso Mansi,Author
681,Kristopher Standish,Author
682,"Spatiotemporal Dissociation Of Brain Activity Underlying Subjective Awareness, Objective Performance And Confidence",Paper
682,Qi Li,Author
682,Zachary Hill,Author
682,Biyu J. He,Author
683,Neuroscience,Topic
683,Lfads,Paper
683,Variational Auto-Encoder,Topic
683,Synthetic Data,Topic
683,Neural Firing Rates,Topic
683,Latent Dynamics,Topic
684,Lfads,Topic
684,Neural Population Dynamics,Topic
684,Field Programmable Gate Arrays,Topic
684,Xilinx U55C,Topic
684,Xiaohan Liu,Author
684,Chijui Chen,Author
684,Yanlun Huang,Author
684,Lingchi Yang,Author
684,Elham E Khoda,Author
684,Yihui Chen,Author
684,Scott Hauck,Author
684,Shih-Chieh Hsu,Author
684,Bo-Cheng Lai,Author
685,Decoding Continuous Character-Based Language From Non-Invasive Brain Recordings,Paper
685,Cenyuan Zhang,Author
685,Xiaoqing Zheng,Author
685,Ruicheng Yin,Author
685,Shujie Geng,Author
685,Jianhan Xu,Author
685,Xuan Gao,Author
685,Changze Lv,Author
685,Zixuan Ling,Author
685,Xuanjing Huang,Author
685,Miao Cao,Author
685,Jianfeng Feng,Author
686,Stacked Ca,Topic
686,Common Terminology Criteria For Adverse Events (Ctcae),Topic
686,Shiny App,Topic
686,Nsabp R-04,Paper
686,Nsabp B-35,Paper
686,M·rcio A. Diniz,Author
686,Gillian Gresham,Author
686,Sungjin Kim,Author
686,Michael Luu,Author
686,N. Lynn Henry,Author
686,Mourad Tighiouart,Author
686,Greg Yothers,Author
686,Patricia A. Ganz,Author
686,AndrÈ Rogatko,Author
687,Effective Matching Of Patients To Clinical Trials Using Entity Extraction And Neural Re-Ranking,Paper
687,Clinical Trials,Topic
687,Transformer Network,Topic
687,Data Enrichment Technique,Topic
687,Named Entity Recognition,Topic
687,Negation Detection,Topic
687,Patient Descriptions,Topic
687,Ct Eligibility Criteria,Topic
688,Clinical Randomized Controlled Trials,Topic
688,Measurement Efficient Randomized Controlled Trials Using Transformers With Input Masking,Paper
688,Planned Missing Design,Topic
688,Imputation Algorithms,Topic
688,Rct Datasets,Topic
688,Transformer Architecture,Topic
688,Sampling Efficiency,Topic
688,Imputation Performance,Topic
689,Machine Learning,Topic
689,Clinical Neuroscience,Topic
689,Cancer Imaging,Topic
689,Neurologic Diseases,Topic
689,Neuropsychiatric Diseases,Topic
689,Disease Subtyping,Topic
689,Alzheimer Disease,Topic
689,Psychosis,Topic
689,Depression,Topic
689,Autism,Topic
689,Brain Cancer,Topic
689,Junhao Wen,Author
689,Erdem Varol,Author
689,Zhijian Yang,Author
689,Gyujoon Hwang,Author
689,Dominique Dwyer,Author
689,Anahita Fathi Kazerooni,Author
689,Paris Alexandros Lalousis,Author
689,Christos Davatzikos,Author
690,Investigating The Use Of Mastery-Style Online Homework Exercises In Introductory Algebra-Based Mechanics In A Controlled Clinical Study,Paper
690,William R. Evans,Author
690,Mats A. Selen,Author
690,Mastery-Style Homework,Topic
690,Traditional-Style Homework,Topic
690,Introductory Physics,Topic
690,Algebra-Based Mechanics,Topic
690,Calculus-Based Mechanics,Topic
690,Weaker Students,Topic
690,Clinical Trials,Topic
691,Statistical Inference Methods For Cumulative Incidence Function Curves At A Fixed Point In Time,Paper
691,Jinbao Chen,Author
691,Yawen Hou,Author
691,Zheng Chen,Author
692,Revolutionizing Pharma: Unveiling The Ai And Llm Trends In The Pharmaceutical Industry,Paper
692,Artificial Intelligence,Topic
692,Pharmaceutical Industry,Topic
693,Major Depressive Disorder (Mdd),Topic
693,Differential Prototypes Neural Network (Dpnn),Topic
693,David Benrimoh,Author
693,Akiva Kleinerman,Author
693,Toshi A. Furukawa,Author
693,Charles F. Reynolds Iii,Author
693,Eric Lenze,Author
693,Jordan Karp,Author
693,Benoit Mulsant,Author
693,Caitrin Armstrong,Author
693,Joseph Mehltretter,Author
693,Robert Fratila,Author
693,Kelly Perlman,Author
693,Sonia Israel,Author
693,Myriam Tanguay-Sela,Author
693,Christina Popescu,Author
693,Grace Golden,Author
693,Sabrina Qassim,Author
693,Alexandra Anacleto,Author
693,Adam Kapelner,Author
693,Ariel Rosenfeld,Author
693,Gustavo Turecki,Author
694,Single-Arm Phase Ii Oncology Trials,Topic
694,Simon'S Two-Stage Design,Topic
694,Curtailment,Topic
694,Stochastic Curtailment,Topic
694,Non-Stochastic Curtailment,Topic
694,Optimal Stopping Boundaries,Topic
694,Martin Law,Author
694,Michael J. Grayling,Author
694,Adrian P. Mander,Author
694,Optimal Curtailed Designs,Topic
694,Expected Sample Size,Topic
694,Loss Function,Topic
695,Bayesian Nonparametric Common Atoms Regression For Generating Synthetic Controls In Clinical Trials,Paper
695,Noirrit Kiran Chandra,Author
695,Abhra Sarkar,Author
695,John F. De Groot,Author
695,Ying Yuan,Author
695,Peter M¸ller,Author
696,Bi3+3,Topic
696,Jiaxin Liu,Author
696,Shijie Yuan,Author
696,B. Nebiyou Bekele,Author
696,Yuan Ji,Author
697,Randomized Controlled Clinical Trials,Topic
697,Bayesian Paradigm,Topic
697,Discounting Factor,Topic
697,Nonmonotonicity,Topic
697,Weights,Topic
697,Analytical Sample Size Formula,Topic
697,Linearization Technique,Topic
697,Lou E. Whitehead,Author
697,James M. S. Wason,Author
697,Oliver Sailer,Author
697,Haiyan Zheng,Author
697,Bayesian Sample Size Determination Using Robust Commensurate Priors With Interpretable Discrepancy Weights,Paper
698,Ebm-Comet,Topic
698,Micheal Abaho,Author
698,Danushka Bollegala,Author
698,Paula R Williamson,Author
698,Susanna Dodd,Author
698,Biobert,Topic
699,Deep Few-View High-Resolution Photon-Counting Extremity Ct At Halved Dose For A Clinical Trial,Paper
699,Mengzhou Li,Author
699,Chuang Niu,Author
699,Ge Wang,Author
699,Maya R Amma,Author
699,Krishna M Chapagain,Author
699,Stefan Gabrielson,Author
699,Andrew Li,Author
699,Kevin Jonker,Author
699,Niels De Ruiter,Author
699,Jennifer A Clark,Author
699,Phil Butler,Author
699,Anthony Butler,Author
699,Hengyong Yu,Author
700,Cohort Selection,Topic
700,National Nlp Clinical Challenges (N2C2),Topic
700,Samarth Rawal,Author
700,Ashok Prakash,Author
700,Soumya Adhya,Author
700,Sidharth Kulkarni,Author
700,Saadat Anwar,Author
700,Chitta Baral,Author
700,Murthy Devarakonda,Author
700,Clinical Trial Cohort Selection,Topic
700,Machine Learning Model,Topic
700,Lexicon Development,Topic
700,F Measure,Topic
701,Alzheimer'S Disease,Topic
701,Jack Albright,Author
701,Alzheimer'S Disease Neuroimaging Initiative,Topic
701,Machine Learning,Topic
701,Neural Network Model,Topic
701,Clinical Trials,Topic
701,All-Pairs Technique,Topic
701,Mauc,Topic
701,1737 Patients,Topic
701,110 Patients,Topic
702,Proportional Hazards,Topic
702,Confirmatory Clinical Trials,Topic
702,Oncology,Topic
702,Immunotherapy,Topic
702,Novel Targeted Therapies,Topic
702,Non-Proportional Hazards,Topic
702,Hazard Ratio,Topic
702,Log-Rank Test,Topic
702,Sample Size Increase,Topic
702,Weighed Log-Rank Test,Topic
702,Restricted Mean Survival Time (Rmst),Topic
702,Simulation Study,Topic
702,Treatment Effect Estimation,Topic
702,JosÈ L. JimÈnez,Author
703,Ultrasound Computed Tomography (Usct),Topic
703,Breast Imaging,Topic
703,Computer-Simulation Studies,Topic
703,Realistic Numerical Phantoms,Topic
703,Three-Dimensional (3D) Numerical Breast Phantoms,Topic
703,Fu Li,Author
703,Umberto Villa,Author
703,Seonyeong Park,Author
703,Mark A. Anastasio,Author
704,Model-Informed Precision Dosing (Mipd),Topic
704,Corinna Maier,Author
704,Jana De Wiljes,Author
704,Niklas Hartung,Author
704,Charlotte Kloft,Author
704,Wilhelm Huisinga,Author
704,Paclitaxel,Topic
705,Assessing Contribution Of Treatment Phases Through Tipping Point Analyses Via Counterfactual Elicitation Using Rank Preserving Structural Failure Time Models,Paper
705,Tipping Point Analyses,Topic
705,Rank-Preserving-Structural-Failure-Time Modelling,Topic
705,Oncology Clinical Research,Topic
705,Statistical Approaches,Topic
706,P2T2,Topic
706,Hadas Ben-Atya,Author
706,Moti Freiman,Author
706,T2 Relaxation Time Distributions,Topic
706,Mri,Topic
706,Neurodegenerative Disorders,Topic
706,Osteoarthritis,Topic
706,Tumors,Topic
707,Benchmarking Drug Efficacy,Topic
707,Clinical Trial Design,Topic
707,Scientific Papers,Topic
707,Machine Learning Approach,Topic
707,Efficacy Endpoints,Topic
707,Aline Gendrin-Brokmann,Author
707,Eden Harrison,Author
707,Julianne Noveras,Author
707,Leonidas Souliotis,Author
707,Harris Vince,Author
707,Ines Smit,Author
707,Francisco Costa,Author
707,David Milward,Author
707,Sashka Dimitrievska,Author
707,Paul Metcalfe,Author
707,Emilie Louvet,Author
708,Intracranial Arterial Calcification,Topic
708,Ischaemic Stroke,Topic
708,Ct Head Scans,Topic
708,Artificial Intelligence Methods,Topic
708,International Stroke Trial (Ist-3),Paper
708,Benjamin Jin,Author
708,Maria Del C. ValdÈs Hern·ndez,Author
708,Alessandro Fontanella,Author
708,Wenwen Li,Author
708,Eleanor Platt,Author
708,Paul Armitage,Author
708,Amos Storkey,Author
708,Joanna M. Wardlaw,Author
708,Grant Mair,Author
709,Understanding The Function Of Complex Cortical Circuits,Topic
709,Action Potentials,Topic
709,Neurons,Topic
709,Awake And Behaving Animals,Topic
709,Extracellularly Recording,Topic
709,Single Wire Electrodes,Topic
709,Human Hippocampus,Topic
709,Analytic Techniques,Topic
709,Offline Spike Sorting Approaches,Topic
709,Human Brain,Topic
709,Online Sorting And Detection Algorithms,Topic
709,Response Properties Of The Recorded Neurons,Topic
709,Method For Detecting And Sorting Extracellular Single-Wire Recordings,Topic
709,Data Set From Chronically-Implanted Depth Electrodes,Topic
709,Human Epilepsy Patients,Topic
709,Noisy Clinical Environment,Topic
709,Closed-Loop Experiments,Topic
709,Ueli Rutishauser,Author
709,Erin M. Schuman,Author
709,Adam N. Mamelak,Author
710,Artificial Intelligence,Topic
710,Intracranial Electroencephalography,Topic
710,Ai-Ieeg For Neuroscience,Topic
710,Ai-Ieeg For Neurotechnology,Topic
710,Julia Berezutskaya,Author
710,Anne-Lise Saive,Author
710,Karim Jerbi,Author
710,Marcel Van Gerven,Author
711,Pennsieve,Topic
711,Zack Goldblum,Author
711,Zhongchuan Xu,Author
711,Haoer Shi,Author
711,Patryk Orzechowski,Author
711,Jamaal Spence,Author
711,Kathryn A Davis,Author
711,Brian Litt,Author
711,Nishant Sinha,Author
711,Joost Wagenaar,Author
711,Nih Sparc Initiative,Topic
711,Nih Heal Initiative'S Precision Human Pain Network,Topic
711,Nih Heal Re-Join Initiative,Topic
711,University Of Pennsylvania,Topic
711,Sparc.Science,Topic
711,Epilepsy.Science,Topic
711,Pennsieve Discover,Topic
712,Negative-Binomial Distribution Model,Topic
712,Poisson Process,Topic
712,Over-Dispersion,Topic
712,Neurophysiological Data,Topic
712,Wahiba Taouali,Author
712,Giacomo Benvenuti,Author
712,Pascal Wallisch,Author
712,FrÈdÈric Chavane,Author
712,Laurent Perrinet,Author
712,Testing The Odds Of Inherent Versus Observed Over-Dispersion In Neural Spike Counts,Paper
713,Neuroscience Data Analysis,Topic
713,Stimuli Bundle,Topic
713,Dapp Model,Topic
713,Chris Glynn,Author
713,Surya T Tokdar,Author
713,Azeem Zaman,Author
713,Valeria C Caruso,Author
713,Jeffrey T Mohl,Author
713,Shawn M Willett,Author
713,Jennifer M Groh,Author
714,Sars-Cov-2,Topic
714,Covid-19,Topic
714,Elizabeth Krieger,Author
714,Nicole Vissichelli,Author
714,Stefan Leichtle,Author
714,Markos Kashioris,Author
714,Roy Sabo,Author
714,Don Brophy,Author
714,Xiang-Yang Wang,Author
714,Pamela Kimbal,Author
714,Michael Neale,Author
714,Myrna G. Serrano,Author
714,Gregory A. Buck,Author
714,Catherine Roberts,Author
714,Rehan Qayyum,Author
714,Daniel Nixon,Author
714,Steven Grossman,Author
714,Amir A. Toor,Author
715,Human Brain,Topic
715,Network Neuroscience,Topic
715,Cognitive Deficits,Topic
715,Mental Abilities,Topic
715,Network Control Theory,Topic
715,John D. Medaglia,Author
715,Perry Zurn,Author
715,Walter Sinnott-Armstrong,Author
715,Danielle S. Bassett,Author
716,Event-Based Gesture Recognition With Dynamic Background Suppression Using Smartphone Computational Capabilities,Paper
716,Gesture Recognition,Topic
716,Event Based Camera,Topic
716,Mobile Phone,Topic
716,Time-Surfaces,Topic
716,Dynamic Backgrounds,Topic
716,High Temporal Resolution,Topic
716,Dynamic Scenarios,Topic
716,Uncontrolled Lighting Conditions,Topic
716,Publicly Available Event-Based Dataset,Topic
716,Human-Machine Interactions,Topic
716,Visually-Impaired,Topic
716,Elderly,Topic
716,Prior Works,Topic
716,Computational And Memory Constraints,Topic
717,Computational Models,Topic
717,Electroencephalography (Eeg),Topic
717,Katharina Glomb,Author
717,Joana Cabral,Author
717,Anna Cattani,Author
717,Alberto Mazzoni,Author
717,Ashish Raj,Author
717,Benedetta Franceschiello,Author
718,Computational Medical Extended Reality (Cmxr),Topic
718,George Papagiannakis,Author
718,Walter Greenleaf,Author
718,Michael Cole,Author
718,Mark Zhang,Author
718,Rabi Datta,Author
718,Mathias Delahaye,Author
718,Eleni Grigoriou,Author
718,Manos Kamarianakis,Author
718,Antonis Protopsaltis,Author
718,Philippe Bijlenga,Author
718,Nadia Magnenat-Thalmann,Author
718,Eleftherios Tsiridis,Author
718,Eustathios Kenanidis,Author
718,Kyriakos Vamvakidis,Author
718,Ioannis Koutelidakis,Author
718,Oliver A Kannape,Author
719,Neuroscience,Topic
719,Electrophysiological Recordings,Topic
719,Eeg,Topic
719,Hemodynamic Modalities,Topic
719,Fmri,Topic
719,Spatiotemporal Alignment Of Multimodal Brain Activity,Paper
720,Treatment Regime,Topic
720,Patient Outcomes,Topic
720,Statisticians,Topic
720,Clinical Scientists,Topic
720,If-Then Statements,Topic
720,Optimal Regime,Topic
720,Simulation Experiments,Topic
720,Clinical Trials,Topic
720,Yichi Zhang,Author
720,Eric B. Laber,Author
720,Anastasios Tsiatis,Author
720,Marie Davidian,Author
721,Correlational Dueling Bandits With Application To Clinical Treatment In Large Decision Spaces,Paper
721,Corrduel,Topic
721,Dueling Bandits Problem,Topic
722,Unstructured Clinical Text In Ehrs,Topic
722,Decision Support,Topic
722,Trial Matching,Topic
722,Retrospective Research,Topic
722,Bert-Based Models,Topic
722,Snipbert,Topic
722,Kexin Huang,Author
722,Sankeerth Garapati,Author
722,Alexander S. Rich,Author
722,An Interpretable End-To-End Fine-Tuning Approach For Long Clinical Text,Paper
723,Parkinson'S Disease,Topic
723,Gait Impairment,Topic
723,Model,Topic
723,Clinical Measures,Topic
723,Biomechanical Measures,Topic
723,Pd Subjects,Topic
723,Xgboost,Topic
723,Feed Forward Neural Networks,Topic
723,Neural Network,Topic
723,Ppv,Topic
723,Variance,Topic
723,Vyom Raval,Author
723,Kevin P. Nguyen,Author
723,Ashley Gerald,Author
723,Richard B. Dewey Jr.,Author
723,Albert Montillo,Author
724,Clinical Data,Topic
724,Machine Learning Methods,Topic
724,Precision Medicine,Topic
724,Disease Phenotypes,Topic
724,Individual Disease Prediction,Topic
724,Deep Learning Methods,Topic
724,Adaptivenet,Paper
724,Rheumatoid Arthritis,Topic
724,Swiss Clinical Quality Management Registry,Topic
724,10.000 Patients,Topic
724,65.000 Patient Visits,Topic
724,Fully-Connected Neural Networks,Topic
724,Classical Machine Learning Methods,Topic
724,Disease Progression Prediction,Topic
725,Adaptive Therapy,Topic
725,Metastatic Castrate Resistant Prostate Cancer,Topic
725,Ovarian Cancer,Topic
725,Braf-Mutant Melanoma,Topic
725,Jeffrey West,Author
725,Fred Adler,Author
725,Jill Gallaher,Author
725,Maximilian Strobl,Author
725,Renee Brady-Nicholls,Author
725,Joel S. Brown,Author
725,Mark Robertson-Tessi,Author
725,Eunjung Kim,Author
725,Robert Noble,Author
725,Yannick Viossat,Author
725,David Basanta,Author
725,Alexander R. A. Anderson,Author
726,Anonymising Clinical Data For Secondary Use,Paper
726,Irene Ferreira,Author
726,Chris Harbron,Author
726,Alex Hughes,Author
726,Tamsin Sargood,Author
726,Christoph Gerlinger,Author
727,Natural Language Inference For Clinical Trials,Topic
727,Tldr,Paper
727,Spandan Das,Author
727,Vinay Samuel,Author
727,Shahriar Noroozizadeh,Author
728,Causal Machine Learning For Predicting Treatment Outcomes,Paper
729,Tuh Eeg Seizure Corpus,Topic
729,Vinit Shah,Author
729,Eva Von Weltin,Author
729,Silvia Lopez,Author
729,James Riley Mchugh,Author
729,Lily Veloso,Author
729,Meysam Golmohammadi,Author
729,Iyad Obeid,Author
729,Joseph Picone,Author
730,Effective And Interpretable Fmri Analysis Via Functional Brain Network Generation,Paper
731,Clinical Diagnosis Of The Eye,Topic
731,Diabetic Retinopathy,Topic
731,Diabetic Macular Edema,Topic
731,Ophthalmic Labels For Investigating Visual Eye Semantics,Paper
731,Olives Dataset,Topic
731,Optical Coherence Tomography,Topic
731,Near-Ir Fundus Images,Topic
731,Biomarker Labels,Topic
731,Clinical Labels,Topic
731,Disease Labels,Topic
731,Time-Series Patient Treatment Information,Topic
731,1268 Near-Ir Fundus Images,Topic
731,49 Oct Scans,Topic
731,16 Biomarkers,Topic
731,4 Clinical Labels,Topic
731,96 Eyes' Data,Topic
731,66 Weeks,Topic
731,7 Injections,Topic
731,Two Years,Topic
732,Clinical Prediction Models,Topic
732,Performative Prediction,Topic
732,Hold-Out Sets,Topic
732,Ethical Principles,Topic
732,Informed Consent,Topic
732,Clinical Equipoise,Topic
732,Truth-Telling,Topic
732,Louis Chislett,Author
732,Louis Jm Aslett,Author
732,Alisha R Davies,Author
732,Catalina A Vallejos,Author
732,James Liley,Author
733,Transcranial Ultrasonic Stimulation,Topic
733,Tulika Nandi,Author
733,Benjamin R. Kop,Author
733,Kim Butts Pauly,Author
733,Charlotte J. Stagg,Author
733,Lennart Verhagen,Author
734,A Scoping Review Of Publicly Available Language Tasks In Clinical Natural Language Processing,Paper
734,Clinical Natural Language Processing,Topic
735,Efron,Author
735,Biased Coin Design,Topic
735,Tigran Markaryan,Author
735,William F. Rosenberger,Author
735,Biometrika 58 (1971) 403--417,Paper
736,Randomized Urn Models Revisited Using Stochastic Approximation,Paper
737,Addressing Missing Data Mechanism Uncertainty Using Multiple-Model Multiple Imputation: Application To A Longitudinal Clinical Trial,Paper
738,"A Two-Stage, Phase Ii Clinical Trial Design With Nested Criteria For Early Stopping And Efficacy",Paper
738,Daniel Zelterman,Author
738,Clinical Trial,Topic
738,Early Stopping Rule,Topic
738,Efficacy,Topic
738,Lung Cancer,Topic
738,Novel Drug Combination,Topic
738,Progression-Free Survival (Pfs),Topic
738,Phase Ii Design,Topic
739,Variable Selection For Optimal Treatment Regime,Topic
739,Gunter Et Al. (2011),Author
739,Ailin Fan,Author
739,Wenbin Lu,Author
739,Rui Song,Author
739,Sequential Advantage Selection For Optimal Treatment Regimes,Paper
740,Generalized PÛlya Urn,Topic
740,Adaptive Randomly Reinforced Urn Model,Topic
740,Law Of Large Numbers,Topic
740,Central Limit Theorem,Topic
740,Response-Adaptive Randomization,Topic
740,Andrea Ghiglietti,Author
740,Anand N. Vidyashankar,Author
740,William F. Rosenberger,Author
741,Dynamic Prediction For Multiple Repeated Measures And Event Time Data: An Application To Parkinson'S Disease,Paper
741,Parkinson'S Disease,Topic
742,Pairwise Sequential Randomization,Topic
742,Yichen Qin,Author
742,Yang Li,Author
742,Wei Ma,Author
742,Feifang Hu,Author
742,Causal Inference,Topic
742,Clinical Trials,Topic
742,Covariate Imbalance,Topic
742,Big Data,Topic
743,An Information-Theoretic Approach For Selecting Arms In Clinical Trials,Paper
744,Bayesian Nonparametric Inference For Panel Count Data With An Informative Observation Process,Paper
744,Ye Liang,Author
744,Yang Li,Author
744,Bin Zhang,Author
745,Learning Disentangled Representations Of Texts With Application To Biomedical Abstracts,Paper
745,Sarthak Jain,Author
745,Edward Banner,Author
745,Jan-Willem Van De Meent,Author
745,Iain J. Marshall,Author
745,Byron C. Wallace,Author
745,Biomedical Abstracts,Topic
746,Subgroup Identification Using Covariate Adjusted Interaction Trees,Paper
746,Jon Arni Steingrimsson,Author
746,Jiabei Yang,Author
746,Recursive Partitioning Methods,Topic
746,Classification And Regression Tree Algorithm,Topic
746,Covariate Adjusted Estimators,Topic
746,Clinical Trial,Topic
746,Motivational Interviews,Topic
746,Substance Abusers,Topic
747,Equivalence Of Regression Curves Sharing Common Parameters,Paper
748,Oncology Clinical Trials,Topic
748,Experimental Drug,Topic
748,Control Group,Topic
748,Overall Survival Benefit,Topic
748,Statistical Methods,Topic
748,Inverse Probability Of Censoring Weighting (Ipcw),Topic
748,Iterative Parameter Estimation (Ipe),Topic
748,Rank-Preserving Structural Failure Time Models (Rpsftm),Topic
748,Stratified Rpsftm,Topic
748,Random-Forest-Based Prediction,Topic
748,Simulation Study,Topic
748,Yuqing Xu,Author
748,Meijing Wu,Author
748,Weili He,Author
748,Qiming Liao,Author
748,Yabing Mai,Author
749,Simulation-Based Sample Size Determination,Topic
749,Duncan T. Wilson,Author
749,Rebecca E. A. Walwyn,Author
749,Richard Hooper,Author
749,Julia Brown,Author
749,Amanda J. Farrin,Author
750,Randomized Controlled Trials (Rcts),Topic
750,Rct Conclusion Generation Task,Topic
750,Pubmed 200K Rct Sentence Classification Dataset,Topic
750,Pointer-Generator Baseline Model,Topic
750,Gpt-2 Language Model,Topic
750,Alexander Te-Wei Shieh,Author
750,Yung-Sung Chuang,Author
750,Shang-Yu Su,Author
750,Yun-Nung Chen,Author
751,Hodgkin Lymphoma,Topic
751,CÈdric Beaulac,Author
751,Jeffrey S. Rosenthal,Author
751,Qinglin Pei,Author
751,Debra Friedman,Author
751,Suzanne Wolden,Author
751,David Hodgson,Author
751,Ahod0031 Trial,Topic
751,Cox Proportional Hazard Model,Topic
751,Machine Learning Algorithms,Topic
751,Survival Analysis,Topic
751,Concordance Index,Topic
751,Brier Score,Topic
751,Artificial Intelligence,Topic
752,Pocock And Simon'S Marginal Procedure,Topic
752,Feifang Hu,Author
752,Li-Xin Zhang,Author
752,On The Theory Of Covariate-Adaptive Designs,Paper
753,Power Calculations For Replication Studies,Paper
753,Charlotte Micheloud,Author
753,Leonhard Held,Author
753,Replication Studies,Topic
753,Bayesian Methods,Topic
753,Predictive Power,Topic
753,Conditional Power,Topic
753,Social Sciences,Topic
754,Functional Additive Model,Topic
754,Randomized Clinical Trial,Topic
754,Depression Clinical Trial,Topic
754,Hyung Park,Author
754,Eva Petkova,Author
754,Thaddeus Tarpey,Author
754,R. Todd Ogden,Author
755,Ivist,Topic
755,Multi-Point Plastic Scintillator Dosimeter,Topic
755,Photomultiplier Tubes Assembly,Topic
755,Python-Based Graphical User Interface,Topic
755,Clinical Trial,Topic
755,Haydee M. Linares Rosales,Author
755,Audrey Cantin,Author
755,Sylviane Aubin,Author
755,Sam Beddar,Author
755,Luc Beaulieu,Author
756,Censored Survival Data,Topic
756,Sensitivity Analysis,Topic
756,Multiple Imputation,Topic
756,Martingale,Topic
756,Smim,Paper
757,Adaptive Dose-Response Studies To Establish Proof-Of-Concept In Learning-Phase Clinical Trials,Paper
757,Shiyang Ma,Author
757,Michael P. Mcdermott,Author
758,Data Sharing Barriers,Topic
758,Multicenter Clinical Trials,Topic
758,Data Use Agreement,Topic
758,Causal Inference Framework,Topic
758,Summary Statistics,Topic
758,Collaborative Inference,Topic
758,Statistical Power,Topic
758,Mengtong Hu,Author
758,Xu Shi,Author
758,Peter X. -K. Song,Author
758,Basal Insulin Treatment,Topic
758,Post-Transplantation Diabetes,Topic
758,Kidney-Transplant Patients,Topic
759,Multistate Process Data,Topic
759,Chronic Diseases,Topic
759,Cancer,Topic
759,Precision Medicine,Topic
759,Optimal Individualized Treatment Rules,Topic
759,Nonparametric Outcome Weighted Learning Approach,Topic
759,Randomized Clinical Trial,Topic
759,Fisher Consistency,Topic
759,Asymptotic Normality,Topic
759,Variance Estimator,Topic
759,Confidence Intervals,Topic
759,Simulation Studies,Topic
759,Metastatic Squamous-Cell Carcinoma Of The Head And Neck,Topic
759,Giorgos Bakoyannis,Author
760,Monotone Safe Ucb,Topic
761,Joint Modelling Of Longitudinal And Time-To-Event Data Applied To Group Sequential Clinical Trials,Paper
762,"Predicting Subgroup Treatment Effects For A New Study: Motivations, Results And Learnings From Running A Data Challenge In A Pharmaceutical Corporation",Paper
762,Subgroup Identification,Topic
762,Phase Iii Clinical Trials,Topic
762,Data Challenge,Topic
763,Clinical Trials With Rescue Medication Applied According To A Deterministic Rule,Paper
764,Optimal Benchmark,Topic
764,O'Quigley Et Al. 2002,Paper
764,Cheung 2014,Paper
764,Phase I Clinical Trial,Topic
764,Phase I/Ii Clinical Trial,Topic
765,Alzheimer'S Disease,Topic
765,Photobiomodulation,Topic
765,Joachim Enengl,Author
765,Peter Dungel,Author
765,Photobiomodulation Against Alzheimer'S Disease: A Systematic Review,Paper
766,Random Allocation Models,Topic
766,Clinical Trials,Topic
766,Play The Winner,Topic
766,Randomized Play The Winner Rule,Topic
766,Bayesian Method Using Decreasingly Informative Priors,Topic
766,Dynamic Linear Model (Dlm),Topic
766,Sensitivity Analysis,Topic
766,Bayes Factor,Topic
766,Albert. H. Lee Iii,Author
766,Edward L Boone,Author
766,Roy T. Sabo,Author
766,Erin Donahue,Author
767,Hopes,Topic
767,Beiwe,Topic
767,Sars-Cov-2 Pandemic,Topic
767,Xuancong Wang,Author
767,Nikola Vouk,Author
767,Creighton Heaukulani,Author
767,Thisum Buddhika,Author
767,Wijaya Martanto,Author
767,Jimmy Lee,Author
767,Robert Jt Morris,Author
768,Testing The Equality Of Proportions For Combined Unilateral And Bilateral Data,Paper
768,Chang-Xing Ma,Author
768,Kejia Wang,Author
768,Bilateral Data,Topic
768,Unilateral Data,Topic
768,Statistical Tests,Topic
768,Intra-Class Correlation,Topic
768,Likelihood Estimate Algorithm,Topic
768,Score Test,Topic
769,Cauchycp,Topic
769,Cox Proportional Hazards Model,Topic
769,Randomized Clinical Trials,Topic
769,Cauchycp Test,Topic
770,Vaccine Efficacy,Topic
770,Clinical Interventions,Topic
770,Covid-19 Vaccines,Topic
770,Yasin Memari,Author
771,Randomized Block Factorial Experiments,Topic
771,Linear Model And Analysis Of Covariance,Topic
771,Finite Population Joint Central Limit Theorem,Topic
771,Factorial Effect Estimators,Topic
771,Covariate Adjustment Methods,Topic
771,Neyman-Type Conservative Estimators,Topic
771,Hanzhong Liu,Author
771,Jiyang Ren,Author
771,Yuehan Yang,Author
772,Group Sequential Design (Gsd),Topic
772,Weighted Parametric Group Sequential Design (Wpgsd),Topic
772,Keaven M. Anderson,Author
772,Zifang Guo,Author
772,Jing Zhao,Author
772,Linda Z. Sun,Author
772,Clinical Trials,Topic
772,Type I Error Rate (Fwer),Topic
772,Multiple Hypotheses,Topic
772,Simulation Study,Topic
773,Classification Of Hierarchical Text Using Geometric Deep Learning: The Case Of Clinical Trials Corpus,Paper
773,Geometric Deep Learning,Topic
773,Graph Neural Networks,Topic
773,Selective Graph Pooling,Topic
773,Clinical Trial Protocols,Topic
773,Completed Category,Topic
773,Terminated Category,Topic
773,F1-Scores,Topic
773,Ct Registry,Topic
773,360K Protocols,Topic
773,Ct Termination Status Prediction,Topic
774,Return-To-Baseline,Topic
774,Missing Values,Topic
774,Clinical Trials,Topic
774,Yongming Qu,Author
774,Biyue Dai,Author
774,Novel Return-To-Baseline Imputation Method,Topic
775,Alzheimer'S Disease,Topic
775,Oneflorida Data Trust,Topic
775,Zhe He,Author
775,Shubo Tian,Author
775,Arslan Erdengasileng,Author
775,Neil Charness,Author
775,Jiang Bian,Author
775,Temporal Subtyping Of Alzheimer'S Disease Using Medical Conditions Preceding Alzheimer'S Disease Onset In Electronic Health Records,Paper
776,Biotechnologies,Topic
776,2020,Topic
776,74 Biotech Startups,Paper
776,2021,Topic
776,60 Biotech Startups,Paper
776,Leadership,Topic
776,Technological Focus,Topic
776,Clinical Trials,Topic
776,Financing,Topic
776,Advanced Degrees,Topic
776,Intellectual Property,Topic
776,Large Private Rounds,Topic
776,Time-To-Ipo,Topic
776,Post-Ipo Stock Performance,Topic
776,Covid,Topic
776,138 Biotech Ipos,Paper
776,Sebastian G. Huayamares,Author
776,Melissa P. Lokugamage,Author
776,Alejandro J. Da Silva Sanchez,Author
776,James E. Dahlman,Author
777,Covariate Adjustment,Topic
777,Randomized Clinical Trials,Topic
777,Treatment Effects,Topic
777,Time-To-Event Analysis,Topic
777,Covariate Adjusted Pseudovalue Regression,Topic
777,Restricted Mean Survival Times (Rmst),Topic
777,Yunfan Li,Author
777,Jessica L. Ross,Author
777,Aaron M. Smith,Author
777,David P. Miller,Author
778,Stochastic Volatility,Topic
778,Arc Length,Topic
778,Hazard Rate,Topic
778,Cox Proportional Hazards Model,Topic
778,Bayesian Arc Length Survival Analysis Model (Balsam),Paper
778,Cd4 Count,Topic
778,Hiv/Aids Clinical Trial,Topic
778,Cumulative Variations,Topic
778,Mortality,Topic
778,Measurement Errors,Topic
778,Relevant Variables,Topic
779,Pro Development,Topic
779,Qualitative Research,Topic
779,Saturation,Topic
779,Fda Guidance,Topic
779,Chris Barker,Author
779,Francis 2010,Author
779,Mason 2010,Author
779,Marshall 2013,Author
779,Guest 2006,Author
780,False Positive Risk,Topic
780,Publication Bias,Topic
780,Ulrich Schimmack,Author
780,Frantiöek Bartoö,Author
780,Medical Research,Topic
780,Clinical Trials,Topic
780,Significance Criterion,Topic
781,Heterogeneous Treatment Effects,Topic
781,Precision Medicine,Topic
781,Randomized Clinical Trials,Topic
781,High-Dimensional Predictive Markers,Topic
781,Two-Stage Statistical Learning Procedure,Topic
781,Optimal Efficiency Augmentation,Topic
781,Extreme Gradient Boosting Trees,Topic
781,Mean Difference,Topic
781,Risk Ratio,Topic
781,Specialized Loss Functions,Topic
781,Permutation Test,Topic
781,Prostate Cancer Prevention Trial,Topic
781,Heng Chen,Author
781,Michael L. Leblanc,Author
781,James Y. Dai,Author
781,Augmented Learning Of Heterogeneous Treatment Effects Via Gradient Boosting Trees,Paper
782,Dynamic Borrowing Method For Historical Information Using A Frequentist Approach For Hybrid Control Design,Paper
782,Bayesian Information Borrowing Methods,Topic
782,Test-Then-Pool Methods,Topic
782,Equivalence-Based Test-Then-Pool Methods,Topic
782,Monte Carlo Simulations,Topic
782,Clinical Trial Data,Topic
782,Rare And Pediatric Diseases,Topic
782,Statistical Hypothesis Testing,Topic
783,Aipw Estimator,Topic
783,Marlena S. Bannick,Author
783,Jun Shao,Author
783,Jingyi Liu,Author
783,Yu Du,Author
783,Yanyao Yi,Author
783,Ting Ye,Author
783,R Package Robincar,Topic
784,Intracerebral Hemorrhage,Topic
784,Prognostic Model For Ich,Paper
784,Wenao Ma,Author
784,Cheng Chen,Author
784,Jill Abrigo,Author
784,Calvin Hoi-Kwan Mak,Author
784,Yuqi Gong,Author
784,Nga Yan Chan,Author
784,Chu Han,Author
784,Zaiyi Liu,Author
784,Qi Dou,Author
785,Difference In Proportions,Topic
785,Treatment Effect,Topic
785,Binary Outcomes,Topic
785,Randomized Clinical Trials,Topic
785,Prognostic Baseline Covariates,Topic
785,Standardization,Topic
785,G-Computation,Topic
785,Unconditional Difference In Proportions,Topic
785,Model Misspecification,Topic
785,Uncertainty And Confidence Intervals,Topic
785,Small Sample Sizes,Topic
785,Robust Sandwich Estimator,Topic
785,Finite Sample Performance,Topic
785,Jialuo Liu,Author
785,Dong Xi,Author
786,Personalized Adaptive Interventions,Topic
786,N-Of-1 Trial Study Design,Topic
786,Online Reinforcement Learning Agent,Topic
786,Physical Exercise Recommendations,Topic
786,Endometriosis,Topic
786,Dominik Meier,Author
786,Ipek Ensari,Author
786,Stefan Konigorski,Author
787,Estimands And Cumulative Incidence Function Regression In Clinical Trials: Some New Results On Interpretability And Robustness,Paper
787,Fine-Gray Model,Topic
787,Direct Binomial Regression,Topic
787,Cumulative Incidence Function Regression,Topic
787,Breast Cancer Metastatic To Bone,Topic
788,Constrained Markov Decision Process (Cmdp),Topic
788,Stef Baas,Author
788,Aleida Braaksma,Author
788,Richard J. Boucherie,Author
789,Network Meta-Analysis,Topic
789,Publication Bias,Topic
789,Inverse Probability Weighting,Topic
789,Ao Huang,Author
789,Yi Zhou,Author
789,Satoshi Hattori,Author
789,Publication Bias Adjustment In Network Meta-Analysis: An Inverse Probability Weighting Approach Using Clinical Trial Registries,Paper
790,Log-Rank Test,Topic
790,Cox Proportional Hazards Model,Topic
790,Time-To-Event Data,Topic
790,Clinical Trials,Topic
790,Proportional Hazards,Topic
790,Immunotherapies,Topic
790,Two-Stage Test Procedure,Topic
790,Permutation Test Framework,Topic
790,Jonas Brugger,Author
790,Tim Friede,Author
790,Florian Klinglm¸ller,Author
790,Martin Posch,Author
790,Robin Ristl,Author
790,Franz Kˆnig,Author
791,American Statistical Association,Topic
791,Interval Null Hypothesis Framework,Topic
791,Bayes Factor-Based Tests,Topic
791,Bayesian Hypothesis Testing,Topic
791,Abhisek Chakraborty,Author
791,Megan H. Murray,Author
791,Ilya Lipkovich,Author
791,Yu Du,Author
792,Continuous Glucose Monitoring,Topic
792,Clinical Trial,Topic
792,Glycemic Control,Topic
792,Type 1 Diabetes,Topic
792,Multilevel Functional Model,Topic
792,Cgm Distributions,Topic
792,The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Group,Author
792,Marcos Matabuena,Author
792,Ciprian M. Crainiceanu,Author
792,Github,Topic
793,Clinical Trials,Topic
793,Drug Development,Topic
793,Global Win Probability,Topic
793,Winp,Topic
793,Sample Size Formula,Topic
793,Confidence Interval,Topic
793,Probability,Topic
793,Receiver Operating Characteristic Curve,Topic
793,Auc,Topic
793,Parkinson'S Disease Clinical Trial,Topic
793,Di Shu,Author
793,Guangyong Zou,Author
794,Multi-Regional Clinical Trials (Mrcts),Topic
794,Kaiyuan Hua,Author
794,Hwanhee Hong,Author
794,Xiaofei Wang,Author
794,Restricted Mean Survival Time,Topic
794,Acute Coronary Syndromes,Topic
795,Safe And Reliable Natural Language Inference,Topic
795,Clinical Trial Reports,Topic
795,Data Augmentation Technique,Topic
795,Biomedical Natural Language Inference,Topic
795,Synthetic Examples,Topic
795,Semantic Perturbations,Topic
795,Domain-Specific Vocabulary Replacement,Topic
795,Numerical And Quantitative Reasoning,Topic
795,Multi-Task Learning,Topic
795,Deberta Architecture,Topic
795,Nli4Ct 2024 Benchmark,Topic
795,Dke-Research,Author
795,Yuqi Wang,Author
795,Zeqiang Wang,Author
795,Wei Wang,Author
795,Qi Chen,Author
795,Kaizhu Huang,Author
795,Anh Nguyen,Author
795,Suparna De,Author
796,Parametric Assumptions,Topic
796,Piecewise Exponential Hazard Model,Topic
796,Pwexp Package,Topic
796,Tianchen Xu,Author
796,Rachael Wen,Author
797,Covariate-Adaptive Randomization,Topic
797,Interventional Studies,Topic
797,Clinical Trials,Topic
797,Development Economics,Topic
797,"Bugni Et Al. (2018, 2019)",Author
797,Jiahui Xin,Author
797,Hanzhong Liu,Author
797,Wei Ma,Author
797,Stratified Block Randomization,Topic
797,Simple Randomization,Topic
797,Inference Under Covariate-Adaptive Randomization,Topic
797,Weighted Regression Adjustment,Topic
797,Asymptotic Theory,Topic
797,Practical Algorithms,Topic
798,Average Hazard,Topic
798,Uno And Horiguchi,Author
798,Cox'S Hazard Ratio,Topic
798,Comparative Effectiveness Research,Topic
798,Hong Xiong,Author
798,Jean Connors,Author
798,Deb Schrag,Author
798,Hajime Uno,Author
798,Comparative Effectiveness Research With Average Hazard For Censored Time-To-Event Outcomes: A Numerical Study,Paper
799,Win Ratio With Multiple Thresholds,Topic
799,Cardiovascular Clinical Trials,Topic
799,Pocock Et Al. (2012),Author
799,Yunhan Mou,Author
799,Tassos Kyriakides,Author
799,Scott Hummel,Author
799,Fan Li,Author
799,Yuan Huang,Author
800,Semeval-2024 Safe Biomedical Natural Language Inference For Clinical Trials,Topic
800,Mistral-7B,Topic
800,Clinical Trial Reports,Topic
800,Artur Guimar„es,Author
800,Bruno Martins,Author
800,Jo„o Magalh„es,Author
801,International Council For Harmonisation Of Technical Requirements For Pharmaceuticals For Human Use (Ich) E9 (R1) Addendum,Topic
801,Treatment Policy Strategy,Topic
801,Missing Values,Topic
801,Hypothetical Strategy,Topic
801,Retrieved Dropout Imputation,Topic
801,Rong Liu,Author
801,Yongming Qu,Author
801,Anti-Diabetes Treatment,Topic
802,Covid-19,Topic
802,Drug Repurposing,Topic
802,Dexamethasone,Topic
802,Resveratrol,Topic
802,Methotrexate,Topic
802,Indomethacin,Topic
802,Quercetin,Topic
802,Yonghyun Nam,Author
802,Jae-Seung Yun,Author
802,Seung Mi Lee,Author
802,Ji Won Park,Author
802,Ziqi Chen,Author
802,Brian Lee,Author
802,Anurag Verma,Author
802,Xia Ning,Author
802,Li Shen,Author
802,Dokyoon Kim,Author
802,Dgdr-Net,Topic
802,Comorbidities,Topic
802,Clinical Trials,Topic
803,Measuring Disease Progression In Clinical Trials For Testing Novel Treatments For Multifaceted Diseases As Progressive Supranuclear Palsy (Psp),Topic
803,Progressive Supranuclear Palsy Rating Scale (Psprs),Topic
803,Item Response Theory Models,Topic
803,Abbv-8E12 Clinical Trial,Topic
803,Elham Yousefi,Author
803,Mohamed Gewily,Author
803,Franz Kˆnig,Author
803,G¸nter Hˆglinger,Author
803,Franziska Hopfner,Author
803,Mats O. Karlsson,Author
803,Robin Ristl,Author
803,Sonja Zehetmayer,Author
803,Martin Posch,Author
804,Estimands Using The Treatment Policy Strategy For Addressing Intercurrent Events,Topic
804,Phase Iii Clinical Trials,Topic
804,Retrieved Dropout,Topic
804,Likelihood-Based Methods,Topic
804,Pioneer 1 Phase Iii Clinical Trial,Topic
804,James Bell,Author
804,Thomas Drury,Author
804,Tobias M¸tze,Author
804,Christian Bressen Pipper,Author
804,Lorenzo Guizzaro,Author
804,Marian Mitroiu,Author
804,Khadija Rerhou Rantell,Author
804,Marcel Wolbers,Author
804,David Wright,Author
805,"Generative Ai For Health Technology Assessment: Opportunities, Challenges, And Policy Considerations",Paper
805,Rachael Fleurence,Author
805,Jiang Bian,Author
805,Xiaoyan Wang,Author
805,Hua Xu,Author
805,Dalia Dawoud,Author
805,Mitch Higashi,Author
805,Jagpreet Chhatwal,Author
805,Generative Ai,Topic
805,Health Technology Assessment,Topic
805,Large Language Models,Topic
805,Evidence Synthesis,Topic
805,Evidence Generation,Topic
805,Clinical Trials,Topic
805,Economic Modeling,Topic
805,Real-World Data,Topic
805,Real-World Evidence,Topic
805,Health Economic Models,Topic
805,Policy Landscape,Topic
806,Asymptotics In Randomized Urn Models,Paper
807,Statistical Methodology For Non-Inferiority Trials,Topic
807,M. Mielke,Author
807,A. Munk,Author
807,Non-Inferiority Trials,Topic
807,Wald-Type Test Procedure,Topic
807,Sample Size Allocation Rule,Topic
807,Clinical Trials For Depression,Topic
807,Clinical Trials For Epilepsy,Topic
807,R Software,Topic
808,Optimal Design Of A Phase I Cancer Trial,Topic
808,Approximate Dynamic Programming And Its Applications To The Design Of Phase I Cancer Trials,Paper
808,Treatment Design,Topic
808,Learning Design,Topic
808,Babb Et Al.'S Escalation With Overdose Control,Topic
808,Haines Et Al.'S $C$-Optimal Design,Topic
808,Bayesian Optimal Design,Topic
808,Phase I Trials,Topic
808,Simulation Study,Topic
808,Nonparametric Step-Up/Down Schemes,Topic
808,Bayesian Parametric Model,Topic
809,Bayesian Hypothesis Assessment In Two-Arm Trials Using Relative Belief Ratios,Paper
809,Saman Muthukumarana,Author
809,Michael Evans,Author
810,Non-Equilibrium Fluctuation Dissipation Theorem,Topic
810,Critically Ill Patients,Topic
810,Treatment,Topic
810,Hospital Monitoring Devices,Topic
810,Spontaneous Breathing Trial,Topic
810,Personalized Critical Care,Topic
810,Heart Rate Response,Topic
810,Man Chen,Author
810,Liang Ren Niestemski,Author
810,Robert Prevost,Author
810,Michael Mcrae,Author
810,Sharath Cholleti,Author
810,Gabriel Najarro,Author
810,Timothy G. Buchman,Author
810,Michael W. Deem,Author
811,Clinical Trial,Topic
811,Treatment Effect,Topic
811,Odds Ratio,Topic
811,Logistic Regression,Topic
811,J. N. S. Matthews,Author
811,Nuri H. Badi,Author
812,Targeted Therapies On The Basis Of Genomic Aberrations Analysis,Topic
812,Cancer Prognosis And Treatment,Topic
812,Adaptive Bayesian Clinical Trial Design,Topic
812,Yanxun Xu,Author
812,Peter Mueller,Author
812,Apostolia M Tsimberidou,Author
812,Donald Berry,Author
813,Interval-Based Dose-Finding Designs,Paper
813,Idesigns,Topic
813,Ib-Designs,Topic
813,Tpi,Topic
813,Mtpi,Topic
813,Mtpi-2,Topic
813,Ccd,Topic
813,Boin,Topic
813,Crm,Topic
813,3+3,Topic
814,Multi-Arm Multi-Stage Trial Designs,Topic
814,Drug Development Process,Topic
814,Patient Variance In Response,Topic
814,T-Test Statistics,Topic
814,Quantile Substitution Procedure,Topic
814,Familywise Error-Rate,Topic
814,Monte Carlo Simulation,Topic
814,Group Size,Topic
814,Stopping Boundaries,Topic
814,Optimality Criteria,Topic
814,R Code,Topic
814,Michael Grayling,Author
814,James Wason,Author
814,Adrian Mander,Author
814,Optimised Multi-Arm Multi-Stage Clinical Trial Design For Unknown Variance,Paper
815,Noniterative Sample Size Procedure,Topic
815,T Distribution,Topic
815,Guenther'S Approach,Topic
815,Ancova,Topic
815,Mmrm,Topic
815,Superiority Tests,Topic
815,Noninferiority Tests,Topic
815,Equivalence Tests,Topic
815,Yongqiang Tang,Author
816,"Sample Size Determination In Superiority Or Non-Inferiority Clinical Trials With Time-To-Event Data Under Exponential, Weibull And Gompertz Distributions",Paper
817,Case-Mix Heterogeneity,Topic
817,Meta-Analyses,Topic
817,Treatment Effect,Topic
817,Individual Patient Data (Ipd),Topic
817,Outcome Regression (Ocr),Topic
817,Inverse Probability Weighting (Ipw),Topic
817,Random-Effect Meta-Analysis Models,Topic
817,Tat-Thang Vo,Author
817,Raphael Porcher,Author
817,Anna Chaimani,Author
817,Stijn Vansteelandt,Author
818,Dose-Finding Studies,Topic
818,Dose-Limiting Toxicity (Dlt),Topic
818,Oncology Dose-Finding Trials,Topic
818,Advanced Soft-Tissue Sarcoma,Topic
818,Lucie Biard,Author
818,Bin Cheng,Author
818,Gulam A. Manji,Author
818,Shing M. Lee,Author
818,Time-To-Event Continual Reassessment Method (Tite-Crm),Topic
818,Simulation Study,Topic
819,Interim Monitoring In Sequential Multiple Assignment Randomized Trials,Paper
819,Sequential Multiple Assignment Randomized Trial,Topic
820,Hierarchical Random Effect Models,Topic
820,Population Parameters,Topic
820,Treatment Effects,Topic
820,Group Differences,Topic
820,Optimal Design,Topic
820,Individual Predictions,Topic
820,Multi-Center Trials,Topic
820,Balanced Design,Topic
820,Maryna Prus,Author
820,Norbert Benda,Author
820,Rainer Schwabe,Author
820,Optimal Design In Hierarchical Models With Application In Multi-Center Trials,Paper
821,Covid-19 Treatment Trials,Topic
821,Sars-Cov-2,Topic
821,Jan Beyersmann,Author
821,Tim Friede,Author
821,Claudia Schmoor,Author
821,Design Aspects Of Covid-19 Treatment Trials: Improving Probability And Time Of Favourable Events,Paper
822,Dose-Finding Clinical Trials In Oncology,Topic
822,Maximum Tolerated Dose (Mtd),Topic
822,Dose-Limiting Toxicities (Dlts),Topic
822,Bayesian Cumulative Modeling Approach,Topic
822,Dice (Dose-Finding Cumulative),Topic
822,Time-To-Event Continual Reassessment Method (Tite-Crm),Topic
822,Moreno Ursino,Author
822,Lucie Biard,Author
822,Sylvie Chevret,Author
823,Ci3+3 Design For Dual-Agent Combination Dose-Finding Clinical Trials,Paper
823,Shijie Yuan,Author
823,Tianjian Zhou,Author
823,Yawen Lin,Author
823,Yuan Ji,Author
824,Estimating The Distribution Of Ratio Of Paired Event Times In Phase Ii Oncology Trials,Paper
824,Li Chen,Author
824,Mark Burkard,Author
824,Jianrong Wu,Author
824,Jill M. Kolesar,Author
824,Chi Wang,Author
825,Caden,Topic
825,Cvrs,Topic
826,Real-World Evidence (Rwe),Topic
826,Randomized Controlled Trials (Rcts),Topic
826,Rct Duplicate Initiative,Topic
826,Franklin Et Al.,Author
826,Statistical Matching Algorithm,Topic
826,Hormone Replacement Therapy (Hrt),Topic
826,Women'S Health Initiative (Whi),Topic
826,R Package Match2C,Topic
826,Bo Zhang,Author
827,Borrowing Of Information From Historical Or External Data,Topic
827,Precision Medicine,Topic
827,Bayesian Approaches,Topic
827,Frequentist Operating Characteristics,Topic
827,Type I Error,Topic
827,Power,Topic
827,Annette Kopp-Schneider,Author
827,Manuel Wiesenfarth,Author
827,Leonhard Held,Author
827,Silvia Calderazzo,Author
828,Basket Trials,Topic
828,Bayesian Methods,Topic
828,Fujikawa Et Al. (2020),Author
828,Power Priors,Topic
828,Lukas Baumann,Author
828,Lukas Sauer,Author
828,Meinhard Kieser,Author
829,Mci3+3,Topic
829,Jiaxin Liu,Author
829,Shijie Yuan,Author
829,Qiqi Deng,Author
829,Yuan Ji,Author
830,Mediation Analysis In Sw-Crts,Topic
830,R Package Mediateswcrt,Topic
831,Diffusion Weighted Imaging,Topic
831,Diffusion Tensor Imaging,Topic
831,Tw-Bag,Paper
831,Human Connectome Project,Topic
831,Zihao Tang,Author
831,Xinyi Wang,Author
831,Lihaowen Zhu,Author
831,Mariano Cabezas,Author
831,Dongnan Liu,Author
831,Michael Barnett,Author
831,Weidong Cai,Author
831,Chengyu Wang,Author
832,Blended Survival Curves: A New Approach To Extrapolation For Time-To-Event Outcomes From Clinical Trial In Health Technology Assessment,Paper
832,Zhaojing Che,Author
832,Nathan Green,Author
832,Gianluca Baio,Author
832,Chronic Lymphocytic Leukemia,Topic
833,Bayesian Approach For Exploratory Clinical Trials,Topic
833,John Whitehead,Author
833,Faye Cleary,Author
833,Amanda Turner,Author
834,Bayesian Meta-Analysis Of Multiple Continuous Treatments: An Application To Antipsychotic Drugs,Paper
834,Jacob Spertus,Author
834,Marcela Horvitz-Lennon,Author
834,Sharon-Lise Normand,Author
834,Paliperidone,Topic
834,Risperidone,Topic
834,Olanzapine,Topic
834,Schizophrenia,Topic
835,Robust Optimal Design Of Two-Armed Trials With Side Information,Paper
835,Personalized Medicine,Topic
835,Clinical Trials,Topic
835,Patient Covariates,Topic
835,Robust Optimization,Topic
836,Chance Imbalance In Baseline Characteristics,Topic
836,Randomized Clinical Trials,Topic
836,Regression Adjustment,Topic
836,Analysis Of Covariance (Ancova),Topic
836,Inverse Probability Weighting (Ipw),Topic
836,Propensity Scores,Topic
836,Overlap Weighting (Ow),Topic
836,Best Apnea Interventions For Research (Bestair),Topic
836,Shuxi Zeng,Author
836,Fan Li,Author
836,Rui Wang,Author
836,Psweight,Topic
837,Incorporating Historical Information To Improve Phase I Clinical Trial Designs,Paper
837,Model-Based Designs,Topic
837,Model-Assisted Designs,Topic
837,Skeleton Approach,Topic
837,Bayesian Optimal Interval,Topic
837,Continuous Reassessment Method,Topic
837,Modified Toxicity Probability Interval,Topic
837,Prior Effective Sample Size,Topic
837,Dose Limiting Toxicity,Topic
838,Randomized Clinical Trials,Topic
838,Test Treatment,Topic
838,Control Treatment,Topic
838,Patient Heterogeneity,Topic
838,Statistical Approaches,Topic
838,Regulatory Approval,Topic
838,Safe And Efficacious Therapies,Topic
838,Baseline Covariates,Topic
838,Analysis Plan,Topic
838,Survival Times,Topic
838,Noise Covariates,Topic
838,Elastic Net Cox Regression,Topic
838,Conditional Inference Tree Algorithm,Topic
838,Risk Strata,Topic
838,Treatment Comparison,Topic
838,Stratum-Level Results,Topic
838,Statistical Inference,Topic
838,5-Step Stratified Testing And Amalgamation Routine,Topic
838,5-Star,Topic
838,Logrank Test,Topic
838,Personalized Medicine,Topic
838,Fivestar R Package,Topic
838,Devan V. Mehrotra,Author
838,Rachel Marceau West,Author
838,Https://Github.Com/Rmarceauwest/Fivestar,Paper
839,Randomized Controlled Trials,Topic
839,Intercurrent Events,Topic
839,Estimand,Topic
839,International Council For Harmonisation E9 (R1),Topic
839,Treatment Policy,Topic
839,Hypothetical,Topic
839,Composite Variable,Topic
839,While On Treatment,Topic
839,Principal Stratum,Topic
839,Yongming Qu,Author
839,Linda Shurzinske,Author
839,Shanthi Sethuraman,Author
840,Breakthroughs In Cancer Biology,Topic
840,Therapies That Target Specific Pathways In Tumor Cells,Topic
840,Clinical Trial Design,Topic
840,Master Protocols,Topic
840,Subpopulation Heterogeneity,Topic
840,Statistical Designs Of Master Protocols,Topic
840,Alexander M. Kaizer,Author
840,Joseph S. Koopmeiners,Author
840,Nan Chen,Author
840,Brian P. Hobbs,Author
841,Toward Better Practice Of Covariate Adjustment In Analyzing Randomized Clinical Trials,Paper
841,Ting Ye,Author
841,Jun Shao,Author
841,Yanyao Yi,Author
841,Qingyuan Zhao,Author
841,Model-Assisted Approach,Topic
841,Covariate Adjustment,Topic
841,Statistical Efficiency,Topic
842,Patient-Level Health Economic Data,Topic
842,Technology Appraisal,Topic
842,Resource Allocation Decisions,Topic
842,End Of Life Treatments,Topic
842,Cancer Treatments,Topic
842,Partitioned Survival Analysis,Topic
842,Health-Related Quality Of Life,Topic
842,Survival Time,Topic
842,Quality-Adjusted Survival,Topic
842,Resource Use Data,Topic
842,Health Records,Topic
842,Cost Components,Topic
842,Bayesian Modelling,Topic
842,Health Economics,Topic
842,Statistical Literature,Topic
842,Bayesian Framework,Topic
842,Policymakers,Topic
842,Decision-Making Process,Topic
842,Advanced Non-Small-Cell Lung Cancer,Topic
842,Andrea Gabrio,Author
843,New Medicine,Topic
843,Quantitative Risk Metrics,Topic
843,Regulatory Approval,Topic
843,Pharmaceutical Companies,Topic
843,Probability Of Success (Pos),Topic
843,Phase Ii,Topic
843,Phase Iib Studies,Topic
843,Phase Iii Trials,Topic
843,Accelerated Drug Development Pathways,Topic
843,Lisa V Hampson,Author
843,Bjˆrn Bornkamp,Author
843,Bjˆrn Holzhauer,Author
843,Joseph Kahn,Author
843,Markus R Lange,Author
843,Wen-Lin Luo,Author
843,Giovanni Della Cioppa,Author
843,Kelvin Stott,Author
843,Steffen Ballerstedt,Author
844,Studentized Permutation Method For Comparing Restricted Mean Survival Times With Small Sample From Randomized Trials,Paper
844,Marc Ditzhaus,Author
844,Menggang Yu,Author
844,Jin Xu,Author
844,Restricted Mean Survival Time (Rmst),Topic
844,Cancer Immunotherapy Clinical Trials,Topic
845,Determination Of Posterior Probability For Go-No-Go Decision And Predictive Power,Topic
845,Madan G. Kundu,Author
845,Sandipan Samanta,Author
845,Shoubhik Mondal,Author
845,Probability Of Success Measures,Topic
845,Frequentist And Bayesian Paradigms,Topic
845,Conditional Power (Cp),Topic
845,Predictive Power Of Success (Ppos),Topic
845,Probability Of Success (Pos),Topic
845,Longcart Package,Topic
845,R Shiny App,Topic
845,Https://Ppos.Herokuapp.Com/,Topic
846,Hazard Ratio,Topic
846,Treatment Effect,Topic
846,Composite Endpoint,Topic
846,Zodiac Trial,Topic
846,Jordi CortÈs MartÌnez,Author
846,MoisËs GÛmez Mateu,Author
846,Kyungmann Kim,Author
846,Guadalupe GÛmez Melis,Author
847,Kaplan-Meier Estimator,Topic
847,Sample Size Calculation,Topic
847,Small Sample Properties,Topic
847,Arcsine Square-Root Transformation,Topic
847,Kengo Nagashima,Author
847,Hisashi Noma,Author
847,Yasunori Sato,Author
847,Masahiko Gosho,Author
848,Causal Inference Methods,Topic
848,Pharmaceutical Drug Development,Topic
848,E9 Guideline,Topic
848,International Council For Harmonisation,Topic
848,Instrumental Variables Methods,Topic
848,Graphical Diagrams,Topic
848,Potential Outcomes,Topic
848,Treatment Policy,Topic
848,Principal Stratum,Topic
848,Hypothetical Estimand Strategies,Topic
848,Standard Regression Models,Topic
848,Sensitivity Analyses,Topic
848,Simulated Data,Topic
848,Jack Bowden,Author
848,Bjoern Bornkamp,Author
848,Ekkehard Glimm,Author
848,Frank Bretz,Author
849,Phase I Clinical Trials,Topic
849,Sdf-Bayes,Paper
850,Threshold-Response Function,Topic
850,Nonparametric Efficient Estimator,Topic
850,Sequential Regression Estimator,Topic
850,Inverse-Probability-Weighting,Topic
850,Lars Van Der Laan,Author
850,Wenbo Zhang,Author
850,Peter B. Gilbert,Author
850,Dengue Vaccine Trials,Topic
851,Publication Bias Adjustment In Meta-Analysis,Topic
851,Ao Huang,Author
851,Kosuke Morikawa,Author
851,Tim Friede,Author
851,Satoshi Hattori,Author
852,Intercurrent Events,Topic
852,Randomized Trials,Topic
852,Treatment Effects,Topic
852,Estimand,Topic
852,Decision Maker,Topic
852,Drug Developer,Topic
852,Research Question,Topic
852,Mats J. Stensrud,Author
852,Oliver Dukes,Author
852,Conditional Effects,Topic
852,Sequential Regime Effects,Topic
852,Separable Effects,Topic
852,Principal Stratum Effects,Topic
853,Principal Causal Effect,Topic
853,Monotonicity,Topic
853,Principal Ignorability,Topic
853,Cross-World Principal Ignorability,Topic
853,Cross-World Principal Stratum Independence,Topic
853,2X2 Cross-Over Study,Paper
853,Yongming Qu,Author
853,Ilya Lipkovich,Author
853,Stephen J. Ruberg,Author
854,Predictive Biomarker Discovery,Topic
854,Precision Medicine,Topic
854,Treatment Rule Estimation,Topic
854,False Discovery Rates,Topic
854,Variable Importance Parameter,Topic
854,Nonparametric Inference Procedure,Topic
854,Tumor Gene Expression Data,Topic
854,Metastatic Renal Cell Carcinoma,Topic
854,Unicate R Package,Topic
854,Philippe Boileau,Author
854,Nina Ting Qi,Author
854,Mark J. Van Der Laan,Author
854,Sandrine Dudoit,Author
854,Ning Leng,Author
855,Whole-Body Model Of The Metabolism In Man,Topic
855,Metabolic Networks,Topic
855,Carbohydrates,Topic
855,Proteins,Topic
855,Lipids,Topic
855,7 Organs,Topic
855,16 Metabolites,Topic
855,31 Enzymatic Reactions,Topic
855,Michaelis-Menten Kinetics,Topic
855,Insulin,Topic
855,Glucagon,Topic
855,Glycogen,Topic
855,Muscle Protein,Topic
855,Lipid Droplets,Topic
855,Virtual Clinical Trials,Topic
855,Medicine Development,Topic
855,Control Algorithms,Topic
855,Peter Emil Carstensen,Author
855,Jacob Bendsen,Author
855,Asbj¯rn Thode Reenberg,Author
855,Tobias K. S. Ritschel,Author
855,John Bagterp J¯rgensen,Author
856,Antihistamines,Topic
856,Bruno L. Travi,Author
856,Infectious Diseases,Topic
857,Quantification Of Follow-Up Time In Oncology Clinical Trials With A Time-To-Event Endpoint: Asking The Right Questions,Paper
857,Kaspar Rufibach,Author
857,Lynda Grinsted,Author
857,Jiang Li,Author
857,Hans-Jochen Weber,Author
857,Cheng Zheng,Author
857,Jiangxiu Zhou,Author
858,Towards Optimal Use Of Surrogate Markers To Improve Power,Paper
858,Xuan Wang,Author
858,Layla Parast,Author
858,Lu Tian,Author
858,Tianxi Cai,Author
858,Surrogate Marker,Topic
858,Treatment Effect,Topic
858,Diabetes Prevention Program,Topic
859,Confirmatory Adaptive Group Sequential Designs For Clinical Trials With Multiple Time-To-Event Outcomes In Markov Models,Paper
859,Moritz Fabian Danzer,Author
859,Andreas Faldum,Author
859,Thorsten Simon,Author
859,Barbara Hero,Author
859,Rene Schmidt,Author
860,Bayesian Hierarchical Mixture Cure Modelling Framework,Topic
860,Nathan Green,Author
860,Murat Kurt,Author
860,Andriy Moshyk,Author
860,James Larkin,Author
860,Gianluca Baio,Author
860,Checkmate 067 Phase 3 Trial,Topic
861,Gene Therapies,Topic
861,Rare Genetic Defects,Topic
861,Long-Term Effectiveness,Topic
861,Bayesian Framework,Topic
861,Long-Term Efficacy,Topic
861,Factor Ix (Fix) Levels,Topic
861,Hemgenix,Paper
861,Fda-Approved Gene Therapy,Topic
861,Severe Hemophilia B,Topic
861,Phase 3 Study,Topic
861,5-Year Fix Levels,Topic
861,Posterior Convergence Properties,Topic
862,Adaptive Interventions,Topic
862,Clustered Adaptive Interventions (Cais),Topic
862,"Clustered, Sequential Multiple-Assignment Randomized Trials (Csmarts)",Topic
862,Finite-Sample Adjustment (Fsa) Methods,Topic
862,Adaptive School-Based Implementation Of Cbt (Asic) Study,Paper
863,Immunotherapy,Topic
863,Glioblastoma,Topic
863,Radiogenomics,Topic
863,Biomarkers,Topic
863,Prajwal Ghimire,Author
863,Ben Kinnersley,Author
863,Golestan Karami,Author
863,Prabhu Arumugam,Author
863,Richard Houlston,Author
863,Keyoumars Ashkan,Author
863,Marc Modat,Author
863,Thomas C Booth,Author
863,Systematic Review,Paper
863,Crd42022340968,Paper
864,Adaptive Treatment Assignment Algorithms,Topic
864,Digital Health Intervention Clinical Trials,Topic
864,Causal Inference,Topic
864,Statistical Analyses,Topic
864,Replicability,Topic
864,Replicable Bandit Algorithm,Topic
864,Mobile Health Oral Health Self-Care Intervention,Topic
864,Kelly W. Zhang,Author
864,Nowell Closser,Author
864,Anna L. Trella,Author
864,Susan A. Murphy,Author
865,Artificial Intelligence-Based Decision Support Systems,Topic
865,Post-Hepatectomy Liver Failure,Topic
865,Hepatocellular Carcinoma,Topic
865,Variational Autoencoder-Multilayer Perceptron Model,Topic
865,Counterfactuals,Topic
865,Layerwise Relevance Propagation,Topic
865,Methodological Framework For Evaluating Explainability,Topic
865,Xian Zhong,Author
865,Zohaib Salahuddin,Author
865,Yi Chen,Author
865,Henry C Woodruff,Author
865,Haiyi Long,Author
865,Jianyun Peng,Author
865,Nuwan Udawatte,Author
865,Roberto Casale,Author
865,Ayoub Mokhtari,Author
865,Xiaoer Zhang,Author
865,Jiayao Huang,Author
865,Qingyu Wu,Author
865,Li Tan,Author
865,Lili Chen,Author
865,Dongming Li,Author
865,Xiaoyan Xie,Author
865,Manxia Lin,Author
865,Philippe Lambin,Author
866,Multi-Arm Trials,Topic
866,Response-Adaptive Design,Topic
866,Continuous Endpoints,Topic
866,Gianmarco Caruso,Author
866,Pavel Mozgunov,Author
866,Phase Iia Proof-Of-Concept Oncology Clinical Trials,Topic
867,Robin,Topic
867,Abel CorrÍa Dias,Author
867,Viviane Pereira Moreira,Author
867,Jo„o Luiz Dihl Comba,Author
867,Cochrane Database Of Systematic Reviews,Topic
867,Pubmed,Topic
867,Robinext,Topic
867,Robingen,Topic
868,Information Borrowing In Bayesian Clinical Trials: Choice Of Tuning Parameters For The Robust Mixture Prior,Paper
868,Bayesian Framework,Topic
868,Robust Mixture Prior,Topic
868,Informative Prior Distributions,Topic
868,Operating Characteristics,Topic
868,Type I Error Rate,Topic
868,Mse,Topic
869,External Data In Clinical Trials,Topic
869,Bayesian Inference,Topic
869,Heterogeneity,Topic
869,Clustering,Topic
869,Overlapping Clustering Index (Oci),Topic
869,Overlapping Evidence Index (Oei),Topic
869,K-Means Algorithm,Topic
869,Prior Synthesis Framework,Topic
869,Bayesian Clustering Map Priors,Topic
869,Xuetao Lu,Author
869,J. Jack Lee,Author
870,Ich E9 (R1) Estimands Framework,Topic
870,Causal Inference,Topic
870,Thomas Drury,Author
870,Jonathan W. Bartlett,Author
870,David Wright,Author
870,Oliver N. Keene,Author
871,Malignant Gliomas,Topic
871,Chemotherapy,Topic
871,Car-T Cells Therapy,Topic
871,Dmitry Sinelshchikov,Author
871,Juan Belmonte-Beitia,Author
871,Matteo Italia,Author
871,Mathematical Model,Topic
871,Tumor Growth Rate,Topic
871,Tumor Immunosuppression,Topic
871,Survival Time,Topic
871,In Silico Trials,Topic
871,Optimal Protocols,Topic
872,Ulcerative Colitis,Topic
872,Mayo Endoscopic Subscore,Topic
872,Evan Schwab,Author
872,Gabriela Oana Cula,Author
872,Kristopher Standish,Author
872,Stephen S. F. Yip,Author
872,Aleksandar Stojmirovic,Author
872,Louis Ghanem,Author
872,Christel Chehoud,Author
872,Automatic Estimation Of Ulcerative Colitis Severity From Endoscopy Videos Using Ordinal Multi-Instance Learning,Paper
873,Metastatic Clear Cell Renal Cell Carcinoma,Topic
873,Angioscore,Topic
873,Deep Learning Model,Topic
873,Angiogenesis Inhibitors,Topic
873,Immune Checkpoint Inhibitors,Topic
873,Mtor Inhibitors,Topic
873,Hif2 Inhibitor,Topic
873,Cd31,Topic
873,Jay Jasti,Author
873,Hua Zhong,Author
873,Vandana Panwar,Author
873,Vipul Jarmale,Author
873,Jeffrey Miyata,Author
873,Deyssy Carrillo,Author
873,Alana Christie,Author
873,Dinesh Rakheja,Author
873,Zora Modrusan,Author
873,Edward Ernest Kadel Iii,Author
873,Niha Beig,Author
873,Mahrukh Huseni,Author
873,James Brugarolas,Author
873,Payal Kapur,Author
873,Satwik Rajaram,Author
874,Major Depressive Disorder,Topic
874,Artificial Intelligence In Depression Medication Enhancement Study,Topic
874,David Benrimoh,Author
874,Caitrin Armstrong,Author
874,Joseph Mehltretter,Author
874,Robert Fratila,Author
874,Kelly Perlman,Author
874,Sonia Israel,Author
874,Adam Kapelner,Author
874,Sagar V. Parikh,Author
874,Jordan F. Karp,Author
874,Katherine Heller,Author
874,Gustavo Turecki,Author
874,Deep Learning Model,Topic
874,Escitalopram,Topic
875,Giorgio Parisi,Author
875,Idiotypic Network Among Antibodies,Topic
875,Immunological Memory,Topic
875,Memory Capacity Model,Topic
875,Introduction To Modern Immunology,Topic
876,Hepatitis C Virus (Hcv) Coinfection,Topic
876,Hiv-Infected Patients,Topic
876,Highly Active Antiretroviral Therapy (Haart),Topic
876,Hiv Dynamics,Topic
876,Aids Clinical Trials,Topic
876,Hiv Epidemiology Research Study (Hers),Topic
876,Li Su,Author
876,Joseph W. Hogan,Author
877,Principal Stratification,Topic
877,Causal Effects,Topic
877,Complier Average Causal Effect (Cace),Topic
877,Bayesian Perspective,Topic
877,Markov Chain Monte Carlo,Topic
877,Injury Severity,Topic
877,Corwin M. Zigler,Author
877,Thomas R. Belin,Author
877,Clinical Trial For Jaw Fractures,Paper
878,Common Medical Conditions,Topic
878,Sleep Abnormalities,Topic
878,Patients With Medical Disorders,Topic
878,Poor Sleep Quality,Topic
878,Healthy Individuals,Topic
878,Sleep/Wake Patterns,Topic
878,Personalized Digital Markers,Topic
878,Objective Measurements,Topic
878,Efficient Disease Management,Topic
878,Big Data Technologies,Topic
878,Advanced Analytics Methods,Topic
878,Clinical Research Processes,Topic
878,Digital Data,Topic
878,Clinical Trials,Topic
878,Actigraphy,Topic
878,Non-Invasive Activity Monitoring Method,Topic
878,Activities And Movement Disorders,Topic
878,Sleep/Wake Behavior,Topic
878,Cluster Headache Disorder,Topic
878,Wearable Device,Topic
878,Clinical Trial,Topic
878,Deep Convolutional Neural Networks,Topic
878,Cnn,Topic
878,Sequential Cnn,Topic
878,Bi-Directional Cnn,Topic
878,Multi-Task Learning,Topic
878,Mtl Based Model,Topic
878,Falling Asleep,Topic
878,Siesta,Topic
878,Sleep/Wake States,Topic
878,Cluster Headache Attacks,Topic
878,Lena Granovsky,Author
878,Gabi Shalev,Author
878,Nancy Yacovzada,Author
878,Yotam Frank,Author
878,Shai Fine,Author
879,Percutaneous Coronary Interventions,Topic
879,Catheter,Topic
879,Stent,Topic
879,Wrist Access,Topic
879,Groin Access,Topic
879,Clinical Trials,Topic
879,Hospitalization Charges,Topic
879,Samrachana Adhikari,Author
879,Sherri Rose,Author
879,Sharon-Lise Normand,Author
879,Bayesian Instrumental Variable Analysis,Topic
879,Latent Index Modeling,Topic
879,Dirichlet Process Mixture Models,Topic
879,"7,963 Patients",Topic
880,Lesionvis,Topic
880,Pls,Topic
880,Siba-Net,Topic
880,P-Siba,Topic
880,Bo Zhou,Author
880,Randolph Crawford,Author
880,Belma Dogdas,Author
880,Gregory Goldmacher,Author
880,Antong Chen,Author
881,Covid 19,Topic
881,Ards,Topic
881,Mscs,Topic
881,Adrita Chanda,Author
881,Adrija Aich,Author
881,Arka Sanyal,Author
881,Anantika Chandra,Author
881,Saumyadeep Goswami,Author
881,Mesenchymal Stem Cell Therapy,Topic
881,Covid Induced Ards,Topic
882,Mixed Models For Repeated Measures,Topic
882,Progression Models For Repeated Measures,Topic
882,Lars Lau Raket,Author
882,Alzheimer'S Disease,Topic
882,Clinical Trials,Topic
882,Treatment Effects,Topic
882,Disease Progression Models,Topic
882,Longitudinal Data Analysis,Topic
883,Huntington Disease,Topic
883,Ace Imputation,Topic
883,Kyle F. Grosser,Author
883,Sarah C. Lotspeich,Author
883,Tanya P. Garcia,Author
883,Mission Imputable: Correcting For Berkson Error When Imputing A Censored Covariate,Paper
884,Image-Based Precision Medicine,Topic
884,Bayesian Deep Learning,Topic
884,Joshua Durso-Finley,Author
884,Jean-Pierre Falet,Author
884,Raghav Mehta,Author
884,Douglas L. Arnold,Author
884,Nick Pawlowski,Author
884,Tal Arbel,Author
885,Data Science Roundtable Meeting,Topic
885,Boin Design,Topic
885,Accelerated Boin Design,Topic
885,3+3 Design,Topic
885,Clinical Phase I Trial,Topic
885,Masahiro Kojima,Author
885,Wu Wende,Author
885,Henry Zhao,Author
885,Simulation Study,Topic
885,Mtd Selection,Topic
885,Case Study,Topic
885,Clinical Oncology Dose Escalation Trials,Topic
886,Corticospinal Tract,Topic
886,Diffusion Tensor Tractography,Topic
886,Intracerebral Haemorrhage,Topic
886,Nnu-Net,Topic
886,Mistie Iii,Topic
886,Olivia N Murray,Author
886,Hamied Haroon,Author
886,Paul Ryu,Author
886,Hiren Patel,Author
886,George Harston,Author
886,Marieke Wermer,Author
886,Wilmar Jolink,Author
886,Daniel Hanley,Author
886,Catharina Klijn,Author
886,Ulrike Hammerbeck,Author
886,Adrian Parry-Jones,Author
886,Timothy Cootes,Author
887,Ich E9(R1) Addendum,Topic
887,Estimands Framework,Topic
887,Treatment Switching,Topic
887,Simulation Study,Topic
887,Randomized Clinical Trials (Rcts),Topic
887,Overall Survival Data,Topic
887,Treatment Policy Estimand,Topic
887,Hypothetical Estimand,Topic
887,Quang Vuong,Author
887,Rebecca K. Metcalfe,Author
887,Antonio Remiro-AzÛcar,Author
887,Anders Gorst-Rasmussen,Author
887,Oliver Keene,Author
887,Jay J. H. Park,Author
888,Joint Modeling Of Longitudinal Covariates And Partly-Interval Censored Time-To-Event Data,Topic
888,Cox Model For Time-To-Event Data,Topic
888,Penalised Likelihood Approach,Topic
888,Anti-Pd1 Brain Collaboration Clinical Trial,Topic
888,Annabel Webb,Author
888,Nan Zou,Author
888,Serigne Lo,Author
888,Jun Ma,Author
889,Restricted Mean Survival Time (Rmst),Topic
889,Jinghao Sun,Author
889,Douglas E. Schaubel,Author
889,Eric J. Tchetgen Tchetgen,Author
889,Adarmst,Topic
890,Cerebral Cortex,Topic
890,Neurons,Topic
890,Vmt Method,Topic
890,Martin Pospischil,Author
890,Zuzanna Piwkowska,Author
890,Thierry Bal,Author
890,Alain Destexhe,Author
890,Guinea-Pig Visual Cortex Neurons,Topic
890,Dynamic-Clamp Experiments,Topic
891,Multivariate Pattern Analysis,Topic
891,Fmri Data,Topic
891,Brain Computing Interfaces,Topic
891,Time-Series Neuroimaging Data,Topic
891,Meg,Topic
891,Eeg,Topic
891,Cognitive Neuroscience,Topic
891,Decoding Analysis Pipeline,Topic
891,Tijl Grootswagers,Author
891,Susan G. Wardle,Author
891,Thomas A. Carlson,Author
891,Decoding Dynamic Brain Patterns,Topic
891,Representational Similarity Analysis,Topic
891,Temporal Generalisation,Topic
891,Classifier Weight Maps,Topic
891,Time-Series Decoding Experiments,Topic
892,A Goal-Based Movement Model For Continuous Multi-Agent Tasks,Paper
892,Shariq Iqbal,Author
892,John Pearson,Author
892,Neuroscience Data,Topic
892,Behavioral Analysis,Topic
892,Decision Paradigms,Topic
892,Machine Learning Methods,Topic
893,Deep Learning As A Tool For Neural Data Analysis: Speech Classification And Cross-Frequency Coupling In Human Sensorimotor Cortex,Paper
893,Neuroscience,Topic
893,Neural Activity,Topic
893,Deep Networks,Topic
893,Speech Syllables,Topic
893,Cortical Surface Electric Potentials,Topic
893,Human Sensorimotor Cortex,Topic
893,High-Gamma Band,Topic
893,Lower-Frequencies,Topic
894,Kawato,Author
894,Aurelio Cortese,Author
894,Biological Cybernetics,Topic
894,Computational Neuroscience Model Of Metacognition,Paper
895,Phase I Clinical Trial,Topic
895,Maximum Tolerated Dose (Mtd),Topic
895,Dose-Escalation Study,Topic
895,Continual Reassessment Method (Crm),Topic
895,Randomized Crm (Rcrm),Topic
895,Joseph S. Koopmeiners,Author
895,Andrew Wey,Author
896,"Estimating The Sample Mean And Standard Deviation From The Sample Size, Median, Range And/Or Interquartile Range",Paper
896,Xiang Wan,Author
896,Wenqian Wang,Author
896,Jiming Liu,Author
896,Tiejun Tong,Author
897,"Improved Precision In The Analysis Of Randomized Trials With Survival Outcomes, Without Assuming Proportional Hazards",Paper
897,Iv·n DÌaz,Author
897,Elizabeth Colantuoni,Author
897,Daniel F. Hanley,Author
897,Michael Rosenblum,Author
898,Clinicaltrials.Gov,Topic
898,Pubmed,Topic
898,Adam G. Dunn,Author
898,Enrico Coiera,Author
898,Florence Bourgeois,Author
898,Document Similarity Methods,Topic
898,Reporting Biases,Topic
898,Systematic Reviews,Topic
898,Unreported Links,Topic
898,Trial Registrations,Topic
898,Corresponding Articles,Topic
899,Randomized Clinical Trials,Topic
899,Subgroup Treatment Effect,Topic
899,Principal Stratification Framework,Topic
899,Bayesian Methods,Topic
899,Siponimod,Topic
899,Secondary Progressive Multiple Sclerosis,Topic
899,Baldur P. Magnusson,Author
899,Heinz Schmidli,Author
899,Nicolas Rouyrre,Author
899,Daniel O. Scharfstein,Author
899,Placebo-Controlled Trial,Topic
899,Disability Progression,Topic
899,Regulatory Guidance Ich E9(R1),Topic
900,Identifying Treatment Effect Heterogeneity In Dose-Finding Trials Using Bayesian Hierarchical Models,Paper
900,Bayesian Hierarchical Dose-Response Model,Topic
900,Predictive Covariates,Topic
900,Prognostic Covariates,Topic
900,Treatment Effect Heterogeneity,Topic
900,Dose-Finding Trials,Topic
900,Shrinkage Priors,Topic
900,Phase Ii Dose-Finding Trial,Topic
901,Causal Inference For Comprehensive Cohort Studies,Paper
901,Yi Lu,Author
901,Daniel O. Scharfstein,Author
901,Maria M. Brooks,Author
901,Kevin Quach,Author
901,Edward H. Kennedy,Author
901,Bypass Angioplasty Revascularization Investigation,Topic
902,Clustered Observations,Topic
902,Novel Model For The Analysis Of Clustered Observations,Paper
902,Marginal Distributions,Topic
902,Linear Transformation Model,Topic
902,Joint Multivariate Normal Distribution,Topic
902,Marginal Odds Ratios,Topic
902,Toe Nail Data,Topic
902,Clinical Trials,Topic
902,Bounded Visual Analog Scale,Topic
902,Marginal Proportional-Odds Models,Topic
902,Disease-Free Survival In Rectal Cancer Patients,Topic
902,Marginal Hazard Ratio,Topic
902,Weibull And Cox Models,Topic
902,Tram Add-On Package,Topic
902,R System,Topic
902,General Estimation Equations,Topic
902,Conditional Mixed-Effects Models,Topic
903,Confirmatory Cancer Clinical Trials,Topic
903,Overall Survival,Topic
903,Intention-To-Treat Analysis,Topic
903,Treatment Switching,Topic
903,Modified Weighted Log-Rank Test,Topic
903,Record-1 Trial,Topic
903,Everolimus,Topic
903,Placebo,Topic
903,JosÈ L. JimÈnez,Author
903,Julia Niewczas,Author
903,Alexander Bore,Author
903,Carl-Fredrik Burman,Author
904,Sample Size Derivation,Topic
904,Confirmatory Trial,Topic
904,Type I Error Rate,Topic
904,Power,Topic
904,Effect Size,Topic
904,Bayesian Perspective,Topic
904,Hybrid Approaches,Topic
904,Assurance,Topic
904,Probability Of Success,Topic
904,Expected Power,Topic
904,Clinical Trials,Topic
904,Kevin Kunzmann,Author
904,Michael J. Grayling,Author
904,Kim May Lee,Author
904,David S. Robertson,Author
904,Kaspar Rufibach,Author
904,James M. S. Wason,Author
905,A Bayesian Machine Learning Approach For Estimating Heterogeneous Survivor Causal Effects: Applications To A Critical Care Trial,Paper
905,Xinyuan Chen,Author
905,Michael O. Harhay,Author
905,Guangyu Tong,Author
905,Fan Li,Author
905,Ardsnetwork,Topic
905,Arma Trial,Topic
905,Bayesian Additive Regression Trees (Bart),Topic
905,Low Tidal Volume Treatment,Topic
905,Sex,Topic
905,Alveolar-Arterial Oxygen Gradient,Topic
906,Clinical Trial,Topic
906,Frequentist Analysis,Topic
906,Interim Analyses,Topic
906,Rao-Blackwellisation,Topic
906,Sepsis Treatments Comparison,Topic
906,John Whitehead,Author
906,Yasin Desai,Author
906,Thomas Jaki,Author
907,Reproducibility In Scientific Research,Topic
907,Obstetrics And Gynecology Trials,Topic
907,Aaron Bowers,Author
907,Shelby Rauh,Author
907,Drayton Rorah,Author
907,Daniel Tritz,Author
907,Lance Frye,Author
907,Matt Vassar,Author
908,Tissue-Agnostic Trials,Topic
908,Bayesian Hierarchical Model (Bhm),Topic
908,Optimal Bhm (Obhm),Topic
908,Clustered Obhm (Cobhm),Topic
908,Adaptive Obhm (Aobhm),Topic
908,Liyun Jiang,Author
908,Lei Nie,Author
908,Fangrong Yan,Author
908,Ying Yuan,Author
909,Bayesian Estimation,Topic
909,Hypothesis Testing,Topic
909,Model-Averaging,Topic
909,Parametric Survival Analysis,Topic
909,Frequentist Approach,Topic
909,Colon Cancer Trial,Topic
909,Robsa R Package,Topic
909,Frantiöek Bartoö,Author
909,Frederik Aust,Author
909,Julia M. Haaf,Author
910,Statistical Methods For Analysis Of Clinical And Virus Genetics Data,Topic
910,Covid-19,Topic
910,Sars-Cov-2,Topic
910,"Phase 3 Randomized, Placebo-Controlled Trials",Topic
910,Vaccine Efficacy (Ve),Topic
910,Strain-Specific Ve,Topic
910,Cox Proportional Hazards Model,Topic
910,Inverse Probability Weighted Complete-Case (Ipw) Estimator,Topic
910,Augmented Inverse Probability Weighted Complete-Case (Aipw) Estimator,Topic
910,Fei Heng,Author
910,Yanqing Sun,Author
910,Peter B. Gilbert,Author
910,Estimation And Hypothesis Testing Of Strain-Specific Vaccine Efficacy With Missing Strain Types,Paper
911,Heterogeneous Treatment Effects,Topic
911,Cluster-Randomized Trials,Topic
911,Multilevel Multiple Imputation,Topic
911,Bayesian Mmi,Topic
911,"Work, Family, And Health Study",Topic
911,Bryan S. Blette,Author
911,Scott D. Halpern,Author
911,Fan Li,Author
911,Michael O. Harhay,Author
912,Sequential Multiple Assignment Randomized Trial (Smart),Topic
912,Wu Et Al. (2021),Author
912,Cole Manschot,Author
912,Eric Laber,Author
912,Marie Davidian,Author
912,Behavioral Pain Interventions For Breast Cancer Patients,Topic
913,Dynamic Treatment Regimes (Dtrs),Topic
913,Sequential Multiple Assignment Randomized Trial (Smart),Topic
913,Smart-Exam,Topic
913,Xinru Wang,Author
913,Nina Deliu,Author
913,Yusuke Narita,Author
913,Bibhas Chakraborty,Author
913,Attention-Deficit/Hyperactivity Disorder (Adhd),Topic
914,Covariate Adjustment And Methods Of Incorporating Historical Data In Randomized Clinical Trials,Topic
914,Cochran-Mantel-Haenszel Test,Topic
914,Procova-Cmh,Topic
914,Alyssa M. Vanderbeek,Author
914,Jessica L. Ross,Author
914,David P. Miller,Author
914,Alejandro Schuler,Author
914,Alzheimer'S Disease,Topic
915,Mental Health And Psychological Distress,Topic
915,Wellbeing Promotion,Topic
915,Interactive Social Robots,Topic
915,Health Programs,Topic
915,Wellbeing Technique Training,Topic
915,Pilot Randomised Controlled Trial,Topic
915,Autonomous Humanoid Social Robot,Topic
915,Mindful Breathing Technique,Topic
915,Relationship-Building Discussion,Topic
915,Simple Rapport,Topic
915,Health-Related Topics,Topic
915,Convenience Sampling,Topic
915,Participants,Topic
915,Technique Enjoyment,Topic
915,Perceived Usefulness,Topic
915,Likelihood To Repeat The Technique,Topic
915,Gender,Topic
915,Distress Levels,Topic
915,Autonomous Wellbeing Intervention,Topic
915,Robot-Delivered Mindfulness Training Program,Topic
915,Sub-Clinical Population,Topic
915,Nicole Robinson,Author
915,Jennifer Connolly,Author
915,Gavin Suddrey,Author
915,David J. Kavanagh,Author
915,A Brief Wellbeing Training Session Delivered By A Humanoid Social Robot: A Pilot Randomized Controlled Trial,Paper
916,Stepped Wedge Cluster Randomized Trials (Sw-Crts),Topic
916,Mary M. Ryan,Author
916,Denise Esserman,Author
916,Monica Taljaard,Author
916,Fan Li,Author
916,Stratified Marginal Cox Model,Topic
916,Power Calculation,Topic
916,R Shiny Application,Topic
916,New Electronic Reminder System,Topic
916,Time To Catheter Removal,Topic
916,Censored Time-To-Event Outcomes,Topic
916,Wald And Robust Score Tests,Topic
916,Robust Sandwich Variance,Topic
916,Cross-Sectional Sw-Crts,Topic
916,Clinically Meaningful Effect Size,Topic
917,Phase I Clinical Trials,Topic
917,3+3 Method,Topic
917,Continual Reassessment Method (Crm),Topic
917,Partial Ordering Crm (Pocrm),Topic
917,Bayesian Model Averaged Pocrm (Bma-Pocrm),Topic
917,Luka Kovacevic,Author
917,Thomas Jaki,Author
917,Helen Barnett,Author
917,Pavel Mozgunov,Author
918,Patient-Centered Outcomes,Topic
918,Survivor Average Causal Effect (Sace),Topic
918,Cluster-Randomized Trials (Crts),Topic
918,Dane Isenberg,Author
918,Michael Harhay,Author
918,Nandita Mitra,Author
918,Fan Li,Author
919,Online Ai Decision-Making Algorithms,Topic
919,Digital Interventions,Topic
919,Treatment,Topic
919,Guidelines For Monitoring,Topic
919,Oralytics,Topic
919,Miwaves,Topic
919,Anna L. Trella,Author
919,Susobhan Ghosh,Author
919,Erin E. Bonar,Author
919,Lara Coughlin,Author
919,Finale Doshi-Velez,Author
919,Yongyi Guo,Author
919,Pei-Yao Hung,Author
919,Inbal Nahum-Shani,Author
919,Vivek Shetty,Author
919,Maureen Walton,Author
919,Iris Yan,Author
919,Kelly W. Zhang,Author
919,Susan A. Murphy,Author
920,Phase I Clinical Trial Designs,Topic
920,Maximum Tolerated Doses,Topic
920,Dose-Escalation Designs,Topic
920,Continual Reassessment Method,Topic
920,Partial Ordering Crm,Topic
920,Weishi Chen,Author
920,Pavel Mozgunov,Author
921,Restricted Win Probability With Bayesian Estimation For Implementing The Estimand Framework In Clinical Trials With A Time-To-Event Outcome,Paper
921,Michelle Leeberg,Author
921,Xianghua Luo,Author
921,Thomas A. Murray,Author
921,Bayesian Estimation,Topic
921,Time-To-Event Outcome,Topic
921,Estimand Framework,Topic
921,Oncology Trials,Topic
922,Phase I Trial,Topic
922,Dose-Finding Design,Topic
922,Bayesian Logistic Regression Model,Topic
922,Sandrine Boulet,Author
922,Emmanuelle Comets,Author
922,Antoine Guillon,Author
922,Linda B. S. Aulin,Author
922,Robin Michelet,Author
922,Charlotte Kloft,Author
922,Sarah Zohar,Author
922,Moreno Ursino,Author
923,Bupd,Topic
923,Ryo Kitabayashi,Author
923,Hiroyuki Sato,Author
923,Akihiro Hirakawa,Author
924,Personalized Medicine,Topic
924,Individualized Treatment Rules (Itrs),Topic
924,Outcome Weighted Learning (Owl),Topic
924,Residual Weighted Learning (Rwl),Topic
924,Zhao Et Al. (2012),Author
924,Xin Zhou,Author
924,Nicole Mayer-Hamblett,Author
924,Umer Khan,Author
924,Michael R. Kosorok,Author
924,Cystic Fibrosis Clinical Trial Data,Topic
925,Deepradiologynet,Topic
925,Ct Head Scans,Topic
925,Deep Convolutional Neural Networks,Topic
925,Clinical Trial,Topic
925,Us Board Certified Radiologists,Topic
926,Clinical Disease Registries,Topic
926,Causal Inference,Topic
926,Emory Als Clinic Registry,Topic
926,Percutaneous Endoscopic Gastrostomy (Peg),Topic
926,Body Mass Index (Bmi),Topic
926,Pallavi Mishra-Kalyani,Author
926,Brent A. Johnson,Author
926,Jonathan D. Glass,Author
926,Qi Long,Author
927,Real-World Multi-Domain Data Applications For Generalizations To Clinical Settings,Paper
927,Nooshin Mojab,Author
927,Vahid Noroozi,Author
927,Darvin Yi,Author
927,Manoj Prabhakar Nallabothula,Author
927,Abdullah Aleem,Author
927,Phillip S. Yu,Author
927,Joelle A. Hallak,Author
928,Test Of Significance For High-Dimensional Thresholds With Application To Individualized Minimal Clinically Important Difference,Paper
928,Huijie Feng,Author
928,Jingyi Duan,Author
928,Yang Ning,Author
928,Jiwei Zhao,Author
929,Imputed Clinical Data,Topic
930,Anti-Gravity Therapy,Topic
930,Exonet,Topic
930,Post-Stroke Rehabilitation,Topic
930,Courtney Celian,Author
930,Partha Ryali,Author
930,Valentino Wilson,Author
930,Adith Srivatsaa,Author
930,James L. Patton,Author
930,Chronic Stroke Survivors,Topic
930,Box And Blocks Scores,Topic
930,Arat Scores,Topic
930,Muscle Activity,Topic
930,Clinical Metrics,Topic
931,High-Quality Biomedical Datasets,Topic
931,Nih-Funded Bridge2Ai Project,Topic
931,"1,699 Dataset Papers",Topic
931,Nucleic Acids Research (Nar) Database,Topic
931,Bridge2Ai Talent Knowledge Graph,Topic
931,Team Attributes,Topic
931,Scientific Impact,Topic
931,Relative Citation Ratio Percentile,Topic
931,Clinical Translation Power,Topic
931,Apt,Topic
931,Shap Explainable Ai Framework,Topic
931,Dataset Success,Topic
931,Principal Investigator Leadership,Topic
931,Team Academic Prowess,Topic
931,Team Size,Topic
931,Career Age,Topic
931,Female Representation,Topic
931,Jiawei Xu,Author
931,Qingnan Xie,Author
931,Meijun Liu,Author
931,Zhandos Sembay,Author
931,Swathi Thaker,Author
931,Pamela Payne-Foster,Author
931,Jake Chen,Author
931,Ying Ding,Author
932,Machine Learning,Topic
932,Neuroscience,Topic
932,Diagnostics,Topic
932,Characterization,Topic
932,Treatment Outcome Prediction,Topic
932,Psychiatric Disorders,Topic
932,Neurological Disorders,Topic
932,Epilepsy,Topic
932,Depression,Topic
932,Data-Driven Approaches,Topic
932,Structural Neuroimaging,Topic
932,Functional Neuroimaging,Topic
932,Neuroimaging Markers,Topic
932,Data Preparation Pipeline,Topic
932,Artifactual Signal Fluctuations,Topic
932,Pattern Recognition Approaches,Topic
932,Graph-Based Pattern Recognition Approaches,Topic
932,Noise-Aware Neuroimaging Data Processing Pipeline,Topic
932,Pilot Study,Topic
932,Classification Accuracy,Topic
932,Maxim Sharaev,Author
932,Alexander Andreev,Author
932,Alexey Artemov,Author
932,Alexander Bernstein,Author
932,Evgeny Burnaev,Author
932,Ekaterina Kondratyeva,Author
932,Svetlana Sushchinskaya,Author
932,Renat Akzhigitov,Author
933,Deep Learning Image Analysis Methods,Topic
933,Large-Scale Imaging Datasets,Topic
933,Imaging Neuroscience,Topic
933,Epidemiology,Topic
933,Clinical Translation,Topic
933,Data Availability,Topic
933,Interpretability,Topic
933,Evaluation,Topic
933,Logistical Challenges,Topic
933,Big Data Deep Learning Approaches,Topic
933,Nicola K Dinsdale,Author
933,Emma Bluemke,Author
933,Vaanathi Sundaresan,Author
933,Mark Jenkinson,Author
933,Stephen Smith,Author
933,Ana Il Namburete,Author
934,Deep Learning,Topic
934,Computer Vision,Topic
934,Natural Language Processing,Topic
934,Biomedical Research,Topic
934,Neuroscience,Topic
934,Electrophysiological Neuroimaging,Topic
934,Large-Scale Clinical Eeg Dataset,Paper
935,Mri Dataset Nigeria,Topic
935,Eberechi Wogu,Author
935,Patrick Filima,Author
935,Bradley Caron,Author
935,Daniel Levitas,Author
935,Peer Herholz,Author
935,Catherine Leal,Author
935,Mohammed F. Mehboob,Author
935,Soichi Hayashi,Author
935,Simisola Akintoye,Author
935,George Ogoh,Author
935,Tawe Godwin,Author
935,Damian Eke,Author
935,Franco Pestilli,Author
936,Quantitative Magnetic Resonance Imaging,Topic
936,Summit,Topic
936,Guoyan Lao,Author
936,Ruimin Feng,Author
936,Haikun Qi,Author
936,Zhenfeng Lv,Author
936,Qiangqiang Liu,Author
936,Chunlei Liu,Author
936,Yuyao Zhang,Author
936,Hongjiang Wei,Author
937,Electroencephalogram (Eeg),Topic
937,Graph Signal Processing (Gsp),Topic
937,Eeg Graph Mutual Attention Convolutional Network (Eeg-Gmacn),Topic
937,Haili Ye,Author
937,Stephan Goerttler,Author
937,Fei He,Author
938,Standardization Of Data Items In Paediatric Clinical Trials,Topic
938,Clinical Data Interchange Standards Consortium (Cdisc),Topic
938,Conect4Children Consortium,Topic
938,Cross-Cutting Paediatric Data Dictionary (Ccpdd),Topic
938,Anando Sen,Author
938,Victoria Hedley,Author
938,John Owen,Author
938,Ronald Cornet,Author
938,Dipak Kalra,Author
938,Corinna Engel,Author
938,Avril Palmeri,Author
938,Joanne Lee,Author
938,Jean-Christophe Roze,Author
938,Joseph F Standing,Author
938,Adilia Warris,Author
938,Claudia Pansieri,Author
938,Rebecca Leary,Author
938,Mark Turner,Author
938,Volker Straub,Author
939,Covid-19 Management,Topic
939,Orient-Covid,Paper
939,Clinical Decision Support Systems,Topic
939,Decision Tree Navigation,Topic
939,Randomized Controlled Trial,Topic
939,Guideline Adherence,Topic
939,Medical Students,Topic
939,Paper Guidelines,Topic
940,Abimed,Topic
940,Medication Review,Topic
940,Abdelmalek Mouazer,Author
940,Sophie Dubois,Author
940,Romain LÈguillon,Author
940,Nada Boudegzdame,Author
940,Thibaud Levrard,Author
940,Yoann Le Bars,Author
940,Christian Simon,Author
940,Brigitte SÈroussi,Author
940,Julien Grosjean,Author
940,Romain Lelong,Author
940,Catherine Letord,Author
940,StÈfan Darmoni,Author
940,Karima Sedki,Author
940,Pierre Meneton,Author
940,Rosy Tsopra,Author
940,Hector Falcoff,Author
940,Jean-Baptiste Lamy,Author
941,Information Theory,Topic
941,Transfer Entropy,Topic
941,Gomez-Herrero,Author
941,Patricia Wollstadt,Author
941,Mario MartÌnez-Zarzuela,Author
941,Raul Vicente,Author
941,Francisco J. DÌaz-Pernas,Author
941,Michael Wibral,Author
942,Survival-Agreement Plot,Topic
942,Survival Analysis,Topic
942,Chronic Hepatitis C,Topic
942,Chorda Tympani Nerve Involvement,Topic
942,B. De B. Pereira,Author
942,E. M. Nascimento,Author
942,F. Felix,Author
942,G. F. M. Rezende,Author
943,Optimal Treatment Regimes,Topic
943,Runchao Jiang,Author
943,Wenbin Lu,Author
943,Rui Song,Author
943,Marie Davidian,Author
944,Speech-Language Pathologists,Topic
944,Speech Disorders,Topic
944,Technology For Speech Analysis,Topic
944,Mixed Speech Signals,Topic
944,Loudness,Topic
944,Pitch,Topic
944,Shimmer,Topic
944,Jitter,Topic
944,Semitone Standard Deviation,Topic
944,Sharpness,Topic
944,Parkinson Disease,Topic
944,Healthy Controls,Topic
944,Multi-Smartwatch System For Assessing Speech Characteristics Of People With Dysarthria In Group Settings,Paper
945,Precision Medicine,Topic
945,Optimal Treatment Regime,Topic
945,Residual Weighted Learning (Rwl),Topic
945,Augmented Outcome-Weighted Learning (Aol),Topic
945,Zhou Et Al. (2017),Author
945,Xin Zhou,Author
945,Michael R. Kosorok,Author
945,Nefazodone-Cbasp Clinical Trial Data,Topic
946,A Likelihood-Based Alternative To Null Hypothesis Significance Testing,Paper
946,P-Value,Topic
946,Null Hypothesis Significance Testing,Topic
946,Likelihood Function,Topic
946,S-Value,Topic
946,Woman Trial,Topic
946,Relief Trial,Topic
947,Hybrid Sequential Deep Learning Model,Topic
947,Amd Progression,Topic
947,Rnn Model,Topic
947,Random Forest Model,Topic
947,Clinical Trial Dataset,Topic
948,Prism,Topic
948,Thomas O. Jemielita,Author
948,Devan V. Mehrotra,Author
949,Predictimand Framework,Topic
949,Clinical Prediction Model,Topic
949,End-Stage Kidney Disease,Topic
949,Nan Van Geloven,Author
949,Sonja Swanson,Author
949,Chava Ramspek,Author
949,Kim Luijken,Author
949,Merel Van Diepen,Author
949,Tim Morris,Author
949,Rolf Groenwold,Author
949,Hans Van Houwelingen,Author
949,Hein Putter,Author
949,Saskia Le Cessie,Author
950,Medical Reports,Topic
950,Lambr,Topic
950,Chen-Han Tsai,Author
950,Nahum Kiryati,Author
950,Eli Konen,Author
950,Miri Sklair-Levy,Author
950,Arnaldo Mayer,Author
951,Sepsis,Topic
951,Mimic-Iii Database,Topic
951,Chih-Hao Fang,Author
951,Vikram Ravindra,Author
951,Salma Akhter,Author
951,Mohammad Adibuzzaman,Author
951,Paul Griffin,Author
951,Shankar Subramaniam,Author
951,Ananth Grama,Author
951,Identifying And Analyzing Sepsis States: A Retrospective Study On Patients With Sepsis In Icus,Paper
952,Bayesian Nonparametric Utility-Based Group Sequential Design,Topic
952,Randomized Clinical Trial,Topic
952,Gel Sealant,Topic
952,Standard Care,Topic
952,Air Leaks,Topic
952,Pulmonary Resection,Topic
952,Yanxun Xu,Author
952,Peter F. Thall,Author
952,Peter Mueller,Author
952,Mehran J. Reza,Author
952,Decision-Theoretic Comparison Of Treatments To Resolve Air Leaks After Lung Surgery Based On Nonparametric Modeling,Paper
953,Gastrointestinal Cancers,Topic
953,Endoscopic Submucosal Dissection,Topic
953,Esd Cyclops System,Paper
954,Medical Imaging,Topic
954,Radiology Reports,Topic
954,Artificial Intelligence,Topic
954,Memory-Driven Transformer,Topic
954,Iu X-Ray,Topic
954,Mimic-Cxr,Topic
954,Zhihong Chen,Author
954,Yan Song,Author
954,Tsung-Hui Chang,Author
954,Xiang Wan,Author
954,Proposed Approach,Paper
955,Incorporating External Knowledge Into Named Entity Recognition (Ner) Systems,Topic
955,Clinical Domain,Topic
955,Zero-Shot Ner Systems,Topic
955,Auxiliary Gazetteer Model,Topic
955,Qing Sun,Author
955,Parminder Bhatia,Author
955,I2B2 Dataset,Topic
955,Neural Entity Recognition With Gazetteer Based Fusion,Paper
956,Automatic Detection Of Covid-19 And Pneumonia From Chest X-Ray Using Deep Learning,Paper
956,X-Ray Images,Topic
956,Transfer Learning,Topic
956,Deep Learning,Topic
957,Longitudinal Patient Stratification Of Electronic Health Records With Flexible Adjustment For Clinical Outcomes,Paper
958,Flexible Inference Of Optimal Individualized Treatment Strategy In Covariate Adjusted Randomization With Multiple Covariates,Paper
959,Digital Therapeutics For Mental Health: Is Attrition The Achilles Heel?,Paper
959,Adaora Nwosu,Author
959,Samantha Boardman,Author
959,Mustafa M. Husain,Author
959,P. Murali Doraiswamy,Author
959,Digital Therapeutics,Topic
959,Mental Health Care,Topic
959,User Engagement,Topic
959,Clinical Trials,Topic
960,Duration Of Response (Dor),Topic
960,Time To Response (Ttr),Topic
960,Best Overall Response (Bor),Topic
960,Overall Response Rate (Orr),Topic
960,Estimand Framework,Topic
960,Mantle Cell Lymphoma,Topic
960,Hans-Jochen Weber,Author
960,Stephen Corson,Author
960,Jiang Li,Author
960,Francois Mercier,Author
960,Satrajit Roychoudhury,Author
960,Martin Oliver Sailer,Author
960,Stephen Sun,Author
960,Alexander Todd,Author
960,Godwin Yung,Author
961,Smart Data Extractor,Topic
961,Sophie Quennelle,Author
961,Maxime Douillet,Author
961,Lisa Friedlander,Author
961,Olivia Boyer,Author
961,Anita Burgun,Author
961,Antoine Neuraz,Author
961,Nicolas Garcelon,Author
961,Manual Data Collection,Topic
962,Nlp Model Generalization,Topic
962,Aparna Elangovan,Author
962,Jiayuan He,Author
962,Yuan Li,Author
962,Karin Verspoor,Author
963,Care,Topic
963,Aakanksha Naik,Author
963,Bailey Kuehl,Author
963,Erin Bransom,Author
963,Doug Downey,Author
963,Tom Hope,Author
963,Biomedicine,Topic
963,Clinical Trials,Topic
963,Case Reports,Topic
963,Computer Science,Topic
963,Materials Science,Topic
963,Gpt4,Topic
964,Non-Small Cell Lung Cancer,Topic
964,Benjamin Schneider,Author
964,SÈbastien Benzekry,Author
964,Jonathan Mochel,Author
964,Clinical Trials In Nsclc,Topic
964,Bevacizumab-Antiproliferative Combination Therapy,Topic
964,Clinical Model Of Nsclc Growth,Topic
964,Acquired Resistance To Pharmaceuticals,Topic
964,Anti-Vegf Therapy,Topic
964,5-Year Survival Rate For Metastatic Disease,Topic
964,Late-Stage Disease Diagnosis,Topic
965,Large Language Models,Topic
965,Oncology,Topic
965,Openai Models,Topic
965,Adjuvant Radiation Therapy,Topic
965,Chemotherapy,Topic
965,Breast Cancer,Topic
965,Tristen Pool,Author
965,Dennis Trujillo,Author
965,Langchain Prompt Engineering Pipeline,Topic
965,Clinical Trial,Topic
965,U.S. Cancer Patients,Topic
965,Quality Care,Topic
966,Intervention Calculus When The Dag Is Absent (Ida),Topic
966,Peter Clarks (Pc)-Algorithm,Topic
966,Chronologically Ordered Pc-Algorithm (Copc-Algorithm),Topic
966,Completed Partially Directed Acyclic Graphs (Cpdags),Topic
966,Time-Dependent Immunological Biomarkers,Topic
966,Metastatic Melanoma,Topic
966,VahÈ Asvatourian,Author
966,ClÈlia Coutzac,Author
966,Nathalie Chaput,Author
966,Caroline Robert,Author
966,Stefan Michiels,Author
966,Emilie Lanoy,Author
967,Glomerulosclerosis,Topic
967,Interstitial Fibrosis,Topic
967,Tubular Atrophy,Topic
967,Artificial Intelligence,Topic
967,Computer Vision,Topic
967,Convolutional Neural Networks,Topic
967,Renal Biopsies,Topic
967,Brandon Ginley,Author
967,Kuang-Yu Jen,Author
967,Avi Rosenberg,Author
967,Felicia Yen,Author
967,Sanjay Jain,Author
967,Agnes Fogo,Author
967,Pinaki Sarder,Author
968,Haplo-Identical Transplantation,Topic
968,Hla Mismatches,Topic
968,Gramm,Topic
968,Zuriya Ansbacher-Feldman,Author
968,Sapir Israeli,Author
968,Martin Maiers,Author
968,Loren Gragert,Author
968,Dianne De Santis,Author
968,Moshe Israeli,Author
968,Yoram Louzoun,Author
968,Israeli Population Dataset,Topic
968,Australian Population Dataset,Topic
968,Recombination Events,Topic
968,Alleles Imputation Accuracy,Topic
968,False Positive Rate,Topic
968,Recombination Rate,Topic
968,Https://Gramm.Math.Biu.Ac.Il/,Topic
969,Modular Sparse Distributed Code (Msdc),Topic
969,Neuroscience,Topic
969,Sparse Distributed Codes (Sdcs),Topic
969,Neocortex,Topic
969,Hippocampus,Topic
969,Wta Competitive Modules (Cms),Topic
969,Binary Units,Topic
969,Single-Trial Unsupervised Learning Algorithm,Topic
969,Fixed Time Best-Match Retrieval,Topic
969,Fixed Time Belief Update,Topic
969,Novelty Of The Input,Topic
969,Spatial Patterns,Topic
970,Advances In Power Electronics,Topic
970,High Power Levels,Topic
970,High Output Bandwidths,Topic
970,Multichannel Wireless Power Transfer,Topic
970,Medical Applications,Topic
970,Neuroscience Applications,Topic
970,Conventional Inverters,Topic
970,Resonant Circuits,Topic
970,Gallium-Nitride (Gan) Transistors,Topic
970,Modular Cascaded Double-H Bridge Circuits,Topic
970,Lightweight Embedded Control Solution,Topic
970,Look-Up-Table Digital Synthesizer,Topic
970,Adaptive-Bias-Elimination Nearest-Level Modulation,Topic
970,Prototype,Topic
970,Jinshui Zhang,Author
970,Boshuo Wang,Author
970,Xiaoyang Tian,Author
970,Angel Peterchev,Author
970,Stefan Goetz,Author
971,Decoding Non-Invasive Brain Recordings,Topic
971,Vision Transformer 3D,Topic
971,Large Language Models (Llms),Topic
971,Guobin Shen,Author
971,Dongcheng Zhao,Author
971,Xiang He,Author
971,Linghao Feng,Author
971,Yiting Dong,Author
971,Jihang Wang,Author
971,Qian Zhang,Author
971,Yi Zeng,Author
971,Neuro-Vision To Language: Enhancing Brain Recording-Based Visual Reconstruction And Language Interaction,Paper
972,Gaussian Processes,Topic
972,Dimensionality Reduction,Topic
972,Neuroscience,Topic
972,Multi-Population Interactions,Topic
972,Multi-Group Gaussian Process Factor Models,Topic
972,Inducing Variables,Topic
972,Frequency Domain,Topic
972,Evren Gokcen,Author
972,Anna I. Jasper,Author
972,Adam Kohn,Author
972,Christian K. Machens,Author
972,Byron M. Yu,Author
973,Savvy Project,Topic
974,Estimands Framework,Topic
974,Ich E9 (R1),Topic
974,Treatment Policy Strategy,Topic
974,Mixed Model For Repeated Measures (Mmrm),Topic
974,Multiple Imputation (Mi),Topic
974,Phase 3 Trial,Topic
974,Respiratory Disease,Topic
974,Thomas Drury,Author
974,Juan J Abellan,Author
974,Nicky Best,Author
974,Ian R. White,Author
975,Prognostic Model For Relapses In Rrms,Topic
975,Relapsing-Remitting Multiple Sclerosis (Rrms),Topic
975,Konstantina Chalkou,Author
975,Ewout Steyerberg,Author
975,Patrick Bossuyt,Author
975,Suvitha Subramanian,Author
975,Pascal Benkert,Author
975,Jens Kuhle,Author
975,Giulio Disanto,Author
975,Ludwig Kappos,Author
975,Matthias Egger,Author
975,Georgia Salanti,Author
976,Machine Learning Methods,Topic
976,Multi-Parametric Biomarkers,Topic
976,Neuroimaging,Topic
976,Dementia,Topic
976,Early Diagnosis Of Dementia,Topic
976,Individuals At-Risk Of Developing Dementia,Topic
976,Seven Grand Challenges,Topic
976,Screening,Topic
976,Clinical Status Estimation,Topic
976,Prediction,Topic
976,Monitoring In (Pre-Clinical) Dementia,Topic
976,Clinical Questions,Topic
976,Performance Metrics,Topic
976,Validation Process,Topic
976,Data Preprocessing,Topic
976,Input Features,Topic
976,State-Of-The-Art Performances,Topic
976,Statistical Analysis,Topic
976,Clinical Questions Beyond Alzheimer'S Disease,Topic
976,Testing Data Beyond The Alzheimer'S Disease Neuroimaging Initiative,Topic
976,Generalizability Of Algorithm Performance,Topic
976,Larger Testing Data Sizes,Topic
976,Sharing Algorithms Rather Than Data,Topic
976,Esther E. Bron,Author
976,Stefan Klein,Author
976,Annika Reinke,Author
976,Janne M. Papma,Author
976,Lena Maier-Hein,Author
976,Daniel C. Alexander,Author
976,Neil P. Oxtoby,Author
977,Sensing Danger: Innate Immunology For Intrusion Detection,Paper
978,Theoretical Immunology,Topic
978,Disordered Statistical Mechanics,Topic
978,Quantitative Theoretical Immunology,Topic
978,Adaptive Immune Response,Topic
978,Adriano Barra,Author
978,Elena Agliari,Author
978,Research Article,Paper
979,A Beginners Guide To Systems Simulation In Immunology,Paper
979,Monte Carlo Simulations,Topic
979,System Dynamics,Topic
979,Discrete-Event Simulation,Topic
979,Agent-Based Simulation,Topic
979,Immunology Research,Topic
979,Simulation Models,Topic
979,Modelling And Simulation,Topic
979,Simulation Problem,Topic
980,T-Cell Receptors,Topic
980,Antigenic Peptides,Topic
980,Artificial Neural Networks,Topic
980,Immunological Recognition,Topic
980,Jin Xu,Author
980,Junghyo Jo,Author
981,Covid-19 Vaccines,Topic
981,Sars-Cov-2 Infection,Topic
981,Vaccine-Induced Immunological Memory,Topic
981,Neutralizing Antibodies,Topic
981,Mathematical Model,Topic
981,Coronavac,Topic
981,Vaccine-Induced Immune Response,Topic
981,Viral Infection Datasets,Topic
981,Vaccination Datasets,Topic
981,Booster Shot,Topic
981,Maximum Viral Load,Topic
981,Recovery Time,Topic
981,Vaccination Regimen,Topic
981,Fourth Dose,Topic
981,Virus Transmission,Topic
981,Public Health Policies,Topic
981,Xin Gao,Author
981,Jianwei Li,Author
981,Dianjie Li,Author
982,Natural Language Processing,Topic
982,Clinical Trials,Topic
982,N2C2 Challenge,Topic
982,Mimic,Topic
982,Weakly Supervised Method,Topic
982,Terminology-Based Approach,Topic
982,Xavier Tannier,Author
982,Nicolas Paris,Author
982,Hugo Cisneros,Author
982,Christel Daniel,Author
982,Matthieu Doutreligne,Author
982,Catherine Duclos,Author
982,Nicolas Griffon,Author
982,Claire Hassen-Khodja,Author
982,Ivan Lerner,Author
982,Adrien Parrot,Author
982,…ric Sadou,Author
982,Cyrina Saussol,Author
982,Pascal Vaillant,Author
982,N2C2 Dataset,Topic
982,F1-Measure,Topic
982,Patient Phenotypes,Topic
983,Acute Neuroprotection In Clinical Trials,Topic
983,Clinical Trial Issues,Topic
983,Neuroprotective Moiety Issues,Topic
983,Conditioning Strategies,Topic
983,Neuroprotective Framework,Topic
983,Tauskela Joseph S.,Author
983,Blondeau Nicolas,Author
984,Pharmaceutical Companies,Topic
984,Clinical Trial Results,Topic
984,Public Pharma Market Value,Topic
984,Bert-Based Model,Topic
984,Temporal Fusion Transformer,Topic
984,Graph Convolution Network,Topic
984,Gradient Boosting,Topic
984,Drug Portfolio Size,Topic
984,Network Effect,Topic
984,Fda Announcement Dataset,Topic
984,Semen Budennyy,Author
984,Alexey Kazakov,Author
984,Elizaveta Kovtun,Author
984,Leonid Zhukov,Author
984,New Drugs And Stock Market: How To Predict Pharma Market Reaction To Clinical Trial Announcements,Paper
985,Drug Repurposing Network,Topic
985,Breast Cancer,Topic
985,Chatgpt,Author
985,Ahmed Abdeen Hamed,Author
985,Tamer E. Fandy,Author
985,Kegg Database,Topic
985,Signaling Pathway Id Hsa:2064,Topic
985,Signaling Pathway Id Hsa:1499,Topic
986,Leads,Topic
986,Systematic Literature Review,Topic
986,Artificial Intelligence,Topic
986,Clinical Trials,Topic
986,Expert Workflows,Topic
986,Zifeng Wang,Author
986,Lang Cao,Author
986,Qiao Jin,Author
986,Joey Chan,Author
986,Nicholas Wan,Author
986,Behdad Afzali,Author
986,Hyun-Jin Cho,Author
986,Chang-In Choi,Author
986,Mehdi Emamverdi,Author
986,Manjot K. Gill,Author
986,Sun-Hyung Kim,Author
986,Yijia Li,Author
986,Yi Liu,Author
986,Hanley Ong,Author
986,Justin Rousseau,Author
986,Irfan Sheikh,Author
986,Jenny J. Wei,Author
986,Ziyang Xu,Author
986,Christopher M. Zallek,Author
986,Kyungsang Kim,Author
986,Yifan Peng,Author
986,Zhiyong Lu,Author
986,Jimeng Sun,Author
987,Blockchain Technology,Topic
987,Healthcare Industry,Topic
987,Electronic Health Records (Ehr),Topic
987,Medical Supply Chain Management System,Topic
987,Genomic Market,Topic
987,Neuroscience Technology,Topic
987,Clinical Research,Topic
987,Pharmaceutical Medicine,Topic
987,H. Sami Ullah,Author
987,S. Aslam,Author
987,"Blockchain In Healthcare And Medicine: A Contemporary Research Of Applications, Challenges, And Future Perspectives",Paper
988,Estimating Intra- And Extra-Axonal Microstructure Parameters,Topic
988,Standard Model (Sm),Topic
988,Diffusion Mri (Dmri),Topic
988,20 Healthy Volunteers,Topic
988,Santiago Coelho,Author
988,Steven H. Baete,Author
988,Gregory Lemberskiy,Author
988,Benjamin Ades-Aaron,Author
988,Genevieve Barrol,Author
988,Jelle Veraart,Author
988,Dmitry S. Novikov,Author
988,Els Fieremans,Author
989,Generative Adversarial Networks,Topic
989,Deep Learning,Topic
989,Generative Methods,Topic
989,Neurological Conditions,Topic
989,Applications Of Generative Adversarial Networks In Neuroimaging And Clinical Neuroscience,Paper
990,Neural Electrical Activity,Topic
990,Brainwave,Paper
990,Brain Function,Topic
990,Cognitive And Behavioral Processes,Topic
990,Brain Diseases,Topic
990,Neurological Disorders,Topic
990,Ai-Driven Approaches,Topic
990,Neuroscience Research,Topic
991,5Th Workshop On Machine Learning And Interpretation In Neuroimaging (Mlini),Topic
991,Neural Information Processing Systems (Nips 2015),Topic
991,I. Rish,Author
991,L. Wehbe,Author
991,G. Langs,Author
991,M. Grosse-Wentrup,Author
991,B. Murphy,Author
991,G. Cecchi,Author
992,Computational Logic For Biomedicine And Neurosciences,Paper
992,Systems Biology,Topic
992,Neuroscience,Topic
992,Biomedicine,Topic
992,Calculus Of Inductive Constructions (Cic),Topic
992,Coq,Topic
992,Drug Discovery,Topic
992,Disease Diagnosis,Topic
993,Simple Rgc,Topic
993,Rgc Counter,Paper
993,Rgc Transduction,Paper
993,Rgc Batch,Paper
993,Tiger Cross,Author
993,Rasika Navarange,Author
993,Joon-Ho Son,Author
993,William Burr,Author
993,Arjun Singh,Author
993,Kelvin Zhang,Author
993,Miruna Rusu,Author
993,Konstantinos Gkoutzis,Author
993,Andrew Osborne,Author
993,Bart Nieuwenhuis,Author
994,Closed-Loop Brain Stimulation,Topic
994,Portiloop,Paper
995,Human Brain,Topic
995,Neuroscience Research,Topic
995,Graph Neural Networks,Topic
995,Deep Models,Topic
995,Interpretable Framework,Topic
995,Regions Of Interest,Topic
995,Biomarkers,Topic
995,Hejie Cui,Author
995,Wei Dai,Author
995,Yanqiao Zhu,Author
995,Xiaoxiao Li,Author
995,Lifang He,Author
995,Carl Yang,Author
995,Ibgnn,Paper
996,Noninvasive Brain Stimulation And Neuroimaging,Topic
996,Brain Biomarkers,Topic
996,Reliability,Topic
996,Validity,Topic
996,Tms-Eeg Biomarkers,Topic
996,Sara Parmigiani,Author
996,Jessica M. Ross,Author
996,Christopher Cline,Author
996,Christopher B. Minasi,Author
996,Juha Gogulski,Author
996,Corey J Keller,Author
997,Neuralizer,Topic
997,Steffen Czolbe,Author
997,Adrian V. Dalca,Author
997,Neuroimage Processing Tasks,Topic
998,Foundation Models,Topic
998,Medical Image Analysis,Topic
998,Neuroscience Research,Topic
998,Brain Network Foundation Models,Topic
998,Dataset,Topic
998,Brainmass Framework,Topic
998,Mask-Roi Modeling,Topic
998,Latent Representation Alignment,Topic
998,Yanwu Yang,Author
998,Chenfei Ye,Author
998,Guinan Su,Author
998,Ziyao Zhang,Author
998,Zhikai Chang,Author
998,Hairui Chen,Author
998,Piu Chan,Author
998,Yue Yu,Author
998,Ting Ma,Author
999,Precision Medicine,Topic
999,Treatment Regime,Topic
999,Optimal Treatment Regime,Topic
999,Yichi Zhang,Author
999,Eric B. Laber,Author
999,Anastasios Tsiatis,Author
999,Marie Davidian,Author
999,Bipolar Disorder,Topic
999,Sequential Clinical Trial,Topic
999,Exploratory Analysis,Topic
999,Black-Box Estimation Methods,Topic
999,Decision Rules,Topic
999,If-Then Statements,Topic
999,Simulation Examples,Topic
1000,Chexpedition: Investigating Generalization Challenges For Translation Of Chest X-Ray Algorithms To The Clinical Setting,Paper
1000,Pranav Rajpurkar,Author
1000,Anirudh Joshi,Author
1000,Anuj Pareek,Author
1000,Phil Chen,Author
1000,Amirhossein Kiani,Author
1000,Jeremy Irvin,Author
1000,Andrew Y. Ng,Author
1000,Matthew P. Lungren,Author
1000,Chexpert,Topic
1000,Deep Learning Algorithms,Topic
1000,Chest X-Ray Interpretation,Topic
1000,Tb Detection,Topic
1000,Pathology Detection,Topic
1000,Auc,Topic
1000,Clinical Decision Support Tools,Topic
1001,Reinforcement Learning Framework,Topic
1001,Intensive Care Units,Topic
1001,Sepsis Treatment,Topic
1001,Luchen Li,Author
1001,Ignacio Albert-Smet,Author
1001,Aldo A. Faisal,Author
1002,Personalized Medicine,Topic
1002,High-Throughput Sequencing,Topic
1002,Targeted Therapies,Topic
1002,Treatment Assignment Algorithm,Topic
1002,Causal Framework,Topic
1002,Precision Medicine Strategies,Topic
1002,Clinical Trials,Topic
1002,Gold Standard Treatment,Topic
1002,Observed Treatments,Topic
1002,Random Assignment Of Targeted Treatments,Topic
1002,Rshiny Interactive Application,Topic
1002,Patient-Derived Xenografts (Pdx),Topic
1002,Jonas BÈal,Author
1002,AurÈlien Latouche,Author
1003,Clinical Eye,Topic
1003,Virdocd,Topic
1003,Dengue,Topic
1003,Amit K Chattopadhyay,Author
1003,Subhagata Chattopadhyay,Author
1003,Statistical And Machine Intelligence Tools (Smi),Topic
1003,Multiple Linear Regression (Mlr),Topic
1003,Random Forest Classification (Rf),Topic
1003,Covid-19,Topic
1004,Predicting Clinical Outcome Of Stroke Patients With Tractographic Feature,Paper
1004,Po-Yu Kao,Author
1004,Jefferson W. Chen,Author
1004,B. S. Manjunath,Author
1004,Modified Rankin Scale,Topic
1004,Stroke Lesion,Topic
1004,Tractographic Feature,Topic
1004,Ischemic Stroke Lesion Segmentation 2017,Topic
1005,Image Quality Assessment,Topic
1005,Medical Imaging,Topic
1005,Machine Learning,Topic
1005,Computed Tomography,Topic
1005,National Lung Screening Trial,Topic
1005,Quality Assessment Tool For Machine Learning With Clinical Ct,Paper
1005,Riqiang Gao,Author
1005,Mirza S. Khan,Author
1005,Yucheng Tang,Author
1005,Kaiwen Xu,Author
1005,Steve Deppen,Author
1005,Yuankai Huo,Author
1005,Kim L. Sandler,Author
1005,Pierre P. Massion,Author
1005,Bennett A. Landman,Author
1006,Stroke,Topic
1006,Neurological Injury,Topic
1006,Cognition,Topic
1006,Language,Topic
1006,Sensory Functions,Topic
1006,Motor Functions,Topic
1006,Clinical Recovery,Topic
1006,Ninds Tpa Trial,Paper
1006,Trajectory Profile Clustering (Tpc),Topic
1006,Graph Neural Networks,Topic
1006,Sanjukta Krishnagopal,Author
1006,Keith Lohse,Author
1006,Robynne Braun,Author
1006,Stroke Recovery Phenotyping,Topic
1006,Symptom Progression Subtypes,Topic
1007,Artificial Intelligence (Ai)-Based Methods,Topic
1007,Oncologic Positron Emission Tomography (Pet) Images,Topic
1007,Dice Score,Topic
1007,Metabolic Tumor Volume (Mtv),Topic
1007,Total Lesion Glycolysis (Tlg),Topic
1007,Non-Small Cell Lung Cancer,Topic
1007,Ecog-Acrin 6668/Rtog 0235,Topic
1007,Ziping Liu,Author
1007,Joyce C. Mhlanga,Author
1007,Barry A. Siegel,Author
1007,Abhinav K. Jha,Author
1008,Machine Learning,Topic
1008,Dementia Research,Topic
1008,Magda Bucholc,Author
1008,Charlotte James,Author
1008,Ahmad Al Khleifat,Author
1008,Amanpreet Badhwar,Author
1008,Natasha Clarke,Author
1008,Amir Dehsarvi,Author
1008,Christopher R. Madan,Author
1008,Sarah J. Marzi,Author
1008,Cameron Shand,Author
1008,Brian M. Schilder,Author
1008,Stefano Tamburin,Author
1008,Hanz M. Tantiangco,Author
1008,Ilianna Lourida,Author
1008,David J. Llewellyn,Author
1008,Janice M. Ranson,Author
1009,Harmonization Across Imaging Locations(Hail): One-Shot Learning For Brain Mri,Paper
1009,Abhijeet Parida,Author
1009,Zhifan Jiang,Author
1009,Syed Muhammad Anwar,Author
1009,Nicholas Foreman,Author
1009,Nicholas Stence,Author
1009,Michael J. Fisher,Author
1009,Roger J. Packer,Author
1009,Robert A. Avery,Author
1009,Marius George Linguraru,Author
1010,Chatgpt Advanced Data Analysis,Topic
1010,Machine Learning,Topic
1010,Clinical Data Analysis,Topic
1010,Soroosh Tayebi Arasteh,Author
1010,Tianyu Han,Author
1010,Mahshad Lotfinia,Author
1010,Christiane Kuhl,Author
1010,Jakob Nikolas Kather,Author
1010,Daniel Truhn,Author
1010,Sven Nebelung,Author
1011,Chronic Itch,Topic
1011,Us Population,Topic
1011,Home Radio Device,Topic
1011,Artificial Intelligence,Topic
1011,Chronic Pruritus Patients,Topic
1011,Infrared Camera,Topic
1011,Sleep Quality,Topic
1011,Michail Ouroutzoglou,Author
1011,Mingmin Zhao,Author
1011,Joshua Hellerstein,Author
1011,Hariharan Rahul,Author
1011,Asima Badic,Author
1011,Brian S. Kim,Author
1011,Dina Katabi,Author
1011,Clinical Study,Topic
1011,Sleep Efficiency,Topic
1011,Sleep Latency,Topic
1011,Quantifying Itch,Topic
1011,Machine Learning,Topic
1011,Radio Signals,Topic
1012,Randomized Controlled Trials,Topic
1012,Single-Arm Studies,Topic
1012,Hybrid Controlled Trials,Topic
1012,Real-World Data,Topic
1012,W. Katherine Tan,Author
1012,Brian D. Segal,Author
1012,Melissa D. Curtis,Author
1012,Shrujal S. Baxi,Author
1012,William B. Capra,Author
1012,Elizabeth Garrett-Mayer,Author
1012,Brian P. Hobbs,Author
1012,David S. Hong,Author
1012,Rebecca A. Hubbard,Author
1012,Jiawen Zhu,Author
1012,Somnath Sarkar,Author
1012,Meghna Samant,Author
1013,Testing For Treatment Effect Twice Using Internal And External Controls In Clinical Trials,Paper
1013,Yanyao Yi,Author
1013,Ying Zhang,Author
1013,Yu Du,Author
1013,Ting Ye,Author
1014,A Wavelet Based Algorithm For The Identification Of Oscillatory Event-Related Potential Components,Paper
1014,Event Related Potentials (Erps),Topic
1014,N170 Erp,Topic
1014,Asymmetry Method,Topic
1014,Matching Wavelet Algorithm,Topic
1014,T-Cwt Method,Topic
1015,The Right Time To Learn: Mechanisms And Optimization Of Spaced Learning,Paper
1015,Paul Smolen,Author
1015,Yili Zhang,Author
1015,John H. Byrne,Author
1015,Spaced Training,Topic
1015,Massed Training,Topic
1015,Cognitive Theories,Topic
1015,Cellular And Molecular Mechanisms,Topic
1015,Computational Models,Topic
1015,Pharmacotherapy,Topic
1016,Neural Circuits,Topic
1016,Decision-Making Theory,Topic
1016,Neural Activity,Topic
1016,Drift-Diffusion Model,Topic
1016,Recurrent State-Space Models,Topic
1016,Variational Laplace-Em Inference Algorithm,Topic
1016,Monkey Parietal Cortex,Topic
1016,Parietal Neurons,Topic
1016,Lip Neuron,Topic
1016,David M. Zoltowski,Author
1016,Jonathan W. Pillow,Author
1016,Scott W. Linderman,Author
1017,Reinforcement Learning Framework For Deep Brain Stimulation Study,Paper
1018,Characterizing Spreading Dynamics Of Subsampled Systems With Non-Stationary External Input,Paper
1018,Jorge De Heuvel,Author
1018,Jens Wilting,Author
1018,Moritz Becker,Author
1018,Viola Priesemann,Author
1018,Johannes Zierenberg,Author
1019,Quantifying Similarity Between Neural Representations,Topic
1019,Lyndon R. Duong,Author
1019,Jingyang Zhou,Author
1019,Josue Nassar,Author
1019,Jules Berman,Author
1019,Jeroen Olieslagers,Author
1019,Alex H. Williams,Author
1019,Stochastic Representations,Topic
1019,Deterministic Responses,Topic
1019,Neurobiological Representations,Topic
1019,Deep Network Representations,Topic
1019,Training Hyperparameters,Topic
1020,Fluctuation Theorem,Topic
1020,Motor Proteins,Topic
1020,F1-Atpase,Topic
1020,Kinesin,Topic
1020,Dynein,Topic
1020,Kumiko Hayashi,Author
1021,Decoding Spiking Mechanism With Dynamic Learning On Neuron Population,Paper
1021,Neuron Activation Network,Topic
1021,Retinal Ganglion Cells,Topic
1022,Technological Advancements,Topic
1022,Spiking Activities,Topic
1022,Neuron Ensembles,Topic
1022,Statistical Analysis,Topic
1022,Neuroscience Experiments,Topic
1022,Randomized Interventions,Topic
1022,Groups Of Neurons,Topic
1022,Stimulation Responses,Topic
1022,Observed Data,Topic
1022,Neural Responses,Topic
1022,Response Latencies,Topic
1022,Additive Shape Invariant Model,Topic
1022,Model Parameters,Topic
1022,Future Experiments,Topic
1022,Simulation Studies,Topic
1022,Neural Data,Topic
1022,Mice,Topic
1022,Zitong Zhang,Author
1022,Shizhe Chen,Author
1023,Tadpole Challenge,Topic
1023,Alzheimer'S Disease Neuroimaging Initiative,Topic
1023,Adni-3 Rollover Participants,Topic
1023,Team Frog,Author
1023,Team Emc1,Author
1023,Benchmarkme,Topic
1023,Razvan V. Marinescu,Author
1023,Neil P. Oxtoby,Author
1023,Alexandra L. Young,Author
1023,Esther E. Bron,Author
1023,Arthur W. Toga,Author
1023,Michael W. Weiner,Author
1023,Frederik Barkhof,Author
1023,Nick C. Fox,Author
1023,Polina Golland,Author
1023,Stefan Klein,Author
1023,Daniel C. Alexander,Author
1024,Smart Devices,Topic
1024,Thermistors,Topic
1024,Temperature Monitoring,Topic
1024,Core Body Temperature,Topic
1024,Joseph Breda,Author
1024,Shwetak Patel,Author
1024,Clinical Study,Topic
1024,Smartphone Fever Monitoring,Topic
1025,Radiation-Induced Erectile Dysfunction (Ried),Topic
1025,Prostate Cancer,Topic
1025,Internal-Pudendal-Arteries (Ipa),Topic
1025,Deep Learning (Dl)-Based Auto-Segmentation Model,Topic
1025,Ct And Mri,Topic
1025,86 Patients,Topic
1025,Squeeze-And-Excite Blocks,Topic
1025,Novel Loss Function,Topic
1025,Modality Dropout Strategy,Topic
1025,Dsc,Topic
1025,Asd,Topic
1025,Hd95,Topic
1025,Ai Contours,Topic
1025,Expert Physicians,Author
1025,Inexperienced Physicians,Author
1025,Anjali Balagopal,Author
1025,Michael Dohopolski,Author
1025,Young Suk Kwon,Author
1025,Steven Montalvo,Author
1025,Howard Morgan,Author
1025,Ti Bai,Author
1025,Dan Nguyen,Author
1025,Xiao Liang,Author
1025,Xinran Zhong,Author
1025,Mu-Han Lin,Author
1025,Neil Desai,Author
1025,Steve Jiang,Author
1026,Artificial Intelligence,Topic
1026,Virtual Imaging Trials,Topic
1026,Covid-19,Topic
1026,3D Resnet-Like,Topic
1026,2D Efficientnetv2,Topic
1026,Auc,Topic
1026,Delong Method,Topic
1026,Fakrul Islam Tushar,Author
1026,Lavsen Dahal,Author
1026,Saman Sotoudeh-Paima,Author
1026,Ehsan Abadi,Author
1026,W. Paul Segars,Author
1026,Ehsan Samei,Author
1026,Joseph Y. Lo,Author
1027,Resotran,Topic
1027,Resovist,Topic
1027,Ferrotran,Topic
1027,Perimag,Topic
1027,Fabian Mohn,Author
1027,Konrad Scheffler,Author
1027,Justin Ackers,Author
1027,Agnes Weimer,Author
1027,Franz Wegner,Author
1027,Florian Thieben,Author
1027,Mandy Ahlborg,Author
1027,Patrick Vogel,Author
1027,Matthias Graeser,Author
1027,Tobias Knopp,Author
1028,Prostate Sbrt Treatment Survey,Topic
1028,Proton Therapy Centers,Topic
1028,Survey Results,Topic
1028,Reasons For Not Offering Sbrt,Topic
1028,Common Practices In Sbrt,Topic
1028,Patient-Specific Qa,Topic
1028,Treatment Planning,Topic
1029,Stereotactic Arrhythmia Radioablation (Star),Topic
1029,Refractory Ventricular Tachycardia (Vt),Topic
1029,Keyur D. Shah,Author
1029,Chih-Wei Chang,Author
1029,Sibo Tian,Author
1029,Pretesh Patel,Author
1029,Richard Qiu,Author
1029,Justin Roper,Author
1029,Jun Zhou,Author
1029,Zhen Tian,Author
1029,Xiaofeng Yang,Author
1029,Systematic Review And Meta-Analysis,Paper
1030,Vrnq,Topic
1030,Vrise,Topic
1030,Panagiotis Kourtesis,Author
1030,Simona Collina,Author
1030,Leonidas A. A. Doumas,Author
1030,Sarah E. Macpherson,Author
1030,Vr_Session_Duration,Topic
1030,Participants,Topic
1031,Virtual Reality Everyday Assessment Lab (Vr-Eal),Topic
1031,Panagiotis Kourtesis,Author
1031,Danai Korre,Author
1031,Simona Collina,Author
1031,Leonidas A. A. Doumas,Author
1031,Sarah E. Macpherson,Author
1031,Vr Induced Symptoms And Effects (Vrise),Topic
1031,Cognitive Neuroscience,Topic
1031,Neuropsychology,Topic
1031,Unity,Topic
1031,Vr Neuroscience Questionnaire (Vrnq),Topic
1031,Participants,Topic
1031,User Experience,Topic
1031,Game Mechanics,Topic
1031,In-Game Assistance,Topic
1031,Graphics,Topic
1031,Vrise,Topic
1032,A Mutagenetic Tree Hidden Markov Model For Longitudinal Clonal Hiv Sequence Data,Paper
1033,Didemnins,Topic
1033,Jonathan L. Belof,Author
1034,A New Family Of Covariate-Adjusted Response Adaptive Designs And Their Asymptotic Properties,Paper
1034,Li-Xin Zhang,Author
1034,Feifang Hu,Author
1035,Odds Theorem,Topic
1035,Odds Algorithm,Topic
1035,Optimal Stopping Problems,Topic
1035,RÈmi Dendievel,Author
1035,2000,Topic
1035,Secretary Problems,Topic
1035,Robotic Maintenance Problems,Topic
1035,Compassionate Use Clinical Trials,Topic
1035,New Developments,Topic
1035,Gnew Developments,Topic
1036,Human Dynamics,Topic
1036,Stochastic Processes,Topic
1036,Survival Analysis,Topic
1036,Generative Model,Topic
1036,Trevor Fenner,Author
1036,Mark Levene,Author
1036,George Loizou,Author
1037,Online Learning Of Finite Markov Decision Process (Mdp) Problems,Topic
1037,Yasin Abbasi-Yadkori,Author
1037,Gergely Neu,Author
1037,Computationally Efficient Algorithm,Topic
1037,Regret Bound,Topic
1037,Optimal Dynamic Policy,Topic
1037,Applications Such As Clinical Trials And Recommendation Systems,Topic
1037,Episodic Structure,Topic
1037,Number Of Rounds,Topic
1038,Gaussian Comparison Inequalities,Topic
1038,Multivariate Gaussian Random Vectors,Topic
1038,Cumulative Distribution Function,Topic
1038,Multivariate Normal Random Vector,Topic
1038,Standard Normal Random Variable,Topic
1038,Bayesian Design Of A Clinical Trial,Topic
1038,Amanda Turner,Author
1038,John Whitehead,Author
1039,Stroke,Topic
1039,A Statistical Model For Stroke Outcome Prediction And Treatment Planning,Paper
1039,Abhishek Sengupta,Author
1039,Vaibhav Rajan,Author
1039,Sakyajit Bhattacharya,Author
1039,G R K Sarma,Author
1040,Thresholding Bandit For Dose-Ranging: The Impact Of Monotonicity,Paper
1041,Vrc01,Topic
1041,Hiv Infection Rate,Topic
1041,Lily Zhang,Author
1041,Peter B. Gilbert,Author
1041,Edmund Capparelli,Author
1041,Yunda Huang,Author
1041,Pharmacokinetics Simulations For Studying Correlates Of Prevention Efficacy Of Passive Hiv-1 Antibody Prophylaxis In The Antibody Mediated Prevention (Amp) Study,Paper
1042,Learning Patient Representations From Text,Paper
1042,Dmitriy Dligach,Author
1042,Timothy Miller,Author
1042,Phenotyping,Topic
1042,Applications Of Phenotyping,Topic
1042,Supervised Machine Learning,Topic
1042,Neural Network Model,Topic
1042,Comorbidity Detection Task,Topic
1043,Electronic Health Record System,Topic
1043,Patient Information,Topic
1043,Deep Learning Model,Topic
1043,De-Convolutional Neural Network,Topic
1043,Bi-Directional Lstm-Cnn,Topic
1043,Regular Expressions,Topic
1043,Phi Scrubber: A Deep Learning Approach,Paper
1043,Abhai Kollara Dilip,Author
1043,Kamal Raj K,Author
1043,Malaikannan Sankarasubbu,Author
1044,Online Convex Optimization,Topic
1044,Risk-Averse Stochastic Convex Bandit,Paper
1045,Multi-Parameter Regression Model For Interval Censored Survival Data,Paper
1046,Energy Distance And Kernel Mean Embeddings For Two-Sample Survival Testing,Paper
1047,Subjective Bayesian Prior Distributions,Topic
1047,Equal Weight Aggregation,Topic
1047,Classical Method,Topic
1047,Sheffield Elicitation Framework,Topic
1047,Clinical Trial,Topic
1047,Cameron J. Williams,Author
1047,Kevin J. Wilson,Author
1047,Nina Wilson,Author
1047,A Comparison Of Prior Elicitation Aggregation Using The Classical Method And Shelf,Paper
1048,Corrupted Contextual Bandits,Topic
1048,Djallel Bouneffouf,Author
1049,Andersen-Gill Model,Topic
1049,Recurrent Events,Topic
1049,Wald Test,Topic
1049,Superiority Trials,Topic
1049,Noninferiority Trials,Topic
1049,Equivalence Trials,Topic
1049,Yongqiang Tang,Author
1049,Ronan Fitzpatrick,Author
1050,Ai Ethics In Smart Healthcare,Topic
1050,Sudeep Pasricha,Author
1051,Teaching Cycle Based On Bloom'S Learning For Mastery,Topic
1051,Stack Online Assessment System,Topic
1051,University Level Engineering Students,Topic
1051,Timo Pelkola,Author
1051,Antti Rasila,Author
1051,Christopher Sangwin,Author
1051,Blended Mastery Learning In Mathematics,Paper
1052,Identifying Mediating Variables With Graphical Models: An Application To The Study Of Causal Pathways In People Living With Hiv,Paper
1052,Adrian Dobra,Author
1052,Katherine Buhikire,Author
1052,Joachim G. Voss,Author
1052,Graphical Models,Topic
1052,Causal Pathways,Topic
1052,Hiv,Topic
1052,Mediation,Topic
1053,Novel Non-Parametric Method,Topic
1053,Sudipta Bhattacharya,Author
1053,Recurrent Events,Topic
1054,Chemistry42,Topic
1054,Insilico Medicine Pharma.Ai,Topic
1054,Yan A. Ivanenkov,Author
1054,Alex Zhebrak,Author
1054,Dmitry Bezrukov,Author
1054,Bogdan Zagribelnyy,Author
1054,Vladimir Aladinskiy,Author
1054,Daniil Polykovskiy,Author
1054,Evgeny Putin,Author
1054,Petrina Kamya,Author
1054,Alexander Aliper,Author
1054,Alex Zhavoronkov,Author
1055,What Clinical Trials Can Teach Us About The Development Of More Resilient Ai For Cybersecurity,Paper
1055,Edmon Begoli,Author
1055,Robert A. Bridges,Author
1055,Sean Oesch,Author
1055,Kathryn E. Knight,Author
1056,Ai-Based Medical Consultation System,Topic
1056,Knowledge Graph Embedding,Topic
1056,Reinforcement Learning,Topic
1056,Yining Huang,Author
1056,Meilian Chen,Author
1056,Keke Tang,Author
1056,Training Like Playing: A Reinforcement Learning And Knowledge Graph-Based Framework For Building Automatic Consultation System In Medical Field,Paper
1057,Data Integration In Causal Inference,Paper
1057,Xu Shi,Author
1057,Ziyang Pan,Author
1057,Wang Miao,Author
1057,Causal Inference Methods,Topic
1057,Data Integration,Topic
1057,Mendelian Randomization,Topic
1057,Bayesian Causal Inference,Topic
1057,Causal Discovery Methods,Topic
1058,The Role Of Pairwise Matching In Experimental Design For An Incidence Outcome,Paper
1059,Testing Homogeneity Of Proportion Ratios For Stratified Bilateral Correlated Data,Paper
1059,Bilateral Data,Topic
1059,Statistical Methods,Topic
1059,Control Variables,Topic
1059,Monte Carlo Simulations,Topic
1059,Type I Error,Topic
1059,Power,Topic
1060,Confidence Intervals For Ratios Of Proportions In Stratified Bilateral Correlated Data,Paper
1060,Wanqing Tian,Author
1060,Chang-Xing Ma,Author
1061,Randomized Play-The-Winner Model,Topic
1061,PÛlya Urn Process,Topic
1061,Sars-Cov-2,Topic
1061,Ivan Specht,Author
1061,Michael Mitzenmacher,Author
1062,Heterogeneous Treatment Effect (Hte),Topic
1062,Rulefit Method,Topic
1062,S-Learner,Topic
1062,Mayu Hiraishi,Author
1062,Ke Wan,Author
1062,Kensuke Tanioka,Author
1062,Hiroshi Yadohisa,Author
1062,Toshio Shimokawa,Author
1062,Causal Rule Ensemble Method,Paper
1063,Extracting Scalar Measures From Curves,Paper
1063,Lanqiu Yao,Author
1063,Thaddeus Tarpey,Author
1063,Functional Outcomes,Topic
1063,Average Rate Of Change,Topic
1063,Change Score,Topic
1063,Analysis Of Covariance,Topic
1063,Depression Clinical Trial,Topic
1064,Nli4Ct,Topic
1064,Mistral,Topic
1064,Dfki-Nlp,Author
1065,Fzi-Wim At Semeval-2024 Task 2,Paper
1065,Jin Liu,Author
1065,Steffen Thoma,Author
1065,Safe Biomedical Natural Language Inference For Clinical Trials,Topic
1065,Chain Of Thought (Cot),Topic
1065,Self-Consistency,Topic
1065,Majority Voting,Topic
1065,Baseline F1 Score,Topic
1065,Faithfulness Score,Topic
1065,Consistency Score,Topic
1066,Experimental Design For Causal Inference Through An Optimization Lens,Paper
1067,Categorical Data Analysis,Paper
1067,Dandan Chen,Author
1067,Carolyn Anderson,Author
1068,Generative Ai In Medicine,Topic
1068,Divya Shanmugam,Author
1068,Monica Agrawal,Author
1068,Rajiv Movva,Author
1068,Irene Y. Chen,Author
1068,Marzyeh Ghassemi,Author
1068,Maia Jacobs,Author
1068,Emma Pierson,Author
1069,Bhandari Et Al. (2009),Topic
1069,Sampurna Kundu,Author
1069,Jayant Jha,Author
1069,Subir Kumar Bhandari,Author
1069,Adaptive Sequential Procedure,Topic
1069,Two-Treatment Clinical Trials,Topic
1069,Less Effective Drug,Topic
1069,Expected Number Of Applications,Topic
1069,Discrepancy In Sample Size,Topic
1070,France,Topic
1070,National Plan For Open Science,Topic
1070,French Open Science Monitor,Topic
1070,Laetitia Bracco,Author
1070,Eric Jeangirard,Author
1070,Anne L'HÙte,Author
1070,Laurent Romary,Author
1071,A Bureaucratic Theory Of Statistics,Paper
1072,Dynamics Of Multi-Stable States During Ongoing And Evoked Cortical Activity,Paper
1072,Cortical Circuits Dynamics,Topic
1072,Metastability,Topic
1072,Sensory Coding,Topic
1072,Memory,Topic
1072,Decision-Making,Topic
1072,Gustatory Cortex,Topic
1072,Recurrent Spiking Network Model,Topic
1072,Neural Clusters,Topic
1072,External Stimuli,Topic
1073,Human Brain,Topic
1073,Cognitive Tasks,Topic
1073,Information Theory,Topic
1073,Electrocorticography (Ecog),Topic
1073,Õcaro Rodolfo Soares Coelho Da Paz,Author
1073,Pedro F. A. Silva,Author
1073,Helena Bordini De Lucas,Author
1073,SÈrgio H. A. Lira,Author
1073,Osvaldo A. Rosso,Author
1073,Fernanda Selingardi Matias,Author
1074,Nonlinear Mixed-Effect Models For Prostate-Specific Antigen Kinetics And Link With Survival In The Context Of Metastatic Prostate Cancer: A Comparison By Simulation Of Two-Stage And Joint Approaches,Paper
1074,SolÈne DesmÈe,Author
1074,France MentrÈ,Author
1074,Christine Veyrat-Follet,Author
1074,JÈrÈmie Guedj,Author
1074,Mcrpc,Topic
1074,Psa,Topic
1074,Joint Modelling,Topic
1074,Stochastic Approximation Expectation-Maximization Algorithm,Topic
1074,Clinical Trial,Topic
1075,Dynamic Path Analysis - A Useful Tool To Investigate Mediation Processes In Clinical Survival Trials,Paper
1075,Susanne Strohmaier,Author
1075,Kjetil R¯ysland,Author
1075,Rune Hoff,Author
1075,ÿrnulf Borgan,Author
1075,Terje Pedersen,Author
1075,Odd O. Aalen,Author
1075,Clinical Survival Trials,Topic
1075,Lipid Lowering Treatments,Topic
1075,Myocardial Infarctions,Topic
1076,Big Data,Topic
1076,Evidence-Based Medicine,Topic
1076,Meta-Analysis,Topic
1076,Sample Mean,Topic
1076,Standard Deviation,Topic
1076,Dehui Luo,Author
1076,Xiang Wan,Author
1076,Jiming Liu,Author
1076,Tiejun Tong,Author
1076,Optimal Estimation,Topic
1076,Clinical Trials,Topic
1076,Treatment Effectiveness,Topic
1076,Real Data Application,Topic
1077,Outcome Modeling Using Clinical Dvh Data,Paper
1077,Correlation And Regression Analysis,Topic
1077,Dose Volume Histogram (Dvh),Topic
1077,Local Injury Model,Topic
1077,Radiation-Induced Damage,Topic
1077,Functional Loss,Topic
1077,Risk,Topic
1077,Sigmoid Cumulative Distribution,Topic
1077,Bernoulli Function,Topic
1077,Homogeneous Patient Cohort,Topic
1077,Dvh Metrics,Topic
1077,Smoothness Regularization,Topic
1077,Integral Lung Damage,Topic
1077,Ventilation,Topic
1077,Perfusion,Topic
1077,Radiographic Damage,Topic
1078,Individual Treatment Effect Prediction For Als Patients,Paper
1078,Riluzole,Topic
1078,Amyotrophic Lateral Sclerosis,Topic
1078,Pro-Act Database,Topic
1079,Autosomal Polycystic Kidney Disease (Arpkd),Topic
1079,Jake A. Nieto,Author
1079,Michael A. Yamin,Author
1079,Itzhak D. Goldberg,Author
1079,Prakash Narayan,Author
1079,Empirical Biomarker-Based Calculator For Autosomal Recessive Polycystic Kidney Disease - The Nieto-Narayan Formula,Paper
1080,Devices And Sensors For Identification Of Fallers,Topic
1080,Timed Up And Go Test,Topic
1080,Accelerometer Data,Topic
1080,Community Dwelling Healthy Older Persons,Topic
1080,Moacir Ponti,Author
1080,Patricia Bet,Author
1080,Caroline Oliveira,Author
1080,Paula C. Castro,Author
1080,Auc Of 0.84,Topic
1080,Sensitivity=Specificity=0.83,Topic
1080,95% Ci 0.62-0.91,Topic
1080,Dual Tasks Tug,Topic
1080,Fallers,Topic
1080,Non-Fallers,Topic
1081,Optimal Exact Tests For Multiple Binary Endpoints,Paper
1081,Robin Ristl,Author
1081,Dong Xi,Author
1081,Ekkehard Glimm,Author
1081,Martin Posch,Author
1082,Immune Interventions,Topic
1082,Interleukine-7 (Il-7) Injections,Topic
1082,Hiv-Infected Patients,Topic
1082,Cd4+ T Lymphocytes,Topic
1082,ChloÈ Pasin,Author
1082,FranÁois Dufour,Author
1082,Laura Villain,Author
1082,Huilong Zhang,Author
1082,Rodolphe ThiÈbaut,Author
1083,Meta-Analytic Methods,Topic
1083,Normal-Normal Hierarchical Model (Nnhm),Topic
1083,Random-Effect,Topic
1083,Between-Study Heterogeneity,Topic
1083,Shrinkage Estimate,Topic
1083,Small-Scale Randomized Controlled Trial,Topic
1083,Non-Randomized Study,Topic
1083,Clinical Registry,Topic
1083,Rare Diseases,Topic
1083,Creutzfeld-Jakob Disease,Topic
1083,Bayesian Random-Effects Meta-Analysis,Topic
1083,Immunosuppression Following Liver Transplantation In Children,Topic
1083,Christian Rˆver,Author
1083,Tim Friede,Author
1084,Optimizing Adaptive Cancer Therapy: Dynamic Programming And Evolutionary Game Theory,Paper
1084,Adaptive Drug Therapy,Topic
1084,Standard Mtd-Based Policy,Topic
1084,Evolutionary Game Theory,Topic
1084,Dynamic Programming,Topic
1084,Hamilton-Jacobi-Bellman Equation,Topic
1084,Cancer Treatment,Topic
1085,Estimation Of Group Means In Generalized Linear Mixed Models,Paper
1085,Generalized Linear Models,Topic
1085,Generalized Linear Mixed Model (Glmm),Topic
1085,Healthcare Professionals,Topic
1086,Optimizing Graphical Procedures For Multiplicity Control In A Confirmatory Clinical Trial Via Deep Learning,Paper
1086,Tianyu Zhan,Author
1086,Alan H Hartford,Author
1086,Jian Kang,Author
1086,Walter W Offen,Author
1086,Phase Ii Study,Topic
1086,Phase Iii Study,Topic
1086,Deep Learning,Topic
1086,Fnns,Topic
1086,Stochastic Search Method,Topic
1086,Multiple Testing Procedure,Topic
1087,"Theory On Covariate-Adaptive Randomized Clinical Trials: Efficiency, Selection Bias And Randomization Methods",Paper
1087,Li-Xin Zhang,Author
1087,Covariate-Adaptive Randomized Clinical Trials,Topic
1087,Hypothesis Testing,Topic
1087,Selection Bias,Topic
1087,Power Of Hypothesis Testing,Topic
1087,Randomization Procedures,Topic
1088,Data Mining In Clinical Trial Text: Transformers For Classification And Question Answering Tasks,Paper
1088,Lena Schmidt,Author
1088,Julie Weeds,Author
1088,Julian P. T. Higgins,Author
1088,Natural Language Processing,Topic
1088,Pico Framework,Topic
1088,Transformers,Topic
1088,Data Extraction,Topic
1088,Systematic Review Automation,Topic
1088,Named Entity Recognition,Topic
1088,Transfer Learning,Topic
1088,Biomedical Literature,Topic
1089,Concorde Clinical Trial,Topic
1089,Zidovudine,Topic
1089,Alessandra Mattei,Author
1089,Peng Ding,Author
1089,Veronica Ballerini,Author
1089,Fabrizia Mealli,Author
1090,Testing For Treatment Effect In Covariate-Adaptive Randomized Clinical Trials With Generalized Linear Models And Omitted Covariates,Paper
1090,Li Yang,Author
1090,Wei Ma,Author
1090,Yichen Qin,Author
1090,Feifang Hu,Author
1091,Optical Character Recognition Software,Topic
1091,Data Extraction Method,Topic
1091,Macular Degeneration,Topic
1091,Bland-Altman Analysis,Topic
1091,Automated Data Extraction,Topic
1091,Manual Data Extraction,Topic
1091,Alex Carderas,Author
1091,Ye Yuan,Author
1091,Itamar Livnat,Author
1091,Ryan Yanagihara,Author
1091,Rosita Saul,Author
1091,Gabrielle Montes De Oca,Author
1091,Kai Zheng,Author
1091,Andrew W. Browne,Author
1092,Sars-Cov-2,Topic
1092,Covid-19,Topic
1092,Monoclonal Antibody Therapies,Topic
1092,U.S. Fda,Author
1092,Regeneron,Author
1092,Eli Elly,Author
1092,Topological Ai-Designed Mabs,Topic
1092,Jiahui Chen,Author
1092,Guo-Wei Wei,Author
1093,Improving Safety Of The Continual Reassessment Method Via A Modified Allocation Rule,Paper
1093,Pavel Mozgunov,Author
1093,Thomas Jaki,Author
1094,Surrogate Endpoints,Topic
1094,Regulatory Decision-Making,Topic
1094,Healthcare,Topic
1094,Bivariate Meta-Analysis Methods,Topic
1094,Treatment Effect,Topic
1094,Final Outcome,Topic
1094,Bivariate Network Meta-Analysis (Bvnma),Topic
1094,Advanced Colorectal Cancer,Topic
1094,Sylwia Bujkiewicz,Author
1094,Dan Jackson,Author
1094,John R Thompson,Author
1094,Rebecca Turner,Author
1094,Keith R Abrams,Author
1094,Ian R White,Author
1095,Empirical Likelihood Weighted Estimation Of Average Treatment Effects,Paper
1095,Yuanyao Tan,Author
1095,Xialing Wen,Author
1095,Wei Liang,Author
1095,Ying Yan,Author
1095,Average Treatment Effect,Topic
1095,Empirical Likelihood Method,Topic
1095,Constrained Empirical Likelihood Estimation,Topic
1095,Aids Clinical Trials Group Protocol 175,Topic
1096,Scale Transformed Power Prior,Topic
1096,Historical Data,Topic
1096,Current Data,Topic
1096,Binary Data,Topic
1096,Continuous Data,Topic
1096,Clinical Trials,Topic
1096,Power Prior,Topic
1096,Fisher Information Matrices,Topic
1096,Brady Nifong,Author
1096,Matthew A. Psioda,Author
1096,Joseph G. Ibrahim,Author
1096,Real Dataset,Topic
1096,Transitional Care Model For Stroke Survivors,Topic
1096,Simulation Studies,Topic
1096,Performance Advantages,Topic
1097,Covid-19 Therapeutics Trials,Topic
1097,Ordinal Categorical Variable,Topic
1097,Odds Ratio,Topic
1097,Proportional Odds Model,Topic
1097,Censored Outcome,Topic
1097,Interim Analysis,Topic
1097,Anastasios A. Tsiatis,Author
1097,Marie Davidian,Author
1097,Shannon T. Holloway,Author
1097,Covariate-Adjusted Estimator,Topic
1097,Randomized Clinical Trial,Topic
1098,Multi-Criteria Decision Analysis (Mcda),Topic
1098,Drug Benefit-Risk Assessment (Bra),Topic
1098,Utility Score Function,Topic
1098,Linear Utility Score,Topic
1098,Product Model,Topic
1098,Multi-Linear Model,Topic
1098,Scale Loss Score Model,Topic
1098,Tom Menzies,Author
1098,Gaelle Saint-Hilary,Author
1098,Pavel Mozgunov,Author
1098,A Comparison Of Various Aggregation Functions In Multi-Criteria Decision Analysis For Drug Benefit-Risk Assessment,Paper
1099,Phase I-Ii Cancer Clinical Trial Designs,Topic
1099,Drug Development,Topic
1099,Maximum Tolerated Dose (Mtd),Topic
1099,Two-Stage Design,Topic
1099,Cytotoxic Agents,Topic
1099,Single Patient Population,Topic
1099,Conditional Escalation With Overdose Control (Ewoc),Topic
1099,Adaptive Randomization Approach,Topic
1099,JosÈ L. JimÈnez,Author
1099,Mourad Tighiouart,Author
1100,Chemotherapy,Topic
1100,Combination Chemotherapy Optimization With Discrete Dosing,Paper
1101,Explainable Artificial Intelligence (Xai),Topic
1101,Deep Learning,Topic
1101,Autism Spectrum Disorder (Asd),Topic
1101,Convolutional Neural Network (Cnn),Topic
1101,Electroencephalography (Eeg),Topic
1101,Remove-And-Retrain (Roar) Methodology,Topic
1101,Layer-Wise Relevance Propagation (Lrp),Topic
1101,Patternnet,Topic
1101,Pattern-Attribution,Topic
1101,Smooth-Grad Squared,Topic
1101,Juan Manuel Mayor-Torres,Author
1101,Sara Medina-Devilliers,Author
1101,Tessa Clarkson,Author
1101,Matthew D. Lerner,Author
1101,Giuseppe Riccardi,Author
1102,Bayesian Semi-Parametric Inference For Clustered Recurrent Events With Zero-Inflation And A Terminal Event,Paper
1103,Cox Proportional Hazards Model,Topic
1103,Change-Points,Topic
1103,Aic-Type Information Criteria,Topic
1103,Ryoto Ozaki,Author
1103,Yoshiyuki Ninomiya,Author
1104,Clinical Trials,Topic
1104,Wald Statistics,Topic
1104,Anovas,Topic
1104,Manovas,Topic
1104,Multiple Comparison Tests,Topic
1104,Multivariate Covariance Generalized Linear Models (Mcglms),Topic
1104,R Language,Topic
1104,Probiotics,Topic
1104,Addiction And Binge Eating Disorder,Topic
1104,Lineu Alberto Cavazani De Freitas,Author
1104,Ligia De Oliveira Carlos,Author
1104,AntÙnio Carlos Ligocki Campos,Author
1104,Wagner Hugo Bonat,Author
1105,Drug Effects On Chronic Diseases,Topic
1105,Randomized Clinical Trials,Topic
1105,Kidney Disease Study,Topic
1105,Average Treatment Effects,Topic
1105,Semiparametric Efficiency Bound,Topic
1105,Doubly Robust Estimator,Topic
1105,Inverse Probability Weighted Estimator,Topic
1105,Oral Hydroxychloroquine,Topic
1105,Renal Failure,Topic
1105,Wenjie Hu,Author
1105,Xiaohua Zhou,Author
1105,Peng Wu,Author
1106,Modeling Symptom Progression To Identify Informative Subjects For A New Huntington'S Disease Clinical Trial,Topic
1106,Huntington'S Disease,Topic
1106,Sarah C. Lotspeich,Author
1106,Tanya P. Garcia,Author
1106,Hybrid Approach,Topic
1106,Semiparametric Survival Estimator,Topic
1106,Parametric Extension,Topic
1106,Extrapolation Then Imputation,Topic
1106,Censored Covariates,Topic
1106,Conditional Means,Topic
1106,Survival Function,Topic
1106,Cox Model,Topic
1106,Breslow'S Estimator,Topic
1106,Simulation Studies,Topic
1106,Clinical Trials,Topic
1107,Restricted Mean Survival Time (Rmst),Topic
1107,Satoshi Hattori,Author
1107,Hajime Uno,Author
1107,Sample Size Determination For Restricted Mean Survival Time-Based Tests In Randomized Clinical Trials,Paper
1108,Causal Inference Under Data Restrictions,Paper
1108,Neoadjuvant Clinical Trials,Topic
1108,Distributed Data Networks,Topic
1108,Robust Individualized Decision Making,Topic
1108,Principal Stratification Framework,Topic
1108,Censored Outcome Data,Topic
1108,Tree-Based Model Averaging,Topic
1108,Conditional Average Treatment Effects,Topic
1108,Oxygen Therapy,Topic
1108,Hospital Survival Rates,Topic
1108,Robust Individualized Decision Learning Framework,Topic
1108,Sensitive Variables,Topic
1108,Quantile-Optimal Decision Rule,Topic
1108,Conditional Fairness,Topic
1108,Synthetic Experiments,Topic
1108,Real-Data Applications,Topic
1109,Accelerated Failure Time (Aft) Models,Topic
1109,Survival Data,Topic
1109,Randomised Clinical Trial Dataset,Topic
1109,Semiparametric Aft Model,Topic
1109,Gaussian Basis Functions,Topic
1109,Maximum Penalised Likelihood Approach,Topic
1109,Advanced Melanoma,Topic
1109,Aishwarya Bhaskaran,Author
1109,Ding Ma,Author
1109,Benoit Liquet,Author
1109,Angela Hong,Author
1109,Stephane Heritier,Author
1109,Serigne N Lo,Author
1109,Jun Ma,Author
1110,Autism Spectrum Disorder,Topic
1110,Caroline Gora,Author
1110,Ana Dudas,Author
1110,OcÈane Vaugrente,Author
1110,Lucile Drobecq,Author
1110,Emmanuel Pecnard,Author
1110,GaÎlle Lefort,Author
1110,Lucie P. Pellissier,Author
1110,Egr1,Topic
1110,Foxp1,Topic
1110,Homer1A,Topic
1110,Oxt,Topic
1110,Oxtr,Topic
1110,Asd Mouse Models,Topic
1110,Social Circuit,Topic
1110,Molecular Markers,Topic
1110,Clinical Trials,Topic
1110,Personalized Medicine,Topic
1111,Non-Linear Mixed Effects Modeling And Simulation (Nlme M&S),Topic
1111,Standardization,Topic
1111,Causal Inference,Topic
1111,Pharmacometrics,Topic
1111,Causal Prediction,Topic
1111,Christian Bartels,Author
1111,Martina Scauda,Author
1111,Neva Coello,Author
1111,Thomas Dumortier,Author
1111,Bjoern Bornkamp,Author
1111,Giusi Moffa,Author
1112,Randomized Play-The-Winner Rule,Topic
1112,Elephant Random Walk,Topic
1112,Recursive Stochastic Algorithm,Topic
1112,Gaussian Approximation,Topic
1112,Li-Xin Zhang,Author
1113,Bayesian Generalized Method Of Moments Applied To Pseudo-Observations In Survival Analysis,Paper
1113,Bayesian Approach,Topic
1113,Generalized Methods Of Moments (Gmm),Topic
1113,Pseudo-Observations,Topic
1113,Cox Model,Topic
1113,Generalized Estimating Equation (Gee),Topic
1113,Bayesian Piecewise Exponential Models,Topic
1113,Ewing Sarcoma,Topic
1114,Semiparametric Piecewise Accelerated Failure Time Model For The Analysis Of Immune-Oncology Clinical Trials,Paper
1114,Immune-Oncology Chemotherapies,Topic
1114,Clinical Trials,Topic
1114,Hazard Ratio,Topic
1114,Restricted Mean Survival Time,Topic
1114,Lag-Time,Topic
1115,Identifying Treatment Response Subgroups In Observational Time-To-Event Data,Paper
1116,Stratification In Randomised Clinical Trials And Analysis Of Covariance: Some Simple Theory And Recommendations,Paper
1116,Continuous Covariate,Topic
1116,Treatment Effect,Topic
1116,Variance Inflation Factor,Topic
1116,Mean Square Error Effect,Topic
1116,Second Order Precision,Topic
1117,Radiation Therapy,Topic
1117,Cervical Cancer,Topic
1117,Aranet,Paper
1117,Lu Wen,Author
1117,Wenxia Yin,Author
1117,Zhenghao Feng,Author
1117,Xi Wu,Author
1117,Deng Xiong,Author
1117,Yan Wang,Author
1118,Nonparametric Inference Methods,Topic
1118,Survival Data,Topic
1118,Cancer Therapies,Topic
1118,Mixture Cure Framework,Topic
1118,Kaplan-Meier Estimator,Topic
1118,Checkmate 067,Paper
1118,Yi-Cheng Tai,Author
1118,Weijing Wang,Author
1118,Martin T. Wells,Author
1119,Marker-Based Optical Motion Capture (Omc),Topic
1119,Markerless Motion Capture (Mmc),Topic
1119,Biomechanical Modeling,Topic
1119,Stroke Patients,Topic
1119,Drinking Task,Topic
1119,Tim Unger,Author
1119,Arash Sal Moslehian,Author
1119,J. D. Peiffer,Author
1119,Johann Ullrich,Author
1119,Roger Gassert,Author
1119,Olivier Lambercy,Author
1119,R. James Cotton,Author
1119,Chris Awai Easthope,Author
1120,Computer Assisted Technologies Based On Algorithmic Software Segmentation,Topic
1120,Growcut (Gc),Topic
1120,J¸rgen Wallner,Author
1120,Kerstin Hochegger,Author
1120,Xiaojun Chen,Author
1120,Irene Mischak,Author
1120,Knut Reinbacher,Author
1120,Mauro Pau,Author
1120,Tomislav Zrnc,Author
1120,Katja Schwenzer-Zimmerer,Author
1120,Wolfgang Zemann,Author
1120,Dieter Schmalstieg,Author
1120,Jan Egger,Author
1120,Ct Lower Jaw Data-Sets,Topic
1120,Mandibular Bone,Topic
1120,Clinical Practice,Topic
1120,Surgical Treatment Planning,Topic
1120,Postoperative Results,Topic
1120,Segmentation Time,Topic
1120,Volume,Topic
1120,Voxel Number,Topic
1120,Dice Score (Dsc),Topic
1120,Hausdorff Distance (Hd),Topic
1120,Statistical Differences,Topic
1120,Correlation Coefficients,Topic
1120,Functional Stable,Topic
1120,Time Saving Segmentations,Topic
1120,High Accuracy,Topic
1120,High Positive Correlation,Topic
1120,Algorithmic Alternative,Topic
1120,Image-Based Segmentation,Topic
1120,Systematic Comparisons,Topic
1120,Future Works,Topic
1121,Oropharyngeal Squamous Cell Carcinoma,Topic
1121,Probabilistic Model For Ipsilateral Lymphatic Spread,Topic
1121,Hidden Markov Model,Topic
1121,Opscc Patients,Topic
1121,Roman Ludwig,Author
1121,Adrian Schubert,Author
1121,Dorothea Barbatei,Author
1121,Lauence Bauwens,Author
1121,Jean-Marc Hoffmann,Author
1121,Sandrine Werlen,Author
1121,Olgun Elicin,Author
1121,Matthias Dettmer,Author
1121,Philippe Zrounba,Author
1121,Bertrand Pouymayou,Author
1121,Panagiotis Balermpas,Author
1121,Vincent GrÈgoire,Author
1121,Roland Giger,Author
1121,Jan Unkelbach,Author
1122,Current Clinical Decision Support Systems,Topic
1122,Observational Data,Topic
1122,Randomized Clinical Trial,Topic
1122,Rct Data,Topic
1122,Multi-Armed Rct,Topic
1122,Tinnitus Patients,Topic
1122,Treatment,Topic
1122,Vishnu Unnikrishnan,Author
1122,Clara Puga,Author
1122,Miro Schleicher,Author
1122,Uli Niemann,Author
1122,Berthod Langguth,Author
1122,Stefan Schoisswohl,Author
1122,Birgit Mazurek,Author
1122,Rilana Cima,Author
1122,Jose Antonio Lopez-Escamez,Author
1122,Dimitris Kikidis,Author
1122,Eleftheria Vellidou,Author
1122,Ruediger Pryss,Author
1122,Winfried Schlee,Author
1122,Myra Spiliopoulou,Author
1123,Personalized Treatment Evaluator,Topic
1123,Personalized Medicine,Topic
1123,Adam Kapelner,Author
1123,Justin Bleich,Author
1123,Alina Levine,Author
1123,Zachary D. Cohen,Author
1123,Robert J. Derubeis,Author
1123,Richard Berk,Author
1124,Causal Mediation Analysis,Topic
1124,Ordinary Least Squares (Ols),Topic
1124,Instrumental Variables (Iv),Topic
1124,Two-Stage Least Squares (Tsls),Topic
1124,Semi-Parametric Stein-Like (Spsl) Estimator,Topic
1124,Randomized Controlled Trials,Topic
1124,Simulation Study,Topic
1124,Mental Health Trial,Topic
1124,Cedric E. Ginestet,Author
1124,Richard Emsley,Author
1124,Sabine Landau,Author
1125,Health Economic Evaluations,Topic
1125,Patient-Level Data,Topic
1125,Clinical Trials,Topic
1125,Resource Allocation Decisions,Topic
1125,Missing Data,Topic
1125,Qalys,Topic
1125,Joint Longitudinal Models,Topic
1125,Cost-Effectiveness Analysis,Topic
1125,Andrea Gabrio,Author
1125,Rachael Hunter,Author
1125,Alexina J. Mason,Author
1125,Gianluca Baio,Author
1126,Proportional Hazards,Topic
1126,Confirmatory Clinical Trials,Topic
1126,Oncology,Topic
1126,Hazard Ratio,Topic
1126,Weighted Log-Rank Test,Topic
1126,Fleming And Harrington Class Of Weights,Topic
1126,Sample Size Calculation,Topic
1126,Power,Topic
1126,Type-I Error Rate,Topic
1126,Jose L Jimenez,Author
1126,Viktoriya Stalbovskaya,Author
1126,Byron Jones,Author
1127,Randomized Controlled Trials,Topic
1127,Knowledge Gradient For Randomized Controlled Trials,Topic
1127,Onur Atan,Author
1127,William R. Zame,Author
1127,Mihaela Van Der Schaar,Author
1128,Conditional Power Calculations,Topic
1128,Interim Decision Procedure,Topic
1128,Treatment Effect Estimation,Topic
1128,Prediction Models,Topic
1128,Efficiency Gain,Topic
1128,Adaptive Designs,Topic
1128,Monte Carlo Simulations,Topic
1128,Kelly Van Lancker,Author
1128,An Vandebosch,Author
1128,Stijn Vansteelandt,Author
1129,"Sample Size Estimation Using A Latent Variable Model For Mixed Outcome Co-Primary, Multiple Primary And Composite Endpoints",Paper
1129,Martina Mcmenamin,Author
1129,Jessica K. Barrett,Author
1129,Anna Berglind,Author
1129,James M. S. Wason,Author
1129,Mixed Outcome Endpoints,Topic
1129,Latent Variable Model,Topic
1129,Sample Size Estimation,Topic
1129,Muse Trial,Topic
1130,Cvrs,Topic
1130,Cvrs2,Topic
1130,Svetlana Cherlin,Author
1130,James M. S. Wason,Author
1130,Psychiatry Trial,Topic
1130,Psychology Clinical Trial,Topic
1131,Bayesian Sample Size Calculations For Smart Studies,Paper
1131,Armando Turchetta,Author
1131,Erica E. M. Moodie,Author
1131,David A. Stephens,Author
1131,Sylvie D. Lambert,Author
1131,Adaptive Treatment Strategies,Topic
1131,Sequential Multiple Assignment Randomized Trials,Topic
1131,Bayesian Framework,Topic
1132,A Review Of Available Software For Adaptive Clinical Trial Design,Paper
1132,Adaptive Designs,Topic
1132,Drug Development,Topic
1133,Use Of Historical Data In Clinical Trial Design And Analysis,Topic
1133,Meta-Analytic-Predictive (Map) Approach,Topic
1133,Rbest (R Bayesian Evidence Synthesis Tools),Paper
1134,Tuberculosis,Topic
1134,Strituvad,Topic
1134,Ruti,Topic
1134,Id93/Gla-Se,Topic
1134,Giulia Russo,Author
1134,Francesco Pappalardo,Author
1134,Miguel A. Juarez,Author
1134,Marzio Pennisi,Author
1134,Pere Joan Cardona,Author
1134,Rhea Coler,Author
1134,Epifanio Fichera,Author
1134,Marco Viceconti,Author
1135,Non-Proportional Hazards,Topic
1135,Weighted Log-Rank Tests,Topic
1135,Maxcombo Test,Topic
1135,Interim Analyses,Topic
1135,Simulation-Free Approach,Topic
1135,Lili Wang,Author
1135,Xiaodong Luo,Author
1135,Cheng Zheng,Author
1135,A Simulation-Free Group Sequential Design With Max-Combo Tests In The Presence Of Non-Proportional Hazards,Paper
1136,Statistical Methodology,Topic
1136,Fda,Topic
1136,Ema,Topic
1136,Two-Trials Rule,Topic
1136,Harmonic Mean Of The Squared Study-Specific Test Statistics,Topic
1136,Null Distribution,Topic
1136,P-Values,Topic
1136,Confidence Intervals,Topic
1136,Overall Treatment Effect,Topic
1136,Carvedilol,Topic
1136,Leonhard Held,Author
1136,Clinical Trials,Topic
1136,Moderate To Severe Heart Failure,Topic
1137,Network Meta-Analysis,Topic
1137,Individual Patient Data,Topic
1137,Penalized Poisson Regression Model,Topic
1137,Edouard Ollier,Author
1137,Pierre Blanchard,Author
1137,GwÈnaÎl Le Teuff,Author
1137,Stefan Michiels,Author
1137,Nasopharyngeal Carcinoma,Topic
1137,Overall Survival,Topic
1137,Chemotherapy,Topic
1137,Radiotherapy,Topic
1138,Cluster Randomized Trials,Topic
1138,Two-Stage Targeted Minimum Loss-Based Estimator,Topic
1138,Search Community Randomized Trial,Topic
1138,Laura B. Balzer,Author
1138,Mark Van Der Laan,Author
1138,James Ayieko,Author
1138,Moses Kamya,Author
1138,Gabriel Chamie,Author
1138,Joshua Schwab,Author
1138,Diane V. Havlir,Author
1138,Maya L. Petersen,Author
1139,"Optimizing Precision And Power By Machine Learning In Randomized Trials, With An Application To Covid-19",Paper
1139,Nicholas Williams,Author
1139,Michael Rosenblum,Author
1139,Iv·n DÌaz,Author
1139,Covid-19 Trials,Topic
1139,Weill Cornell Medicine New York Presbyterian Hospital,Topic
1139,L1-Regularization,Topic
1139,Random Forests,Topic
1139,Xgboost,Topic
1139,Multivariate Adaptive Regression Splines,Topic
1139,Covariate Adjustment,Topic
1139,Asymptotic Normality,Topic
1139,Asymptotic Variance,Topic
1139,Longitudinal Data,Topic
1139,Type 1 Error,Topic
1139,Adjrct,Topic
1140,Parkinson'S Disease,Topic
1140,Mds-Unified Parkinson'S Disease Rating Scale,Topic
1140,Alessandro Noci,Author
1140,Marcel Wolbers,Author
1140,Markus Abt,Author
1140,Corine Baayen,Author
1140,Hans Ulrich Burger,Author
1140,Man Jin,Author
1140,Weining Zhao Robieson,Author
1140,A Comparison Of Estimand And Estimation Strategies For Clinical Trials In Early Parkinson'S Disease,Paper
1141,Smart,Topic
1141,Q-Learning,Topic
1141,Covid-19 Prophylaxis And Treatment Smart,Paper
1142,"Comparisons Of Treatments, Interventions, Or Exposures",Topic
1142,Epidemiology,Topic
1142,Triple Antiretroviral Therapy,Topic
1142,Mono Antiretroviral Therapy,Topic
1142,Aids Clinical Trial Group (Actg) 175,Paper
1142,Aids Clinical Trial Group (Actg) 320,Paper
1142,Risk Difference,Topic
1142,Inverse Probability Weighting Estimator,Topic
1142,Shared Trial Arms,Topic
1142,Fusion Diagnostic,Topic
1142,Paul N Zivich,Author
1142,Stephen R Cole,Author
1142,Jessie K Edwards,Author
1142,Bonnie E Shook-Sa,Author
1142,Alexander Breskin,Author
1142,Michael G Hudgens,Author
1143,Analysis Of Two Binomial Proportions In Non-Inferiority Confirmatory Trials,Paper
1143,Hassan Lakkis,Author
1143,Andrew Lakkis,Author
1143,Exact Likelihood Score Test,Topic
1143,Non-Inferiority Comparison,Topic
1144,Bayesian Design And Analysis Of Two-Arm Cluster Randomised Trials Using Assurance,Paper
1144,Two-Arm Superiority Cluster Randomised Controlled Trial,Topic
1144,Bayesian Inference,Topic
1144,Linear Mixed-Effects Model,Topic
1144,Treatment Effect,Topic
1144,Sample Size,Topic
1144,Monte Carlo Sampling Scheme,Topic
1144,Prior Distribution,Topic
1144,Post-Stroke Incontinence,Topic
1144,Wald Test,Topic
1144,Parameter Mis-Specification,Topic
1144,Clinically Important Difference,Topic
1145,A Flexible Multi-Metric Bayesian Framework For Decision-Making In Phase Ii Multi-Arm Multi-Stage Studies,Paper
1145,Suzanne M. Dufault,Author
1145,Angela M. Crook,Author
1145,Katie Rolfe,Author
1145,Patrick P. J. Phillips,Author
1145,Multi-Arm Multi-Stage Phase Ii Clinical Trials,Topic
1145,Bayesian Framework,Topic
1145,Target Product Profile,Topic
1145,Novel Tb Arms,Topic
1145,Intermediate Outcomes,Topic
1145,Primary Outcome,Topic
1145,Drug Development,Topic
1146,"Jointly Extracting Interventions, Outcomes, And Findings From Rct Reports With Llms",Paper
1147,Causal Effect Of Chemotherapy Received Dose Intensity On Survival Outcome: A Retrospective Study In Osteosarcoma,Paper
1147,Marta Spreafico,Author
1147,Francesca Ieva,Author
1147,Marta Fiocco,Author
1147,Osteosarcoma,Topic
1148,Causal Inference Under Transportability Assumptions For Conditional Relative Effect Measures,Paper
1148,Transportability Condition,Topic
1148,Conditional Difference Effect Measures,Topic
1148,Marginal Causal Mean Difference,Topic
1148,Conditional Relative Effect Measures,Topic
1148,Marginal Counterfactual Mean Difference,Topic
1148,Marginal Counterfactual Ratio,Topic
1148,Simulation Studies,Topic
1148,Paliperidone,Topic
1148,Schizophrenia,Topic
1149,Instrumental Variables,Topic
1149,Switcher Average Treatment Effect,Topic
1149,"Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial",Paper
1149,Rui Wang,Author
1149,Ying-Qi Zhao,Author
1149,Oliver Dukes,Author
1149,Bo Zhang,Author
1150,Precision Medicine,Topic
1150,Bayesian Adaptive Enrichment Design,Topic
1150,Lara Maleyeff,Author
1150,Shirin Golchi,Author
1150,Erica E. M. Moodie,Author
1150,Marie Hudson,Author
1151,Single-Arm Clinical Trials,Topic
1151,Average Treatment Effect On The Treated (Att),Topic
1151,Average Treatment Effect (Ate),Topic
1151,Regression Model,Topic
1151,Propensity Score Matching,Topic
1151,Mahalanobis Distance Matching,Topic
1151,Coarsened Exact Matching,Topic
1151,Inverse Probability Weighting,Topic
1151,Augmented Inverse Probability Weighting (Aipw),Topic
1151,Aipw With Superlearner,Topic
1151,Targeted Maximum Likelihood Estimator (Tmle) With Superlearner,Topic
1151,Huan Wang,Author
1151,Fei Wu,Author
1151,Yeh-Fong Chen,Author
1152,Dose Selection,Topic
1152,Pharmaceutical Drug Development,Topic
1152,Therapeutic Efficacy,Topic
1152,Patient Safety,Topic
1152,Generalized Multiple Comparison Procedures And Modeling (Mcp-Mod),Topic
1152,Phase Ii Trials,Topic
1152,Dose-Response Relationships,Topic
1152,Penalized Maximum Likelihood Estimation (Mle),Topic
1152,Randomization-Based Inference,Topic
1152,Logistic Regression,Topic
1152,Type-I Error Rates,Topic
1152,Residual-Based Randomization Tests,Topic
1152,Lukas Pin,Author
1152,Oleksandr Sverdlov,Author
1152,Frank Bretz,Author
1152,Bjˆrn Bornkamp,Author
1153,Cluster Or Group Randomized Trials (Crts),Topic
1153,Hiv Prevention Crt,Topic
1153,Shubhadeep Chakraborty,Author
1153,Bo Wang,Author
1153,Ram Tiwari,Author
1153,Samiran Ghosh,Author
1154,Machine Learning,Topic
1154,Medical Research,Topic
1154,Diagnostic Accuracy,Topic
1154,Personalized Treatments,Topic
1154,General Ml Model,Topic
1154,Subject-Specific Models,Topic
1154,Random Forest (Rf) Model,Topic
1154,Gideon Vos,Author
1154,Liza Van Eijk,Author
1154,Zoltan Sarnyai,Author
1154,Mostafa Rahimi Azghadi,Author
1154,Novel Validation Approach,Topic
1154,Feature Importance,Topic
1154,Clinical Research,Topic
1155,Sequential Tests And Estimates After Overrunning Based On P-Value Combination,Paper
1155,Brownian Motion With Drift,Topic
1155,Adding Weighted Zs Method,Topic
1155,Sequential Clinical Trials,Topic
1156,Familiar Statistical Tests And Estimates,Topic
1156,Clinical Trial Of A New Drug,Topic
1156,New Scientific Devices Such As Microarrays,Topic
1156,Empirical Bayes Methodology,Topic
1156,Bradley Efron,Author
1156,The Future Of Indirect Evidence,Paper
1157,Cara Design,Topic
1157,Treatment Effect,Topic
1157,Yuan-Chin Ivan Chang,Author
1157,Eunsik Park,Author
1158,Multistage Decision Problem,Topic
1158,Censored Data,Topic
1158,Q-Learning Algorithm,Topic
1158,Yair Goldberg,Author
1158,Michael R. Kosorok,Author
1158,Personalized Medicine Trials,Topic
1158,Cancer,Topic
1158,Life-Threatening Diseases,Topic
1158,Finite Sample Bounds,Topic
1158,Optimal Q-Function,Topic
1158,Expected Survival Time,Topic
1158,Individualized Treatment Regimens,Topic
1158,Multistage Clinical Trial,Topic
1159,Testing For Efficacy In Single-Subject Trials With Intervention Analysis,Paper
1159,A. Savenkov,Author
1159,S. Wu,Author
1159,D. Neal,Author
1159,Intervention Analysis Model,Topic
1159,Single-Subject Data,Topic
1159,Type I Error,Topic
1159,Constraint Induced Language Therapy,Topic
1159,Aphasia Patients,Topic
1160,Conventional Approaches To Statistical Inference,Topic
1160,Perfusion Computed Tomography,Topic
1160,Functional Imaging Biomarkers,Topic
1160,Cancerous Regions Of The Liver,Topic
1160,Noncancerous Regions,Topic
1160,Hierarchical Model Structure,Topic
1160,Penalized Splines,Topic
1160,Nonparametric Regression,Topic
1160,Liver Cancer Data,Topic
1160,Semiparametric Hazard Model,Topic
1160,Clinical Trial,Topic
1160,Colorectal Cancer Treatments,Topic
1160,Previous Trial,Topic
1160,Generalized Mixture Commensurate Priors,Topic
1160,Thomas A. Murray,Author
1160,Brian P. Hobbs,Author
1160,Bradley P. Carlin,Author
1161,Mmrm,Topic
1161,Pmm,Topic
1161,Sas Proc Mi,Topic
1161,Yongqiang Tang,Author
1161,Antidepressant Trial,Topic
1161,Missing Data Imputation Algorithm,Topic
1161,Multiple Imputation Algorithm,Topic
1162,Function Driven Diffusion For Personalized Counterfactual Inference,Paper
1162,High Dimensional Data,Topic
1162,Counterfactual Functions,Topic
1162,Individualized Treatment Effectiveness,Topic
1162,Diffusion Metric,Topic
1162,Localized Filtration,Topic
1162,Drug Trials,Topic
1162,Synthetic And Real World Clinical Trials,Topic
1162,Individualized Notions Of Benefit From Treatment,Topic
1163,Causal Modelling Framework For Reference-Based Imputation And Tipping Point Analysis,Paper
1164,Instrument-Armed Bandits,Topic
1164,Nathan Kallus,Author
1164,Multi-Armed Bandit Model,Topic
1164,Noncompliance,Topic
1164,Instrument-Armed Bandit Problem,Topic
1164,Regret,Topic
1164,Dynamic Clinical Trials,Topic
1164,Controlled Trials,Topic
1164,New Algorithms For The Iab Problem,Topic
1164,Regret Bounds,Topic
1164,Standard Mab Algorithms,Topic
1165,Stanford Health Care,Topic
1165,Electronic Medical Records,Topic
1165,Personalized Treatment Recommendations,Topic
1165,Treatment Effect Estimation Methods,Topic
1165,The Sprint Data Analysis Challenge,Topic
1165,Scott Powers,Author
1165,Junyang Qian,Author
1165,Kenneth Jung,Author
1165,Alejandro Schuler,Author
1165,Nigam H. Shah,Author
1165,Trevor Hastie,Author
1165,Robert Tibshirani,Author
1166,Diagnosing Glaucoma Progression With Visual Field Data Using A Spatiotemporal Boundary Detection Method,Paper
1166,Samuel I. Berchuck,Author
1166,Jean-Claude Mwanza,Author
1166,Joshua L. Warren,Author
1166,Vein Pulsation Study Trial In Glaucoma,Topic
1166,Lions Eye Institute Trial Registry,Topic
1166,Womblr,Topic
1167,Joint Distribution Of Progression-Free And Overall Survival,Topic
1167,Matthias Meller,Author
1167,Jan Beyersmann,Author
1167,Kaspar Rufibach,Author
1167,Pearson'S Correlation Coefficient,Topic
1167,Progression-Free Survival,Topic
1167,Overall Survival,Topic
1167,Breast Cancer Clinical Trial,Topic
1168,Partial Effectiveness Of Drugs,Topic
1168,Pharmaceutical Industry,Topic
1168,Randomized Controlled Trials,Topic
1168,Subgroup Sensitive To Treatment,Topic
1168,Model Of Treatment Response,Topic
1168,Placebo Responders,Topic
1168,Drug Responders,Topic
1168,Treatment-Specific Effect,Topic
1168,Prevalence Of Drug Responders,Topic
1168,One-Stage Rct Designs,Topic
1168,Two-Stage Rct Designs,Topic
1168,Multicenter Rcts,Topic
1168,Hochberg'S Step-Up Procedure,Topic
1168,Numerical Optimization Methods,Topic
1168,Adaptive Multicenter Designs,Topic
1168,Daria Rukina,Author
1169,Estimating Malaria Vaccine Efficacy In The Absence Of A Gold Standard Case Definition: Mendelian Factorial Design,Paper
1169,Raiden B. Hasegawa,Author
1169,Dylan S. Small,Author
1170,Treatment Effect Heterogeneity,Topic
1170,Prognostic Score Matching,Topic
1170,Conditional Inference Trees,Topic
1170,Randomized Binary Treatment,Topic
1170,Type I Error Rate,Topic
1170,Clinical Trials,Topic
1170,Tehtrees,Topic
1170,Nutrition Trial Dataset,Topic
1170,Ashwini Venkatasubramaniam,Author
1170,Brandon Koch,Author
1170,Lauren Erickson,Author
1170,Simone French,Author
1170,David Vock,Author
1170,Julian Wolfson,Author
1171,Composite Hypothesis Testing,Topic
1171,Uniformly Most Powerful (Ump) Unbiased Test,Topic
1171,Covid-19 Pandemic,Topic
1171,Adaptive Clinical Trials,Topic
1171,Machine Learning Methods,Topic
1171,Deep Neural Networks (Dnn),Topic
1171,Tianyu Zhan,Author
1171,Jian Kang,Author
1171,Finite-Sample Two-Group Composite Hypothesis Testing Via Machine Learning,Paper
1172,Randomized Clinical Trials,Topic
1172,Causal Effects,Topic
1172,Adverse Effects,Topic
1172,Interventions,Topic
1172,Observational Studies,Topic
1172,Generalized Propensity Scores,Topic
1172,Treatment Effects,Topic
1172,Approximate Bayesian Bootstrap Algorithm,Topic
1172,Point And Interval Estimates,Topic
1172,Categorical Outcomes,Topic
1172,Unconfoundedness Assumption,Topic
1172,Cardiovascular Safety,Topic
1172,Anti-Diabetic Treatment Regimens,Topic
1172,Type 2 Diabetes Mellitus,Topic
1172,Anthony D. Scotina,Author
1172,Andrew R. Zullo,Author
1172,Robert J. Smith,Author
1172,Roee Gutman,Author
1172,Approximate Bayesian Bootstrap Procedures To Estimate Multilevel Treatment Effects In Observational Studies With Application To Type 2 Diabetes Treatment Regimens,Paper
1173,Borrowing From Supplemental Sources To Estimate Causal Effects From A Primary Data Source,Paper
1173,Causal Effect Estimators,Topic
1173,Bayesian Linear Model,Topic
1173,Bayesian Additive Regression Trees,Topic
1173,Very Low Nicotine Content Cigarettes,Topic
1173,Smoking Behavior,Topic
1174,Unstructured Primary Outcome In Randomized Controlled Trials,Paper
1174,Daniel Taylor-Rodriguez,Author
1174,David Lovitz,Author
1174,Nora Mattek,Author
1174,Chao-Yi Wu,Author
1174,Hiroko Dodge,Author
1174,Jeffrey Kaye,Author
1174,Bruno M. Jedynak,Author
1175,Nonparametric Analysis Of Delayed Treatment Effects Using Single-Crossing Constraints,Paper
1175,Nicholas C. Henderson,Author
1175,Kijoeng Nam,Author
1175,Dai Feng,Author
1175,Immuno-Oncology Therapies,Topic
1176,Randomized Controlled Trials,Topic
1176,Treatment Effect,Topic
1176,International Council On Harmonisation (Ich)-E9 Addendum (R1),Topic
1176,Intercurrent Events (Ices),Topic
1176,Principal Stratum,Topic
1176,Qu Et Al. (2020),Author
1176,Adherer Average Causal Effect (Adace),Topic
1176,Multiple Imputation (Mi),Topic
1176,Bootstrapping,Topic
1176,Real Clinical Trial,Topic
1176,Type 1 Diabetes,Topic
1176,Junxiang Luo,Author
1176,Stephen J. Ruberg,Author
1176,Yongming Qu,Author
1177,Shortcomings Of Randomized Clinical Trials,Topic
1177,Urgent Health Crises,Topic
1177,Effective Treatments,Topic
1177,Short-Term Surrogates,Topic
1177,Real-World Data (Rwd),Topic
1177,Proportion Of Treatment Effect (Pte),Topic
1177,Novel Estimators,Topic
1177,Inverse Probability Weighted And Doubly Robust (Dr) Estimators,Topic
1177,Optimal Transformation Of The Surrogate,Topic
1177,Baseline Covariates,Topic
1177,Asymptotically Normal,Topic
1177,Propensity Score Model,Topic
1177,Outcome Regression Model,Topic
1177,Cross-Trial Comparison,Topic
1177,Biologic Therapies For Ulcerative Colitis,Topic
1177,Larry Han,Author
1177,Xuan Wang,Author
1177,Tianxi Cai,Author
1178,Planner,Topic
1178,Policy,Topic
1178,Local Population,Topic
1178,Intervention Studies,Topic
1178,Manski (2020),Author
1178,Minimax-Regret Criterion,Topic
1178,Active Labor Market Policy,Topic
1178,Remdesivir,Topic
1178,Covid-19 Treatment,Topic
1178,Takuya Ishihara,Author
1178,Toru Kitagawa,Author
1179,Response-Adaptive Randomization,Topic
1179,Type I Error Rate,Topic
1179,Familywise Error Rate,Topic
1179,Robertson And Wason,Author
1179,Ekkehard Glimm,Author
1179,David Robertson,Author
1179,Block-Randomised Trials,Topic
1179,Negative Weights For Blocks Of Data,Topic
1179,Power Advantage,Topic
1180,Randomized Controlled Trials,Topic
1180,Causal Inference,Topic
1180,Evidence-Based Medicine,Topic
1180,Observational Data,Topic
1180,Power Likelihood Approach,Topic
1180,Treatment Effect Estimation,Topic
1180,Expected Log Predictive Density,Topic
1180,Simulation Study,Topic
1180,Real-World Data Fusion Study,Topic
1180,Pioneer 6 Clinical Trial,Topic
1180,Us Health Claims Dataset,Topic
1180,Xi Lin,Author
1180,Jens Magelund Tarp,Author
1180,Robin J. Evans,Author
1181,Randomized Experiments,Topic
1181,Data-Driven Decision Making,Topic
1181,Medicine,Topic
1181,Randomized Controlled Trials (Rcts),Topic
1181,Clinical Trial Methodology,Topic
1181,New Drugs And Therapies,Topic
1181,Existing Treatments,Topic
1181,Placebo,Topic
1181,Business And Marketing,Topic
1181,A/B Tests,Topic
1181,Multivariate A/B Tests,Topic
1181,Ad Campaigns,Topic
1181,Website Layouts,Topic
1181,Customer Subpopulations,Topic
1181,Multivariate A/B Testing,Paper
1181,Sequential Monitoring,Topic
1181,Multiple Comparisons,Topic
1181,Standard Statistical Software,Topic
1181,Simulation Studies,Topic
1181,Bayesian Sequentially Monitored Multi-Arm Experiments With Multiple Comparison Adjustments,Paper
1181,Andrew W. Correia,Author
1182,A Matching Procedure For Sequential Experiments That Iteratively Learns Which Covariates Improve Power,Paper
1182,Adam Kapelner,Author
1182,Abba Krieger,Author
1182,Average Treatment Effect,Topic
1182,Sequential Randomized Trials,Topic
1182,Dynamic Allocation Procedure,Topic
1182,Seqexpmatch,Topic
1182,Dynamic Matching Criterion,Topic
1182,Estimators,Topic
1182,Exact Test,Topic
1182,Clinical Trial Dataset,Topic
1182,Simulated Scenarios,Topic
1183,Targeted Therapeutics For Cancer Treatment,Topic
1183,Drug Resistance Factors,Topic
1183,Combination Cancer Therapies (Ccts),Topic
1183,Mathematical Modeling In Cancer Treatment,Topic
1183,Joseph Malinzi,Author
1183,Kevin Bosire Basita,Author
1183,Sara Padidar,Author
1183,Henry A. Adeola,Author
1184,Unblinded Sample Size Re-Estimation (Ssr),Topic
1184,Proof-Of Concept (Poc),Topic
1184,Phase Ii Dose Finding Study,Topic
1184,Frequentist Conditional Power,Topic
1184,Bayesian Posterior Predictive Power,Topic
1184,Qingyang Liu,Author
1184,Guanyu Hu,Author
1184,Binqi Ye,Author
1184,Susan Wang,Author
1184,Yaoshi Wu,Author
1184,Multi-Arm Trials,Topic
1184,Sample Size Re-Estimation In Phase 2 Dose-Finding: Conditional Power Vs. Bayesian Predictive Power,Paper
1185,Shape-Constrained Methods,Topic
1185,Immune Response Profiles,Topic
1185,Hvtn 097,Topic
1185,Hvtn 100,Topic
1185,Igg Binding Immune Responses,Topic
1185,Stochastic Dominance,Topic
1185,Hellinger Distance,Topic
1185,Nilanjana Laha,Author
1185,Zoe Moodie,Author
1185,Ying Huang,Author
1185,Alex Luedtke,Author
1186,Clinical Trials With Longitudinal Outcomes,Topic
1186,Bayesian Random Multiple Imputation,Topic
1186,Rubin'S Rule,Topic
1186,Deterministic Conditional Mean Imputation,Topic
1186,Jackknife For Inference,Topic
1186,Missing-At-Random Assumption,Topic
1186,Marcel Wolbers,Author
1186,Alessandro Noci,Author
1186,Paul Delmar,Author
1186,Craig Gower-Page,Author
1186,Sean Yiu,Author
1186,Jonathan W. Bartlett,Author
1187,Markets For Innovation,Topic
1187,"Schmookler, 1966",Author
1187,"Acemoglu And Linn, 2004",Author
1187,"Bryan And Williams, 2021",Author
1187,Demographical Shifts,Topic
1187,New Drugs,Topic
1187,"Cerda Et Al., 2007",Author
1187,Market Size,Topic
1187,Active Clinical Trials,Topic
1187,Product Recalls,Topic
1187,Us Market Size,Topic
1187,Atc-3 Level,Topic
1187,"Wooldridge Et Al., 2019",Author
1187,Federico Nutarelli,Author
1187,Massimo Riccaboni,Author
1187,Andrea Morescalchi,Author
1188,Statistical Methods For Accommodating Immortal Time: A Selective Review And Comparison,Paper
1188,Immortal Time,Topic
1188,Biased Estimation,Topic
1188,Time-Varying Treatment Modeling,Topic
1188,Sequential Trial Methods,Topic
1188,Causal Inference,Topic
1189,Phase Ii Basket Trials,Topic
1189,Treatment Targeting Genetic Alteration,Topic
1189,Bayesian Hierarchical Modelling,Topic
1189,Variance Parameter,Topic
1189,Shrinkage,Topic
1189,Prior Choice On The Variance,Topic
1189,Penalized Complexity (Pc) Priors,Topic
1189,Half-T Prior,Topic
1189,Massimo Ventrucci,Author
1189,Alessandro Vagheggini,Author
1190,Modeling And Predictive Control For The Treatment Of Hyperthyroidism,Paper
1190,Tobias M. Wolff,Author
1190,Maylin Menzel,Author
1190,Johannes W. Dietrich,Author
1190,Matthias A. M¸ller,Author
1190,Hyperthyroidism,Topic
1191,Principal Stratification With Time-To-Event Outcomes,Paper
1191,Bo Liu,Author
1191,Lisa Wruck,Author
1191,Fan Li,Author
1191,Adaptable Trial,Topic
1192,Chromium Supplementation And The Essentiality Of Chromium To Human Nutrition: A Narrative Review,Paper
1192,Chromium,Topic
1192,Type 2 Diabetes Mellitus,Topic
1193,Projection-Based Testing For Mean Trajectory Differences,Topic
1193,Wang (2021),Author
1193,Fpass,Topic
1193,Salil Koner,Author
1193,Sheng Luo,Author
1193,Parkinson'S Disease,Topic
1193,Biostatistical Applications,Topic
1193,Clinical Trials,Topic
1194,Hidden Yet Quantifiable: A Lower Bound For Confounding Strength Using Randomized Trials,Paper
1194,Observational Studies,Topic
1194,Randomized Trials,Topic
1194,Unobserved Confounding,Topic
1194,Statistical Test,Topic
1194,Causal Conclusions,Topic
1195,Optimal Adaptive Smart Designs With Binary Outcomes,Paper
1195,Rik Ghosh,Author
1195,Bibhas Chakraborty,Author
1195,Inbal Nahum-Shani,Author
1195,Megan E. Patrick,Author
1195,Palash Ghosh,Author
1195,Smart,Topic
1195,M-Bridge,Topic
1196,Unified Three-State Model Framework For Analysis Of Treatment Crossover In Survival Trials,Paper
1196,Treatment Effect,Topic
1196,Treatment Crossover,Topic
1196,Statistical Methodologies,Topic
1196,Tsm Framework,Topic
1196,Imputation Method,Topic
1197,Rank-Based Approach For Univariate Two-Sample Testing,Topic
1197,Wilcoxon-Mann-Whitney Test,Topic
1197,Yijin Zeng,Author
1197,Niall M. Adams,Author
1197,Dean A. Bodenham,Author
1197,Complex Clinical Trial Data,Topic
1198,Bayesian Estimator Of Sample Size,Topic
1198,Dehua Bi,Author
1198,Yuan Ji,Author
1198,Oncology Dose Optimization Clinical Trials,Topic
1199,Oncology Drug Development,Topic
1199,Dose Escalation Phase,Topic
1199,Maximal Tolerable Dose (Mtd),Topic
1199,Dose Limiting Toxicity (Dlt),Topic
1199,Model-Based Dose Escalation Trial Designs,Topic
1199,Pharmacokinetic (Pk) Data,Topic
1199,Bayesian Joint Modeling Framework,Topic
1199,Dose-Pk Relationship,Topic
1199,Pk-Dlt Relationship,Topic
1199,Real-Life Case Study,Topic
1199,Simulation,Topic
1199,Arnab Kumar Maity,Author
1199,Satrajit Roy Chowdhury,Author
1199,Ray Li,Author
1199,Lada Markovtsova,Author
1199,Roberto Bugarini,Author
1200,Randomized Trials,Topic
1200,Observational Studies,Topic
1200,Piersilvio De Bartolomeis,Author
1200,Javier Abad,Author
1200,Konstantin Donhauser,Author
1200,Fanny Yang,Author
1200,Benchmarking Strategy,Topic
1200,Treatment Effect Bias,Topic
1201,Transportability Of Principal Causal Effects,Paper
1201,Justin M. Clark,Author
1201,Kollin W. Rott,Author
1201,James S. Hodges,Author
1201,Jared D. Huling,Author
1202,Starting Small: Prioritizing Safety Over Efficacy In Randomized Experiments Using The Exact Finite Sample Likelihood,Paper
1203,A/B Testing,Topic
1203,Bootstrap Matching,Topic
1203,Difference-In-Differences,Topic
1203,Propensity Score Matching,Topic
1203,Zihao Zheng,Author
1203,Carol Liu,Author
1203,Online Advertising,Topic
1203,Digital Marketing,Topic
1203,Empirical Economics,Topic
1203,Clinical Trials,Topic
1203,High-Dimensional Bioinformatics,Topic
1204,Covid-19 Pandemic,Topic
1204,Vaccine Policies,Topic
1204,Traditional Clinical Trials,Topic
1204,Public Health Strategies,Topic
1204,Ethical Concerns,Topic
1204,Reinforcement Learning,Topic
1204,Vaccine Policy Development,Topic
1204,Tabular Q-Learning,Topic
1204,Microsimulation,Topic
1204,Recurrent Neural Network,Topic
1204,Public Health Vaccine Policymaking,Topic
1204,Q-Learning Model,Topic
1204,Covid-19 Booster Policies,Topic
1204,Guoxuan Ma,Author
1204,Lili Zhao,Author
1204,Jian Kang,Author
1205,Intercurrent Events,Topic
1205,Principal Stratification,Topic
1205,Latent Subpopulations,Topic
1205,Monotonicity,Topic
1205,Counterfactual Intermediate Independence,Topic
1205,Semiparametric Framework,Topic
1205,Conditional Odds Ratio Sensitivity Parameter,Topic
1205,Principal Ignorability,Topic
1205,Nonparametric Identification Formulas,Topic
1205,Conditionally Doubly Robust Parametric Estimator,Topic
1205,De-Biased Machine Learning Estimator,Topic
1205,Data-Adaptive Nuisance Estimators,Topic
1205,Critical Care Trial,Topic
1205,Semiparametric Sensitivity Analysis,Topic
1205,Jiaqi Tong,Author
1205,Brennan Kahan,Author
1205,Michael O. Harhay,Author
1205,Fan Li,Author
1206,Machine Learning,Topic
1206,Healthcare,Topic
1206,Reproducibility Crisis,Topic
1206,Medicine,Topic
1206,Neuroimaging,Topic
1206,Alzheimer'S Disease,Topic
1206,Schizophrenia,Topic
1206,Brain Aging,Topic
1206,Weighted Empirical Risk Minimization,Topic
1206,"15,363 Individuals",Topic
1206,20 Neuroimaging Studies,Topic
1206,Rongguang Wang,Author
1206,Guray Erus,Author
1206,Pratik Chaudhari,Author
1206,Christos Davatzikos,Author
1207,Threshold-Free Summary Index For Quantifying The Capacity Of Covariates To Yield Efficient Treatment Rules,Paper
1207,Covariates,Topic
1207,Treatment Rules,Topic
1207,Randomized Trial,Topic
1207,Decision Theory,Topic
1207,Clinical Trial Of Preventive Antibiotic Therapy For Reducing Exacerbation Rate In Chronic Obstructive Pulmonary Disease,Topic
1208,Covariate Adjustment In Subgroup Analyses Of Randomized Clinical Trials: A Propensity Score Approach,Paper
1208,Siyun Yang,Author
1208,Fan Li,Author
1208,Laine E. Thomas,Author
1209,Savvy,Topic
1209,Adverse Events,Topic
1209,Randomized Clinical Trials,Topic
1209,Kaspar Rufibach,Author
1209,Regina Stegherr,Author
1209,Claudia Schmoor,Author
1209,Valentine Jehl,Author
1209,Arthur Allignol,Author
1209,Annette Boeckenhoff,Author
1209,Cornelia Dunger-Baldauf,Author
1209,Lewin Eisele,Author
1209,Thomas K¸nzel,Author
1209,Katrin Kupas,Author
1209,Friedhelm Leverkus,Author
1209,Matthias Trampisch,Author
1209,Yumin Zhao,Author
1209,Tim Friede,Author
1209,Jan Beyersmann,Author
1210,Randomised Controlled Trials,Topic
1210,Ordinal Outcome,Topic
1210,Scoping Review,Topic
1210,Chris J. Selman,Author
1210,Katherine J. Lee,Author
1210,Robert K. Mahar,Author
1210,Bmj,Topic
1210,Nejm,Topic
1210,The Lancet,Topic
1210,Jama,Topic
1210,Pubmed,Topic
1210,Prisma-Scr Checklist,Topic
1210,1-Jan-12,Topic
1210,31-Jul-22,Topic
1211,Clinical Trials,Topic
1211,Electronic Health Records,Topic
1211,Natural Language Processing,Topic
1211,Generative Pre-Trained Transformer,Topic
1211,Mojdeh Rahmanian,Author
1211,Seyed Mostafa Fakhrahmad,Author
1211,Seyedeh Zahra Mousavi,Author
1211,2018 N2C2 Challenge,Topic
1211,Snomed Ct,Topic
1211,Cohort Selection Task,Topic
1211,Eligibility Criteria,Topic
1211,Micro F Measure,Topic
1211,Macro F Measure,Topic
1212,Randomized Controlled Trials,Topic
1212,Forest Plots,Topic
1212,Treatment Effect Estimates,Topic
1212,Subgroups,Topic
1212,Bayesian Shrinkage Methods,Topic
1212,Cox Model,Topic
1212,Penalized Partial Likelihood Estimation,Topic
1212,Bayesian Estimation,Topic
1212,Credible Intervals,Topic
1212,Treatment Effect Estimators,Topic
1212,R Package Bonsaiforest,Topic
1212,Marcel Wolbers,Author
1212,Mar V·zquez RabuÒal,Author
1212,Ke Li,Author
1212,Kaspar Rufibach,Author
1212,Daniel SabanÈs BovÈ,Author
1213,Chauhan Weighted Trajectory Analysis,Topic
1213,Utkarsh Chauhan,Author
1213,Daylen Mackey,Author
1213,John R Mackey,Author
1213,Risk Benefit Analysis,Topic
1213,Randomized Controlled Trials,Topic
1213,Advanced Cancer Trial,Topic
1213,Dose Escalation Phase I Trial,Topic
1213,Ctcae Scale,Topic
1213,Recist 1.1 Health Statuses,Topic
1214,Semiparametric Joint Modeling To Estimate The Treatment Effect On A Longitudinal Surrogate With Application To Chronic Kidney Disease Trials,Paper
1214,Xuan Wang,Author
1214,Jie Zhou,Author
1214,Layla Parast,Author
1214,Tom Greene,Author
1214,Chronic Kidney Disease,Topic
1214,Glomerular Filtration Rate,Topic
1214,Losartan,Topic
1214,Renaal Trial,Topic
1215,Response-Adaptive Designs,Topic
1215,Covariate-Adjusted Response-Adaptive Designs,Topic
1215,K Treatments,Topic
1215,Generalized Linear Models,Topic
1215,Linear Model,Topic
1215,Logistic Regression Model,Topic
1215,Li-Xin Zhang,Author
1215,Feifang Hu,Author
1215,Siu Hung Cheung,Author
1215,Wai Sum Chan,Author
1215,Asymptotic Properties Of Covariate-Adjusted Adaptive Designs,Paper
1216,Nonparametric Estimators Of The Mean Total Cost,Topic
1216,Clinical Trials,Topic
1216,Longitudinal Framework,Topic
1216,Net Present Value,Topic
1216,Medical Cost Data,Topic
1216,Regression Model,Topic
1216,Heteroscedasticity,Topic
1216,Skewness,Topic
1216,Censoring In Cost Data,Topic
1216,Joseph C. Gardiner,Author
1216,Lin Liu,Author
1216,Zhehui Luo,Author
1217,Urn Models,Topic
1217,Immigrated Urn (Imu) Models,Topic
1217,Li-Xin Zhang,Author
1217,Feifang Hu,Author
1217,Siu Hung Cheung,Author
1217,Wei Sum Chan,Author
1217,Clinical Studies,Topic
1217,Treatment Allocation Schemes,Topic
1217,Statistical Inferences,Topic
1217,Classical Urn Models,Topic
1217,Imu Framework,Topic
1218,A New Latent Cure Rate Marker Model For Survival Data,Paper
1218,Sungduk Kim,Author
1218,Yingmei Xi,Author
1218,Ming-Hui Chen,Author
1219,Twitter,Topic
1219,Medical Papers,Topic
1219,Jens Peter Andersen,Author
1219,Stefanie Haustein,Author
1219,Embase,Topic
1219,Meta-Analyses,Topic
1219,Systematic Reviews,Topic
1219,Clinical Trials,Topic
1219,Basic Research,Topic
1220,Phase Ii Dose Finding Studies,Topic
1220,Dose Response Relationship,Topic
1220,New Drug,Topic
1220,Model Selection,Topic
1220,Model Averaging,Topic
1220,Mathematical Properties,Topic
1220,Simulations,Topic
1220,Asymptotic Properties Of Model Selection Criteria,Topic
1220,Sample Size,Topic
1220,Effect Size,Topic
1220,Large Scale Simulation Study,Topic
1220,Phase Ii Dosefinding Study,Topic
1220,Chronic Obstructive Pulmonary Disease,Topic
1220,Kirsten Schorning,Author
1220,Bjˆrn Bornkamp,Author
1220,Frank Bretz,Author
1220,Holger Dette,Author
1220,Model Selection Versus Model Averaging In Dose Finding Studies,Paper
1221,Closed-Loop Deep Brain Stimulation,Topic
1221,Neurological Movement Disorders,Topic
1221,Control Algorithms,Topic
1221,Metric For System Performance,Topic
1221,Parkinson'S Disease,Topic
1221,Tremor Treatment,Topic
1221,Power Savings,Topic
1221,Jeffrey Herron,Author
1221,Anca Velisar,Author
1221,Mahsa Malekmohammadi,Author
1221,Helen Bronte-Stewart,Author
1221,Howard Jay Chizeck,Author
1221,Clinicaltrials.Gov Identifier: Nct02384421,Paper
1222,Robotics,Topic
1222,Endoscopes,Topic
1222,Gi Tract,Topic
1222,Robotically Actuated Tendon Sheath Mechanisms,Topic
1222,Surgical Endoscopy,Topic
1222,Surgeon Movements,Topic
1222,Tissue Manipulation,Topic
1222,Endoscopic Submucosal Dissection,Topic
1222,Full-Thickness Resection,Topic
1222,Surgical Outcomes,Topic
1222,Master-Slave Surgical Robotics,Topic
1222,Position And Force Sensors,Topic
1222,Tactile Feedback,Topic
1222,Robotic Assisted Gi Luminal Surgeries,Topic
1222,Notes Surgeries,Topic
1222,Gastroenterologists,Topic
1222,Tian En Timothy Seah,Author
1222,Thanh Nho Do,Author
1222,Nobuyoshi Takeshita,Author
1222,Khek Yu Ho,Author
1222,Soo Jay Phee,Author
1223,A Novel Method Of Subgroup Identification By Combining Virtual Twins With Guide (Vg) For Development Of Precision Medicines,Paper
1223,Virtual Twins,Topic
1223,Guide,Topic
1224,Alzheimer'S Disease,Topic
1224,Quantitative Electroencephalography,Topic
1224,Riemannian Tangent Space Mapping,Topic
1224,Elastic Net Regression,Topic
1224,Brain Atrophy Markers,Topic
1224,Wolfgang Fruehwirt,Author
1224,Matthias Gerstgrasser,Author
1224,Pengfei Zhang,Author
1224,Leonard Weydemann,Author
1224,Markus Waser,Author
1224,Reinhold Schmidt,Author
1224,Thomas Benke,Author
1224,Peter Dal-Bianco,Author
1224,Gerhard Ransmayr,Author
1224,Dieter Grossegger,Author
1224,Heinrich Garn,Author
1224,Gareth W. Peters,Author
1224,Stephen Roberts,Author
1224,Georg Dorffner,Author
1225,Biomarker Measurements,Topic
1225,Compound,Topic
1225,Patients,Topic
1225,Drug,Topic
1225,Treatment Effect,Topic
1225,Subgroup,Topic
1225,Causal Conclusions,Topic
1225,Causal Inference,Topic
1225,Subgroup Effects,Topic
1225,Simulations,Topic
1225,Case-Study,Topic
1225,Randomized Clinical Trials,Topic
1225,Time-To-Event Endpoint,Topic
1225,Bjˆrn Bornkamp,Author
1225,Georgina Bermann,Author
1226,Inverse Probability Of Treatment Weighting (Iptw),Topic
1226,Sample Average Treatment Effects (Sate),Topic
1226,Observational Data,Topic
1226,Positivity Assumption,Topic
1226,Treatment Assignment Model,Topic
1226,Truncation,Topic
1226,Covariate-Balancing Propensity Scores,Topic
1226,Stable Balancing Weights,Topic
1226,Kernel Optimal Matching (Kom),Topic
1226,Spine Surgery,Topic
1226,Conditional Mean Squared Error,Topic
1226,Clinical Registry,Topic
1226,Nathan Kallus,Author
1226,Brenton Pennicooke,Author
1226,Michele Santacatterina,Author
1227,A Family-Based Graphical Approach For Testing Hierarchically Ordered Families Of Hypotheses,Paper
1227,Zhiying Qiu,Author
1227,Li Yu,Author
1227,Wenge Guo,Author
1227,Gatekeeping Strategies,Topic
1227,Familywise Error Rate,Topic
1228,Knee Osteoarthritis,Topic
1228,Multi-Modal Machine Learning-Based Oa Progression Prediction Model,Topic
1228,Aleksei Tiulpin,Author
1228,Stefan Klein,Author
1228,Sita M. A. Bierma-Zeinstra,Author
1228,JÈrÙme Thevenot,Author
1228,Esa Rahtu,Author
1228,Joyce Van Meurs,Author
1228,Edwin H. G. Oei,Author
1228,Simo Saarakkala,Author
1228,"3,918 Knee Images",Topic
1228,"2,129 Subjects",Topic
1228,0.79 Auc,Topic
1228,0.68 Ap,Topic
1228,0.75 Auc,Topic
1228,0.62 Ap,Topic
1229,Augmented Reality,Topic
1229,Image Guided Surgery,Topic
1229,Magnetic Resonance Elastography,Topic
1229,Michael Barrow,Author
1229,Alice Chao,Author
1229,Qizhi He,Author
1229,Sonia Ramamoorthy,Author
1229,Claude Sirlin,Author
1229,Ryan Kastner,Author
1229,Patient Specific Biomechanics,Topic
1229,Surgical Landmarks,Topic
1229,Mre Data Driven Simulation,Topic
1229,Traditional Method,Topic
1229,Animal Model Trials,Topic
1230,Prediction Of Thrombectomy Functional Outcomes Using Multimodal Data,Paper
1230,Zeynel A. Samak,Author
1230,Philip Clatworthy,Author
1230,Majid Mirmehdi,Author
1230,Ischaemic Stroke,Topic
1230,Endovascular Thrombectomy,Topic
1230,Deep Learning,Topic
1230,Multimodal Data,Topic
1230,Modified Rankin Scale Score,Topic
1230,Auc,Topic
1230,Classification Accuracy,Topic
1231,Causal Network Models Of Sars-Cov-2 Expression And Aging To Identify Candidates For Drug Repurposing,Paper
1231,Anastasiya Belyaeva,Author
1231,Louis Cammarata,Author
1231,Adityanarayanan Radhakrishnan,Author
1231,Chandler Squires,Author
1231,Karren Dai Yang,Author
1231,G. V. Shivashankar,Author
1231,Caroline Uhler,Author
1231,Sars-Cov-2,Topic
1231,Drug Repurposing,Topic
1231,Aging,Topic
1232,Pure-Exploration Problem In Stochastic Multi-Armed Bandits,Topic
1232,Epsilon-Good Arm,Topic
1232,Best-Arm Identification,Topic
1232,Top-K Arm Identification,Topic
1232,All Arms With Means Above A Specified Threshold,Topic
1232,Virologist,Author
1232,Blake Mason,Author
1232,Lalit Jain,Author
1232,Ardhendu Tripathy,Author
1232,Robert Nowak,Author
1232,Large-Scale Crowd-Sourced Dataset,Topic
1232,Dataset Testing Hundreds Of Possible Cancer Drugs,Topic
1233,Drug Repurposing,Topic
1233,Real World Data,Topic
1233,Coronary Artery Disease,Topic
1233,Ruoqi Liu,Author
1233,Lai Wei,Author
1233,Ping Zhang,Author
1233,Framework For Drug Repurposing,Topic
1233,Drug Candidates,Topic
1233,Medical Claims Database,Topic
1233,Causal Inference,Topic
1233,Deep Learning,Topic
1234,The Impact Of The Covid-19 Pandemic On Scientific Research In The Life Sciences,Paper
1234,Massimo Riccaboni,Author
1234,Luca Verginer,Author
1234,Covid-19,Topic
1234,Life Sciences,Topic
1235,Molecular Origin Of Blood-Based Infrared Fingerprints,Paper
1236,Dementia,Topic
1237,Robot-Assisted Intervention,Topic
1237,Conservative Actor-Critic With Smooth Gradient (Casog),Paper
1237,Vascular Robotic Systems,Topic
1237,Clinical Trials,Topic
1237,Q-Function,Topic
1237,Convolution Layers,Topic
1237,Pre-Clinical Environment,Topic
1238,Mixed Effects Model For Repeated Measures,Topic
1238,Multivariate Skew-T Distribution,Topic
1238,Markov Chain Monte Carlo Algorithm,Topic
1238,Longitudinal Clinical Trials,Topic
1238,Yongqiang Tang,Author
1239,Warfarin,Topic
1239,Pharmgkb,Topic
1239,Hai Xiao,Author
1239,Multi-Armed Bandit Algorithms,Topic
1239,Warfarin Clinical Dosing Algorithm,Topic
1239,Fixed-Dose Approach,Topic
1239,Warfarin Clinical Algorithm,Topic
1240,Hand-Held Interface For Type 1 Diabetes,Topic
1240,Type 1 Diabetes,Topic
1240,Robert Spence,Author
1240,Chukwuma Uduku,Author
1240,Kezhi Li,Author
1240,Nick Oliver,Author
1240,Pantelis Georgiou,Author
1241,Restricted Mean Time Lost,Topic
1241,Sub-Distribution Hazard Ratio,Topic
1241,Jingjing Lyu,Author
1241,Yawen Hou,Author
1241,Zheng Chen,Author
1241,Sdiff,Topic
1241,Diff,Topic
1241,Monte Carlo Simulations,Topic
1241,Real Examples,Topic
1241,Treatment Effects,Topic
1242,Social Robot Project,Topic
1242,Mary Ellen Foster,Author
1242,Ronald P. A. Petrick,Author
1243,Digital Pathology Imaging,Topic
1243,Deep Learning Methods,Topic
1243,Tumor Descriptors,Topic
1243,Lung Adenocarcinoma,Topic
1243,Prognostic Model,Topic
1243,Esteban Fern·ndez Morales,Author
1243,Cong Zhang,Author
1243,Guanghua Xiao,Author
1243,Chul Moon,Author
1243,Qiwei Li,Author
1243,Github Repository,Topic
1244,Multi-Center Clinical Trials,Topic
1244,Summarized Clinical Data,Topic
1244,Statistical Methods,Topic
1244,Jing Qin,Author
1244,Yukun Liu,Author
1244,Pengfei Li,Author
1244,Big Data,Topic
1244,Generalized Method Of Moments,Topic
1244,Estimating Equations,Topic
1244,Empirical Likelihood Method,Topic
1244,Meta Analysis,Topic
1245,Meta-Analysis Of Censored Adverse Events,Paper
1245,Xinyue Qi,Author
1245,Shouhao Zhou,Author
1245,Christine B. Peterson,Author
1245,Yucai Wang,Author
1245,Xinying Fang,Author
1245,Michael L. Wang,Author
1245,Chan Shen,Author
1246,Estimating Conditional Average Treatment Effect,Topic
1246,Randomized Clinical Trials,Topic
1246,Observational Datasets,Topic
1246,Difference In Differences,Topic
1246,Synthesized Difference In Differences,Topic
1246,Eric V. Strobl,Author
1246,Thomas A. Lasko,Author
1247,Machine Learning Applications For Therapeutic Tasks With Genomics Data,Paper
1247,Kexin Huang,Author
1247,Cao Xiao,Author
1247,Lucas M. Glass,Author
1247,Cathy W. Critchlow,Author
1247,Greg Gibson,Author
1247,Jimeng Sun,Author
1248,Eb-Rmap,Topic
1248,Box'S Prior Predictive P-Value,Topic
1248,Binary,Topic
1248,Normal,Topic
1248,Time-To-Event,Topic
1248,Clinical Dataset,Topic
1248,Hongtao Zhang,Author
1248,Yueqi Shen,Author
1248,Alan Y Chiang,Author
1248,Judy Li,Author
1249,Estimation Of Treatment Efficacy Of Real-World Clinical Interventions,Topic
1249,Chirag Nagpal,Author
1249,Mononito Goswami,Author
1249,Keith Dufendach,Author
1249,Artur Dubrawski,Author
1249,Counterfactual Phenotyping With Censored Time-To-Events,Paper
1250,Pathologybert,Topic
1250,Natural Language Understanding,Topic
1250,Breast Cancer Diagnose Classification,Topic
1250,Thiago Santos,Author
1250,Amara Tariq,Author
1250,Susmita Das,Author
1250,Kavyasree Vayalpati,Author
1250,Geoffrey H. Smith,Author
1250,Hari Trivedi,Author
1250,Imon Banerjee,Author
1251,Treatment Discontinuation,Topic
1251,Insulin Peglispro,Topic
1251,Yongming Qu,Author
1251,Robin D. White,Author
1251,Stephen J. Ruberg,Author
1251,Current Case Report Form,Topic
1251,Phase 2 And Phase 3 Studies,Topic
1251,Clinical Data Interchange Standards Consortium,Topic
1252,Biomarker,Topic
1252,Selective Genotyping,Topic
1252,Reverse-Regression Least Squares Estimator,Topic
1252,A. Adam Ding,Author
1252,Natalie Delrocco,Author
1252,Samuel Wu,Author
1252,Chronic Pain Clinical Trial,Topic
1252,Monte Carlo Simulations,Topic
1252,Joint Normal Distribution Assumption,Topic
1252,Biomarker Testing Landscape,Topic
1252,Biomarker Value,Topic
1252,Response,Topic
1253,Perpetual Observational Studies,Topic
1253,Ecraid,Topic
1253,N. Hassoun-Kheir,Author
1253,C. H. Van Werkhoven,Author
1253,J. Dunning,Author
1253,T. Jaenisch,Author
1253,J. Van Beek,Author
1253,J. Bielicki,Author
1253,C. Butler,Author
1253,B. Francois,Author
1253,S. Harbarth,Author
1253,A. C. Hernandez Padilla,Author
1253,P. Horby,Author
1253,M. Koopmans,Author
1253,J. Lee,Author
1253,J. Rodriguez-BaÒo,Author
1253,E. Tacconelli,Author
1253,Y. Themistocleous,Author
1253,A. W. Van Der Velden,Author
1253,M. Bonten,Author
1253,H. Goossens,Author
1253,M. E. A. De Kraker,Author
1254,Patient-Specific Cardiac Computational Models,Topic
1254,Precision Medicine,Topic
1254,In-Silico Clinical Trials,Topic
1254,Digital Twins,Topic
1254,Cardiac Digital Twins,Topic
1254,Patient-Specific Diagnosis,Topic
1254,Therapy Stratification,Topic
1254,Deep Learning Based Patient-Specific Computational Model,Paper
1254,Eikonal Model,Topic
1254,Ventricular Activation Properties,Topic
1254,Conduction Velocities,Topic
1254,Root Nodes,Topic
1254,Electrocardiogram (Ecg),Topic
1254,Simulated Data,Topic
1254,Computational Time,Topic
1255,Echocardiographic Image Quality Assessment Using Deep Neural Networks,Paper
1255,Robert B. Labs,Author
1255,Massoud Zolgharni,Author
1255,Jonathan P. Loo,Author
1255,Echocardiography,Topic
1256,Medical Imaging Datasets,Topic
1256,Precision Medicine,Topic
1256,Unsupervised Autoencoder Framework,Topic
1256,Contrastive Loss,Topic
1256,Latent Space,Topic
1256,Benchmark Datasets,Topic
1256,Supervised Transfer Learning,Topic
1256,Matteo Ferrante,Author
1256,Tommaso Boccato,Author
1256,Simeon Spasov,Author
1256,Andrea Duggento,Author
1256,Nicola Toschi,Author
1257,Mechanical Ventilation,Topic
1257,Deepvent,Paper
1257,Conservative Q-Learning,Topic
1257,Deep Reinforcement Learning,Topic
1257,Mimic-Iii Dataset,Topic
1257,Fitted Q Evaluation,Topic
1257,Patients With Pulmonary Impairment,Topic
1257,Healthcare Workers,Topic
1258,Digital Health Twin,Topic
1258,Computational Pathology,Topic
1258,Privacy Safeguards,Topic
1258,Real-World Evidence,Topic
1258,Manuel Cossio,Author
1259,Heterogeneous Treatment Effects,Topic
1259,Randomized Controlled Trials,Topic
1259,Precision Medicine,Topic
1259,Subgroups,Topic
1259,Framework For Partitioning The Covariate Space,Topic
1259,Algorithm,Topic
1259,Synthetic And Semi-Synthetic Data,Topic
1259,Peniel N. Argaw,Author
1259,Elizabeth Healey,Author
1259,Isaac S. Kohane,Author
1259,Identifying Heterogeneous Treatment Effects In Multiple Outcomes Using Joint Confidence Intervals,Paper
1260,Immunotherapies,Topic
1260,Cart-Cell Therapy,Topic
1260,Viren Shah,Author
1260,Justin Womack,Author
1260,Anthony E. Zamora,Author
1260,Scott S. Terhune,Author
1260,Ranjan K. Dash,Author
1260,Cancer,Topic
1260,Fda,Topic
1260,Clinical Trials,Topic
1260,Computational Frameworks,Topic
1260,Signaling Signatures,Topic
1260,Tumor Cells,Topic
1260,In Silico,Topic
1261,Penalized Splines,Topic
1261,Linear Mixed Effects Model (Lmm),Topic
1261,Permutation Tests,Topic
1261,Boyu Ren,Author
1261,Stuart R. Lipsitz,Author
1261,Garrett M. Fitzmaurice,Author
1261,Roger D. Weiss,Author
1261,Stimulant Use Disorder Psychosocial Clinical Trial,Topic
1262,Biodynamic Profiles,Topic
1262,Canine B-Cell Lymphoma,Topic
1262,Fresh Tumor Biopsies,Topic
1262,Flash-Frozen Biopsies,Topic
1262,Digital Speckle Holography,Topic
1262,Zhen Hua,Author
1262,John Turek,Author
1262,Mike Childress,Author
1262,David Nolte,Author
1262,Thawed Samples,Topic
1262,Chemosensitivity Testing,Topic
1262,Tissue Banks,Topic
1263,Bioequivalence Study,Topic
1263,Clinical Trial,Topic
1263,Drug Formulation,Topic
1263,Pharmacokinetic Profiles,Topic
1263,Food And Drug Administration,Author
1263,Confidence Interval Approach,Topic
1263,Kexuan Li,Author
1263,Susie Sinks,Author
1263,Peng Sun,Author
1263,Lingli Yang,Author
1264,Guidance On Individualized Treatment Rule Estimation In High Dimensions,Paper
1264,Philippe Boileau,Author
1264,Ning Leng,Author
1264,Sandrine Dudoit,Author
1264,Individualized Treatment Rules,Topic
1264,Precision Medicine,Topic
1264,High-Dimensional Covariate Settings,Topic
1264,Data-Generating Processes,Topic
1264,Randomized Studies,Topic
1264,Observational Studies,Topic
1265,Drug Discovery,Topic
1265,Data Science,Topic
1265,Informatics,Topic
1265,Artificial Intelligence (Ai),Topic
1265,Catrin Hasselgren,Author
1265,Tudor I. Oprea,Author
1265,Small Molecule Drugs,Topic
1265,Generative Chemistry,Topic
1265,Machine Learning,Topic
1265,Multi-Property Optimization,Topic
1265,Reproducibility Crisis,Topic
1265,Artificial Intelligence For Drug Discovery: Are We There Yet?,Paper
1266,Heterogeneous Treatment Effects,Topic
1266,Causal Forests,Topic
1266,Vik Shirvaikar,Author
1266,Xi Lin,Author
1266,Chris Holmes,Author
1266,Relative Risk Causal Forests,Topic
1266,Clinical Trial Analysis,Topic
1267,Recent Advances In Large Language Models,Topic
1267,Clinical Applications,Topic
1267,Clinical Decision Support,Topic
1267,Trial Recommendations,Topic
1267,Gpt-4,Topic
1267,Icd Codes,Topic
1267,Medical Coding Tasks,Topic
1267,Llm-Codex,Topic
1267,Lstm-Based Verification Stage,Topic
1267,Mimic Dataset,Topic
1267,Zhichao Yang,Author
1267,Sanjit Singh Batra,Author
1267,Joel Stremmel,Author
1267,Eran Halperin,Author
1268,Meta-Analysis Of Study Twins,Topic
1268,Christian Rˆver,Author
1268,Tim Friede,Author
1269,Adaptive Experiment,Topic
1269,Cate,Topic
1269,Social Welfare,Topic
1269,Regret,Topic
1269,Contextual Bandit Framework,Topic
1269,Privacy Concerns,Topic
1269,Treatment Allocation Mechanism,Topic
1269,Tradeoff,Topic
1269,Pareto Optimality,Topic
1269,Differentially Private Algorithms,Topic
1269,Asymptotic Normality,Topic
1269,Jiachun Li,Author
1269,Kaining Shi,Author
1269,David Simchi-Levi,Author
1270,Population-Based Biobanks,Topic
1270,Epidemiological Research,Topic
1270,Clinical Research,Topic
1270,Biobank Data,Topic
1270,Cumulative Incidence Function (Cif) Estimator,Topic
1270,Malka Gorfine,Author
1270,David M. Zucker,Author
1270,Shoval Shoham,Author
1271,Nli4Ct Task,Topic
1271,Large Language Models,Topic
1271,Peft Method,Topic
1271,Gpt-4,Author
1271,Aryo Pradipta Gema,Author
1271,Giwon Hong,Author
1271,Pasquale Minervini,Author
1271,Luke Daines,Author
1271,Beatrice Alex,Author
1272,Large Language Models (Llms),Topic
1272,Transformers,Topic
1272,Natural Language Inference Capabilities,Topic
1272,Clinical Trial Reports,Topic
1272,Gemini,Author
1272,Duygu Altinok,Author
1272,D-Nlp At Semeval-2024 Task 2,Paper
1273,Radex,Topic
1273,Daniel Reichenpfader,Author
1273,Jonas Knupp,Author
1273,AndrÈ Sander,Author
1273,Kerstin Denecke,Author
1274,Dynamic Treatment Regimes,Topic
1274,Precision Medicine,Topic
1274,Optimal Regime,Topic
1274,Scalar Outcome,Topic
1274,Multiple Outcomes,Topic
1274,Utility Functions,Topic
1274,Inverse Reinforcement Learning,Topic
1274,Hiv/Sti Prevention,Topic
1274,Kyle Duke,Author
1274,Eric B. Laber,Author
1274,Marie Davidian,Author
1274,Michael Newcomb,Author
1274,Brian Mustanski,Author
1275,Outcome Reporting Bias,Topic
1275,Meta-Analytic Findings,Topic
1275,Alessandra Gaia Saracini,Author
1275,Leonhard Held,Author
1275,Orb-Adjustment Techniques,Topic
1275,Clinical Trials,Topic
1275,Heterogeneity,Topic
1275,Treatment Effect Estimation,Topic
1275,Simulation Study,Topic
1276,Dengue Virus,Topic
1276,Dengvaxia,Paper
1277,Comorbid Anxiety Disorders,Topic
1277,Major Depressive Disorder (Mdd),Topic
1277,Machine Learning Techniques,Topic
1277,Gad-7 Questionnaire,Topic
1277,Smartphone-Based Interventions,Topic
1277,Morgan B. Talbot,Author
1277,Jessica M. Lipschitz,Author
1277,Omar Costilla-Reyes,Author
1277,Clinical Trial,Topic
1277,Treatment Response Prediction,Topic
1277,Smartphone-Delivered Psychotherapy,Topic
1278,Large Language Models,Topic
1278,Medical Applications,Topic
1278,Equityguard,Topic
1278,Yuelyu Ji,Author
1278,Wenhe Ma,Author
1278,Sonish Sivarajkumar,Author
1278,Hang Zhang,Author
1278,Eugene Mathew Sadhu,Author
1278,Zhuochun Li,Author
1278,Xizhi Wu,Author
1278,Shyam Visweswaran,Author
1278,Yanshan Wang,Author
1279,Area Under The Curve (Auc),Topic
1279,Mean Cumulative Function (Mcf),Topic
1279,Lin-Wei-Yang-Ying (Lwyy) Model,Topic
1279,Covariate Adjustment Approach,Topic
1279,Jiren Sun,Author
1279,Tuo Wang,Author
1279,Yanyao Yi,Author
1279,Ting Ye,Author
1279,Jun Shao,Author
1279,Yu Du,Author
1280,Dynamic Treatment Regime,Topic
1280,Bayesian Model,Topic
1280,Jiefeng Bi,Author
1280,Matteo Borrotti,Author
1280,Bernardo Nipoti,Author
1280,Severe Acute Arterial Hypertension,Topic
1280,Uncertainty Quantification,Topic
1280,Multi-Stage Variable Selection,Topic
1280,Clinical Trial Data,Topic
1280,Dimensionality Reduction,Topic
1280,Prognostic Factors,Topic
1280,Optimal Decision Sequences,Topic
1280,Simulation Studies,Topic
1281,Geometric-Based Nail Segmentation For Clinical Measurements,Paper
1281,Toenail Segmentation Method,Topic
1281,Hough Transform,Topic
1281,Watershed Transform,Topic
1281,348-Image Medical Dataset,Topic
1282,Sars-Cov-2 Spike Glycoprotein,Topic
1282,Hiv Drugs,Topic
1282,Covid-19 Disease,Topic
1282,Vini In Silico Model,Topic
1282,Fda-Approved Antiviral Drugs,Topic
1282,Cobicistat_Abacavir_Rilpivirine,Topic
1282,Karolj Skala,Author
1282,Attila Marcel Szasz,Author
1282,Melinda Rezeli,Author
1282,Jozsef Petrik,Author
1282,Branka Medved Rogina,Author
1283,Technology Based Intervention Methodologies,Topic
1283,Autism Spectrum Disorder,Topic
1283,Computer Aided Systems,Topic
1283,Computer Vision Assisted Technologies,Topic
1283,Virtual Reality,Topic
1283,Artificial Intelligence,Topic
1283,Muhammad Shoaib Jaliawala,Author
1283,Rizwan Ahmed Khan,Author
1284,Rapid-Eye-Movement Sleep Behaviour Disorder,Topic
1284,Parkinson'S Disease,Topic
1284,Automated Sleep Staging,Topic
1284,Rbd Detection,Topic
1284,Random Forest Classifier,Topic
1284,Polysomnography,Topic
1284,Electroencephalogram,Topic
1284,Electrooculogram,Topic
1284,Electromyogram,Topic
1284,Cohen'S Kappa Score,Topic
1284,Wearable Take-Home Technology,Topic
1284,Navin Cooray,Author
1284,Fernando Andreotti,Author
1284,Christine Lo,Author
1284,Mkael Symmonds,Author
1284,Michele T. M. Hu,Author
1284,Maarten De Vos,Author
1285,Diffusion Magnetic Resonance Imaging,Topic
1285,Double Diffusion Encoding,Topic
1285,Rafael N. Henriques,Author
1285,Marco Palombo,Author
1285,Sune N. Jespersen,Author
1285,Noam Shemesh,Author
1285,Henrik Lundell,Author
1286,Brain Tissue Segmentation From Multimodal Mri,Topic
1286,Deep Neural Networks (Dnns),Topic
1286,Joint Tissue And Lesion Segmentation Model,Topic
1286,Reuben Dorent,Author
1286,Wenqi Li,Author
1286,Jinendra Ekanayake,Author
1286,Sebastien Ourselin,Author
1286,Tom Vercauteren,Author
1287,Functional Magnetic Resonance Imaging (Fmri),Topic
1287,Fbnetgen,Paper
1287,Adolescent Brain Cognitive Development (Abcd),Topic
1287,Pnc,Topic
1287,Xuan Kan,Author
1287,Hejie Cui,Author
1287,Joshua Lukemire,Author
1287,Ying Guo,Author
1287,Carl Yang,Author
1288,Epilepsy,Topic
1288,Machine Learning,Topic
1288,Seeg,Topic
1288,Brainnet,Paper
1288,Junru Chen,Author
1288,Yang Yang,Author
1288,Tao Yu,Author
1288,Yingying Fan,Author
1288,Xiaolong Mo,Author
1288,Carl Yang,Author
1289,Hierarchical Event Descriptor Library Schema For Eeg Data Annotation,Paper
1290,Hiv Rna Copies,Topic
1290,Viral Load,Topic
1290,Arv Therapies,Topic
1290,Hiv Pathogenesis,Topic
1290,Long-Term Treatment,Topic
1290,Drug Resistance,Topic
1290,Adherence,Topic
1290,Differential Equation Models,Topic
1290,Bayesian Nonlinear Mixed-Effects Modeling,Topic
1290,Yangxin Huang,Author
1290,Tao Lu,Author
1291,Sepsis,Topic
1291,Innate Immune Response Agent-Based Model (Iirabm),Topic
1291,"Adaptive, Personalized Multi-Cytokine Mediation Therapy",Topic
1291,Brenden K. Petersen,Author
1291,Jiachen Yang,Author
1291,Will S. Grathwohl,Author
1291,Chase Cockrell,Author
1291,Claudio Santiago,Author
1291,Gary An,Author
1291,Daniel M. Faissol,Author
1292,Longitudinal Assessment Of Brain Atrophy,Topic
1292,Alzheimer'S Disease,Topic
1292,Deepatrophy,Paper
1292,Regional Deep Atrophy,Paper
1292,Mengjin Dong,Author
1292,Long Xie,Author
1292,Sandhitsu R. Das,Author
1292,Jiancong Wang,Author
1292,Laura E. M. Wisse,Author
1292,Robin Deflores,Author
1292,David A. Wolk,Author
1292,Paul A. Yushkevich,Author
1293,Two-Part Joint Models For A Longitudinal Semicontinuous Biomarker And A Terminal Event,Topic
1293,Frequentist Estimation,Topic
1293,Bayesian Estimation,Topic
1293,Integrated Nested Laplace Approximation,Topic
1293,Frailtypack,Topic
1293,Gercor,Topic
1293,Prime,Topic
1293,Denis Rustand,Author
1293,Janet Van Niekerk,Author
1293,HÂvard Rue,Author
1293,Christophe Tournigand,Author
1293,Virginie Rondeau,Author
1293,Laurent Briollais,Author
1294,Pressure Ulcers,Topic
1294,Uk,Topic
1294,National Health Service,Topic
1294,Mersey Care Nhs Foundation Trust,Author
1294,Paul Fergus,Author
1294,Carl Chalmers,Author
1294,William Henderson,Author
1294,Danny Roberts,Author
1294,Atif Waraich,Author
1294,Clinical Trial,Topic
1294,Convolutional Neural Network,Topic
1294,Deep Learning,Topic
1294,Pressure Ulcer Categorisation,Topic
1294,Mean Average Precision,Topic
1294,Recall,Topic
1294,F1-Score,Topic
1295,False Approval Rate,Topic
1295,Error Rate Familywise,Topic
1295,Error Rate Per Family,Topic
1295,Regulatory Agency,Topic
1295,Platform Trials,Topic
1295,Xinping Cui,Author
1295,Emily Ouyang,Author
1295,Yi Liu,Author
1295,Jingjing Schneider,Author
1295,Hong Tian,Author
1295,Bushi Wang,Author
1295,Jason C. Hsu,Author
1296,Non-Small Cell Lung Cancer (Nsclc),Topic
1296,Benjamin K. Schneider,Author
1296,Sebastien Benzekry,Author
1296,Jonathan P. Mochel,Author
1296,Mathematical Modeling,Topic
1296,Bevacizumab,Topic
1296,Pemetrexed-Cisplatin,Topic
1296,Clinical Trials,Topic
1296,Therapeutics,Topic
1296,Tumor Data,Topic
1296,Tumor Reduction,Topic
1296,Sequential Administration,Topic
1296,Concomitant Administration,Topic
1296,Treatment Outcomes,Topic
1296,Acquired Resistance,Topic
1296,Vascular Remodeling,Topic
1296,Clinical Parameters,Topic
1297,Recent Technological Advances In Brain Recording And Artificial Intelligence,Topic
1297,Naturalistic Neuroscience,Topic
1297,"Automated Approach For Analyzing Simultaneously Recorded Long-Term, Naturalistic Electrocorticography (Ecog) And Naturalistic Behavior Video Data",Topic
1297,Computer Vision,Topic
1297,Discrete Latent-Variable Modeling,Topic
1297,String Pattern-Matching,Topic
1297,Naturalistic Human Upper-Limb Movement Events,Topic
1297,Brain-Computer Interfacing Applications,Topic
1297,Curated Dataset,Topic
1297,Satpreet H. Singh,Author
1297,Steven M. Peterson,Author
1297,Rajesh P. N. Rao,Author
1297,Bingni W. Brunton,Author
1298,Randomized Controlled Trials,Topic
1298,Paediatric Multiple Sclerosis,Topic
1298,Creutzfeldt-Jakob Disease,Topic
1298,Steffen Unkel,Author
1298,Christian Rˆver,Author
1298,Nigel Stallard,Author
1298,Norbert Benda,Author
1298,Martin Posch,Author
1298,Sarah Zohar,Author
1298,Tim Friede,Author
1299,Vietnarms,Topic
1299,Hepatitis C,Topic
1299,L. Mccabe,Author
1299,I. R. White,Author
1299,N. V. Vinh Chau,Author
1299,E. Barnes,Author
1299,S. L. Pett,Author
1299,G. S. Cooke,Author
1299,A. S. Walker,Author
1300,Sample Size Determination For Cluster Randomised Trials,Topic
1300,Intra-Cluster Correlation Coefficient,Topic
1300,Minimal Clinically Important Difference,Topic
1300,Standard Deviation,Topic
1300,Coefficient Of Variation Of The Cluster Size,Topic
1300,Bayesian Assurance,Topic
1300,Frequentist Analysis,Topic
1300,Post-Stroke Incontinence,Topic
1300,S. Faye Williamson,Author
1300,Svetlana V. Tishkovskaya,Author
1300,Kevin J. Wilson,Author
1301,Cluster-Randomized Trials,Topic
1301,Mary Ryan Baumann,Author
1301,Monica Taljaard,Author
1301,Patrick J. Heagerty,Author
1301,Michael O. Harhay,Author
1301,Guangyu Tong,Author
1301,Rui Wang,Author
1301,Fan Li,Author
1301,Sample Size Methodology,Topic
1301,Power Calculations,Topic
1301,Treatment Effect Heterogeneity,Topic
1301,Online R Shiny Calculator,Topic
1301,Intracluster Correlation Coefficients,Topic
1301,Real Crt Examples,Topic
1302,Monitoring Fetal Electroencephalogram Intrapartum: A Systematic Literature Review,Paper
1302,Fetal Electroencephalogram,Topic
1303,Clinical Cohort Studies,Topic
1303,Ccs Explorer,Paper
1303,Pubmed,Topic
1303,Biobert,Topic
1303,Pubmedbert,Topic
1304,Rehabilitation Research,Topic
1304,Redwine,Paper
1304,Electronic Health Records,Topic
1304,Observational Health Data Sciences And Informatics,Topic
1304,Open Health Natural Language Processing,Topic
1304,David Oniani,Author
1304,Bambang Parmanto,Author
1304,Andi Saptono,Author
1304,Allyn Bove,Author
1304,Janet Freburger,Author
1304,Shyam Visweswaran Nickie Cappella,Author
1304,Brian Mclay,Author
1304,Jonathan C. Silverstein,Author
1304,Michael J. Becich,Author
1304,Anthony Delitto,Author
1304,Elizabeth Skidmore,Author
1304,Yanshan Wang,Author
1305,Clinical Practice Guidelines,Topic
1305,Research Studies,Topic
1305,Study Cohorts,Topic
1305,Study Cohort Ontology,Topic
1305,Semanticscience Integrated Ontology,Topic
1305,Table 1,Topic
1305,Shruthi Chari,Author
1305,Miao Qi,Author
1305,Nkcheniyere N. Agu,Author
1305,Oshani Seneviratne,Author
1305,James P. Mccusker,Author
1305,Kristin P. Bennett,Author
1305,Amar K. Das,Author
1305,Deborah L. Mcguinness,Author
1306,Cvit-Covid Dataset,Topic
1306,University Of Waterloo,Author
1306,Mosmed,Topic
1306,Fakrul Islam Tushar,Author
1306,Ehsan Abadi,Author
1306,Saman Sotoudeh-Paima,Author
1306,Rafael B. Fricks,Author
1306,Maciej A. Mazurowski,Author
1306,W. Paul Segars,Author
1306,Ehsan Samei,Author
1306,Joseph Y. Lo,Author
1307,Human Brain Connectivity,Topic
1307,Single Pulse Electrical Stimulation,Topic
1307,Intracranial Eeg Measurements,Topic
1307,Cortico-Cortical Evoked Potentials (Ccep),Topic
1307,Common Average Referencing (Car),Topic
1307,Car By Least Anticorrelation (Carla),Topic
1307,Simulated Ccep Data,Topic
1307,Real Ccep Data,Topic
1307,Four Human Participants,Topic
1307,Mean Cross-Trial Covariance,Topic
1307,Shared Noise,Topic
1307,Signal Quality,Topic
1307,Mean R-Squared,Topic
1307,Inter-Channel Dependency,Topic
1307,Specificity,Topic
1307,Sensitivity,Topic
1307,Harvey Huang,Author
1307,Gabriela Ojeda Valencia,Author
1307,Nicholas M. Gregg,Author
1307,Gamaleldin M. Osman,Author
1307,Morgan N. Montoya,Author
1307,Gregory A. Worrell,Author
1307,Kai J. Miller,Author
1307,Dora Hermes,Author
1308,Quantitative Susceptibility Mapping,Topic
1308,Fahad Salman,Author
1308,Abhisri Ramesh,Author
1308,Thomas Jochmann,Author
1308,Mirjam Prayer,Author
1308,Ademola Adegbemigun,Author
1308,Jack A. Reeves,Author
1308,Gregory E. Wilding,Author
1308,Junghun Cho,Author
1308,Dejan Jakimovski,Author
1308,Niels Bergsland,Author
1308,Michael G. Dwyer,Author
1308,Robert Zivadinov,Author
1308,Ferdinand Schweser,Author
1309,Personalized Medical Treatments Using Novel Reinforcement Learning Algorithms,Paper
1309,Yousuf M. Soliman,Author
1309,Computer Science,Topic
1309,Medicine,Topic
1309,Personalized Treatment Policies,Topic
1309,Q-Learning Algorithm,Topic
1309,Censored Q-Learning Algorithm,Topic
1309,Chronic Depression Data,Topic
1309,Hypothetical Clinical Trial,Topic
1309,Algorithmic Framework,Topic
1309,Multistage Decision Problem,Topic
1309,Expected Survival Times,Topic
1309,Optimal Treatment Path,Topic
1310,Nancy Flournoy,Author
1310,"Long Beach, California",Topic
1310,Polytechnic School,Topic
1310,Ucla,Topic
1310,Southwest Laboratory For Education Research And Development,Topic
1310,Fred Hutchinson Cancer Research Center,Topic
1310,University Of Washington,Topic
1310,National Science Foundation,Topic
1310,Department Of Mathematics And Statistics At American University,Topic
1310,University Of Missouri,Topic
1311,Malignant Melanoma,Topic
1311,Dermoscopy,Topic
1311,Image Processing,Topic
1311,Machine Learning,Topic
1311,Nabin K. Mishra,Author
1311,M. Emre Celebi,Author
1311,Computerized Detection Of Melanoma,Paper
1312,Warfarin Dosing,Topic
1312,Machine Learning Algorithms,Topic
1312,Iwpc Algorithm,Topic
1312,Stack 1,Topic
1312,Stack 2,Topic
1312,Cyp2C9,Topic
1312,Vkorc1,Topic
1312,Zhiyuan Ma,Author
1312,Ping Wang,Author
1312,Zehui Gao,Author
1312,Ruobing Wang,Author
1312,Koroush Khalighi,Author
1313,Pre-Symptomatic Alzheimer'S Disease,Topic
1313,Alzheimer'S Disease Neuroimaging Initiative,Topic
1313,Dan Li,Author
1313,Samuel Iddi,Author
1313,Paul S. Aisen,Author
1313,Wesley K. Thompson,Author
1313,Michael C. Donohue,Author
1314,Artificial Intelligence For Pediatric Ophthalmology,Paper
1314,Pediatric Ophthalmology,Topic
1315,Oligonucleotide-Based Agents,Topic
1315,Bioconjugated Oligonucleotides,Topic
1315,Antisense Dna (Aso),Topic
1315,Rna Interference (Rnai),Topic
1315,Galnac,Topic
1315,Cell Penetrating Peptides,Topic
1315,Aptamers,Topic
1315,Antibodies,Topic
1315,Cholesterol,Topic
1315,Squalene,Topic
1315,Fatty Acids,Topic
1315,Nucleolipids,Topic
1315,Bioconjugation Chemistry,Topic
1315,SÈbastien Benizri,Author
1315,Arnaud Gissot,Author
1315,Andrew Martin,Author
1315,Brune Vialet,Author
1315,Mark Grinstaff,Author
1315,Philippe BarthÈlÈmy,Author
1316,Vts Glove,Topic
1316,Chronic Stroke Survivors,Topic
1316,Caitlyn E. Seim,Author
1316,Steven L. Wolf,Author
1316,Thad E. Starner,Author
1316,Feasibility Study,Topic
1316,Vibrotactile Stimulation,Topic
1316,Semmes-Weinstein Monofilament Exam,Topic
1316,Modified Ashworth Measures,Topic
1316,Voluntary Finger Flexion,Topic
1316,Elbow And Shoulder Range Of Motion,Topic
1317,Causal Structure Discovery From Ehr Data,Paper
1317,Xinpeng Shen,Author
1317,Sisi Ma,Author
1317,Prashanthi Vemuri,Author
1317,M. Regina Castro,Author
1317,Pedro J. Caraballo,Author
1317,Gyorgy J. Simon,Author
1317,Type-2 Diabetes Mellitus,Topic
1318,Causal Prediction Models,Topic
1318,Lijing Lin,Author
1318,Matthew Sperrin,Author
1318,David A. Jenkins,Author
1318,Glen P. Martin,Author
1318,Niels Peek,Author
1318,Prediction Models,Topic
1318,Causal Inference,Topic
1318,Observational Data,Topic
1318,Clinical Trials,Topic
1318,Meta-Analyses,Topic
1319,Drug Discovery,Topic
1319,Lead Optimization,Topic
1319,Machine Learning,Topic
1319,Molecular Modeling,Topic
1319,Physics-Based Molecular Dynamics Simulation,Topic
1319,Temporal Dynamism Representation,Topic
1319,Unsupervised Convolutional Variational Autoencoder,Topic
1319,Conventional Clustering Method,Topic
1319,Cvae-Based Clustering Method,Topic
1319,Leili Zhang,Author
1319,Giacomo Domeniconi,Author
1319,Chih-Chieh Yang,Author
1319,Seung-Gu Kang,Author
1319,Ruhong Zhou,Author
1319,Guojing Cong,Author
1320,Trecap,Topic
1320,R. P. Bremm,Author
1320,A. Werle,Author
1320,C. Auer,Author
1320,F. Hertel,Author
1320,J. GonÁalves,Author
1320,K. P. Koch,Author
1320,Parkinson'S Disease,Topic
1320,Wearable Sensors,Topic
1320,Machine Learning,Topic
1320,Support Vector Machine Algorithms,Topic
1320,Clinical Trials,Topic
1321,Multiple Sclerosis,Topic
1321,Neuroimaging Data,Topic
1321,Magnetic Resonance Imaging,Topic
1321,Clinical Laboratory Tests,Topic
1321,Subhrajit Roy,Author
1321,Diana Mincu,Author
1321,Lev Proleev,Author
1321,Negar Rostamzadeh,Author
1321,Chintan Ghate,Author
1321,Natalie Harris,Author
1321,Christina Chen,Author
1321,Jessica Schrouff,Author
1321,Nenad Tomasev,Author
1321,Fletcher Lee Hartsell,Author
1321,Katherine Heller,Author
1321,Performance Outcome Measures,Topic
1321,Demographic Data,Topic
1321,Machine Learning Models,Topic
1321,Disease Progression,Topic
1321,Feature Ablation Studies,Topic
1321,End-To-End Reusable Pre-Processing And Machine Learning Framework,Topic
1322,Chronic Cancer Pain Dataset,Topic
1322,Catherine Ordun,Author
1322,Alexandra N. Cha,Author
1322,Edward Raff,Author
1322,Byron Gaskin,Author
1322,Alex Hanson,Author
1322,Mason Rule,Author
1322,Sanjay Purushotham,Author
1322,James L. Gulley,Author
1323,A Decision-Theoretic Model For Using Scientific Data,Paper
1323,Artificial Intelligence Systems,Topic
1323,Scientific Methodology,Topic
1323,Decision Analysis,Topic
1323,Medical Research,Topic
1323,Influence Diagram,Topic
1323,Clinical Research Practices,Topic
1323,Clinical Epidemiological Advisory Systems,Topic
1323,Statistical Workstations,Topic
1323,Meta-Analytic Reviews,Topic
1323,Case-Control Studies,Topic
1323,Cohort Studies,Topic
1323,Controlled Clinical Trials,Topic
1324,Neutropenia,Topic
1324,Acute Myeloid Leukemia,Topic
1324,Mathematical Modeling,Topic
1324,Population Pk/Pd Model,Topic
1324,Cytarabine,Topic
1324,Granulocyte-Colony Stimulating Factor,Topic
1324,Clinical Trial,Topic
1324,Felix Jost,Author
1324,Enrico Schalk,Author
1324,Daniela Weber,Author
1324,Hartmut Doehner,Author
1324,Thomas Fischer,Author
1324,Sebastian Sager,Author
1325,Data-Adaptive Effect Estimators,Topic
1325,Bioinformatic And Clinical Studies,Topic
1325,Refine2,Topic
1325,Xiang Meng,Author
1325,Jonathan Huang,Author
1326,Lung Cancer Risk Estimation With Incomplete Data: A Joint Missing Imputation Perspective,Paper
1326,Conditional Pbigan,Topic
1327,Burn Resuscitation Protocols,Topic
1327,Burn Pathophysiology,Topic
1327,Mathematical Model,Topic
1327,Ghazal Arabidarrehdor,Author
1327,Ali Tivay,Author
1327,Chris Meador,Author
1327,George C. Kramer,Author
1327,Jin-Oh Hahn,Author
1327,Jose Salinas,Author
1327,233 Burn Patients,Topic
1327,Physiological Responses,Topic
1327,Inflammatory Response,Topic
1327,Mortality Risk,Topic
1327,Fluid Retention,Topic
1327,Demographic Characteristics,Topic
1327,Injury Severity,Topic
1327,Inhalational Injury,Topic
1328,Pain Patient States,Topic
1328,Jenna M. Reinen,Author
1328,Carla Agurto,Author
1328,Guillermo Cecchi,Author
1328,Jeffrey L. Rogers,Author
1328,Navitas,Author
1328,Envision Studies Physician Author Group,Author
1328,Boston Scientific Research Scientists Consortium,Author
1328,Chronic Pain Patients,Topic
1328,Clinical Trial,Topic
1328,Data-Driven Approach,Topic
1328,Clustering Analysis,Topic
1328,Quality-Of-Life Assessment,Topic
1328,Disability Assessment,Topic
1328,Mobile Device Monitoring,Topic
1329,Alzheimer'S Disease,Topic
1329,Amyloid-Beta Peptide,Topic
1329,Astrocytes,Topic
1329,Adni Data,Topic
1329,Stochastic Models,Topic
1329,Bayesian Inference,Topic
1329,Hina Shaheen,Author
1329,Roderick Melnik,Author
1329,The Alzheimer'S Disease Neuroimaging Initiative,Author
1330,Medical Imaging,Topic
1330,Cnns,Topic
1330,Transformers,Topic
1330,Transf/Attention,Topic
1330,Hybrid Cnn-Transf/Attention Models,Topic
1330,Giorgos Papanastasiou,Author
1330,Nikolaos Dikaios,Author
1330,Jiahao Huang,Author
1330,Chengjia Wang,Author
1330,Guang Yang,Author
1330,Is Attention All You Need In Medical Image Analysis? A Review,Paper
1331,Cancer,Topic
1331,Personalized Treatment Strategies,Topic
1331,Genomic Profiling,Topic
1331,Drug Response Prediction Models,Topic
1331,Transfer Learning,Topic
1331,Transformer Based Method,Topic
1331,Treatment Recommendation System,Topic
1331,"National University Hospital, Singapore",Topic
1331,Aishwarya Jayagopal,Author
1331,Hansheng Xue,Author
1331,Ziyang He,Author
1331,Robert J. Walsh,Author
1331,Krishna Kumar Hariprasannan,Author
1331,David Shao Peng Tan,Author
1331,Tuan Zea Tan,Author
1331,Jason J. Pitt,Author
1331,Anand D. Jeyasekharan,Author
1331,Vaibhav Rajan,Author
1332,Deepcre,Topic
1332,Therapeutic Application,Topic
1332,Drug Research And Development,Topic
1332,Cross-Drug Response Evaluation,Topic
1332,Ai Model,Topic
1332,Colorectal Cancer Organoids,Topic
1332,Yushuai Wu,Author
1332,Ting Zhang,Author
1332,Hao Zhou,Author
1332,Hainan Wu,Author
1332,Hanwen Sunchu,Author
1332,Lei Hu,Author
1332,Xiaofang Chen,Author
1332,Suyuan Zhao,Author
1332,Gaochao Liu,Author
1332,Chao Sun,Author
1332,Jiahuan Zhang,Author
1332,Yizhen Luo,Author
1332,Peng Liu,Author
1332,Zaiqing Nie,Author
1333,Transcranial Ultrasound,Topic
1333,Tusnet,Paper
1333,Kasra Naftchi-Ardebili,Author
1333,Karanpartap Singh,Author
1333,Gerald R. Popelka,Author
1333,Kim Butts Pauly,Author
1333,Opioid Addiction,Topic
1333,Alzheimer'S Disease,Topic
1333,Dementia,Topic
1333,Epilepsy,Topic
1333,Glioblastoma,Topic
1333,K-Wave,Topic
1334,Large Language Models,Topic
1334,Medical Applications,Topic
1334,Drug Discovery,Topic
1334,Clinical Decision Support,Topic
1334,Telemedicine,Topic
1334,Medical Devices,Topic
1334,Healthcare Insurance Applications,Topic
1334,Llm-Powered Medical Ai Applications,Topic
1334,Three-Step Framework,Topic
1334,Modeling,Topic
1334,Optimization,Topic
1334,System Engineering,Topic
1334,Clinical Trial Design,Topic
1334,Medical Imaging Analysis,Topic
1334,Zifeng Wang,Author
1334,Hanyin Wang,Author
1334,Benjamin Danek,Author
1334,Ying Li,Author
1334,Christina Mack,Author
1334,Hoifung Poon,Author
1334,Yajuan Wang,Author
1334,Pranav Rajpurkar,Author
1334,Jimeng Sun,Author
1335,Alzheimer'S Disease,Topic
1335,Sustain Algorithm,Topic
1335,Emma Prevot,Author
1335,Cameron Shand,Author
1335,Neil Oxtoby,Author
1335,Alzheimer'S Disease Neuroimaging Initiative,Author
1335,T1-Weighted Mri Data,Topic
1335,Anmerge,Topic
1335,Oasis,Topic
1335,Adni,Topic
1335,Typical Subtype,Topic
1335,Cortical Subtype,Topic
1335,Subcortical Subtype,Topic
1335,Posterior Cortical Atrophy,Topic
1335,Cohort Composition,Topic
1335,Dataset Diversity,Topic
1335,Ethnic Representation,Topic
1336,Computational Modelling Of Biological Systems,Topic
1336,Cardiovascular System,Topic
1336,Digital Twins,Topic
1336,In Silico Methods,Topic
1336,Axel Loewe,Author
1336,Peter J. Hunter,Author
1336,Peter Kohl,Author
1337,Mental Disorders,Topic
1337,Psychiatrists,Topic
1337,Artificial Intelligence-Based Training System,Paper
1337,Large Language Models,Topic
1337,Knowledge Graphs,Topic
1337,Expert Systems,Topic
1337,B/S Architecture,Topic
1337,Vue.Js,Topic
1337,Node.Js,Topic
1337,Deep Learning Algorithms,Topic
1337,Clinical Trial,Topic
1337,System Stability,Topic
1337,Ai Dialogue Accuracy,Topic
1337,Diagnostic Accuracy,Topic
1337,User Satisfaction,Topic
1337,Knowledge Mastery,Topic
1337,Clinical Thinking,Topic
1337,Diagnostic Skills,Topic
1337,Psychiatrist Training,Topic
1337,Mental Health Professional Development,Topic
1338,Compressed Genotyping,Topic
1338,Yaniv Erlich,Author
1338,Assaf Gordon,Author
1338,Michael Brand,Author
1338,Gregory J. Hannon,Author
1338,Partha P. Mitra,Author
1338,Cystic Fibrosis,Topic
1338,Mental Retardation,Topic
1339,Hepatic Encephalopathy,Topic
1339,Portacaval Shunt,Topic
1339,Morris Water Maze,Topic
1339,M. MÈndez,Author
1339,M. MÈndez-LÛpez,Author
1339,L. LÛpez,Author
1339,M. A. Aller,Author
1339,J. Arias,Author
1339,J. L. Arias,Author
1340,Computational Methods,Topic
1340,Experimental And Clinical Neurosciences,Topic
1340,Nervous Systems,Topic
1340,Health,Topic
1340,Disease,Topic
1340,Neuromodulation,Topic
1340,Electric And Magnetic Stimulation,Topic
1340,Chronic And Intractable Diseases,Topic
1340,Translational Computational Neuroscience,Topic
1340,Dynamical Network Biomarkers (Dnb),Topic
1340,Episodic Manifestations Of Chronic Disorders,Topic
1340,Migraine,Topic
1340,Early-Warning Signals,Topic
1340,Markus A. Dahlem,Author
1340,Sebastian Rode,Author
1340,Arne May,Author
1340,Naoya Fujiwara,Author
1340,Yoshito Hirata,Author
1340,Kazuyuki Aihara,Author
1340,J¸rgen Kurths,Author
1341,The Potential Of The Human Connectome As A Biomarker Of Brain Disease,Paper
1341,Marcus Kaiser,Author
1341,Connectome,Topic
1341,Brain Disorders,Topic
1341,Cognitive Deficits,Topic
1341,Biomarkers,Topic
1341,Dynamic Connectome,Topic
1341,Structural Connectivity,Topic
1341,Functional Connectivity,Topic
1341,Effective Connectivity,Topic
1342,Electrical High Frequency Stimulation,Topic
1342,Deep Brain Regions,Topic
1342,Movement Disorders,Topic
1342,Neurological Disorders,Topic
1342,Computational Model Of The Basal Ganglia Network,Topic
1342,Subthalamic Nucleus,Topic
1342,Sensorimotor Input,Topic
1342,Thalamo-Cortical Relay Cells,Topic
1342,Gaba,Topic
1342,Felix Njap,Author
1342,Jens Christian Claussen,Author
1342,Andreas Moser,Author
1342,Ulrich G. Hofmann,Author
1342,Rubin And Terman,Author
1342,"J Comput Neurosci, 16, 211-223, 2004",Paper
1342,Simulated Parkinsonian State,Topic
1343,Mathematical Modeling Approaches,Topic
1343,Clinical Neuroscience,Topic
1343,Migraine Generator Network,Topic
1343,Premonitory Symptoms,Topic
1343,Tipping Point,Topic
1343,Neuronal And Autonomic Subnetworks,Topic
1343,Dynamical Network Biomarker Of Migraine,Topic
1343,Markus A. Dahlem,Author
1343,J¸rgen Kurths,Author
1343,Michel D. Ferrari,Author
1343,Kazuyuki Aihara,Author
1343,Marten Scheffer,Author
1343,Arne May,Author
1344,Bi-Directional Motion Detection: A Neural Intelligent Model For Perception Of Cognitive Robots,Paper
1344,Spiking Neuronal Network Model,Topic
1344,Cognitive Robots,Topic
1344,Neuronal Circuit,Topic
1344,Blocking Problems,Topic
1344,Pioneer Cognitive Robot,Topic
1344,Sensory Networks,Topic
1344,Intrinsic Delay,Topic
1344,High-Speed Circuits,Topic
1345,Braitenberg Vehicles,Topic
1345,Cognitive Studies,Topic
1345,Robotics,Topic
1345,Neurorobotics,Topic
1345,Motion Detection,Topic
1345,Intelligent Braitenberg Vehicles,Topic
1345,Neuronal Circuit,Topic
1345,Curved Movements,Topic
1345,Modular Structure,Topic
1345,Sensory-Biosystems,Topic
1345,Epileptic Seizures,Topic
1345,Excitatory Stimuli,Topic
1345,Inhibitory Stimuli,Topic
1345,Straight Movements,Topic
1345,Pioneer,Topic
1345,Neurosensors,Topic
1345,Curved Trajectory Detector,Topic
1345,Matin Macktoobian,Author
1345,Curved Trajectory Detection : A Novel Neurocognitive Perception Approach For Autonomous Smart Robots,Paper
1346,Graph-Theoretical Analyses Of Complex Brain Networks,Topic
1346,Gerrit Ansmann,Author
1346,Klaus Lehnertz,Author
1346,Weighted Functional Brain Networks,Topic
1346,Surrogate Networks,Topic
1346,Epilepsy Patients,Topic
1346,Control Subjects,Topic
1346,Eeg/Meg Recordings,Topic
1346,Behavioral States,Topic
1346,Surrogate-Assisted Analysis Approach,Topic
1347,Curved Trajectory Detection,Topic
1347,Depth Detection Module,Topic
1347,Matin Macktoobian,Author
1347,Mohammad Jafari,Author
1347,Erfan Attarzadeh Gh,Author
1347,Pioneer Mobile Robot,Topic
1348,Statistical Machine Learning Methods,Topic
1348,Neuroimaging Data Analysis,Topic
1348,Scikit-Learn,Topic
1348,Alexandre Abraham,Author
1348,Fabian Pedregosa,Author
1348,Michael Eickenberg,Author
1348,Philippe Gervais,Author
1348,Andreas Muller,Author
1348,Jean Kossaifi,Author
1348,Alexandre Gramfort,Author
1348,Bertrand Thirion,Author
1348,G‰el Varoquaux,Author
1349,Functional Brain Imaging: A Comprehensive Survey,Paper
1349,Functional Brain Imaging,Topic
1349,Functional Magnetic Resonance Imaging (Fmri),Topic
1349,Functional Optical Imaging,Topic
1350,"The Connected Brain: Causality, Models And Intrinsic Dynamics",Paper
1350,Adeel Razi,Author
1350,Karl Friston,Author
1350,Brain Initiative,Topic
1350,European Human Brain Project,Topic
1350,Human Connectome Project,Topic
1350,Functional Neuroimaging,Topic
1350,Functional Connectivity,Topic
1350,Causal Modeling,Topic
1350,Connectomics,Topic
1350,Multivariate Analyses Of Distributed Patterns Of Brain Responses,Topic
1351,On The Formal Development Of Behavioral Reactive Agents: A Systematic Braitenberg-Vehicle Approach,Paper
1351,Braitenberg Vehicle,Topic
1351,Reactive Agents,Topic
1352,Computational Psychiatry In Borderline Personality Disorder,Paper
1353,Data Assimilation,Topic
1353,Neuroscience,Topic
1353,Electroencephalography (Eeg),Topic
1353,Kalman Filtering,Topic
1353,Ary'S Model Of The Head,Topic
1353,Lara Escuain-Poole,Author
1353,Jordi Garcia-Ojalvo,Author
1353,Antonio J. Pons,Author
1353,Extracranial Electrodes,Topic
1354,Machine Learning Models,Topic
1354,Neuroimaging Data,Topic
1354,Weight Maps,Topic
1354,Classifiers,Topic
1354,Signal Differences,Topic
1354,False Positives,Topic
1354,Electrocorticography (Ecog),Topic
1354,Signal-To-Noise Ratio,Topic
1354,Sparsity Of The Neural Signal,Topic
1354,Cognitive Neuroscience,Topic
1354,Clinical Neuroscience,Topic
1354,Jessica Schrouff,Author
1354,Janaina Mourao-Miranda,Author
1355,Mice Vocalizations,Topic
1355,Ultrasonic Vocalizations (Usvs),Topic
1355,Manual Analysis Of Usvs,Topic
1355,New Method For Usvs,Topic
1355,Spectral Clustering,Topic
1355,Performance Measures,Topic
1355,Jiaxi Wang,Author
1355,Karel Mundnich,Author
1355,Allison T. Knoll,Author
1355,Pat Levitt,Author
1355,Shrikanth Narayanan,Author
1356,Brain Stimulation,Topic
1356,Non-Invasive Brain Stimulation (Nibs),Topic
1356,Non-Human Primate (Nhp) Models,Topic
1356,Oculomotor Network,Topic
1356,Sebastian J Lehmann,Author
1356,Brian D Corneil,Author
1357,Real Time Seizure Detection,Topic
1357,Epileptic Disease,Topic
1357,Computational Method,Topic
1357,Topological Analysis,Topic
1357,Persistent Homology,Topic
1357,Ximena Fern·ndez,Author
1357,Diego Mateos,Author
1357,Scalp Electroencephalograms,Topic
1357,Intracranial Electroencephalograms,Topic
1357,Magnetoencephalograms,Topic
1357,Interictal States,Topic
1357,Ictal States,Topic
1358,Spontaneous Thought,Topic
1358,Kieran C. R. Fox,Author
1358,Kalina Christoff,Author
1358,Interdisciplinary Science Of Spontaneous Thought,Topic
1359,Applications Of Machine Learning And Graph Theory Techniques To Neuroscience,Topic
1359,Nav1.7,Topic
1359,Chronic Painful Syndromes,Topic
1359,Alberto Toffano,Author
1359,Giacomo Chiarot,Author
1359,Stefano Zamuner,Author
1359,Margherita Marchi,Author
1359,Erika Salvi,Author
1359,Stephen G. Waxman,Author
1359,Catharina G. Faber,Author
1359,Giuseppe Lauria,Author
1359,Achille Giacometti,Author
1359,Marta Simeoni,Author
1359,Computational Pipeline,Topic
1360,Few-Shot Learning,Topic
1360,Neuroimaging Data,Topic
1360,Neuroimaging Benchmark Dataset,Topic
1360,Brain Signals,Topic
1360,Biomarkers,Topic
1360,Brain Scans,Topic
1360,Cognitive Tasks,Topic
1360,Myriam Bontonou,Author
1360,Giulia Lioi,Author
1360,Nicolas Farrugia,Author
1360,Vincent Gripon,Author
1361,Brain,Topic
1361,Emmanuelle Tognoli,Author
1361,Daniela Benites,Author
1361,J. A. Scott Kelso,Author
1361,Spatiotemporal Patterns,Topic
1361,Neuroscience,Topic
1361,Biologically-Inspired Engineering,Topic
1361,Electrophysiological Data,Topic
1361,Brain Connectivity Disorders,Topic
1362,Statistical Challenges In Neuroimaging Data Analysis,Topic
1362,Hongtu Zhu,Author
1362,Tengfei Li,Author
1362,Bingxin Zhao,Author
1363,Dynamic Functional Connectivity,Topic
1363,Christine Ahrends,Author
1363,Diego Vidaurre,Author
1364,Human Brain,Topic
1364,Neuroscience,Topic
1364,Graph Neural Networks,Topic
1364,Ptgb,Paper
1364,Yi Yang,Author
1364,Hejie Cui,Author
1364,Carl Yang,Author
1365,Bayesian Time-Series Classifier For Decoding Simple Visual Stimuli From Intracranial Neural Activity,Paper
1365,Navid Ziaei,Author
1365,Reza Saadatifard,Author
1365,Ali Yousefi,Author
1365,Behzad Nazari,Author
1365,Sydney S. Cash,Author
1365,Angelique C. Paulk,Author
1365,Neural Data,Topic
1365,Visual Task,Topic
1366,Diffusion Magnetic Resonance Imaging,Topic
1366,Ying Liao,Author
1366,Santiago Coelho,Author
1366,Jenny Chen,Author
1366,Benjamin Ades-Aron,Author
1366,Michelle Pang,Author
1366,Ricardo Osorio,Author
1366,Timothy Shepherd,Author
1366,Yvonne W. Lui,Author
1366,Dmitry S. Novikov,Author
1366,Els Fieremans,Author
1367,Brain Tissue Segmentation,Topic
1367,Longitudinal Data,Topic
1367,Dual Meta-Learning Paradigm,Topic
1367,Iseg2019,Topic
1367,Adni,Topic
1367,Yongheng Sun,Author
1367,Fan Wang,Author
1367,Jun Shu,Author
1367,Haifeng Wang,Author
1367,Li Wang,Author
1367,Deyu Meng,Author
1367,Chunfeng Lian,Author
1367,Dual Meta-Learning With Longitudinally Generalized Regularization For One-Shot Brain Tissue Segmentation Across The Human Lifespan,Paper
1368,Linking Fast And Slow: The Case For Generative Models,Paper
1368,Neuronal Connectivity,Topic
1368,Bayesian Inference,Topic
1368,State-Space Modeling,Topic
1368,Generative Models,Topic
1369,Noninvasive Brain Stimulation,Topic
1369,Transcranial Stimulation Techniques,Topic
1369,Depression,Topic
1369,Anxiety,Topic
1369,Chronic Pain,Topic
1369,Computer Science Semantic Reporting Methods,Topic
1369,Neuroscience Nibs Studies,Topic
1369,Fair,Topic
1369,Repetitive Transcranial Magnetic Stimulation,Topic
1369,Open Research Knowledge Graph,Topic
1369,Toward Semantic Publishing In Non-Invasive Brain Stimulation: A Comprehensive Analysis Of Rtms Studies,Paper
1370,Michael W. Cole,Author
1370,Brain Connectivity,Topic
1370,Task-Evoked Brain Activation Patterns,Topic
1370,Activity Flow Models,Topic
1370,Neurocognitive Functions,Topic
1370,Brain Disorders,Topic
1370,Activity Flow Modeling,Topic
1370,Computational Models,Topic
1371,Wishart Process,Topic
1371,Sequential Monte Carlo,Topic
1371,Mcmc,Topic
1371,Variational Inference,Topic
1371,Dynamic Covariance,Topic
1371,Hester Huijsdens,Author
1371,David Leeftink,Author
1371,Linda Geerligs,Author
1371,Max Hinne,Author
1371,Clinical Depression,Topic
1371,Econometrics,Topic
1371,Neuroscience,Topic
1371,Computational Psychology,Topic
1372,Individual Brain Parcellation,Topic
1372,Chengyi Li,Author
1372,Shan Yu,Author
1372,Yue Cui,Author
1373,Eeg-Ssm,Topic
1373,State-Space Models,Topic
1373,Dementia,Topic
1373,Healthy Control,Topic
1373,Frontotemporal Dementia,Topic
1373,Alzheimer'S Disease,Topic
1373,Xuan-The Tran,Author
1373,Linh Le,Author
1373,Quoc Toan Nguyen,Author
1373,Thomas Do,Author
1373,Chin-Teng Lin,Author
1374,Chatgpt 4O-Mini,Topic
1374,Mike Thelwall,Author
1374,Abdallah Yaghi,Author
1374,Research Excellence Framework 2021,Topic
1374,Journal Articles,Topic
1374,Large Language Models,Topic
1374,Citation-Based Indicators,Topic
1374,Philosophy,Topic
1374,"Psychology, Psychiatry And Neuroscience",Topic
1374,Clinical Medicine,Topic
1374,Health Sciences,Topic
1374,Physical Sciences,Topic
1374,Engineering,Topic
1374,Multidisciplinary Assessments,Topic
1375,Cwa-T,Topic
1375,Electroencephalogram (Eeg) Signals,Topic
1375,Tuh Abnormal Eeg Corpus,Topic
1375,Youshen Zhao,Author
1375,Keiji Iramina,Author
1376,Human Brain,Topic
1376,Sulcal Depth,Topic
1376,Maxime DieudonnÈ,Author
1376,Guillaume Auzias,Author
1376,Julien LefËvre,Author
1376,"1,987 Subjects",Topic
1377,Immunological Synapse,Topic
1377,Subhadip Raychaudhuri,Author
1377,Arup K. Chakraborty,Author
1377,Mehran Kardar,Author
1378,Simmune,Topic
1378,Immune System,Topic
1378,M. Meier-Schellersheim,Author
1378,G. Mack,Author
1379,Immune System,Topic
1379,Cognitive System,Topic
1379,Engineering Problems,Topic
1379,Immunological Principles,Topic
1379,Anomaly Detection Algorithm,Topic
1379,Applications,Topic
1379,Fault Detection,Topic
1379,P. J. Costa Branco,Author
1379,J. A. Dente,Author
1379,R. Vilela Mendes,Author
1380,Agent-Based Modeling Of Host-Pathogen Systems: The Successes And Challenges,Paper
1380,Immunology,Topic
1380,Disease Pathology,Topic
1380,Host-Pathogen Systems,Topic
1380,Agent-Based Models,Topic
1380,Reproducibility,Topic
1380,Model Validation,Topic
1381,Immunological Memory,Topic
1381,B And T Lymphocytes,Topic
1381,Monocytes,Topic
1381,Macrophages,Topic
1381,Dendritic Cells (Dcs),Topic
1381,Yiqiang Wang,Author
1381,Shuyi,Author
1382,Improved Immunological Assay,Topic
1382,Earl Bloch,Author
1382,Lou Massa,Author
1382,Kilian Dill,Author
1382,Quantum Dots,Topic
1382,Antigen Detection,Topic
1383,Towards A Mathematical Foundation Of Immunology And Amino Acid Chains,Paper
1384,Supervised Learning And Anti-Learning Of Colorectal Cancer Classes And Survival Rates From Cellular Biology Parameters,Paper
1384,Chris Roadknight,Author
1384,Uwe Aickelin,Author
1384,Guoping Qiu,Author
1384,John Scholefield,Author
1384,Lindy Durrant,Author
1384,Colorectal Cancer,Topic
1384,Immunological Status,Topic
1384,Tumour Classification,Topic
1384,Post-Operative Survival,Topic
1384,Machine Learning,Topic
1384,Anti-Learning,Topic
1384,Dataset,Topic
1384,Cancer Stage Prediction,Topic
1385,A Generation Method Of Immunological Memory In Clonal Selection Algorithm By Using Restricted Boltzmann Machines,Paper
1385,Shin Kamada,Author
1385,Takumi Ichimura,Author
1385,Image Processing,Topic
1385,Mobile Phone Based Participatory Sensing (Mpps) System,Topic
1385,Clonal Selection Algorithm With Immunological Memory Cell (Csaim),Topic
1385,Restricted Boltzmann Machines,Topic
1385,Deep Learning,Topic
1386,5G Networks,Topic
1386,Network Security Architecture,Topic
1386,Immunology,Topic
1386,Immune System,Topic
1386,Security And Availability Balance,Topic
1386,Situation-Awareness,Topic
1386,Community Cooperation,Topic
1386,Defense Capability,Topic
1386,Immunology-Inspired Network Security Architecture,Paper
1387,A Guideline For The Statistical Analysis Of Compositional Data In Immunology,Paper
1388,Neural Ensembles,Topic
1388,Dimensionality Of Neural Space,Topic
1388,Sensory Cortex Of Alert Rats,Topic
1388,Spiking Network Model,Topic
1388,Luca Mazzucato,Author
1388,Alfredo Fontanini,Author
1388,Giancarlo La Camera,Author
1389,Patient Monitoring In Intensive Care Units,Topic
1389,Biosensors,Topic
1389,It Infrastructures,Topic
1389,Clinical Decision Support Systems,Topic
1389,Artifacts,Topic
1389,Video Recordings,Topic
1389,Object Detection Methods,Topic
1389,Blurred Videos,Topic
1389,Temporal Succession Of Video Frames,Topic
1389,Yolov5 Baseline Model,Topic
1389,Raphael Emberger,Author
1389,Jens Michael Boss,Author
1389,Daniel Baumann,Author
1389,Marko Seric,Author
1389,Shufan Huo,Author
1389,Lukas Tuggener,Author
1389,Emanuela Keller,Author
1389,Thilo Stadelmann,Author
1390,Ep-Abc Algorithm,Topic
1390,Approximate Bayesian Computation (Abc),Topic
1390,Expectation Propagation,Topic
1390,Simon BarthelmÈ,Author
1390,Nicolas Chopin,Author
1391,Phase Diagram Of Spiking Neural Networks,Paper
1391,Spiking Neural Networks,Topic
1391,Parameters,Topic
1391,Dynamic Range,Topic
1391,Frequency,Topic
1391,Synaptic Weights,Topic
1391,Connections,Topic
1391,Excitatory Neurons,Topic
1391,Inhibitory Neurons,Topic
1392,Magneto- And Electro-Encephalography,Topic
1392,Bayesian Multi-Dipole Localization Method,Topic
1392,Dics,Topic
1392,Gianvittorio Luria,Author
1392,Dunja Duran,Author
1392,Elisa Visani,Author
1392,Sara Sommariva,Author
1392,Fabio Rotondi,Author
1392,Davide Rossi Sebastiano,Author
1392,Ferruccio Panzica,Author
1392,Michele Piana,Author
1392,Alberto Sorrentino,Author
1393,Factorized Neural Processes For Neural Processes: K-Shot Prediction Of Neural Responses,Paper
1393,Artificial Neural Networks,Topic
1393,Visual Cortex,Topic
1393,Neural Process,Topic
1393,Factorized Neural Process,Topic
1394,Trial-And-Error Learning,Topic
1394,Interval Timing Production Task,Topic
1394,Reward Sensitive Gaussian Process (Rsgp),Topic
1394,Recurrent Neural Networks,Topic
1394,Jing Wang,Author
1394,Yousuf El-Jayyousi,Author
1394,Ilker Ozden,Author
1394,Neural Network Model For Timing Control With Reinforcement,Paper
1395,Erdiff,Topic
1395,Yule Wang,Author
1395,Zijing Wu,Author
1395,Chengrui Li,Author
1395,Anqi Wu,Author
1395,Extraction And Recovery Of Spatio-Temporal Structure In Latent Dynamics Alignment With Diffusion Models,Paper
1396,Working Memory,Topic
1396,Worm,Paper
1396,Ankur Sikarwar,Author
1396,Mengmi Zhang,Author
1397,Humans,Topic
1397,Human-Object Interaction (Hoi),Topic
1397,Neuroscience,Topic
1397,Cognitive Science,Topic
1397,Graph Attention Networks,Topic
1397,Persistent-Transient Duality,Topic
1397,Hung Tran,Author
1397,Vuong Le,Author
1397,Svetha Venkatesh,Author
1397,Truyen Tran,Author
1398,Neuroassist,Topic
1398,Eeshan G. Dandamudi,Author
1398,Brain-Computer Interface (Bci) Systems,Topic
1398,Computational Neuroscience,Topic
1398,Machine Learning (Ml),Topic
1398,Natural Language Processing (Nlp) Bert Model,Topic
1398,Lstm Networks,Topic
1398,Spiking Neural Networks (Snns),Topic
1398,Deep Q-Networks (Dqn),Topic
1398,Common Spatial Pattern (Csp),Topic
1398,Gigascience,Topic
1398,Bci-Competition-Iv-2A Datasets,Topic
1398,Eeg Data,Topic
1398,Motor Imagery (Mi),Topic
1398,Eeg Temporal Characteristics,Topic
1398,Classification Accuracy Of 99.17%,Topic
1398,Assistive Technology,Topic
1399,Transcranial Magnetic Stimulation (Tms),Topic
1399,Image-Guided Robotic System For Tms,Paper
1400,Hiv Cure Research,Topic
1400,Latency-Reversing Agents,Topic
1400,Stochastic Model,Topic
1400,Alison L. Hill,Author
1400,Daniel I. S. Rosenbloom,Author
1400,Feng Fu,Author
1400,Martin A. Nowak,Author
1400,Robert F. Siliciano,Author
1401,Clinical Decision Support Systems,Topic
1401,Treatment Effectiveness Measure,Topic
1401,Secure Multiparty Computation,Topic
1401,Thomas Attema,Author
1401,Emiliano Mancini,Author
1401,Gabriele Spini,Author
1401,Mark Abspoel,Author
1401,Jan De Gier,Author
1401,Serge Fehr,Author
1401,Thijs Veugen,Author
1401,Maran Van Heesch,Author
1401,DaniÎl Worm,Author
1401,Andrea De Luca,Author
1401,Ronald Cramer,Author
1401,Peter M. A. Sloot,Author
1401,A New Approach To Privacy-Preserving Clinical Decision Support Systems,Paper
1402,Tumor Segmentation In Oncological Pet,Topic
1402,Bayesian Approach To Tissue-Fraction Estimation,Topic
1402,Ziping Liu,Author
1402,Joyce C. Mhlanga,Author
1402,Richard Laforest,Author
1402,Paul-Robert Derenoncourt,Author
1402,Barry A. Siegel,Author
1402,Abhinav K. Jha,Author
1402,Acrin 6668/Rtog 0235,Topic
1402,Lung Cancer,Topic
1402,Non-Small Cell Lung Cancer,Topic
1402,Dice Similarity Coefficient,Topic
1403,Multiple Sclerosis,Topic
1403,Msbase Registry,Topic
1403,Edward De Brouwer,Author
1403,Thijs Becker,Author
1403,Yves Moreau,Author
1403,Eva Kubala Havrdova,Author
1403,Maria Trojano,Author
1403,Sara Eichau,Author
1403,Serkan Ozakbas,Author
1403,Marco Onofrj,Author
1403,Pierre Grammond,Author
1403,Jens Kuhle,Author
1403,Ludwig Kappos,Author
1403,Patrizia Sola,Author
1403,Elisabetta Cartechini,Author
1403,Jeannette Lechner-Scott,Author
1403,Raed Alroughani,Author
1403,Oliver Gerlach,Author
1403,Tomas Kalincik,Author
1403,Franco Granella,Author
1403,Francois Grandmaison,Author
1403,Roberto Bergamaschi,Author
1403,Maria Jose Sa,Author
1403,Bart Van Wijmeersch,Author
1403,Aysun Soysal,Author
1403,Jose Luis Sanchez-Menoyo,Author
1403,Claudio Solaro,Author
1403,Cavit Boz,Author
1403,Gerardo Iuliano,Author
1403,Katherine Buzzard,Author
1403,Eduardo Aguera-Morales,Author
1403,Murat Terzi,Author
1403,Tamara Castillo Trivio,Author
1403,Daniele Spitaleri,Author
1403,Vincent Van Pesch,Author
1403,Vahid Shaygannej,Author
1403,Fraser Moore,Author
1403,Celia Oreja Guevara,Author
1403,Davide Maimone,Author
1403,Riadh Gouider,Author
1403,Tunde Csepany,Author
1403,Cristina Ramo-Tello,Author
1403,Liesbet Peeters,Author
1404,Joint Modelling Of Longitudinal And Survival Data,Topic
1404,Prostate Cancer,Topic
1404,Prostate-Specific Antigen (Psa),Topic
1404,Relapse,Topic
1404,Multi-State Model,Topic
1404,Linear Mixed Sub-Model,Topic
1404,Proportional Hazards,Topic
1404,Maximum Likelihood Framework,Topic
1404,Em Algorithm,Topic
1404,Quasi-Newton Algorithm,Topic
1404,R,Topic
1404,Mstate Package,Topic
1404,Jm Package,Topic
1404,LoÔc Ferrer,Author
1404,Virginie Rondeau,Author
1404,James J. Dignam,Author
1404,Tom Pickles,Author
1404,HÈlËne Jacqmin-Gadda,Author
1404,CÈcile Proust-Lima,Author
1405,Self-Supervised Learning-Based Approach To Clustering Multivariate Time-Series Data With Missing Values (Slac-Time),Paper
1405,Traumatic Brain Injury (Tbi),Topic
1405,Transforming Research And Clinical Knowledge In Traumatic Brain Injury (Track-Tbi) Study,Topic
1406,Artificial Intelligence-Based Methods,Topic
1406,Nuclear Medicine,Topic
1406,Deep-Learning (Dl)-Based Approaches,Topic
1406,Denoising Images,Topic
1406,Fidelity-Based Figures Of Merit (Foms),Topic
1406,Rmse,Topic
1406,Ssim,Topic
1406,Clinical Tasks,Topic
1406,Virtual Clinical Trials (Vcts),Topic
1406,Myocardial Perfusion Spect (Mps) Images,Topic
1406,Zitong Yu,Author
1406,Md Ashequr Rahman,Author
1406,Richard Laforest,Author
1406,Thomas H. Schindler,Author
1406,Robert J. Gropler,Author
1406,Richard L. Wahl,Author
1406,Barry A. Siegel,Author
1406,Abhinav K. Jha,Author
1407,Circulating Tumour Dna (Ctdna) Detection Of Molecular Residual Disease (Mrd),Topic
1407,Patient Outcomes,Topic
1407,Tumor Volume,Topic
1407,Mrd Assays,Topic
1407,0.01% Tumour Fraction,Topic
1407,Archer,Author
1407,Signatera,Author
1407,Astrazeneca Translational Medicine,Author
1407,Dan Stetson,Author
1407,Paul Labrousse,Author
1407,Hugh Russell,Author
1407,David Shera,Author
1407,Chris Abbosh,Author
1407,Brian Dougherty,Author
1407,J. Carl Barrett,Author
1407,Darren Hodgson,Author
1407,James Hadfield,Author
1408,High-Throughput Ai-Based System,Topic
1408,Virchow2,Topic
1408,H&E Whole Slide Images,Topic
1408,Msk-Impact,Topic
1408,Biomarkers,Topic
1408,Cancer Types,Topic
1408,Ai In Cancer Screening,Topic
1408,Authors,Author
1409,Influence Of Medical Foreign Bodies On Dark-Field Chest Radiographs: First Experiences,Paper
1409,Chronic Obstructive Pulmonary Disease,Topic
1409,Covid-19,Topic
1409,Dark-Field Radiography,Topic
1409,Conventional Radiography,Topic
1410,O1-Preview,Topic
1410,Peter G. Brodeur,Author
1410,Thomas A. Buckley,Author
1410,Zahir Kanjee,Author
1410,Ethan Goh,Author
1410,Evelyn Bin Ling,Author
1410,Priyank Jain,Author
1410,Stephanie Cabral,Author
1410,Raja-Elie Abdulnour,Author
1410,Adrian Haimovich,Author
1410,Jason A. Freed,Author
1410,Andrew Olson,Author
1410,Daniel J. Morgan,Author
1410,Jason Hom,Author
1410,Robert Gallo,Author
1410,Eric Horvitz,Author
1410,Jonathan Chen,Author
1410,Arjun K. Manrai,Author
1410,Adam Rodman,Author
1411,Deep Learning,Topic
1411,Least-Squares Fitting,Topic
1411,Quantitative Mri,Topic
1411,Neural Controlled Differential Equations,Topic
1411,Daan Kuppens,Author
1411,Sebastiano Barbieri,Author
1411,Daisy Van Den Berg,Author
1411,Pepijn Schouten,Author
1411,Harriet C. Thoeny,Author
1411,Myrte Wennen,Author
1411,Oliver J. Gurney-Champion,Author
1412,Pediatric Tumors Of The Central Nervous System,Topic
1412,High-Grade Gliomas,Topic
1412,Cbtn-Connect-Dipgr-Asnr-Miccai Brats-Peds Challenge,Topic
1412,Anahita Fathi Kazerooni,Author
1412,Nastaran Khalili,Author
1412,Xinyang Liu,Author
1412,Deep Gandhi,Author
1412,Zhifan Jiang,Author
1412,Syed Muhammed Anwar,Author
1412,Jake Albrecht,Author
1412,Maruf Adewole,Author
1412,Udunna Anazodo,Author
1412,Hannah Anderson,Author
1412,Ujjwal Baid,Author
1412,Timothy Bergquist,Author
1412,Austin J. Borja,Author
1412,Evan Calabrese,Author
1412,Verena Chung,Author
1412,Gian-Marco Conte,Author
1412,Farouk Dako,Author
1412,James Eddy,Author
1412,Ivan Ezhov,Author
1412,Ariana Familiar,Author
1412,Keyvan Farahani,Author
1412,Andrea Franson,Author
1412,Anurag Gottipati,Author
1412,Shuvanjan Haldar,Author
1412,Juan Eugenio Iglesias,Author
1412,Anastasia Janas,Author
1412,Elaine Johansen,Author
1412,Blaise V Jones,Author
1412,Neda Khalili,Author
1412,Florian Kofler,Author
1412,Dominic Labella,Author
1412,Hollie Anne Lai,Author
1412,Koen Van Leemput,Author
1412,Hongwei Bran Li,Author
1412,Nazanin Maleki,Author
1412,Aaron S Mcallister,Author
1412,Zeke Meier,Author
1412,Bjoern Menze,Author
1412,Ahmed W Moawad,Author
1412,Khanak K Nandolia,Author
1412,Julija Pavaine,Author
1412,Marie Piraud,Author
1412,Tina Poussaint,Author
1412,Sanjay P Prabhu,Author
1412,Zachary Reitman,Author
1412,Jeffrey D Rudie,Author
1412,Mariana Sanchez-Montano,Author
1412,Ibraheem Salman Shaikh,Author
1412,Nakul Sheth,Author
1412,Wenxin Tu,Author
1412,Chunhao Wang,Author
1412,Jeffrey B Ware,Author
1412,Benedikt Wiestler,Author
1412,Anna Zapaishchykova,Author
1412,Miriam Bornhorst,Author
1412,Michelle Deutsch,Author
1412,Maryam Fouladi,Author
1412,Margot Lazow,Author
1412,Leonie Mikael,Author
1412,Trent Hummel,Author
1412,Benjamin Kann,Author
1412,Peter De Blank,Author
1412,Lindsey Hoffman,Author
1412,Mariam Aboian,Author
1412,Ali Nabavizadeh,Author
1412,Roger Packer,Author
1412,Spyridon Bakas,Author
1412,Adam Resnick,Author
1412,Brian Rood,Author
1412,Arastoo Vossough,Author
1412,Marius George Linguraru,Author
1413,Pediatric Central Nervous System Tumors,Topic
1413,Brats-Peds 2023,Paper
1413,High-Grade Glioma,Topic
1413,Pediatric Brain Tumors,Topic
1413,Ai Approaches For Pediatric Tumor Analysis,Topic
1413,Volumetric Segmentation Algorithms,Topic
1413,Magnetic Resonance Imaging,Topic
1413,Clinical Trials,Topic
1413,Neuro-Oncologists,Topic
1413,Neuroradiologists,Topic
1414,Multi-Levels Nonlinear Mixed Effects Models (Mnlmems),Topic
1414,Saem-Mcmc Algorithm,Topic
1414,Pharmacokinetic Cross-Over Simulated Trials,Topic
1414,Tenofovir,Topic
1414,Atazanavir,Topic
1414,XaviËre Panhard,Author
1414,Adeline Samson,Author
1415,Clinical Trials,Topic
1415,Binary Response,Topic
1415,Neyman Allocation,Topic
1415,Adaptive Design,Topic
1415,Pitman Criterion,Topic
1415,Bahadur Approach,Topic
1415,Balanced Allocation,Topic
1415,David Azriel,Author
1415,Micha Mandel,Author
1415,Yosef Rinott,Author
1416,Local Dynamic Stability,Topic
1416,Gait,Topic
1416,Fall Risk,Topic
1416,Barefoot Walking,Topic
1416,Shod Walking,Topic
1416,Philippe Terrier,Author
1416,Fabienne Reynard,Author
1416,Healthy Individuals,Topic
1416,Intrasession Repeatability,Topic
1416,70 M Indoor Corridor,Topic
1416,3D-Accelerometer,Topic
1416,Finite-Time Maximal Lyapunov Exponent Method,Topic
1416,Intraclass Correlation Coefficient,Topic
1416,Average Standardized Effect Size,Topic
1416,High In Sw,Topic
1416,Slightly Higher In Bw,Topic
1417,Haart,Topic
1417,Cd4_Counts,Topic
1417,Marginal_Structural_Models,Topic
1417,Dynamical_Models,Topic
1417,Lim,Topic
1417,Ode_Nlme,Topic
1417,Anrs_Co3_Aquitaine_Cohort,Topic
1417,Swiss_Hiv_Cohort_Study,Topic
1417,M_Prague,Author
1417,D_Commenges,Author
1417,J_M_Gran,Author
1417,B_Ledergerber,Author
1417,J_Young,Author
1417,H_Furrer,Author
1417,R_ThiÈbaut,Author
1418,Mycobacterium Bovis Bacille Calmette-GuÈrin (Bcg),Topic
1418,Tuberculosis (Tb),Topic
1418,Masking Mechanism,Topic
1418,Blocking Mechanism,Topic
1418,Bcg-Revac Clinical Trials,Topic
1418,Sergio Arregui,Author
1418,JoaquÌn Sanz,Author
1418,Dessislava Marinova,Author
1418,Carlos MartÌn,Author
1418,Yamir Moreno,Author
1419,Assessing The Treatment Effect Heterogeneity With A Latent Variable,Paper
1419,Yunjian Yin,Author
1419,Lan Liu,Author
1419,Zhi Geng,Author
1420,Brain Connectivity,Topic
1420,Electroencephalography (Eeg),Topic
1420,Parafac2,Topic
1420,Loukianos Spyrou,Author
1420,Mario Parra,Author
1420,Javier Escudero,Author
1420,Mild Cognitive Impairment,Topic
1420,Alzheimer'S Disease,Topic
1420,Traditional Tensor Analysis,Topic
1420,Complex Tensor Factorisation,Topic
1420,Eeg Dataset,Topic
1421,Individuals,Topic
1421,Personalized Medicine,Topic
1421,Non-Parametric Accelerated Failure Time Model,Topic
1421,Heterogeneous Treatment Effects (Hte),Topic
1421,Bayesian Additive Regression Trees,Topic
1421,Mean-Constrained Dirichlet Process Mixture Model,Topic
1421,Individual Treatment Effect,Topic
1421,Congestive Heart Failure,Topic
1421,Angiotensin-Converting Enzyme Inhibitor,Topic
1421,Nicholas C. Henderson,Author
1421,Thomas A. Louis,Author
1421,Gary L. Rosner,Author
1421,Ravi Varadhan,Author
1421,Two Large Clinical Trials,Topic
1421,Treatment Effect,Topic
1421,User Input,Topic
1422,Seismocardiography,Topic
1422,Heart Rate Monitoring During Different Lung Volume Phases Using Seismocardiography,Paper
1422,Electrocardiogram,Topic
1422,Heart Rate,Topic
1422,Lung Volume,Topic
1422,Healthy Subjects,Topic
1422,Postural Positions,Topic
1423,Treating Children With Autism Spectrum Disorders (Asd) With Behavioral Interventions,Topic
1423,Pivotal Response Treatment (Prt),Topic
1423,Nicha C. Dvornek,Author
1423,Daniel Yang,Author
1423,Archana Venkataraman,Author
1423,Pamela Ventola,Author
1423,Lawrence H. Staib,Author
1423,Kevin A. Pelphrey,Author
1423,James S. Duncan,Author
1423,Random Forest And Tree Bagging Strategy,Topic
1423,Baseline Task-Based Fmri,Topic
1423,19 Asd Children,Topic
1423,16 Week Trial Of Prt,Topic
1423,Leave-One-Out Cross-Validation Framework,Topic
1423,Highest Prediction Accuracy,Topic
1424,Hvtn 505 Trial,Topic
1424,Hiv Infection,Topic
1424,Vaccine,Topic
1424,Immune Response Markers,Topic
1424,Qualitative Interaction,Topic
1424,Psem Methods,Topic
1424,Sace Literature,Topic
1424,Binary Intermediate Response Variable,Topic
1424,Peter B. Gilbert,Author
1424,Bryan S. Blette,Author
1424,Bryan E. Shepherd,Author
1424,Michael G. Hudgens,Author
1425,Composite Endpoints,Topic
1425,Clinical Trials,Topic
1425,Chronic Conditions,Topic
1425,Systemic Lupus Erythematosus (Sle),Topic
1425,Latent Variable Model,Topic
1425,Phase Iib Muse Trial,Topic
1425,Martina Mcmenamin,Author
1425,Jessica K. Barrett,Author
1425,Anna Berglind,Author
1425,James M. S. Wason,Author
1426,Nonparametric Analysis Of Nonhomogeneous Multi-State Processes Based On Clustered Observations,Paper
1426,Clinical Trials,Topic
1426,Observational Studies,Topic
1426,Multi-State Models,Topic
1426,Nonparametric Estimation,Topic
1426,Two-Sample Testing,Topic
1426,Population-Averaged Transition Probabilities,Topic
1426,State Occupation Probabilities,Topic
1426,Right-Censored Observations,Topic
1426,Left-Truncated Observations,Topic
1426,Clustered Observations,Topic
1426,Markov Processes,Topic
1426,Non-Markov Processes,Topic
1426,Empirical Process Theory,Topic
1426,Simultaneous Confidence Bands,Topic
1426,Nonparametric Cluster Bootstrap,Topic
1426,Multicenter Randomized Controlled Trial,Topic
1427,Estimation And Validation Of Ratio-Based Conditional Average Treatment Effects Using Observational Data,Paper
1427,Treatment-Covariate Interactions,Topic
1427,Precision Medicine,Topic
1427,Multiple Sclerosis,Topic
1427,Dimethyl Fumarate,Topic
1427,Teriflunomide,Topic
1428,Lung Lesion Response Prediction,Topic
1428,Non-Small Cell Lung Cancer,Topic
1428,Response Evaluation Criteria In Solid Tumors,Topic
1428,Antong Chen,Author
1428,Jennifer Saouaf,Author
1428,Bo Zhou,Author
1428,Randolph Crawford,Author
1428,Jianda Yuan,Author
1428,Junshui Ma,Author
1428,Richard Baumgartner,Author
1428,Shubing Wang,Author
1428,Gregory Goldmacher,Author
1429,Epidemiological Evidence,Topic
1429,Do-Search,Topic
1429,Salt-Adding Behavior,Topic
1429,Juha Karvanen,Author
1429,Santtu Tikka,Author
1429,Antti Hyttinen,Author
1429,Nhanes 2013--2016,Topic
1430,Bayesian Sample Size Determination Using Commensurate Priors To Leverage Pre-Experimental Data,Paper
1430,Haiyan Zheng,Author
1430,Thomas Jaki,Author
1430,James M. S. Wason,Author
1431,A Comparison Of Model-Free Phase I Dose Escalation Designs For Dual-Agent Combination Therapies,Paper
1431,Helen Yvette Barnett,Author
1431,Matthew George,Author
1431,Donia Skanji,Author
1431,Gaelle Saint-Hilary,Author
1431,Thomas Jaki,Author
1431,Pavel Mozgunov,Author
1432,Pediatric Patients,Topic
1432,Medicines,Topic
1432,Safety And Efficacy,Topic
1432,Pediatric Clinical Development Plan,Topic
1432,Safety Database,Topic
1432,Benefit-Risk Assessment,Topic
1432,Extrapolation From Adults,Topic
1432,Safety Assessments,Topic
1432,Adverse Events (Aes),Topic
1432,Bayesian Approaches,Topic
1432,Margaret Gamalo,Author
1432,Yihua Zhao,Author
1432,Aijun Gao,Author
1432,Jingjing Ye,Author
1432,Ralph Demasi,Author
1432,Eiji Eshida,Author
1432,Yj Choi,Author
1432,Robert Nelson,Author
1433,Bayesian Semi-Parametric Model,Topic
1433,Pediatric Acute Myeloid Leukemia (Aml),Topic
1433,Phase Iii Aaml1031 Clinical Trial,Topic
1433,Anthracyclines (Act),Topic
1433,Survival Probability,Topic
1433,Gamma Process Priors,Topic
1433,G-Computation Procedure,Topic
1434,Estimating Marginal Treatment Effect In Cluster Randomized Trials With Multi-Level Missing Outcomes,Paper
1434,Chia-Rui Chang,Author
1434,Rui Wang,Author
1434,Cluster Randomized Trials,Topic
1435,Population-Wise Error Rate (Pwer),Topic
1435,Remi Luschei,Author
1435,Werner Brannath,Author
1435,Clinical Trials,Topic
1435,Efficacy,Topic
1435,Strata-Specific Family Wise Error Rates,Topic
1435,Maximum-Likelihood Estimator,Topic
1435,Multinomial Distribution,Topic
1435,Simulations,Topic
1435,Expected Pwer,Topic
1435,Study-Specific Pwer,Topic
1435,Overlapping Populations,Topic
1435,Sample Sizes,Topic
1435,Maximum Strata-Wise Family Wise Error Rate,Topic
1435,Significance Level,Topic
1436,Predictively Consistent Prior Effective Sample Sizes,Paper
1436,Prior Effective Sample Size,Topic
1436,Control Group,Topic
1436,Hierarchical Subgroup Analyses,Topic
1436,Prior Information,Topic
1436,Randomized Clinical Trials,Topic
1436,Expected Local-Information-Ratio Ess,Topic
1436,Current Methods,Topic
1436,Posterior Ess,Topic
1437,Knowledge Transfer Research,Topic
1437,Hancheng Cao,Author
1437,Mengjie Cheng,Author
1437,Zhepeng Cen,Author
1437,Daniel A. Mcfarland,Author
1437,Xiang Ren,Author
1437,Translational Research,Topic
1437,Text Mining And Predictive Modeling,Topic
1437,Scientific Concepts,Topic
1437,Knowledge Transfer Mechanisms,Topic
1438,Anti-Drug Antibody (Ada) Formation,Topic
1438,Biologic Treatment,Topic
1438,Randomized Controlled Trial,Topic
1438,Principal Stratum Estimand Strategy,Topic
1438,Treatment Effect,Topic
1438,Weighted Principal Stratum Approach,Topic
1438,Baseline Covariates,Topic
1438,Longitudinal Information,Topic
1438,Causal Conclusions,Topic
1438,Simulations,Topic
1438,Clinical Study,Topic
1438,Shengchun Kong,Author
1438,Dominik Heinzmann,Author
1438,Sabine Lauer,Author
1438,Tian Lu,Author
1438,Weighted Approach For Estimating Effects In Principal Strata With Missing Data For A Categorical Post-Baseline Variable In Randomized Controlled Trials,Paper
1439,Data Science Task,Topic
1439,Big Data,Topic
1439,Healthcare Practitioners,Topic
1439,Causality,Topic
1439,Observational Studies,Topic
1439,Selection Bias,Topic
1439,Confounding Bias,Topic
1439,Causal Inference,Topic
1439,Reinforcement Learning,Topic
1439,Wenhao Zhang,Author
1439,Ramin Ramezani,Author
1439,Arash Naeim,Author
1440,A Bayesian Adaptive Design For Dual-Agent Phase I-Ii Oncology Trials Integrating Efficacy Data Across Stages,Paper
1441,Science,Topic
1441,All-In Meta-Analysis,Topic
1441,Judith Ter Schure,Author
1441,Peter Gr¸nwald,Author
1442,Evidence-Based Medicine,Topic
1442,Systematic Reviews,Topic
1442,Randomised Controlled Trial,Topic
1442,Named Entity Recognition,Topic
1442,Relation Extraction,Topic
1442,Deep Neural Net Models,Topic
1442,Transfer Learning,Topic
1442,Transformer-Based Language Representations,Topic
1442,Gold-Standard Corpus,Topic
1442,Clinical Trial Results,Topic
1442,Jetsun Whitton,Author
1442,Anthony Hunter,Author
1442,Evidence Tables,Topic
1442,Automatic Tabulation,Topic
1442,Semi-Automated,Topic
1442,Systematic Reviews,Topic
1443,Estimating Average Causal Effects From Patient Trajectories,Paper
1443,Deepace,Topic
1443,Dennis Frauen,Author
1443,Tobias Hatt,Author
1443,Valentyn Melnychuk,Author
1443,Stefan Feuerriegel,Author
1444,Synthetic Control Method,Topic
1444,Counterfactual Reality,Topic
1444,Donor Units,Topic
1444,Linear Model,Topic
1444,Pre-Intervention Period,Topic
1444,Spatiotemporal Information,Topic
1444,Transformer Model,Topic
1444,Positional Embeddings,Topic
1444,Decoder Attention Mask,Topic
1444,Pre-Training Task,Topic
1444,Spatiotemporal Sequence-To-Sequence Modeling,Topic
1444,Synthetic Data,Topic
1444,Healthcare Insights,Topic
1444,Public Health Policy,Topic
1444,Asthma Medications,Topic
1444,Friedreich'S Ataxia,Topic
1444,Clinical Decision-Making,Topic
1444,Personalized Therapy,Topic
1444,Bhishma Dedhia,Author
1444,Roshini Balasubramanian,Author
1444,Niraj K. Jha,Author
1445,Generalized Linear Mixed Models (Glmm),Topic
1445,Cluster-Randomized Trials (Crts),Topic
1445,Hongxiang Qiu,Author
1445,Andrea J. Cook,Author
1445,Jennifer F. Bobb,Author
1446,Strategy Training,Topic
1446,Natural Language Processing,Topic
1446,Bert Model,Topic
1446,Hunter Osterhoudt,Author
1446,Courtney E. Schneider,Author
1446,Haneef A Mohammad,Author
1446,Minmei Shih,Author
1446,Alexandra E. Harper,Author
1446,Leming Zhou,Author
1446,Elizabeth R Skidmore,Author
1446,Yanshan Wang,Author
1447,Surrogate Marker,Topic
1447,Layla Parast,Author
1447,Tianxi Cai,Author
1447,Lu Tian,Author
1447,Aids Clinical Trial,Topic
1447,Cd4 Count,Topic
1447,Rna,Topic
1448,Hazard Ratios,Topic
1448,Hazard Difference,Topic
1448,Causal Hazard Differences,Topic
1448,Selection Bias,Topic
1448,Effect Heterogeneity,Topic
1448,Randomized Controlled Trial,Topic
1448,Chemotherapy,Topic
1448,Survival Time,Topic
1448,Carcinoma Of The Oropharynx,Topic
1448,Richard Post,Author
1448,Edwin Van Den Heuvel,Author
1448,Hein Putter,Author
1449,Multi-Document Summarization,Topic
1449,Film Reviews,Topic
1449,Biomedical Systematic Reviews,Topic
1449,Opinion And Evidence Synthesis Datasets,Topic
1449,Fine-Tuned Transformers,Topic
1449,Gpt-4,Topic
1449,Jay Deyoung,Author
1449,Stephanie C. Martinez,Author
1449,Iain J. Marshall,Author
1449,Byron C. Wallace,Author
1450,Asymptotic Properties Of Multi-Treatment Covariate Adaptive Randomization Procedures For Balancing Observed And Unobserved Covariates,Paper
1450,Li-Xin Zhang,Author
1450,Car,Topic
1450,Multi-Treatment Clinical Trials,Topic
1450,Covariate Features,Topic
1450,Imbalance Vectors,Topic
1450,Treatment Effect Test,Topic
1450,Heteroscedastic Linear Model,Topic
1450,Unobserved Covariates,Topic
1451,Bayesian Model-Averaged Meta-Analysis,Topic
1451,Cochrane Database Of Systematic Reviews,Topic
1451,Binary Outcomes,Topic
1451,Time-To-Event Outcomes,Topic
1451,Frantiöek Bartoö,Author
1451,Willem M. Otte,Author
1451,Quentin F. Gronau,Author
1451,Bram Timmers,Author
1451,Alexander Ly,Author
1451,Eric-Jan Wagenmakers,Author
1452,Machine Learning,Topic
1452,Healthcare,Topic
1452,Alzheimer'S Disease,Topic
1452,Adni Dataset,Topic
1452,3D Convolutional Neural Network,Topic
1452,Rosanna Turrisi,Author
1452,Alessandro Verri,Author
1452,Annalisa Barla,Author
1452,Data Augmentation,Topic
1452,Model Complexity,Topic
1452,Predictive Models,Topic
1452,Convolutional Layers,Topic
1452,Accuracy,Topic
1453,Intrusion Research,Topic
1453,Causal Relationships,Topic
1453,Adaptive Design,Topic
1453,Honeypot Deployment Study,Topic
1453,Ssh Vulnerability,Topic
1453,Kate Highnam,Author
1453,Zach Hanif,Author
1453,Ellie Van Vogt,Author
1453,Sonali Parbhoo,Author
1453,Sergio Maffeis,Author
1453,Nicholas R. Jennings,Author
1454,Immunotherapies And Targeted Therapies,Topic
1454,Optimal Biological Dose (Obd),Topic
1454,Maximum Tolerated Dose (Mtd),Topic
1454,Pharmacokinetics (Pk) Outcomes,Topic
1454,Pkboin-12,Topic
1454,Tite-Pkboin-12,Topic
1454,Hao Sun,Author
1454,Jieqi Tu,Author
1455,Uptime,Topic
1455,Myalgic Encephalomyelitis/Chronic Fatigue Syndrome,Topic
1455,Long Covid,Topic
1455,Yifei Sun,Author
1455,Suzanne D. Vernon,Author
1455,Shad Roundy,Author
1455,Wearable Sensor,Topic
1455,Inertial Measurement Unit,Topic
1455,Clinical Research,Topic
1456,Natural,Topic
1456,Causal Effect Estimation,Topic
1456,Nikita Dhawan,Author
1456,Leonardo Cotta,Author
1456,Karen Ullrich,Author
1456,Rahul G. Krishnan,Author
1456,Chris J. Maddison,Author
1457,Adaptive Weight Selection For Time-To-Event Data Under Non-Proportional Hazards,Paper
1457,Moritz Fabian Danzer,Author
1457,Ina Dormuth,Author
1457,Time-To-Event Endpoint,Topic
1457,Clinical Trial,Topic
1457,Effect Size,Topic
1457,Proportional Hazards,Topic
1457,Hazard Ratio,Topic
1457,Log-Rank Test,Topic
1457,Survival Data,Topic
1457,Multi-Stage Design,Topic
1457,Combination-Type Tests,Topic
1457,Royston-Parmar Spline Models,Topic
1457,Real-World Data Example,Topic
1457,Simulation Studies,Topic
1457,Power Performance,Topic
1457,Flexibility,Topic
1458,Nonparametric Bayesian Approach For Dynamic Borrowing Of Historical Control Data,Paper
1458,Historical Control Data,Topic
1458,Randomized Controlled Trial Data,Topic
1458,Dynamic Borrowing Method,Topic
1458,Dependent Dirichlet Process Mixture,Topic
1458,Simulation Study,Topic
1458,Clinical Trial Examples,Topic
1459,Dynamic Indicators Of Adherence And Retention In Digital Health Studies: Insights From The Brighten Study,Paper
1459,Dylan Hamitouche,Author
1459,Youcef Barkat,Author
1459,Deven Parekh,Author
1459,Eva Hammer,Author
1459,David Benrimoh,Author
1459,Brighten Study,Topic
1460,Hybrid Clinical Trials,Topic
1460,Real-World Data,Topic
1460,Rare Diseases,Topic
1460,Yuan Et Al. (2019),Paper
1461,Causal Inference Across Multiple Data Sources,Topic
1461,Data Integration Methods For Time-To-Event Outcomes,Topic
1461,Survival Analysis,Topic
1461,Novel Approaches For Multi-Source Causal Survival Analysis,Topic
1461,Semiparametric Efficient Estimator,Topic
1461,Federated Learning Framework,Topic
1461,Nonparametric Machine Learning Models,Topic
1461,Hvtn 704/Hptn 085,Paper
1461,Hvtn 703/Hptn 081,Paper
1461,Yi Liu,Author
1461,Alexander W. Levis,Author
1461,Ke Zhu,Author
1461,Shu Yang,Author
1461,Peter B. Gilbert,Author
1461,Larry Han,Author
1462,Cybernetical Neuroscience,Topic
1462,Alexander Fradkov,Author
1463,Analyzing Incomplete Discrete Longitudinal Clinical Trial Data,Paper
1464,Clinical Research And Drug Development In Orphan Diseases,Topic
1464,Bayesian Meta-Analytic Approach,Topic
1464,Phase Iii Study,Topic
1464,Phase Ii Data,Topic
1464,Fda Approval In Herpetic Keratitis,Topic
1464,Simon Wandel,Author
1464,Beat Neuenschwander,Author
1464,Tim Friede,Author
1464,Christian Rˆver,Author
1465,Analysis Of Adverse Events,Topic
1465,Steffen Unkel,Author
1465,Marjan Amiri,Author
1465,Norbert Benda,Author
1465,Jan Beyersmann,Author
1465,Dietrich Knoerzer,Author
1465,Katrin Kupas,Author
1465,Frank Langer,Author
1465,Friedhelm Leverkus,Author
1465,Anja Loos,Author
1465,Claudia Ose,Author
1465,Tanja Proctor,Author
1465,Claudia Schmoor,Author
1465,Carsten Schwenke,Author
1465,Guido Skipka,Author
1465,Kristina Unnebrink,Author
1465,Florian Voss,Author
1465,Tim Friede,Author
1466,Clozapine,Topic
1466,Electronic Health Records,Topic
1466,Adverse Events,Topic
1466,Ehtesham Iqbal,Author
1466,Risha Govind,Author
1466,Alvin Romero,Author
1466,Olubanke Dzahini,Author
1466,Matthew Broadbent,Author
1466,Robert Stewart,Author
1466,Tanya Smith,Author
1466,Chi-Hun Kim,Author
1466,Nomi Werbeloff,Author
1466,Richard Dobson,Author
1466,Zina Ibrahim,Author
1467,A Machine Learning Alternative To Placebo-Controlled Clinical Trials Upon New Diseases: A Primer,Paper
1468,3D Augmented Reality-Assisted Ct-Guided Interventions: System Design And Preclinical Trial On An Abdominal Phantom Using Hololens 2,Paper
1468,Brian J. Park,Author
1468,Stephen J. Hunt,Author
1468,Gregory J. Nadolski,Author
1468,Terence P. Gade,Author
1468,Augmented Reality,Topic
1468,Ct-Guided Interventions,Topic
1469,Mindfulness-Based Interventions,Topic
1469,Post-Traumatic Stress Disorder (Ptsd),Topic
1469,Mindfulness-Based Stress Reduction (Mbsr),Topic
1469,Randomized Clinical Trial (Rct),Topic
1469,Veterans,Topic
1469,Seung Suk Kang,Author
1469,Scott R. Sponheim,Author
1469,Kelvin O. Lim,Author
1469,Ptsd Checklist,Topic
1469,Electroencephalography (Eeg),Topic
1469,Anterior Cingulate Cortex,Topic
1469,Anterior Insular Cortex,Topic
1469,Lateral Prefrontal Cortex,Topic
1470,Adverse Drug Reactions,Topic
1470,Randomized Clinical Trials,Topic
1470,Postmarketing Pharmacovigilance,Topic
1470,Knowledge Graphs,Topic
1470,Drug Classifications,Topic
1470,Biomolecular Features,Topic
1470,Decision Trees,Topic
1470,Classification Rules,Topic
1470,Gene Ontology Terms,Topic
1470,Drug Targets,Topic
1470,Pathway Names,Topic
1470,Dili,Topic
1470,Scar,Topic
1470,Emmanuel Bresso,Author
1470,Pierre Monnin,Author
1470,CÈdric Bousquet,Author
1470,FranÁois-Elie Calvier,Author
1470,Ndeye-Coumba Ndiaye,Author
1470,Nadine Petitpain,Author
1470,Malika SmaÔl-Tabbone,Author
1470,Adrien Coulet,Author
1471,Drug Repurposing,Topic
1471,Dexamethasone,Paper
1471,Baricitinib,Paper
1471,Covid-19,Topic
1471,Triamcinolone,Paper
1471,Gallopamil,Paper
1471,Sars-Cov-2,Topic
1471,In Silico Approach,Topic
1471,Mechanism Of Action Analysis,Topic
1471,MÈabh Macmahon,Author
1471,Woochang Hwang,Author
1471,Soorin Yim,Author
1471,Eoghan Macmahon,Author
1471,Alexandre Abraham,Author
1471,Justin Barton,Author
1471,Mukunthan Tharmakulasingam,Author
1471,Paul Bilokon,Author
1471,Vasanthi Priyadarshini Gaddi,Author
1471,Namshik Han,Author
1472,Evaluating Causal Effects On Time-To-Event Outcomes In An Rct In Oncology With Treatment Discontinuation,Paper
1473,Acute Lymphoblastic Leukemia (All),Topic
1473,Minimal Residual Disease (Mrd),Topic
1473,St. Jude Children'S Research Hospital,Topic
1473,Bayesian Model,Topic
1473,Induction Phase,Topic
1473,Drug Sensitivity Profiles,Topic
1473,Leukemic Subtypes,Topic
1473,Andrea Cremaschi,Author
1473,Wenjian Yang,Author
1473,Maria De Iorio,Author
1473,William E. Evans,Author
1473,Jun J. Yang,Author
1473,Gary L. Rosner,Author
1474,Stability Basin,Topic
1474,Sit-To-Stand (Sts),Topic
1474,Patrick D. Holmes,Author
1474,Shannon M. Danforth,Author
1474,Xiao-Yu Fu,Author
1474,Talia Y. Moore,Author
1474,Ram Vasudevan,Author
1474,Falls,Topic
1475,Biomedical Text Tagging Systems,Topic
1475,Pre-Trained Encoders,Topic
1475,Pico Annotation,Topic
1475,Gaurav Singh,Author
1475,Zahra Sabet,Author
1475,John Shawe-Taylor,Author
1475,James Thomas,Author
1476,Clinical Trials Investigating Interventions On Physical Activity,Topic
1476,Accelerometers,Topic
1476,Step Count,Topic
1476,Epoch-Level Missingness,Topic
1476,Mia S. Tackney,Author
1476,Elizabeth Williamson,Author
1476,Derek G. Cook,Author
1476,Elizabeth Limb,Author
1476,Tess Harris,Author
1476,James Carpenter,Author
1476,2017 Pace-Up Trial,Topic
1476,Parametric Approach,Topic
1476,Non-Parametric Approach,Topic
1476,Multiple Imputation (Mi),Topic
1477,Personalized Medicine,Topic
1477,Individualized Treatment Rules (Itrs),Topic
1477,Machine Learning Methods,Topic
1477,Randomized Control Trials,Topic
1477,Florie Bouvier,Author
1477,Etienne Peyrot,Author
1477,Alan Balendran,Author
1477,Corentin SÈgalas,Author
1477,Ian Roberts,Author
1477,FranÁois Petit,Author
1477,RaphaÎl Porcher,Author
1478,Digital Breast Tomosynthesis,Topic
1478,Reconstruction Algorithms,Topic
1478,I. Reiser,Author
1478,J. Bian,Author
1478,R. M. Nishikawa,Author
1478,E. Y. Sidky,Author
1478,X. Pan,Author
1479,A Partitioning Deletion/Substitution/Addition Algorithm For Creating Survival Risk Groups,Paper
1479,Cart,Topic
1479,Partdsa,Topic
1479,Censored Outcome Data,Topic
1479,Brain Cancer Patients,Topic
1480,Random Forest,Topic
1480,Random Survival Forests,Topic
1480,Randomforestsrc Package,Topic
1480,Ggrandomforests Package,Topic
1480,Primary Biliary Cirrhosis Of The Liver Data,Topic
1480,John Ehrlinger,Author
1481,A Machine Learning Approach To Drug Repositioning Based On Drug Expression Profiles: Applications To Schizophrenia And Depression/Anxiety Disorders,Paper
1481,Drug Repositioning,Topic
1481,Psychiatry,Topic
1481,Schizophrenia,Topic
1481,Depression,Topic
1481,Anxiety Disorders,Topic
1481,Machine Learning,Topic
1482,Variability In Drug Efficacy And Adverse Effects,Topic
1482,Genetic Variability In Classical Pharmacokinetic Genes,Topic
1482,Genetic Variation In Drug Targets,Topic
1482,Exac Dataset,Topic
1482,Functional-Variants In Drug-Related Genes,Topic
1482,Fda Approved Drugs,Topic
1482,Oncological Drug Targets,Topic
1482,Charlotta P. I. Sch‰rfe,Author
1482,Roman Tremmel,Author
1482,Matthias Schwab,Author
1482,Oliver Kohlbacher,Author
1482,Debora S. Marks,Author
1483,Clinical Prediction Models,Topic
1483,Marginal Structural Models,Topic
1483,Matthew Sperrin,Author
1483,Glen Martin,Author
1483,Tjeerd Van Staa,Author
1483,Niels Peek,Author
1483,Iain Buchan,Author
1484,A Bayesian Mark Interaction Model For Analysis Of Tumor Pathology Images,Paper
1484,Qiwei Li,Author
1484,Xinlei Wang,Author
1484,Faming Liang,Author
1484,Guanghua Xiao,Author
1484,Tumor Pathology Images,Topic
1484,Deep-Learning Methods,Topic
1484,Spatial Correlations,Topic
1484,Cell-Cell Interactions,Topic
1484,National Lung Screening Trial,Topic
1484,Lung Cancer,Topic
1485,Artificial Intelligence,Topic
1485,Computer Vision,Topic
1485,Medical Imaging,Topic
1485,Optical Coherence Tomography Angiography,Topic
1485,Octa,Topic
1485,Ai Algorithm,Topic
1485,Vasculature Maps,Topic
1485,Structural Optical Coherence Tomography,Topic
1485,Deep Learning,Topic
1485,Cecilia S. Lee,Author
1485,Ariel J. Tyring,Author
1485,Yue Wu,Author
1485,Sa Xiao,Author
1485,Ariel S. Rokem,Author
1485,Nicolaas P. Deruyter,Author
1485,Qinqin Zhang,Author
1485,Adnan Tufail,Author
1485,Ruikang K. Wang,Author
1485,Aaron Y. Lee,Author
1486,Natural Language Processing,Topic
1486,Electronic Health Records,Topic
1486,Computational Phenotyping,Topic
1486,Zexian Zeng,Author
1486,Yu Deng,Author
1486,Xiaoyu Li,Author
1486,Tristan Naumann,Author
1486,Yuan Luo,Author
1487,Virtual Reality Experience,Topic
1487,Brian A. Cohn,Author
1487,Dilan D. Shah,Author
1487,Ali Marjaninejad,Author
1487,Martin Shapiro,Author
1487,Serhan Ulkumen,Author
1487,Christopher M. Laine,Author
1487,Francisco J. Valero-Cuevas,Author
1487,Kenneth H. Hayashida,Author
1487,Sarah Ingersoll,Author
1488,Engineered Microbubbles,Topic
1488,Calcium-Containing Hydroxyapatite Substrate,Topic
1488,Nephrolithiasis,Topic
1488,David G. Bell,Author
1488,Matthew A. Hopcroft,Author
1488,William M. Behnke-Parks,Author
1488,"High-Throughput, Semi-Autonomous Measurement Of Cavitation-Mediated Material Breakage",Paper
1489,Mild Cognitive Impairment,Topic
1489,Alzheimer'S Disease Dementia,Topic
1489,Deep Learning Model,Topic
1489,Mri Scans,Topic
1489,Hongming Li,Author
1489,Mohamad Habes,Author
1489,David A. Wolk,Author
1489,Yong Fan,Author
1489,2146 Subjects,Topic
1489,C-Index,Topic
1489,Adni Testing Mci Subjects,Topic
1489,Aibl Testing Mci Subjects,Topic
1489,Clinical Trials,Topic
1490,Landmark Proportional Subdistribution Hazards Models For Dynamic Prediction Of Cumulative Incidence Functions,Paper
1490,Qing Liu,Author
1490,Gong Tang,Author
1490,Joseph P. Costantino,Author
1490,Chung-Chou H. Chang,Author
1491,Radiopathomics: Integration Of Radiographic And Histologic Characteristics For Prognostication In Glioblastoma,Paper
1491,Glioblastoma,Topic
1491,Rad Imaging,Topic
1491,Path Images,Topic
1491,The Cancer Imaging Archive,Topic
1491,Support Vector Machine,Topic
1491,Support Vector Regression,Topic
1492,Covid-19,Topic
1492,Mohammad Reza Dayer,Author
1492,Hiv-1 Protease Inhibitors,Topic
1492,Anti Bronchitis Drugs,Topic
1492,Drug Design,Topic
1493,Heterogeneous Treatment Effects Model,Topic
1493,Multiple Sclerosis,Topic
1493,Natalizumab,Topic
1493,Glatiramer Acetate,Topic
1493,Dimethyl Fumarate,Topic
1493,Konstantina Chalkou,Author
1493,Ewout Steyerberg,Author
1493,Matthias Egger,Author
1493,Andrea Manca,Author
1493,Fabio Pellegrini,Author
1493,Georgia Salanti,Author
1494,Learning Individualized Treatment Rules With Estimated Translated Inverse Propensity Score,Paper
1494,Zhiliang Wu,Author
1494,Yinchong Yang,Author
1494,Yunpu Ma,Author
1494,Yushan Liu,Author
1494,Rui Zhao,Author
1494,Michael Moor,Author
1494,Volker Tresp,Author
1494,Individualized Treatment Rules,Topic
1494,Contextual Bandit Problem,Topic
1494,Intravenous Fluids,Topic
1494,Vasopressors,Topic
1495,Smile-Gan,Topic
1495,Alzheimer'S Disease,Topic
1495,Zhijian Yang,Author
1495,Ilya M. Nasrallah,Author
1495,Haochang Shou,Author
1495,Junhao Wen,Author
1495,Jimit Doshi,Author
1495,Mohamad Habes,Author
1495,Guray Erus,Author
1495,Ahmed Abdulkadir,Author
1495,Susan M. Resnick,Author
1495,David Wolk,Author
1495,Christos Davatzikos,Author
1496,Human-Curated Disease Ontologies,Topic
1496,Disease Modules (Dms),Topic
1496,Giorgio Grani,Author
1496,Lorenzo Madeddu,Author
1496,Paola Velardi,Author
1496,Human-Curated Disease Taxonomy,Topic
1496,Interactome,Topic
1497,Cohort Bias Adaptation In Aggregated Datasets For Lesion Segmentation,Paper
1497,Brennan Nichyporuk,Author
1497,Jillian Cardinell,Author
1497,Justin Szeto,Author
1497,Raghav Mehta,Author
1497,Sotirios Tsaftaris,Author
1497,Douglas L. Arnold,Author
1497,Tal Arbel,Author
1497,Source-Conditioned Instance Normalization (Scin),Topic
1497,Cohort Bias,Topic
1497,Multiple Sclerosis (Ms),Topic
1498,Precision Medicine For Chronic Diseases,Topic
1498,Multiple Sclerosis,Topic
1498,Deep Neural Network Model,Topic
1498,Baseline Magnetic Resonance Imaging,Topic
1498,Joshua Durso-Finley,Author
1498,Jean-Pierre R. Falet,Author
1498,Brennan Nichyporuk,Author
1498,Douglas L. Arnold,Author
1498,Tal Arbel,Author
1498,Proprietary Federated Dataset,Topic
1498,Multi-Sequence Mris,Topic
1498,Multi-Centre Randomized Clinical Trials,Topic
1498,Average Precision,Topic
1498,Binarized Regression,Topic
1498,Personalized Treatment Recommendation,Topic
1499,Restricted Mean Survival Time,Topic
1499,Pseudo-Survival Time Method,Topic
1499,Inverse Probability Of Censoring Weighting (Ipcw) Method,Topic
1499,Keisuke Hanada,Author
1499,Junji Moriya,Author
1499,Masahiro Kojima,Author
1499,Example Dataset,Topic
1499,Computer Simulations,Topic
1500,Randomized Controlled Trials,Topic
1500,Real-World Evidence,Topic
1500,Real-World Data,Topic
1500,Electronic Health Records,Topic
1500,Natural Language Processing,Topic
1500,Computational Phenotyping,Topic
1500,Mass General Brigham,Topic
1500,Jue Hou,Author
1500,Rachel Zhao,Author
1500,Jessica Gronsbell,Author
1500,Brett K. Beaulieu-Jones,Author
1500,Griffin Webber,Author
1500,Thomas Jemielita,Author
1500,Shuyan Wan,Author
1500,Chuan Hong,Author
1500,Yucong Lin,Author
1500,Tianrun Cai,Author
1500,Jun Wen,Author
1500,Vidul A. Panickan,Author
1500,Clara-Lea Bonzel,Author
1500,Kai-Li Liaw,Author
1500,Katherine P. Liao,Author
1500,Tianxi Cai,Author
1501,Clinical Research Studies,Topic
1501,Internal Validity,Topic
1501,External Validity,Topic
1501,Prospective Observational Studies,Topic
1501,Confounding,Topic
1501,Transportability,Topic
1501,Data-Fusion,Topic
1501,Calibration Method,Topic
1501,Target Population Average Treatment Effect,Topic
1501,Doubly-Robust Methods,Topic
1501,Simulation Study,Topic
1501,Biguanides,Topic
1501,Sulfonylureas,Topic
1501,All-Cause Mortality,Topic
1501,Kevin P. Josey,Author
1501,Fan Yang,Author
1501,Debashis Ghosh,Author
1501,Sridharan Raghavan,Author
1502,Ai In Healthcare,Topic
1502,Radiology,Topic
1502,Dermatology,Topic
1502,Ophthalmology,Topic
1502,In Vitro Fertilization (Ivf),Topic
1502,Ethical Issues In Ivf,Topic
1502,Interpretable Models,Topic
1502,Clinical Effectiveness Trials,Topic
1502,Michael Anis Mihdi Afnan,Author
1502,Cynthia Rudin,Author
1502,Vincent Conitzer,Author
1502,Julian Savulescu,Author
1502,Abhishek Mishra,Author
1502,Yanhe Liu,Author
1502,Masoud Afnan,Author
1503,Emergency Department,Topic
1503,Machine Learning,Topic
1503,Hospital Admission,Topic
1503,Georgios Feretzakis,Author
1503,George Karlis,Author
1503,Evangelos Loupelis,Author
1503,Dimitris Kalles,Author
1503,Rea Chatzikyriakou,Author
1503,Nikolaos Trakas,Author
1503,Eugenia Karakou,Author
1503,Aikaterini Sakagianni,Author
1503,Lazaros Tzelves,Author
1503,Stavroula Petropoulou,Author
1503,Aikaterini Tika,Author
1503,Ilias Dalainas,Author
1503,Vasileios Kaldis,Author
1503,Biomarkers,Topic
1503,Ed Visits,Topic
1503,F-Measure,Topic
1503,Roc Area,Topic
1504,Geoecg: Data Augmentation Via Wasserstein Geodesic Perturbation For Robust Electrocardiogram Prediction,Paper
1504,Jiacheng Zhu,Author
1504,Jielin Qiu,Author
1504,Zhuolin Yang,Author
1504,Douglas Weber,Author
1504,Michael A. Rosenberg,Author
1504,Emerson Liu,Author
1504,Bo Li,Author
1504,Ding Zhao,Author
1505,Counterfactual Image Synthesis For Discovery Of Personalized Predictive Image Markers,Paper
1505,Amar Kumar,Author
1505,Anjun Hu,Author
1505,Brennan Nichyporuk,Author
1505,Jean-Pierre R. Falet,Author
1505,Douglas L. Arnold,Author
1505,Sotirios Tsaftaris,Author
1505,Tal Arbel,Author
1505,Multiple Sclerosis,Topic
1505,Deep Learning,Topic
1505,Biomarker Discovery,Topic
1505,Counterfactual Synthesis,Topic
1505,Magnetic Resonance Imaging,Topic
1505,Relapsing-Remitting Multiple Sclerosis,Topic
1506,Causally-Interpretable Meta-Analysis,Topic
1506,Kollin W. Rott,Author
1506,Gert Bronfort,Author
1506,Haitao Chu,Author
1506,Jared D. Huling,Author
1506,Brent Leininger,Author
1506,Mohammad Hassan Murad,Author
1506,Zhen Wang,Author
1506,James S. Hodges,Author
1507,Multimodal And Multicontrast Image Fusion Via Deep Generative Models,Paper
1507,Giovanna Maria Dimitri,Author
1507,Simeon Spasov,Author
1507,Andrea Duggento,Author
1507,Luca Passamonti,Author
1507,Pietro Li`O,Author
1507,Nicola Toschi,Author
1508,Artificial Intelligence,Topic
1508,Drug-Drug Interactions,Topic
1508,Xuan Lin,Author
1508,Lichang Dai,Author
1508,Yafang Zhou,Author
1508,Zu-Guo Yu,Author
1508,Wen Zhang,Author
1508,Jian-Yu Shi,Author
1508,Dong-Sheng Cao,Author
1508,Li Zeng,Author
1508,Haowen Chen,Author
1508,Bosheng Song,Author
1508,Philip S. Yu,Author
1508,Xiangxiang Zeng,Author
1508,Deep Learning,Topic
1508,Graph Learning,Topic
1508,Molecular Representation,Topic
1508,Graph Neural Network Models,Topic
1508,Drug Discovery,Topic
1508,Clinical Research,Topic
1509,Conditional Flow Variational Autoencoder For Controllable Synthesis Of Virtual Populations Of Anatomy,Paper
1509,Haoran Dou,Author
1509,Nishant Ravikumar,Author
1509,Alejandro F. Frangi,Author
1509,Virtual Populations,Topic
1509,Conditional Variational Autoencoder,Topic
1509,Normalising Flows,Topic
1509,Cardiac Left Ventricles,Topic
1509,Demographic Information,Topic
1509,Clinical Measurements,Topic
1509,Generalisation Errors,Topic
1509,Specificity Errors,Topic
1509,Clinically Relevant Biomarkers,Topic
1509,Left Ventricular Blood Pool,Topic
1509,Myocardial Volume,Topic
1509,Real Observed Population,Topic
1510,Opioids,Topic
1510,Opioid Use Disorder,Topic
1510,Sybille LÈgitime,Author
1510,Kaustubh Prabhu,Author
1510,Devin Mcconnell,Author
1510,Bing Wang,Author
1510,Dipak K. Dey,Author
1510,Derek Aguiar,Author
1510,Oud Risk Estimation Framework,Topic
1511,Histological Examination,Topic
1511,Two-Color Stimulated Raman Histology,Topic
1511,High-Content Stimulated Raman Histology (Hc-Srh),Topic
1511,Breast Tissue,Topic
1511,Fiber Laser-Based Srs Microscopy,Topic
1511,Nucleic Acid,Topic
1511,Solid-State Ester,Topic
1511,Hongli Ni,Author
1511,Chinmayee Prabhu Dessai,Author
1511,Haonan Lin,Author
1511,Wei Wang,Author
1511,Shaoxiong Chen,Author
1511,Yuhao Yuan,Author
1511,Xiaowei Ge,Author
1511,Jianpeng Ao,Author
1511,Nolan Vild,Author
1511,Ji-Xin Cheng,Author
1512,Visuospatial Neglect,Topic
1512,Stroke,Topic
1512,Artificial Intelligence Solution,Topic
1512,Gaussian Process Regression,Topic
1512,Gamification,Topic
1512,Tele-Rehabilitation,Topic
1512,Personalised Healthcare,Topic
1512,Clinical Trials,Topic
1512,Ai-Based Assessment,Topic
1512,Vr Application,Topic
1512,Ivan De Boi,Author
1512,Elissa Embrechts,Author
1512,Quirine Schatteman,Author
1512,Rudi Penne,Author
1512,Steven Truijen,Author
1512,Wim Saeys,Author
1513,Intracortical Brain-Computer Interfaces (Ibcis),Topic
1513,Amyotrophic Lateral Sclerosis (Als),Topic
1513,Self-Recalibration Of Communication Ibcis,Topic
1513,Large Language Models (Lms),Topic
1513,Continual Online Recalibration With Pseudo-Labels (Corp),Topic
1513,93.84%,Topic
1513,Plug-And-Play Stability For Intracortical Brain-Computer Interfaces: A One-Year Demonstration Of Seamless Brain-To-Text Communication,Paper
1514,Radiation Therapy,Topic
1514,Sp-Diffdose,Paper
1514,Swintransformer,Topic
1514,Linjie Fu,Author
1514,Xia Li,Author
1514,Xiuding Cai,Author
1514,Yingkai Wang,Author
1514,Xueyao Wang,Author
1514,Yu Yao,Author
1514,Yali Shen,Author
1515,Synthetic Data Generation,Topic
1515,Clinical Cohort,Topic
1515,Heterogeneity,Topic
1515,Variational Autoencoders,Topic
1515,Propensity Score Regression,Topic
1515,Kiana Farhadyar,Author
1515,Federico Bonofiglio,Author
1515,Maren Hackenberg,Author
1515,Daniela Zoeller,Author
1515,Harald Binder,Author
1515,International Stroke Trial,Topic
1516,Hierarchical Classification System For Breast Cancer Specimen Report (Hcsbc),Topic
1516,Thiago Santos,Author
1516,Harish Kamath,Author
1516,Christopher R. Mcadams,Author
1516,Mary S. Newell,Author
1516,Marina Mosunjac,Author
1516,Gabriela Oprea-Ilies,Author
1516,Geoffrey Smith,Author
1516,Constance Lehman,Author
1516,Judy Gichoya,Author
1516,Imon Banerjee,Author
1516,Hari Trivedi,Author
1517,Qtnet,Topic
1517,Dofetilide,Topic
1517,Massachusetts General Hospital,Topic
1517,Ecgrdvq-Dataset,Topic
1517,Ridwan Alam,Author
1517,Aaron Aguirre,Author
1517,Collin Stultz,Author
1518,Cardiac Digital Twin,Topic
1518,Automated Pipeline,Topic
1518,Dofetilide,Topic
1518,Julia Camps,Author
1518,Zhinuo Jenny Wang,Author
1518,Ruben Doste,Author
1518,Maxx Holmes,Author
1518,Brodie Lawson,Author
1518,Jakub Tomek,Author
1518,Kevin Burrage,Author
1518,Alfonso Bueno-Orovio,Author
1518,Blanca Rodriguez,Author
1519,Learning Optimal Dynamic Treatment Regimes From Longitudinal Data,Paper
1519,Optimal Dynamic Treatment Rule,Topic
1520,Concurrency Of Transcranial Magnetic Stimulation With Electroencephalography,Topic
1520,Tms-Eeg Methodology,Topic
1520,Intermittent Theta-Burst Stimulation,Topic
1520,Continuous Theta-Burst Stimulation,Topic
1520,Left Dorsolateral Prefrontal Cortex,Topic
1520,Brainstorm,Author
1520,Hua Cheng,Author
1521,Clinical Decision-Making,Topic
1521,Randomized Controlled Trials,Topic
1521,Machine Learning Models,Topic
1521,Clinical Decision Support System,Topic
1521,Multiple Myeloma,Topic
1521,Interventional Study,Topic
1521,Zeshan Hussain,Author
1521,Barbara D. Lam,Author
1521,Fernando A. Acosta-Perez,Author
1521,Irbaz Bin Riaz,Author
1521,Maia Jacobs,Author
1521,Andrew J. Yee,Author
1521,David Sontag,Author
1522,Digital Twin,Topic
1522,Digital Twin Generators,Topic
1522,Machine Learning,Topic
1522,Health Records,Topic
1522,Clinical Trials,Topic
1522,Personalized Treatment,Topic
1522,Authors,Author
1523,Van Der Heijde Modification Of The Sharp Score,Topic
1523,Rheumatoid Arthritis,Topic
1523,Automated Pipeline,Topic
1523,Deep Learning Models To Automate The Scoring Of Hand Radiographs For Rheumatoid Arthritis,Paper
1524,Biobanks,Topic
1524,Biomedical And Clinical Research,Topic
1524,Rodrigo Dorantes-Gilardi,Author
1524,Kerry Ivey,Author
1524,Lauren Costa,Author
1524,Rachael Matty,Author
1524,Kelly Cho,Author
1524,John Michael Gaziano,Author
1524,Albert-L·szlÛ Barab·si,Author
1524,Scientific Articles,Topic
1524,Grants,Topic
1524,Patents,Topic
1524,Clinical Trials,Topic
1524,Public Policy Documents,Topic
1524,Obesity,Topic
1524,Alzheimer'S Disease,Topic
1524,Breast Cancer,Topic
1524,Diabetes,Topic
1524,Open-Access Web Application,Topic
1524,Impact Of Biobanks,Topic
1525,Objective Structured Assessments Of Technical Skills (Osats),Topic
1525,Global Rating Scale (Grs),Topic
1525,Jigsaws Dataset,Topic
1525,Recurrent Transformer Model,Topic
1525,Julien Quarez,Author
1525,Marc Modat,Author
1525,Sebastien Ourselin,Author
1525,Jonathan Shapey,Author
1525,Alejandro Granados,Author
1525,Spearman'S Correlation Coefficients (Scc),Topic
1525,Automated Surgical Skill Assessment Pipelines,Topic
1525,Senior Surgeon,Topic
1526,X-Ray Dark-Field Imaging,Topic
1526,Yongjin Sung,Author
1526,Brandon Nelson,Author
1526,Rajiv Gupta,Author
1526,Xdfi Simulation,Topic
1526,Emphysema,Topic
1526,Fibrosis,Topic
1526,Atelectasis,Topic
1526,Edema,Topic
1526,Pneumonia,Topic
1526,Xcat Phantom,Topic
1526,Voronoi Grids,Topic
1526,Multi-Layer Wave-Optics Propagation,Topic
1526,Realistic Xdfi Images,Topic
1526,Lung Pathologies,Topic
1526,In-Silico Clinical Trials,Topic
1526,Hardware And Software Optimization,Topic
1527,Design And Inference For Multi-Arm Clinical Trials With Informational Borrowing: The Interacting Urns Design,Paper
1528,Segmenting Brain Tumors In Multi-Parametric Magnetic Resonance Imaging,Topic
1528,Brain Tumor Segmentation (Brats) Challenge,Topic
1528,Deep Learning-Based Ensemble Strategy,Topic
1528,Daniel Capell·n-MartÌn,Author
1528,Zhifan Jiang,Author
1528,Abhijeet Parida,Author
1528,Xinyang Liu,Author
1528,Van Lam,Author
1528,Hareem Nisar,Author
1528,Austin Tapp,Author
1528,Sarah Elsharkawi,Author
1528,Maria J. Ledesma-Carbayo,Author
1528,Syed Muhammad Anwar,Author
1528,Marius George Linguraru,Author
1528,Pediatric Brain Tumors (Ped),Topic
1528,Intracranial Meningioma (Men),Topic
1528,Brain Metastases (Met),Topic
1529,Randomised Clinical Trial,Topic
1529,Primary Endpoint,Topic
1529,Secondary Endpoints,Topic
1529,Type I Error Risk,Topic
1529,Co-Primary Endpoints,Topic
1529,Hierarchical Test Procedure,Topic
1529,Silvy Laporte,Author
1529,Marine DivinÈ,Author
1529,DaniËle Girault,Author
1529,Pierre Boutouyrie,Author
1529,Olivier Chassany,Author
1529,Michel Cucherat,Author
1529,HervÈ De Trogoff,Author
1529,Sophie Dubois,Author
1529,Cecile Fouret,Author
1529,Natalie Hoog-Labouret,Author
1529,Pascale Jolliet,Author
1529,Patrick Mismetti,Author
1529,RaphaÎl Porcher,Author
1529,CÈcile Rey-Coquais,Author
1529,Eric Vicaut,Author
1530,Challenges In Rare Disease Drug Development,Topic
1530,Real-World Evidence (Rwe) Scientific Working Group,Author
1530,Jie Chen,Author
1530,Lei Nie,Author
1530,Shiowjen Lee,Author
1530,Haitao Chu,Author
1530,Haijun Tian,Author
1530,Yan Wang,Author
1530,Weili He,Author
1530,Thomas Jemielita,Author
1530,Susan Gruber,Author
1530,Yang Song,Author
1530,Roy Tamura,Author
1530,Lu Tian,Author
1530,Yihua Zhao,Author
1530,Yong Chen,Author
1530,Mark Van Der Laan,Author
1530,Hana Lee,Author
1530,Regulatory Agencies,Topic
1530,Statistical Perspective,Topic
1530,Development Pathway For Rare Disease Drugs,Topic
1530,Evidence For Regulatory Decision-Making,Topic
1531,Transportability Analysis,Topic
1531,Target Aggregate Data Adjustment,Topic
1531,Yichen Yan,Author
1531,Quang Vuong,Author
1531,Rebecca K Metcalfe,Author
1531,Tianyu Guan,Author
1531,Haolun Shi,Author
1531,Jay Jh Park,Author
1532,Finepico,Topic
1532,Fangyi Chen,Author
1532,Gongbo Zhang,Author
1532,Yilu Fang,Author
1532,Yifan Peng,Author
1532,Chunhua Weng,Author
1532,Pico,Topic
1532,Ner,Topic
1532,Clinical Trial Literature,Topic
1532,Precision,Topic
1532,Recall,Topic
1532,F1 Score,Topic
1532,Public Datasets,Topic
1532,Semi-Supervised Method,Topic
1532,Annotated Data,Topic
1532,Unlabeled Data,Topic
1532,Performance Evaluation,Topic
1532,Generalizability,Topic
1532,Baseline Model,Topic
1532,Experimental Settings,Topic
1533,Psoriasis,Topic
1533,Pasi,Topic
1533,Pso-Net,Paper
1533,Sharif A. Kamran,Author
1533,Molly V. Lucas,Author
1533,Brendon Lutnick,Author
1533,Chaitanya Parmar,Author
1533,Basudha Pal,Author
1533,Asha Patel Shah,Author
1533,David Apfel,Author
1533,Steven Fakharzadeh,Author
1533,Lloyd Miller,Author
1533,Stephen Yip,Author
1533,Kristopher Standish,Author
1533,Gabriela Oana Cula,Author
1534,Arachidonic Acid,Topic
1534,Cyclooxygenase,Topic
1534,Reactive Oxygen Species,Topic
1534,Ischemic Brain,Topic
1534,Cyclooxygenase-2,Topic
1534,Neurodegeneration,Topic
1534,Ischemic Injury,Topic
1534,Nimesulide,Author
1534,Gerbils,Topic
1534,Cerebral Ischemia,Topic
1534,Oxidative Stress,Topic
1534,Hippocampus,Topic
1534,Glutathione Depletion,Topic
1534,Lipid Peroxidation,Topic
1534,Malondialdehyde,Topic
1534,4-Hydroxy-Alkenals,Topic
1534,Lipid Hydroperoxides,Topic
1534,Fluoro-Jade B,Topic
1534,Ca1 Region,Topic
1534,E. Candelario-Jalil,Author
1534,D. Alvarez,Author
1534,N. Merino,Author
1534,O. S. Leon,Author
1535,Brain Computer Interface Technologies In The Coming Decades,Paper
1535,Brent J. Lance,Author
1535,Scott E. Kerick,Author
1535,Anthony J. Ries,Author
1535,Kelvin S. Oie,Author
1535,Kaleb Mcdowell,Author
1535,Brain-Computer Interfaces,Topic
1535,Neuroscience Research,Topic
1535,Human-System Interactions,Topic
1535,Technological Advancements,Topic
1535,Flexible And Adaptive Brain-Based Neurotechnologies,Topic
1535,Clinical Populations,Topic
1535,Advanced Communications,Topic
1535,Prostheses,Topic
1535,Wheelchairs,Topic
1535,Task-Oriented Applications,Topic
1535,Pervasive Technologies,Topic
1535,Analytical Approaches,Topic
1535,Critical Brain Information,Topic
1535,Behavioral Information,Topic
1535,Task Information,Topic
1535,Environmental Information,Topic
1535,Communications Applications,Topic
1536,Percolation Under Noise: Detecting Explosive Percolation Using The Second Largest Component,Paper
1536,Wes Viles,Author
1536,Cedric E. Ginestet,Author
1536,Ariana Tang,Author
1536,Mark A. Kramer,Author
1536,Eric D. Kolaczyk,Author
1536,Classical Percolation,Topic
1536,Explosive Percolation,Topic
1536,Noise In Observations,Topic
1536,Hidden Markov Graph Model,Topic
1536,Discriminatory Power,Topic
1537,Spatial Neural Networks And Their Functional Samples: Similarities And Differences,Paper
1537,Neural Networks,Topic
1537,Functional Networks,Topic
1537,Mesoscopic Network Dynamics,Topic
1537,Microscopic Network Structure,Topic
1537,Eeg,Topic
1538,Neuroscience,Topic
1538,Neuroimaging Technologies,Topic
1538,Diffusion Tensor Imaging,Topic
1538,Structural Graphs,Topic
1538,Functional Graphs,Topic
1538,Functional Connectivity,Topic
1538,Cassiano O. Becker,Author
1538,Sergio Pequito,Author
1538,George J. Pappas,Author
1538,Michael B. Miller,Author
1538,Scott T. Grafton,Author
1538,Danielle S. Bassett,Author
1538,Victor M. Preciado,Author
1538,Cognitive Systems,Topic
1538,Clinical Populations,Topic
1538,Developmental Populations,Topic
1539,Rt-Fmri,Topic
1539,Decnef,Topic
1539,Aurelio Cortese,Author
1539,Kaoru Amano,Author
1539,Ai Koizumi,Author
1539,Hakwan Lau,Author
1539,Mitsuo Kawato,Author
1540,Contemporary Systems Biology,Topic
1540,Network,Topic
1540,Molecular Species,Topic
1540,Cellular Species,Topic
1540,Organismal Species,Topic
1540,Graph Of Dependencies,Topic
1540,High-Throughput Data Acquisition Technologies,Topic
1540,Genomics,Topic
1540,Metabolomics,Topic
1540,Neuroscience,Topic
1540,Reverse-Engineering,Topic
1540,System Architectures,Topic
1540,Predictions,Topic
1540,Drug Discovery,Topic
1540,Disease Treatment,Topic
1540,Network Inference Algorithms,Topic
1540,Joseph L. Natale,Author
1540,David Hofmann,Author
1540,Damian G. Hern·ndez,Author
1540,Ilya Nemenman,Author
1541,Morphospace Of Consciousness,Topic
1541,Xerxes D. Arsiwalla,Author
1541,Ricard Sole,Author
1541,Clement Moulin-Frier,Author
1541,Ivan Herreros,Author
1541,Marti Sanchez-Fibla,Author
1541,Paul Verschure,Author
1541,Autonomous Complexity,Topic
1541,Cognitive Complexity,Topic
1541,Social Complexity,Topic
1541,Biological Consciousness,Topic
1541,Synthetic Consciousness,Topic
1541,Group Consciousness,Topic
1541,Simulated Consciousness,Topic
1541,Conscious Systems,Topic
1541,Synthetic Systems,Topic
1541,Artificially Intelligent Machines,Topic
1541,Synthetically Engineered Life Forms,Topic
1541,Cognitive Robotics,Topic
1541,Evolutionary Game-Theoretic Strategy,Topic
1541,Comparative Signatures Of Consciousness,Topic
1541,Design Principles For Conscious Machines,Topic
1541,Cognitive Neuroscience,Topic
1541,Biomedical Engineering,Topic
1541,Biomimetics,Topic
1542,Electroencephalogram (Eeg),Topic
1542,Wavelet Packet Transform Followed By Independent Component Analysis (Wptica),Topic
1542,Wavelet Packet Transform Followed By Empirical Mode Decomposition (Wptemd),Topic
1542,Root Mean Square Error (Rmse),Topic
1542,Artifact To Signal Ratio (Asr),Topic
1542,Enobio,Topic
1542,Valentina Bono,Author
1542,Saptarshi Das,Author
1542,Wasifa Jamal,Author
1542,Koushik Maharatna,Author
1542,Hybrid Wavelet And Emd/Ica Approach For Artifact Suppression In Pervasive Eeg,Paper
1543,Independent Component Analysis,Topic
1543,Hint,Paper
1543,Joshua Lukemire,Author
1543,Yikai Wang,Author
1543,Amit Verma,Author
1543,Ying Guo,Author
1544,Diffusion Imaging,Topic
1544,Neuroscience,Topic
1544,Mri,Topic
1544,Deep Learning Residual Network,Topic
1544,Spherical Harmonic Residual Network For Diffusion Signal Harmonization,Paper
1545,Biomechanic And Motor Control Models,Topic
1545,Bipedal Robots,Topic
1545,Human Locomotion,Topic
1545,Potential Energy Model,Topic
1545,Task-Space Planner,Topic
1545,Rehabilitation Robotics,Topic
1545,Computational Neuroscience,Topic
1545,Centre Of Mass (Com) Trajectories,Topic
1545,Foot Swing Trajectories,Topic
1545,Base Of Support (Bos),Topic
1545,Carlo Tiseo,Author
1545,Kalyana C Veluvolu,Author
1545,Wei Tech Ang,Author
1546,Alzheimer'S Disease,Topic
1546,Core-Periphery Structure,Topic
1546,Dwi,Topic
1546,Fmri,Topic
1546,Meg,Topic
1546,Cognitive Impairment,Topic
1546,Memory Impairment,Topic
1546,Jeremy Guillon,Author
1546,Mario Chavez,Author
1546,Federico Battiston,Author
1546,Yohan Attal,Author
1546,Valentina La Corte,Author
1546,Michel Thiebaut De Schotten,Author
1546,Bruno Dubois,Author
1546,Denis Schwartz,Author
1546,Olivier Colliot,Author
1546,Fabrizio De Vico Fallani,Author
1547,Dynamic Causal Modelling (Dcm),Topic
1547,Fmri,Topic
1547,Parametric Empirical Bayes,Topic
1547,Peter Zeidman,Author
1547,Amirhossein Jafarian,Author
1547,NadËge Corbin,Author
1547,Mohamed L. Seghier,Author
1547,Adeel Razi,Author
1547,Cathy J. Price,Author
1547,Karl J. Friston,Author
1548,Multi-Articulate Prostheses,Topic
1548,Modified Kalman Filter (Mkf),Topic
1548,Deka 'Luke' Arm,Topic
1548,Neural Firing Rates,Topic
1548,Utah Slanted Electrode Arrays,Topic
1548,Intramuscular Electromyographic (Emg) Recordings,Topic
1548,Jacob A. George,Author
1548,Tyler S. Davis,Author
1548,Mark R. Brinton,Author
1548,Gregory A. Clark,Author
1549,T2-Buda-Gslider,Topic
1549,Xiaozhi Cao,Author
1549,Congyu Liao,Author
1549,Zijing Zhang,Author
1549,Siddharth Srinivasan Iyer,Author
1549,Kang Wang,Author
1549,Hongjian He,Author
1549,Huafeng Liu,Author
1549,Kawin Setsompop,Author
1549,Jianhui Zhong,Author
1549,Berkin Bilgic,Author
1550,Working Memory,Topic
1550,Central Executive Function,Topic
1550,Event-Related Potential,Topic
1550,Pankaj,Author
1550,Jamuna Rajeswaran,Author
1550,Divya Sadana,Author
1550,Thirty Healthy Educated Subjects,Paper
1550,Inhibition And Set-Shifting Tasks In Central Executive Function Of Working Memory: An Event-Related Potential (Erp) Study,Paper
1551,Adaptive Behavior,Topic
1551,Cognitive Agents,Topic
1551,Environmental Demands,Topic
1551,Information Processing,Topic
1551,Bayesian Model,Topic
1551,Wisconsin Card Sorting Test,Topic
1551,Bayesian Brain Theory,Topic
1551,Marco D'Alessandro,Author
1551,Stefan T. Radev,Author
1551,Andreas Voss,Author
1551,Luigi Lombardi,Author
1552,Transcranial Magnetic Stimulation (Tms),Topic
1552,Computational Dosimetry,Topic
1552,Jose Gomez-Tames,Author
1552,Ilkka Laakso,Author
1552,Akimasa Hirata,Author
1552,Review On Biophysical Modelling And Simulation Studies For Transcranial Magnetic Stimulation,Paper
1553,Fiber Tractography,Topic
1553,Diffusion Magnetic Resonance Imaging,Topic
1553,Dmri,Topic
1553,Tomer Weiss,Author
1553,Sanketh Vedula,Author
1553,Ortal Senouf,Author
1553,Oleg Michailovich,Author
1553,Alex Bronstein,Author
1553,Human Connectome Project,Topic
1554,Desire-Motivation Model,Topic
1554,Recurrent Gating Desire-Motivation Model,Topic
1554,Ventral Tegmental Area,Topic
1554,Individual Personality,Topic
1554,Depressive Disorder,Topic
1554,Yu Liu,Author
1554,Yinghong Zhao,Author
1554,Mo Chen,Author
1555,Epileptic Seizures,Topic
1555,Percolation,Topic
1555,Random Graph Hidden Markov Models,Topic
1555,Xiaojing Zhu,Author
1555,Heather Shappell,Author
1555,Mark A. Kramer,Author
1555,Catherine J. Chu,Author
1555,Eric D. Kolaczyk,Author
1556,Diffusion Magnetic Resonance Imaging,Topic
1556,Noddi Model,Topic
1556,Microstructure Estimation Using A Deep Network,Paper
1556,Amico Algorithm,Topic
1556,Brain Dmri Scans,Topic
1557,Evidence-Based Medicine,Topic
1557,Cultural Biases,Topic
1557,Invasive Mechanical Ventilatory Therapy,Topic
1557,Retrospective Observational Study,Paper
1557,Adult General Intensive Care Unit,Topic
1557,Specialist Neurosciences Intensive Care Unit,Topic
1557,Paediatric Intensive Care Unit,Topic
1557,Tertiary Referral Hospital,Topic
1557,Peep,Topic
1557,Rr,Topic
1557,Pinsp,Topic
1557,Monte Carlo Method,Topic
1557,Superstitions,Topic
1557,Number 13,Topic
1558,Functional Magnetic Resonance Imaging,Topic
1558,Functional Connectivity,Topic
1558,Multiple-View Clustering Method,Topic
1558,Wishart Mixture Models,Topic
1558,Tomoki Tokuda,Author
1558,Okito Yamashita,Author
1558,Junichiro Yoshimoto,Author
1559,Few-Shot Learning,Topic
1559,Graph Neural Networks,Topic
1559,One-Shot Learning,Topic
1559,Connectional Brain Template,Topic
1559,Umut Guvercin,Author
1559,Mohammed Amine Gharsallaoui,Author
1559,Islem Rekik,Author
1559,One-Representative Cbt,Topic
1559,Brain Connectivity Classification,Topic
1559,Evolution Prediction,Topic
1559,Https://Github.Com/Basiralab/One-Representative-Shot-Learning,Topic
1560,Mental Health Research,Topic
1560,Brain Function Measures,Topic
1560,Mental Health Disorders,Topic
1560,Data-Driven Analyses,Topic
1560,Population-Level Datasets,Topic
1560,Canonical Correlation Analysis (Cca),Topic
1560,Resting-State Mri Functional Connectivity,Topic
1560,Subject Measures Of Cognition And Behavior,Topic
1560,Well-Being,Topic
1560,Developmental Dataset,Topic
1560,Primary Cca Mode,Topic
1560,Variance Explained,Topic
1560,Neurotypical Relationship,Topic
1560,Nikhil Goyal,Author
1560,Dustin Moraczewski,Author
1560,Peter A. Bandettini,Author
1560,Emily S. Finn,Author
1560,Adam G. Thomas,Author
1560,Smith Et Al. 2015,Paper
1561,Optical Neuroimaging,Topic
1561,Functional Near-Infrared Spectroscopy (Fnirs),Topic
1561,Deep Learning (Dl),Topic
1561,Brain-Computer Interface,Topic
1561,Neuro-Impairment Diagnosis,Topic
1561,Neuroscience Discovery,Topic
1561,Condell Eastmond,Author
1561,Aseem Subedi,Author
1561,Suvranu De,Author
1561,Xavier Intes,Author
1561,Deep Learning In Fnirs: A Review,Paper
1562,Graph Neural Networks,Topic
1562,Medical Imaging,Topic
1562,Network Neuroscience,Topic
1562,Autism,Topic
1562,Federated Learning,Topic
1562,Mehmet Yigit Balik,Author
1562,Arwa Rekik,Author
1562,Islem Rekik,Author
1562,Reproducibility Of Federated Gnn Models,Topic
1562,Connectomic Datasets,Topic
1562,Https://Github.Com/Basiralab/Reproduciblefedgnn,Paper
1563,Effective Connectivity,Topic
1563,Neural Perturbational Inference,Topic
1563,Zixiang Luo,Author
1563,Kaining Peng,Author
1563,Zhichao Liang,Author
1563,Shengyuan Cai,Author
1563,Chenyu Xu,Author
1563,Dan Li,Author
1563,Yu Hu,Author
1563,Changsong Zhou,Author
1563,Quanying Liu,Author
1564,Explainable Brain Age Prediction Using Covariance Neural Networks,Paper
1564,Saurabh Sihag,Author
1564,Gonzalo Mateos,Author
1564,Corey Mcmillan,Author
1564,Alejandro Ribeiro,Author
1564,Computational Neuroscience,Topic
1564,Brain Age,Topic
1564,Brain Age Gap,Topic
1564,Alzheimer'S Disease,Topic
1564,Machine Learning Algorithms,Topic
1564,Brain Imaging Data,Topic
1564,Cortical Thickness Features,Topic
1564,Vnn,Topic
1564,Anatomical Covariance Matrix,Topic
1565,Immunotherapy,Topic
1565,Fda Approval,Topic
1565,Cancer Treatment,Topic
1565,Nikita Vladimirov,Author
1565,Or Perlman,Author
1565,Magnetic Resonance Imaging,Topic
1565,Molecular Mri,Topic
1565,Artificial Intelligence,Topic
1565,Preclinical Studies,Topic
1565,Clinical Studies,Topic
1566,Gaussian Processes,Topic
1566,Rvgp,Paper
1566,Robert L. Peach,Author
1566,Matteo Vinao-Carl,Author
1566,Nir Grossman,Author
1566,Michael David,Author
1566,Emma Mallas,Author
1566,David Sharp,Author
1566,Paresh A. Malhotra,Author
1566,Pierre Vandergheynst,Author
1566,Adam Gosztolai,Author
1567,Electroencephalographic (Eeg) Signals,Topic
1567,Eeg Denoising Model,Topic
1567,Eegdenoisenet Dataset,Topic
1567,Matteo Gabardi,Author
1567,Aurora Saibene,Author
1567,Francesca Gasparini,Author
1567,Daniele Rizzo,Author
1567,Fabio Antonio Stella,Author
1568,Joint Alignment Of Multivariate Quasi-Periodic Functional Data Using Deep Learning,Paper
1568,Vi Thanh Pham,Author
1568,Jonas Bille Nielsen,Author
1568,Klaus Fuglsang Kofoed,Author
1568,J¯rgen Tobias K¸hl,Author
1568,Andreas Kryger Jensen,Author
1568,Signal Processing,Topic
1568,Neuroscience,Topic
1568,Medicine,Topic
1568,Wearable Devices,Topic
1568,Deep Neural Networks,Topic
1568,Fisher-Rao Metric,Topic
1568,Electrocardiogram,Topic
1569,Diffusion Mri With Machine Learning,Paper
1569,Dmri,Topic
1569,Machine Learning,Topic
1570,Electroencephalogram (Eeg),Topic
1570,Filter Average Short-Term (Fast) Functional Connectivity,Topic
1570,Visual Short Term Memory (Vstm),Topic
1570,Event-Related Potentials (Erps),Topic
1570,Alzheimer'S Disease,Topic
1570,Om Roy,Author
1570,Yashar Moshfeghi,Author
1570,Agustin Ibanez,Author
1570,Francisco Lopera,Author
1570,Mario A Parra,Author
1570,Keith M Smith,Author
1571,Brain-Computer Interface (Bci) Systems,Topic
1571,Severely Disabled Individuals,Topic
1571,Deep Learning And Riemannian Geometry-Based Classification Models,Topic
1571,Motor Imagery (Mi) Based Bci,Topic
1571,Electroencephalography (Eeg),Topic
1571,Optimal Transport Theory-Based Approach,Topic
1571,Earth Mover'S Distance (Emd),Topic
1571,Explainable Ai (Xai) Techniques,Topic
1571,Riemannian Geometry-Based Classifier,Paper
1571,Eegnet,Paper
1571,Eeg Conformer,Paper
1571,Param Rajpura,Author
1571,Hubert Cecotti,Author
1571,Yogesh Kumar Meena,Author
1572,Endovascular Brain-Computer Interfaces (Ebcis),Topic
1572,Wireless Data And Power Transmission,Topic
1572,Endovascular Electrocorticography (Ecog),Topic
1572,Sensing Stent,Topic
1572,Optical Telemetry Module,Topic
1572,Focused Ultrasound (Fus) Power Transfer System,Topic
1572,Zhangyu Xu,Author
1572,Majid Khazaee,Author
1572,Nhan Duy Truong,Author
1572,Deniel Havenga,Author
1572,Armin Nikpour,Author
1572,Arman Ahnood,Author
1572,Omid Kavehei,Author
1573,Local Field Potential (Lfp),Topic
1573,Nucleus Accumbens,Topic
1573,Hippocampus,Topic
1573,Morphine,Topic
1573,Natural Food,Topic
1573,Long Short Term Memory (Lstm),Topic
1573,Echo State Network (Esn),Topic
1573,Deep Echo State Network (Deepesn),Topic
1573,Radial Basis Function (Rbf),Topic
1573,Local Linear Model Tree (Llm),Topic
1573,Lolimot,Topic
1573,Maedeh Sadeghi,Author
1573,Mahdi Aliyari Shoorehdeli,Author
1573,Shole Jamali,Author
1573,Abbas Haghparast,Author
1573,A Global Data-Driven Model For The Hippocampus And Nucleus Accumbens Of Rat From The Local Field Potential Recordings (Lfp),Paper
1574,Loci-Diffcom,Paper
1574,Zihao Zhu,Author
1574,Tianli Tao,Author
1574,Yitian Tao,Author
1574,Haowen Deng,Author
1574,Xinyi Cai,Author
1574,Gaofeng Wu,Author
1574,Kaidong Wang,Author
1574,Haifeng Tang,Author
1574,Lixuan Zhu,Author
1574,Zhuoyang Gu,Author
1574,Jiawei Huang,Author
1574,Dinggang Shen,Author
1574,Han Zhang,Author
1575,Electroencephalogram (Eeg) Technology,Topic
1575,High-Density Eeg (Hd Eeg) Devices,Topic
1575,Neuroscience,Topic
1575,Epilepsy Focus Localization,Topic
1575,Spatio-Temporal Adaptive Diffusion Models (Stad),Topic
1575,Low-Resolution Eeg,Topic
1575,High-Resolution Eeg,Topic
1575,Multi-Scale Transformer Denoising Module,Topic
1575,Tong Zhou,Author
1575,Shuqiang Wang,Author
1576,Electroencephalography (Eeg),Topic
1576,Eegnet,Topic
1576,Quantum-Eegnet (Qeegnet),Paper
1576,Bci Competition Iv 2A,Topic
1577,T-Fake Dataset,Topic
1577,Philipp Flotho,Author
1577,Moritz Piening,Author
1577,Anna Kukleva,Author
1577,Gabriele Steidl,Author
1577,Rgb2Thermal Loss Function,Topic
1577,Probabilistic Landmark Prediction,Topic
1577,Label Adaptation Networks,Topic
1578,Diffusion Tensor Imaging (Dti),Topic
1578,Dodti,Topic
1578,Jialong Li,Author
1578,Zhicheng Zhang,Author
1578,Yunwei Chen,Author
1578,Qiqi Lu,Author
1578,Ye Wu,Author
1578,Xiaoming Liu,Author
1578,Qianjin Feng,Author
1578,Yanqiu Feng,Author
1578,Xinyuan Zhang,Author
1579,Neural Transcoding Vision Transformer,Topic
1579,Romeo Lanzino,Author
1579,Federico Fontana,Author
1579,Luigi Cinque,Author
1579,Francesco Scarcello,Author
1579,Atsuto Maki,Author
1579,Domain Matching,Topic
1580,Multimodal Brain Magnetic Resonance Imaging,Topic
1580,Tumsyn,Paper
1581,Hyperbrain,Topic
1581,Sadaf Sadeghian,Author
1581,Xiaoxiao Li,Author
1581,Margo Seltzer,Author
1581,Autism Spectrum Disorder,Topic
1581,Attention Deficit Hyperactivity Disorder,Topic
1582,Block-Term Tensor Regression,Topic
1582,Federated Block-Term Tensor Regression,Topic
1582,Healthcare,Topic
1582,Neuroscience,Topic
1582,Finger Movement Decoding,Topic
1582,Heart Disease Prediction,Topic
1582,Axel Faes,Author
1582,Ashkan Pirmani,Author
1582,Yves Moreau,Author
1582,Liesbet M. Peeters,Author
1583,Brain Dynamics,Topic
1583,Fractal Geometry,Topic
1583,Eeg,Topic
1583,Lucas G. S. FranÁa,Author
1583,JosÈ G. V. Miranda,Author
1583,Marco Leite,Author
1583,Niraj K. Sharma,Author
1583,Matthew C. Walker,Author
1583,Louis Lemieux,Author
1583,Yujiang Wang,Author
1583,Chhabra-Jensen Algorithm,Topic
1584,Fmri Data Collection And Analysis,Topic
1584,Functional Brain Imaging,Topic
1584,Quality Control (Qc) Process,Topic
1584,Flag-Qc,Topic
1584,Matthew Kollada,Author
1584,Qingzhu Gao,Author
1584,Monika S Mellem,Author
1584,Tathagata Banerjee,Author
1584,William J Martin,Author
1585,Major Depressive Disorder,Topic
1585,Nils R. Winter,Author
1585,Ramona Leenings,Author
1585,Jan Ernsting,Author
1585,Kelvin Sarink,Author
1585,Lukas Fisch,Author
1585,Daniel Emden,Author
1585,Julian Blanke,Author
1585,Janik Goltermann,Author
1585,Nils Opel,Author
1585,Carlotta Barkhau,Author
1585,Susanne Meinert,Author
1585,Katharina Dohm,Author
1585,Jonathan Repple,Author
1585,Marco Mauritz,Author
1585,Marius Gruber,Author
1585,Elisabeth J. Leehr,Author
1585,Dominik Grotegerd,Author
1585,Ronny Redlich,Author
1585,Andreas Jansen,Author
1585,Igor Nenadic,Author
1585,Markus Nˆthen,Author
1585,Andreas Forstner,Author
1585,Marcella Rietschel,Author
1585,Joachim Groﬂ,Author
1585,Jochen Bauer,Author
1585,Walter Heindel,Author
1585,Till Andlauer,Author
1585,Simon Eickhoff,Author
1585,Tilo Kircher,Author
1585,Udo Dannlowski,Author
1585,Tim Hahn,Author
1585,Neuroimaging Modalities,Topic
1585,Healthy Controls,Topic
1585,Participants,Topic
1585,Polygenic Risk Score,Topic
1585,Environmental Variables,Topic
1585,Biological Psychiatry,Topic
1585,Computational Psychiatry,Topic
1585,Multivariate Machine Learning,Topic
1585,Ecologically Valid Phenotyping,Topic
1586,Magnetic Resonance Imaging,Topic
1586,Radiofrequency Excitation,Topic
1586,Biophysical Data,Topic
1586,Mri Contrasts,Topic
1586,Rf Sequences,Topic
1586,Vision Transformer-Based Framework,Topic
1586,Spatiotemporal Magnetic Signal Evolution,Topic
1586,Brain Tissue Response,Topic
1586,Mri On A Chip,Topic
1586,Calibration Scan,Topic
1586,Image Contrasts,Topic
1586,Molecular Composition,Topic
1586,Human Brain Tissue,Topic
1586,Dinor Nagar,Author
1586,Moritz Zaiss,Author
1586,Or Perlman,Author
1586,Deepmonc,Topic
1586,Cancer Patient,Topic
1586,Healthy Subjects,Topic
1586,Imaging Sites,Topic
1586,Alternative Protocols,Topic
1587,Teaching Computational Neuroscience,Topic
1587,PÈter …rdi,Author
1587,Three New Textbooks,Paper
1588,Fabian,Topic
1588,HÈlËne Lajous,Author
1588,Christopher W. Roy,Author
1588,Tom Hilbert,Author
1588,Priscille De Dumast,Author
1588,SÈbastien Tourbier,Author
1588,Yasser Alem·n-GÛmez,Author
1588,JÈrÙme Yerly,Author
1588,Thomas Yu,Author
1588,Hamza Kebiri,Author
1588,Kelly Payette,Author
1588,Jean-Baptiste Ledoux,Author
1588,Reto Meuli,Author
1588,Patric Hagmann,Author
1588,Andras Jakab,Author
1588,Vincent Dunet,Author
1588,MÈriam Koob,Author
1588,Tobias Kober,Author
1588,Matthias Stuber,Author
1588,Meritxell Bach Cuadra,Author
1589,Tailored Patient Information (Tpi) Systems,Topic
1589,Natural-Language Generation (Nlg) Community,Topic
1589,Medical Community,Topic
1589,Asthma-Information Booklets,Topic
1589,Smoking-Cessation Letters,Topic
1589,Ehud Reiter,Author
1589,Liesl Osman,Author
1589,Tailored Patient Information: Some Issues And Questions,Paper
1590,Generalized PÛlya Urn,Topic
1590,Sequential Estimation-Adjusted Urn Model,Topic
1590,Li-X. Zhang,Author
1590,Feifang Hu,Author
1590,Siu Hung Cheung,Author
1591,Bayesian Transformation Hazard Models,Topic
1591,Gousheng Yin,Author
1591,Joseph G. Ibrahim,Author
1592,"Fatigue, Sleepiness And Disturbed Sleep",Topic
1592,Electrophysiology,Topic
1592,Enobio,Topic
1592,G. Ruffini,Author
1592,S. Dunne,Author
1592,L. Fuentemilla,Author
1592,C. Grau,Author
1592,E. Farres,Author
1592,J. Marco-Pallares,Author
1592,P. C. P. Watts,Author
1592,S. R. P. Silva,Author
1593,Cell Cycling Models Of Carcinogenesis: A Complex Systems Analysis,Paper
1593,V. I. Prisecaru,Author
1593,I. C. Baianu,Author
1593,Carcinogenesis,Topic
1593,Cyclins,Topic
1593,Tp53,Topic
1593,Thomsen-Friedenreich Antigen,Topic
1593,Rb,Topic
1593,Mdm2,Topic
1593,C-Myc,Topic
1593,P21,Topic
1593,P27,Topic
1593,Bax,Topic
1593,Bad,Topic
1593,Bcl-2,Topic
1594,Drug Effectiveness,Topic
1594,Patient Compliance,Topic
1594,Latent Factors,Topic
1594,Quantum Processes,Topic
1594,Dominik Janzing,Author
1594,Thomas Beth,Author
1595,Biology As An Emergent Science,Paper
1595,Biological System,Topic
1595,Young'S Model,Topic
1595,Cancer Cachexia,Topic
1596,Neural Networks In 3D Medical Scan Visualization,Paper
1596,Andreas Elsner,Author
1596,Gitta Domik,Author
1597,Friedman'S Urn Model,Topic
1597,Multi-Dimensional Gaussian Process,Topic
1597,Stochastic Differential Equation,Topic
1597,Asymptotic Normality,Topic
1597,Law Of The Iterated Logarithm,Topic
1597,Randomized-Play-The-Winner Rule,Topic
1597,Li-Xin Zhang,Author
1597,Feifang Hu,Author
1597,Gaussian Approximation For Multi-Color Generalized Friedman'S Urn Model,Paper
1598,Inference For Censored Quantile Regression Models In Longitudinal Studies,Paper
1599,Spatio-Temporal Structuring Of Brain Activity - Description Of Interictal Eeg In Paediatric Frontal Lobe Epilepsy,Paper
1600,Nonparametric Methodology For The Time-Dependent Partial Area Under The Roc Curve,Paper
1600,Hung Hung,Author
1600,Chin-Tsang Chiang,Author
1600,Roc Curve,Topic
1600,Pauc,Topic
1600,Biomarker,Topic
1600,Aids Clinical Trials Group (Actg) 175 Study,Topic
1601,Arch. Gen. Psychiatry 66 (2009) 128--133,Paper
1601,Individualized Treatment Rule,Topic
1601,Clinical Trial Data,Topic
1601,L_1-Penalized Least Squares,Topic
1601,Min Qian,Author
1601,Susan A. Murphy,Author
1602,Functional Uniform Priors For Nonlinear Modelling,Paper
1603,Sequential Monitoring In Clinical Trials,Topic
1603,Randomization-Based Context,Topic
1603,Conditional Tests,Topic
1603,Information Fraction,Topic
1603,Efron'S Biased Coin Design,Topic
1603,Victoria Plamadeala,Author
1603,William F. Rosenberger,Author
1604,Multi-Objective Optimal Designs In Comparative Clinical Trials With Covariates: The Reinforced Doubly Adaptive Biased Coin Design,Paper
1605,A Dual-Beam Irradiation Facility For A Novel Hybrid Cancer Therapy,Paper
1606,Alzheimer'S Disease,Topic
1606,Decision-Making Model,Topic
1606,Athanasios Alexiou,Author
1606,Panayiotis Vlamos,Author
1607,Balancing Treatment Allocation For Influential Covariates,Topic
1607,Clinical Trials,Topic
1607,Biomarkers,Topic
1607,Translational Research,Topic
1607,Genomics,Topic
1607,Proteomics,Topic
1607,Metabolomics,Topic
1607,Stratified Permuted Block Randomization,Topic
1607,Minimization Methods,Topic
1607,Covariate-Adaptive Design,Topic
1607,Yanqing Hu,Author
1607,Feifang Hu,Author
1608,Exact Methods For Multistage Estimation Of A Binomial Proportion,Paper
1609,Influence Diagrams,Topic
1609,Bayesian Statistical Models,Topic
1609,User-Based Architecture,Topic
1609,Physicians,Topic
1609,Two-Arm Parallel Randomized Clinical Trials (Taprct),Topic
1609,Patient-Flow Diagram,Topic
1609,Cohort-State Diagram,Topic
1609,Construction Steps,Topic
1609,Thomas,Topic
1609,Harold P. Lehmann,Author
1609,Ross D. Shachter,Author
1610,Cost Effectiveness Statistic: A Proposal To Take Into Account The Patient Stratification Factors,Paper
1610,Randomized Clinical Trials,Topic
1610,Incremental Cost-Effective Ratio (Icer),Topic
1610,Cancer Therapy,Topic
1610,Cluster Analysis,Topic
1610,Patient Stratification Factors,Topic
1610,Age,Topic
1610,Gender,Topic
1610,Disease Severity,Topic
1611,Combinatorial Biomarkers,Topic
1611,Alzheimer'S Disease,Topic
1611,Dementia,Topic
1611,Scarf,Paper
1612,Identifiability Of Subgroup Causal Effects In Randomized Experiments With Nonignorable Missing Covariates,Paper
1612,Peng Ding,Author
1612,Zhi Geng,Author
1613,Da-Crm,Topic
1613,Toxicity Outcome,Topic
1613,Bayesian Data Augmentation,Topic
1613,Phase I Cancer Clinical Trials,Topic
1613,Suyu Liu,Author
1613,Guosheng Yin,Author
1613,Ying Yuan,Author
1614,Survregcenscov,Topic
1614,Stanislas Hubeaux,Author
1614,Kaspar Rufibach,Author
1615,Biased-Coin Designs,Topic
1615,Efron'S Biased-Coin Rule,Topic
1615,Anthony C. Atkinson,Author
1615,Loss Of Information,Topic
1615,Selection Bias,Topic
1615,Bayesian Rule,Topic
1615,Large Sample,Topic
1615,Small-Sample Simulations,Topic
1615,Treatment Allocation,Topic
1615,Imbalance,Topic
1616,Sharp Bounds On The Variance,Topic
1616,Difference-In-Means Estimator,Topic
1616,Completely Randomized Experiments,Topic
1616,Identification Problem In Causal Inference,Topic
1616,Wald-Type Confidence Intervals,Topic
1616,Randomized Controlled Trials,Topic
1616,Randomized Clinical Trials,Topic
1616,Peter M. Aronow,Author
1616,Donald P. Green,Author
1616,Donald K. K. Lee,Author
1617,Two-Stage Adaptive Dose-Response Study Designs,Topic
1617,Maximum Likelihood Estimate,Topic
1617,Bayesian Optimal Design,Topic
1617,Parameter Uncertainty,Topic
1617,Sigmoid Emax Dose-Response Model,Topic
1617,D-Optimality Criterion,Topic
1617,Emma Mccallum,Author
1617,Bjˆrn Bornkamp,Author
1618,Breast Imaging,Topic
1618,Numerical Observers,Topic
1618,Human Observer,Topic
1618,Spatiotemporal Contrast Sensitivity Function,Topic
1618,Multi-Slice Channelized Hotelling Observer,Topic
1618,Contrast Masking,Topic
1618,Ali R. N. Avanaki,Author
1618,Kathryn S. Espig,Author
1618,Albert Xthona,Author
1618,Tom R. L. Kimpe,Author
1618,Predrag R. Bakic,Author
1618,Andrew D. A. Maidment,Author
1619,Multgee,Topic
1619,Anestis Touloumis,Author
1620,A Stochastic Evolutionary Model For Capturing Human Dynamics,Paper
1620,Trevor Fenner,Author
1620,Mark Levene,Author
1620,George Loizou,Author
1621,Funnel Plot,Topic
1621,Meta-Analysis,Topic
1621,Cambridge Science Festival,Topic
1621,Jack Bowden,Author
1621,Chris Jackson,Author
1622,A Heteroscedastic Accelerated Failure Time Model For Survival Analysis,Paper
1622,Yifan Wang,Author
1622,Tian You,Author
1622,Martin Lysy,Author
1622,Survival Analysis,Topic
1622,Parametric Likelihood-Based Estimators,Topic
1622,Expectation-Conditional-Maximization (Ecm) Algorithm,Topic
1622,Colon Cancer Clinical Trial,Topic
1622,Haft Maximum Likelihood Estimator,Topic
1622,Homoscedastic Model,Topic
1622,Heteroscedasticity,Topic
1623,Modeling Long-Term Outcomes And Treatment Effects After Androgen Deprivation Therapy For Prostate Cancer,Paper
1624,Differentially Private Algorithms For Stochastic Multi-Armed Bandit Problem,Topic
1624,Aristide Tossou,Author
1624,Christos Dimitrakakis,Author
1625,Stochastic Processes,Topic
1625,Human Behaviour,Topic
1625,Mobile Phone Networks,Topic
1625,Social Media,Topic
1625,Stochastic Urn-Based Model,Topic
1625,Mixture Models,Topic
1625,Exponential Distributions,Topic
1625,Survival Analysis,Topic
1625,Clinical Trials,Topic
1625,Reliability Analysis,Topic
1625,Large Data Sets,Topic
1625,Heterogeneity In Data,Topic
1625,Search Engine Queries,Topic
1625,Trevor Fenner,Author
1625,Mark Levene,Author
1625,George Loizou,Author
1626,Conditional Estimation In Two-Stage Adaptive Designs,Paper
1626,Bias,Topic
1626,Estimators,Topic
1626,Simulation Study,Topic
1626,Clinical Trial Setting,Topic
1627,Control Of Directional Errors In Fixed Sequence Multiple Testing,Paper
1627,Mixed Directional Familywise Error Rate,Topic
1627,R-Package Fixseqmtp,Topic
1628,Imputation Of Missing Attribute Values In Medical Datasets,Topic
1628,Yelipe Usharani,Author
1628,P. Sammulal,Author
1628,An Innovative Imputation And Classification Approach For Accurate Disease Prediction,Paper
1629,Phase Ii Clinical Trials,Topic
1629,Dose Response Curves,Topic
1629,Parametric Regression Models,Topic
1629,Treatment Groups,Topic
1629,Optimal Design Theory,Topic
1629,Support Points,Topic
1629,D-Optimal Designs,Topic
1629,Dose-Finding Study,Topic
1629,Chrystel Feller,Author
1629,Kirsten Schorning,Author
1629,Holger Dette,Author
1629,Georgina Bermann,Author
1629,Bjˆrn Bornkamp,Author
1630,Cox Model,Topic
1630,Additive Hazard Model,Topic
1630,Accelerated Failure Time Model,Topic
1630,Transformation Model,Topic
1630,Shape-Invariant Hazard Regression Model,Topic
1630,Moment-Based Inference Procedures,Topic
1630,Risk Prediction,Topic
1630,Goodness Of Fit Test,Topic
1630,Veteran'S Administration Lung Cancer Data,Topic
1630,Hivnet 012 Data,Topic
1630,Nevirapine Treatment,Topic
1630,Cheng Zheng,Author
1630,Ying Qing Chen,Author
1631,An Approach To Find Missing Values In Medical Datasets,Paper
1631,B. Mathura Bai,Author
1631,N. Mangathayaru,Author
1631,B. Padmaja Rani,Author
1632,Weighted Parametric Multiple Test Procedures,Topic
1632,Closure Principle,Topic
1632,Adjusted Significance Levels,Topic
1632,Adjusted P-Values,Topic
1632,Intersection Hypotheses,Topic
1632,Exact Alpha-Level Parametric Tests,Topic
1632,Consonance Property,Topic
1632,Clinical Trial Example,Topic
1632,Dong Xi,Author
1632,Ekkehard Glimm,Author
1632,Willi Maurer,Author
1632,Frank Bretz,Author
1633,Bayesian Index,Topic
1633,Kawasaki And Miyaoka (2012B),Author
1634,Assessing The Similarity Of Dose Response And Target Doses In Two Non-Overlapping Subgroups,Paper
1635,L0 Regularisation For The Estimation Of Piecewise Constant Hazard Rates In Survival Analysis,Paper
1636,Mtpi,Topic
1636,Mtpi-2,Topic
1636,Wentian Guo,Author
1636,Sue-Jane Wang,Author
1636,Shengjie Yang,Author
1636,Suiheng Lin,Author
1636,Yuan Ji,Author
1637,Rank Verification For Exponential Families,Paper
1637,Statistical Experiments,Topic
1637,Public Opinion Poll,Topic
1637,Social Scientific Survey,Topic
1637,Clinical Trial,Topic
1638,Bonferroni Based Multiple Testing Procedure,Topic
1638,Zhiying Qiu,Author
1638,Wenge Guo,Author
1638,Sanat Sarkar,Author
1638,Complex Clinical Trials,Topic
1639,A Noise-Filtering Approach For Cancer Drug Sensitivity Prediction,Paper
1639,Turki Turki,Author
1639,Zhi Wei,Author
1639,Cancer,Topic
1640,Ranking Biomarkers Through Mutual Information,Paper
1641,Meboost,Topic
1641,Box Lunch Study,Topic
1641,Benjamin Brown,Author
1641,Timothy Weaver,Author
1641,Julian Wolfson,Author
1641,Convex Conditioned Lasso,Topic
1641,Lasso,Topic
1642,Parametric Hypothesis Testing,Topic
1642,Two Independent Samples,Topic
1642,Wald-Type Tests,Topic
1642,Minimum Density Power Divergence Estimators,Topic
1642,Simple Two-Sample Hypothesis,Topic
1642,General Two-Sample Hypotheses,Topic
1642,Nuisance Parameters,Topic
1642,Asymptotic Properties,Topic
1642,Theoretical Robustness Properties,Topic
1642,One-Sided Alternatives,Topic
1642,Treatment Effectiveness,Topic
1642,Clinical Trials,Topic
1642,Real Data Examples,Topic
1642,Abhik Ghosh,Author
1642,Nirian Martin,Author
1642,Ayanendranath Basu,Author
1642,Leandro Pardo,Author
1643,Context Attentive Bandits: Contextual Bandit With Restricted Context,Paper
1643,Multi-Armed Bandit Model,Topic
1643,Contextual Bandit With Restricted Context,Topic
1643,Thompson Sampling,Topic
1643,Thompson Sampling With Restricted Context,Topic
1643,Windows Thompson Sampling With Restricted Context,Topic
1643,Stationary Environments,Topic
1643,Nonstationary Environments,Topic
1643,Clinical Trials,Topic
1643,Recommender Systems,Topic
1643,Attention Modeling,Topic
1643,Real-Life Datasets,Topic
1644,Estimating Individualized Treatment Rules,Topic
1644,Yifan Cui,Author
1644,Ruoqing Zhu,Author
1644,Michael Kosorok,Author
1644,Tree Based Weighted Learning For Estimating Individualized Treatment Rules With Censored Data,Paper
1645,Subgroup Analysis Of Treatment Effects For Misclassified Biomarkers With Time-To-Event Data,Paper
1646,Why Adaptively Collected Data Have Negative Bias And How To Correct For It,Paper
1646,Xinkun Nie,Author
1646,Xiaoying Tian,Author
1646,Jonathan Taylor,Author
1646,James Zou,Author
1647,Global Hypothesis Tests,Topic
1647,Clinical Trials,Topic
1647,Genetic Studies,Topic
1647,Meta Analyses,Topic
1647,Global Null Hypothesis,Topic
1647,Combinations Tests,Topic
1647,Bonferroni Test,Topic
1647,Simes Test,Topic
1647,Omnibus Test,Topic
1647,R-Package Omnibus,Topic
1647,Andreas Futschik,Author
1647,Thomas Taus,Author
1647,Sonja Zehetmayer,Author
1648,Likelihood Methods For Measuring Statistical Evidence,Topic
1648,Sequential Study Designs,Topic
1648,Sample Size Projections,Topic
1648,Time-To-Event Outcomes,Topic
1648,Efficacy And Futility,Topic
1648,Phase Ii Cancer Clinical Trial,Topic
1648,Jeffrey D Blume,Author
1648,Leena Choi,Author
1648,Likelihood Based Study Designs For Time-To-Event Endpoints,Paper
1649,Dasgupta Et Al. (2015),Author
1649,Randomized Controlled $2^2$ Factorial Design,Topic
1649,Binary Outcome,Topic
1649,Randomization-Based Causal Inference Framework,Topic
1649,Sampling Variance Of The Randomization-Based Factorial Effect Estimator,Topic
1649,New Variance Estimator,Topic
1649,Jiannan Lu,Author
1649,Real-Life Datasets From Randomized Clinical Trials,Topic
1650,Bayesian Optimal Designs For Dose-Response Curves With Common Parameters,Paper
1651,Pancreas Segmentation In Computed Tomography Imaging,Topic
1651,3D Fully Convolutional Network,Topic
1651,Holger Roth,Author
1651,Masahiro Oda,Author
1651,Natsuki Shimizu,Author
1651,Hirohisa Oda,Author
1651,Yuichiro Hayashi,Author
1651,Takayuki Kitasaka,Author
1651,Michitaka Fujiwara,Author
1651,Kazunari Misawa,Author
1651,Kensaku Mori,Author
1651,147 Contrast Enhanced Abdominal Ct Scans,Topic
1651,Dice Score Of 89.7 ± 3.8,Topic
1651,State-Of-The-Art Performance In Pancreas Segmentation,Topic
1651,Gastric Cancer Patients,Topic
1652,Optimal Treatment Regimes,Topic
1652,Causal K-Nearest Neighbor Method,Topic
1652,Causal Inference Framework,Topic
1652,Causal K-Nearest Neighbor Regime,Topic
1652,Curse Of Dimensionality,Topic
1652,Adaptive Causal K-Nearest Neighbor Method,Topic
1652,Xin Zhou,Author
1652,Michael R. Kosorok,Author
1652,Chronic Depression Clinical Trial,Topic
1652,Simulation Studies,Topic
1653,Two-Stage Fisher Exact Test For Multi-Arm Studies With Binary Outcome Variables,Paper
1653,Fisher'S Exact Test,Topic
1653,Exact Binomial Tests,Topic
1654,Alzheimer'S Disease,Topic
1654,Anti-Amyloid Beta Antibodies,Topic
1654,D'Artagnan Greene,Author
1654,Theodora Po,Author
1654,Jennifer Pan,Author
1654,Tanya Tabibian,Author
1654,Ray Luo,Author
1654,Computational Analysis For The Rational Design Of Anti-Amyloid Beta (Abeta) Antibodies,Paper
1655,Monte Carlo Modified Profile Likelihood In Models For Clustered Data,Paper
1655,Clustered Data,Topic
1655,Monte Carlo Simulation,Topic
1655,Modified Profile Likelihood,Topic
1655,Missing-Data Models,Topic
1655,Survival Models,Topic
1655,Clinical Trial Applications,Topic
1656,Testing For Equivalence: An Intersection-Union Permutation Solution,Paper
1656,R. Arboretti,Author
1656,E. Carrozzo,Author
1656,F. Pesarin,Author
1656,L. Salmaso,Author
1656,Clinical Trials,Topic
1656,Pharmaceutical Experiments,Topic
1656,Bioequivalence,Topic
1656,Quality Control,Topic
1656,Intersection-Union Principle,Topic
1656,Likelihood Techniques,Topic
1656,Nonparametric Setting,Topic
1656,Iu Permutation Test,Topic
1657,Cell Counting,Topic
1657,Convolutional Neural Network,Topic
1657,Feature Pyramid Network,Topic
1657,Vgg-Style Neural Network,Topic
1657,Microscopy Image,Topic
1657,Deep Learning For Segmentation And Counting Within Microscopy Data,Paper
1657,Carlos X. Hern·ndez,Author
1657,Mohammad M. Sultan,Author
1657,Vijay S. Pande,Author
1658,Truncation By Death Problem,Topic
1658,Potential Outcomes Framework,Topic
1658,Survival Information,Topic
1658,Fan Yang,Author
1658,Peng Ding,Author
1658,Using Survival Information In Truncation By Death Problems Without The Monotonicity Assumption,Paper
1659,Lgbtq Health Issues,Topic
1659,Public Health Policy,Topic
1659,Computational Approach,Topic
1659,Men Who Have Sex With Men,Topic
1659,Diseases And Disorders,Topic
1659,Frank Webb,Author
1659,Amir Karami,Author
1659,Vanessa Kitzie,Author
1660,Respiratory Rate Estimation Algorithm,Topic
1660,Pressure-Sensitive Mat (Psm) Technology,Topic
1660,Neonatal Intensive Care Units (Nicu),Topic
1660,S. Nizami,Author
1660,A. Bekele,Author
1660,M. Hozayen,Author
1660,K. Greenwood,Author
1660,J. Harrold,Author
1660,J. R. Green,Author
1661,Crossing Survival Curves,Topic
1661,Clinical Trial'S Primary Endpoint,Topic
1661,Individual Survival Curves,Topic
1661,Crossing Point,Topic
1661,Survival Curve Errors,Topic
1661,Crossing Point Errors,Topic
1661,System Conditions,Topic
1661,Thomas Mcandrew,Author
1661,Bjorn Redfors,Author
1661,Yiran Zhang,Author
1661,Aaron Crowley,Author
1661,Shmuel Chen,Author
1661,Gregg Stone,Author
1661,Paul Jenkins,Author
1662,Digital Science'S Dimensions,Topic
1662,Chaomei Chen,Author
1662,Cascading Citation Expansion,Topic
1663,"A Corpus With Multi-Level Annotations Of Patients, Interventions And Outcomes To Support Language Processing For Medical Literature",Paper
1664,Protein Design Algorithms,Topic
1664,Mark A. Hallen,Author
1664,Bruce R. Donald,Author
1664,Computer Science Classes,Topic
1664,Molecular Therapies,Topic
1664,Therapeutics Development,Topic
1665,Randomized Clinical Trials,Topic
1665,Causal Effects,Topic
1665,Observational Data,Topic
1665,Matching,Topic
1665,Matching Algorithms,Topic
1665,Anthony D. Scotina,Author
1665,Roee Gutman,Author
1665,Matching Algorithms For Causal Inference With Multiple Treatments,Paper
1666,Interval Estimation Of Individual-Level Causal Effects Under Unobserved Confounding,Paper
1666,Nathan Kallus,Author
1666,Xiaojie Mao,Author
1666,Angela Zhou,Author
1667,Online Learning Procedures,Topic
1667,Cost Minimizing Algorithms,Topic
1667,Ucb-Algorithms,Topic
1667,Non-Iid Case,Topic
1667,Adaptive Tests,Topic
1667,A/B Tests,Topic
1667,RÈmy Degenne,Author
1667,Thomas Nedelec,Author
1667,ClÈment CalauzËnes,Author
1667,Vianney Perchet,Author
1668,Kernel-Based Goodness-Of-Fit Test For Censored Data,Topic
1668,Tamara Fern·ndez,Author
1668,Arthur Gretton,Author
1668,Log-Rank Test,Topic
1668,Periodic And Weibull Hazard Functions,Topic
1668,Classical Tests,Topic
1669,Model Selection Based On Experimental Data,Topic
1669,Biological Data Science,Topic
1669,Geometric Properties Of Input Data,Topic
1669,Algebraic Model,Topic
1669,Staircase,Topic
1669,Linear Shift Of A Staircase,Topic
1669,Unique Reduced Grˆbner Basis,Topic
1669,Boolean Model Of The Lac Operon,Topic
1669,E. Coli,Topic
1669,Elena S. Dimitrova,Author
1669,Qijun He,Author
1669,Brandilyn Stigler,Author
1669,Anyu Zhang,Author
1670,Contextual,Topic
1670,Robin Van Emden,Author
1670,Maurits Kaptein,Author
1671,Vaccine Dose Optimization,Topic
1671,Immunostimulation/Immunodynamic Modelling,Topic
1671,Sophie J. Rhodes,Author
1671,Gwenan M. Knight,Author
1671,Denise E. Kirschner,Author
1671,Richard G. White,Author
1671,Thomas G. Evans,Author
1672,Quantile Regression Modeling Of Recurrent Event Risk,Paper
1672,Huijuan Ma,Author
1672,Limin Peng,Author
1672,Chiung-Yu Huang,Author
1672,Haoda Fu,Author
1672,Recurrent Event Risk,Topic
1673,Evaluating And Optimizing Network Sampling Designs: Decision Theory And Information Theory Perspectives,Paper
1673,SimÛn LunagÛmez,Author
1673,Marios Papamichalis,Author
1673,Patrick J. Wolfe,Author
1673,Edoardo M. Airoldi,Author
1673,Respondent-Driven Sampling,Topic
1673,Decision Theory,Topic
1673,Information Theory,Topic
1673,Sufficiency,Topic
1673,Goel-Degroot Criterion,Topic
1674,Quantification Of Sulfated Polysaccharides In Urine Samples,Topic
1674,Heparin Red Kit,Topic
1674,Inorganic Sulfate,Topic
1674,Hydrochloric Acid,Topic
1674,Magnesium Chloride,Topic
1674,Ulrich Warttinger,Author
1674,Roland Kr‰mer,Author
1675,Applications Of Blockchain In Healthcare: Current Landscape & Challenges,Paper
1675,Healthcare,Topic
1675,Blockchain,Topic
1676,A Sequential Significance Test For Treatment By Covariate Interactions,Paper
1676,Min Qian,Author
1676,Bibhas Chakraborty,Author
1676,Raju Maiti,Author
1676,Ying Kuen Cheung,Author
1677,Robust Kernel Association Test,Topic
1677,Kara Martinez,Author
1677,Arnab Maity,Author
1677,Robert Yolken,Author
1677,Patrick Sullivan,Author
1677,Jung-Ying Tzeng,Author
1677,Catie Clinical Trial,Topic
1677,Snp-Sets,Topic
1678,Separable Effects For Causal Inference In The Presence Of Competing Events,Paper
1679,Tissue Classification,Topic
1679,Magnetic Resonance Imaging (Mri),Topic
1679,Brain Tissue Classification,Topic
1679,Surgical Planning,Topic
1679,Monitoring Therapy,Topic
1679,Clinical Drug Trials,Topic
1679,Image Registration,Topic
1679,Stereotactic Neurosurgery,Topic
1679,Radiotherapy,Topic
1679,Unsupervised Classification Algorithms,Topic
1679,Itk,Topic
1679,White Matter,Topic
1679,Gray Matter,Topic
1679,Cerebrospinal Fluid (Csf),Topic
1679,Background Of The Human Brain,Topic
1679,5 Grayscale Head Mri Scans,Topic
1679,Otsu Thresholding,Topic
1679,Bayesian Classification,Topic
1679,Bayesian Classification With Gaussian Smoothing,Topic
1679,Results And Discussion Section,Topic
1679,Unsupervised Segmentation Algorithms' Implementation In Itk For Tissue Classification Via Human Head Mri Scans,Paper
1679,Shadman Sakib,Author
1679,Md. Abu Bakr Siddique,Author
1680,Interval Null Hypothesis Testing,Topic
1680,Lakens Et Al (2018),Paper
1680,Lakens And Harms (2017),Paper
1680,Bayes Factor,Topic
1680,Region Of Practical Equivalence (Rope),Topic
1680,J. G. Liao,Author
1680,Vishal Midya,Author
1680,Arthur Berg,Author
1681,Admet,Topic
1681,Cheminformatics,Topic
1681,Medicinal Chemistry,Topic
1681,Potentialnet,Paper
1682,Multicompartment Mathematical Model,Topic
1682,Dose-Dense Protocols,Topic
1682,Combination Cancer Chemotherapy,Topic
1682,¡lvaro G. LÛpez,Author
1682,Kelly C. Iarosz,Author
1682,Antonio M. Batista,Author
1682,Jes˙s M. Seoane,Author
1682,Ricardo L. Viana,Author
1682,Miguel A. F. Sanju·n,Author
1683,Response-Adaptive Randomization,Topic
1683,Type-I Error,Topic
1683,Robust Blocked Response-Adaptive Randomization Designs,Paper
1684,Two-Stage Adaptive Optimal Design,Topic
1684,Clinical Trials,Topic
1684,Maximum Likelihood Estimator (Mle),Topic
1684,Nonlinear Regression Models,Topic
1684,Independent Normal Errors,Topic
1684,Pilot Study,Topic
1684,Fisher Information,Topic
1684,Random Information Measures,Topic
1684,Observed Information,Topic
1684,Zhantao Lin,Author
1684,Nancy Flournoy,Author
1684,William F. Rosenberger,Author
1684,Random Norming Aids Analysis Of Non-Linear Regression Models With Sequential Informative Dose Selection,Paper
1685,Bone Age Assessment,Topic
1685,Tanner-Whitehouse,Topic
1685,Greulich And Pyle,Topic
1685,Finger Joint Localization Strategy,Topic
1685,Deep Neural Network,Topic
1685,A Deep Framework For Bone Age Assessment Based On Finger Joint Localization,Paper
1686,Frailty Models,Topic
1686,Heterogeneous Survival Data,Topic
1686,Random Effects,Topic
1686,Fixed Effects,Topic
1686,Cox Model,Topic
1686,Maximisation Of The Integrated Partial Likelihood,Topic
1686,Stochastic Estimation Procedure,Topic
1686,Cancer Clinical Trial Data,Topic
1686,Oodally Ajmal,Author
1686,Luc Duchateau,Author
1686,Estelle Kuhn,Author
1687,Robust Inference For Skewed Data In Health Sciences,Paper
1687,Skew-Normal Distributions,Topic
1687,Health Data,Topic
1687,Robust Methodology,Topic
1687,Outliers,Topic
1687,Australian Institute Of Sports,Topic
1687,Aids Clinical Trial Data,Topic
1688,Precision Medicine,Topic
1688,Random Interaction Forest (Rif),Topic
1688,Clostridium Difficile,Topic
1688,Zhen Zeng,Author
1688,Yuefeng Lu,Author
1688,Judong Shen,Author
1688,Wei Zheng,Author
1688,Peter Shaw,Author
1688,Mary Beth Dorr,Author
1689,Proportional Hazards Model,Topic
1689,Proportional Odds Model,Topic
1689,Accelerated Failure Time Model,Topic
1689,Yp Model,Topic
1689,Fabio N. Demarqui,Author
1689,Vinicius D. Mayrink,Author
1689,Survival Data,Topic
1689,Piecewise Exponential Distribution,Topic
1689,Cancer Clinical Trial,Topic
1689,Simulation Study,Topic
1690,Equivalence Tests For Binary Efficacy-Toxicity Responses,Paper
1690,Efficacy And Toxicity,Topic
1690,Clinical Trials,Topic
1690,Parametric Bootstrap,Topic
1690,2-Dimensional Gumbel Model,Topic
1690,Simulation Study,Topic
1690,Case Study,Topic
1691,Baymedr,Topic
1691,Maximilian Linde,Author
1691,Don Van Ravenzwaaij,Author
1691,Frequentist Statistical Methods,Topic
1691,Bayesian Inference,Topic
1692,Electroencephalogram (Eeg),Topic
1692,Ibrahim Kaya,Author
1692,Eeg Applications,Topic
1692,Eeg Artifacts,Topic
1692,Eeg Techniques,Topic
1693,Boosting Algorithms For Estimating Optimal Individualized Treatment Rules,Paper
1693,Xgboost,Topic
1693,Additive Regression Trees,Topic
1693,Boosting Technique,Topic
1693,Parametric Methods,Topic
1693,Diabetes Phase Iii Trial,Topic
1694,Beta-Stacy Bootstrap,Topic
1694,Beta-Stacy Process,Topic
1694,Andrea ArfË,Author
1694,Pietro Muliere,Author
1694,Survival Data From A Real Clinical Trial,Topic
1695,Online Batch Decision-Making With High-Dimensional Covariates,Paper
1695,Teamwork Lasso Bandit Algorithm,Topic
1695,Sequential Decision Making,Topic
1695,Batch Models,Topic
1695,Interactive Marketing,Topic
1695,Clinical Trial,Topic
1695,Treatment Efficacy,Topic
1695,High-Dimensional User Covariates,Topic
1695,Explore-Exploit Dilemma,Topic
1695,Lasso Estimate,Topic
1695,Cumulative Regret,Topic
1696,Intelligentpooling,Topic
1696,Mobile Health,Topic
1696,Sabina Tomkins,Author
1696,Peng Liao,Author
1696,Predrag Klasnja,Author
1696,Serena Yeung,Author
1696,Susan Murphy,Author
1696,Rapidly Personalizing Mobile Health Treatment Policies With Limited Data,Paper
1697,Optimizing Lower-Body Exoskeleton Walking Gaits For User Comfort,Topic
1697,Linecospar,Topic
1697,Maegan Tucker,Author
1697,Myra Cheng,Author
1697,Ellen Novoseller,Author
1697,Richard Cheng,Author
1697,Yisong Yue,Author
1697,Joel W. Burdick,Author
1697,Aaron D. Ames,Author
1698,Covid-19,Topic
1698,China,Topic
1698,Jiwei Jia,Author
1698,Siyu Liu,Author
1698,Jing Ding,Author
1698,Guidong Liao,Author
1698,Lihua Zhang,Author
1698,Ran Zhang,Author
1698,Imported Cases,Topic
1698,Epidemic Control,Topic
1698,Clinical Trials,Topic
1698,Control Strategies,Topic
1698,Epidemic Trends,Topic
1698,Medical Burden,Topic
1699,Shrinkage Estimation In A Meta-Analysis Framework,Topic
1699,Dynamical Borrowing Of Information,Topic
1699,Randomized Controlled Trial (Rct),Topic
1699,Clinical Registry,Topic
1699,Bayesian Meta-Analysis,Topic
1699,Creutzfeldt-Jakob Disease,Topic
1699,Fetal Monitoring,Topic
1699,Metabolic Acidosis,Topic
1699,Christian Rˆver,Author
1699,Tim Friede,Author
1700,Inactivity Time,Topic
1700,Mortality Data,Topic
1700,Quantile Inactivity Time,Topic
1700,Regression Method,Topic
1700,Variance-Covariance Matrix,Topic
1700,Breast Cancer Clinical Trial,Topic
1700,Lauren C. Balmert,Author
1700,Ruosha Li,Author
1700,Limin Peng,Author
1700,Jong-Hyeon Jeong,Author
1701,Contextual Bandits,Topic
1701,Mobile Health,Topic
1701,Clinical Trial,Topic
1701,Jiayu Yao,Author
1701,Emma Brunskill,Author
1701,Weiwei Pan,Author
1701,Susan Murphy,Author
1701,Finale Doshi-Velez,Author
1701,Power Constrained Bandits,Paper
1702,Covid-19,Topic
1702,Sars-Cov-2,Topic
1702,Rna-Dependent Rna Polymerase,Topic
1702,Angiotensin-Converting Enzyme 2,Topic
1702,Spike Glycoprotein,Topic
1702,Limonin,Topic
1702,Scopadulcic Acid B,Topic
1702,Paracetamol,Topic
1702,Hydroxychloroquine,Topic
1702,Seshu Vardhan,Author
1702,Suban K Sahoo,Author
1702,Molecular Docking,Topic
1702,Phytochemicals,Topic
1702,Therapeutic Target Proteins,Topic
1702,Approved Drugs,Topic
1702,Clinical Trials,Topic
1702,Medicinal Plants Extracts,Topic
1703,Covid-19,Topic
1703,Sars-Cov-2,Topic
1703,Tyrphostin-Ag-1478,Topic
1703,Brefeldin-A,Topic
1703,Zhihan Wang,Author
1703,Kai Guo,Author
1703,Pan Gao,Author
1703,Qinqin Pu,Author
1703,Min Wu,Author
1703,Changlong Li,Author
1703,Junguk Hur,Author
1703,Fda-Approved Drugs,Topic
1703,Clinical Trials,Topic
1704,Best Arm Identification,Topic
1704,Bandit Models,Topic
1704,Graph Smoothness Constraint,Topic
1704,Gradient Ascent Algorithm,Topic
1704,Sample Complexity,Topic
1704,Non-Smooth Max-Min Problem,Topic
1704,Asymptotically Optimal Strategy,Topic
1704,Numerical Experiments,Topic
1704,Tom·ö Koc·k,Author
1704,AurÈlien Garivier,Author
1705,Sparse Additive Modeling,Topic
1705,Treatment Effect-Modification,Topic
1705,Hyung Park,Author
1705,Eva Petkova,Author
1705,Thaddeus Tarpey,Author
1705,R. Todd Ogden,Author
1705,Constrained Sparse Additive Model,Topic
1705,Randomized Clinical Trial,Topic
1706,Text Retrieval Conference,Topic
1706,Precision Medicine,Topic
1706,Pubmed,Topic
1706,Clinical Trials,Topic
1706,Sequential Model-Based Algorithm Configuration,Topic
1706,Bm25-Based Search Engine,Topic
1706,Gold Standard Data,Topic
1706,Infndcg Metric,Topic
1706,Erik Faessler,Author
1706,Michel Oleynik,Author
1706,Udo Hahn,Author
1706,What Makes A Top-Performing Precision Medicine Search Engine? Tracing Main System Features In A Systematic Way,Paper
1707,Balanced Representation Learning Methods,Topic
1707,Counterfactual Inference,Topic
1707,Survival Outcomes,Topic
1707,Survival Data,Topic
1707,Medical Applications,Topic
1707,Drug Development,Topic
1707,Risk Profiling,Topic
1707,Clinical Trials,Topic
1707,Manufacturing,Topic
1707,Censored Events,Topic
1707,Hazard Ratio Metric,Topic
1707,Treatment Effects,Topic
1707,Paidamoyo Chapfuwa,Author
1707,Serge Assaad,Author
1707,Shuxi Zeng,Author
1707,Michael J. Pencina,Author
1707,Lawrence Carin,Author
1707,Ricardo Henao,Author
1708,Covid-19,Topic
1708,Sars-Cov-2,Topic
1708,Sars-Cov,Topic
1708,Antibody Therapies,Topic
1708,Jiahui Chen,Author
1708,Kaifu Gao,Author
1708,Rui Wang,Author
1708,Duc Duy Nguyen,Author
1708,Guo-Wei Wei,Author
1708,Protein Data Bank,Topic
1708,Topological Data Analysis (Tda),Topic
1708,Angiotensin-Converting Enzyme 2 (Ace2),Topic
1708,Three-Dimensional (3D) Structures,Topic
1708,Binding Affinities,Topic
1708,Covid-19 Antibody Clinical Trials,Topic
1709,Causal Relationships In Health Sciences,Topic
1709,Randomized Controlled Trials,Topic
1709,Causal Inference Theory,Topic
1709,Survival Analysis,Topic
1709,Hazard Ratio,Topic
1709,Observational Studies,Topic
1709,Novel Approach For Hazard Ratios,Topic
1709,Ewing'S Sarcoma,Topic
1709,Riddhiman Adib,Author
1709,Paul Griffin,Author
1709,Sheikh Iqbal Ahamed,Author
1709,Mohammad Adibuzzaman,Author
1710,Stratified Clinical Trial Design,Topic
1710,Log-Rank Test,Topic
1710,Cox Regression Analyses,Topic
1710,Madan G. Kundu,Author
1710,Shoubhik Mondal,Author
1710,Time To Event Analyses,Topic
1710,Stratification Factors,Topic
1710,Hr Estimate,Topic
1710,Power Of The Stratified Log-Rank Test,Topic
1710,Bias And Standard Error,Topic
1710,Multivariate Cox Analysis,Topic
1710,Stratified Cox Analysis,Topic
1710,Simulation,Topic
1710,Study Design,Topic
1711,Nlnde,Topic
1711,Natural Language Processing,Topic
1711,Meddocan,Topic
1712,On Second Order Correctness Of Bootstrap In Logistic Regression,Paper
1712,Debraj Das,Author
1712,Priyam Das,Author
1713,Contextual Bandit With Missing Rewards,Paper
1713,Djallel Bouneffouf,Author
1713,Sohini Upadhyay,Author
1713,Yasaman Khazaeni,Author
1714,Covariate-Adaptive Randomization Schemes,Topic
1714,Clinical Trials,Topic
1714,Treatment Assignments,Topic
1714,Prognostic Factors,Topic
1714,Inference After Covariate-Adaptive Randomization,Topic
1714,Average Treatment Effect,Topic
1714,Ting Ye,Author
1714,Yanyao Yi,Author
1714,Jun Shao,Author
1714,Estimators,Topic
1714,Asymptotic Normality,Topic
1714,Minimization,Topic
1714,Variance Estimators,Topic
1714,Asymptotic Inference,Topic
1714,Asymptotic Relative Efficiencies,Topic
1714,Finite Sample Properties,Topic
1714,Valid And Model Free Inference,Topic
1715,Predicting Interactions Among Heterogenous Graph Structured Data,Topic
1715,Knowledge Graph Completion,Topic
1715,Recommendation Systems,Topic
1715,Drug Discovery,Topic
1715,Few-Shot Link Prediction,Topic
1715,Inductive Rgcn,Paper
1715,Drug-Repurposing Knowledge Graph (Drkg),Topic
1715,Covid-19,Topic
1715,Biological Entities,Topic
1715,Drugs Used In Clinical Trials,Topic
1715,Drug Candidates,Topic
1716,Drug Discovery,Topic
1716,Deep Graph Generative Models,Topic
1716,Karan Yang,Author
1716,Chengxi Zang,Author
1716,Fei Wang,Author
1716,Visualization Framework,Topic
1717,Panrep,Topic
1717,Vassilis N. Ioannidis,Author
1717,Da Zheng,Author
1717,George Karypis,Author
1717,Node Classification,Topic
1717,Link Prediction,Topic
1717,Drug Repurposing,Topic
1717,Covid-19,Topic
1718,Seenet,Topic
1718,Deeplesion,Topic
1718,Youbao Tang,Author
1718,Ke Yan,Author
1718,Jing Xiao,Author
1718,Ranold M. Summers,Author
1719,On The Programmatic Generation Of Reproducible Documents,Paper
1719,R Markdown,Topic
1719,Listdown Package,Topic
1720,Dynamic Linear Models,Topic
1720,Random Allocation Models,Topic
1720,"Lee, Boone, Et Al (2020)",Author
1720,Bayesian Adaptive Allocation Models,Topic
1720,Sensitivity Analysis,Topic
1720,Power Analysis,Topic
1720,Application Of Dynamic Linear Models To Random Allocation Clinical Trials With Covariates,Paper
1721,Sars-Cov-2,Topic
1721,Covid-19,Topic
1721,Spike Protein,Topic
1721,Rdrp,Topic
1721,Hemoglobin,Topic
1721,Orthocoronavirinae,Topic
1721,Lokesh Agrawal,Author
1721,Thanasis Poullikkas,Author
1721,Scott Eisenhower,Author
1721,Carlo Monsanto,Author
1721,Ranjith Kumar Bakku,Author
1722,A General Bayesian Model For Heteroskedastic Data With Fully Conjugate Full-Conditional Distributions,Paper
1722,Paul A. Parker,Author
1722,Scott H. Holan,Author
1722,Skye A. Wills,Author
1722,Financial Time Series,Topic
1722,Environmental Statistics,Topic
1722,High Dimensional Soil Dataset,Topic
1722,Asset Volatility,Topic
1722,Clinical Trial Data For Creatinine,Topic
1723,Identification Of Disease Genes,Topic
1723,Biomedical Knowledge Graph,Topic
1723,Machine Learning Method,Topic
1723,Relation Types,Topic
1723,Disease Gene Identification,Topic
1723,Open Targets,Topic
1723,Parkinson'S Disease,Topic
1723,Srivamshi Pittala,Author
1723,William Koehler,Author
1723,Jonathan Deans,Author
1723,Daniel Salinas,Author
1723,Martin Bringmann,Author
1723,Katharina Sophia Volz,Author
1723,Berk Kapicioglu,Author
1724,Systemic Lupus Erythematosus,Topic
1724,Aditi Deokar,Author
1724,Gene Expression Data,Topic
1724,Immune Pathways,Topic
1724,High Interferon Levels,Topic
1724,High Autoantibody Levels,Topic
1724,Dysregulation Of The Mitochondrial Apoptosis Pathway,Topic
1724,K-Means Clustering,Topic
1724,Pca,Topic
1724,Umap,Topic
1724,Six Clusters,Topic
1724,Therapeutic Targets For Sle,Topic
1725,Adverse Childhood Experiences,Topic
1725,Explainable Artificial Intelligence Recommendation System,Paper
1725,Knowledge Graph Generation,Topic
1725,Question-Answering Agent,Topic
1725,Google Dialogflow,Topic
1725,"Children Hospital In Memphis, Tennessee",Topic
1725,Optimization Algorithm,Topic
1725,Privacy Layer,Topic
1725,Clinical Trial,Topic
1725,Health Care Practitioners,Topic
1726,"A General Theory Of Regression Adjustment For Covariate-Adaptive Randomization: Ols, Lasso, And Beyond",Paper
1726,Hanzhong Liu,Author
1726,Fuyi Tu,Author
1726,Wei Ma,Author
1726,Treatment Effects,Topic
1726,Covariate-Adaptive Randomization,Topic
1726,Lasso-Adjusted Treatment Effect Estimators,Topic
1727,Sars-Cov-2,Topic
1727,Covid-19,Topic
1727,Artificial Intelligence,Topic
1727,Natural Language Processing,Topic
1727,Clinical Trial Information,Topic
1727,Preclinical Studies,Topic
1727,Text Mining,Topic
1727,Yutong Jin,Author
1727,Jie Li,Author
1727,Xinyu Wang,Author
1727,Peiyao Li,Author
1727,Jinjiang Guo,Author
1727,Junfeng Wu,Author
1727,Dawei Leng,Author
1727,Lurong Pan,Author
1728,Sharp Inference On Selected Subgroups In Observational Studies,Paper
1728,Xinzhou Guo,Author
1728,Linqing Wei,Author
1728,Chong Wu,Author
1728,Jingshen Wang,Author
1728,Observational Data,Topic
1728,Subgroup Selection Bias,Topic
1728,Uk Biobank Data,Topic
1729,Batched Neural Bandits,Paper
1729,Batchneuralucb,Topic
1730,Simultaneous Inference For Partial Areas Under Receiver Operating Curves -- With A View Towards Efficiency,Paper
1731,Surrogate Endpoint,Topic
1731,True Outcome,Topic
1731,Causal Inference Approaches,Topic
1731,Treatment Effect,Topic
1731,Principal Surrogacy Criteria,Topic
1731,Bayesian Methods,Topic
1731,Muscular Dystrophy Gene Therapy,Topic
1731,Emily Roberts,Author
1731,Michael Elliott,Author
1731,Jeremy M. G. Taylor,Author
1732,Multiple Hypothesis Testing,Topic
1732,Economic Foundation For Practices,Topic
1732,Regulatory Approval,Topic
1732,Clinical Trials,Topic
1732,Davide Viviano,Author
1732,Kaspar Wuthrich,Author
1732,Paul Niehaus,Author
1733,Reference Based Multiple Imputation,Topic
1733,Rubin'S Variance Estimator,Topic
1733,Randomised Clinical Trials,Topic
1733,Frequentist Variance,Topic
1733,Bootstrapping,Topic
1733,Jonathan W. Bartlett,Author
1733,Repeated Sampling Variance,Topic
1733,Variance Estimators,Topic
1733,Missing Data,Topic
1733,Multiple Imputation,Topic
1734,Hepatitis B Virus,Topic
1734,World Health Organisation,Author
1734,Farzad Fatehi,Author
1734,Richard J. Bingham,Author
1734,Eric C. Dykeman,Author
1734,Peter G. Stockley,Author
1734,Reidun Twarock,Author
1734,Age-Structured Model,Topic
1734,Immune Response,Topic
1734,Viral Life Cycle,Topic
1734,Antiviral Treatment,Topic
1734,Antibody Therapies,Topic
1734,Treatment Options,Topic
1734,Immune Response Exhaustion,Topic
1734,Non-Infectious Subviral Particles,Topic
1734,Viral Load,Topic
1734,Viral Clearance,Topic
1734,Clinical Trials,Topic
1735,Improving The Power Of Economic Experiments Using Adaptive Designs,Paper
1735,Sebastian Jobjˆrnsson,Author
1735,Henning Schaak,Author
1735,Oliver Muﬂhoff,Author
1735,Tim Friede,Author
1735,Adaptive Designs,Topic
1735,Economic Experiments,Topic
1735,Type I Error Probability,Topic
1736,Operational Learning-Based Boundary Estimation In Electromagnetic Medical Imaging,Paper
1736,A. Al-Saffar,Author
1736,A. Stancombe,Author
1736,A. Zamani,Author
1736,A. Abbosh,Author
1736,Electromagnetic Medical Imaging,Topic
1736,Boundary Detection,Topic
1736,Head Imaging System,Topic
1736,16-Element Antenna Array,Topic
1736,0.7-1.6 Ghz,Topic
1737,Periodontitis And Preeclampsia In Pregnancy: A Systematic Review And Meta-Analysis,Paper
1737,Periodontitis,Topic
1737,Preeclampsia,Topic
1738,Safe Multi-Armed Bandits With Logarithmic Regret And Risk,Paper
1739,Linear Transformation Model,Topic
1739,Proportional Hazards Model,Topic
1739,Proportional Odds Model,Topic
1739,Measurement Error In Covariates,Topic
1739,Estimators Of Regression Coefficients,Topic
1739,Instrumental Variables,Topic
1739,Counting Process Based Estimating Equations,Topic
1739,Martingale Representation,Topic
1739,Monte Carlo Simulation Study,Topic
1739,Aids Clinical Trial (Actg 175),Topic
1739,Sudheesh K. K.,Author
1739,Deemat C. Mathew,Author
1739,Litty Mathew,Author
1739,Min Xie,Author
1740,Effect Size Measures And Visualization Techniques,Topic
1740,Hannah K¸mpel,Author
1740,Sabine Hoffmann,Author
1740,Parametric Regression,Topic
1740,Bayesian Approach,Topic
1740,Frequentist Inference,Topic
1740,Clinical Trial,Topic
1740,Multi-Analyst Study,Topic
1740,Common Mathematical Setting,Topic
1740,Formal Framework,Topic
1741,Mrsa Colonization,Topic
1741,Decolonization Protocols,Topic
1741,Machine Learning Model,Topic
1741,Randomized Controlled Trial (Rct),Topic
1741,Onur Poyraz,Author
1741,Mohamad R. A. Sater,Author
1741,Loren G. Miller,Author
1741,James A. Mckinnell,Author
1741,Susan S. Huang,Author
1741,Yonatan H. Grad,Author
1741,Pekka Marttinen,Author
1742,Semi-Competing Risks Data,Topic
1742,Medical Research,Topic
1742,Clinical Trials,Topic
1742,Illness-Death Model,Topic
1742,Shared Frailty,Topic
1742,Broken Adaptive Ridge (Bar) Penalty,Topic
1742,Fatemeh Mahmoudi,Author
1742,Xuewen Lu,Author
1742,Colon Cancer Study,Topic
1743,Homogeneity Tests And Interval Estimations Of Risk Differences For Stratified Bilateral And Unilateral Correlated Data,Paper
1743,Shuyi Liang,Author
1743,Kai-Tai Fang,Author
1743,Xin-Wei Huang,Author
1743,Yijing Xin,Author
1743,Chang-Xing Ma,Author
1744,Experimentation Platforms Meet Reinforcement Learning: Bayesian Sequential Decision-Making For Continuous Monitoring,Paper
1744,Runzhe Wan,Author
1744,Yu Liu,Author
1744,James Mcqueen,Author
1744,Doug Hains,Author
1744,Rui Song,Author
1745,Hiv Dynamical Models,Topic
1745,Non-Linear Systems Of Ordinary Differential Equations,Topic
1745,Hierarchical Likelihood,Topic
1745,Maximum H-Likelihood Estimators,Topic
1745,D. Commenges,Author
1745,D. Jolly,Author
1745,H. Putter,Author
1745,R. Thiebaut,Author
1745,Clinical Trial,Topic
1745,Simulation Study,Topic
1745,Parametric Bootstrap Procedure,Topic
1746,Interactive Evolution,Topic
1746,Eye Tracking,Topic
1746,Nick Cheney,Author
1746,Jeff Clune,Author
1746,Jason Yosinski,Author
1746,Hod Lipson,Author
1746,Hands-Free Evolution Of 3D-Printable Objects Via Eye Tracking,Paper
1747,"Subgroup Mixable Inference In Personalized Medicine, With An Application To Time-To-Event Outcomes",Paper
1747,Ying Ding,Author
1747,Hui-Min Lin,Author
1747,Jason C. Hsu,Author
1747,Personalized Medicine,Topic
1747,Mixture Population,Topic
1747,Subgroup Mixable Estimation,Topic
1747,Hazard Ratio,Topic
1748,On Prediction And Tolerance Intervals For Dynamic Treatment Regimes,Paper
1749,Abcd Multi-Arm Multi-Stage Experiment,Topic
1749,Drug Development Process,Topic
1749,Michael Grayling,Author
1749,James Wason,Author
1749,Adrian Mander,Author
1749,Generalised Error-Rates,Topic
1749,Statistical Operating Characteristics,Topic
1749,Multi-Arm Multi-Stage Experiments,Topic
1749,Type-I Familywise Error-Rate,Topic
1749,Type-Ii Familywise Error-Rate,Topic
1749,Clinical Trial,Topic
1750,Alzheimer'S Dementia,Topic
1750,Mild Cognitive Impairment,Topic
1750,Christian Dansereau,Author
1750,Angela Tam,Author
1750,Amanpreet Badhwar,Author
1750,Sebastian Urchs,Author
1750,Pierre Orban,Author
1750,Pedro Rosa-Neto,Author
1750,Pierre Bellec,Author
1750,Brain Signature,Topic
1750,Machine Learning Model,Topic
1750,Brain Atrophy,Topic
1750,Functional Dysconnectivity,Topic
1750,Mci Subpopulation,Topic
1751,Equivalence Test,Topic
1751,Frequentist Tool,Topic
1751,Equivalence Margin,Topic
1751,Harlan Campbell,Author
1751,Paul Gustafson,Author
1751,Clinical Trials Research,Topic
1752,Endovascular Technique,Topic
1752,Robotically Steerable Catheters,Topic
1752,Shape Memory Alloys (Sma) Actuators,Topic
1752,Active Sma-Based Catheters,Topic
1752,Thibault Couture,Author
1752,JÈrome Szewczyk,Author
1752,Silicon-Based Arterial Model,Topic
1752,23-Kg Pig,Topic
1752,Supra-Aortic Trunks,Topic
1752,Renal Arteries,Topic
1752,6F Catheter,Topic
1752,70 Different Prototypes,Topic
1752,Core Body,Topic
1752,Metallic Beams,Topic
1752,Sma Actuators,Topic
1752,Anatomical Constraints,Topic
1752,Trial-Error Campaign,Topic
1752,Best Dimensions,Topic
1752,Final Prototype,Topic
1752,Design And Experimental Validation,Topic
1753,Brain Signal Classification,Topic
1753,Schizophrenia,Topic
1753,David Calhas,Author
1753,Enrique Romero,Author
1753,Rui Henriques,Author
1753,Siamese Neural Network Architecture,Topic
1753,Electroencephalography,Topic
1753,Cosine Contrastive Loss,Topic
1753,Multivariate Order Of The Signal,Topic
1753,Spectral Features,Topic
1753,Neuronal Diseases,Topic
1753,Electrophysiological Brain Activity,Topic
1753,Data Augmentation,Topic
1753,Convolutional Layers,Topic
1753,Case-Control Population,Topic
1753,Improved Schizophrenia Diagnosis,Topic
1754,Bayesian Two-Sample T-Test,Topic
1754,Gibbs Sampler,Topic
1754,Effect Size,Topic
1754,Region Of Practical Equivalence (Rope),Topic
1754,R Package Bayest,Topic
1755,Optimal Experimental Designs For Treatment Contrasts In Heteroscedastic Models With Covariates,Paper
1755,Samuel Rosa,Author
1755,Treatment,Topic
1755,Covariates,Topic
1755,Heteroscedasticity,Topic
1755,D-Optimality,Topic
1755,A-Optimality,Topic
1755,E-Optimality,Topic
1755,Linear Programming,Topic
1755,Sparsification Method,Topic
1756,Bispatial Inference,Topic
1756,Bayesian Method,Topic
1756,P Values,Topic
1756,Post-Data Density Function,Topic
1756,Post-Data Opinion Curves,Topic
1756,Russell J. Bowater,Author
1756,Clinical Trial Data,Topic
1756,Fiducial Inference,Topic
1756,Sharp Hypotheses,Topic
1757,Modeling Variables With A Detection Limit Using A Truncated Normal Distribution With Censoring,Paper
1757,Justin R. Williams,Author
1757,Hyung-Woo Kim,Author
1757,Catherine M. Crespi,Author
1757,Tcensreg,Topic
1757,Tobit Regression,Topic
1757,Single Imputation,Topic
1757,Vision Quality Data,Topic
1758,Hiv-1,Topic
1758,Broadly Neutralizing Antibodies,Topic
1758,Matthijs Meijers,Author
1758,Kanika Vanshylla,Author
1758,Henning Gruell,Author
1758,Florian Klein,Author
1758,Michael Laessig,Author
1758,Fitness Landscape,Topic
1758,Viral Load,Topic
1758,Antibody Dosage,Topic
1758,Escape Dynamics,Topic
1758,Resistance-Cost Tradeoff Curves,Topic
1759,Adverse Drug Events,Topic
1759,Spontaneous Reporting Systems,Topic
1759,Aer2Vec,Topic
1759,Rxnorm,Topic
1759,Pharmacovigilance Signal Detection,Topic
1759,Xiruo Ding,Author
1759,Trevor Cohen,Author
1759,Retrofitting Vector Representations Of Adverse Event Reporting Data To Structured Knowledge To Improve Pharmacovigilance Signal Detection,Paper
1760,"Performing Company Valuations Within The Domain Of Biotechnology, Pharmacy And Medical Technology",Topic
1760,"Automated Knowledge Discovery, Extraction And Data Fusion",Topic
1760,Clinical Trials,Topic
1760,Company Valuation Ontology,Topic
1760,Albert Weichselbraun,Author
1760,Philipp Kuntschik,Author
1760,Sandro Hˆrler,Author
1761,Bayesian Multivariate Probability Of Success Using Historical Data With Strict Control Of Family-Wise Error Rate,Paper
1761,Ethan M. Alt,Author
1761,Matthew A. Psioda,Author
1761,Joseph G. Ibrahim,Author
1762,Automatic Segmentation Of Brain Glioma From Multimodal Mri Scans,Topic
1762,End-To-End Deep-Learning-Based Segmentation Method,Topic
1762,Multi-Decoder Architecture,Topic
1762,Smoothing Methods,Topic
1762,Quantification Of Uncertainty In Segmentation In The Brain Tumors In Multimodal Magnetic Resonance Imaging Challenge 2020,Topic
1762,Minh H. Vu,Author
1762,Tufve Nyholm,Author
1762,Tommy Lˆfstedt,Author
1762,Proposed Method,Topic
1762,Validation Performance,Topic
1762,Denoised Versions,Topic
1762,Segmentation,Topic
1763,Kaplan-Meier Survival Analysis,Topic
1763,Treatment Efficacy,Topic
1763,Oncology,Topic
1763,Precision Medicine,Topic
1763,Patient Censoring,Topic
1763,Incomplete Observation,Topic
1763,Disease/Progression Free Survival,Topic
1763,Overall Survival,Topic
1763,Right-Censoring,Topic
1763,Surrogate Of Patient Lost To Follow-Up,Topic
1763,Hazard Ratio,Topic
1763,Bias Indexes,Topic
1763,Public Available Datasets,Topic
1763,Enrique BarrajÛn,Author
1763,Laura BarrajÛn,Author
1764,Multi-Armed Bandit,Topic
1764,Clinical Trials,Topic
1764,Adaptive Routing,Topic
1764,Epsilon-Greedy,Topic
1764,Upper Confident Bound (Ucb),Topic
1764,Thompson Sampling (Ts),Topic
1764,Djallel Bouneffouf,Author
1765,Us Food And Drug Administration,Topic
1765,Real-World Data,Topic
1765,Artificial Intelligence,Topic
1765,Machine- And Deep-Learning Methods,Topic
1765,Drug Development,Topic
1765,Adverse Event Detection,Topic
1765,Trial Recruitment,Topic
1765,Drug Repurposing,Topic
1765,Zhaoyi Chen,Author
1765,Xiong Liu,Author
1765,William Hogan,Author
1765,Elizabeth Shenkman,Author
1765,Jiang Bian,Author
1766,Health And Demographic Surveillance System,Topic
1766,2030 Agenda,Topic
1766,Samuel J. Clark,Author
1767,Contextual Bandit,Topic
1767,Recommendation Systems,Topic
1767,Online Advertising,Topic
1767,Clinical Trials,Topic
1767,Privacy-Preserving Bandit Framework,Topic
1767,Homomorphic Encryption,Topic
1767,Linear Contextual Bandits,Topic
1767,Evrard Garcelon,Author
1767,Vianney Perchet,Author
1767,Matteo Pirotta,Author
1768,Distance Assisted Recursive Testing,Topic
1768,Xuechan Li,Author
1768,Anthony Sung,Author
1768,Jichun Xie,Author
1769,Pair-Switching Rerandomization,Topic
1769,Fisher Randomization Tests,Topic
1769,Difference-In-Means Estimator,Topic
1769,Ke Zhu,Author
1769,Hanzhong Liu,Author
1769,Clinical Trial Datasets,Topic
1769,Classical Rerandomization,Topic
1770,Ict Revolution,Topic
1770,Digital Traces,Topic
1770,Knowledge-Driven Domains,Topic
1770,Science,Topic
1770,Interdisciplinary Innovations,Topic
1770,Social Sciences,Topic
1770,Computational Sciences,Topic
1770,Complex Systems Approaches,Topic
1770,Phylomemies,Topic
1770,Knowledge,Topic
1770,Phylomemy Reconstruction Process,Topic
1770,Synchronic Approaches,Topic
1770,Diachronic Approaches,Topic
1770,Phylomemetic Networks,Topic
1770,Graphical Projections,Topic
1770,Interactive Visualizations,Topic
1770,Seabed Views,Topic
1770,Kinship Views,Topic
1770,Macro-To-Micro Methodology,Topic
1770,Memiescape,Topic
1770,Scientific Publications,Topic
1770,Clinical Trials,Topic
1770,Quentin LobbÈ,Author
1770,Alexandre DelanoÎ,Author
1770,David Chavalarias,Author
1771,Exploration,Topic
1771,Online Learning,Topic
1771,Long-Term Reward,Topic
1771,Short-Term Regret,Topic
1771,Clinical Trial Setting,Topic
1771,Sub-Optimal Treatment,Topic
1771,Natural Groups,Topic
1771,Race,Topic
1771,Age,Topic
1771,Grouped Bandit Model,Topic
1771,Axiomatic Bargaining,Topic
1771,Nash Bargaining Solution,Topic
1771,Regret-Optimal Policy,Topic
1771,Disadvantaged Groups,Topic
1771,Optimally Fair Policies,Topic
1771,Price Of Fairness,Topic
1771,Algorithmic Framework,Topic
1771,Contextual Bandits,Topic
1771,Warfarin Dosing,Topic
1771,Jackie Baek,Author
1771,Vivek F. Farias,Author
1772,Robust Stochastic Linear Contextual Bandits Under Adversarial Attacks,Paper
1772,Stochastic Linear Contextual Bandit Algorithms,Topic
1772,Adversarial Attacks,Topic
1772,Robust Bandit Algorithms,Topic
1773,Multi-Armed Bandit Requiring Monotone Arm Sequences,Paper
1773,Ningyuan Chen,Author
1773,Monotone Arm Sequences,Topic
1774,Dominant PÛlya Sequences,Topic
1774,Hristo Sariev,Author
1774,Sandra Fortini,Author
1774,Sonia Petrone,Author
1774,Randomized Clinical Trials,Topic
1774,Species Sampling,Topic
1774,Bayesian Inference,Topic
1774,Random Probability Measure,Topic
1774,Set Of Dominant Colors,Topic
1774,Predictive Probabilities,Topic
1774,Empirical Frequencies,Topic
1774,Total Variation,Topic
1774,Expected Reinforcement,Topic
1774,Color-Specific Random Weights,Topic
1774,Unbounded Number Of Possible Colors,Topic
1774,"$	Ilde{P}$",Topic
1774,"$	Ilde{P}(	Ext{D})=1$",Topic
1774,"$	Ext{D}$",Topic
1775,Multi-Type Recurrent Events,Topic
1775,Medical Applications,Topic
1775,Nonmelanoma Skin Cancers,Topic
1775,Clinical Trial For Skin Cancer Prevention,Topic
1775,Copula-Frailty Models,Topic
1775,Monte Carlo Expectation-Maximization (Mcem) Algorithm,Topic
1775,Khaled F. Bedair,Author
1775,Yili Hong,Author
1775,Hussein R. Al-Khalidi,Author
1775,Recurrences Of Skin Cancer,Topic
1776,Bayesian Optimization,Topic
1776,Cost-Constrained Bayesian Optimization,Topic
1776,Eric Hans Lee,Author
1776,David Eriksson,Author
1776,Valerio Perrone,Author
1776,Matthias Seeger,Author
1776,A Nonmyopic Approach To Cost-Constrained Bayesian Optimization,Paper
1777,Reversible Covalent Kinase Inhibitors,Topic
1777,Pemphigus,Topic
1777,Zheng Zhao,Author
1777,Philip E. Bourne,Author
1778,Covid-19,Topic
1778,Human Coronaviruses,Topic
1778,Shuting Jin,Author
1778,Xiangxiang Zeng,Author
1778,Wei Huang,Author
1778,Feng Xia,Author
1778,Changzhi Jiang,Author
1778,Xiangrong Liu,Author
1778,Shaoliang Peng,Author
1779,Matching-Adjusted Indirect Comparison,Topic
1779,Calibration Estimation,Topic
1779,Jixian Wang,Author
1779,Health Technology Assessment,Topic
1779,Drug Regulatory Submissions,Topic
1779,Entropy Balancing Approach,Topic
1779,Standard Error Estimation,Topic
1779,Simulation,Topic
1780,Hidden Markov Models,Topic
1780,Missing Data,Topic
1780,Mnar,Topic
1780,Mar,Topic
1780,State-Dependent Missingness,Topic
1780,Time-Dependent Missingness,Topic
1780,Maarten Speekenbrink,Author
1780,Ingmar Visser,Author
1780,Severity Of Schizophrenic Symptoms,Topic
1780,Clinical Trial,Topic
1781,Multiple Sclerosis,Topic
1781,Scopus Database,Topic
1781,1/1/21,Topic
1781,1/1/22,Topic
1781,Nazlahshaniza Shafina,Author
1781,Che Aishah Nazariah Ismaila,Author
1781,Mohd Zulkifli Mustafa,Author
1781,Nurhafizah Ghani,Author
1781,Asma Hayati Ahmad,Author
1781,Zahiruddin Othman,Author
1781,Adi Wijaya,Author
1781,Rahimah Zakaria,Author
1781,Covid-19,Topic
1781,Teriflunomide,Topic
1781,Clinical Trial,Topic
1781,Microglia,Topic
1781,B Cells,Topic
1781,Myelin,Topic
1781,Brain,Topic
1781,White Matter,Topic
1781,Functional Connectivity,Topic
1781,Pain,Topic
1781,Employment,Topic
1781,Health-Related Quality Of Life,Topic
1781,Meta-Analysis,Topic
1781,Comorbidity,Topic
1782,Extended Rayleigh Lomax Distribution,Topic
1782,Rayleigh Lomax Distribution,Topic
1782,Jones (2004),Author
1782,N. I. Badmus,Author
1782,O. Faweya,Author
1782,S. A. Ige,Author
1782,Covid-19 Death Cases Data,Topic
1782,Anderson Darling (Ad),Topic
1782,Cramervon Misses (Cvm),Topic
1782,Kolmogorov Smirnov (Ks),Topic
1782,Akaike Information Criterion (Aic),Topic
1782,Bayesian Information Criterion (Bic),Topic
1782,Consistent Akaike Information Criterion (Caic),Topic
1782,Survival Data,Topic
1782,Clinical Trials,Topic
1782,Skewness,Topic
1782,Kurtosis,Topic
1782,Coefficient Of Variation,Topic
1782,Hazard Rate,Topic
1782,Reverse Hazard Rate,Topic
1782,Likelihood Functions,Topic
1782,Moment Generating Functions,Topic
1782,Probability Density Function,Topic
1782,Cumulative Density Function,Topic
1782,Reliability Rate,Topic
1782,Goodness Of Fit,Topic
1782,Model Selection Criteria,Topic
1782,Better Distribution,Topic
1782,Competing Models,Topic
1782,States In Nigeria,Topic
1783,Canonical Fundamental Skew-T Linear Mixed Model (St-Lmm),Topic
1783,Fernanda L. Schumacher,Author
1783,Larissa A. Matos,Author
1783,Celso R. B. Cabral,Author
1783,Clinical Trials,Topic
1783,Longitudinal Data,Topic
1783,Clustered Data,Topic
1783,Linear Mixed Models (Lmms),Topic
1783,Gaussian Assumptions,Topic
1783,Random Effect,Topic
1783,Error Terms,Topic
1783,Skewness,Topic
1783,Heavy-Tails,Topic
1783,Outliers,Topic
1783,Parameter Estimation,Topic
1783,Maximum Likelihood,Topic
1783,Standard Errors,Topic
1783,Random Effects,Topic
1783,Schizophrenia Data,Topic
1783,Simulation Studies,Topic
1784,Survtrace,Topic
1784,Zifeng Wang,Author
1784,Jimeng Sun,Author
1784,Survival Analysis,Topic
1784,Competing Events,Topic
1784,Metabric,Topic
1784,Support,Topic
1784,Seer,Topic
1785,Interval Estimation Of Relative Risks For Combined Unilateral And Bilateral Correlated Data,Paper
1785,Relative Risk,Topic
1785,Confidence Intervals,Topic
1785,Fisher Scoring Method,Topic
1785,Simulation Studies,Topic
1786,Covid-19 Clinical Decision Support Systems,Topic
1786,Logistic Regression Models,Topic
1786,New York City,Topic
1786,Yifan Li,Author
1786,Garrett Yoon,Author
1786,Mustafa Nasir-Moin,Author
1786,David Rosenberg,Author
1786,Sean Neifert,Author
1786,Douglas Kondziolka,Author
1786,Eric Karl Oermann,Author
1786,Covid-19 Mortality,Topic
1786,Ventilator Status,Topic
1786,Inpatient Status,Topic
1786,Real-World Dataset,Topic
1786,Algorithmic Bias,Topic
1786,Sensitivity Of Predictive Models,Topic
1786,Area Under The Receiver/Operating Curve (Auc),Topic
1786,Bias In Algorithms,Topic
1787,Prediction Method For Imaging Data,Topic
1787,Steatosis Prediction,Topic
1787,Matthias Perkonigg,Author
1787,Peter Mesenbrink,Author
1787,Alexander Goehler,Author
1787,Miljen Martic,Author
1787,Ahmed Ba-Ssalamah,Author
1787,Georg Langs,Author
1788,Model-Assisted Complier Average Treatment Effect Estimates In Randomized Experiments With Non-Compliance And A Binary Outcome,Paper
1788,Jiyang Ren,Author
1788,Complier Average Treatment Effect,Topic
1788,Randomized Experiments,Topic
1788,Non-Compliance,Topic
1788,Binary Outcome,Topic
1788,Wald Estimator,Topic
1788,Neyman-Type Conservative Variance Estimators,Topic
1788,Academic Services,Topic
1788,Academic Performance,Topic
1789,Personal Health Navigation (Phn),Topic
1789,Nitish Nag,Author
1789,Hyungik Oh,Author
1789,Mengfan Tang,Author
1789,Mingshu Shi,Author
1789,Ramesh Jain,Author
1789,Cardiology,Topic
1789,Cardiovascular Exercise Response Variability,Topic
1789,Smartwatch Data-Set,Topic
1789,Health Computing Challenges,Topic
1789,Health Trajectory,Topic
1790,Phase I Dose-Finding Clinical Trial,Topic
1790,Dose-Finding Designs,Topic
1790,Decision Framework,Topic
1790,Mtpi,Topic
1790,Boin,Topic
1790,Crm,Topic
1790,Yunshan Duan,Author
1790,Shijie Yuan,Author
1790,Yuan Ji,Author
1790,Peter Mueller,Author
1791,Learning Personalized Decision Policies,Topic
1791,Target Population,Topic
1791,Training Data,Topic
1791,Standard Policy Learning Methods,Topic
1791,Novel Framework,Topic
1791,Sample Selection Bias,Topic
1791,Selection Variable,Topic
1791,Minimax Value,Topic
1791,Uncertainty Set,Topic
1791,Convex-Concave Procedure,Topic
1791,Logistic Policies,Topic
1791,Tobias Hatt,Author
1791,Daniel Tschernutter,Author
1791,Stefan Feuerriegel,Author
1792,Power And Sample Size Analysis,Topic
1792,Clinical Trial Study Design,Topic
1792,Bayesian Paradigm,Topic
1792,O'Hagan And Stevens (2001),Author
1792,General Bayesian Framework,Topic
1792,Simulation-Based Sample Size Determination,Topic
1792,Conjugate Bayesian Linear Regression Models,Topic
1792,Frequentist Solutions,Topic
1792,Jane Pan,Author
1792,Sudipto Banerjee,Author
1792,A Unifying Bayesian Approach For Sample Size Determination Using Design And Analysis Priors,Paper
1793,Longitudinal Studies,Topic
1793,Ich E9(R1) Addendum,Topic
1793,Treatment Effect Estimand,Topic
1793,Intercurrent Events,Topic
1793,Jump-To-Reference (J2R),Topic
1793,Average Treatment Effect,Topic
1793,Potential Outcomes Framework,Topic
1793,Nuisance Functions,Topic
1793,Simulation Studies,Topic
1793,Antidepressant Clinical Trial,Topic
1793,Siyi Liu,Author
1793,Shu Yang,Author
1793,Yilong Zhang,Author
1793,Guanghan,Author
1793,Liu,Author
1794,Delayed Separation Of Survival Curves,Topic
1794,Immuno-Oncology,Topic
1794,Statistical Methods,Topic
1794,Weighted Log-Rank Tests,Topic
1794,Baseline Variable,Topic
1794,Dominic Magirr,Author
1794,JosÈ L. JimÈnez,Author
1794,Randomized Clinical Trials,Topic
1794,Stratified Modestly-Weighted Log-Rank Tests,Topic
1794,Simulation Study,Topic
1795,Covariate-Adjusted Log-Rank Test: Guaranteed Efficiency Gain And Universal Applicability,Paper
1796,Warfarin,Topic
1796,Deep Reinforcement Learning-Based Dosing Model,Topic
1796,Pharmacokinetic/Pharmacodynamic Model,Topic
1796,Sadjad Anzabi Zadeh,Author
1796,W. Nick Street,Author
1796,Barrett W. Thomas,Author
1797,Automated Architecture Search For Brain-Inspired Hyperdimensional Computing,Paper
1797,Hyperdimensional Computing,Topic
1798,Quantile Regression Models,Topic
1798,Clustered Data,Topic
1798,Random Effects,Topic
1798,Small Clusters,Topic
1798,Bias-Adjusted Estimator,Topic
1798,Aids Clinical Trial Group (Actg) Study,Topic
1798,Maria Laura Battagliola,Author
1798,Helle S¯rensen,Author
1798,Anders Tolver,Author
1798,Ana-Maria Staicu,Author
1798,Two-Step Estimation Methodology,Topic
1798,Pseudo Likelihood Approach (Lqmm Method),Topic
1798,Bootstrap Sampling Procedure,Topic
1798,Simulation Studies,Topic
1799,Ensemble Method For Estimating Individualized Treatment Effects,Paper
1799,Kevin Wu Han,Author
1799,Han Wu,Author
1799,Individualized Treatment Effects,Topic
1799,Machine Learning Models,Topic
1799,Randomized Experiment,Topic
1799,Clinical Trials,Topic
1799,A/B Testing,Topic
1799,Model Selection,Topic
1799,Ensembling,Topic
1799,Benchmark Datasets,Topic
1800,Model-Free Artificial Pancreas,Topic
1800,Type 1 Diabetes,Topic
1800,Tobias K. S. Ritschel,Author
1800,Asbj¯rn Thode Reenberg,Author
1800,Emilie B. Lindkvist,Author
1800,Christian Laugesen,Author
1800,Jannet Svensson,Author
1800,Ajenthen G. Ranjan,Author
1800,Kirsten N¯rgaard,Author
1800,Bernd Dammann,Author
1800,John Bagterp J¯rgensen,Author
1801,Conditional Variational Autoencoders,Topic
1801,Siddharth Ramchandran,Author
1801,Gleb Tikhonov,Author
1801,Otto Lˆnnroth,Author
1801,Pekka Tiikkainen,Author
1801,Harri L‰hdesm‰ki,Author
1801,Learning Conditional Variational Autoencoders With Missing Covariates,Paper
1802,A Single Index Model For Longitudinal Outcomes To Optimize Individual Treatment Decision Rules,Paper
1802,Precision Medicine,Topic
1802,Longitudinal Data,Topic
1802,Kullback-Leibler Divergence,Topic
1802,Biosignatures,Topic
1803,Bayesassurance,Topic
1803,Jane Pan,Author
1803,Sudipto Banerjee,Author
1804,Digital Therapeutics (Dtx),Topic
1804,Software As A Medical Device (Samd),Topic
1804,Mobile And Wearable Devices,Topic
1804,Randomized Clinical Trials,Topic
1804,Uichin Lee,Author
1804,Gyuwon Jung,Author
1804,Eun-Yeol Ma,Author
1804,Jin San Kim,Author
1804,Heepyung Kim,Author
1804,Jumabek Alikhanov,Author
1804,Youngtae Noh,Author
1804,Heeyoung Kim,Author
1804,Data-Driven Dtx Analytics,Topic
1804,Dtx Engagement,Topic
1804,Behavioral Adherence,Topic
1804,Contextual Patterns,Topic
1804,Mobile Sensor And Interaction Datasets,Topic
1804,Receptivity Of Existing Dtx,Topic
1805,Learning Personalized Cancer Treatment With Machine Learning,Topic
1805,Mingyu Lu,Author
1805,Yifang Chen,Author
1805,Su-In Lee,Author
1805,A Deep Bayesian Bandits Approach For Anticancer Therapy: Exploration Via Functional Prior,Paper
1806,Reinforcement Learning,Topic
1806,Bayesian Sequential Design,Topic
1806,Mauricio Tec,Author
1806,Yunshan Duan,Author
1806,Peter M¸ller,Author
1806,Healthcare Applications,Topic
1807,A Survey Of Risk-Aware Multi-Armed Bandits,Paper
1808,Value Of Information (Voi) Analysis,Topic
1808,Unit Normal Loss Integral (Unli),Topic
1808,Closed-Form Solution,Topic
1808,Two-Dimensional Unli,Topic
1808,Three-Arm Clinical Trial,Topic
1808,Predtools Package,Topic
1808,Tae Yoon Lee,Author
1808,Paul Gustafson,Author
1808,Mohsen Sadatsafavi,Author
1809,Markov Decision Process,Topic
1809,Model Uncertainty,Topic
1809,Bayesian Framework,Topic
1809,State Process,Topic
1809,Controls,Topic
1809,Cost,Topic
1809,Risk Measures,Topic
1809,Risk Filters,Topic
1809,Bellman Principle Of Optimality,Topic
1809,Optimal Investment,Topic
1809,Clinical Trials,Topic
1809,Tomasz R. Bielecki,Author
1809,Igor Cialenco,Author
1810,Bayesian Optimization Under Stochastic Delayed Feedback,Paper
1810,Arun Verma,Author
1810,Zhongxiang Dai,Author
1810,Bryan Kian Hsiang Low,Author
1810,Bayesian Optimization,Topic
1810,Stochastic Delayed Feedback,Topic
1810,Function Evaluation,Topic
1810,Sub-Linear Regret Guarantees,Topic
1810,Batch Bo,Topic
1810,Contextual Gaussian Process Bandits,Topic
1811,Constrained D-Optimal Design For Paid Research Study,Paper
1812,Ai-Assisted Colonoscopy,Topic
1812,Hsiang-Ting Chen,Author
1812,Yuan Zhang,Author
1812,Gustavo Carneiro,Author
1812,Seon Ho Shin,Author
1812,Rajvinder Singh,Author
1812,Human-Centered Ai-Assisted Colonoscopy System,Paper
1813,Comparing Results Of Thermographic Images Based Diagnosis For Breast Diseases,Paper
1813,Infrared Imaging,Topic
1813,Support Vector Machine,Topic
1813,Pro Engenharia Public Database,Topic
1813,Universidade Federal De Pernambuco,Topic
1814,An Empathetic Ai Coach For Self-Attachment Therapy,Paper
1814,Self-Attachment Therapy,Topic
1814,Digital Coach,Topic
1814,Deep-Learning Classifier,Topic
1814,Rule-Based Conversational Agent,Topic
1814,Human-Like Personas,Topic
1814,User Engagement,Topic
1814,Empathy,Topic
1814,Usefulness,Topic
1814,Non-Clinical Trial,Topic
1814,Participants,Topic
1815,Pocock And Simon'S Minimization Method,Topic
1815,Limiting Covariance Matrix,Topic
1815,Bootstrap-Based Estimator,Topic
1815,Le Cam'S Third Lemma,Topic
1815,Robust Tests,Topic
1815,Zixuan Zhao,Author
1815,Yanglei Song,Author
1815,Wenyu Jiang,Author
1815,Dongsheng Tu,Author
1815,Consistent Covariance Estimation For Stratum Imbalances Under Minimization Method For Covariate-Adaptive Randomization,Paper
1816,Optimal Personalized Treatment Selection,Topic
1816,Chathura Siriwardhana,Author
1816,K. B. Kulasekera,Author
1816,Somnath Datta,Author
1817,Feature Selection With Respect To Time-To-Event Outcomes,Topic
1817,Clinical Trials,Topic
1817,Biomarker Discovery Studies,Topic
1817,Statistical Methods,Topic
1817,Sample Size,Topic
1817,Covariates,Topic
1817,Simulation Study,Topic
1817,Cox Proportional Hazards Models,Topic
1817,Covariates,Topic
1817,Gaussian Regression,Topic
1817,Cox Regression,Topic
1817,Rong Lu,Author
1818,Deep Conditional Transformation Models For Survival Analysis,Paper
1818,Gabriele Campanella,Author
1818,Lucas Kook,Author
1818,Ida H‰ggstrˆm,Author
1818,Torsten Hothorn,Author
1818,Thomas J. Fuchs,Author
1819,Hybrid Censored Quantile Regression Forest (Hcqrf),Topic
1819,Censored Response Variable,Topic
1819,Treatment Effects,Topic
1819,Quantiles,Topic
1819,Variable Importance Decomposition,Topic
1819,Huichen Zhu,Author
1819,Yifei Sun,Author
1819,Ying Wei,Author
1819,Colorectal Cancer Clinical Trial,Topic
1819,Simulation Studies,Topic
1820,Stratified Medicine,Topic
1820,Predictive Biomarkers,Topic
1820,Randomized Data,Topic
1820,Rare Cancers,Topic
1820,Clinical Registries,Topic
1820,Observational Studies,Topic
1820,Average Treatment Effect,Topic
1820,Confounder Adjustment,Topic
1820,Regression Modelling,Topic
1820,Predmob,Paper
1820,Covariate Adjustment,Topic
1820,Matching,Topic
1820,Inverse Probability Of Treatment Weighting (Iptw),Topic
1820,German Breast Cancer Study Group (Gbsg) Trial 2,Paper
1820,Julia Krzykalla,Author
1820,Axel Benner,Author
1820,Annette Kopp-Schneider,Author
1821,Frailty Model With Change Point For Survival Analysis,Paper
1821,Cox Proportional Hazard Model,Topic
1821,Expectation-Maximization Algorithm,Topic
1821,R Package,Topic
1821,Simulation Studies,Topic
1821,Clinical Trials,Topic
1821,Random Effects,Topic
1821,Heterogeneity,Topic
1821,Change Points,Topic
1821,Accuracy,Topic
1822,Mild Cognitive Impairment,Topic
1822,Dementia,Topic
1822,Psychiatric Disorders,Topic
1822,Depression,Topic
1822,Mood Disorders,Topic
1822,Schizophrenia,Topic
1822,Disability-Adjusted Life-Years,Topic
1822,Healthcare Burden,Topic
1822,Drug Trials,Topic
1822,Alzheimer'S Disease,Topic
1822,Non-Drug-Based Therapies,Topic
1822,Ultrasound Ablation Of Amyloid Plaques,Topic
1822,Neurofeedback Therapy,Topic
1822,Neuroplasticity,Topic
1822,Pathophysiological Aspects,Topic
1822,Non-Pharmacological Interventions,Topic
1822,Sheng Mai,Author
1823,Black Box Optimisation,Topic
1823,Kernel Based Bandit Problem,Topic
1823,Bayesian Optimisation,Topic
1823,Stochastically Delayed Feedback,Topic
1823,Algorithm,Topic
1823,Sattar Vakili,Author
1823,Danyal Ahmed,Author
1823,Alberto Bernacchia,Author
1823,Ciara Pike-Burke,Author
1823,Verma Et Al. (2022),Paper
1823,"$	Ilde{	Ext{O}}(	Ext{Sqrt}(	Ext{Gamma}_K(T)T)+	Ext{E}[	Au])$ Regret",Topic
1823,"$	Ilde{	Ext{O}}(	Ext{Gamma}_K(T)	Ext{Sqrt}(T)+	Ext{E}[	Au]	Ext{Gamma}_K(T))$",Topic
1823,Simulations,Topic
1824,Factorial Survival Analysis For Treatment Effects Under Dependent Censoring,Paper
1824,Takeshi Emura,Author
1824,Marc Ditzhaus,Author
1824,Dennis Dobler,Author
1824,Kenta Murotani,Author
1824,Surv.Factorial,Topic
1825,Multi-Task Representation Learning For Pure Exploration In Linear Bandits,Paper
1825,Yihan Du,Author
1825,Longbo Huang,Author
1825,Wen Sun,Author
1825,Linear Bandits,Topic
1825,Contextual Linear Bandits,Topic
1825,Best Arm Identification,Topic
1825,Best Policy Identification,Topic
1825,Douexpdes,Topic
1825,C-Douexpdes,Topic
1826,Number Of Repetitions In Re-Randomization Tests,Paper
1826,Yilong Zhang,Author
1826,Yujie Zhao,Author
1826,Yiwen Luo,Author
1827,Is Calendar Time The True Clock Of Innovation?,Paper
1827,Martin Ho,Author
1827,Henry Cw Price,Author
1827,Tim S Evans,Author
1827,Eoin O'Sullivan,Author
1828,Multiple Information Borrowing (Minbo),Topic
1828,Atherosclerosis Risk In Communities Study,Topic
1828,Chixiang Chen,Author
1828,Ming Wang,Author
1828,Shuo Chen,Author
1828,An Efficient Data Integration Scheme For Synthesizing Information From Multiple Secondary Datasets For The Parameter Inference Of The Main Analysis,Paper
1829,Latent Exchangeability Prior,Topic
1829,Ethan M. Alt,Author
1829,Xiuya Chang,Author
1829,Xun Jiang,Author
1829,Qing Liu,Author
1829,May Mo,Author
1829,H. Amy Xia,Author
1829,Joseph G. Ibrahim,Author
1829,Historical Data,Topic
1829,Propensity Score Approaches,Topic
1829,Phase 3 Clinical Trial,Topic
1829,Plaque Psoriasis,Topic
1830,Smartstate,Topic
1830,Samuel E. Armstrong,Author
1830,Mitchell A. Klusty,Author
1830,Aaron D. Mullen,Author
1830,Jeffery C. Talbert,Author
1830,V. K. Cody Bumgardner,Author
1831,Dirichlet Process Mixture Models For The Analysis Of Repeated Attempt Designs,Paper
1831,Michael J. Daniels,Author
1831,Minji Lee,Author
1831,Wei Feng,Author
1832,Type 1 Diabetes,Topic
1832,Artificial Pancreas Systems,Topic
1832,Exercise-Induced Glucose Intake,Topic
1832,Hypoglycemia,Topic
1832,Existing Exercise Detection Methods,Topic
1832,Ensemble Learning Framework,Topic
1832,Public Dataset,Topic
1832,True Positive Rate,Topic
1832,True Negative Rate,Topic
1832,An Ensemble Learning Approach For Exercise Detection In Type 1 Diabetes Patients,Paper
1832,Ke Ma,Author
1832,Hongkai Chen,Author
1832,Shan Lin,Author
1833,Best Arm Identification,Topic
1833,Multi-Armed Bandit Model,Topic
1833,El Mehdi Saad,Author
1833,Gilles Blanchard,Author
1833,Nicolas Verzelen,Author
1833,Covariance Adaptive Best Arm Identification,Paper
1834,Should I Stop Or Should I Go: Early Stopping With Heterogeneous Populations,Paper
1834,Hammaad Adam,Author
1834,Fan Yin,Author
1834,Huibin,Author
1834,Hu,Author
1834,Neil Tenenholtz,Author
1834,Lorin Crawford,Author
1834,Lester Mackey,Author
1834,Allison Koenecke,Author
1835,Web Scraping,Topic
1835,Medicine,Topic
1835,Medical Ministrations,Topic
1835,Niketha Sabesan,Author
1835,Nivethitha,Author
1835,J. N Shreyah,Author
1835,Pranauv A J,Author
1835,Shyam R,Author
1836,A Direct Approach To Simultaneous Tests Of Superiority And Noninferiority With Multiple Endpoints,Paper
1836,Wenfeng Chen,Author
1836,Naiqing Zhao,Author
1836,Guoyou Qin,Author
1836,Jie Chen,Author
1836,Clinical Trials,Topic
1836,Superiority Hypothesis,Topic
1836,Non-Inferiority Hypothesis,Topic
1836,Type I Error Rate,Topic
1836,Simulations,Topic
1836,Confidence Intervals,Topic
1837,Clinical Trials,Topic
1837,Medical Image Analysis Challenges,Topic
1837,Reproducibility Of Methods,Topic
1837,2019 Robust Medical Image Segmentation Challenge,Topic
1837,Annika Reinke,Author
1837,Georg Grab,Author
1837,Lena Maier-Hein,Author
1838,Parkinson'S Disease,Topic
1838,Subgroups,Topic
1838,Clinical Trials,Topic
1838,Biomarkers,Topic
1838,Cluster Analysis,Topic
1838,Longitudinal Data,Topic
1838,Time-To-Event Data,Topic
1838,Divisive Hierarchical Bayesian Clustering,Topic
1838,Idiopathic Pd,Topic
1838,Parkinson'S Progression Markers Initiative,Topic
1838,Elliot Burghardt,Author
1838,Daniel Sewell,Author
1838,Joseph Cavanaugh,Author
1839,Vertxgradenet,Topic
1839,Msasss,Topic
1839,Yuanhan Mo,Author
1839,Yao Chen,Author
1839,Aimee Readie,Author
1839,Gregory Ligozio,Author
1839,Thibaud Coroller,Author
1839,Vertxnet,Topic
1839,Axial Spondylarthritis,Topic
1840,Drugchat,Topic
1840,Youwei Liang,Author
1840,Ruiyi Zhang,Author
1840,Li Zhang,Author
1840,Pengtao Xie,Author
1840,Drug Discovery,Topic
1840,Structure-Activity Relationships,Topic
1840,Lead Optimization,Topic
1840,Drug Repurposing,Topic
1840,Clinical Trials,Topic
1840,Graph Neural Network,Topic
1840,Large Language Model,Topic
1840,Adaptor,Topic
1840,Instruction Tuning Datasets,Topic
1840,Drug Compounds,Topic
1840,Question-Answer Pairs,Topic
1841,Healthfc,Topic
1841,Juraj Vladika,Author
1841,Phillip Schneider,Author
1841,Florian Matthes,Author
1842,Neyman Allocation,Topic
1842,Jinglong Zhao,Author
1842,Multi-Stage Experimental Design,Topic
1842,Adaptive Neyman Allocation Algorithm,Topic
1842,Online A/B Testing,Topic
1843,Heterogeneous Treatment Effect Estimation Method,Topic
1843,Rulefit,Topic
1843,Aids Clinical Trials Group Protocol 175 Dataset,Topic
1843,Ke Wan,Author
1843,Kensuke Tanioka,Author
1843,Toshio Shimokawa,Author
1844,Physical Experiments In National Security,Topic
1844,Test Engineers,Topic
1844,Bayesian Adaptive Designs,Topic
1844,Predictive Probability,Topic
1844,Daniel Ries,Author
1844,Victoria R. C. Sieck,Author
1844,Philip Jones,Author
1844,Julie Shaffer,Author
1844,Measuring The Robustness Of Predictive Probability For Early Stopping In Experimental Design,Paper
1845,Human Genetic Diseases,Topic
1845,Point Mutations,Topic
1845,Genome Editing Techniques,Topic
1845,Base Editing,Topic
1845,Editing Efficiency,Topic
1845,Unintended Mutations,Topic
1845,Trial-And-Error Experimentation,Topic
1845,Attention-Based Two-Stage Machine Learning Model,Paper
1845,Genomic Target Sequence,Topic
1845,Multi-Task Learning Schema,Topic
1845,Base Editors,Topic
1845,Predictions,Topic
1845,Experimental Results,Topic
1845,Datasets,Topic
1845,Base Editor Variants,Topic
1845,Models' Capacity,Topic
1845,Base Editing Designs,Topic
1846,Reference Based Imputation,Topic
1846,Conditional Mean Imputation,Topic
1846,Mixed Model For Repeated Measures,Topic
1846,Sequential Linear Regression,Topic
1846,Sean Yiu,Author
1847,Contextual Bandit Algorithms,Topic
1847,Recommender Systems,Topic
1847,Clinical Trials,Topic
1847,Optimal Portfolio Selection,Topic
1847,Siddhant Chaudhary,Author
1847,Abhishek Sinha,Author
1848,Accurate Cancer Risk Estimation,Topic
1848,Clinical Decision-Making,Topic
1848,High-Risk People For Screening,Topic
1848,Cancer Risk Models,Topic
1848,Epidemiologic Studies,Topic
1848,Population-Based Health Surveys,Topic
1848,Time-To-Cancer Incidence Data,Topic
1848,Time-To-Cancer Specific Mortality,Topic
1848,Vital Statistics,Topic
1848,Calibrated Pseudoweighting Methods,Topic
1848,Individual-Level Data,Topic
1848,Cohort,Topic
1848,Summary Statistics Of Cancer Incidence,Topic
1848,National Cancer Registries,Topic
1848,Cox Regression,Topic
1848,Inverse-Propensity Pseudoweighting Method,Topic
1848,Lung Cancer Incidence Pure Risk Model,Topic
1848,"Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial",Topic
1848,National Health Interview Survey,Topic
1848,Cancer Registries,Topic
1848,Lingxiao Wang,Author
1848,Yan Li,Author
1848,Barry Graubard,Author
1848,Hormuzd Katki,Author
1849,Thomas Guilmeau,Author
1849,Nicola Branchini,Author
1849,Emilie Chouzenoux,Author
1849,VÌctor Elvira,Author
1850,Translation,Topic
1850,Biomedical Translation,Topic
1850,Nih,Author
1850,Darpa,Author
1850,Martin Ho,Author
1850,Henry Cw Price,Author
1850,Tim S Evans,Author
1850,Eoin O'Sullivan,Author
1851,A Multilingual Virtual Guide For Self-Attachment Technique,Paper
1851,Self-Attachment Technique,Topic
1852,Coronary Artery Disease,Topic
1852,Stenting,Topic
1852,Bypass Surgery,Topic
1852,Angioplasty,Topic
1852,Forssmann,Author
1852,Dotter,Author
1852,Gruentzig,Author
1852,Bare Metal Stents,Topic
1852,Drug-Eluting Stents,Topic
1852,Bioresorbable Vascular Scaffolds,Topic
1852,Clinical Trials,Topic
1852,Personalized Stenting,Topic
1852,Umme Hafsa Momy,Author
1853,Human Genetic Diseases,Topic
1853,Point Mutations,Topic
1853,Genome Editing Techniques,Topic
1853,Base Editing,Topic
1853,Editing Efficiency,Topic
1853,Unintended Mutations,Topic
1853,Trial-And-Error Experimentation,Topic
1853,Attention-Based Two-Stage Machine Learning Model,Paper
1853,Genomic Target Sequence,Topic
1853,Multi-Task Learning Schema,Topic
1853,Base Editors,Topic
1853,Predictions,Topic
1853,Experimental Results,Topic
1853,Datasets,Topic
1853,Base Editor Variants,Topic
1853,Models' Capacity,Topic
1853,Base Editing Designs,Topic
1854,Incremental Cost-Effectiveness Statistical Inference: Calculations And Communications,Paper
1854,Robert L. Obenchain,Author
1854,Nonparametric Statistical Methods,Topic
1854,Incremental Cost Effectiveness (Ice) Methods,Topic
1854,Bootstrapping,Topic
1854,Shadow Price Of Health,Topic
1854,Iceinfer R-Package,Topic
1854,Qaly,Topic
1854,Histograms,Topic
1854,Health-Care Stakeholders,Topic
1855,Survtimesurvival: Survival Analysis On Patients With Multiple Visits/Records,Paper
1855,Hung Le,Author
1855,Ong Eng-Jon,Author
1855,Bober Miroslaw,Author
1856,Mobile Health Interventions,Topic
1856,Contextual Bandits,Topic
1856,Count Data Models,Topic
1856,Thompson Sampling,Topic
1856,Drink Less Trial,Topic
1856,Xueqing Liu,Author
1856,Nina Deliu,Author
1856,Tanujit Chakraborty,Author
1856,Lauren Bell,Author
1856,Bibhas Chakraborty,Author
1857,Treatment-Covariate Interaction Tests,Topic
1857,Covariate-Adaptive Randomization,Topic
1857,Interaction Tests,Topic
1857,Personalized Medicine,Topic
1857,Likun Zhang,Author
1857,Wei Ma,Author
1858,Semi-Supervised Learning,Topic
1858,Linear Parameters,Topic
1858,Model Misspecification,Topic
1858,High Dimensions,Topic
1858,Robust Semi-Supervised Estimators,Topic
1858,Regression Coefficient,Topic
1858,Sparse Structures,Topic
1858,Large-Scale Unlabeled Data,Topic
1858,Estimation Accuracy,Topic
1858,Inference Robustness,Topic
1858,Sparse Linear Slope,Topic
1858,Covariate Shift,Topic
1858,Numerical Studies,Topic
1858,Simulations,Topic
1858,Aids Clinical Trials Group Protocol 175,Paper
1858,Kai Chen,Author
1858,Yuqian Zhang,Author
1859,Experimental And Observational Studies,Topic
1859,Spurious Association,Topic
1859,Outcome,Topic
1859,Independent Variables,Topic
1859,Intervention,Topic
1859,Confounding,Topic
1859,Third-Party Factors,Topic
1859,Randomized Clinical Trials,Topic
1859,Small Sample Sizes,Topic
1859,New Study,Topic
1859,Ethical Concerns,Topic
1859,Hypothetical Studies,Topic
1859,Dependencies,Topic
1859,Observed Confounders,Topic
1859,Historic Studies,Topic
1859,Effect Size,Topic
1859,Orestis Loukas,Author
1859,Ho Ryun Chung,Author
1860,A Class Of Computational Methods To Reduce Selection Bias When Designing Phase 3 Clinical Trials,Paper
1860,Phase 3 Studies,Topic
1860,Treatment Effect,Topic
1860,Estimation Bias,Topic
1860,Mean Squared Error,Topic
1860,Computational Methods,Topic
1860,Selection Problems,Topic
1861,Emax Dose-Response Model,Topic
1861,Giacomo Aletti,Author
1861,Nancy Flournoy,Author
1861,Caterina May,Author
1861,Chiara Tommasi,Author
1861,"Maximum Likelihood Estimation Under The Emax Model: Existence, Geometry And Efficiency",Paper
1862,Cure Rate Models,Topic
1862,Cancer Clinical Trials,Topic
1862,Infectious Diseases,Topic
1862,Tournoud And Ecochard,Author
1862,2008,Topic
1862,Poisson Distribution,Topic
1862,New Cure Rate Model,Topic
1862,Expectation Maximization Algorithm,Topic
1862,Monte Carlo Simulation Study,Topic
1862,Likelihood Ratio Test,Topic
1862,Information-Based Criteria,Topic
1862,Covid-19,Topic
1862,Suvra Pal,Author
1863,Testing For Similarity Of Multivariate Mixed Outcomes Using Generalised Joint Regression Models With Application To Efficacy-Toxicity Responses,Paper
1864,Posterior Shrinkage Towards Linear Subspaces,Paper
1864,Prior Beliefs,Topic
1864,Exponential Tilting,Topic
1864,Antihypertensive Clinical Trial Dataset,Topic
1864,Monthly Influenza And Pneumonia Data,Topic
1864,R Package Subset,Topic
1865,Effect Size Estimates,Topic
1865,Intervention/Exposure,Topic
1865,Confounders,Topic
1865,Outcome,Topic
1865,Causal Inference,Topic
1865,Observational Studies,Topic
1865,Randomized Clinical Trials,Topic
1865,Combinatorics,Topic
1865,Information Theory,Topic
1865,Logistic Regression,Topic
1865,Mantel-Haenszel Estimator,Topic
1865,Orestis Loukas,Author
1865,Ho Ryun Chung,Author
1866,Individualized Treatment Effects Estimation,Topic
1866,Ghadeer O. Ghosheh,Author
1866,Moritz Gˆgl,Author
1866,Tingting Zhu,Author
1867,Machine Learning Methods For Estimating Heterogeneous Treatment Effects (Hte),Topic
1867,Disha Makhija,Author
1867,Joydeep Ghosh,Author
1867,Yejin Kim,Author
1867,Federated Learning For Estimating Heterogeneous Treatment Effects,Paper
1868,Vqsynergy,Topic
1868,Jiawei Wu,Author
1868,Mingyuan Yan,Author
1868,Dianbo Liu,Author
1868,Drug Synergy,Topic
1868,Cancer Treatment,Topic
1869,Vaccination,Topic
1869,NicolÚ Alessandro Girardini,Author
1869,Arkadiusz Stopczynski,Author
1869,Olga Baranov,Author
1869,Cornelia Betsch,Author
1869,Dirk Brockmann,Author
1869,Sune Lehmann,Author
1869,Robert Bˆhm,Author
1869,Using Smartphones To Study Vaccination Decisions In The Wild,Paper
1870,Treatment Effect Estimation,Topic
1870,Kg-Treat,Paper
1870,Biomedical Knowledge Graphs,Topic
1870,Patient Outcomes,Topic
1870,Treatment-Covariate Relationships,Topic
1870,Outcome-Covariate Relationships,Topic
1870,Area Under The Roc Curve,Topic
1870,Influence Function-Based Precision Of Estimating Heterogeneous Effects,Topic
1870,Randomized Clinical Trial Findings,Topic
1871,Generative Modelling For Shapes,Topic
1871,In-Silico Clinical Trials (Iscts),Topic
1871,Synthetic Anatomical Shapes,Topic
1871,3D Surface Meshes,Topic
1871,Ai Models,Topic
1871,Graph Representations For Meshes,Topic
1871,Unsupervised Geometric Deep-Learning Model,Topic
1871,Shape Correspondences,Topic
1871,Population-Derived Atlas,Topic
1871,Realistic Synthetic Shapes,Topic
1871,Joint Shape Generative-Clustering Multi-Atlas Framework,Topic
1871,Liver Models,Topic
1871,Left-Ventricular Models,Topic
1871,Computational Medicine,Topic
1871,End-To-End Deep Learning Generative Framework For Refinable Shape Matching And Generation,Paper
1871,Soodeh Kalaie,Author
1871,Andy Bulpitt,Author
1871,Alejandro F. Frangi,Author
1871,Ali Gooya,Author
1872,Copula Based Dependent Censoring In Cure Models,Paper
1872,Morine Delhelle,Author
1872,Ingrid Van Keilegom,Author
1872,Time-To-Event Variable,Topic
1872,Random Right Censoring,Topic
1872,Bivariate Distribution,Topic
1872,Parametric Copula,Topic
1872,Marginal Distributions,Topic
1872,Survival Function,Topic
1872,Breast Cancer Data,Topic
1873,Clinical Trial,Topic
1873,Survival Times,Topic
1873,Treatment Group,Topic
1873,Control Group,Topic
1873,Propensity Score Methods,Topic
1873,Logistic Regression Model,Topic
1873,Confounders,Topic
1873,Coarsened Exact Matching (Cem),Topic
1873,Weighted Log-Rank Statistic,Topic
1873,Asymptotic Properties,Topic
1873,Gaussian Process,Topic
1873,Asymptotic Normality,Topic
1873,Null Hypothesis,Topic
1873,Log-Rank Test,Topic
1873,Tomoya Baba,Author
1873,Nakahiro Yoshida,Author
1874,Bayesppdsurv,Topic
1874,Yueqi Shen,Author
1874,Matthew A. Psioda,Author
1874,Joseph G. Ibrahim,Author
1875,Quantitative Systems Pharmacology,Topic
1875,Universal Physics-Informed Neural Networks,Topic
1875,Chemotherapy Pharmacodynamics,Topic
1875,Doxorubicin,Topic
1875,Lena Podina,Author
1875,Ali Ghodsi,Author
1875,Mohammad Kohandel,Author
1876,Analysis Of Covariance (Ancova),Topic
1876,Multiple Contrast Test Procedure (Mctp),Topic
1876,Wild-Bootstrap Method,Topic
1876,Matthias Becher,Author
1876,Ludwig A. Hothorn,Author
1876,Frank Konietschke,Author
1876,Unlocking Insights: Enhanced Analysis Of Covariance In General Factorial Designs Through Multiple Contrast Tests Under Variance Heteroscedasticity,Paper
1877,Retinal Implants,Topic
1877,Degenerative Retinal Disease,Topic
1877,Phosphenes,Topic
1877,Argus Ii Retinal Prosthesis System,Topic
1877,Yuchen Hou,Author
1877,Laya Pullela,Author
1877,Jiaxin Su,Author
1877,Sriya Aluru,Author
1877,Shivani Sista,Author
1877,Xiankun Lu,Author
1877,Michael Beyeler,Author
1877,Predicting The Temporal Dynamics Of Prosthetic Vision,Paper
1878,Enhanced Diagnostic Techniques,Topic
1878,Gas Chromatography-Ion Mobility Spectrometry (Gc-Ims),Topic
1878,Machine Learning Algorithms,Topic
1878,Laboratory Information Management System (Lims),Topic
1878,Christos Sardianos,Author
1878,Chrysostomos Symvoulidis,Author
1878,Matthias Schlˆgl,Author
1878,Iraklis Varlamis,Author
1878,Georgios Th. Papadopoulos,Author
1878,Preliminary Study,Paper
1879,Investigating The Causal Effects Of Multiple Treatments Using Longitudinal Data: A Simulation Study,Paper
1879,Robins Generalised Methods,Topic
1879,G-Methods,Topic
1879,Uk Cf Registry,Topic
1880,Vascularpilot3D,Topic
1880,Jingwei Song,Author
1880,Keke Yang,Author
1880,Han Chen,Author
1880,Jiayi Liu,Author
1880,Yinan Gu,Author
1880,Qianxin Hui,Author
1880,Yanqi Huang,Author
1880,Meng Li,Author
1880,Zheng Zhang,Author
1880,Tuoyu Cao,Author
1880,Maani Ghaffari,Author
1881,Graph Feedback Bandits With Similar Arms,Paper
1881,Stochastic Multi-Armed Bandit Problem,Topic
1881,Graph Feedback,Topic
1881,Clinical Trials,Topic
1881,Recommendation Problem,Topic
1881,D-Ucb,Topic
1881,C-Ucb,Topic
1881,Q&A Platforms,Topic
1881,Product Reviews,Topic
1881,Reddit,Topic
1881,Stack Overflow,Topic
1881,Quora,Topic
1881,Amazon,Topic
1881,Flipkart,Topic
1882,Marc Harary,Author
1882,Pearson Correlation Coefficient,Topic
1882,Welford'S Online Algorithm,Topic
1882,Bivariate Data,Topic
1882,Time-Series Analysis,Topic
1882,Sensitivity Algorithms,Topic
1882,Cython-Wrapped C,Topic
1882,Econometrics,Topic
1882,Operations Research,Topic
1882,Clinical Trials,Topic
1882,Climatology,Topic
1882,Differential Privacy,Topic
1882,Bioinformatics,Topic
1882,Https://Github.Com/Marc-Harary/Sensitivity,Topic
1883,Ai/Ml Evaluations Using An Estimands Framework,Paper
1883,Olivier Binette,Author
1883,Jerome P. Reiter,Author
1883,Estimands Framework,Topic
1883,Benchmark Performance,Topic
1883,Evaluation Methodologies,Topic
1884,Causal Inference With Outcomes Truncated By Death And Missing Not At Random,Paper
1884,Wei Li,Author
1884,Yuan Liu,Author
1884,Shanshan Luo,Author
1884,Zhi Geng,Author
1884,Principal Stratification Analysis,Topic
1884,Truncation By Death,Topic
1884,Average Treatment Effect,Topic
1884,Proxy Variable,Topic
1884,Causal Parameters,Topic
1884,Human Immunodeficiency Virus (Hiv) Study,Topic
1885,Dental Disease,Topic
1885,Oralytics,Paper
1886,Medical Imaging Datasets,Topic
1886,Patient Analysis,Topic
1886,Annotations,Topic
1886,Artificial Intelligence,Topic
1886,Totalsegmentator Method,Topic
1886,National Lung Screening Trial,Topic
1886,Deepa Krishnaswamy,Author
1886,Vamsi Krishna Thiriveedhi,Author
1886,Cosmin Ciausu,Author
1886,David Clunie,Author
1886,Steve Pieper,Author
1886,Ron Kikinis,Author
1886,Andrey Fedorov,Author
1886,Cloudsegmentatorresults,Paper
1887,Automatic Cohort Retrieval,Topic
1887,Dung Ngoc Thai,Author
1887,Victor Ardulov,Author
1887,Jose Ulises Mena,Author
1887,Simran Tiwari,Author
1887,Gleb Erofeev,Author
1887,Ramy Eskander,Author
1887,Karim Tarabishy,Author
1887,Ravi B Parikh,Author
1887,Wael Salloum,Author
1887,Acr: A Benchmark For Automatic Cohort Retrieval,Paper
1888,Functional Linear Regression Models,Topic
1888,Partial Shape Constraints,Topic
1888,Kernel- And Spline-Based Methods,Topic
1888,L^2-Distance,Topic
1888,Large-Sample Analysis,Topic
1888,Finite-Sample Analysis,Topic
1888,Neurobloc,Topic
1888,Type A-Resistant Cervical Dystonia,Topic
1888,National Institute Of Mental Health Schizophrenia Study,Topic
1888,Kyunghee Han,Author
1888,Yeonjoo Park,Author
1888,Soo-Young Kim,Author
1889,Drugclip,Topic
1889,Yingzhou Lu,Author
1889,Yaojun Hu,Author
1889,Chenhao Li,Author
1889,Drug Repurposing,Topic
1890,Mrex,Topic
1890,Rex,Topic
1890,D-Optimality,Topic
1890,P·l Somogyi,Author
1890,Samuel Rosa,Author
1890,Radoslav Harman,Author
1891,Preference-Based Abstract Argumentation For Case-Based Reasoning,Topic
1891,Adam Gould,Author
1891,Guilherme Paulino-Passos,Author
1891,Seema Dadhania,Author
1891,Matthew Williams,Author
1891,Francesca Toni,Author
1891,Real-World Medical Dataset,Topic
1891,Clinical Trial,Topic
1891,Primary Brain Tumour,Topic
1891,Interpretable Machine Learning Models,Topic
1892,Estimating The Maximum Mean,Topic
1892,Upper Confidence Bound Approach To Estimating The Maximum Mean,Paper
1893,Causal Inference Methods For Observational Data,Topic
1893,Randomized Clinical Trials (Rcts),Topic
1893,Causal Directed Acyclic Graphs (Dags),Topic
1893,Observational Studies In Medicine,Topic
1893,Midway Insights,Topic
1893,Identification And Positivity,Topic
1893,Aneurysmal Subarachnoid Hemorrhage (Asah),Topic
1893,External Ventricular Drain (Evd),Topic
1893,Multicenter Studies,Topic
1893,Instrumental Variable (Iv) Inference,Topic
1893,Carlo Berzuini,Author
1893,Davide Luciani,Author
1893,Hiren C. Patel,Author
1894,Aligned Nanofibers,Topic
1894,Tissue Engineering,Topic
1894,Gayatri Patel,Author
1894,Louis-S. Bouchard,Author
1895,Learning Robust Treatment Rules For Censored Data,Paper
1895,Yifan Cui,Author
1895,Junyi Liu,Author
1895,Tao Shen,Author
1895,Zhengling Qi,Author
1895,Xi Chen,Author
1895,Censored Survival Outcomes,Topic
1895,Optimal Treatment Rules,Topic
1895,Restricted Mean Survival Time,Topic
1895,Buffered Survival Probabilities,Topic
1895,Aids Clinical Trial Data,Topic
1896,Randomized Controlled Trials,Topic
1896,Spillover Time Series Causal,Paper
1896,Observational Studies,Topic
1896,Analysis Of Covariance,Topic
1896,Real-World Budget-Control Experiment,Topic
1896,5% Live Experiment,Topic
1896,50% Live Experiment,Topic
1896,Treatment Effect,Topic
1896,Vanilla Estimation,Topic
1896,Robust Estimation,Topic
1897,Drug Discovery And Development,Topic
1897,Quantum Computing,Topic
1897,Yidong Zhou,Author
1897,Jintai Chen,Author
1897,Jinglei Cheng,Author
1897,Gopal Karemore,Author
1897,Marinka Zitnik,Author
1897,Frederic T. Chong,Author
1897,Junyu Liu,Author
1897,Tianfan Fu,Author
1897,Zhiding Liang,Author
1897,Quantum-Machine-Assisted Drug Discovery: Survey And Perspective,Paper
1898,Miwaves Reinforcement Learning Algorithm,Topic
1898,Susobhan Ghosh,Author
1898,Yongyi Guo,Author
1898,Pei-Yao Hung,Author
1898,Lara Coughlin,Author
1898,Erin Bonar,Author
1898,Inbal Nahum-Shani,Author
1898,Maureen Walton,Author
1898,Susan Murphy,Author
1898,Cannabis Use,Topic
1898,Emerging Adults,Topic
1898,Public Health Challenge,Topic
1898,Reinforcement Learning Algorithm,Topic
1898,Clinical Trial,Topic
1898,Mar-24,Topic
1898,May-24,Topic
1899,Ich E9 (R1) Addendum,Topic
1899,Model-Free Treatment Effect Estimands,Topic
1899,Traditional Model-Dependent Approaches,Topic
1899,Stijn Vansteelandt,Author
1899,Kelly Van Lancker,Author
1899,Chasing Shadows: How Implausible Assumptions Skew Our Understanding Of Causal Estimands,Paper
1900,Alzheimer'S Disease,Topic
1900,Dementia,Topic
1900,Convolutional Neural Networks,Topic
1900,Synthetic Minority Oversampling Technique,Topic
1900,Demned Dementia Network,Topic
1900,Sajjad Aghasi Javid,Author
1900,Mahmood Mohassel Feghhi,Author
1900,Mri Scans,Topic
1900,Class Imbalance,Topic
1900,Deep Learning Model,Topic
1900,Accuracy Of 98.67%,Topic
1901,Estimating Interpretable Heterogeneous Treatment Effect With Causal Subgroup Discovery In Survival Outcomes,Paper
1901,Na Bo,Author
1901,Ying Ding,Author
1901,Heterogeneous Treatment Effect,Topic
1901,Survival Outcomes,Topic
1901,Age-Related Macular Degeneration,Topic
1902,Binary Emax Model,Topic
1902,Dose-Response Analysis,Topic
1902,Drug Development,Topic
1902,Nonignorable Missing Binary Responses,Topic
1902,Non-Responder Imputation,Topic
1902,Separation,Topic
1902,Penalized Likelihood-Based Method,Topic
1902,Expectation-Maximization Algorithm,Topic
1902,Ibrahim And Lipsitz,Topic
1902,Noninformative Jeffreys Prior,Topic
1902,Parameter Estimation,Topic
1902,Nri,Topic
1902,Phase Ii Clinical Trial,Topic
1902,Ememax,Topic
1902,Jiangshan Zhang,Author
1902,Vivek Pradhan,Author
1902,Yuxi Zhao,Author
1903,Nonparametric Tests Of Treatment Effect Homogeneity For Policy-Makers,Paper
1904,Digital Twins In Healthcare,Topic
1904,Hugo Chenel,Author
1904,Malvina Marku,Author
1904,Tim James,Author
1904,Andrei Zinovyev,Author
1904,Vera Pancaldi,Author
1905,Crossover Design,Topic
1905,Salil Koner,Author
1905,Clinical Trials,Topic
1905,Ab-Ba Design,Topic
1905,Higher-Order Designs,Topic
1905,Statistical Inference Methods,Topic
1905,Multivariate And Categorical Responses,Topic
1905,Open Problems,Topic
1906,Hierarchical Upper Confidence Bounds For Constrained Online Learning,Paper
1907,Cdsampling,Topic
1907,Yifei Huang,Author
1907,Liping Tong,Author
1907,Jie Yang,Author
1908,Rapiddock,Topic
1908,Molecular Docking,Topic
1908,Drug Discovery,Topic
1908,Posebusters,Topic
1908,Dockgen,Topic
1908,Bazyli Klockiewicz,Author
1908,Bartosz Topolski,Author
1908,Dariusz Plewczynski,Author
1909,Anti-Tuberculosis Drugs,Topic
1909,Degree-Based Topological Indices,Topic
1909,Distance Based Indices,Topic
1909,Molecular Graph,Topic
1909,D. C. Gunawardhana,Author
1909,G. H. J. Lanel,Author
1909,K. K. K. R. Perera,Author
1909,A. G. M. J. Gunaratna,Author
1909,Quantitative Structure-Property Relationship (Qspr),Topic
1909,Theoretical Model,Topic
1910,Antibody Drug,Topic
1910,Biotechnology,Topic
1910,Monoclonal Antibody,Topic
1910,Energy-Based Generative Models,Topic
1910,Paul Pereira,Author
1910,HervÈ Minoux,Author
1910,Aleksandra M. Walczak,Author
1910,Thierry Mora,Author
1911,Multi-Regional Clinical Trial (Mrct),Topic
1911,"Fda Guidance ""Demonstrating Substantial Evidence Of Effectiveness For Human Drug And Biological Products Guidance For Industry""",Topic
1911,Kunhai Qing,Author
1911,Xinru Ren,Author
1911,Jin Xu,Author
1912,Storm: Strategic Orchestration Of Modalities For Rare Event Classification,Paper
1912,Biomedical,Topic
1912,Artificial Intelligence,Topic
1912,Multi-Modal Learning,Topic
1912,Entropy-Based Algorithm,Topic
1912,Seizure Onset Zone Detection,Topic
1913,Patient Weighted While-Alive Estimand,Topic
1913,Alessandra Ragni,Author
1913,Torben Martinussen,Author
1913,Thomas Scheike,Author
1914,Aspire,Topic
1914,Information Retrieval,Topic
1914,Georgios Peikos,Author
1914,Wojciech Kusa,Author
1914,Symeon Symeonidis,Author
1914,Trec Clinical Trials,Topic
1915,Denoising Data With Measurement Error Using A Reproducing Kernel-Based Diffusion Model,Paper
1916,Electrooculography,Topic
1916,Human Tracking Interfaces,Topic
1916,Eog Communication Interface For Quadriplegics: Prototype & Signal Processing,Paper
1916,Aniket Raj,Author
1916,Amit Kumar,Author
1916,Esp32 Board,Topic
1916,Quadriplegic Patients,Topic
1916,Assistive Technology,Topic
1917,Contextual Bandit Problem,Topic
1917,Yiting Hu,Author
1917,Lingjie Duan,Author
1917,Adaptive Clinical Trials,Topic
1917,Ucb Family Algorithms,Topic
1917,Thompson Sampling,Topic
1917,Explore-Then-Commit (Etc),Topic
1917,Epsilon-Greedy Algorithm,Topic
1917,Linear Program,Topic
1917,Frequentist Regret,Topic
1917,Numerical Experiments,Topic
1917,Private Context Misreporting,Topic
1918,Interpretable Model,Topic
1918,Interpretability,Topic
1918,Functional Skeleton,Topic
1918,Mallows'S C_P-Statistic,Topic
1918,Adaptive Clinical Trial Designs,Topic
1918,Bayesian Go/No-Go Paradigm,Topic
1918,Fisher'S Exact Test,Topic
1918,Nhanes,Topic
1918,Tianyu Zhan,Author
1918,Jian Kang,Author
1919,Causal Inference,Topic
1919,Randomized Controlled Trials,Topic
1919,Observational Studies,Topic
1919,Estimand Of Interest,Topic
1919,Ideal Trial,Topic
1919,Target Trial Framework,Topic
1919,Respiratory Epidemiology,Topic
1919,Margarita Moreno-Betancur,Author
1919,Rushani Wijesuriya,Author
1919,John B. Carlin,Author
1920,Overtreatment Of Early-Stage Low-Risk Prostate Cancer Patients,Topic
1920,Genetic And Molecular Markers,Topic
1920,Gene Expression Signature,Topic
1920,Lethal Prostate Cancer,Topic
1920,Biopsy Specimens,Topic
1920,Gleason 6 Tumors,Topic
1920,Gleason 7 Tumors,Topic
1920,Swedish Watchful Waiting Cohort,Topic
1920,98-Genes Ges,Topic
1920,Death Events,Topic
1920,Malignant Field Effect,Topic
1920,Clinical Trial,Topic
1920,Diagnostic And Prognostic Tests,Topic
1920,Active Surveillance Programs,Topic
1920,Gennadi Glinsky,Author
1921,Patient-Specific 3D Volumetric Reconstruction Of Bioresorbable Stents: A Method To Generate 3D Geometries For Computational Analysis Of Coronaries Treated With Bioresorbable Stents,Paper
1921,Boyi Yang,Author
1921,Marina Piccinelli,Author
1921,Gaetano Esposito,Author
1921,Tianli Han,Author
1921,Yasir Bouchi,Author
1921,Bill Gogas,Author
1921,Don Giddens,Author
1921,Habib Samady,Author
1921,Alessandro Veneziani,Author
1921,Computational Fluid Dynamics,Topic
1921,Bioresorbable Vascular Stents,Topic
1922,Evidence-Based Medicine,Topic
1922,Clinical Question,Topic
1922,Pico,Topic
1922,Deep Learning Model,Topic
1922,Biomedical Abstracts,Topic
1922,Bidirectional Long-Short Term Memory,Topic
1922,Conditional Random Field,Topic
1922,Adversarial Training,Topic
1922,Unsupervised Pre-Training,Topic
1922,Pubmed-Pico Dataset,Topic
1922,Nicta-Piboso,Topic
1922,Di Jin,Author
1922,Peter Szolovits,Author
1923,Lung Nodule Detection And Cancer Prediction,Topic
1923,Long Short-Term Memory (Lstm),Topic
1923,Distanced Lstm (Dlstm),Topic
1923,Temporal Emphasis Model (Tem),Topic
1923,National Lung Screening Trial (Nlst),Topic
1923,Riqiang Gao,Author
1923,Yuankai Huo,Author
1923,Shunxing Bao,Author
1923,Yucheng Tang,Author
1923,Sanja L. Antic,Author
1923,Emily S. Epstein,Author
1923,Aneri B. Balar,Author
1923,Steve Deppen,Author
1923,Alexis B. Paulson,Author
1923,Kim L. Sandler,Author
1923,Pierre P. Massion,Author
1923,Bennett A. Landman,Author
1924,A Precision Medicine Approach To Develop And Internally Validate Optimal Exercise And Weight Loss Treatments For Overweight And Obese Adults With Knee Osteoarthritis,Paper
1925,Fetal Heart Rate (Fhr) Temporal Dynamics,Topic
1925,Cardiovascular Decompensation (Cvd),Topic
1925,Animal Model Of Human Labor,Topic
1925,Near-Term Ovine Fetuses,Topic
1925,Umbilical Cord Occlusions (Uco),Topic
1925,Metabolites,Topic
1925,Ph,Topic
1925,Electrocardiogram (Ecg),Topic
1925,Systemic Arterial Blood Pressure,Topic
1925,Fhr Variability Features,Topic
1925,Self-Referencing Metric,Topic
1925,StÈphane G. Roux,Author
1925,Nicolas B. Garnier,Author
1925,Patrice Abry,Author
1925,Nathan Gold,Author
1925,Martin G. Frasch,Author
1926,Chatgpt-4,Topic
1926,Chatgpt-3.5,Topic
1926,Radiation Oncology,Topic
1926,Usmle,Topic
1926,Medqa,Topic
1926,Acr Radiation Oncology In-Training Exam,Topic
1926,Red Journal Gray Zone Cases,Topic
1926,Yixing Huang,Author
1926,Ahmed Gomaa,Author
1926,Sabine Semrau,Author
1926,Marlen Haderlein,Author
1926,Sebastian Lettmaier,Author
1926,Thomas Weissmann,Author
1926,Johanna Grigo,Author
1926,Hassen Ben Tkhayat,Author
1926,Benjamin Frey,Author
1926,Udo S. Gaipl,Author
1926,Luitpold V. Distel,Author
1926,Andreas Maier,Author
1926,Rainer Fietkau,Author
1926,Christoph Bert,Author
1926,Florian Putz,Author
1927,Theia,Topic
1927,Diabetic Retinopathy,Topic
1927,New Zealand Diabetic Screening Programme,Topic
1927,Ehsan Vaghefi,Author
1927,Song Yang,Author
1927,Li Xie,Author
1927,David Han,Author
1927,David Squirrell,Author
1927,Multi-Center Prospective Study,Topic
1928,Decision Curve Analysis,Topic
1928,Personalized Model,Topic
1928,Treatment Options,Topic
1928,Network Meta-Analysis (Nma),Topic
1928,Relapsing-Remitting Multiple Sclerosis,Topic
1928,Natalizumab,Topic
1928,Dimethyl Fumarate,Topic
1928,Glatiramer Acetate,Topic
1928,Placebo,Topic
1928,Konstantina Chalkou,Author
1928,Andrew J. Vickers,Author
1928,Fabio Pellegrini,Author
1928,Andrea Manca,Author
1928,Georgia Salanti,Author
1929,Traumatic Brain Injury,Topic
1929,Neuroimaging Biomarker Of Extracellular Free Water Content,Topic
1929,Chronic Neurological Complications,Topic
1929,Long-Term Disability,Topic
1929,Neuroinflammation,Topic
1929,Neurodegeneration,Topic
1929,Biomarkers,Topic
1929,Clinical Trials Of Neuroprotective Therapies,Topic
1929,64 Adult Patients,Paper
1930,Large Medical Imaging Data Sets,Topic
1930,Sample Quality,Topic
1930,Artefacts,Topic
1930,Machine Learning Models,Topic
1930,Framework,Topic
1930,Artefact Generators,Topic
1930,Brain Mri Scans,Topic
1930,Training Dataset,Topic
1930,Abstract And Engineered Features,Topic
1930,Feature Selection Process,Topic
1930,Svm Classifiers,Topic
1930,Synthetic Brain Mri Scans,Topic
1930,Data Augmentation,Topic
1930,Multiple Sclerosis Clinical Trial,Topic
1930,Daniele Ravi,Author
1930,Frederik Barkhof,Author
1930,Daniel C. Alexander,Author
1930,Lemuel Puglisi,Author
1930,Geoffrey Jm Parker,Author
1930,Arman Eshaghi,Author
1931,Quantitative Decision-Making Principles,Topic
1931,Clinical Drug Development,Topic
1931,Qdm Methods,Topic
1931,Study Level,Topic
1931,Project Level,Topic
1931,Portfolio Level,Topic
1931,Special Interest Group On Qdm,Topic
1931,Juan J. Abellan,Author
1931,Nicolas Bonnet,Author
1931,Alex Carlton,Author
1931,Paul Frewer,Author
1931,Heiko Gˆtte,Author
1931,John-Philip Lawo,Author
1931,Jesper Madsen,Author
1931,Oliver Sailer,Author
1931,Guido Thˆmmes,Author
1931,GaÎlle Saint-Hilary,Author
1932,Thorium-227-Based Alpha-Particle Radiopharmaceutical Therapies,Topic
1932,Thorium-227,Topic
1932,Radium-223,Topic
1932,Spect,Topic
1932,Multiple-Energy-Window Projection-Domain Quantification (Mew-Pdq) Method,Topic
1932,Zekun Li,Author
1932,Nadia Benabdallah,Author
1932,Richard Laforest,Author
1932,Richard L. Wahl,Author
1932,Daniel L. J. Thorek,Author
1932,Abhinav K. Jha,Author
1932,Prostate Cancer,Topic
1932,Bone Metastases,Topic
1933,Flash Or Ultra-High Dose Rate (Uhdr) Radiation Therapy,Topic
1933,Conventional Dose Rate (Cdr) Rt,Topic
1933,Electron Flash Units,Topic
1933,Allison Palmiero,Author
1933,Kevin Liu,Author
1933,Julie Colnot,Author
1933,Nitish Chopra,Author
1933,Denae Neill,Author
1933,Luke Connell,Author
1933,Brett Velasquez,Author
1933,Albert C. Koong,Author
1933,Steven H. Lin,Author
1933,Peter Balter,Author
1933,Ramesh Tailor,Author
1933,Charlotte Robert,Author
1933,Jean-FranÁois Germond,Author
1933,Patrik GonÁalves Jorge,Author
1933,Reiner Geyer,Author
1933,Sam Beddar,Author
1933,Raphael Moeckli,Author
1933,Emil Sch¸ler,Author
1934,Abdomenatlas,Topic
1934,Wenxuan Li,Author
1934,Chongyu Qu,Author
1934,Xiaoxi Chen,Author
1934,Pedro R. A. S. Bassi,Author
1934,Yijia Shi,Author
1934,Yuxiang Lai,Author
1934,Qian Yu,Author
1934,Huimin Xue,Author
1934,Yixiong Chen,Author
1934,Xiaorui Lin,Author
1934,Yutong Tang,Author
1934,Yining Cao,Author
1934,Haoqi Han,Author
1934,Zheyuan Zhang,Author
1934,Jiawei Liu,Author
1934,Tiezheng Zhang,Author
1934,Yujiu Ma,Author
1934,Jincheng Wang,Author
1934,Guang Zhang,Author
1934,Alan Yuille,Author
1934,Zongwei Zhou,Author
1935,Large Language Models,Topic
1935,Healthcare,Topic
1935,Clinical Documentation,Topic
1935,Clinical Trials,Topic
1935,Medical Questions,Topic
1935,Actionable Guideline,Topic
1935,Best Practices,Topic
1935,Prompt Engineering,Topic
1935,Fine-Tuning,Topic
1935,Deployment,Topic
1935,Regulatory Compliance,Topic
1935,Ethical Guidelines,Topic
1935,Continuous Monitoring,Topic
1935,Demystifying Large Language Models For Medicine: A Primer,Paper
1935,Qiao Jin,Author
1935,Nicholas Wan,Author
1935,Robert Leaman,Author
1935,Shubo Tian,Author
1935,Zhizheng Wang,Author
1935,Yifan Yang,Author
1935,Zifeng Wang,Author
1935,Guangzhi Xiong,Author
1935,Po-Ting Lai,Author
1935,Qingqing Zhu,Author
1935,Benjamin Hou,Author
1935,Maame Sarfo-Gyamfi,Author
1935,Gongbo Zhang,Author
1935,Aidan Gilson,Author
1935,Balu Bhasuran,Author
1935,Zhe He,Author
1935,Aidong Zhang,Author
1935,Jimeng Sun,Author
1935,Chunhua Weng,Author
1935,Ronald M. Summers,Author
1935,Qingyu Chen,Author
1935,Yifan Peng,Author
1935,Zhiyong Lu,Author
1936,Cognitive Neuroscience,Topic
1936,Population Neuroscience,Topic
1936,"A Paradigm Shift In Neuroscience Driven By Big Data: State Of Art, Challenges, And Proof Of Concept",Paper
1936,Zi-Xuan Zhou,Author
1936,Xi-Nian Zuo,Author
1937,Computer Systems,Topic
1937,Computer Security,Topic
1937,Human Immune System,Topic
1937,Danger Theory,Topic
1937,Artificial Immune Systems,Topic
1937,Intrusion Detection Systems,Topic
1937,Julie Greensmith,Author
1937,Uwe Aickelin,Author
1937,Jamie Twycross,Author
1937,Detecting Danger: Applying A Novel Immunological Concept To Intrusion Detection Systems,Paper
1938,Gompertz Law Of Dependence Of Human Mortality Rate On Age,Topic
1938,B. I. Shklovskii,Author
1938,Model Of Death As A Result Of The Exponentially Rare Escape Of Abnormal Cells From Immunological Response,Topic
1938,Simple Derivation Of The Gompertz Law For Human Mortality,Topic
1939,An Immune System Inspired Approach To Automated Program Verification,Paper
1939,Artificial Immune System (Ais),Topic
1939,Automated Program Verification,Topic
1939,Program Invariants,Topic
1939,Benchmark Programs,Topic
1940,Immune Surveillance,Topic
1940,Pathogen,Topic
1940,N,Topic
1940,Biological Parameters,Topic
1940,Partial Order,Topic
1940,Immune Regulation,Topic
1940,Asymptotically Stable Fixed Point,Topic
1940,Host Response,Topic
1940,Edgar Delgado-Eckert,Author
1940,Michael Shapiro,Author
1941,"Additive, Multiplicative, And Odd Ratio Neutral Models",Topic
1941,Jorge Fernandez-De-Cossio,Author
1941,Jorge Fernandez-De-Cossio-Diaz,Author
1941,Toshifumi Takao,Author
1941,Yasser Perera,Author
1942,Tumour-Infiltrating Lymphocytes (Tils),Topic
1942,Triple-Negative Breast Cancer (Bc),Topic
1942,Computational Til Assessment (Cta),Topic
1942,Ectil,Topic
1942,Yoni Schirris,Author
1942,Rosie Voorthuis,Author
1942,Mark Opdam,Author
1942,Marte Liefaard,Author
1942,Gabe S Sonke,Author
1942,Gwen Dackus,Author
1942,Vincent De Jong,Author
1942,Yuwei Wang,Author
1942,Annelot Van Rossum,Author
1942,Tessa G Steenbruggen,Author
1942,Lars C Steggink,Author
1942,Liesbeth G. E. De Vries,Author
1942,Marc Van De Vijver,Author
1942,Roberto Salgado,Author
1942,Efstratios Gavves,Author
1942,Paul J Van Diest,Author
1942,Sabine C Linn,Author
1942,Jonas Teuwen,Author
1942,Renee Menezes,Author
1942,Marleen Kok,Author
1942,Hugo Horlings,Author
1943,Prostate Biopsies,Topic
1943,Artificial Intelligence,Topic
1943,Sthlm3 Diagnostic Study,Topic
1943,Peter Strˆm,Author
1943,Kimmo Kartasalo,Author
1943,Henrik Olsson,Author
1943,Leslie Solorzano,Author
1943,Brett Delahunt,Author
1943,Daniel M. Berney,Author
1943,David G. Bostwick,Author
1943,Andrew J. Evans,Author
1943,David J. Grignon,Author
1943,Peter A. Humphrey,Author
1943,Kenneth A. Iczkowski,Author
1943,James G. Kench,Author
1943,Glen Kristiansen,Author
1943,Theodorus H. Van Der Kwast,Author
1943,Katia R. M. Leite,Author
1943,Jesse K. Mckenney,Author
1943,Jon Oxley,Author
1943,Chin-Chen Pan,Author
1943,Hemamali Samaratunga,Author
1943,John R. Srigley,Author
1943,Hiroyuki Takahashi,Author
1943,Toyonori Tsuzuki,Author
1943,Murali Varma,Author
1943,Ming Zhou,Author
1943,Johan Lindberg,Author
1943,Cecilia Bergstrˆm,Author
1943,Pekka Ruusuvuori,Author
1943,Carolina W‰hlby,Author
1943,Henrik Grˆnberg,Author
1943,Mattias Rantalainen,Author
1943,Lars Egevad,Author
1943,Martin Eklund,Author
1944,Vision,Topic
1944,Support Surface Translation Study,Paper
1944,Low-Frequency Range,Topic
1944,Mid-Frequency Range,Topic
1944,High-Frequency Range,Topic
1944,Single Inverted Pendulum Model,Topic
1944,Double Inverted Pendulum Model,Topic
1944,Eyes Closed Condition,Topic
1944,Stroboscopic Illumination Condition,Topic
1944,Eyes Open Continuous Illumination Condition,Topic
1945,Recurrent Neural Networks,Topic
1945,Time-Series Data,Topic
1945,Machine Learning Community,Topic
1945,Neuroscience Community,Topic
1945,Switching Linear Dynamical System,Topic
1945,First-Order Taylor Series Expansion,Topic
1945,Auxiliary Function,Topic
1945,Synthetic Tasks,Topic
1945,Lfads,Topic
1945,Jimmy T. H. Smith,Author
1945,Scott W. Linderman,Author
1945,David Sussillo,Author
1946,Multi-Modal Gaussian Process Variational Autoencoders For Neural And Behavioral Data,Paper
1946,Rabia Gondur,Author
1946,Usama Bin Sikandar,Author
1946,Evan Schaffer,Author
1946,Mikio Christian Aoi,Author
1946,Stephen L Keeley,Author
1946,Gaussian Process Factor Analysis,Topic
1946,Gaussian Process Variational Autoencoders,Topic
1946,Drosophila Whole-Brain Calcium Imaging,Topic
1946,Manduca Sexta Spike Train Measurements,Topic
1946,Poisson Spike Counts,Topic
1946,Mnist Images,Topic
1947,Pressure Ulcers,Topic
1947,Tongue Display Unit-Tdu,Topic
1947,Spinal Cord Injuries,Topic
1947,A. Moreau-Gaudry,Author
1947,O. Chenu,Author
1947,M. Dang,Author
1947,J. L. Bosson,Author
1947,M. Hommel,Author
1947,J. Demongeot,Author
1947,F. Cannard,Author
1947,B. Diot,Author
1947,A. Prince,Author
1947,C. Hughes,Author
1947,Nicolas Vuillerme,Author
1947,Yohan Payan,Author
1947,Reduction Of Prolonged Excessive Pressure In Seated Persons With Paraplegia Using Wireless Lingual Tactile Feedback: A Randomized Controlled Trial,Paper
1948,Precision Medicine,Topic
1948,Individualized Treatment Regime (Itr),Topic
1948,Crossover Study Design,Topic
1948,Estimating Individualized Treatment Regimes From Crossover Designs,Paper
1949,Concentration Of Benefit Index,Topic
1949,Mohsen Sadatsafavi,Author
1949,Mohammad Ali Mansournia,Author
1949,Paul Gustafson,Author
1950,Drug Development Programs,Topic
1950,Early Stage Clinical Trials,Topic
1950,Expert Judgements,Topic
1950,Sheffield Elicitation Framework (Shelf),Topic
1950,Asthma Drug,Topic
1950,Bjˆrn Holzhauer,Author
1950,Lisa V. Hampson,Author
1950,John Paul Gosling,Author
1950,Bjˆrn Bornkamp,Author
1950,Joseph Kahn,Author
1950,Markus R. Lange,Author
1950,Wen-Lin Luo,Author
1950,Caterina Brindicci,Author
1950,David Lawrence,Author
1950,Steffen Ballerstedt,Author
1950,Anthony O'Hagan,Author
1951,Large Language Models,Topic
1951,Radiation Oncology Physics,Topic
1951,Mayo Clinic,Topic
1951,Chatgpt (Gpt-3.5),Author
1951,Chatgpt (Gpt-4),Author
1951,Bard (Lamda),Author
1951,Bloomz,Author
1951,Jason Holmes,Author
1951,Zhengliang Liu,Author
1951,Lian Zhang,Author
1951,Yuzhen Ding,Author
1951,Terence T. Sio,Author
1951,Lisa A. Mcgee,Author
1951,Jonathan B. Ashman,Author
1951,Xiang Li,Author
1951,Tianming Liu,Author
1951,Jiajian Shen,Author
1951,Wei Liu,Author
1952,Adaptive Resistance To Genetic-Based Targeted Therapies,Topic
1952,Solid Malignancies,Topic
1952,Braf-Mutated Melanoma,Topic
1952,Braf Inhibition,Topic
1952,Single-Cell Proteomic Level,Topic
1952,Co-Targeted Hub/Pathways,Topic
1952,Hur,Topic
1952,Perk,Topic
1952,Egfr,Topic
1952,Aurore Bugi-Marteyn,Author
1952,Fanny Noulet,Author
1952,Nicolas Liaudet,Author
1952,Rastine Merat,Author
1952,Mutual Information (Mi),Topic
1952,Immunohistochemistry (Ihc),Topic
1952,Xenograft Models,Topic
1952,Clinical Trials,Topic
1953,Cluster Randomized Trials,Topic
1953,Causal Effects,Topic
1953,Estimators,Topic
1953,Tmle,Topic
1953,Preterm Birth Initiative,Topic
1953,Alejandra Benitez,Author
1953,Maya L. Petersen,Author
1953,Mark J. Van Der Laan,Author
1953,Nicole Santos,Author
1953,Elizabeth Butrick,Author
1953,Dilys Walker,Author
1953,Rakesh Ghosh,Author
1953,Phelgona Otieno,Author
1953,Peter Waiswa,Author
1953,Laura B. Balzer,Author
1954,Cost-Effectiveness Analysis For Therapy Sequence In Advanced Cancer: A Microsimulation Approach With Application To Metastatic Prostate Cancer,Paper
1954,Elizabeth A. Handorf,Author
1954,J. Robert Beck,Author
1954,Andres Correa,Author
1954,Chethan Ramamurthy,Author
1954,Daniel M. Geynisman,Author
1954,Metastatic Prostate Cancer,Topic
1954,Microsimulation Framework,Topic
1954,Discrete-Time State Transition Model,Topic
1954,Docetaxel,Topic
1954,Abiraterone Acetate,Topic
1954,Quality-Adjusted Life Years,Topic
1954,Incremental Cost Effectiveness Ratio,Topic
1955,Diagnostic Errors In Radiology,Topic
1955,Radiologists,Topic
1955,Eye-Tracking Technology,Topic
1955,Suspicious Pulmonary Nodules,Topic
1955,Automated Feedback-Driven Educational Framework,Topic
1955,Carolina Ramirez-Tamayo,Author
1955,Syed Hasib Akhter Faruqui,Author
1955,Stanford Martinez,Author
1955,Angel Brisco,Author
1955,Nicholas Czarnek,Author
1955,Adel Alaeddini,Author
1955,Jeffrey R. Mock,Author
1955,Edward J. Golob,Author
1955,Kal L. Clark,Author
1956,"Item-Level Heterogeneous Treatment Effects Of Selective Serotonin Reuptake Inhibitors (Ssris) On Depression: Implications For Inference, Generalizability, And Identification",Paper
1956,Item Response Theory (Irt),Topic
1956,Selective Serotonin Reuptake Inhibitors (Ssris),Topic
1956,Depression,Topic
1956,Monte Carlo Simulation,Topic
1956,17-Item Hamilton Depression Rating Scale (Hdrs-17),Topic
1956,Hdrs-6,Topic
1957,Alzheimer'S Disease,Topic
1957,Cognitive Decline,Topic
1957,Predictive Models,Topic
1957,Cognitive Test Scores,Topic
1957,Hiroyuki Sato,Author
1957,Keisuke Suzuki,Author
1957,Atsushi Hashizume,Author
1957,Ryoichi Hanazawa,Author
1957,Masanao Sasaki,Author
1957,Akihiro Hirakawa,Author
1957,Japanese Alzheimer'S Disease Neuroimaging Initiative,Author
1957,Alzheimer'S Disease Neuroimaging Initiative,Author
1957,Longitudinal Disease Progression,Topic
1957,Randomized Controlled Trial Design,Topic
1958,Hyperpolarized 13C Mri,Topic
1958,Data Format Standardization And Dicom Integration For Hyperpolarized 13C Mri,Paper
1959,Octcube-M,Topic
1959,Octcube,Topic
1959,Coep,Topic
1959,Octcube-Ir,Topic
1959,Octcube-Ef,Topic
1959,Zixuan Liu,Author
1959,Hanwen Xu,Author
1959,Addie Woicik,Author
1959,Linda G. Shapiro,Author
1959,Marian Blazes,Author
1959,Yue Wu,Author
1959,Verena Steffen,Author
1959,Catherine Cukras,Author
1959,Cecilia S. Lee,Author
1959,Miao Zhang,Author
1959,Aaron Y. Lee,Author
1959,Sheng Wang,Author
1960,Artificial Immune Systems,Topic
1960,Biological Immune Functions,Topic
1960,Robotic Applications,Topic
1960,Ais-Based Robotic Applications,Topic
1960,Antigen,Topic
1960,Co-Stimulatory Signal,Topic
1960,Immune Functions,Topic
1960,Evolved Antibodies,Topic
1960,Maturity Of Dendritic Cells,Topic
1960,Actuation Signals,Topic
1960,Immuno-Inspired Robotic Applications,Paper
1960,Ali Raza,Author
1960,Benito R. Fernandez,Author
1960,Innate Immunity,Topic
1960,Robot Embodiment,Topic
1960,Modern Trends,Topic
1961,Immunological Self/Not-Self Discrimination,Topic
1961,T Cells,Topic
1961,Major Histocompatibility Complex Proteins,Topic
1961,Pmhcs,Topic
1961,Donald R. Forsdyke,Author
1961,Lymphocyte Repertoire Selection,Topic
1961,Intracellular Self/Not-Self Discrimination,Topic
1961,Pyrexia,Topic
1961,Female Susceptibility To Autoimmune Disease,Topic
1962,Muscular Dystrophy,Topic
1962,Mathematical Models Of Md,Topic
1962,Amanda N. Cameron,Author
1962,Matthew T. Houston,Author
1962,Juan B. Gutierrez,Author
1962,Systems Biology Approach,Topic
1963,Immunological Systems,Topic
1963,Computer Scientists,Topic
1963,Immune Memory,Topic
1963,Vaccines,Topic
1963,Antigenic Mutation,Topic
1963,Alexandre De Castro,Author
1963,Carlos Frederico Fronza,Author
1963,Domingos Alves,Author
1963,"Monroy, Saab, Godinez, 2004",Paper
1963,"Lundegaard, Lund, Kesmir, Brunak, Nielsen, 2007",Paper
1964,The Human Body,Topic
1964,Immune System,Topic
1964,Immunology,Topic
1964,Computer Network Security,Topic
1964,New Network Security Model,Topic
1964,Lans,Topic
1964,Datalink Layer,Topic
1964,Foreign Frames,Topic
1964,Almotasem Bellah Alajlouni,Author
1964,Exploring The Potential Of The Innate Immune System For Computers Network Security,Paper
1965,Adaptive Immune System,Topic
1965,Antigens,Topic
1965,Antigen-Binding Antibodies,Topic
1965,T-Cell Receptors,Topic
1965,Immune Repertoire,Topic
1965,Disease,Topic
1965,Infection,Topic
1965,Autoimmunity,Topic
1965,Cancer,Topic
1965,Hiv,Topic
1965,Adaptive Immune Receptor Repertoire Sequencing (Airr-Seq),Topic
1965,Immune Receptor Sequence Landscape,Topic
1965,Computational And Statistical Analysis,Topic
1965,Large-Scale Airr-Seq Data,Topic
1965,Adaptive Immunity,Topic
1965,Diversity,Topic
1965,Clustering And Network,Topic
1965,Phylogenetic Methods,Topic
1965,Machine Learning Methods,Topic
1965,Computational Immunology,Topic
1965,Systems Immunology,Topic
1965,Immunotherapeutics,Topic
1965,Vaccines,Topic
1965,Immunodiagnostics,Topic
1965,Enkelejda Miho,Author
1965,Alexander Yermanos,Author
1965,CÈdric R. Weber,Author
1965,Christoph T. Berger,Author
1965,Sai T. Reddy,Author
1965,Victor Greiff,Author
1966,Clonal Selection Principle,Topic
1966,Adaptive Immune Response,Topic
1966,Affinity Maturation,Topic
1966,Immunological Memory Cells,Topic
1966,Coronary Heart Disease Database,Topic
1966,Takumi Ichimura,Author
1966,Shin Kamada,Author
1966,Computational Implementation Of Clonal Selection Principle,Paper
1967,Dengue Virus,Topic
1967,Dengue Hemorrhagic Fever (Dhf),Topic
1967,Cross-Reactive Antibodies,Topic
1967,Multi-Scale Modeling Approach,Topic
1967,Within-Host Model,Topic
1967,Epidemiological Spread,Topic
1967,Vector-Host Partial Differential Equation Model,Topic
1967,Primary Infection,Topic
1967,Secondary Infections,Topic
1967,Immunological Variables,Topic
1967,Hayriye Gulbudak,Author
1967,Cameron J. Browne,Author
1968,Computational And Systems Biology Advances To Enable Bioagent-Agnostic Signatures,Paper
1968,Andy Lin,Author
1968,Cameron Torres,Author
1968,Errett C. Hobbs,Author
1968,Jaydeep Bardhan,Author
1968,Stephen B. Aley,Author
1968,Charles T. Spencer,Author
1968,Karen L. Taylor,Author
1968,Tony Chiang,Author
1969,Cognitive Tasks,Topic
1969,Interference,Topic
1969,Visual Working Memory Tasks,Topic
1969,Probabilistic Inference Model,Topic
1969,Recurrent Network,Topic
1969,Zachary P Kilpatrick,Author
1970,Generalizability Analyses With A Partially Nested Trial Design,Topic
1970,Necrotizing Enterocolitis Surgery Trial,Paper
1970,Partially Nested Trial Design,Topic
1970,Randomized Individuals,Topic
1970,Non-Randomized Individuals,Topic
1971,Trial Engagement Effects,Topic
1971,Randomized Trial,Topic
1971,Generalizability,Topic
1971,Transportability,Topic
1971,Average Treatment Effects,Topic
1971,Lawson Ung,Author
1971,Tyler J. Vanderweele,Author
1971,Issa J. Dahabreh,Author
1972,Radiomics,Topic
1972,Automated Machine Learning,Topic
1972,Clinical Applications,Topic
1972,Liposarcoma,Topic
1972,Desmoid-Type Fibromatosis,Topic
1972,Primary Liver Tumors,Topic
1972,Gastrointestinal Stromal Tumors,Topic
1972,Colorectal Liver Metastases,Topic
1972,Melanoma Metastases,Topic
1972,Hepatocellular Carcinoma,Topic
1972,Mesenteric Fibrosis,Topic
1972,Prostate Cancer,Topic
1972,Glioma,Topic
1972,Alzheimer'S Disease,Topic
1972,Head And Neck Cancer,Topic
1972,Framework,Topic
1972,Authors,Author
1973,The Alzheimer'S Disease Prediction Of Longitudinal Evolution Challenge,Topic
1973,Alzheimer'S Disease,Topic
1973,Razvan V. Marinescu,Author
1973,Neil P. Oxtoby,Author
1973,Alexandra L. Young,Author
1973,Esther E. Bron,Author
1973,Arthur W. Toga,Author
1973,Michael W. Weiner,Author
1973,Frederik Barkhof,Author
1973,Nick C. Fox,Author
1973,Arman Eshaghi,Author
1973,Tina Toni,Author
1973,Marcin Salaterski,Author
1973,Veronika Lunina,Author
1973,Manon Ansart,Author
1973,Stanley Durrleman,Author
1973,Pascal Lu,Author
1973,Samuel Iddi,Author
1973,Dan Li,Author
1973,Wesley K. Thompson,Author
1973,Michael C. Donohue,Author
1973,Aviv Nahon,Author
1973,Yarden Levy,Author
1973,Dan Halbersberg,Author
1973,Mariya Cohen,Author
1973,Huiling Liao,Author
1973,Tengfei Li,Author
1973,Kaixian Yu,Author
1973,Hongtu Zhu,Author
1973,Jose G. Tamez-Pena,Author
1973,Aya Ismail,Author
1973,Timothy Wood,Author
1973,Hector Corrada Bravo,Author
1973,Minh Nguyen,Author
1973,Nanbo Sun,Author
1973,Jiashi Feng,Author
1973,B. T. Thomas Yeo,Author
1973,Gang Chen,Author
1973,Ke Qi,Author
1973,Shiyang Chen,Author
1973,Deqiang Qiu,Author
1973,Ionut Buciuman,Author
1973,Alex Kelner,Author
1973,Raluca Pop,Author
1973,Denisa Rimocea,Author
1973,Mostafa M. Ghazi,Author
1973,Mads Nielsen,Author
1973,Sebastien Ourselin,Author
1973,Lauge Sorensen,Author
1973,Vikram Venkatraghavan,Author
1973,Keli Liu,Author
1973,Christina Rabe,Author
1973,Paul Manser,Author
1973,Steven M. Hill,Author
1973,James Howlett,Author
1973,Zhiyue Huang,Author
1973,Steven Kiddle,Author
1973,Sach Mukherjee,Author
1973,Anais Rouanet,Author
1973,Bernd Taschler,Author
1973,Brian D. M. Tom,Author
1973,Simon R. White,Author
1973,Noel Faux,Author
1973,Suman Sedai,Author
1973,Javier De Velasco Oriol,Author
1973,Edgar E. V. Clemente,Author
1973,Karol Estrada,Author
1973,Leon Aksman,Author
1973,Andre Altmann,Author
1973,Cynthia M. Stonnington,Author
1973,Yalin Wang,Author
1973,Jianfeng Wu,Author
1973,Vivek Devadas,Author
1973,Clementine Fourrier,Author
1973,Lars Lau Raket,Author
1973,Aristeidis Sotiras,Author
1973,Guray Erus,Author
1973,Jimit Doshi,Author
1973,Christos Davatzikos,Author
1973,Jacob Vogel,Author
1973,Andrew Doyle,Author
1973,Angela Tam,Author
1973,Alex Diaz-Papkovich,Author
1973,Emmanuel Jammeh,Author
1973,Igor Koval,Author
1973,Paul Moore,Author
1973,Terry J. Lyons,Author
1973,John Gallacher,Author
1973,Jussi Tohka,Author
1973,Robert Ciszek,Author
1973,Bruno Jedynak,Author
1973,Kruti Pandya,Author
1973,Murat Bilgel,Author
1973,William Engels,Author
1973,Joseph Cole,Author
1973,Polina Golland,Author
1973,Stefan Klein,Author
1973,Daniel C. Alexander,Author
1974,Radiotherapy For Head And Neck Cancer,Topic
1974,Dysphagia,Topic
1974,Pharyngeal Mucosa,Topic
1974,Jamie A. Dean,Author
1974,Liam C. Welsh,Author
1974,Kevin J. Harrington,Author
1974,Christopher M. Nutting,Author
1974,Sarah L. Gulliford,Author
1974,3D Dose Distributions,Topic
1974,Predictive Modelling,Topic
1974,Support Vector Classification Model,Topic
1974,Dicom Data,Topic
1974,Numpy,Topic
1974,Scipy,Topic
1974,Pandas,Topic
1974,Scikit-Learn,Topic
1974,Matplotlib,Topic
1974,Mayavi,Topic
1975,Monte Carlo-Based Biological Dose Optimization,Topic
1975,H. Wan Chan Tseung,Author
1975,J. Ma,Author
1975,C. R. Kreofsky,Author
1975,D. Ma,Author
1975,C. Beltran,Author
1976,Artemisinin Resistance,Topic
1976,Malaria,Topic
1976,Artemisinin-Based Drugs,Topic
1976,Dihydroartemisinin (Dha),Topic
1976,Plasmodium Falciparum,Topic
1976,Pengxing Cao,Author
1976,Nectarios Klonis,Author
1976,Sophie Zaloumis,Author
1976,Con Dogovski,Author
1976,Stanley C. Xie,Author
1976,Sompob Saralamba,Author
1976,Lisa J. White,Author
1976,Freya J. I. Fowkes,Author
1976,Leann Tilley,Author
1976,Julie A. Simpson,Author
1976,James M. Mccaw,Author
1977,Gynaecologists And Obstetricians,Topic
1977,Cardiotocography (Ctg),Topic
1977,International Federation Of Gynaecology And Obstetrics (Figo),Topic
1977,Positive Predictive Value,Topic
1977,Machine Learning Models,Topic
1977,Synthetic Data,Topic
1977,One Dimensional Convolutional Neural Network (1Dcnn),Topic
1977,Multilayer Perceptron (Mlp) Ensemble,Topic
1977,Modelling Segmented Cardiotocography Time-Series Signals Using One-Dimensional Convolutional Neural Networks For The Early Detection Of Abnormal Birth Outcomes,Paper
1978,Network Medicine Framework For Identifying Drug Repurposing Opportunities For Covid-19,Paper
1978,Deisy Morselli Gysi,Author
1978,Õtalo Do Valle,Author
1978,Marinka Zitnik,Author
1978,Asher Ameli,Author
1978,Xiao Gan,Author
1978,Onur Varol,Author
1978,Susan Dina Ghiassian,Author
1978,Jj Patten,Author
1978,Robert Davey,Author
1978,Joseph Loscalzo,Author
1978,Albert-L·szlÛ Barab·si,Author
1979,Multivariable Prediction Models,Topic
1979,Optimism Corrections,Topic
1979,Prediction Accuracy Measures,Topic
1979,Bootstrap-Based Correction Methods,Topic
1979,Delong'S Confidence Interval,Topic
1979,C-Statistic,Topic
1979,Location-Shifted Bootstrap Confidence Intervals,Topic
1979,Two-Stage Bootstrap Confidence Intervals,Topic
1979,Harrell'S Bias Correction,Topic
1979,0.632 Method,Topic
1979,0.632+ Method,Topic
1979,Ridge Regression,Topic
1979,Lasso Regression,Topic
1979,R Package Predboot,Topic
1979,Gusto-I Clinical Trial,Topic
1979,Hisashi Noma,Author
1979,Tomohiro Shinozaki,Author
1979,Katsuhiro Iba,Author
1979,Satoshi Teramukai,Author
1979,Toshi A. Furukawa,Author
1980,Cox Proportional Hazards (Coxph) Models,Topic
1980,Hazard Ratio (Hr),Topic
1980,Tree-Based Machine Learning (Ml) Models,Topic
1980,Shapley Additive Explanation (Shap) Values,Topic
1980,Xgboost,Topic
1980,Survival Data,Topic
1980,Sameer Sundrani,Author
1980,James Lu,Author
1980,Colon Cancer Data Set,Topic
1980,Breast Cancer Data Set,Topic
1980,Pan-Cancer Dataset,Topic
1980,Kaplan-Meier Plots,Topic
1980,Open-Source Libraries In Python And R,Topic
1981,Coronary Computed Tomography Angiography (Ccta),Topic
1981,Emergency Department (Ed),Topic
1981,Artificial Intelligence (Ai) Algorithm,Topic
1981,Phase 1,Topic
1981,Phase 2,Topic
1981,Area Under The Receiver-Operating-Characteristic Curve (Auc-Roc),Topic
1981,Richard D. White,Author
1981,Barbaros S. Erdal,Author
1981,Mutlu Demirer,Author
1981,Vikash Gupta,Author
1981,Matthew T. Bigelow,Author
1981,Engin Dikici,Author
1981,Sema Candemir,Author
1981,Mauricio S. Galizia,Author
1981,Jessica L. Carpenter,Author
1981,Thomas P. O Donnell,Author
1981,Abdul H. Halabi,Author
1981,Luciano M. Prevedello,Author
1982,A Randomized Trial,Topic
1982,Intercurrent Events,Topic
1982,Principal Stratum Strategy,Topic
1982,Bjˆrn Bornkamp,Author
1982,Kaspar Rufibach,Author
1982,Jianchang Lin,Author
1982,Yi Liu,Author
1982,Devan V. Mehrotra,Author
1982,Satrajit Roychoudhury,Author
1982,Heinz Schmidli,Author
1982,Yue Shentu,Author
1982,Marcel Wolbers,Author
1983,Drug Repurposing For Covid-19 Via Knowledge Graph Completion,Paper
1983,Rui Zhang,Author
1983,Dimitar Hristovski,Author
1983,Dalton Schutte,Author
1983,Andrej Kastrin,Author
1983,Marcelo Fiszman,Author
1983,Halil Kilicoglu,Author
1983,Pubmed,Topic
1983,Covid-19,Topic
1983,Bert,Topic
1983,Transe,Topic
1983,Paclitaxel,Topic
1983,Sb 203580,Topic
1983,Alpha 2-Antiplasmin,Topic
1983,Pyrrolidine Dithiocarbamate,Topic
1983,Butylated Hydroxytoluene,Topic
1984,Machine Learning For Real-World Evidence Analysis Of Covid-19 Pharmacotherapy,Paper
1984,Covid-19,Topic
1984,Real-World Evidence,Topic
1984,Machine Learning,Topic
1984,Valencian Region,Topic
1984,Remdesivir,Topic
1984,Tocilizumab,Topic
1984,Corticosteroids,Topic
1984,Lopinavir-Ritonavir,Topic
1984,Azithromycin,Topic
1984,Chloroquine/Hydroxychloroquine,Topic
1985,Fast Image Search For Histopathology (Fish),Topic
1985,Chengkuan Chen,Author
1985,Ming Y. Lu,Author
1985,Drew F. K. Williamson,Author
1985,Tiffany Y. Chen,Author
1985,Andrew J. Schaumberg,Author
1985,Faisal Mahmood,Author
1986,Systemic Lupus Erythematosus,Topic
1986,Lupus Nephritis,Topic
1986,Electronic Health Records,Topic
1986,Vanderbilt University Medical Center,Topic
1986,Yu Deng,Author
1986,Jennifer A. Pacheco,Author
1986,Anh Chung,Author
1986,Chengsheng Mao,Author
1986,Joshua C. Smith,Author
1986,Juan Zhao,Author
1986,Wei-Qi Wei,Author
1986,April Barnado,Author
1986,Chunhua Weng,Author
1986,Cong Liu,Author
1986,Adam Cordon,Author
1986,Jingzhi Yu,Author
1986,Yacob Tedla,Author
1986,Abel Kho,Author
1986,Rosalind Ramsey-Goldman,Author
1986,Theresa Walunas,Author
1986,Yuan Luo,Author
1987,Reproduction Of Pre-Clinical Results,Topic
1987,Medical Sciences,Topic
1987,Plant Sciences,Topic
1987,Protocols,Topic
1987,Jeremy S. C. Clark,Author
1987,Anna Salacka,Author
1987,Agnieszka Boron,Author
1987,Thierry Van De Wetering,Author
1987,Konrad Podsiadlo,Author
1987,Kamila Rydzewska,Author
1987,Krzysztof Safranow,Author
1987,Kazimierz Ciechanowski,Author
1987,Leszek Domanski,Author
1987,Andrzej Ciechanowicz,Author
1987,2017,Topic
1987,2019,Topic
1987,Triple-Result Protocols,Topic
1987,Replication-Error Protocol,Topic
1987,Meta-Analyses,Topic
1987,Non-Replicated,Topic
1987,Global,Topic
1987,Human Studies,Topic
1987,Plant Studies,Topic
1987,Fungal Studies,Topic
1987,Phased Clinical Trials,Topic
1987,Pilot Studies,Topic
1987,Cases,Topic
1987,Reviews,Topic
1987,Technology,Topic
1987,Rare Subjects,Topic
1987,#NAME?,Topic
1987,Journal Citation Reports 2017/2019,Topic
1987,Google,Topic
1987,Replicability Crisis,Topic
1988,Observational Studies,Topic
1988,Clinical Trial,Topic
1988,Causal Inference Methods,Topic
1988,Instrumental Variable Method,Topic
1988,Heterogeneity Statistic,Topic
1988,Sodium-Glucose Co-Transporter-2 Inhibitors,Topic
1988,Dipeptidyl Peptidase-4 Inhibitors,Topic
1988,Type 2 Diabetes,Topic
1988,Laura G¸demann,Author
1988,John M. Dennis,Author
1988,Andrew P. Mcgovern,Author
1988,Lauren R. Rodgers,Author
1988,Beverley M. Shields,Author
1988,William Henley,Author
1988,Jack Bowden,Author
1989,Lung Cancer,Topic
1989,Lung Cancer Screening,Topic
1989,Low-Dose Computed Tomography,Topic
1989,Machine/Deep Learning Algorithms,Topic
1989,Deepcad-Nlm-L,Paper
1990,A Scalable Workflow To Build Machine Learning Classifiers With Clinician-In-The-Loop To Identify Patients In Specific Diseases,Paper
1990,International Classification Of Diseases (Icd),Topic
1990,Electronic Health Records (Ehrs),Topic
1990,Mimic-Iii Dataset,Topic
1990,Nlp,Topic
1990,Automl,Topic
1990,Clinician-In-The-Loop Mechanism,Topic
1990,Ovarian Cancer,Topic
1990,Lung Cancer,Topic
1990,Cancer Cachexia,Topic
1990,Lupus Nephritis,Topic
1991,Nlstt,Topic
1991,Lung Nodules,Topic
1991,Siamese Encoder,Topic
1991,Spatial-Temporal Mixer,Topic
1991,Jiansheng Fang,Author
1991,Jingwen Wang,Author
1991,Anwei Li,Author
1991,Yuguang Yan,Author
1991,Yonghe Hou,Author
1991,Chao Song,Author
1991,Hongbo Liu,Author
1991,Jiang Liu,Author
1992,Value Of Information Analysis For External Validation Of Risk Prediction Models,Paper
1992,Mohsen Sadatsafavi,Author
1992,Tae Yoon Lee,Author
1992,Laure Wynants,Author
1992,Andrew Vickers,Author
1992,Paul Gustafson,Author
1992,Expected Value Of Perfect Information (Evpi),Topic
1992,Net Benefit (Nb),Topic
1992,Myocardial Infarction,Topic
1992,Simulation Studies,Topic
1992,Clinical Trial,Topic
1992,Heart Attacks In The Us,Topic
1993,Freezing Of Gait (Fog),Topic
1993,Parkinson'S Disease,Topic
1993,Adversarial Spatio-Temporal Network (Astn),Topic
1993,Kun Hu,Author
1993,Shaohui Mei,Author
1993,Wei Wang,Author
1993,Kaylena A. Ehgoetz Martens,Author
1993,Liang Wang,Author
1993,Simon J. G. Lewis,Author
1993,David D. Feng,Author
1993,Zhiyong Wang,Author
1994,Proton Vertebral Body Sparing Craniospinal Irradiation (Vbs Csi),Topic
1994,Pediatric Patients,Topic
1994,Monte Carlo Robust Planning,Topic
1994,Magnetic Resonance (Mr) Scans,Topic
1994,Radiation Damage Quantification Method,Topic
1994,Fatty Marrow Filtration,Topic
1994,Radiation-Induced Marrow Damage,Topic
1994,Early Vertebral Marrow Damage Identification,Topic
1994,Chih-Wei Chang,Author
1994,Matt Goette,Author
1994,Nadja Kadom,Author
1994,Yinan Wang,Author
1994,Jacob Wynne,Author
1994,Tonghe Wang,Author
1994,Tian Liu,Author
1994,Natia Esiashvili,Author
1994,Jun Zhou,Author
1994,Bree R. Eaton,Author
1994,Xiaofeng Yang,Author
1995,Electronic Health Records,Topic
1995,Foresight,Paper
1995,King'S College Hospital,Topic
1995,South London And Maudsley,Topic
1995,Mimic-Iii,Topic
1995,Zeljko Kraljevic,Author
1995,Dan Bean,Author
1995,Anthony Shek,Author
1995,Rebecca Bendayan,Author
1995,Harry Hemingway,Author
1995,Joshua Au Yeung,Author
1995,Alexander Deng,Author
1995,Alfie Baston,Author
1995,Jack Ross,Author
1995,Esther Idowu,Author
1995,James T Teo,Author
1995,Richard J Dobson,Author
1996,Proton Flash Therapy,Topic
1996,Chang Gung Memorial Hospital,Topic
1996,Tung-Yuan Hsiao,Author
1996,Lu-Kai Wang,Author
1996,Tzung-Yuang Chen,Author
1996,Ching-Fang Yu,Author
1996,Pan,Author
1996,Cheng-Ya,Author
1996,Chun-Chieh Wang,Author
1996,Chien-Yu Lin,Author
1996,I-Chun Cho,Author
1996,Huan Niu,Author
1996,Chien-Hsu Chen,Author
1997,Lung Cancer,Topic
1997,National Lung Screening Trial,Topic
1997,Penalized Deep Partially Linear Cox Model,Topic
1997,Yuming Sun,Author
1997,Jian Kang,Author
1997,Chinmay Haridas,Author
1997,Nicholas R. Mayne,Author
1997,Alexandra L. Potter,Author
1997,Chi-Fu Jeffrey Yang,Author
1997,David C. Christiani,Author
1997,Yi Li,Author
1998,Causal Roadmap For Generating High-Quality Real-World Evidence,Paper
1998,Lauren E Dang,Author
1998,Susan Gruber,Author
1998,Hana Lee,Author
1998,Issa Dahabreh,Author
1998,Elizabeth A Stuart,Author
1998,Brian D Williamson,Author
1998,Richard Wyss,Author
1998,Iv·n DÌaz,Author
1998,Debashis Ghosh,Author
1998,Demissie Alemayehu,Author
1998,Katherine L Hoffman,Author
1998,Carla Y Vossen,Author
1998,Raymond A Huml,Author
1998,Henrik Ravn,Author
1998,Kajsa Kvist,Author
1998,Richard Pratley,Author
1998,Mei-Chiung Shih,Author
1998,Gene Pennello,Author
1998,David Martin,Author
1998,Salina P Waddy,Author
1998,Charles E Barr,Author
1998,Mouna Akacha,Author
1998,John B Buse,Author
1998,Mark Van Der Laan,Author
1998,Maya Petersen,Author
1999,Flash Radiotherapy,Topic
1999,Flash Beam Scintillator Monitor,Topic
1999,Daniel S. Levin,Author
1999,Peter S. Friedman,Author
1999,Claudio Ferretti,Author
1999,Nicholas Ristow,Author
1999,Monica Tecchio,Author
1999,Dale W. Litzenberg,Author
1999,Vladimir Bashkirov,Author
1999,Reinhard Schulte,Author